Citrus Sinensis ID: 004565
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 745 | 2.2.26 [Sep-21-2011] | |||||||
| O65238 | 872 | G-type lectin S-receptor- | yes | no | 0.975 | 0.833 | 0.532 | 0.0 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.907 | 0.823 | 0.371 | 1e-127 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.838 | 0.753 | 0.352 | 2e-95 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.808 | 0.727 | 0.342 | 5e-84 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.837 | 0.715 | 0.305 | 2e-83 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.816 | 0.762 | 0.308 | 9e-80 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.832 | 0.745 | 0.322 | 5e-77 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.837 | 0.763 | 0.314 | 7e-72 | |
| Q94C25 | 452 | Probable receptor-like pr | no | no | 0.405 | 0.668 | 0.422 | 9e-67 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.429 | 0.310 | 0.391 | 3e-64 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 799 bits (2063), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/766 (53%), Positives = 538/766 (70%), Gaps = 39/766 (5%)
Query: 1 MLDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLS 60
+L S V S++L ++GNL+LLD NVSLW+SFD PTD+IV GQ L++G L+ SVS +D S
Sbjct: 125 VLASPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFS 184
Query: 61 VGEYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFV 120
G+Y F+V + DG++QW YWKL M+ A DS+ PV +L+V +GL L+A +G+ V
Sbjct: 185 TGDYKFLVGESDGLMQWRGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVV 244
Query: 121 LKVSLD-AAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIGLCS---- 175
++V+L ++ FR+AK++ SG+ IVS+ G NLV E + P+++C+IPF C ++GLC+
Sbjct: 245 VRVALPPSSDFRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNA 304
Query: 176 --GGSCSCPSGFHAEL-NGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFAN 232
SCSCP + G CVP++ SLSLP C A N I+YL+LG GV YF+
Sbjct: 305 SENQSCSCPDEMRMDAGKGVCVPVSQSLSLPVSCEARN-------ISYLELGLGVSYFST 357
Query: 233 DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTL--MSSSDNERVRL 290
F PV+ G+ L C D+CS NCSCLG+F++++S SCY +++ G+L + +S +
Sbjct: 358 HFTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLI 417
Query: 291 GYIKAMVLSSDGSKKAED-ENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKV 349
GY+K + ++ + GS FPV LVL+P S + I +G LWWR R V
Sbjct: 418 GYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWR------RCAV 471
Query: 350 IKLGS-------RNSSSEELELTS--IAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYK 400
++ S R S E +L S I GLP++F +EEL AT+NF IGSGGFG+VYK
Sbjct: 472 MRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYK 531
Query: 401 GILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460
G L D++++AVKKI + G+ G++EFCTEI IIGNI H NLV+L+GFCA+GRQ LVYEYM
Sbjct: 532 GTLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYM 591
Query: 461 NKGSLDRTLF-GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519
N GSL++TLF GNG VLEW+ERF+IALGTARGLAYLH+GCD KIIHCDVKPENILLHD
Sbjct: 592 NHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHF 651
Query: 520 QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
Q KISDFGLSKLL E+SSLFTTMRGTRGYLAPEW+T++AIS+K DVYSYGMVLLE++SG
Sbjct: 652 QPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSG 711
Query: 580 RKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIE 639
RKN S + +S S +D+ N SS++ + VYFPL AL++HEQ RY+ELAD R+E
Sbjct: 712 RKNCSFRSRSNSVTEDN----NQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLE 767
Query: 640 GQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRF 699
G+V+ ++ EKLVRIALCCV EEP LRP+MA VV M EG +PLG PR+ESL FLRFYG RF
Sbjct: 768 GRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNPRMESLNFLRFYGLRF 827
Query: 700 NEASTIEESNELNLQFILQSETNGTNTTGSYNSLSYISSQQVSGPR 745
E+S +E N + + + +N+ GS S SYI+SQ+VSGPR
Sbjct: 828 AESSMVEGQNGESETMVFHRRES-SNSGGSRQSASYIASQEVSGPR 872
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-127, Method: Compositional matrix adjust.
Identities = 284/764 (37%), Positives = 429/764 (56%), Gaps = 88/764 (11%)
Query: 6 VSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYS 65
S ++L++SGNLV++ S+W+SFD PTD ++T Q + G L +S S ++++ Y+
Sbjct: 122 ASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMT---YA 178
Query: 66 FVVTDGDGVLQWNQMT---YWKLSMYSYAFKDSDAPV-----------SFLSVNRTGLYL 111
+ GD VL N +T YW ++ + D V F + L+
Sbjct: 179 LEIKSGDMVLSVNSLTPQVYWSMANARERIINKDGGVVTSSSLLGNSWRFFDQKQVLLW- 237
Query: 112 LASDGSRFVLKVSLDAAGFRIAKLEPSGRLIVSKLVGDNLVQE--LAIPVENCRIPFFCK 169
+FV + D IA L +G + S L + IP + C P C
Sbjct: 238 ------QFVFSDNKDDNTTWIAVLGNNGVISFSNLGSGASAADSSTKIPSDLCGTPEPCG 291
Query: 170 EIGLCSGGS-CSCPSGFHAELNGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVD 228
+CSG C C SG + DC + ++ P + NA+ + + G+GVD
Sbjct: 292 PYYVCSGSKVCGCVSGL-SRARSDC---KTGITSPCKKTKDNAT---LPLQLVSAGDGVD 344
Query: 229 YFANDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERV 288
YFA + P + L C++ C NCSCLG+F +SS +C F+ +++G+ +S +
Sbjct: 345 YFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFFQNSSGNC-FLFDYIGSFKTSGNGGSG 403
Query: 289 RLGYIKAMVLSSDGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAK 348
+ YIK + + G +++G FP ++++ + + ++ F+ +RI+ R K
Sbjct: 404 FVSYIK-IASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIAVLI--FVAFRIHK---RKK 457
Query: 349 VIKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSV 408
+I + SS E+ L +++G+P RF+Y++L +AT+NF+ +G GGFG+VY+G L D S
Sbjct: 458 MILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSR 517
Query: 409 VAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRT 468
+AVKK+ G QGKKEF E++IIG+IHH++LVRL+GFCA+G R L YE+++KGSL+R
Sbjct: 518 LAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERW 576
Query: 469 LF--GNGSVL-EWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525
+F +G VL +W RF IALGTA+GLAYLH CD +I+HCD+KPENILL D K+SD
Sbjct: 577 IFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSD 636
Query: 526 FGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585
FGL+KL+T EQS +FTTMRGTRGYLAPEW+T+ AIS+K+DVYSYGMVLLE+I GRKN
Sbjct: 637 FGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYD- 695
Query: 586 KIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEG-QVSD 644
PS + S++ +FP A + E+ + +++ D +++ V+D
Sbjct: 696 -----------------PSET-----SEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTD 733
Query: 645 EDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEAST 704
E V++ ++ AL C+QE+ RPSM+ VV MLEG P+ +P S R Y F
Sbjct: 734 ERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTMGSRLYSSFFKSI-- 791
Query: 705 IEESNELNLQFILQSETNGTNTT---GSYNSLSYISSQQVSGPR 745
SE G T+ NS +Y+S+ ++SGPR
Sbjct: 792 --------------SEDGGATTSSGPSDCNSENYLSAVRLSGPR 821
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 249/706 (35%), Positives = 359/706 (50%), Gaps = 81/706 (11%)
Query: 6 VSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYS 65
V+S ++++G +LL+ R+V +W SFD+PTD IV Q GK L + G YS
Sbjct: 114 VTSGSIEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQNFTAGKILRS---------GLYS 164
Query: 66 FVVT-DGDGVLQWN-QMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASD----GSRF 119
F + G+ L+WN YW + S + +P LS+ G+ + G+
Sbjct: 165 FQLERSGNLTLRWNTSAIYWNHGLNSSFSSNLSSPR--LSLQTNGVVSIFESNLLGGAEI 222
Query: 120 VLKVSL-DAAGFRIAKLEPSGRLIVSKLVGDN--LVQELAIPVENCRIPFFCKEIGLCSG 176
V D+ FR KL+ G L + N V V+ C + +C G+CS
Sbjct: 223 VYSGDYGDSNTFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAVDQCLVYGYCGNFGICSY 282
Query: 177 GS----CSCPSGFHAELNGDCVPINSSLSLPNGCS-ATNASGLNSSITYLKLGNGVDYFA 231
CSCPS N D V +N GC S + + T L L + +
Sbjct: 283 NDTNPICSCPS-----RNFDFVDVNDRR---KGCKRKVELSDCSGNTTMLDLVHTRLFTY 334
Query: 232 NDFIQPVKRGVGLSDCQDLCSWNCSCLG-IFHDDSSESCYFIENHLGTLMSSSDNERV-R 289
D G S C+ C + CL + D S +C+ + H G+ + V
Sbjct: 335 EDDPNSESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCW--QKHPGSFFTGYQWPSVPS 392
Query: 290 LGYIKA---MVLSSDGSKKAEDENGSKFP--VAGLVLIPSSLLAIAIVVGFLWWRINSKR 344
Y+K +V ++ D+N SK + + +I L +A+ +G LWW K
Sbjct: 393 TSYVKVCGPVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIG-LWWCCCRKN 451
Query: 345 ARAKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQ 404
R G+ +S LE S G P +F+Y+EL T +F +G+GGFGTVY+G+L
Sbjct: 452 PR-----FGTLSSHYTLLEYAS--GAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLT 504
Query: 405 DKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463
+++VVAVK++ GI QG+K+F E+ I + HH+NLVRL GFC+QGR R LVYE+M G
Sbjct: 505 NRTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNG 562
Query: 464 SLDRTLFGNGSV--LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQV 521
SLD LF S L W RF IALGTA+G+ YLH C I+HCD+KPENIL+ D
Sbjct: 563 SLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAA 622
Query: 522 KISDFGLSKLLTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
K+SDFGL+KLL P+ + +++RGTRGYLAPEWL + I+ K+DVYSYGMVLLE++SG+
Sbjct: 623 KVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGK 682
Query: 581 KNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRI-E 639
+N + ++ K F + A E E+ + D+R+ E
Sbjct: 683 RN--FDVSEKTNHKK---------------------FSIWAYEEFEKGNTKAILDTRLSE 719
Query: 640 GQVSD-EDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEP 684
Q D E V ++V+ + C+QE+P+ RP+M VV MLEG + P
Sbjct: 720 DQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNP 765
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (801), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 253/739 (34%), Positives = 351/739 (47%), Gaps = 137/739 (18%)
Query: 4 SRVSSMQ--LQESGNLVLLD-----ARNVSLWQSFDSPTDAIVTGQTLRV----GKS--L 50
S VS+++ LQ+ GNLVL + NV LWQSFD P D + G +R+ GKS L
Sbjct: 116 SSVSALEAVLQDDGNLVLRTGGSSLSANV-LWQSFDHPGDTWLPGVKIRLDKRTGKSQRL 174
Query: 51 AASVSENDLSVGEYSFVVTDGDGV-LQWN-QMTYWKLSMYSYAFKDSDA----------P 98
+ S D S G +S + + + WN YW ++ + D+
Sbjct: 175 TSWKSLEDPSPGLFSLELDESTAYKILWNGSNEYWSSGPWNPQSRIFDSVPEMRLNYIYN 234
Query: 99 VSFLSVNRTGLYLLAS-----DGSRFVLKVSLDAAGFRIAKLEPSGRLIVSKLVGDNLVQ 153
SF S N T Y S + SRFV+ VS F + + L S+
Sbjct: 235 FSFFS-NTTDSYFTYSIYNQLNVSRFVMDVSGQIKQFTWLEGNKAWNLFWSQ-------- 285
Query: 154 ELAIPVENCRIPFFCKEIGLCSGGS---CSCPSGFHA---------ELNGDCV------- 194
P + C++ +C G+CS S C CP GF + + CV
Sbjct: 286 ----PRQQCQVYRYCGSFGICSDKSEPFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQC 341
Query: 195 ---PINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFANDFIQPVKRGVGLSDCQDLC 251
IN LPN A N+ L + LS C C
Sbjct: 342 SRGDINQFFRLPNMKLADNSEVLTRT-------------------------SLSICASAC 376
Query: 252 SWNCSCLGIFHDDSSESCYFIENHLGTLMSSSD-NERVRLGYIKAMVLSSDGSKKAEDEN 310
+CSC +D+ S C + L D N + Y++ + S + A ++
Sbjct: 377 QGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLR-LAASDVPNVGASGKS 435
Query: 311 GSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKVIKLGSRNSSSEELELTSIAGL 370
+K + G VL ++ ++V L I R R + G + G
Sbjct: 436 NNKGLIFGAVLG-----SLGVIVLVLLVVILILRYRRRKRMRGEKGD-----------GT 479
Query: 371 PRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEIT 430
FSY EL AT NF+ +G GGFG+V+KG L D S +AVK++ QG+K+F TE+
Sbjct: 480 LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGIS-QGEKQFRTEVV 538
Query: 431 IIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGS----VLEWRERFEIAL 486
IG I HVNLVRL+GFC++G ++ LVY+YM GSLD LF N VL W+ RF+IAL
Sbjct: 539 TIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIAL 598
Query: 487 GTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546
GTARGLAYLH C IIHCD+KPENILL + K++DFGL+KL+ + S + TTMRGT
Sbjct: 599 GTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGT 658
Query: 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSS 606
RGYLAPEW++ AI+ K DVYSYGM+L E++SGR+N TE+
Sbjct: 659 RGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRN---------TEQ------------ 697
Query: 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSD-EDVEKLVRIALCCVQEEPMLR 665
S E R + A L + L D R+EG D E+V + ++A C+Q+E R
Sbjct: 698 -SENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHR 756
Query: 666 PSMANVVSMLEGGMPLGEP 684
P+M+ VV +LEG + + P
Sbjct: 757 PAMSQVVQILEGVLEVNPP 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 223/729 (30%), Positives = 366/729 (50%), Gaps = 105/729 (14%)
Query: 6 VSSMQLQESGNLVLLDAR---NVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVG 62
V S + ESGN +LL ++WQSF P+D ++ Q L V L ++ S + G
Sbjct: 123 VESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPS--RHG 180
Query: 63 EYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLS----VNRTG---------- 108
YS +LQ Q T L + D A S+ S N TG
Sbjct: 181 HYSL------KMLQ--QHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTG 232
Query: 109 ----LYLLASDGSRFVLKVSLD-------AAGFRIAK--------LEPSGRLIVSKLVGD 149
+Y +S G+ +V K +D ++ + K LE +G L + + D
Sbjct: 233 SFKIVYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRWDND 292
Query: 150 NLVQELAIPVENCRIPFFCKEIGLCSGGSCSCPSGFHAELNGDCVPINSSLSLPNG---- 205
+P E + C G+C G C+ + N DC+ + S+ LP+
Sbjct: 293 MNGSSQWVP-EWAAVSNPCDIAGICGNGVCNLD---RTKKNADCLCLPGSVKLPDQENAK 348
Query: 206 -CSATNA------SGLNSSITY-LKLGNGVDYFAND--FIQPVKRGVGLSDCQDLCSWNC 255
CS ++ S +N + ++ + +Y+ ++ I+ + + C ++C +C
Sbjct: 349 LCSDNSSLVQECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDC 408
Query: 256 SCLGIFH--DDSSESCYFIEN-HLGTLMSSSDNERVRL-GYIKAMVLSSDGSKKAEDENG 311
C+ + DD C+ +++ + G V+ S++ K+ +G
Sbjct: 409 KCVASVYGLDDEKPYCWILKSLNFGGFRDPGSTLFVKTRANESYPSNSNNNDSKSRKSHG 468
Query: 312 SKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKVIKLGSRNSSSEELELTSIAGLP 371
+ V + ++ L+ +A++ L++ ++ KR +K ++NS + P
Sbjct: 469 LRQKVLVIPIVVGMLVLVALLGMLLYYNLDRKRT----LKRAAKNS-------LILCDSP 517
Query: 372 RRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITI 431
F+Y +L T+NF+ +GSGGFGTVYKG + +++VAVK+++ G++EF TE+
Sbjct: 518 VSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNT 577
Query: 432 IGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGN---GSVLEWRERFEIALGT 488
IG++HH+NLVRL G+C++ R LVYEYM GSLD+ +F + ++L+WR RFEIA+ T
Sbjct: 578 IGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVAT 637
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG 548
A+G+AY H C ++IIHCD+KPENILL D K+SDFGL+K++ E S + T +RGTRG
Sbjct: 638 AQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRG 697
Query: 549 YLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSS 608
YLAPEW+++ I+ K DVYSYGM+LLEI+ GR+N +
Sbjct: 698 YLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSY--------------------- 736
Query: 609 PRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSM 668
+++ ++P A + L+ D R++G +E+V K +++A C+Q+E +RPSM
Sbjct: 737 --DAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSM 794
Query: 669 ANVVSMLEG 677
VV +LEG
Sbjct: 795 GEVVKLLEG 803
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (764), Expect = 9e-80, Method: Compositional matrix adjust.
Identities = 213/690 (30%), Positives = 327/690 (47%), Gaps = 82/690 (11%)
Query: 7 SSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYSF 66
+ + E+GNL+L++ +WQSFD+PTD + G + ++ + S D S G YS
Sbjct: 114 TDFRFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTGLTAMTSWRSLFDPSPGFYSL 173
Query: 67 VVTDGDGVLQW---NQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLL------ASDGS 117
++ Q YW ++ +A V + +Y S
Sbjct: 174 RLSPSFNEFQLVYKGTTPYWSTGNWT-----GEAFVGVPEMTIPYIYRFHFVNPYTPTAS 228
Query: 118 RFVLKVSLDAAG-FRIAKLEPSGRLIVSKLVGDNLVQELAI----PVENCRIPFFCKEIG 172
+ + LD+ R+ + + + D Q + P + CR+ C ++G
Sbjct: 229 FWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDPQTQSWNMFWLQPEDPCRVYNLCGQLG 288
Query: 173 LCSG---GSCSCPSGFHAELNGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDY 229
CS C+C GF + S +GC N S T+ +G D
Sbjct: 289 FCSSELLKPCACIRGFRPRNDAAW----RSDDYSDGCRRENGDSGEKSDTFEAVG---DL 341
Query: 230 FANDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVR 289
+ ++ + V S C C N SC+G +H + S C + L +S N
Sbjct: 342 RYDGDVKMSRLQVSKSSCAKTCLGNSSCVGFYHKEKSNLCKILLESPNNLKNSKGNISKS 401
Query: 290 LGYIKAMVLSSDGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKV 349
+ + ++V GS + +L+P LL +
Sbjct: 402 IIILCSVV-------------GSISVLGFTLLVPLILLKRSRK----------------- 431
Query: 350 IKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSV- 408
+ + ++ + ++ L + FS++EL +AT+ F+ +G GGFG V+KG L S
Sbjct: 432 ----RKKTRKQDEDGFAVLNL-KVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTF 486
Query: 409 VAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRT 468
VAVK++ G G+ EF E+ IGNI HVNLVRL+GFC++ R LVY+YM +GSL
Sbjct: 487 VAVKRLERPG-SGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSY 545
Query: 469 LF-GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFG 527
L + +L W RF IALGTA+G+AYLH GC IIHCD+KPENILL K+SDFG
Sbjct: 546 LSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFG 605
Query: 528 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587
L+KLL + S + TMRGT GY+APEW++ I+ K DVYS+GM LLE+I GR+N +
Sbjct: 606 LAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNS 665
Query: 588 QSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDV 647
+ EK++ E ++ +FP A Q + DSR+ G+ + E+V
Sbjct: 666 DTLG-EKET--------------EPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEV 710
Query: 648 EKLVRIALCCVQEEPMLRPSMANVVSMLEG 677
++ +A+ C+Q+ +RP+M VV MLEG
Sbjct: 711 TRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 289 bits (740), Expect = 5e-77, Method: Compositional matrix adjust.
Identities = 238/737 (32%), Positives = 355/737 (48%), Gaps = 117/737 (15%)
Query: 6 VSSMQLQESGNLVLL-----DARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLS 60
VS + + GN VL D+ V LW SF++PTD ++ Q + VG++L++ +E
Sbjct: 131 VSRGRFTDDGNFVLFRDGSEDSDEV-LWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFK 189
Query: 61 VGEYSFVVTDGDGVLQW---NQMTYWKLSMYSYAFK----DSDAPVSFLSVNRTG-LYLL 112
G +S + D DG LQ N T + +YS ++ D + P L N++G +Y+L
Sbjct: 190 KGRFSLRLED-DGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVFNQSGEIYVL 248
Query: 113 ASDGSRFVLK-----VSLDA-----AGFRIAKLEP--SGRLIVSKLVGDNLVQELAIPVE 160
+ SRFV+K S+ A GF ++ + P + R++ L+G L ++ +
Sbjct: 249 QRNNSRFVVKDRDPDFSIAAPFYISTGFLLSTIIPKEARRIVGGCLLG--LCRDNMCSPD 306
Query: 161 NCRIPFFCKEIGLCSGGS-----CSCPSGF----HAELNGDCVP-INSSLSLPNGCSATN 210
+ C +CS G+ C CP F + GDC+P P +A +
Sbjct: 307 DALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTANS 366
Query: 211 ASGLNSSITYLKLGNGV-DY--FANDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSE 267
L IT K DY +AN + + + LSDC LC+ IF +
Sbjct: 367 DVNLYEFITLEKTNWPFGDYESYAN-YDEERCKASCLSDC--LCA-----AVIFGTNRDL 418
Query: 268 SCYFIENHLGTLMSSSDNERVRLGYIKAMVLSSDGSKKAEDENGSKFPVAG--------L 319
C+ + L S ER G SD K + + + PV G L
Sbjct: 419 KCWKKKFPL------SHGERSPRG-------DSDTFIKVRNRSIADVPVTGNRAKKLDWL 465
Query: 320 VLIPSSLLAIAIVVGF---LWWRINSK-----RARAKVIKLGSRNSSSEELELTSIAGLP 371
++ S LL + V F +R K + +A+ I + +++ EL L
Sbjct: 466 IIACSVLLGTSAFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNL------- 518
Query: 372 RRFSYEELAAATDNFNTPIGSGGFGTVYKGILQ----DKSVVAVKKINSFGIQGKKEFCT 427
R F+Y ELA AT +F +G G FG VYKG L+ + VAVKK++ + +KEF
Sbjct: 519 RVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKN 578
Query: 428 EITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALG 487
E+ +IG IHH NLVRL GFC +G+ + +VYE++ +G+L LF W +R IA+
Sbjct: 579 EVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRP-SWEDRKNIAVA 637
Query: 488 TARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR 547
ARG+ YLH C +IIHCD+KP+NILL + +ISDFGL+KLL Q+ T +RGT+
Sbjct: 638 IARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTK 697
Query: 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSS 607
GY+APEW +S I+ K DVYSYG++LLEI+ +K L+
Sbjct: 698 GYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDLE--------------------- 736
Query: 608 SPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS 667
V A + Q R +L + E E VE+ V+IA+ C+QEE +RP+
Sbjct: 737 -----DNVILINWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPN 791
Query: 668 MANVVSMLEGGMPLGEP 684
M NV MLEG + + +P
Sbjct: 792 MRNVTQMLEGVIQVFDP 808
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 229/727 (31%), Positives = 342/727 (47%), Gaps = 103/727 (14%)
Query: 6 VSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYS 65
V +L ++GNLV+ D+ ++WQSFDSPTD + Q + L + S G Y
Sbjct: 132 VQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSR--SPGNYI 189
Query: 66 FVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPV---SFLSVNRTGLYLLASDG----SR 118
F +D L + Y + + D D + N T L +L G S
Sbjct: 190 FRFSD----LSVLSLIYHVPQVSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLASSD 245
Query: 119 FVLKVSLDAAGF-----RIAKLEPSGRLIVSKLV---GDNLVQELAIPVENCRIPFFCKE 170
F +L A+ R L+P G L + + G V +A+ + C I C
Sbjct: 246 FADGQALVASDVGPGVKRRLTLDPDGNLRLYSMNDSDGSWSVSMVAM-TQPCNIHGLCGP 304
Query: 171 IGLCS---GGSCSCPSGFHAELNGDCVPINSSLSLPNGCSATNASGLNS----SITYLKL 223
G+C +CSCP G+ G+ GC A + + S+ +++L
Sbjct: 305 NGICHYSPTPTCSCPPGYATRNPGNWT---------EGCMAIVNTTCDRYDKRSMRFVRL 355
Query: 224 GNGVDYFANDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHL--GTLMS 281
N D++ +D Q V L C+D+C +C+C G + + + SCY + +L G
Sbjct: 356 PN-TDFWGSD--QQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCY-PKAYLFSGRTYP 411
Query: 282 SSDNERVRLGYIK---------AMVLSSDG----SKKAEDENGSK-----FPVAGLV--- 320
+SD VR Y+K A++ SD ++ + + +K FP
Sbjct: 412 TSD---VRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGG 468
Query: 321 ---------LIPSSLLAIAIVVGFLWWRINSKRARAKVIKLGSRNSSSEELELTSIAGLP 371
I + + + F W+ + + R + + E ++
Sbjct: 469 ESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELW-------ASEKGYKAMTSNF 521
Query: 372 RRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITI 431
RR+SY EL AT F +G G GTVYKG+L+D VAVKK+ + QGK+ F E+++
Sbjct: 522 RRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLENVR-QGKEVFQAELSV 580
Query: 432 IGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGS--VLEWRERFEIALGTA 489
IG I+H+NLVR+ GFC++G R LV EY+ GSL LF G +L+W RF IALG A
Sbjct: 581 IGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVA 640
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL-FTTMRGTRG 548
+GLAYLH C +IHCDVKPENILL + KI+DFGL KLL S+ + +RGT G
Sbjct: 641 KGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLG 700
Query: 549 YLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSS 608
Y+APEW++S I+ K DVYSYG+VLLE+++G + S L G S
Sbjct: 701 YIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELV-------------GGTDEVHSM 747
Query: 609 PRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSM 668
R+ R+ LE EQ DS++ V+ L+++A+ C++E+ RP+M
Sbjct: 748 LRKLVRMLSA--KLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTM 805
Query: 669 ANVVSML 675
+ V L
Sbjct: 806 EHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94C25|Y5005_ARATH Probable receptor-like protein kinase At5g20050 OS=Arabidopsis thaliana GN=At5g20050 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 255 bits (651), Expect = 9e-67, Method: Compositional matrix adjust.
Identities = 141/334 (42%), Positives = 204/334 (61%), Gaps = 32/334 (9%)
Query: 364 LTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKK 423
L +AG+P +F E+L ATD F + IG GG G+V+KG+L+D S VAVK+I +G++
Sbjct: 83 LRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKGVLKDGSQVAVKRIEGEE-KGER 141
Query: 424 EFCTEITIIGNIHHVNLVRLKGF---CAQGRQRFLVYEYMNKGSLDRTLFGNGSV----- 475
EF +E+ I ++ H NLVRL G+ + R RFLVY+Y+ SLD +F +
Sbjct: 142 EFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSLDIWIFPDRGNRGRSG 201
Query: 476 ---LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532
L W +R+++A+ A+ LAYLH C KI+H DVKPENILL + + ++DFGLSKL+
Sbjct: 202 GGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDFGLSKLI 261
Query: 533 TPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRST 592
++S + T +RGTRGYLAPEWL IS+K+DVYSYG+VLLE+I GR++ S +
Sbjct: 262 ARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRSISRVEVKETK 321
Query: 593 EKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRI--EGQVSDEDVEKL 650
+K YFP + + +R+ +E+ D R+ +V +E+V KL
Sbjct: 322 KKKLE------------------YFPRIVNQKMRERKIMEIVDQRLIEVNEVDEEEVMKL 363
Query: 651 VRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEP 684
V +AL C+QE+ RP M V+ MLEG +P+ EP
Sbjct: 364 VCVALWCIQEKSKKRPDMTMVIEMLEGRVPVNEP 397
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 247 bits (630), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 140/358 (39%), Positives = 206/358 (57%), Gaps = 38/358 (10%)
Query: 329 IAIVVGFLWWRINSKRARAKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFN- 387
++I+ G + + I +R R +++ EL + P F+Y EL +AT +F+
Sbjct: 648 LSILAGVVMFTIRKRRKRY-----------TDDEELLGMDVKPYIFTYSELKSATQDFDP 696
Query: 388 -TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
+G GGFG VYKG L D VVAVK ++ QGK +F EI I ++ H NLV+L G
Sbjct: 697 SNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGC 756
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSV-LEWRERFEIALGTARGLAYLHTGCDHKIIH 505
C +G R LVYEY+ GSLD+ LFG+ ++ L+W R+EI LG ARGL YLH +I+H
Sbjct: 757 CFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVH 816
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
DVK NILL +L +ISDFGL+KL +++ + T + GT GYLAPE+ +++KTD
Sbjct: 817 RDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTD 876
Query: 566 VYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625
VY++G+V LE++SGR NS + E ++ Y A LH
Sbjct: 877 VYAFGVVALELVSGRPNSDENL-----------------------EEEKKYLLEWAWNLH 913
Query: 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGE 683
E+ R +EL D ++ + E+ ++++ IAL C Q LRP M+ VV+ML G + +G+
Sbjct: 914 EKSRDIELIDDKLT-DFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGD 970
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 745 | ||||||
| 225459499 | 1049 | PREDICTED: G-type lectin S-receptor-like | 0.990 | 0.703 | 0.598 | 0.0 | |
| 224145590 | 845 | predicted protein [Populus trichocarpa] | 0.962 | 0.848 | 0.622 | 0.0 | |
| 255545436 | 793 | s-receptor kinase, putative [Ricinus com | 0.986 | 0.926 | 0.575 | 0.0 | |
| 224126665 | 781 | predicted protein [Populus trichocarpa] | 0.876 | 0.836 | 0.627 | 0.0 | |
| 79525859 | 872 | S-locus lectin protein kinase-like prote | 0.975 | 0.833 | 0.532 | 0.0 | |
| 297805088 | 872 | hypothetical protein ARALYDRAFT_493603 [ | 0.978 | 0.836 | 0.533 | 0.0 | |
| 351725125 | 771 | receptor-like protein kinase like protei | 0.981 | 0.948 | 0.558 | 0.0 | |
| 147784458 | 1114 | hypothetical protein VITISV_029567 [Viti | 0.907 | 0.606 | 0.575 | 0.0 | |
| 449507977 | 852 | PREDICTED: G-type lectin S-receptor-like | 0.947 | 0.828 | 0.538 | 0.0 | |
| 449449938 | 828 | PREDICTED: G-type lectin S-receptor-like | 0.938 | 0.844 | 0.542 | 0.0 |
| >gi|225459499|ref|XP_002284416.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2322), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/759 (59%), Positives = 577/759 (76%), Gaps = 21/759 (2%)
Query: 2 LDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSV 61
L S VS++ L E+GNL+LLD N SLWQSFD PTD IV GQ L VG SL+ ++S+NDLS
Sbjct: 297 LKSSVSALLLAETGNLILLDQFNGSLWQSFDYPTDTIVIGQRLPVGTSLSGALSDNDLST 356
Query: 62 GEYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFVL 121
+Y FVV+ + ++QW+ +TYWKLSM + A+K+S+ V ++++N+TGL+L +GS V+
Sbjct: 357 SDYRFVVSTSNAIMQWHGLTYWKLSMDTSAYKNSNYLVEYMAMNQTGLFLFGRNGSVVVI 416
Query: 122 KVSLDAAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIGLCSGGS--- 178
++ L + FRIAKL+ SG+ I+S L G L QE P + CRIPF C +GLC+ +
Sbjct: 417 QMDLSPSDFRIAKLDASGQFIISTLSGTVLKQEYVGPKDACRIPFICGRLGLCTDDTASN 476
Query: 179 ---CSCPSGFHAELNG--DCVPINSSLSLPNGCSATNASGLN--SSITYLKLGNGVDYFA 231
CSCPSGF A+ +CVP +SS SLP+ C+ TN+ + S ++YL L GV+YFA
Sbjct: 477 SPVCSCPSGFRADPKSVTNCVPSDSSYSLPSPCNLTNSVSQSNLSVVSYLMLAYGVEYFA 536
Query: 232 NDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLG 291
N+F +PV+ GV LS C++LCS +CSCLGIFH++SS SCY +EN LG+L+SSS NE V+LG
Sbjct: 537 NNFWEPVQYGVNLSVCENLCSGDCSCLGIFHENSSGSCYLVENVLGSLISSSTNENVQLG 596
Query: 292 YIKAMVLSS---DGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAK 348
IK +V SS DG+ + +++ +FP+A LVL+PS+ + + +GFLWWR ++ +
Sbjct: 597 CIKVLVGSSPNMDGNNSSSNQS-QEFPIAALVLLPSTGFFLFVALGFLWWR-RWGFSKNR 654
Query: 349 VIKLG-SRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKS 407
+KLG S + SSE+L+ SI GLP RF YEE+ AATDNF T IGSGGFG VYKGI+ DK+
Sbjct: 655 DLKLGHSSSPSSEDLDAFSIPGLPIRFEYEEIEAATDNFKTQIGSGGFGAVYKGIMPDKT 714
Query: 408 VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467
+VAVKKI + G+QGKKEFCTEI +IGNIHHVNLV+LKGFCA+GRQR LVYEYMN+ SLDR
Sbjct: 715 LVAVKKITNLGVQGKKEFCTEIAVIGNIHHVNLVKLKGFCAKGRQRLLVYEYMNRSSLDR 774
Query: 468 TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFG 527
TLF NG VLEW+ER +IALGTARGLAYLH+GC+HKIIHCDVKPENILLHD Q KISDFG
Sbjct: 775 TLFSNGPVLEWQERVDIALGTARGLAYLHSGCEHKIIHCDVKPENILLHDNFQAKISDFG 834
Query: 528 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587
LSKLL+PE+S+LFTTMRGTRGYLAPEWLTSSAISDKTDVYS+GMVLLE++SGRKN SL+
Sbjct: 835 LSKLLSPEESTLFTTMRGTRGYLAPEWLTSSAISDKTDVYSFGMVLLELVSGRKNCSLRT 894
Query: 588 QSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDV 647
QS S + SSG SS S+ VYFPL ALE+HEQ RYLELAD R+EG+V+ E+V
Sbjct: 895 QSHSIDDGSSGG----GHSSLLSGSEPVYFPLFALEMHEQGRYLELADPRLEGRVTSEEV 950
Query: 648 EKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEASTIEE 707
EKLV +ALCCV EEP LRP M +VV MLEGG+ L +PR ESL FLRFYG+RF EAS +EE
Sbjct: 951 EKLVLVALCCVHEEPTLRPCMVSVVGMLEGGITLSQPRTESLNFLRFYGRRFTEASMVEE 1010
Query: 708 SN-ELNLQFILQSETNGTNTTGSYNSLSYISSQQVSGPR 745
++ + + Q+ + T+ +GS+ S SYISSQQ+SGPR
Sbjct: 1011 TDGQQTVVLYPQANASLTSISGSHTSFSYISSQQISGPR 1049
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145590|ref|XP_002325698.1| predicted protein [Populus trichocarpa] gi|222862573|gb|EEF00080.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 868 bits (2243), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/744 (62%), Positives = 559/744 (75%), Gaps = 27/744 (3%)
Query: 4 SRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGE 63
S+VS+M+L++SGNLVLL+ NVSLW+SFD PTD IV GQ+L VG S+ +END+SVG+
Sbjct: 127 SQVSAMELRDSGNLVLLNRNNVSLWESFDQPTDTIVMGQSLAVGTSVDCYNAENDMSVGD 186
Query: 64 YSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFVLKV 123
Y VVT GD VLQWN M+YWKLSM +DS PVSFL++N TGL+LL SD S V+K+
Sbjct: 187 YRLVVTGGDAVLQWNGMSYWKLSMEPKGSQDSKVPVSFLALNDTGLFLLGSDRSTVVIKL 246
Query: 124 SLDAAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIGLCSGGSCSCPS 183
+L A FR+AKL G+L V K V N VQE P + C+IP C ++GLCS G CSCP
Sbjct: 247 TLGPADFRVAKLGFDGKLSVRKFVDQNWVQEFVSPADECQIPLSCNKMGLCSSGRCSCPP 306
Query: 184 GFHAELNGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFANDFIQPVKRGVG 243
FH + P++ L NSS+ Y+ LG+ +DYFAN F+ P KR +
Sbjct: 307 NFHGD------PLSKKL--------------NSSVFYVNLGSELDYFANGFMAPAKRDIN 346
Query: 244 LSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLGYIKAMVLSSDGS 303
L CQDLC+ NCSCLGIF+ +SS SCY +EN LG++M +S + RLGY+K +V+SS +
Sbjct: 347 LLACQDLCTRNCSCLGIFYGNSSGSCYLLENPLGSIMEASSSNSKRLGYVKTIVVSSRAN 406
Query: 304 KKAEDENGSKFPVAGLVLIPSS--LLAIAIVVGFLWWRINSKRARAKVIKLGSRNSSSEE 361
K E +KFP+ GLVL+PSS LL I +V+GF+ WR N AK +KLG +SSS E
Sbjct: 407 KVNES---AKFPIVGLVLLPSSGILLIIIVVLGFICWRRNRLYRTAK-LKLGRGDSSSSE 462
Query: 362 LELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQG 421
LE+ SI GLP RF+YE+L AAT++F+T IGSGGFGTVYKG L DKSVVAVKKI + G+QG
Sbjct: 463 LEIISIPGLPVRFNYEDLVAATESFSTQIGSGGFGTVYKGTLPDKSVVAVKKITNVGVQG 522
Query: 422 KKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRER 481
KKEFCTEI IIG+ HVNLV+LKGFCAQGRQRFLVYEYMN+GSLDRTLFGNG VL+W+ER
Sbjct: 523 KKEFCTEIAIIGSTRHVNLVKLKGFCAQGRQRFLVYEYMNRGSLDRTLFGNGPVLKWQER 582
Query: 482 FEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541
FEIALGTARGLAYLH+ C+ KIIHCDVKPENILLHD LQVKISDFGLSKLLTPEQSSLFT
Sbjct: 583 FEIALGTARGLAYLHSYCERKIIHCDVKPENILLHDNLQVKISDFGLSKLLTPEQSSLFT 642
Query: 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGN 601
TMRGTRGYLAPEWL ISDK DVYSYGMVLLEI+ GRKNS+ + QSRS E DSS
Sbjct: 643 TMRGTRGYLAPEWLAGVTISDKADVYSYGMVLLEIVRGRKNSAAQPQSRSIENDSSEGNG 702
Query: 602 GPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEE 661
SSSSS E + YFPL ALE+HE++RY ELADSR+E +V++E+VEKLV++ALCC+ E+
Sbjct: 703 T-SSSSSGWEPRSAYFPLHALEMHEKKRYSELADSRLERRVANEEVEKLVKVALCCLHED 761
Query: 662 PMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEASTIEESNELNLQFILQSET 721
P LRP+M NVV MLEG PL EPR ESL FLRFYG+RF+EAS IE SNE N +
Sbjct: 762 PTLRPTMVNVVGMLEGITPLAEPRQESLNFLRFYGRRFSEASRIEGSNERNEFGLFPQAN 821
Query: 722 NGTNTTGSYNSLSYISSQQVSGPR 745
+ T+ SY S+SY+S+QQ+SGPR
Sbjct: 822 LTSGTSSSYTSMSYLSAQQLSGPR 845
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545436|ref|XP_002513778.1| s-receptor kinase, putative [Ricinus communis] gi|223546864|gb|EEF48361.1| s-receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2189), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/756 (57%), Positives = 551/756 (72%), Gaps = 21/756 (2%)
Query: 2 LDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSV 61
L S V ++ L E GNLVLLD N SLW+SF P D +V GQ L GK L+++VS N+LS
Sbjct: 47 LRSSVYALLLTEMGNLVLLDQLNGSLWESFHYPRDTLVIGQHLPKGKLLSSAVSSNNLST 106
Query: 62 GEYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFVL 121
G Y ++D D +LQW TYWKLSM + A+ +S+ V F+++NRTGL+L +GS V+
Sbjct: 107 GHYRLAISDSDAILQWQGQTYWKLSMDAGAYTNSNYIVDFMAINRTGLFLFGLNGSAIVI 166
Query: 122 KVSLDAAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIGLC-----SG 176
++SL + FR+A+L SG+ +S G N QE P++ C+IP C +IGLC S
Sbjct: 167 QMSLSPSNFRVAQLGASGQFTISSFSGSNKQQEFVGPMDGCQIPLACGKIGLCIDTTSSR 226
Query: 177 GSCSCPSGFH--AELNGDCVPINSSLSLPNGCSAT-NASGLNSS-ITYLKLGNGVDYFAN 232
+CSCP GF ++ + CVP + SLP+ C +T N S LNSS ++Y++LG G+DYFA
Sbjct: 227 PTCSCPLGFRGGSQNSSGCVPSDGP-SLPHACVSTRNGSQLNSSAVSYMRLGYGMDYFAI 285
Query: 233 DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLGY 292
DF +P + GV S CQDLC+ +C+CLGIF+++SS SCY +E LG+++SS+ NE LGY
Sbjct: 286 DFSEPTRYGVNFSVCQDLCTMDCACLGIFYENSSGSCYALEKDLGSIISSTKNENDLLGY 345
Query: 293 IKAMVLSS-DGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKVIK 351
IK + S+ DGS +D +FPV LVL+P + + + + FLWWR + ++ + +K
Sbjct: 346 IKVINRSTPDGS---DDNQNQQFPVVALVLLPFTGFLLVVALYFLWWR-RRRISKDREMK 401
Query: 352 LGSRNS-SSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVA 410
LG +S SS +L I GLP+RF Y+EL AT NF T IGSGGFG+VYKG L DKSVVA
Sbjct: 402 LGCGSSRSSGDLNAFYIPGLPQRFDYDELEVATGNFKTQIGSGGFGSVYKGTLLDKSVVA 461
Query: 411 VKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLF 470
VKKI++ G+QGKK+FCTEI +IG+IHH+NLV+L+GFC QGRQR LVYEYMN+GSLDRTLF
Sbjct: 462 VKKISNLGVQGKKDFCTEIAVIGSIHHINLVKLRGFCVQGRQRLLVYEYMNRGSLDRTLF 521
Query: 471 GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK 530
G+G VLEW+ERFEIALGTARGLAYLH GC+HKIIHCDVKPENILLHD Q KISDFGLSK
Sbjct: 522 GSGPVLEWQERFEIALGTARGLAYLHAGCEHKIIHCDVKPENILLHDHFQAKISDFGLSK 581
Query: 531 LLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSR 590
LL+PEQSSLFTTMRGTRGYLAPEWLT+SAIS+KTDVYS+GMVLLE++SGRKN + QS
Sbjct: 582 LLSPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRKNCWTRSQSA 641
Query: 591 STEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKL 650
S E SG S+S S YFPL ALE+HEQ RYLELAD R+EG+V+ E+V KL
Sbjct: 642 SVENSKSGG----GQSTSSSGSGLTYFPLFALEMHEQGRYLELADPRLEGRVTSEEVGKL 697
Query: 651 VRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEASTIEESNE 710
V IALCCV EEP LRPSM +VV MLEGG+PLG+P+++SL FLRFYG+RF EAS IEE N
Sbjct: 698 VCIALCCVHEEPALRPSMVSVVGMLEGGIPLGQPKVDSLNFLRFYGRRFTEASIIEEENR 757
Query: 711 LNLQFILQSETNGTNTTGSYNS-LSYISSQQVSGPR 745
+ + N ++T Y++ SYISSQ+VSGPR
Sbjct: 758 HSSIMLFPRANNSDSSTSDYHACFSYISSQEVSGPR 793
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126665|ref|XP_002329442.1| predicted protein [Populus trichocarpa] gi|222870122|gb|EEF07253.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 819 bits (2116), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/680 (62%), Positives = 514/680 (75%), Gaps = 27/680 (3%)
Query: 4 SRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGE 63
S+VS+M+L++SGNLVLL+ NVSLW+SFD PTD IV GQ+L VG S+ +END+SVG+
Sbjct: 127 SQVSAMELRDSGNLVLLNRNNVSLWESFDQPTDTIVMGQSLAVGTSVDCYNAENDMSVGD 186
Query: 64 YSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFVLKV 123
Y VVT GD VLQWN M+YWKLSM +DS PVSFL++N TGL+LL SD S V+K+
Sbjct: 187 YRLVVTGGDAVLQWNGMSYWKLSMEPKGSQDSKVPVSFLALNDTGLFLLGSDRSTVVIKL 246
Query: 124 SLDAAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIGLCSGGSCSCPS 183
+L A FR+AKL G+L V K V N VQE P + C+IP C ++GLCS G CSCP
Sbjct: 247 TLGPADFRVAKLGFDGKLSVRKFVDQNWVQEFVSPADECQIPLSCNKMGLCSSGRCSCPP 306
Query: 184 GFHAELNGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFANDFIQPVKRGVG 243
FH + P++ L NSS+ Y+ LG+ +DYFAN F+ P KR +
Sbjct: 307 NFHGD------PLSKKL--------------NSSVFYVNLGSELDYFANGFMAPAKRDIN 346
Query: 244 LSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLGYIKAMVLSSDGS 303
L CQDLC+ NCSCLGIF+ +SS SCY +EN LG++M +S + RLGY+K +V+SS +
Sbjct: 347 LLACQDLCTRNCSCLGIFYGNSSGSCYLLENPLGSIMEASSSNSKRLGYVKTIVVSSRAN 406
Query: 304 KKAEDENGSKFPVAGLVLIPSS--LLAIAIVVGFLWWRINSKRARAKVIKLGSRNSSSEE 361
K E +KFP+ GLVL+PSS LL I +V+GF+ WR N AK +KLG +SSS E
Sbjct: 407 KVNES---AKFPIVGLVLLPSSGILLIIIVVLGFICWRRNRLYRTAK-LKLGRGDSSSSE 462
Query: 362 LELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQG 421
LE+ SI GLP RF+YE+L AAT++F+T IGSGGFGTVYKG L DKSVVAVKKI + G+QG
Sbjct: 463 LEIISIPGLPVRFNYEDLVAATESFSTQIGSGGFGTVYKGTLPDKSVVAVKKITNVGVQG 522
Query: 422 KKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRER 481
KKEFCTEI IIG+ HVNLV+LKGFCAQGRQRFLVYEYMN+GSLDRTLFGNG VL+W+ER
Sbjct: 523 KKEFCTEIAIIGSTRHVNLVKLKGFCAQGRQRFLVYEYMNRGSLDRTLFGNGPVLKWQER 582
Query: 482 FEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541
FEIALGTARGLAYLH+ C+ KIIHCDVKPENILLHD LQVKISDFGLSKLLTPEQSSLFT
Sbjct: 583 FEIALGTARGLAYLHSYCERKIIHCDVKPENILLHDNLQVKISDFGLSKLLTPEQSSLFT 642
Query: 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGN 601
TMRGTRGYLAPEWL ISDK DVYSYGMVLLEI+ GRKNS+ + QSRS E DSS
Sbjct: 643 TMRGTRGYLAPEWLAGVTISDKADVYSYGMVLLEIVRGRKNSAAQPQSRSIENDSSEGNG 702
Query: 602 GPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEE 661
SSSSS E + YFPL ALE+HE++RY ELADSR+E +V++E+VEKLV++ALCC+ E+
Sbjct: 703 T-SSSSSGWEPRSAYFPLHALEMHEKKRYSELADSRLERRVANEEVEKLVKVALCCLHED 761
Query: 662 PMLRPSMANVVSMLEGGMPL 681
P LRP+M NVV MLEG PL
Sbjct: 762 PTLRPTMVNVVGMLEGITPL 781
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79525859|ref|NP_198387.2| S-locus lectin protein kinase-like protein [Arabidopsis thaliana] gi|313471768|sp|O65238.2|Y5537_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370; Flags: Precursor gi|332006576|gb|AED93959.1| S-locus lectin protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2063), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/766 (53%), Positives = 538/766 (70%), Gaps = 39/766 (5%)
Query: 1 MLDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLS 60
+L S V S++L ++GNL+LLD NVSLW+SFD PTD+IV GQ L++G L+ SVS +D S
Sbjct: 125 VLASPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFS 184
Query: 61 VGEYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFV 120
G+Y F+V + DG++QW YWKL M+ A DS+ PV +L+V +GL L+A +G+ V
Sbjct: 185 TGDYKFLVGESDGLMQWRGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVV 244
Query: 121 LKVSLD-AAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIGLCS---- 175
++V+L ++ FR+AK++ SG+ IVS+ G NLV E + P+++C+IPF C ++GLC+
Sbjct: 245 VRVALPPSSDFRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNA 304
Query: 176 --GGSCSCPSGFHAEL-NGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFAN 232
SCSCP + G CVP++ SLSLP C A N I+YL+LG GV YF+
Sbjct: 305 SENQSCSCPDEMRMDAGKGVCVPVSQSLSLPVSCEARN-------ISYLELGLGVSYFST 357
Query: 233 DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTL--MSSSDNERVRL 290
F PV+ G+ L C D+CS NCSCLG+F++++S SCY +++ G+L + +S +
Sbjct: 358 HFTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLI 417
Query: 291 GYIKAMVLSSDGSKKAED-ENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKV 349
GY+K + ++ + GS FPV LVL+P S + I +G LWWR R V
Sbjct: 418 GYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWR------RCAV 471
Query: 350 IKLGS-------RNSSSEELELTS--IAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYK 400
++ S R S E +L S I GLP++F +EEL AT+NF IGSGGFG+VYK
Sbjct: 472 MRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYK 531
Query: 401 GILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460
G L D++++AVKKI + G+ G++EFCTEI IIGNI H NLV+L+GFCA+GRQ LVYEYM
Sbjct: 532 GTLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYM 591
Query: 461 NKGSLDRTLF-GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519
N GSL++TLF GNG VLEW+ERF+IALGTARGLAYLH+GCD KIIHCDVKPENILLHD
Sbjct: 592 NHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHF 651
Query: 520 QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
Q KISDFGLSKLL E+SSLFTTMRGTRGYLAPEW+T++AIS+K DVYSYGMVLLE++SG
Sbjct: 652 QPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSG 711
Query: 580 RKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIE 639
RKN S + +S S +D+ N SS++ + VYFPL AL++HEQ RY+ELAD R+E
Sbjct: 712 RKNCSFRSRSNSVTEDN----NQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLE 767
Query: 640 GQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRF 699
G+V+ ++ EKLVRIALCCV EEP LRP+MA VV M EG +PLG PR+ESL FLRFYG RF
Sbjct: 768 GRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNPRMESLNFLRFYGLRF 827
Query: 700 NEASTIEESNELNLQFILQSETNGTNTTGSYNSLSYISSQQVSGPR 745
E+S +E N + + + +N+ GS S SYI+SQ+VSGPR
Sbjct: 828 AESSMVEGQNGESETMVFHRRES-SNSGGSRQSASYIASQEVSGPR 872
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297805088|ref|XP_002870428.1| hypothetical protein ARALYDRAFT_493603 [Arabidopsis lyrata subsp. lyrata] gi|297316264|gb|EFH46687.1| hypothetical protein ARALYDRAFT_493603 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/763 (53%), Positives = 537/763 (70%), Gaps = 34/763 (4%)
Query: 1 MLDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLS 60
+L S V S++L ++GNL+LLD NVSLW+SFD PTD+IV GQ L++G L+ SVS +D S
Sbjct: 126 VLPSPVHSLRLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFS 185
Query: 61 VGEYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFV 120
G+Y F+V + D ++QW YWKL M++ A DS+ PV +L+V +GL L+ +G+ V
Sbjct: 186 TGDYKFLVGESDCLMQWKGQNYWKLRMHTRANVDSNFPVEYLTVTTSGLALMGRNGTVVV 245
Query: 121 LKVSLD-AAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIGLC----- 174
++V+L ++ FR+AK++ SG+ IVS+ G NLV E + P+++C+IPF C ++GLC
Sbjct: 246 VRVALPPSSDFRVAKMDSSGKFIVSRFSGKNLVPEFSGPMDSCQIPFVCGKLGLCHLDNA 305
Query: 175 -SGGSCSCPSGFHAEL-NGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFAN 232
SCSCP + G CVP+N SLSLP C A N I+YL+LG GV YF+
Sbjct: 306 SENQSCSCPDEMRLDAGKGVCVPVNQSLSLPVSCEARN-------ISYLELGLGVSYFST 358
Query: 233 DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTL---MSSSDNERVR 289
F PV+ + L C DLCS NCSCLG+F++++S SCY +++ G+L +S DN +
Sbjct: 359 QFTDPVEHDLPLLACHDLCSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPDNHDL- 417
Query: 290 LGYIKAMVLSSDGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWR------INSK 343
+GY+K + + GS FP+ LVL+P S + I +G LWWR +S
Sbjct: 418 IGYVKLSIRKQIAQPSVNNNRGSSFPLIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSI 477
Query: 344 RARAKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGIL 403
R + +V + GS S +L I GLP++F YEEL AT+NF IGSGGFG+VYKG L
Sbjct: 478 REK-QVTRPGSFGSG--DLGSFHIPGLPQKFEYEELEQATENFKLQIGSGGFGSVYKGTL 534
Query: 404 QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463
D++++AVKKI + G+ G++EFCTEI IIGNI H NLV+L+GFCA+GRQ LVYEYMN G
Sbjct: 535 PDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHG 594
Query: 464 SLDRTLF-GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVK 522
SL++TLF GNG VLEW+ERF+IALGTARGLAYLH+GCD KIIHCDVKPENILLHD Q K
Sbjct: 595 SLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPK 654
Query: 523 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKN 582
ISDFGLSKLL E+SSLFTTMRGTRGYLAPEW+T++AIS+K DVYSYGMVLLE++SGRKN
Sbjct: 655 ISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714
Query: 583 SSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQV 642
S + +S S +++ N SS++ + VYFPL AL++HEQ RY+ELAD R+EG+V
Sbjct: 715 CSFRSRSNSVTEEN----NQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRV 770
Query: 643 SDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEA 702
+ ++ EKLVRIALCCV EEP LRP+MA VV M EG +PLG PR+ESL FLRFYG RF E+
Sbjct: 771 TSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNPRMESLNFLRFYGLRFAES 830
Query: 703 STIEESNELNLQFILQSETNGTNTTGSYNSLSYISSQQVSGPR 745
S +E N + + + +N+ GS S+SYI+SQ+VSGPR
Sbjct: 831 SMVEGQNGESETMVFHRRES-SNSVGSRQSVSYIASQEVSGPR 872
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725125|ref|NP_001238617.1| receptor-like protein kinase like protein [Glycine max] gi|223452339|gb|ACM89497.1| receptor-like protein kinase like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2058), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/761 (55%), Positives = 528/761 (69%), Gaps = 30/761 (3%)
Query: 2 LDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSV 61
L S+V+ +QL E GNLVLLD N SLW+SF +PTD IV GQ L VG SL+++ S +DLS
Sbjct: 24 LKSQVNRLQLTEMGNLVLLDKSNGSLWESFQNPTDTIVIGQRLPVGASLSSAASNSDLSK 83
Query: 62 GEYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFVL 121
G Y +T D VLQW TYWKLS + +K+S+ + ++++N TG YL G+ F L
Sbjct: 84 GNYKLTITSSDAVLQWYGQTYWKLSTDTRVYKNSNDMLEYMAINNTGFYLFGDGGTVFQL 143
Query: 122 KVSLDAAGFRIAKLEPSGRLIVSKLVG-DNLVQELAIPVENCRIPFFCKEIGLCSGGS-- 178
+ L A FRIAKL SG+ IV+ G +NL QE P + C+ P C GLC+ +
Sbjct: 144 GLPL--ANFRIAKLGTSGQFIVNSFSGTNNLKQEFVGPEDGCQTPLACGRAGLCTENTVS 201
Query: 179 ----CSCPSGFH--AELNGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFAN 232
CSCP FH + G C P N S SLP C + S+ ++L +G V+YF N
Sbjct: 202 SSPVCSCPPNFHVGSGTFGGCEPSNGSYSLPLACKNS------SAFSFLNIGY-VEYFGN 254
Query: 233 DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSD-NERVRLG 291
+ PV V LS CQ LCS NCSCLGIF+ +S SCY IEN LG++ SS+ +ER LG
Sbjct: 255 FYSDPVLYKVNLSACQSLCSSNCSCLGIFYKSTSGSCYMIENELGSIQSSNGGDERDILG 314
Query: 292 YIKAMVLSS-----DGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRAR 346
+IKA+ ++S DG+ E+ +FPVA VL+P I + + FL WR + ++
Sbjct: 315 FIKAITVASTTSSNDGNDDKENSQNGEFPVAVAVLLPIIGFIILMALIFLVWRRLTLMSK 374
Query: 347 AKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDK 406
+ +KLG + SS +L+ I GLP RF YEEL AT+NF T IGSGGFGTVYKG+L DK
Sbjct: 375 MQEVKLGKNSPSSGDLDAFYIPGLPARFDYEELEEATENFKTLIGSGGFGTVYKGVLPDK 434
Query: 407 SVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466
SVVAVKKI + GIQGKK+FCTEI +IGNIHHVNLV+LKGFCAQGR R LVYEYMN+GSLD
Sbjct: 435 SVVAVKKIGNIGIQGKKDFCTEIAVIGNIHHVNLVKLKGFCAQGRHRLLVYEYMNRGSLD 494
Query: 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDF 526
R LFG VLEW+ERF++ALGTARGLAYLH+GC KIIHCD+KPENILL D+ Q KISDF
Sbjct: 495 RNLFGGEPVLEWQERFDVALGTARGLAYLHSGCVQKIIHCDIKPENILLQDQFQAKISDF 554
Query: 527 GLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586
GLSKLL+ EQS LFTTMRGTRGYLAPEWLT+SAI++KTDVYS+GMVLLE++SGRKN +
Sbjct: 555 GLSKLLSAEQSGLFTTMRGTRGYLAPEWLTNSAITEKTDVYSFGMVLLELVSGRKNCYYR 614
Query: 587 IQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDED 646
+S S + +SG +SS+ + VYFPL ALE+HEQR YLELADSR+EG+V+ E+
Sbjct: 615 SRSHSMDDSNSGG----GNSSTSSTTGLVYFPLFALEMHEQRSYLELADSRLEGRVTCEE 670
Query: 647 VEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEASTIE 706
VEKLVRIALCC EEP LRP+M VV MLEGG PL PRIESL FLRFYG+R+ EASTI
Sbjct: 671 VEKLVRIALCCAHEEPALRPNMVTVVGMLEGGTPLPHPRIESLNFLRFYGRRYTEASTIA 730
Query: 707 ESNELNLQFILQSETNGTN--TTGSYNSLSYISSQQVSGPR 745
E NE + Q+ ++ T+ + S SY+SSQ +SGPR
Sbjct: 731 EENEYGSVMLQQARSSTTSMPSDSSTRGFSYMSSQNISGPR 771
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147784458|emb|CAN72729.1| hypothetical protein VITISV_029567 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/718 (57%), Positives = 522/718 (72%), Gaps = 42/718 (5%)
Query: 2 LDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSV 61
L S VS++ L E+GNL+LLD N SLWQSFD PTD IV GQ L VG SL+ ++S+NDLS
Sbjct: 264 LKSSVSALLLAETGNLILLDQFNGSLWQSFDYPTDTIVIGQRLSVGTSLSGALSDNDLST 323
Query: 62 GEYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFVL 121
+Y FVV+ + ++QW+ +TYWKLSM + A+K+S+ V ++++N+TGL+L +GS V+
Sbjct: 324 SDYRFVVSTSNAIMQWHGLTYWKLSMDTSAYKNSNYLVEYMAMNQTGLFLFGRNGSVVVI 383
Query: 122 KVSLDAAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIGLCSGGS--- 178
++ L + FRIAKL+ SG+ I+S L G L QE P + CRIPF C +GLC+ +
Sbjct: 384 QMDLSPSDFRIAKLDASGQFIISTLSGTVLKQEYVGPKDACRIPFICGRLGLCTDDTASN 443
Query: 179 ---CSCPSGFHAELNG--DCVPINSSLSLPNGCSATNASGLN--SSITYLKLGNGVDYFA 231
CSCPSGF A+ +CVP +SS SLP+ C+ TN+ + S ++YL L GV+YFA
Sbjct: 444 SPVCSCPSGFRADPKSVTNCVPSDSSYSLPSPCNLTNSVSQSNLSVVSYLMLAYGVEYFA 503
Query: 232 NDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLG 291
N+F +PV+ GV LS C++LCS +CSCLGIFH++SS SCY +E LG+L+SSS NE V+LG
Sbjct: 504 NNFWEPVQYGVNLSVCENLCSGDCSCLGIFHENSSGSCYLVEXVLGSLISSSTNENVQLG 563
Query: 292 YIKAMVLSS---DGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAK 348
IK +V SS DG+ + +++ +FP+A LVL+PS+ + + +GFLWWR ++ +
Sbjct: 564 XIKVLVGSSPNMDGNNSSSNQS-QEFPIAALVLLPSTGFFLFVALGFLWWR-RWGFSKNR 621
Query: 349 VIKLG-SRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKS 407
+KLG S + SS +L+ SI GLP RF YEE+ AATDNF T IGSGGFG VYKGI+ DK+
Sbjct: 622 DLKLGHSSSPSSXDLDAFSIPGLPIRFEYEEIEAATDNFKTQIGSGGFGAVYKGIMPDKT 681
Query: 408 VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467
+VAVKKI + G+QGKKEFCTEI +IGNIHH MN+ SLDR
Sbjct: 682 LVAVKKITNLGVQGKKEFCTEIAVIGNIHH----------------------MNRXSLDR 719
Query: 468 TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFG 527
TLF NG VLEW+ER +IALGTARGLAYLH+GC+HKIIHCDVKPENILLHD Q KISDFG
Sbjct: 720 TLFSNGPVLEWQERVDIALGTARGLAYLHSGCEHKIIHCDVKPENILLHDNFQAKISDFG 779
Query: 528 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587
LSKLL+PE+S LFTTMRGTRGYLAPEWLTSSAISDKTDVYS+GMVLLE++SGRKN SL+
Sbjct: 780 LSKLLSPEESXLFTTMRGTRGYLAPEWLTSSAISDKTDVYSFGMVLLELVSGRKNCSLRT 839
Query: 588 QSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDV 647
QS S + SG S + VYFPL ALE+HEQ RYLELAD R+EG+V+ E+V
Sbjct: 840 QSHSXDDGXSGG----GHSXLXSGXEPVYFPLFALEMHEQGRYLELADPRLEGRVASEEV 895
Query: 648 EKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEASTI 705
EKLV +ALCCV EEP LRP M +VV MLEGG+ L +PR ESL FLRFYG+RF EAS I
Sbjct: 896 EKLVLVALCCVHEEPTLRPCMVSVVGMLEGGITLSQPRTESLNFLRFYGRRFTEASMI 953
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449507977|ref|XP_004163183.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2004), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/774 (53%), Positives = 528/774 (68%), Gaps = 68/774 (8%)
Query: 2 LDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSL-AASVSENDLS 60
L S ++SM L +SGNL+LLD NVSLW+SF PTD IV GQ L V SL A ++D+S
Sbjct: 117 LSSPIASMLLLDSGNLLLLDHSNVSLWESFHFPTDTIVVGQRLTVMNSLFPAQPDDHDIS 176
Query: 61 VG--EYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSR 118
+G +Y + T D +LQWN++T+WKLSM AF S APVSFL++N +GLYL + DGS
Sbjct: 177 IGGSQYRLLRTSNDLLLQWNRITFWKLSMDLKAFTHSYAPVSFLAMNASGLYLFSGDGST 236
Query: 119 FVLKVSLDAAG------FRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIG 172
V+ VSL+ FR +L GR + + V+E P E C+IP C ++
Sbjct: 237 VVMHVSLNLNSGSSSDFFRFGRLGFDGRFKIMSFINGGFVEEFLGPSEICQIPTICGKLK 296
Query: 173 LCSGGSCSCPSGFHAELNGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFAN 232
LCS G+CSCP F + G CVP +SS+SL + C + SS +YL+L NGVDYFAN
Sbjct: 297 LCSAGTCSCPPSFTGDSRGGCVPADSSISLASSCGNISTLDSKSSFSYLRLMNGVDYFAN 356
Query: 233 DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLGY 292
F++PV G+ L C+DLCS NCSCLG+F+++SS SC I N +G++MS++ R+G+
Sbjct: 357 TFMEPVTHGIDLQFCKDLCSKNCSCLGLFYENSSSSCLLIWNQIGSIMSANKG---RVGF 413
Query: 293 IKAMVLSSDGSKKAEDENGSKFPVAGLVLIPSS--LLAIAIVVGFLWWRINSKRARAKVI 350
IK + ++ +E + + P+ GL+LIPSS L I VV LW+R R R V+
Sbjct: 414 IKTLQIT----PISEGRSRKRIPLVGLILIPSSALFLVITFVVLLLWFR----RWRISVM 465
Query: 351 KLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVA 410
S +SSS ELE++ I GLP R+SY E+A AT+NF T IGSGGFG VYKG L DK++VA
Sbjct: 466 LQRSDSSSSAELEMSLIPGLPIRYSYNEIATATNNFKTQIGSGGFGIVYKGTLSDKTIVA 525
Query: 411 VKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLF 470
VKKI SFG+QG++ FC EI +IGNIHHVNLVRLKGFC QGR R LV EYMN+GSLD LF
Sbjct: 526 VKKITSFGVQGRRNFCAEIGVIGNIHHVNLVRLKGFCLQGRHRVLVLEYMNRGSLDEALF 585
Query: 471 --GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL 528
G+ VLEW++RF+I LGTARGLAYLH+GCDHKIIHCDVKPENILL+D L VKISDFGL
Sbjct: 586 VDGDDPVLEWKDRFQITLGTARGLAYLHSGCDHKIIHCDVKPENILLNDSLGVKISDFGL 645
Query: 529 SKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQ 588
SKLLTPEQS LFTT+RGTRGYLAPEWLTSS ISDKTDVYS+GMV+LEI+ GRKN L+
Sbjct: 646 SKLLTPEQSGLFTTLRGTRGYLAPEWLTSSTISDKTDVYSFGMVVLEIVRGRKNWLLQ-- 703
Query: 589 SRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVE 648
E +RVYFPLLAL++H + RYLEL D R+EG+V ++VE
Sbjct: 704 ----------------------EEERVYFPLLALQMHMEGRYLELVDPRLEGKVRSDEVE 741
Query: 649 KLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEASTIEES 708
LVR+ LCCV E+P +RP+MANVV MLEGG+P+ +P +ESL FL YG+RF+EA+ +E
Sbjct: 742 MLVRVGLCCVHEDPAMRPTMANVVGMLEGGIPMADPIVESLSFLYLYGRRFSEATMVE-- 799
Query: 709 NELNLQ--FILQ-SETNGTNTTGSY--------------NSLSYISSQQVSGPR 745
L LQ F LQ + T T+T+ + ++ SYISSQQVSGPR
Sbjct: 800 -NLTLQDPFALQRALTLATSTSTRHGHPHNREKNNNDVISTFSYISSQQVSGPR 852
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449449938|ref|XP_004142721.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/757 (54%), Positives = 520/757 (68%), Gaps = 58/757 (7%)
Query: 2 LDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSL-AASVSENDLS 60
L S ++SM L +SGNL+LLD NVSLW+SF PTD IV GQ L V SL A ++D+S
Sbjct: 117 LSSPIASMLLLDSGNLLLLDHSNVSLWESFHYPTDTIVVGQRLTVMNSLFPAQPDDHDIS 176
Query: 61 VG--EYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSR 118
+G +Y ++T D +LQWN++T+WKLSM AF S APVSFL++N +GLYL + DGS
Sbjct: 177 IGGSQYRLLLTSNDLLLQWNRITFWKLSMDLKAFTHSYAPVSFLAMNASGLYLFSGDGST 236
Query: 119 FVLKVSLDAAG------FRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIG 172
V+ VSL+ FR +L GR + + V+E P E C+IP C ++
Sbjct: 237 VVMHVSLNLNSGSSSDFFRFGRLGFDGRFKIMSFINGGFVEEFLGPSEICQIPTICGKLK 296
Query: 173 LCSGGSCSCPSGFHAELNGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFAN 232
LCS G+CSCP F + G CVP +SS+SL + C ++ SS +YL+L NGVDYFAN
Sbjct: 297 LCSAGTCSCPPSFTGDSRGGCVPADSSISLASSCGNISSLDSKSSFSYLRLMNGVDYFAN 356
Query: 233 DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLGY 292
F++PV GV L C+ LCS NCSCLG+F+++SS SC I N +G++MS++ R+G+
Sbjct: 357 TFMEPVTHGVDLQFCKYLCSKNCSCLGLFYENSSSSCLLIWNQIGSIMSANKG---RVGF 413
Query: 293 IKAMVLSSDGSKKAEDENGSKFPVAGLVLIPSS--LLAIAIVVGFLWWRINSKRARAKVI 350
IK + ++ +E + + P+ GL+LIPSS L I VV LW+R R R V+
Sbjct: 414 IKTLQIT----PISEGRSRKRIPLVGLILIPSSALFLVITFVVLLLWFR----RWRISVM 465
Query: 351 KLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVA 410
S +SSS ELE++ I GLP R+SY E+A AT+NF T IGSGGFG VYKG L DK++VA
Sbjct: 466 LQRSDSSSSAELEMSLIPGLPIRYSYNEIATATNNFKTQIGSGGFGIVYKGTLSDKTIVA 525
Query: 411 VKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLF 470
VKKI SFG+QG++ FC EI +IGNIHHVNLVRLKGFC QGR R LV EYMN+GSLD LF
Sbjct: 526 VKKITSFGVQGRRNFCAEIGVIGNIHHVNLVRLKGFCLQGRHRVLVLEYMNRGSLDEALF 585
Query: 471 --GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL 528
G+ VLEW++RF+I LGTARGLAYLH+GCDHKIIHCDVKPENILL+D L VKISDFGL
Sbjct: 586 VDGDDPVLEWKDRFQITLGTARGLAYLHSGCDHKIIHCDVKPENILLNDSLGVKISDFGL 645
Query: 529 SKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQ 588
SKLLTPEQS LFTT+RGTRGYLAPEWLTSS ISDKTDVYS+GMV+LEI+ GRKN L+
Sbjct: 646 SKLLTPEQSGLFTTLRGTRGYLAPEWLTSSTISDKTDVYSFGMVVLEIVRGRKNWLLQ-- 703
Query: 589 SRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVE 648
E +RVYFPLLAL++H + RYLEL D R+EG+V ++VE
Sbjct: 704 ----------------------EEERVYFPLLALQMHMEGRYLELVDPRLEGKVRSDEVE 741
Query: 649 KLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEASTIEES 708
LVR+ LCCV E+P +RP+MANVV MLEGG+P+ +P +ESL FL YG+RF+EA+ +E
Sbjct: 742 MLVRVGLCCVHEDPAMRPTMANVVGMLEGGIPMADPIVESLSFLYLYGRRFSEATMVE-- 799
Query: 709 NELNLQFILQSETNGTNTTGSYNSLSYISSQQVSGPR 745
LQ N + ++ SYISSQQVSGPR
Sbjct: 800 -----NLTLQDPFNNNDIISTF---SYISSQQVSGPR 828
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 745 | ||||||
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.983 | 0.840 | 0.517 | 4.5e-201 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.748 | 0.679 | 0.404 | 1.3e-122 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.739 | 0.664 | 0.358 | 1e-90 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.547 | 0.492 | 0.390 | 6.7e-75 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.441 | 0.407 | 0.368 | 3.8e-68 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.463 | 0.426 | 0.385 | 1.7e-65 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.373 | 0.439 | 0.406 | 6e-65 | |
| TAIR|locus:2147635 | 452 | AT5G20050 [Arabidopsis thalian | 0.455 | 0.75 | 0.408 | 2.9e-64 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.748 | 0.679 | 0.301 | 3.2e-64 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.451 | 0.418 | 0.380 | 3.1e-63 |
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1946 (690.1 bits), Expect = 4.5e-201, P = 4.5e-201
Identities = 393/760 (51%), Positives = 517/760 (68%)
Query: 1 MLDSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLS 60
+L S V S++L ++GNL+LLD NVSLW+SFD PTD+IV GQ L++G L+ SVS +D S
Sbjct: 125 VLASPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFS 184
Query: 61 VGEYSFVVTDGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFV 120
G+Y F+V + DG++QW YWKL M+ A DS+ PV +L+V +GL L+A +G+ V
Sbjct: 185 TGDYKFLVGESDGLMQWRGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVV 244
Query: 121 LKVSLD-AAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIXXXXXXXX 179
++V+L ++ FR+AK++ SG+ IVS+ G NLV E + P+++C+IPF C ++
Sbjct: 245 VRVALPPSSDFRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNA 304
Query: 180 XXXXXFHA--ELNGD-----CVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFAN 232
E+ D CVP++ SLSLP C A N I+YL+LG GV YF+
Sbjct: 305 SENQSCSCPDEMRMDAGKGVCVPVSQSLSLPVSCEARN-------ISYLELGLGVSYFST 357
Query: 233 DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTL--MSSSDNERVRL 290
F PV+ G+ L C D+CS NCSCLG+F++++S SCY +++ G+L + +S +
Sbjct: 358 HFTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLI 417
Query: 291 GYIKAMVLSSDGSKKAEDENG-SKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKV 349
GY+K + ++ + G S FPV LVL+P S + I +G LWWR + + +
Sbjct: 418 GYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSI 477
Query: 350 I-KLGSRNSSSEELELTS--IAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDK 406
K +R S E +L S I GLP++F +EEL AT+NF IGSGGFG+VYKG L D+
Sbjct: 478 REKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDE 537
Query: 407 SVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466
+++AVKKI + G+ G++EFCTEI IIGNI H NLV+L+GFCA+GRQ LVYEYMN GSL+
Sbjct: 538 TLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLE 597
Query: 467 RTLF-GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525
+TLF GNG VLEW+ERF+IALGTARGLAYLH+GCD KIIHCDVKPENILLHD Q KISD
Sbjct: 598 KTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISD 657
Query: 526 FGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585
FGLSKLL E+SSLFTTMRGTRGYLAPEW+T++AIS+K DVYSYGMVLLE++SGRKN S
Sbjct: 658 FGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSF 717
Query: 586 KIQSRSTEKXXXXXXXXXXXXXXXRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDE 645
+ +S S + VYFPL AL++HEQ RY+ELAD R+EG+V+ +
Sbjct: 718 RSRSNSVTEDNNQNHSSTTTTSTGL----VYFPLYALDMHEQGRYMELADPRLEGRVTSQ 773
Query: 646 DVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRIESLRFLRFYGQRFNEASTI 705
+ EKLVRIALCCV EEP LRP+MA VV M EG +PLG PR+ESL FLRFYG RF E+S +
Sbjct: 774 EAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNPRMESLNFLRFYGLRFAESSMV 833
Query: 706 EESNELNLQFILQSEXXXXXXXXSYNSLSYISSQQVSGPR 745
E N + + S S SYI+SQ+VSGPR
Sbjct: 834 EGQNGESETMVFHRRESSNSGG-SRQSASYIASQEVSGPR 872
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-122, Sum P(2) = 1.3e-122
Identities = 238/589 (40%), Positives = 350/589 (59%)
Query: 7 SSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYSF 66
S ++L++SGNLV++ S+W+SFD PTD ++T Q + G L +S S ++++ Y+
Sbjct: 123 SRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMT---YAL 179
Query: 67 VVTDGDGVLQWNQMT---YWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSR----- 118
+ GD VL N +T YW ++ + D V S + G D +
Sbjct: 180 EIKSGDMVLSVNSLTPQVYWSMANARERIINKDGGV-VTSSSLLGNSWRFFDQKQVLLWQ 238
Query: 119 FVLKVSLDAAGFRIAKLEPSGRLIVSKL-VGDNLVQELA-IPVENCRIPFFCKEIXXXXX 176
FV + D IA L +G + S L G + IP + C P C
Sbjct: 239 FVFSDNKDDNTTWIAVLGNNGVISFSNLGSGASAADSSTKIPSDLCGTPEPCGPYYVCSG 298
Query: 177 XXXXXXXXFHAELNGDCVPINSSLSLPNGCSATNASGLNSSITYLKLGNGVDYFANDFIQ 236
+ DC + ++ P C T + + + G+GVDYFA +
Sbjct: 299 SKVCGCVSGLSRARSDC---KTGITSP--CKKTKDNA-TLPLQLVSAGDGVDYFALGYAP 352
Query: 237 PVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLGYIKAM 296
P + L C++ C NCSCLG+F +SS +C F+ +++G+ +S + + YIK
Sbjct: 353 PFSKKTDLDSCKEFCHNNCSCLGLFFQNSSGNC-FLFDYIGSFKTSGNGGSGFVSYIKIA 411
Query: 297 VLSSDGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKVIKLGSRN 356
S G ED+ G FP ++++ ++ IA+++ F+ +RI+ ++ K+I +
Sbjct: 412 STGSGGGDNGEDD-GKHFPYV-VIIVVVTVFIIAVLI-FVAFRIHKRK---KMILEAPQE 465
Query: 357 SSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINS 416
SS E+ L +++G+P RF+Y++L +AT+NF+ +G GGFG+VY+G L D S +AVKK+
Sbjct: 466 SSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEG 525
Query: 417 FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFG--NGS 474
G QGKKEF E++IIG+IHH++LVRL+GFCA+G R L YE+++KGSL+R +F +G
Sbjct: 526 IG-QGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGD 584
Query: 475 VL-EWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT 533
VL +W RF IALGTA+GLAYLH CD +I+HCD+KPENILL D K+SDFGL+KL+T
Sbjct: 585 VLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMT 644
Query: 534 PEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKN 582
EQS +FTTMRGTRGYLAPEW+T+ AIS+K+DVYSYGMVLLE+I GRKN
Sbjct: 645 REQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKN 693
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 1.0e-90, Sum P(2) = 1.0e-90
Identities = 214/597 (35%), Positives = 309/597 (51%)
Query: 6 VSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYS 65
V+S ++++G +LL+ R+V +W SFD+PTD IV Q GK L + G YS
Sbjct: 114 VTSGSIEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQNFTAGKILRS---------GLYS 164
Query: 66 FVVT-DGDGVLQWNQMT-YWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASD---GSRFV 120
F + G+ L+WN YW + S + +P L N + + S+ G+ V
Sbjct: 165 FQLERSGNLTLRWNTSAIYWNHGLNSSFSSNLSSPRLSLQTNGV-VSIFESNLLGGAEIV 223
Query: 121 LKVSL-DAAGFRIAKLEPSGRLIVSKLVGDNL--VQELAIPVENCRIPFFCKEIXXXXXX 177
D+ FR KL+ G L + N V V+ C + +C
Sbjct: 224 YSGDYGDSNTFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAVDQCLVYGYCGNFGICSYN 283
Query: 178 XXXXXXXFHAELNGDCVPINSSLSLPNGCSA-TNASGLNSSITYLKLGNGVDYFANDFIQ 236
+ N D V +N GC S + + T L L + + D
Sbjct: 284 DTNPICSCPSR-NFDFVDVNDRRK---GCKRKVELSDCSGNTTMLDLVHTRLFTYEDDPN 339
Query: 237 PVKRGVGLSDCQDLCSWNCSCLG-IFHDDSSESCYFIENHLGTLMSSSDNERV-RLGYIK 294
G S C+ C + CL + D S +C+ + H G+ + V Y+K
Sbjct: 340 SESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCW--QKHPGSFFTGYQWPSVPSTSYVK 397
Query: 295 AM--VLSSDGSKKAE-DENGSKFP--VAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKV 349
V+++ + + D+N SK + + +I L +A+ +G LWW K R
Sbjct: 398 VCGPVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIG-LWWCCCRKNPR--- 453
Query: 350 IKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVV 409
G+ +S LE S G P +F+Y+EL T +F +G+GGFGTVY+G+L +++VV
Sbjct: 454 --FGTLSSHYTLLEYAS--GAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVV 509
Query: 410 AVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRT 468
AVK++ GI QG+K+F E+ I + HH+NLVRL GFC+QGR R LVYE+M GSLD
Sbjct: 510 AVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNF 567
Query: 469 LFGNGSV--LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDF 526
LF S L W RF IALGTA+G+ YLH C I+HCD+KPENIL+ D K+SDF
Sbjct: 568 LFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDF 627
Query: 527 GLSKLLTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKN 582
GL+KLL P+ + +++RGTRGYLAPEWL + I+ K+DVYSYGMVLLE++SG++N
Sbjct: 628 GLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRN 684
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 682 (245.1 bits), Expect = 6.7e-75, Sum P(2) = 6.7e-75
Identities = 172/441 (39%), Positives = 246/441 (55%)
Query: 244 LSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSD-NERVRLGYIKAMVLSSDG 302
LS C C +CSC +D+ S C + L D N + Y++ + S
Sbjct: 369 LSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLR-LAASDVP 427
Query: 303 SKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKVIKLGSRNSSSEEL 362
+ A ++ +K + G VL ++ + ++V L R +R R + G + +
Sbjct: 428 NVGASGKSNNKGLIFGAVLGSLGVIVLVLLVVILILRYR-RRKRMR----GEKGDGT--- 479
Query: 363 ELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGK 422
L++ FSY EL AT NF+ +G GGFG+V+KG L D S +AVK++ QG+
Sbjct: 480 -LSA-------FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGIS-QGE 530
Query: 423 KEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGS----VLEW 478
K+F TE+ IG I HVNLVRL+GFC++G ++ LVY+YM GSLD LF N VL W
Sbjct: 531 KQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGW 590
Query: 479 RERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538
+ RF+IALGTARGLAYLH C IIHCD+KPENILL + K++DFGL+KL+ + S
Sbjct: 591 KLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSR 650
Query: 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKXXXX 598
+ TTMRGTRGYLAPEW++ AI+ K DVYSYGM+L E++SGR+N+ QS + EK
Sbjct: 651 VLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTE---QSEN-EKVRFF 706
Query: 599 XXXXXXXXXXXRESQRVYFPLL---ALELHEQRRYLELADSRIEGQVSDED-VEKLVRI- 653
+ + + P L A+++ E R ++A I+ + S + ++V+I
Sbjct: 707 PSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQIL 766
Query: 654 -ALCCVQEEPMLRPSMANVVS 673
+ V P R A VVS
Sbjct: 767 EGVLEVNPPPFPRSIQALVVS 787
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 3.8e-68, Sum P(4) = 3.8e-68
Identities = 128/347 (36%), Positives = 191/347 (55%)
Query: 242 VGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLGYIKAMVLSSD 301
V + +CQ C NCSCL + D + ++ + + S E + + ++ +
Sbjct: 363 VNVEECQKSCLHNCSCLAFAYIDGIGCLMWNQDLMDAVQFSEGGELLSIRLARSEL---G 419
Query: 302 GSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKVIKLGSRNSSSEE 361
G+K+ K A +V + SL+ I V F +WR K A + S+ S +
Sbjct: 420 GNKR------KKAITASIVSL--SLVVIIAFVAFCFWRYRVKH-NADITTDASQVSWRND 470
Query: 362 LELTSIAGLPRRFSYEELAAATDNFN--TPIGSGGFGTVYKGILQDKSVVAVKKINSFGI 419
L+ + GL F + AT+NF+ +G GGFG VYKG LQD +AVK+++S
Sbjct: 471 LKPQDVPGLDF-FDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSG 529
Query: 420 QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLE-- 477
QGK+EF EI +I + H NLVR+ G C +G ++ L+YE+M SLD LF + LE
Sbjct: 530 QGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEID 589
Query: 478 WRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT-PEQ 536
W +R +I G ARG+ YLH K+IH D+K NILL +K+ KISDFGL+++ E
Sbjct: 590 WPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEY 649
Query: 537 SSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNS 583
+ GT GY+APE+ + S+K+D+YS+G+++LEIISG K S
Sbjct: 650 QDNTRRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKIS 696
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 1.7e-65, Sum P(3) = 1.7e-65
Identities = 145/376 (38%), Positives = 208/376 (55%)
Query: 222 KLGNGVDYFAN----DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLG 277
K NG + AN DF + V C +C NCSCL Y N +G
Sbjct: 340 KTVNGFYHVANIKPPDFYE-FASFVDAEGCYQICLHNCSCLAF--------AYI--NGIG 388
Query: 278 TLMSSSD-NERVRL---GYIKAMVLSSDGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVV 333
LM + D + V+ G I ++ L+S S+ ++ +K VA +V + SL I
Sbjct: 389 CLMWNQDLMDAVQFSAGGEILSIRLAS--SELGGNKR-NKIIVASIVSL--SLFVILAFA 443
Query: 334 GFLWWRINSKRA-RAKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFN--TPI 390
F + R K AK+ K+ S+ + + +LE ++GL + F + ATDNF+ +
Sbjct: 444 AFCFLRYKVKHTVSAKISKIASKEAWNNDLEPQDVSGL-KFFEMNTIQTATDNFSLSNKL 502
Query: 391 GSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG 450
G GGFG+VYKG LQD +AVK+++S QGK+EF EI +I + H NLVR+ G C +G
Sbjct: 503 GQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEG 562
Query: 451 RQRFLVYEYMNKGSLDRTLFGNGSVLE--WRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+R LVYE++ SLD LF + LE W +RF I G ARGL YLH ++IH D+
Sbjct: 563 EERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDL 622
Query: 509 KPENILLHDKLQVKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
K NILL +K+ KISDFGL+++ E + GT GY+APE+ + S+K+D+Y
Sbjct: 623 KVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIY 682
Query: 568 SYGMVLLEIISGRKNS 583
S+G++LLEII+G K S
Sbjct: 683 SFGVILLEIITGEKIS 698
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 6.0e-65, Sum P(4) = 6.0e-65
Identities = 119/293 (40%), Positives = 172/293 (58%)
Query: 296 MVLSSDGSKKAEDE-NGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKVIKLGS 354
+ L DG ++ NG +A ++ FLWWR R K I
Sbjct: 218 LTLPQDGPDESGTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYR----RNKQIFFDV 273
Query: 355 RNSSSEELELTSIAGLPRRFSYEELAAATDNFNTP--IGSGGFGTVYKGILQDKSVVAVK 412
E+ L G +R++++EL +AT++FN+ +G GG+G VYKG L D ++VAVK
Sbjct: 274 NEQYDPEVSL----GHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVK 329
Query: 413 KINSFGIQGKK-EFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFG 471
++ I G + +F TE+ I H NL+RL+GFC+ ++R LVY YM GS+ L
Sbjct: 330 RLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKD 389
Query: 472 N--GS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL 528
N G L+W R +IA+GTARGL YLH CD KIIH DVK NILL + + + DFGL
Sbjct: 390 NIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 449
Query: 529 SKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRK 581
+KLL S + T +RGT G++APE+L++ S+KTDV+ +G++LLE+I+G+K
Sbjct: 450 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQK 502
|
|
| TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 2.9e-64, P = 2.9e-64
Identities = 151/370 (40%), Positives = 221/370 (59%)
Query: 329 IAIVVGFLWWRINSKRARAKVIKLGSRNSSSEELE---LTSIAGLPRRFSYEELAAATDN 385
I V+ FL R + R ++ + +E L +AG+P +F E+L ATD
Sbjct: 45 ILAVICFLIIRSRYNKERKLLVSRFASEGRELRIEYSFLRKVAGVPTKFKLEDLEEATDG 104
Query: 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
F + IG GG G+V+KG+L+D S VAVK+I +G++EF +E+ I ++ H NLVRL G
Sbjct: 105 FRSLIGKGGSGSVFKGVLKDGSQVAVKRIEGEE-KGEREFRSEVAAIASVQHKNLVRLYG 163
Query: 446 FCAQ---GRQRFLVYEYMNKGSLDRTLF---GN-----GSVLEWRERFEIALGTARGLAY 494
+ + R RFLVY+Y+ SLD +F GN G L W +R+++A+ A+ LAY
Sbjct: 164 YSSSTSANRPRFLVYDYIVNSSLDIWIFPDRGNRGRSGGGCLSWEQRYQVAIDVAKALAY 223
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
LH C KI+H DVKPENILL + + ++DFGLSKL+ ++S + T +RGTRGYLAPEW
Sbjct: 224 LHHDCRSKILHLDVKPENILLDENFRAVVTDFGLSKLIARDESRVLTDIRGTRGYLAPEW 283
Query: 555 LTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKXXXXXXXXXXXXXXXRESQR 614
L IS+K+DVYSYG+VLLE+I GR++ S +++ + T+K RE +
Sbjct: 284 LLEHGISEKSDVYSYGIVLLEMIGGRRSIS-RVEVKETKKKKLEYFPRIVNQKM-RERK- 340
Query: 615 VYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674
+E+ +QR +E+ +V +E+V KLV +AL C+QE+ RP M V+ M
Sbjct: 341 ------IMEIVDQR-LIEV------NEVDEEEVMKLVCVALWCIQEKSKKRPDMTMVIEM 387
Query: 675 LEGGMPLGEP 684
LEG +P+ EP
Sbjct: 388 LEGRVPVNEP 397
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 3.2e-64, Sum P(3) = 3.2e-64
Identities = 181/601 (30%), Positives = 281/601 (46%)
Query: 10 QLQESGNLVLLDARNVS---LWQSFDSPTDAIVTGQTLRVG------KSLAASVSENDLS 60
+L ++GNLV++D NV+ LWQSF+ D ++ +L + L + SE D S
Sbjct: 118 ELLDTGNLVVVD--NVTGNYLWQSFEHLGDTMLPLTSLMYDIPNNKKRVLTSWKSETDPS 175
Query: 61 VGEYSFVVTD---GDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLS-VNRTGLYLLASDG 116
GE+ +T G+++ YW+ ++ + + P S VN G+ +G
Sbjct: 176 PGEFVAEITPQVPSQGLIRKGSSPYWRSGPWA-GTRFTGIPEMDASYVNPLGMVQDEVNG 234
Query: 117 SRFVLKVSLDAAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENCRIPFFCKEIXXXXX 176
+ L KL P G L +++ G + ++ P+ +C + C
Sbjct: 235 TGVFAFCVLRNFNLSYIKLTPEGSLRITRNNGTDWIKHFEGPLTSCDLYGRCGPFGLCVR 294
Query: 177 XXXXXXXXFHA-ELNGDCVPINSSLSLPNGC-SATNASGL-NSSITYLKLGNGVDYFAND 233
E D + + S GC TN S NSS+ V Y ++
Sbjct: 295 SGTPMCQCLKGFEPKSDEEWRSGNWS--RGCVRRTNLSCQGNSSVETQGKDRDVFYHVSN 352
Query: 234 FIQPVKRGVGL----SDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVR 289
P + C C NCSC + + + L T+ E +
Sbjct: 353 IKPPDSYELASFSNEEQCHQGCLRNCSCTAFSYVSGIGCLVWNQELLDTVKFIGGGETLS 412
Query: 290 LGYIKAMVLSSDGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKV 349
L + + G K+ + VA L L S+ I ++V WR K+ + +
Sbjct: 413 LRLAHSELT---GRKRIKI-----ITVATLSL---SVCLILVLVACGCWRYRVKQNGSSL 461
Query: 350 I-KLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNT--PIGSGGFGTVYKGILQDK 406
+ K + +L+ ++GL F +L AT+NF+ +G GGFGTVYKG LQD
Sbjct: 462 VSKDNVEGAWKSDLQSQDVSGL-NFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDG 520
Query: 407 SVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466
+AVK++ S +QG +EF EI +I + H NL+RL G C G ++ LVYEYM SLD
Sbjct: 521 KEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLD 580
Query: 467 RTLFGNGSVLE--WRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKIS 524
+F LE W RF I G ARGL YLH +++H D+K NILL +K+ KIS
Sbjct: 581 IFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKIS 640
Query: 525 DFGLSKLLTPEQSSLFT-TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNS 583
DFGL++L Q T ++ GT GY++PE+ + S+K+D+YS+G+++LEII+G++ S
Sbjct: 641 DFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEIS 700
Query: 584 S 584
S
Sbjct: 701 S 701
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 3.1e-63, Sum P(3) = 3.1e-63
Identities = 136/357 (38%), Positives = 196/357 (54%)
Query: 233 DFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLGY 292
DF + V G +C C NCSCL + + C L +M S G
Sbjct: 350 DFYEFVSSG-SAEECYQSCLHNCSCLAFAYINGI-GCLIWNQELMDVMQFSVG-----GE 402
Query: 293 IKAMVLSSDGSKKAEDENGSKFPVAGLVLIPSSLLAIAIVVGFLWWRINSKRARAKVIKL 352
+ ++ L+S S+ ++ K +A +V I SL F +WR K A V K+
Sbjct: 403 LLSIRLAS--SEMGGNQR-KKTIIASIVSI--SLFVTLASAAFGFWRYRLKH-NAIVSKV 456
Query: 353 GSRNSSSEELELTSIAGLPRRFSYEELAAATDNFN--TPIGSGGFGTVYKGILQDKSVVA 410
+ + +L+ ++GL F + + AT+NF+ +G GGFG VYKG LQD +A
Sbjct: 457 SLQGAWRNDLKSEDVSGL-YFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIA 515
Query: 411 VKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLF 470
VK+++S QGK+EF EI +I + H+NLVR+ G C +G +R LVYE+M SLD +F
Sbjct: 516 VKRLSSSSGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIF 575
Query: 471 GNGSVLE--WRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL 528
+ +E W +RF I G ARGL YLH +IIH DVK NILL DK+ KISDFGL
Sbjct: 576 DSRKRVEIDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGL 635
Query: 529 SKLL--TPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNS 583
+++ T Q + + GT GY++PE+ + S+K+D YS+G++LLE+ISG K S
Sbjct: 636 ARMYEGTKYQDNTRRIV-GTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKIS 691
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O65238 | Y5537_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5326 | 0.9758 | 0.8337 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 745 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-27 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-11 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 9e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 7e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 1e-53
Identities = 81/196 (41%), Positives = 106/196 (54%), Gaps = 9/196 (4%)
Query: 389 PIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKE--FCTEITIIGNIHHVNLVRLKG 445
+GSG FGTVYK + +VAVK + + KK+ EI I+ + H N+VRL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+LV EY G L L G L E +IAL RGL YLH + IIH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGIIH 121
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL-TSSAISDKT 564
D+KPENILL + VKI+DFGL+K L SS TT GT Y+APE L + K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 565 DVYSYGMVLLEIISGR 580
DV+S G++L E+++G+
Sbjct: 181 DVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 7e-52
Identities = 79/191 (41%), Positives = 103/191 (53%), Gaps = 8/191 (4%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
+G GGFGTVY + VA+K I +E EI I+ ++H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+LV EY GSL L N L E I L GL YLH + IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 508 VKPENILLH-DKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE-WLTSSAISDKTD 565
+KPENILL D +VK++DFGLSKLLT SL T+ GT Y+APE L S+K+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 566 VYSYGMVLLEI 576
++S G++L E+
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 88/299 (29%), Positives = 127/299 (42%), Gaps = 53/299 (17%)
Query: 386 FNTPIGSGGFGTVYKGILQDKSV-----VAVKKI-NSFGIQGKKEFCTEITIIGNIHHVN 439
+G G FG VYKG L+ K VAVK + Q +EF E I+ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+V+L G C + ++V EYM G L L N L + AL ARG+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE--- 119
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLT 556
IH D+ N L+ + L VKISDFGLS+ L + RG + ++APE L
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPESLK 176
Query: 557 SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616
+ K+DV+S+G++L EI + G P Y
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT--------------------LG------EQP------Y 204
Query: 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675
+ E+ E YL+ R+ +L + L C E+P RP+ + +V +L
Sbjct: 205 PGMSNEEVLE---YLK-NGYRLP--QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 3e-50
Identities = 68/194 (35%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGF 446
+G G FG VY + +VA+K I I+ +E EI I+ + H N+VRL
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
+ +LV EY G L L G + E RF L YLH I+H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLH---SKGIVHR 121
Query: 507 DVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDV 566
D+KPENILL + VK++DFGL++ L P TT GT Y+APE L D+
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 567 YSYGMVLLEIISGR 580
+S G++L E+++G+
Sbjct: 180 WSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-48
Identities = 85/300 (28%), Positives = 124/300 (41%), Gaps = 54/300 (18%)
Query: 386 FNTPIGSGGFGTVYKGILQDKSV-----VAVKKI-NSFGIQGKKEFCTEITIIGNIHHVN 439
+G G FG VYKG L+ K VAVK + Q +EF E I+ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTL-FGNGSVLEWRERFEIALGTARGLAYLHTG 498
+V+L G C + +V EYM G L L L + AL ARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWL 555
IH D+ N L+ + L VKISDFGLS+ L + ++G + ++APE L
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YKVKGGKLPIRWMAPESL 176
Query: 556 TSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615
+ K+DV+S+G++L EI + G P S E
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT--------------------LGEEPYPGMSNAE---- 212
Query: 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675
LE ++ L +L ++ L C E+P RP+ + +V +L
Sbjct: 213 -----VLEYLKKGYRLPK---------PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 386 FNTPIGSGGFGTVYKGIL-----QDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVN 439
+G G FG VYKG L ++ VAVK + + ++EF E +I+ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+VRL G C QG ++V EYM G L L +G L ++ ++AL A+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE--- 119
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLT 556
+H D+ N L+ + L VKISDFGLS+ + + G + ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY--RKRGGGKLPIKWMAPESLK 177
Query: 557 SSAISDKTDVYSYGMVLLEIISG 579
+ K+DV+S+G++L EI +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 3e-42
Identities = 89/308 (28%), Positives = 132/308 (42%), Gaps = 67/308 (21%)
Query: 389 PIGSGGFGTVYKGILQDKS----VVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG VYKG L+ K VAVK + + +K+F E ++ + H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTL--------FGNGSVLEWRERFEIALGTARGLAYL 495
G C + +LV EYM G L L S L ++ A+ A+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG-----YL 550
K +H D+ N L+ + L VKISDFGLS+ + + + T G ++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY----YRKKTGGKLPIRWM 174
Query: 551 APEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPR 610
APE L + K+DV+S+G++L EI + G ++P
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFT----------------------LG----ATP- 207
Query: 611 ESQRVYFPLLALELHEQRRYLELADSRIE--GQVSDEDVEKLVRIALCCVQEEPMLRPSM 668
Y L E+ E YL R+ DE L + L C Q +P RP+
Sbjct: 208 -----YPGLSNEEVLE---YLR-KGYRLPKPEYCPDE----LYELMLSCWQLDPEDRPTF 254
Query: 669 ANVVSMLE 676
+ +V LE
Sbjct: 255 SELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 8e-36
Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
IG GGFG VYK + VA+K I + K++ EI I+ H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ + ++V E+ + GSL L L + + +GL YLH + IIH D
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRD 123
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
+K NILL +VK+ DFGLS L+ ++ TM GT ++APE + K D++
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTMVGTPYWMAPEVINGKPYDYKADIW 181
Query: 568 SYGMVLLEIISGR 580
S G+ +E+ G+
Sbjct: 182 SLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKG 445
+G G G VYK + + A+KKI+ G + +K+ E+ + + +V+ G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 446 -FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF--EIALGTARGLAYLHTGCDHK 502
F +G + +V EYM+ GSL L V + E IA +GL YLHT
Sbjct: 67 AFYKEG-EISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--KRH 120
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
IIH D+KP N+L++ K +VKI+DFG+SK+L T GT Y++PE + + S
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-DQCNTFVGTVTYMSPERIQGESYSY 179
Query: 563 KTDVYSYGMVLLEIISGR 580
D++S G+ LLE G+
Sbjct: 180 AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRLKG 445
+G G FG+VY + +D ++AVK + ++E EI I+ ++ H N+VR G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 446 FC--AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA---RGLAYLHTGCD 500
+ + EY++ GSL L G + E I T GLAYLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE----PVIRKYTRQILEGLAYLH---S 119
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLL-TPEQSSLFTTMRGTRGYLAPEWLTSSA 559
+ I+H D+K NIL+ VK++DFG +K L E ++RGT ++APE +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 560 ISDKTDVYSYGMVLLEIISGR 580
D++S G ++E+ +G+
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 6e-31
Identities = 78/242 (32%), Positives = 114/242 (47%), Gaps = 20/242 (8%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKIN---SFGIQGKKEFCTEITIIGNI-HHVNLVRLKG 445
+G G FG VY +D+ +VA+K + + + F EI I+ ++ H N+V+L
Sbjct: 8 LGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTL--FGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
F +LV EY++ GSL+ L G L E I L YLH+ I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 504 IHCDVKPENILLHDKL-QVKISDFGLSKLLTPEQSS-----LFTTMRGTRGYLAPEWLTS 557
IH D+KPENILL VK+ DFGL+KLL S+ L +T GT GY+APE L
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 558 S---AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614
S +D++S G+ L E+++G + S +T + P+ S + S
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 615 VY 616
Sbjct: 243 NP 244
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 390 IGSGGFGTVYKG---ILQDKS--VVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG V L D + VAVK +N S Q + +F EI I+ + H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 444 KGFC--AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
KG C GR L+ EY+ GSL L + + + + +G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQ 128
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLT----------PEQSSLFTTMRGTRGYLA 551
+ IH D+ NIL+ + VKISDFGL+K+L P +S +F + A
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF--------WYA 180
Query: 552 PEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSS 584
PE L +S S +DV+S+G+ L E+ + G + S
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 68/193 (35%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
IG G FG V G + + V AVK + + F E +++ + H NLV+L G Q
Sbjct: 14 IGKGEFGDVMLGDYRGQKV-AVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 450 GRQRFLVYEYMNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
G ++V EYM KGSL L G +V+ ++ AL G+ YL + +H D+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDL 128
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
N+L+ + L K+SDFGL+K + Q S ++ T APE L S K+DV+S
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVWS 184
Query: 569 YGMVLLEIIS-GR 580
+G++L EI S GR
Sbjct: 185 FGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 15/198 (7%)
Query: 390 IGSGGFGTVYKGILQDKS----VVAVKKINSFGIQGKK--EFCTEITIIGNIHHVNLVRL 443
IG G FG V +G L+ VA+K + + G K+ +F TE +I+G H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-GSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+G + R ++ EYM GSLD+ L N + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG---TRGYLAPEWLTSSAI 560
+H D+ NIL++ L K+SDFGLS+ L + + +TT G R + APE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLE-DSEATYTTKGGKIPIR-WTAPEAIAYRKF 185
Query: 561 SDKTDVYSYGMVLLEIIS 578
+ +DV+S+G+V+ E++S
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 362 LELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQ 420
L+ G PR Y+ L IG G G VYK VA+KK+ Q
Sbjct: 8 LKDIVSEGDPREL-YKNL--------EKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQ 57
Query: 421 GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRE 480
K+ EI I+ + H N+V G + ++V EYM+ GSL + N + +
Sbjct: 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ 117
Query: 481 RFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540
+ +GL YLH+ +IH D+K +NILL VK++DFG + LT E+S
Sbjct: 118 IAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR- 173
Query: 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
++ GT ++APE + K D++S G++ +E+ G
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 390 IGSGGFGTVYKG-ILQDKSVVAVKKIN-SFGIQGKKEFC-TEITIIGNIHHVNLVRLKGF 446
IG G FG VY D + +K+I+ S + ++E E+ I+ ++H N+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66
Query: 447 CAQGRQRFL-VYEYMNKGSLDR---------TLFGNGSVLEWRERF-EIALGTARGLAYL 495
+ + + V EY + G L + F +L+W F ++ L L YL
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLCLA----LKYL 119
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H KI+H D+KP+NI L VK+ DFG+SK+L+ L T+ GT YL+PE
Sbjct: 120 H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYYLSPELC 175
Query: 556 TSSAISDKTDVYSYGMVLLEIISGRK 581
+ + K+D++S G VL E+ + +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 19/204 (9%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNLVRLKGF 446
IG G FG VY + L ++AVK+I K KE E+ ++ + H NLV+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 447 CAQGRQRFLVY-EYMNKGSLDRTLFGNGSVLEWR--ERFEIALGTARGLAYLHTGCDHKI 503
R++ ++ EY + G+L+ L +G +L+ + + L GLAYLH+ H I
Sbjct: 68 EVH-REKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQL--LEGLAYLHS---HGI 120
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT---TMRGTRGYLAPEWLTSSAI 560
+H D+KP NI L +K+ DFG + L +++ ++ GT Y+APE +T
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 561 SDK---TDVYSYGMVLLEIISGRK 581
D++S G V+LE+ +G++
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGFCA 448
IG G FG VYKG+L+ + VAVK S K F E I+ H N+V+L G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
Q + ++V E + GSL L + L ++ +++L A G+ YL + IH D+
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDL 119
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR----GYLAPEWLTSSAISDKT 564
N L+ + +KISDFG+S+ E+ ++T G + + APE L + ++
Sbjct: 120 AARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 565 DVYSYGMVLLEIISG 579
DV+SYG++L E S
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 389 PIGSGGFGTVYKGIL-----QDKSVVAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLVR 442
+GSG FGTVYKG+ + K VA+K + + KE E ++ ++ H ++VR
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLD------RTLFGNGSVLEWRERFEIALGTARGLAYLH 496
L G C Q L+ + M G L + G+ +L W + A+G++YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPE 553
+ +++H D+ N+L+ VKI+DFGL+KLL ++ G + ++A E
Sbjct: 127 ---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE--GGKVPIKWMALE 181
Query: 554 WLTSSAISDKTDVYSYGMVLLEIIS-GRK 581
+ + K+DV+SYG+ + E+++ G K
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 72/199 (36%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 390 IGSGGFGTVYKGILQDKSVV-AVKKINSFGIQGKKEFC---TEITIIGNIHHVNLVRLKG 445
+G G FG V +D + A+K + I +KE TE I+ I+H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 446 FCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDH 501
+ Q ++ +LV EY G L L G E R RF EI L L YLH+
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLHS---L 112
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
II+ D+KPENILL +K++DFGL+K L+ E S T GT YLAPE L
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NTFCGTPEYLAPEVLLGKGYG 171
Query: 562 DKTDVYSYGMVLLEIISGR 580
D +S G++L E+++G+
Sbjct: 172 KAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G+G FG V++G+ + + VAVK + G K+F E I+ + H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 450 GRQRFLVYEYMNKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
++V E M GSL L G G L+ + ++A A G+AYL IH D+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDL 129
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTD 565
N+L+ + K++DFGL++++ + ++ G + + APE + S K+D
Sbjct: 130 AARNVLVGENNICKVADFGLARVI---KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 566 VYSYGMVLLEIIS-GR 580
V+S+G++L EI++ GR
Sbjct: 187 VWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 14/197 (7%)
Query: 390 IGSGGFGTVYKGILQDKS-VVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNLVRLKGF 446
IG G FG VYKG+ + VA+K+I+ I+ + K EI ++ N+ H N+V+ G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA---RGLAYLHTGCDHKI 503
+++ EY GSL + + G E +A+ +GLAYLH + +
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPE----SLVAVYVYQVLQGLAYLH---EQGV 120
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
IH D+K NIL VK++DFG++ L + S ++ GT ++APE + S S
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 564 TDVYSYGMVLLEIISGR 580
+D++S G ++E+++G
Sbjct: 180 SDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 70/196 (35%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 390 IGSGGFGTVYKGILQDKS--VVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLK 444
+G+G G V K +L + ++AVK I IQ K+ E+ I+ + +V
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQ--KQILRELDILHKCNSPYIVGFY 65
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + EYM+ GSLD+ L + R +IA+ +GL YLH HKII
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKII 123
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
H DVKP NIL++ + Q+K+ DFG+S L +SL T GT Y+APE + + S K+
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 565 DVYSYGMVLLEIISGR 580
D++S G+ L+E+ +GR
Sbjct: 181 DIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 77/255 (30%), Positives = 123/255 (48%), Gaps = 28/255 (10%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G+G FG V G + + VA+K I G + EF E ++ + H LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 450 GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVK 509
R ++V EYM+ G L L +G + + E+ G+AYL + + IH D+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLA 127
Query: 510 PENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTDV 566
N L+ D+ VK+SDFGLS+ + ++ +T+ G++ + PE L S S K+DV
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 567 YSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625
+++G+++ E+ S G+ S + EK S G R+Y P LA E
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG--------------LRLYRPHLASEKV 230
Query: 626 EQRRYL---ELADSR 637
Y E A+ R
Sbjct: 231 YAIMYSCWHEKAEER 245
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 61/196 (31%), Positives = 109/196 (55%), Gaps = 10/196 (5%)
Query: 390 IGSGGFGTVYKGILQ----DKSVVAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVRLK 444
IG+G FG V++GIL+ + VA+K + + + +++F +E +I+G H N++RL+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + + ++ EYM G+LD+ L + + + G A G+ YL D +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYV 129
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG--YLAPEWLTSSAISD 562
H D+ NIL++ L+ K+SDFGLS++L + +TT G + APE + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 563 KTDVYSYGMVLLEIIS 578
+DV+S+G+V+ E++S
Sbjct: 190 ASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 59/192 (30%), Positives = 105/192 (54%), Gaps = 9/192 (4%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+GSG FG V++G+ +++ VA+K + S + +++F E+ + + H +L+ L C+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 450 GRQRFLVYEYMNKGSLDRTLFG-NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
G +++ E M KGSL L G VL ++A A G+AYL + IH D+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY--LAPEWLTSSAISDKTDV 566
NIL+ + L K++DFGL++L+ + ++ + Y APE + S K+DV
Sbjct: 131 AARNILVGEDLVCKVADFGLARLI---KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDV 187
Query: 567 YSYGMVLLEIIS 578
+S+G++L E+ +
Sbjct: 188 WSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 7/192 (3%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G +G+VYK I + VVA+K + +E EI+I+ +V+ G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+ ++V EY GS+ + L E I T +GL YLH +K IH D+
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDI 125
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
K NILL+++ Q K++DFG+S LT + T+ GT ++APE + ++K D++S
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVIGTPFWMAPEVIQEIGYNNKADIWS 184
Query: 569 YGMVLLEIISGR 580
G+ +E+ G+
Sbjct: 185 LGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G+G FG V+ G + VAVK + G + F E I+ + H LV+L C++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 450 GRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
++V EYM+KGSL D G G L + ++A A G+AYL + IH D+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDL 129
Query: 509 KPENILLHDKLQVKISDFGLSKLL-----TPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
NIL+ + L KI+DFGL++L+ T + + F + APE + K
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK-----WTAPEAANYGRFTIK 184
Query: 564 TDVYSYGMVLLEIIS-GR 580
+DV+S+G++L EI++ GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
IGSG FG V+ G +K VA+K I G +++F E ++ + H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
C + LV+E+M G L L + L G+AYL + +IH
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISD 562
D+ N L+ + VK+SDFG+++ + +Q +T+ GT+ + +PE + S S
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 563 KTDVYSYGMVLLEIIS 578
K+DV+S+G+++ E+ S
Sbjct: 181 KSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 68/197 (34%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 390 IGSGGFGTVYKGILQDKSV----VAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
+G G FG+V KG+ KS VAVK + GKKEF E +++ + H +VRL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G C +G LV E G L + L + + E+A A G+AYL +
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPV-SDLKELAHQVAMGMAYLE---SKHFV 117
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAIS 561
H D+ N+LL ++ Q KISDFG+S+ L S + R + APE + S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 562 DKTDVYSYGMVLLEIIS 578
K+DV+SYG+ L E S
Sbjct: 177 SKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+GSG FG V+ G + K VA+K I G + +F E ++ + H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 450 GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVK 509
R F+V EYM G L L L ++ + YL + IH D+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLA 127
Query: 510 PENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTDV 566
N L+ + VK+SDFGL++ + +Q +T+ +GT+ + PE S S K+DV
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 567 YSYGMVLLEIISGRK 581
+S+G+++ E+ S K
Sbjct: 185 WSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 66/201 (32%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 390 IGSGGFGTVYKGIL-QDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
+G G G+V K L + A+K I +K+ E+ I + +V+ G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 448 A--QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF------EIALGTARGLAYLHTGC 499
+ EY GSLD V + R +IA +GL+YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLKGLSYLH--- 122
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
KIIH D+KP NILL K QVK+ DFG+S L + FT GT Y+APE +
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKP 179
Query: 560 ISDKTDVYSYGMVLLEIISGR 580
S +DV+S G+ LLE+ R
Sbjct: 180 YSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 33/207 (15%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKI----NSFGIQGKKEFCT---EITIIGNIHHVNLV 441
+G G +G VYK + +VA+KKI GI T EI+++ + H N+V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP-----STALREISLLKELKHPNIV 61
Query: 442 RLKGFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
+L R+ +LV+EY + K LD+ L I RGLAY H+
Sbjct: 62 KLLDVIHTERKLYLVFEYCDMDLKKYLDK----RPGPLSPNLIKSIMYQLLRGLAYCHS- 116
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT-- 556
H+I+H D+KP+NIL++ +K++DFGL++ + +T T Y APE L
Sbjct: 117 --HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGS 173
Query: 557 ---SSAISDKTDVYSYGMVLLEIISGR 580
S+A+ D++S G + E+I+G+
Sbjct: 174 KHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 73/213 (34%), Positives = 112/213 (52%), Gaps = 29/213 (13%)
Query: 390 IGSGGFGTVYK---GILQDKS--VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
+G G FG+V LQD + VVAVKK+ + ++F EI I+ ++ H N+V+ K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 445 GFC-AQGRQRF-LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
G C + GR+ LV EY+ GSL L + L+ R+ A +G+ YL + +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KR 128
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLL----------TPEQSSLFTTMRGTRGYLAP 552
+H D+ NIL+ + +VKI DFGL+K+L P +S +F + AP
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF--------WYAP 180
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSS 584
E LT S S +DV+S+G+VL E+ + K+ S
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEF----CTEITIIGNIHHVNLVRLK 444
IG G +G VYK + +VA+KKI K+ F EI ++ + H N+VRLK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 445 GF---CAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFE------IALGTARGL 492
+G ++V+EYM+ G LD +F GL
Sbjct: 65 EIVTSKGKG-SIYMVFEYMDHDLTGLLDSPEV----------KFTESQIKCYMKQLLEGL 113
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
YLH + I+H D+K NIL+++ +K++DFGL++ T S+ +T T Y P
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 553 EWLTSSAISD-KTDVYSYGMVLLEIISGR 580
E L + + D++S G +L E+ G+
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKIN-SFGIQG-KKEFCTEITIIGNIHHVNLVRLKG 445
IG G +G VYK +VA+KKI F +G K EI ++ ++H N+++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+LV+E+M L + + L +GLA+ H+ H I+H
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILH 121
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE-WLTSSAISDKT 564
D+KPEN+L++ + +K++DFGL++ +T TR Y APE L S
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 565 DVYSYGMVLLEIISGR 580
D++S G + E++S R
Sbjct: 181 DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 390 IGSGGFGTVYKGILQDKS----VVAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVRLK 444
IG+G FG V G L+ VA+K + + + + +++F +E +I+G H N++ L+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + + +V EYM GSLD L + + + G A G+ YL D +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYV 128
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAIS 561
H D+ NIL++ L K+SDFGLS++L + + +TT RG + + APE + +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAYRKFT 187
Query: 562 DKTDVYSYGMVLLEIIS 578
+DV+SYG+V+ E++S
Sbjct: 188 SASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 36/223 (16%)
Query: 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKIN-SFGIQGKKE--FCTEITIIGNI-HHVNL 440
F IG G F TV + A+K ++ I+ KK E ++ + H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 441 VRLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLH 496
++L + Q + + V EY G L + + GS+ E RF EI L L YLH
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA----LEYLH 119
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL----------------- 539
IIH D+KPENILL + +KI+DFG +K+L P S
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 540 --FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
F + GT Y++PE L +D+++ G ++ ++++G+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 390 IGSGGFGTVYKGILQDKS-VVAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
+G G +G V K + +VA+K K + KK E+ ++ + H N+V LK
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALG----------TARGLAYLH 496
+ + +LV+EY ++RTL LE E L + +AY H
Sbjct: 69 FRRKGRLYLVFEY-----VERTL------LELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
+ H IIH D+KPENIL+ + +K+ DFG ++ L +S T TR Y APE L
Sbjct: 118 S---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 557 SSAISDK-TDVYSYGMVLLEIISGR 580
K DV++ G ++ E++ G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 388 TPIGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNL 440
+G G FG VY+G+ + ++ VA+K +N + ++ + EF E +++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSL---------DRTLFGNGSVLEWRERFEIALGTARG 491
VRL G + G+ +V E M KG L + ++ ++A A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL- 550
+AYL K +H D+ N ++ + L VKI DFG+++ + ++ + +G +G L
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--ETDYYR--KGGKGLLP 184
Query: 551 ----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
APE L + K+DV+S+G+VL E+ +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 376 YEELAAATDNFNTPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE---FCTEITI 431
YE L IG G FGTV K D ++ K+I+ +G +KE +E+ I
Sbjct: 2 YEVLET--------IGKGSFGTVRKVRRKSDGKILVWKEID-YGNMTEKEKQQLVSEVNI 52
Query: 432 IGNIHHVNLVRL--KGFCAQGRQRFLVYEYMNKGSL----DRTLFGNGSVLE---WRERF 482
+ + H N+VR + + ++V EY G L + + E WR
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 483 EIALGTARGLAYLHTGCD--HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540
++ L L H D + ++H D+KP NI L VK+ DFGL+K+L SS
Sbjct: 113 QLLLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFA 167
Query: 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
T GT Y++PE L + +K+D++S G ++ E+ +
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRLKG 445
IG G FG V +D K + A+K +N K E I+ ++H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW- 66
Query: 446 FCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDH 501
+ Q + +LV + + G L L E + +F EI L L YLH+
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA----LEYLHS---K 119
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
IIH D+KP+NILL ++ V I+DF ++ +TP+ + T+ GT GY+APE L S
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--TSTSGTPGYMAPEVLCRQGYS 177
Query: 562 DKTDVYSYGMVLLEIISGRK 581
D +S G+ E + G++
Sbjct: 178 VAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 12/198 (6%)
Query: 390 IGSGGFGTVYKGILQ----DKSVVAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVRLK 444
IG+G FG V +G L+ + VA+K + S + + +++F +E +I+G H N++ L+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + R ++ E+M G+LD L N + + G A G+ YL + +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYV 128
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-LFTTMRGTR---GYLAPEWLTSSAI 560
H D+ NIL++ L K+SDFGLS+ L + S +T+ G + + APE +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 561 SDKTDVYSYGMVLLEIIS 578
+ +DV+SYG+V+ E++S
Sbjct: 189 TSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 38/230 (16%)
Query: 378 ELAAATDNFNTPIGSGGFGTVYKGILQDKS---------VVAVKKINSFGIQGKKEFCTE 428
E+ + F +G G FG VYKG L + + +K+ +Q +EF E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQE 58
Query: 429 ITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGN---------------G 473
++ ++ H N+V L G C + + +++EY+ G L L N
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 474 SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT 533
S L+ + IA+ A G+ YL + H +H D+ N L+ + L VKISDFGLS+ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDI- 174
Query: 534 PEQSSLFTTMRGTRGYLAPEWLTSSAI-----SDKTDVYSYGMVLLEIIS 578
S+ + ++ + L W+ AI + ++D++S+G+VL EI S
Sbjct: 175 --YSADYYRVQS-KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 390 IGSGGFGTVYK-GILQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
+G G +G+VYK L D A+K+++ S + +++ EI I+ +++H N++ K
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 447 CAQGRQRFLVYEYMNKGSLDRTL---FGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
G + +V EY G L + + ++ +E + I + RGL LH + KI
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKI 124
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
+H D+K NILL VKI D G+SK+L ++ T GT Y+APE S K
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEVWKGRPYSYK 181
Query: 564 TDVYSYGMVLLEIISGR 580
+D++S G +L E+ +
Sbjct: 182 SDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 390 IGSGGFGTVY---KGILQDKSVVAVKKINSFGIQGK---KEFCTEITIIGNIHHVNLVRL 443
I G +G V+ K D + A+K I + K + TE I+ +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 444 KGFCA-QGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTG 498
+ + QG++ +LV EY+ G L L GS+ E R EI L L YLH+
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA----LEYLHS- 111
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMR------GTRGYLA 551
+ IIH D+KP+NIL+ +K++DFGLSK+ L Q +L + GT Y+A
Sbjct: 112 --NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 552 PEWLTSSAISDKTDVYSYGMVLLEIISG 579
PE + S D +S G +L E + G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 40/218 (18%)
Query: 390 IGSGGFGTVYKGIL------QDKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVR 442
+G G FG V+ G DK +VAVK + +K+F E ++ N H N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNG-------------SVLEWRERFEIALGTA 489
G C +G +V+EYM G L++ L +G L + +IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT----MRG 545
G+ YL + +H D+ N L+ L VKI DFG+S+ ++TT + G
Sbjct: 133 SGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRVGG 182
Query: 546 TRGYLAPEWLTSSAI-----SDKTDVYSYGMVLLEIIS 578
L W+ +I + ++DV+S+G+VL EI +
Sbjct: 183 HT-MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 390 IGSGGFGTVYKGILQ-DKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
IG G FG V+K + + DK V A+K+I+ + ++E E ++ + ++R
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLE----WRERFEIALGTARGLAYLHTGCDH 501
+ +V EY G L G L WR +I LG LA+LH+
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHS---K 120
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
KI+H D+K N+ L VKI D G++KLL+ ++ T+ GT YL+PE +
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 562 DKTDVYSYGMVLLEIISGR 580
+K+DV++ G+VL E +G+
Sbjct: 180 EKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 37/209 (17%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEF-----CT---EITIIGNI-HHVN 439
+G G FG+VY + +VA+KK+ KK+F C E+ + + H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSL-------DRTLFGNGSVLEWRERFEIALGTARGL 492
+V+LK + + + V+EYM G+L F + I +GL
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVI------RSIIYQILQGL 112
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
A++H H H D+KPEN+L+ VKI+DFGL++ + +T TR Y AP
Sbjct: 113 AHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAP 167
Query: 553 E-WLTSSAISDKTDVYSYGMVLLEIISGR 580
E L S++ S D+++ G ++ E+ + R
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN--SFGIQGK---KEFCTEITIIGNIHHVNLVRL 443
+GSG FG+VY+G+ L D AVK+++ G G+ K+ EI ++ + H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR---GLAYLHTGCD 500
G + ++ E + GSL + L GS E I L T + GL YLH D
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE----PVIRLYTRQILLGLEYLH---D 120
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAI 560
+H D+K NIL+ VK++DFG++K + E S + +G+ ++APE +
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFA-KSFKGSPYWMAPEVIAQQGG 178
Query: 561 SD-KTDVYSYGMVLLEIISGR 580
D++S G +LE+ +G+
Sbjct: 179 YGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-21
Identities = 73/244 (29%), Positives = 116/244 (47%), Gaps = 41/244 (16%)
Query: 354 SRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKK 413
S +SSS S + S EL + N IGSG GTVYK I + + K
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSEL----ERVNR-IGSGAGGTVYKVIHRPTGRLYALK 105
Query: 414 INSFGIQG------KKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467
+ I G +++ C EI I+ +++H N+V+ + ++ E+M+ GSL+
Sbjct: 106 V----IYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161
Query: 468 TLFGNGSVLEWRERF--EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525
T E+F ++A G+AYLH I+H D+KP N+L++ VKI+D
Sbjct: 162 THI-------ADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIAD 211
Query: 526 FGLSKLLT----PEQSSLFTTMRGTRGYLAPEWLTSSAISDK-----TDVYSYGMVLLEI 576
FG+S++L P SS+ GT Y++PE + + D++S G+ +LE
Sbjct: 212 FGVSRILAQTMDPCNSSV-----GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266
Query: 577 ISGR 580
GR
Sbjct: 267 YLGR 270
|
Length = 353 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 64/192 (33%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFC-TEITIIGNIHHVNLVRLKGFC 447
IG G GTVY I + VA+K++N Q KKE EI ++ H N+V
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
G + ++V EY+ GSL + + ++ + + + L +LH+ +++IH D
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHRD 140
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
+K +NILL VK++DFG +TPEQS +TM GT ++APE +T A K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 568 SYGMVLLEIISG 579
S G++ +E++ G
Sbjct: 200 SLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 8e-21
Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 390 IGSGGFGTVYKGILQ-DKSVVAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
IG G FG V+ G L+ D + VAVK + K +F E I+ H N+VRL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
Q + ++V E + G L G L+ +E ++ A G+ YL + IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR----GYLAPEWLTSSAISDK 563
+ N L+ +K +KISDFG+S+ E+ ++ + G + + APE L S +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 564 TDVYSYGMVLLEIIS 578
+DV+S+G++L E S
Sbjct: 177 SDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 65/194 (33%), Positives = 101/194 (52%), Gaps = 12/194 (6%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKK-EFCTEITIIGNIHHVNLVRLKGFCA 448
+G G FG V+KG L+DK+ VAVK Q K +F +E I+ H N+V+L G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
Q + ++V E + G L L+ ++ + AL A G+AYL + IH D+
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDL 119
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR----GYLAPEWLTSSAISDKT 564
N L+ + +KISDFG+S+ E ++++ G + + APE L S ++
Sbjct: 120 AARNCLVGENNVLKISDFGMSR---QEDDGIYSS-SGLKQIPIKWTAPEALNYGRYSSES 175
Query: 565 DVYSYGMVLLEIIS 578
DV+SYG++L E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKK--INSFGIQGKKE-------FCTEITIIGNIHHVN 439
IGSG FG+VY G+ ++AVK+ + S K EI ++ + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+V+ G + EY+ GS+ L G+ E R +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLHN-- 124
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG-------YLAP 552
IIH D+K NIL+ +K +KISDFG+SK L E +SL T G R ++AP
Sbjct: 125 -RGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVFWMAP 181
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIISGR 580
E + ++ + K D++S G +++E+++G+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G+G FG V+ G + VA+K + G + F E ++ + H LVRL Q
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 450 GRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+++ EYM GSL D G L + ++A A G+A++ IH D+
Sbjct: 73 -EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDL 128
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTD 565
+ NIL+ + L KI+DFGL++L+ + +T G + + APE + + K+D
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 566 VYSYGMVLLEIIS-GR 580
V+S+G++L EI++ GR
Sbjct: 186 VWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK-KEFCTEITIIGNIHHVNLVRLKGF 446
IG G VY I L + VA+K+I+ Q E E+ + +H N+V+
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 447 CAQGRQRFLVYEYMNKGS-LD--RTLFGNGSVLEWRERFEIAL---GTARGLAYLHTGCD 500
G + +LV Y++ GS LD ++ + G + E IA +GL YLH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDE----AIIATVLKEVLKGLEYLH---S 120
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSK-LLTPEQSSLF--TTMRGTRGYLAPEWLTS 557
+ IH D+K NILL + VKI+DFG+S L + T GT ++APE +
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 558 SAISD-KTDVYSYGMVLLEIISGR 580
D K D++S+G+ +E+ +G
Sbjct: 181 VHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 58/192 (30%), Positives = 98/192 (51%), Gaps = 12/192 (6%)
Query: 390 IGSGGFGTVYKGILQDKS-VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G +G VY+G+ + S VAVK + ++ +EF E ++ I H NLV+L G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ +++ E+M G+L L + +A + + YL IH D
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 129
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKT 564
+ N L+ + VK++DFGLS+L+T + +T G + + APE L + S K+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 565 DVYSYGMVLLEI 576
DV+++G++L EI
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G+G FG V+ G + + VAVK + G + F E ++ + H LVRL +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 450 GRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+++ EYM KGSL D G + + + + A G+AY+ IH D+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 129
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTD 565
+ N+L+ + L KI+DFGL++++ + +T G + + APE + + + K+D
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 566 VYSYGMVLLEIIS-------GRKNSSL 585
V+S+G++L EI++ G NS +
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 46/225 (20%)
Query: 390 IGSGGFGTVYK----GIL--QDKSVVAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLVR 442
IG G FG V++ G+L + ++VAVK + + +F E ++ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTL---------------------FGNGSVLEWRER 481
L G CA G+ L++EYM G L+ L N L E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 482 FEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541
IA A G+AYL + K +H D+ N L+ + + VKI+DFGLS+ ++++
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-------NIYS 182
Query: 542 T--MRGTRGYLAP-EWLTSSAI-----SDKTDVYSYGMVLLEIIS 578
+ + P W+ +I + ++DV++YG+VL EI S
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 390 IGSGGFGTVYK-GILQDKSVVAVKKINSFGIQGKKEFCT--EITIIGNIHHVNLVRLKGF 446
IG G G V+K + VA+KK+ ++G EI + H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYLHTG 498
G LV EYM L VL ER + + G+AY+H
Sbjct: 68 FPHGSGFVLVMEYM-PSDL-------SEVLRDEER-PLPEAQVKSYMRMLLKGVAYMH-- 116
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
+ I+H D+KP N+L+ +KI+DFGL++L + E+ L++ TR Y APE L +
Sbjct: 117 -ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 559 -AISDKTDVYSYGMVLLEIISGR 580
D+++ G + E+++G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 64/196 (32%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G+G FG V+ G + VAVK + G + F E I+ + H LV+L ++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 450 GRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
++V EYM+KGSL D G G L+ ++A A G+AY+ IH D+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 128
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTD 565
+ NIL+ D L KI+DFGL++L+ + + +T +G + + APE + K+D
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 566 VYSYGMVLLEIIS-GR 580
V+S+G++L E+++ GR
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 67/194 (34%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
IG G FG V G + V AVK I + + F E +++ + H NLV+L G +
Sbjct: 14 IGKGEFGDVMLGDYRGNKV-AVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 450 GRQR-FLVYEYMNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ ++V EYM KGSL L G SVL + +L + YL + +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRD 127
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
+ N+L+ + K+SDFGL+K E SS T + + APE L S K+DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 568 SYGMVLLEIIS-GR 580
S+G++L EI S GR
Sbjct: 184 SFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 24/201 (11%)
Query: 390 IGSGGFGTVYK------GILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G+G G+V K G + K VV + +S +K+ E+ I+ +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV----RKQILRELQIMHECRSPYIVSF 68
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFE----IALGTARGLAYLHTGC 499
G + E+M+ GSLDR G + E IA+ GL YL+
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPI-----PVEILGKIAVAVVEGLTYLYN-- 121
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
H+I+H D+KP NIL++ + Q+K+ DFG+S L +S+ T GT Y++PE +
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADTFVGTSTYMSPERIQGGK 178
Query: 560 ISDKTDVYSYGMVLLEIISGR 580
+ K+DV+S G+ ++E+ G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 47/125 (37%), Positives = 75/125 (60%), Gaps = 10/125 (8%)
Query: 458 EYMNKGSLDRTLFGNGSVLEWRERF--EIALGTARGLAYLHTGCDHKIIHCDVKPENILL 515
E+M+ GSLD+ L G + E +I++ RGL YL HKI+H DVKP NIL+
Sbjct: 79 EHMDGGSLDQVLKKAGRI---PENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 516 HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLE 575
+ + ++K+ DFG+S L S+ + GTR Y++PE L + + ++D++S G+ L+E
Sbjct: 134 NSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 576 IISGR 580
+ GR
Sbjct: 191 MAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 64/194 (32%), Positives = 101/194 (52%), Gaps = 15/194 (7%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKG-F 446
+G G GTVYK L + ++AVK I ++ +K+ +E+ I+ ++ G F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
+ R + E+M+ GSLD VL IA+ +GL YL + KI+H
Sbjct: 69 FVENRIS-ICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILHR 119
Query: 507 DVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDV 566
DVKP N+L++ + QVK+ DFG+S L +S+ T GT Y+APE ++ +DV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 567 YSYGMVLLEIISGR 580
+S G+ +E+ GR
Sbjct: 177 WSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
IG G FG V +G + V AVK I + F E ++ +HH NLVRL G
Sbjct: 14 IGEGEFGAVLQGEYTGQKV-AVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 450 GRQRFLVYEYMNKGSLDRTLFGNGSVL-EWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
++V E M+KG+L L G L + + +L A G+ YL + K++H D+
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDL 126
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
NIL+ + K+SDFGL+++ + + + + APE L S K+DV+S
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVK-WTAPEALKHKKFSSKSDVWS 182
Query: 569 YGMVLLEIIS-GRK---NSSLKIQSRSTEK 594
YG++L E+ S GR SLK EK
Sbjct: 183 YGVLLWEVFSYGRAPYPKMSLKEVKECVEK 212
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 44/222 (19%)
Query: 376 YEELAAATDNFNTPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-----FCTEI 429
YEELA IG G +GTVYK L VA+KK+ + +E EI
Sbjct: 1 YEELAE--------IGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREI 49
Query: 430 TI---IGNIHHVNLVRLKGFCAQGR-----QRFLVYEYMNKGSLDRTLF-------GNGS 474
+ + + H N+VRL C R + LV+E++++ D + G
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLPP 106
Query: 475 VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534
++ RG+ +LH+ H+I+H D+KP+NIL+ QVKI+DFGL+++ +
Sbjct: 107 ETIKDLMRQLL----RGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS- 158
Query: 535 EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEI 576
+ +L T++ T Y APE L S+ + D++S G + E+
Sbjct: 159 FEMAL-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 34/228 (14%)
Query: 378 ELAAATDNFNTPIGSGGFGTVYKGIL-----QDKSVVAVKKINSFG-IQGKKEFCTEITI 431
EL + F +G FG +YKG L +VA+K + Q EF E ++
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 432 IGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLF-------------GNGSV--- 475
+ +HH N+V L G Q + +++EY+N+G L L +G+V
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 476 LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535
L+ + IA+ A G+ YL + H +H D+ NIL+ ++L VKISD GLS+ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 536 -----QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
Q +R ++ PE + S +D++S+G+VL EI S
Sbjct: 178 DYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGFC 447
IG G FG V+KGI + + VVA+K I+ + + E EIT++ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 448 AQGRQRFLVYEYMNKGS-LDRTLFGNGSVLEWRERFEIAL---GTARGLAYLHTGCDHKI 503
+G + +++ EY+ GS LD L G E F+IA +GL YLH+ K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD--LLRAGPFDE----FQIATMLKEILKGLDYLHS---EKK 122
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
IH D+K N+LL ++ VK++DFG++ LT Q T GT ++APE + SA K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIQQSAYDSK 181
Query: 564 TDVYSYGMVLLEIISGRKNSS 584
D++S G+ +E+ G +S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 390 IGSGGFGTVYKGIL------QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG V+ QDK +VAVK + +K+F E ++ N+ H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNG------------SVLEWRERFEIALGTARG 491
G C +G +V+EYM G L++ L +G + L + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL--TPEQSSLFTTMRGTRGY 549
+ YL + +H D+ N L+ + L VKI DFG+S+ + T TM R +
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-W 188
Query: 550 LAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ PE + + ++DV+S G+VL EI +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFC-TEITIIGNIHHVNLVRLKGFC 447
IG G GTV+ I + VA+K+IN Q KKE EI ++ + + N+V
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
G + F+V EY+ GSL + + ++ + + + L +LH +++IH D
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHA---NQVIHRD 140
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
+K +N+LL VK++DFG +TPEQS +TM GT ++APE +T A K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 568 SYGMVLLEIISG 579
S G++ +E++ G
Sbjct: 200 SLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 389 PIGSGGFGTVYKGILQ------DKSVVAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLV 441
+G G FG VY+G+ + + VAVK + S Q + +F E I+ +H N+V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSL------DRTLFGNGSVLEWRERFEIALGTARGLAYL 495
RL G + RF++ E M G L +R S L ++ A A+G YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 496 HTGCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
+ IH D+ N LL K KI+DFG+++ + ++S + +G R L
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYR--KGGRAMLPI 185
Query: 553 EWLTSSAISD-----KTDVYSYGMVLLEIIS 578
+W+ A D KTDV+S+G++L EI S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 40/208 (19%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKIN-------SFGIQGKKEFCTEITIIGNIHHVN 439
IG G FG VYK I DK VVA+K I+ IQ EI +
Sbjct: 9 IGKGSFGEVYKAI--DKRTNQVVAIKVIDLEEAEDEIEDIQ------QEIQFLSQCRSPY 60
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLE------WRERF--EIALGTARG 491
+ + G +G + +++ EY G GS L+ E + I G
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYC----------GGGSCLDLLKPGKLDETYIAFILREVLLG 110
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551
L YLH IH D+K NILL ++ VK++DFG+S LT S T + GT ++A
Sbjct: 111 LEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMA 166
Query: 552 PEWLTSSAISDKTDVYSYGMVLLEIISG 579
PE + S +K D++S G+ +E+ G
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGIQ-GKKEFCTEI-TIIGNIHHVNLVRLKGF 446
IG G FGTV K + + +++AVK+I S + +K ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 447 CAQGRQRFLVYEYMNKGSLD---RTLFGNGSVLEWRERF--EIALGTARGLAYLHTGCDH 501
+ ++ E M+ SLD + ++ E +IA+ T + L YL +
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKS-VIPEEILGKIAVATVKALNYLKE--EL 127
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR-GTRGYLAPEWLTSSAI 560
KIIH DVKP NILL +K+ DFG+S L S+ T G R Y+APE + SA
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 561 SD---KTDVYSYGMVLLEIISGR 580
++DV+S G+ L E+ +G+
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-19
Identities = 70/196 (35%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE----FCTEITIIGNIHHVNLVRLK 444
IG G FG V D AVK + I KKE ++ N+ H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 445 GFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+ Q + + V +Y+N G L L S E R RF A A L YLH+ I
Sbjct: 63 -YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNI 117
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
I+ D+KPENILL + V ++DFGL K E S +T GT YLAPE L
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 564 TDVYSYGMVLLEIISG 579
D + G VL E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 9e-19
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 390 IGSGGFGTVYKGIL-----QDKSVVAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+GSG FGTV+KGI K VA+K I + G Q +E + +G++ H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
G C G LV + GSL + + L+ + + A+G+ YL +H++
Sbjct: 75 LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRM 130
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR-GYLAPEWLTSSAISD 562
+H ++ NILL V+I+DFG++ LL P+ F + T ++A E + +
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 563 KTDVYSYGMVLLEIIS 578
++DV+SYG+ + E++S
Sbjct: 191 QSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 58/201 (28%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 384 DNFN--TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQG--KKEFCTEITIIGNIHHVN 439
D+F + +G+G G V+K + ++ +K+ I+ + + E+ ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+V G + + E+M+ GSLD+ L G + E + ++++ +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSIAVIKGLTYLRE-- 121
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
HKI+H DVKP NIL++ + ++K+ DFG+S L ++ F GTR Y++PE L +
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH 178
Query: 560 ISDKTDVYSYGMVLLEIISGR 580
S ++D++S G+ L+E+ GR
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 64/194 (32%), Positives = 99/194 (51%), Gaps = 16/194 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEF---CTEITIIGNIHHVNLVRLKG 445
IG G FG VY ++ VVA+KK++ G Q +++ E+ + + H N + KG
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ +LV EY GS L + L+ E I G +GLAYLH+ H+ IH
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIH 138
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS---SAISD 562
D+K NILL + VK++DFG + L++P S + GT ++APE + +
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDG 193
Query: 563 KTDVYSYGMVLLEI 576
K DV+S G+ +E+
Sbjct: 194 KVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 64/207 (30%), Positives = 110/207 (53%), Gaps = 28/207 (13%)
Query: 390 IGSGGFGTVYKGILQD--KSVVAVKKIN----SFGIQGKKE-------FCTEITIIG-NI 435
+GSG FG VYK ++ ++++A+K+IN +FG + K+E +E+TII +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG-KDKRERDKSIGDIVSEVTIIKEQL 66
Query: 436 HHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFE------IALGTA 489
H N+VR + + ++V + + L F S+ E ++RF I +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFN--SLKEKKQRFTEERIWNIFVQMV 123
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549
L YLH + +I+H D+ P NI+L + +V I+DFGL+K PE S T++ GT Y
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE--SKLTSVVGTILY 179
Query: 550 LAPEWLTSSAISDKTDVYSYGMVLLEI 576
PE + + +K DV+++G +L ++
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
F +GSG FG V+ G + + VA+K IN G +++F E ++ + H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
C Q + ++V E+M G L L L + G+ YL + IH
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIH 123
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISD 562
D+ N L+ VK+SDFG+++ + ++ +T+ G + + PE S S
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 563 KTDVYSYGMVLLEIIS 578
K+DV+S+G+++ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 383 TDNFN--TPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKK--EFC-TEITIIGNIH 436
NF IG G F VYK I L D VVA+KK+ F + K + C EI ++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 437 HVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTL--FGN-GSVLEWRERFEIALGTARGLA 493
H N+++ + + +V E + G L R + F ++ R ++ + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 494 YLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 553
++H+ +I+H D+KP N+ + VK+ D GL + + + ++ + + GT Y++PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 554 WLTSSAISDKTDVYSYGMVLLEI 576
+ + + K+D++S G +L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 14/194 (7%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEF---CTEITIIGNIHHVNLVRLK 444
IGSG +G VYK + +VA+K I ++ +F EI+++ H N+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + + ++V EY GSL L + + T +GLAYLH I
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKI 123
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD-- 562
H D+K NILL + VK++DFG+S LT + + GT ++APE
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPYWMAPEVAAVERKGGYD 182
Query: 563 -KTDVYSYGMVLLE 575
K D+++ G+ +E
Sbjct: 183 GKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 390 IGSGGFGTVYKG------ILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG V+ +DK +VAVK + + +K+F E ++ N+ H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNG---------------SVLEWRERFEIALGT 488
G C G +V+EYM G L++ L +G L + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT--TMRGT 546
A G+ YL + +H D+ N L+ L VKI DFG+S+ + TM
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
R ++ PE + + ++DV+S+G++L EI +
Sbjct: 190 R-WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 390 IGSGGFGTVYKG-ILQDKSVVAVKKI------NSFGIQGKKEFCTEITIIGNIHHVNLVR 442
IG G +G VY+ +VA+KK+ + I +E IT++ N+ H N+V
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLRHPNIVE 70
Query: 443 LKGFCAQGRQR---FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
LK G+ FLV EY + L L + + + L RGL YLH
Sbjct: 71 LKE-VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH--- 125
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
++ IIH D+K N+LL DK +KI+DFGL++ + + T Y APE L
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCT 184
Query: 560 ISDKT-DVYSYGMVLLEIISGR 580
D+++ G +L E+++ +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 32/208 (15%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE---FCT--EITIIGNIHHVNLVRL 443
+G G + VYK + +VA+KKI + K+ F EI ++ + H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 444 KGFCAQGRQRFLVYEYMNKGSL-----DRTL-FGNGSVLEWRERFEIALGTARGLAYLHT 497
LV+E+M + L D+++ + + L T RGL YLH
Sbjct: 68 LDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSY------MLMTLRGLEYLH- 119
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL-- 555
+ I+H D+KP N+L+ +K++DFGL++ + T TR Y APE L
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 556 ---TSSAISDKTDVYSYGMVLLEIISGR 580
+ D++S G + E++
Sbjct: 177 ARHYGVGV----DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G G FG V+ G + VA+K + G + F E I+ + H LV L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 450 GRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
++V E+M KGSL D G+G L+ + ++A A G+AY+ IH D+
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDL 128
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTD 565
+ NIL+ D L KI+DFGL++L+ + + +T +G + + APE + K+D
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 566 VYSYGMVLLEIIS-GR 580
V+S+G++L E+++ GR
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 69/198 (34%), Positives = 103/198 (52%), Gaps = 10/198 (5%)
Query: 390 IGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGFC 447
IG G FG VYKGI + K VVA+K I+ + + E EIT++ + R G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 448 AQGRQRFLVYEYMNKGS-LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
+G + +++ EY+ GS LD L G LE I +GL YLH+ + IH
Sbjct: 72 LKGTKLWIIMEYLGGGSALD--LLKPGP-LEETYIATILREILKGLDYLHS---ERKIHR 125
Query: 507 DVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDV 566
D+K N+LL ++ VK++DFG++ LT Q T GT ++APE + SA K D+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 567 YSYGMVLLEIISGRKNSS 584
+S G+ +E+ G +S
Sbjct: 185 WSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 5e-18
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLK 444
PIGSG +G V + + VA+KKI++ I K+ EI ++ ++ H N++ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGLL 65
Query: 445 G-FCAQGRQRF----LVYEYMNKGS-LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
+ F +V E M + L + + + + ++ RGL YLH+
Sbjct: 66 DILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQY-FLYQILRGLKYLHSA 122
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG---TRGYLAPEWL 555
+IH D+KP NIL++ +KI DFGL++ + P++ + TR Y APE L
Sbjct: 123 ---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK-GFLTEYVVTRWYRAPELL 178
Query: 556 TSSAISDKT-DVYSYGMVLLEIISGR 580
SS+ K D++S G + E+++ +
Sbjct: 179 LSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 59/196 (30%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G G FG V+ G + VA+K + G + F E ++ + H LV+L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 450 GRQRFLVYEYMNKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
++V EYM+KGSL L G G L + ++A A G+AY+ +H D+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 128
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTD 565
+ NIL+ + L K++DFGL++L+ + + +T +G + + APE + K+D
Sbjct: 129 RAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 566 VYSYGMVLLEIIS-GR 580
V+S+G++L E+ + GR
Sbjct: 186 VWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 390 IGSGGFGTVYKGILQD-------KSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLV 441
+GSG FG VY+G D VAVK + Q KKEF E ++ N +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFG------NGSVLEWRERFEIALGTARGLAYL 495
+L G C ++++ E M G L L +L +E +I L A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQ-----VKISDFGLSKLLTPEQSSLFTTMRGTR--- 547
IH D+ N L+ +K VKI DFGL++ + S + G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI---YKSDYYRKEGEGLLP 176
Query: 548 -GYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
++APE L + ++DV+S+G+++ EI++
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 378 ELAAATDNFNTPIGSGGFGTVYKGILQDKS----VVAVKKINSFGIQGKKE--FCTEITI 431
EL + +G+G FG + +G L+ S VA+ + + G K+ F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA-GCSDKQRRGFLAEALT 59
Query: 432 IGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARG 491
+G H N+VRL+G +G +V EYM+ G+LD L + L + + G A G
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL- 550
+ YL + +H + +L++ L KIS F +L + +++TTM G L
Sbjct: 120 MKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLW 174
Query: 551 -APEWLTSSAISDKTDVYSYGMVLLEIIS 578
APE + S +DV+S+G+V+ E++S
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 388 TPIGSGGFGTVYKGILQDKS---VVAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVR 442
+GSG FGTV KG+ + K VAVK K ++ K E E ++ + + +VR
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
+ G C + LV E G L++ L N V E + E+ + G+ YL +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETN 115
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS--SLFTTMRGTRGYLAPEWLTSSAI 560
+H D+ N+LL + KISDFGLSK L +++ T + + APE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 561 SDKTDVYSYGMVLLEIIS-GRK 581
S K+DV+S+G+++ E S G+K
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 390 IGSGGFGTVYKGILQDKSVV-AVKKINSFGIQGK-KEFCTEITIIGNIHHVNLVRLKGFC 447
+G G +G+VYK + + V A+K+I + K + E+ I+ +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRER---FEIALGTARGLAYLHTGCDHKII 504
++ EYM+ GSLD+ L+ G E I +GL +L +H II
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD-- 562
H DVKP N+L++ QVK+ DFG+S L +SL T G + Y+APE + S +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 563 ----KTDVYSYGMVLLEIISGR 580
++DV+S G+ +LE+ GR
Sbjct: 183 TYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN----SFGIQGKKEFCTEITIIGNIHHV---NLV 441
IG G +G VY+G + VVA+K IN + + E+ ++ + N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS---DIQREVALLSQLRQSQPPNIT 65
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL---GTARGLAYLHTG 498
+ G +G + +++ EY GS+ RTL G + E++ I++ L Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPI---AEKY-ISVIIREVLVALKYIHKV 120
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
+IH D+K NIL+ + VK+ DFG++ LL + SS +T GT ++APE +T
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPYWMAPEVITEG 176
Query: 559 AISD-KTDVYSYGMVLLEIISG 579
D K D++S G+ + E+ +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 6e-18
Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFC-TEITIIGNIHHVNLVRLKGFC 447
IG G GTVY I + VA+K++N Q KKE EI ++ + N+V
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
G + ++V EY+ GSL + + ++ + + + L +LH+ +++IH D
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHS---NQVIHRD 140
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
+K +NILL VK++DFG +TPEQS +TM GT ++APE +T A K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 568 SYGMVLLEIISG 579
S G++ +E++ G
Sbjct: 200 SLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 384 DNFNTPIGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNL 440
DNF IG G G V I DKS VAVKK++ Q ++ E+ I+ + H N+
Sbjct: 22 DNF-VKIGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
V + G + ++V E++ G+L T + + + + L + L++LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGAL--TDIVTHTRMNEEQIATVCLAVLKALSFLHA--- 133
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLT---PEQSSLFTTMRGTRGYLAPEWLTS 557
+IH D+K ++ILL +VK+SDFG ++ P + SL GT ++APE ++
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISR 189
Query: 558 SAISDKTDVYSYGMVLLEIISG 579
+ D++S G++++E++ G
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 38/217 (17%)
Query: 390 IGSGGFGTVY----KGIL--QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG V+ +L QDK +VAVK + +++F E ++ + H ++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNG--------------SVLEWRERFEIALGTA 489
G C +GR +V+EYM G L+R L +G L + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT---MRGT 546
G+ YL + +H D+ N L+ L VKI DFG+S+ +++T G
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTDYYRVGG 182
Query: 547 RGYLAPEWLTSSAI-----SDKTDVYSYGMVLLEIIS 578
R L W+ +I + ++D++S+G+VL EI +
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKK--INSFGIQGKKE--------FCTEITIIGNIHHV 438
IG G +G VY + + ++AVK+ + + +EI + ++ H+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL------GTARGL 492
N+V+ GF + EY+ GS+ GS L RFE L GL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSI-------GSCLRTYGRFEEQLVRFFTEQVLEGL 121
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF-TTMRGTRGYLA 551
AYLH+ I+H D+K +N+L+ KISDFG+SK + +M+G+ ++A
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 552 PEWLTSS--AISDKTDVYSYGMVLLEIISGRK 581
PE + S S K D++S G V+LE+ +GR+
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 16/194 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK---KEFCTEITIIGNIHHVNLVRLKG 445
IG G FG VY +++ VVA+KK++ G Q ++ E+ + + H N ++ +G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ +LV EY GS L + L+ E + G +GLAYLH+ H +IH
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIH 138
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS---SAISD 562
DVK NILL + VK+ DFG + ++ P + GT ++APE + +
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDG 193
Query: 563 KTDVYSYGMVLLEI 576
K DV+S G+ +E+
Sbjct: 194 KVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 19/204 (9%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKI---NSFGIQGKKEF---CTEITIIGNIHHVNLVRL 443
+G G +GTVY G+ ++AVK++ S + +KE+ E+ ++ ++ HVN+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLE--WRERFEIALGTARGLAYLHTGCDH 501
G C + E++ GS+ L G + E + + + L G+AYLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNC-- 122
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLL-----TPEQSSLFTTMRGTRGYLAPEWLT 556
++H D+K N++L +K+ DFG ++ L S++ +M GT ++APE +
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
S K+D++S G + E+ +G+
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 56/193 (29%), Positives = 102/193 (52%), Gaps = 8/193 (4%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQG--KKEFCTEITIIGNIHHVNLVRLKGFC 447
+G+G G V K + ++ +K+ I+ + + E+ ++ + +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ + E+M+ GSLD+ L + E ++++ RGLAYL H+I+H D
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLAYLRE--KHQIMHRD 129
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
VKP NIL++ + ++K+ DFG+S L ++ F GTR Y++PE L + S ++D++
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIW 186
Query: 568 SYGMVLLEIISGR 580
S G+ L+E+ GR
Sbjct: 187 SMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-17
Identities = 65/194 (33%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 390 IGSGGFGTVY-KGILQDKSVVAVKKINSFGIQGK---KEFCTEITIIGNIHHVNLVRLKG 445
IG G FG VY ++ VVA+KK++ G Q ++ E+ + I H N + KG
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ +LV EY GS L + L+ E I G +GLAYLH+ H +IH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIH 148
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS---SAISD 562
D+K NILL + QVK++DFG + + +P S + GT ++APE + +
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYDG 203
Query: 563 KTDVYSYGMVLLEI 576
K DV+S G+ +E+
Sbjct: 204 KVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 390 IGSGGFGTVYKGILQDK-SVVAVKKI--NSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
IG G +G V+K ++ +VA+KK + KK EI ++ + H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRER-------FEIALGTARGLAYLHTGC 499
+ R+ LV+EY D T+ + LE R +I T + + + H
Sbjct: 69 FRRKRKLHLVFEY-----CDHTVL---NELEKNPRGVPEHLIKKIIWQTLQAVNFCHK-- 118
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT-SS 558
H IH DVKPENIL+ + Q+K+ DFG +++LT +T TR Y APE L +
Sbjct: 119 -HNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGDT 176
Query: 559 AISDKTDVYSYGMVLLEIISG 579
DV++ G V E+++G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRL-KGFC 447
+G G FG VYK ++ + A KI + + E F EI I+ H N+V L + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ + L+ E+ + G+LD + L + + L +LH HK+IH D
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD----- 562
+K NILL VK++DFG+S T GT ++APE + D
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 563 KTDVYSYGMVLLEIISGR 580
K D++S G+ L+E+
Sbjct: 188 KADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 386 FNTPIGSGGFGTVYKGILQ---DKSVVAVKKINSFGIQGK-KEFCTEITIIGNI-HHVNL 440
F IG G FG V + +++ K A+K + F + ++F E+ ++ + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSL------DRTL---------FGNGSVLEWRERFEIA 485
+ L G C ++ EY G+L R L G S L ++ + A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 486 LGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM-R 544
A G+ YL + + IH D+ N+L+ + L KI+DFGLS+ E+ + TM R
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179
Query: 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
++A E L S + K+DV+S+G++L EI+S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 38/213 (17%)
Query: 390 IGSGGFGTVY----KGILQDK--SVVAVKKIN-SFGIQGKKEFCTEITIIG--NIHHVNL 440
+G G FG VY KG+++D+ + VA+K +N + ++ + EF E +++ N HHV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-- 71
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLE---------WRERFEIALGTARG 491
VRL G +QG+ ++ E M +G L L +E ++ ++A A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT---MRGTRG 548
+AYL+ +K +H D+ N ++ + VKI DFG+++ ++ T +G +G
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYETDYYRKGGKG 181
Query: 549 YLAPEWLTSSAISD-----KTDVYSYGMVLLEI 576
L W++ ++ D +DV+S+G+VL EI
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 390 IGSGGFGTVYKGILQDKS-VVAVKKINSFGIQG------KKEFCTEITIIGNIHHVNLVR 442
+G G +G V K ++ +VA+KK ++ KK EI ++ + H NLV
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDR-TLFGNGSVLEWRER--FEIALGTARGLAYLHTGC 499
L + ++ +LV+E+++ LD + NG + F+I RG+ + H+
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL----RGIEFCHS-- 118
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
H IIH D+KPENIL+ VK+ DFG ++ L +T TR Y APE L
Sbjct: 119 -HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRWYRAPELLVGDT 176
Query: 560 ISDK-TDVYSYGMVLLEIISG 579
+ D+++ G ++ E+++G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 23/199 (11%)
Query: 390 IGSGGFGTVY--KGILQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
IG G FG +Y K + V +K+I+ ++ K+ E+ ++ + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 446 FCAQGRQRFLVYEYMNKGSLDR-------TLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
+ + F+V EY + G L + LF +L W +I+LG L ++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLG----LKHIH-- 118
Query: 499 CDHKIIHCDVKPENILLHDKLQV-KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
D KI+H D+K +NI L V K+ DFG+++ L + L T GT YL+PE +
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQN 176
Query: 558 SAISDKTDVYSYGMVLLEI 576
++KTD++S G VL E+
Sbjct: 177 RPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 65/194 (33%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK---KEFCTEITIIGNIHHVNLVRLKG 445
IG G FG VY VVAVKK++ G Q ++ E+ + + H N + KG
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ +LV EY GS L + L+ E I G +GLAYLH+ H +IH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIH 144
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS---SAISD 562
D+K NILL + QVK++DFG + +P S + GT ++APE + +
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDG 199
Query: 563 KTDVYSYGMVLLEI 576
K DV+S G+ +E+
Sbjct: 200 KVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 38/215 (17%)
Query: 390 IGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIG--NIHHVNL 440
+G G FG VY+G +D ++ VAVK +N S ++ + EF E +++ HHV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV-- 71
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLE---------WRERFEIALGTARG 491
VRL G ++G+ +V E M G L L E +E ++A A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT---MRGTRG 548
+AYL+ K +H D+ N ++ VKI DFG+++ ++ T +G +G
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETDYYRKGGKG 181
Query: 549 YLAPEWLTSSAISD-----KTDVYSYGMVLLEIIS 578
L W+ ++ D +D++S+G+VL EI S
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 389 PIGSGGFGTVYKGILQD------KSVVAVKKINSFGIQGK-KEFCTEITIIGNI-HHVNL 440
P+G G FG V K S VAVK + + + +E+ ++ I H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGN---------------GSVLEWRERFEIA 485
+ L G C Q ++V EY G+L L L ++ A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 486 LGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545
ARG+ +L + K IH D+ N+L+ + +KI+DFGL++ + + +
Sbjct: 139 YQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKT 191
Query: 546 TRGYLAPEWLTSSAISDK-----TDVYSYGMVLLEIIS 578
T G L +W+ A+ D+ +DV+S+G++L EI +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 378 ELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHH 437
E+ + +G+G FG V+ + VAVK + G + F E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQH 60
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLH 496
LV+L + +++ E+M KGSL D GS + + + A G+A++
Sbjct: 61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPE 553
IH D++ NIL+ L KI+DFGL++++ + + +T G + + APE
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPE 173
Query: 554 WLTSSAISDKTDVYSYGMVLLEIIS-GR 580
+ + + K+DV+S+G++L+EI++ GR
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 22/200 (11%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFC--TEITIIGNIHHVNLVRLKGF 446
+G G FG V+ D+ +V +K+I + + E ++ + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 447 CAQGRQRFLVYEYMNKGSLDR-------TLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+ + +V EY G+L +L ++L + + +AL ++HT
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHVHT-- 119
Query: 500 DHKIIHCDVKPENILLHD-KLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
I+H D+K +NILL K+ VKI DFG+SK+L+ + + T+ GT Y++PE
Sbjct: 120 -KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA--YTVVGTPCYISPELCEGK 176
Query: 559 AISDKTDVYSYGMVLLEIIS 578
+ K+D+++ G VL E+ S
Sbjct: 177 PYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 31/206 (15%)
Query: 390 IGSGGFGTVYKGIL--QDKSV---VAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+GSG FGTVYKGI + ++V VA+K +N + G + EF E I+ ++ H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 444 KGFCAQGRQRFLVYEYMNKGSL------DRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
G C + LV + M G L + G+ +L W + A+G+ YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE- 126
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
+ +++H D+ N+L+ VKI+DFGL++LL ++ G + +W+
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE----YNADGGKMPIKWMAL 180
Query: 558 SAI-----SDKTDVYSYGMVLLEIIS 578
I + ++DV+SYG+ + E+++
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-17
Identities = 62/192 (32%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFC-TEITIIGNIHHVNLVRLKGFC 447
IG G GTVY + + VA++++N Q KKE EI ++ + N+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
G + ++V EY+ GSL + + ++ + + + L +LH+ +++IH D
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHRD 141
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
+K +NILL VK++DFG +TPEQS +TM GT ++APE +T A K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 568 SYGMVLLEIISG 579
S G++ +E+I G
Sbjct: 201 SLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 69/196 (35%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKE----FCTEITIIGNIHHVNLVRLK 444
IG G FG V + D S AVK + I KKE ++ N+ H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
+ + V +Y+N G L L LE R RF A A + YLH+ II
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LNII 118
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
+ D+KPENILL + V ++DFGL K + PE+++ +T GT YLAPE L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT--STFCGTPEYLAPEVLRKEPYDRT 176
Query: 564 TDVYSYGMVLLEIISG 579
D + G VL E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 35/213 (16%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVR----- 442
IG G +G VYK + +VA+K ++ ++E E I+ +H N+
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 443 -LKGFCAQGRQRFLVYEYMNKGS---LDRTLFGNGSVL--EW-----RERFEIALGTARG 491
K Q +LV E GS L + L G L EW RE T RG
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE-------TLRG 125
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551
LAYLH ++K+IH D+K +NILL +VK+ DFG+S L T + GT ++A
Sbjct: 126 LAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMA 181
Query: 552 PEWLTSSAISDKT-----DVYSYGMVLLEIISG 579
PE + D + DV+S G+ +E+ G
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLVRLK 444
IG G +G V VA+KKI+ F + FC EI I+ H N++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGIL 69
Query: 445 GF-CAQGRQRF----LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+ F +V E M L + + L RGL Y+H+
Sbjct: 70 DIIRPPSFESFNDVYIVQELMET-DLYKLI--KTQHLSNDHIQYFLYQILRGLKYIHSA- 125
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE--QSSLFTTMRGTRGYLAPE-WLT 556
++H D+KP N+LL+ +KI DFGL+++ PE + T TR Y APE L
Sbjct: 126 --NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
S + D++S G +L E++S R
Sbjct: 184 SKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 390 IGSGGFGTVYKGILQDKSVV-AVKKINSFGIQGKKE----FCTEITIIGNIHHVNLVRL- 443
+G GGFG V ++ K+ A+K + I + F E I+ +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 444 KGFCAQGRQRFLVY---EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
+ F + + +Y EY G L L G E+ RF IA YLH +
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLH---N 111
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAI 560
II+ D+KPEN+LL VK+ DFG +K L Q + T GT Y+APE + +
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFCGTPEYVAPEIILNKGY 169
Query: 561 SDKTDVYSYGMVLLEIISGR 580
D +S G++L E+++GR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 390 IGSGGFGTVYKGILQDKSV---VAVKKI-NSFG-IQGKKEFCTEITIIGNIHHVNLVRLK 444
IGSG +G V I D VA+KKI ++F K E+ I+ + H N++ ++
Sbjct: 13 IGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 445 GFC----AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA-RGLAYLHTGC 499
A + ++V + M + L + + + E E L RGL Y+H+
Sbjct: 71 DILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTE--EHIRYFLYQLLRGLKYIHSAN 127
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLL--TPEQSSLFTTMR-GTRGYLAPEWLT 556
+IH D+KP N+L+++ +++I DFG+++ L +P + F T TR Y APE L
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 557 SS-AISDKTDVYSYGMVLLEIISGRK 581
S + D++S G + E++ GR+
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 58/202 (28%), Positives = 107/202 (52%), Gaps = 22/202 (10%)
Query: 390 IGSGGFGTVYKGILQDKSV-VAVKKINSFGIQGKKEFCT-EITIIGNIHHVNLVRLKGFC 447
+G G + TVYKG + VA+K+I+ +G EI+++ + H N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYLHTGC 499
+ LV+EYM+K L + + +G R + T + G+A+ H
Sbjct: 68 HTENKLMLVFEYMDK-DLKKYMDTHG------VRGALDPNTVKSFTYQLLKGIAFCH--- 117
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
+++++H D+KP+N+L++ + ++K++DFGL++ ++ F+ T Y AP+ L S
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVVTLWYRAPDVLLGSR 176
Query: 560 I-SDKTDVYSYGMVLLEIISGR 580
S D++S G ++ E+I+GR
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 388 TPIGSGGFGTVYKGILQ------DKSVVAVKKINSFGIQG-KKEFCTEITIIGNIHHVNL 440
T +G G FG V+ + +++V VK + + + EF E+ + + H N+
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEW--------RERFEIALGTARGL 492
VRL G C + +++ EY + G L + L S E +++ + A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
+L + +H D+ N L+ + +VK+S LSK + + +LAP
Sbjct: 131 DHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIIS 578
E + S K+DV+S+G+++ E+ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN-SFGIQGKKEFCTEITI-IGNIHHVNLVRLKGF 446
+G G +G V K + +++AVK+I + Q +K ++ I + ++ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 447 CAQGRQRFLVYEYMNKGSLD---RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+ ++ E M+ SLD + ++ G + +IA+ + L YLH+ +
Sbjct: 69 LFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SV 125
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR-GTRGYLAPEW----LTSS 558
IH DVKP N+L++ QVK+ DFG+S L S+ T+ G + Y+APE L
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 559 AISDKTDVYSYGMVLLEIISGR 580
K+DV+S G+ ++E+ +GR
Sbjct: 183 GYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 57/197 (28%), Positives = 109/197 (55%), Gaps = 14/197 (7%)
Query: 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCT---EITIIGNIHHVNLVRLKG 445
+G G + TV+KG + +++VA+K+I +G CT E++++ ++ H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLHD 71
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ LV+EY++K L + + G+++ RGLAY H K++H
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLH 127
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPE-WLTSSAISDK 563
D+KP+N+L++++ ++K++DFGL++ + P ++ ++ T Y P+ L SS S +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 564 TDVYSYGMVLLEIISGR 580
D++ G + E+ SGR
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 44/213 (20%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN---------SFGIQGKKEFCTEITIIGNIHHVN 439
IG G +G VYK +VA+KKI S I+ EI+++ ++H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-------EISLLKELNHPN 59
Query: 440 LVRLKGFCAQGRQRFLVYEYMN---KGSLDRT-LFGNGSVLEWRERFEIALGTARGLAYL 495
+VRL + +LV+E+++ K +D + L G L +++ +G+AY
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYC 115
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL-------TPEQSSLFTTMRGTRG 548
H+ H+++H D+KP+N+L+ + +K++DFGL++ T E +L+
Sbjct: 116 HS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW-------- 164
Query: 549 YLAPEWLTSSA-ISDKTDVYSYGMVLLEIISGR 580
Y APE L S S D++S G + E+++ R
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT--EITIIGNIH---HVNLVRL 443
IG G +GTVYK VA+K + + T E+ ++ + H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 444 KGFCAQGR-----QRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYL 495
CA R + LV+E+++ + LD+ ++ L RGL +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL---RGLDFL 124
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H C I+H D+KPENIL+ QVK++DFGL+++ + + + T + T Y APE L
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVL 179
Query: 556 TSSAISDKTDVYSYGMVLLEI 576
S + D++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 56/197 (28%), Positives = 106/197 (53%), Gaps = 14/197 (7%)
Query: 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCT---EITIIGNIHHVNLVRLKG 445
+G G + TVYKG + ++VA+K+I +G CT E++++ ++ H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLHD 71
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ LV+EY++K L + L G+ + RGL Y H K++H
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLH 127
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPE-WLTSSAISDK 563
D+KP+N+L++++ ++K++DFGL++ + P ++ ++ T Y P+ L S+ S +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 564 TDVYSYGMVLLEIISGR 580
D++ G + E+ +GR
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-16
Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 43/291 (14%)
Query: 390 IGSGGFGTVYKGILQDKSV-VAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
I G G YKG + VK+IN +EI +G + H N+V+L G C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCR 753
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+ +L++EY+ +L L L W R +IA+G A+ L +LH C ++ ++
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
PE I++ K + + +L P T + Y+APE + I++K+D+Y
Sbjct: 810 SPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYG 863
Query: 569 YGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQR 628
+G++L+E+++G K+ + D+ +G S E R + L++
Sbjct: 864 FGLILIELLTG-KSPA----------DAEFGVHG-----SIVEWARYCYSDCHLDM---- 903
Query: 629 RYLELADSRIEGQVS---DEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
D I G VS +E VE ++ +AL C +P RP +V+ LE
Sbjct: 904 ----WIDPSIRGDVSVNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 59/197 (29%), Positives = 108/197 (54%), Gaps = 14/197 (7%)
Query: 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCT---EITIIGNIHHVNLVRLKG 445
+G G + TV+KG + +++VA+K+I +G CT E++++ N+ H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKNLKHANIVTLHD 70
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
R LV+EY++ L + L G+++ RGL+Y H KI+H
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPE-WLTSSAISDK 563
D+KP+N+L+++K ++K++DFGL++ + P ++ ++ T Y P+ L S+ S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 564 TDVYSYGMVLLEIISGR 580
D++ G +L E+ +GR
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 390 IGSGGFGTVYKGILQD---KSVVAVKKINSFGIQGK-KEFCTEITIIGNI-HHVNLVRLK 444
IG G FG V K ++ + A+K++ + + ++F E+ ++ + HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 445 GFCAQGRQRFLVYEYMNKGSL------DRTL---------FGNGSVLEWRERFEIALGTA 489
G C +L EY G+L R L S L ++ A A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM-RGTRG 548
RG+ YL + IH D+ NIL+ + KI+DFGLS+ ++ + TM R
Sbjct: 123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 549 YLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
++A E L S + +DV+SYG++L EI+S
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 37/210 (17%)
Query: 390 IGSGGFGTVYKGILQDK---SVVAVKKIN---------SFGIQGKKEFCTEITIIGNIHH 437
IG G +G VYK +D+ +A+KKI S I+ EI+++ + H
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIR-------EISLLKEMQH 60
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMN---KGSLDRT-LFGNGSVLEWRERFEIALGTARGLA 493
N+VRL+ ++ +LV+EY++ K +D + F L ++I RG+A
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI----LRGIA 116
Query: 494 YLHTGCDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLL-TPEQSSLFTTMRGTRGYLA 551
Y H+ H+++H D+KP+N+L+ + +K++DFGL++ P ++ FT T Y A
Sbjct: 117 YCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRA 171
Query: 552 PE-WLTSSAISDKTDVYSYGMVLLEIISGR 580
PE L S S D++S G + E+++ +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 65/195 (33%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKE----FCTEITIIGNIHHVNLVRLK 444
IG G FG V + ++ AVK + I KKE ++ N+ H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
+ + V +Y+N G L L LE R RF A A L YLH+ I+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIV 118
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
+ D+KPENILL + + ++DFGL K E + +T GT YLAPE L
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177
Query: 565 DVYSYGMVLLEIISG 579
D + G VL E++ G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK-KEFCTEITIIGNIHHVNLVRLKGFC 447
IG G FG V+KGI + + VVA+K I+ + + ++ EIT++ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 448 AQGRQRFLVYEYMNKGS-LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
+ + +++ EY+ GS LD L G L+ + I +GL YLH+ K IH
Sbjct: 72 LKDTKLWIIMEYLGGGSALD--LLEPGP-LDETQIATILREILKGLDYLHS---EKKIHR 125
Query: 507 DVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDV 566
D+K N+LL + +VK++DFG++ LT Q T GT ++APE + SA K D+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 567 YSYGMVLLEIISG 579
+S G+ +E+ G
Sbjct: 185 WSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 56/233 (24%)
Query: 385 NFNTPIGSGGFGTVYKGI-LQDKSVVAVKKI------NSFGIQGKKEFCTEITIIGNIHH 437
+G G FG VYK ++ VVA+KKI + F I +E I I+ + H
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKILKKLKH 66
Query: 438 VNLVRLKGFC-----AQGRQR---FLVYEYMNKGSLDRT-LFGNGSVLEWRERFE----- 483
N+V L R+R ++V YM+ D + L N SV +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH---DLSGLLENPSV-----KLTESQIK 118
Query: 484 -IALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL--- 539
L G+ YLH ++ I+H D+K NIL+ ++ +KI+DFGL++ +
Sbjct: 119 CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 540 -------FTTMRGTRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGR 580
+T + TR Y PE L ++A+ D++ G V E+ + R
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 390 IGSGGFGTVYKG----ILQDKSVVAVKKINSFGIQG-KKEFCTEITIIGNIHHVNLVRLK 444
+G G FG V +G VAVK + S + +F E I+ ++ H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNG------SVLEWRERFEIALGTARGLAYLHTG 498
G +V E GSL L + S L + A+ A G+ YL +
Sbjct: 63 GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTL-----CDYAVQIANGMRYLES- 115
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWL 555
+ IH D+ NILL +VKI DFGL + L P+ + + + APE L
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRAL-PQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 556 TSSAISDKTDVYSYGMVLLEIIS 578
+ S +DV+ +G+ L E+ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 390 IGSGGFGTVYKGILQD---KSVVAVKKI----NSFGIQGK--KEFCTEITIIGNIHHVNL 440
+G+G F + Y+ +D +++AVK++ N+ Q + + EI ++ ++H ++
Sbjct: 8 LGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIA--LGTARGLAYLHTG 498
+R+ G + L E+M GS+ L G+ ++E I RGL+YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLH-- 120
Query: 499 CDHKIIHCDVKPENILLHDKLQ-VKISDFGLSKLLTPE--QSSLFT-TMRGTRGYLAPEW 554
+++IIH DVK N+L+ Q ++I+DFG + L + + F + GT ++APE
Sbjct: 121 -ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 555 LTSSAISDKTDVYSYGMVLLEIISGR 580
L DV+S G V++E+ + +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 378 ELAAATDNFNTPIGSGGFGTVYKGIL------QDKSVVAVKKI-NSFGIQGKKEFCTEIT 430
E+ +T F +G FG VYKG L + VA+K + + ++EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 431 IIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL------------------DRTLFGN 472
+ + H N+V L G + + +++ Y + L D+T+
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV--- 117
Query: 473 GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL-SKL 531
S LE + I A G+ +L + H ++H D+ N+L+ DKL VKISD GL ++
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 532 LTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ L +++PE + S +D++SYG+VL E+ S
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 390 IGSGGFGTVYKGILQDKSV-VAVKKIN--SFGIQGKKEFCT---EITIIGNIHHVNLVRL 443
+G G FG VY D +AVK++ + KKE EI ++ N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 444 KGFCAQGRQRFLVY-EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
G C + + ++ EYM GS+ L G++ E R + G+ YLH +
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR---GTRGYLAPEWLTSSA 559
I+H D+K NIL VK+ DFG SK L SS T M+ GT +++PE ++
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISGEG 183
Query: 560 ISDKTDVYSYGMVLLEIIS 578
K DV+S G ++E+++
Sbjct: 184 YGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 30/206 (14%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKI----NSFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
IG G +G VYK VVA+KKI + G+ EI+++ ++H N+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 65
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYLH 496
+ +LV+E++++ D F + S L I L + GLA+ H
Sbjct: 66 DVIHTENKLYLVFEFLHQ---DLKKFMDASPLS-----GIPLPLIKSYLFQLLQGLAFCH 117
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL-TPEQSSLFTTMRGTRGYLAPEWL 555
+ H+++H D+KP+N+L++ + +K++DFGL++ P ++ +T T Y APE L
Sbjct: 118 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 172
Query: 556 TSSAI-SDKTDVYSYGMVLLEIISGR 580
S D++S G + E+++ R
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 15/197 (7%)
Query: 390 IGSGGFGTVYKGILQDKS----VVAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
IG G FG VY+G+ VAVK K + +K F E I+ H ++V+L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVKL 72
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
G + ++V E G L L N L+ + + LAYL + +
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRF 128
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR--GYLAPEWLTSSAIS 561
+H D+ N+L+ VK+ DFGLS+ L E S + +G ++APE + +
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 562 DKTDVYSYGMVLLEIIS 578
+DV+ +G+ + EI+
Sbjct: 187 SASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 5e-15
Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 35/211 (16%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKI-NSFGIQ--GKKEFCTEITIIGNI-HHVNLVRLK 444
+G G +G V+K I + K VVA+KKI ++F ++ F EI + + H N+V+L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVKLL 73
Query: 445 G-FCAQ-GRQRFLVYEYMN--------KGSLDRTLFGNGSVLEWRERFEIALGTARGLAY 494
A+ + +LV+EYM L+ + +R+ I + L Y
Sbjct: 74 NVIKAENDKDIYLVFEYMETDLHAVIRANILE----------DVHKRY-IMYQLLKALKY 122
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT----PEQSSLFTTMRGTRGYL 550
+H+G +IH D+KP NILL+ +VK++DFGL++ L+ ++ + T TR Y
Sbjct: 123 IHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 551 APEWLTSS-AISDKTDVYSYGMVLLEIISGR 580
APE L S + D++S G +L E++ G+
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 64/224 (28%), Positives = 111/224 (49%), Gaps = 26/224 (11%)
Query: 362 LELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSV---VAVKKINSFG 418
L+L G PR + D+F IG G G V I +K VAVKK++
Sbjct: 11 LQLVVSPGDPREY--------LDSF-IKIGEGSTGIVC--IATEKHTGKQVAVKKMDLRK 59
Query: 419 IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEW 478
Q ++ E+ I+ + HH N+V + G + ++V E++ G+L T + +
Sbjct: 60 QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL--TDIVTHTRMNE 117
Query: 479 RERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT---PE 535
+ + L R L+YLH +IH D+K ++ILL ++K+SDFG ++ P+
Sbjct: 118 EQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174
Query: 536 QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
+ SL GT ++APE ++ + D++S G++++E+I G
Sbjct: 175 RKSLV----GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 47/157 (29%), Positives = 87/157 (55%), Gaps = 11/157 (7%)
Query: 428 EITIIGNIHHVNLVRLKGFCAQ--GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIA 485
EI I+ N++H N+V+ KG C + G L+ E++ GSL L N + + +++ + A
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 486 LGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545
+ +G+ YL + + +H D+ N+L+ + QVKI DFGL+K + ++ + T++
Sbjct: 116 VQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--YYTVKD 170
Query: 546 TRG----YLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ APE L S +DV+S+G+ L E+++
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKI-NSF-GIQGKKEFCTEITIIGNIHHVNLVRLKG 445
PIG G +G V + VA+KKI N+F K EI ++ ++ H N++ +K
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 446 FC-AQGRQRF----LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
R+ F +VYE M+ L + + + ++ + ++ + RGL Y+H+
Sbjct: 72 IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFL-YQLLRGLKYIHSA-- 127
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAI 560
++H D+KP N+LL+ +KI DFGL++ T E+ T TR Y APE L +
Sbjct: 128 -NVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLNC-- 183
Query: 561 SDKT---DVYSYGMVLLEIISGRK 581
S+ T DV+S G + E++ GRK
Sbjct: 184 SEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 31/206 (15%)
Query: 390 IGSGGFGTVYKGIL-----QDKSVVAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+GSG FGTVYKG+ + K VA+K++ + + KE E ++ ++ + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 444 KGFCAQGRQRFLVYEYMNKGSL------DRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
G C + L+ + M G L + G+ +L W + A+G+ YL
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 126
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
+ +++H D+ N+L+ VKI+DFGL+KLL ++ G + +W+
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE----YHAEGGKVPIKWMAL 180
Query: 558 SAISDKT-----DVYSYGMVLLEIIS 578
+I + DV+SYG+ + E+++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 390 IGSGGFGTVYKGILQDKS-VVAVKKINSFGIQGKKE-----FCTEITIIGNIHHVNLVRL 443
IG G +G VYK +D +VA+KK+ + +KE EI I+ ++H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 444 K----------GFCAQGRQRFLVYEYMNKGSLDRTLFG--NGSVLEWRERFEIALGTA-- 489
K F +LV+EYM D L G ++ + E +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549
GL Y H +H D+K NILL++K Q+K++DFGL++L E+S +T T Y
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 550 LAPEWLTSSA-ISDKTDVYSYGMVLLEIISGR 580
PE L DV+S G +L E+ + +
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 390 IGSGGFGTV----YKGILQDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVR 442
+G+G FG V +K A+K ++ I K+ E I+ +I H LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGC 499
L G +LV EY+ G L L +G E RF ++ L L YLH
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYLH--- 118
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
I++ D+KPEN+LL +KI+DFG +K + T+ GT YLAPE + S
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPEYLAPEIILSKG 174
Query: 560 ISDKTDVYSYGMVLLEIISG 579
D ++ G+++ E+++G
Sbjct: 175 YGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 34/223 (15%)
Query: 390 IGSGGFGTVYKGIL----QDKSVVAVKKINSFGIQGKK--EFCTEITIIGNIHHVNLVRL 443
IG G FG K IL +D +K+IN + K+ E E+ ++ N+ H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDR-------TLFGNGSVLEWRERFEIALGTARGLAYLH 496
+ + ++V +Y G L + LF +L+W +I L L ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICLA----LKHVH 118
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
D KI+H D+K +NI L +K+ DFG++++L L T GT YL+PE
Sbjct: 119 ---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICE 174
Query: 557 SSAISDKTDVYSYGMVLLEIISGR--------KNSSLKIQSRS 591
+ ++K+D+++ G VL E+ + + KN LKI S
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 52/217 (23%)
Query: 390 IGSGGFGTV----YKG--------------ILQDKSVVAV---KKINSFGIQGKKEFCTE 428
+G G FG V KG ILQD V K++ + GK F T
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRV--LALAGKHPFLT- 59
Query: 429 ITIIGNIHHVNLVRLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EI 484
+H C Q + R F V EY+N G L + +G E R RF EI
Sbjct: 60 -----QLHS---------CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI 105
Query: 485 ALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTM 543
LG L +LH + II+ D+K +N+LL + +KI+DFG+ K + ++ +T
Sbjct: 106 VLG----LQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STF 156
Query: 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
GT Y+APE L+ D ++ G++L E+++G+
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 75/325 (23%), Positives = 132/325 (40%), Gaps = 72/325 (22%)
Query: 386 FNTPIGSGGFGTVYKGI------LQDKSVVAVKKINSFGIQGK-KEFCTEITIIGNIHHV 438
+G G FG V K + VAVK + + ++ +E ++ ++H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLDRTL-----FGNGSVLEWRER------------ 481
++++L G C+Q L+ EY GSL L G + R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 482 ------FEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535
A +RG+ YL + K++H D+ N+L+ + ++KISDFGLS+ + E
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 536 QSSLFTTM-RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEK 594
S + + R ++A E L + ++DV+S+G++L EI++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------------- 224
Query: 595 DSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIA 654
G P +P +R+ F LL +R + E++ +
Sbjct: 225 ----LGGNPYPGIAP---ERL-FNLLKTGYRMER--------------PENCSEEMYNLM 262
Query: 655 LCCVQEEPMLRPSMANVVSMLEGGM 679
L C ++EP RP+ A++ LE M
Sbjct: 263 LTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 47/215 (21%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKE-F----CTEITIIGNIHHVNLV 441
I G +G VY+ +DK +VA+KK+ ++ +KE F EI I+ + H N+V
Sbjct: 13 IEEGTYGVVYRA--RDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 442 RLK----GFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIA------LGT 488
+K G + + ++V EY+ K ++ ++ F + L
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETM----------KQPFLQSEVKCLMLQL 115
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL--FTTMRGT 546
G+A+LH D+ I+H D+K N+LL+++ +KI DFGL++ S L +T + T
Sbjct: 116 LSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVVT 169
Query: 547 RGYLAPEWLTSSAI-SDKTDVYSYGMVLLEIISGR 580
Y APE L + S D++S G + E+++ +
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 390 IGSGGFGTVYKGI--LQDKSV-VAVKKINSFGIQG-KKEFCTEITIIGNIHHVNLVRLKG 445
+GSG FG V KG+ ++ K + VA+K + + + + E E I+ + + +VR+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
C + LV E + G L++ L G + E+ + G+ YL +H
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISD 562
D+ N+LL ++ KISDFGLSK L + S + + + APE + S
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 563 KTDVYSYGMVLLEIIS-GRK 581
++DV+SYG+ + E S G+K
Sbjct: 178 RSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 390 IGSGGFGTVYKGILQD----KSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLK 444
IG G FG VY G L D K AVK +N ++ ++F E I+ + H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 445 GFC-AQGRQRFLVYEYMNKGSLD---RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
G C +V YM G L R+ N +V ++ L A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV---KDLIGFGLQVAKGMEYL---AS 116
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTS 557
K +H D+ N +L + VK++DFGL++ + ++ G + ++A E L +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 558 SAISDKTDVYSYGMVLLEIIS 578
+ K+DV+S+G++L E+++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 386 FNTPIGSGGFGTVYKGILQDKSV---VAVKKINSFGIQGK-KEFCTEITIIGNI-HHVNL 440
F IG G FG V K ++ + A+K++ + + ++F E+ ++ + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA----------- 489
+ L G C +L EY G+L VLE F IA TA
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 490 -----RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM- 543
RG+ YL + IH D+ NIL+ + KI+DFGLS+ ++ + TM
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 183
Query: 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
R ++A E L S + +DV+SYG++L EI+S
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 65/195 (33%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKE----FCTEITIIGNIHHVNLVRLK 444
IG G FG V + D AVK + + +KE ++ N+ H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
+ + V +++N G L L S E R RF A A L YLH+ I+
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---INIV 118
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
+ D+KPENILL + V ++DFGL K QS TT GT YLAPE + +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 565 DVYSYGMVLLEIISG 579
D + G VL E++ G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 6/151 (3%)
Query: 428 EITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALG 487
E ++ N++H +++R+K G +V + L L L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 488 TARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR 547
GL YLH +IIH DVK ENI ++D QV I D G ++ P + F + GT
Sbjct: 166 ILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTV 220
Query: 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
APE L + K D++S G+VL E+++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 64/196 (32%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 390 IGSGGFGTVYKGILQDKS-VVAVKKINSFGIQGKKEF---CTEITIIGNIHHVNLVRLKG 445
IG G FG V + +D + A+K I I + E E T++ ++ +V LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 446 FCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIA-LGTARGLAYLHTGCDHKI 503
F Q ++ +LV ++N G L L G R RF A L A L LH +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLH---KFNV 114
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
I+ D+KPENILL + + + DFGL K L + T GT YLAPE L +
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 564 TDVYSYGMVLLEIISG 579
D ++ G++L E+++G
Sbjct: 174 VDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 390 IGSGGFGTVYKGILQDK-SVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKG 445
+G GGFG V ++ + A KK++ + +G++ E I+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLF--GNGSVLEWRERF---EIALGTARGLAYLHTGCD 500
LV MN G L ++ G E R F +I G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLH---Q 113
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAI 560
+I++ D+KPEN+LL D V+ISD GL+ L + GT GY+APE L
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKI-KGRAGTPGYMAPEVLQGEVY 171
Query: 561 SDKTDVYSYGMVLLEIISGR 580
D ++ G L E+I+GR
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G +G VY L + +A+K+I + + EI + + H N+V+ G +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR---GLAYLHTGCDHKIIH 505
+ + E + GSL L L+ E+ I T + GL YLH D++I+H
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQILEGLKYLH---DNQIVH 131
Query: 506 CDVKPENILLHDKLQV-KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK- 563
D+K +N+L++ V KISDFG SK L + T GT Y+APE + DK
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPE------VIDKG 184
Query: 564 -------TDVYSYGMVLLEIISGR 580
D++S G ++E+ +G+
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 390 IGSGGFGTV----YKGILQDK-SVVAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG V Y +VAVK + G Q + EI I+ ++H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 444 KGFCAQGRQR--FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
KG C++ + L+ EY+ GSL L + L F A G+AYLH+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF--AQQICEGMAYLHS---Q 126
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLTSS 558
IH D+ N+LL + VKI DFGL+K + PE + + A E L +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLKEN 185
Query: 559 AISDKTDVYSYGMVLLEIIS 578
S +DV+S+G+ L E+++
Sbjct: 186 KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-14
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 16/169 (9%)
Query: 423 KEFCTEITIIGNIHHVNLVRL--KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRE 480
F E + ++H N+V L G G F V+EY+ +L R + L E
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGLL-FAVFEYVPGRTL-REVLAADGALPAGE 80
Query: 481 RFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH---DKLQVKISDFGLSKLLT---- 533
+ L LA H + I+H D+KP+NI++ + K+ DFG+ LL
Sbjct: 81 TGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137
Query: 534 --PEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
+ T + GT Y APE L ++ +D+Y++G++ LE ++G+
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 37/231 (16%)
Query: 378 ELAAATDNFNTPIGSGGFGTVYK----GILQDKS----VVAVKKINSFGI-QGKKEFCTE 428
EL+ P+G G FG V GI +DK VAVK + + + +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 429 ITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGN--------------- 472
+ ++ I H N++ L G C Q +++ EY +KG+L L
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 473 GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532
L +++ A ARG+ YL + K IH D+ N+L+ + +KI+DFGL++
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR-- 182
Query: 533 TPEQSSLFTTMRGTRGYLAPEWLTSSAISDK-----TDVYSYGMVLLEIIS 578
+ ++ + T G L +W+ A+ D+ +DV+S+G++L EI +
Sbjct: 183 --DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549
RGL YLH+ I+H D+KP N+L++ +KI DFGL+++ P++S T T+ Y
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 550 LAPEWLTSSA-ISDKTDVYSYGMVLLEIISGR 580
APE L S + D++S G + E++ R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 362 LELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDK-SVVAVKKINSFGIQ 420
L++ G PR + DNF IG G G V ++ +VAVKK++ Q
Sbjct: 9 LQMVVDPGDPRTY--------LDNF-IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ 59
Query: 421 GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRE 480
++ E+ I+ + H N+V + G + ++V E++ G+L T + + +
Sbjct: 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL--TDIVTHTRMNEEQ 117
Query: 481 RFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT---PEQS 537
+ L + L+ LH +IH D+K ++ILL +VK+SDFG ++ P +
Sbjct: 118 IAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174
Query: 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
SL GT ++APE ++ + D++S G++++E++ G
Sbjct: 175 SLV----GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 72/226 (31%), Positives = 107/226 (47%), Gaps = 22/226 (9%)
Query: 371 PRRFSYEELAAATDNFNT--PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT 427
E L TD + IG G +G VYK +D S+ AVK ++ +E
Sbjct: 9 SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEA 67
Query: 428 EITIIGNI-HHVNLVRLKGFCAQ-----GRQRFLVYEYMNKGS---LDRTLFGNGSVLEW 478
E I+ ++ +H N+V+ G + G Q +LV E N GS L + L G L+
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 479 RERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538
I G GL +LH +++IIH DVK NILL + VK+ DFG+S LT +
Sbjct: 128 AMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 539 LFTTMRGTRGYLAPEWLTSSAISD-----KTDVYSYGMVLLEIISG 579
T++ GT ++APE + D + DV+S G+ +E+ G
Sbjct: 185 RNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 38/207 (18%)
Query: 390 IGSGGFGTVYKG------------ILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHH 437
+G+G FG V+ ++ V+ +K+ + +K E++ H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH--VHNEKRVLKEVS------H 60
Query: 438 VNLVRLKGFCAQGRQRFL--VYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGL 492
++RL F + QRFL + EY+ G L L +G F EI L
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA----L 114
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
YLH+ +I++ D+KPENILL + +K++DFG +K L T+ GT YLAP
Sbjct: 115 EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----WTLCGTPEYLAP 167
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIISG 579
E + S + D ++ G+++ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 31/206 (15%)
Query: 390 IGSGGFGTVYKGI-LQD----KSVVAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+GSG FGTVYKGI + D K VA+K + + + KE E ++ + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 444 KGFCAQGRQRFLVYEYMNKGSL------DRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
G C + LV + M G L ++ G+ +L W + A+G++YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE- 126
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
+ +++H D+ N+L+ VKI+DFGL++LL ++ T G + +W+
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKVPIKWMAL 180
Query: 558 SAI-----SDKTDVYSYGMVLLEIIS 578
+I + ++DV+SYG+ + E+++
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 389 PIGSGGFGTVYKGILQ--DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
P+G G G V+ + DK V AVKKI Q K EI II + H N+V++
Sbjct: 12 PLGCGSNGLVFSAVDSDCDKRV-AVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 447 CAQGRQR--------------FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGL 492
++V EYM + G + E R RGL
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDL--ANVLEQGPLSEEHARL-FMYQLLRGL 127
Query: 493 AYLHTGCDHKIIHCDVKPENILLH-DKLQVKISDFGLSKLLTPEQS--SLFTTMRGTRGY 549
Y+H+ ++H D+KP N+ ++ + L +KI DFGL++++ P S + T+ Y
Sbjct: 128 KYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 550 LAPEWLTSSAISDKT-DVYSYGMVLLEIISGR 580
+P L S K D+++ G + E+++G+
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 390 IGSGGFG--TVYKGILQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
+G G FG T+Y+ +D S+V K++N + +++ EI I+ + H N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 446 FCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
+ EY N G+L D+ + G + E ++Y+H I+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
H D+K NI L +K+ DFG+SK+L E S+ T+ GT Y++PE + K+
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAETVVGTPYYMSPELCQGVKYNFKS 182
Query: 565 DVYSYGMVLLEIISGRK 581
D+++ G VL E+++ ++
Sbjct: 183 DIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGF-- 446
+G+G +G VYKG +A K+ ++E EI ++ HH N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 447 ----CAQGRQRFLVYEYMNKGS---LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
Q +LV E+ GS L + GN +W I RGLA+LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA-- 139
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
HK+IH D+K +N+LL + +VK+ DFG+S L T GT ++APE +
Sbjct: 140 -HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 560 ISDKT-----DVYSYGMVLLEIISG 579
D T D++S G+ +E+ G
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 67/199 (33%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFC---TEITIIGNIHHVN---LVR 442
IG G FG VY+ +D + + A+K ++ I KKE E I+ +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
LK +LV +YM+ G L L G E R +F IA L +LH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH---KYD 116
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
I++ D+KPENILL + + DFGLSK LT +++ T GT YLAPE L
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT--NTFCGTTEYLAPEVLLDEKGY 174
Query: 562 DK-TDVYSYGMVLLEIISG 579
K D +S G+++ E+ G
Sbjct: 175 TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 8e-14
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFC 447
+G+G +G VYKG ++ + A+K ++ G + ++E EI ++ HH N+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 448 AQGR------QRFLVYEYMNKGS---LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
+ Q +LV E+ GS L + GN EW I RGL++LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH-- 128
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
HK+IH D+K +N+LL + +VK+ DFG+S L T GT ++APE +
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAPEVIACD 186
Query: 559 AISD-----KTDVYSYGMVLLEIISG 579
D K+D++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 393 GGFGTVYKGILQDKSV-----VAVKKI--NSFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
G FG ++ GIL D+ V VK + ++ IQ E ++ + H N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGLSHQNILPILH 75
Query: 446 FCAQGRQR-FLVYEYMNKGSLDRTL-------FGNGSVLEWRERFEIALGTARGLAYLHT 497
C + + F++Y YMN G+L L N L ++ +A+ A G++YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP-EQSSLFTTMRGTRGYLAPEWLT 556
+IH D+ N ++ ++LQVKI+D LS+ L P + L ++A E L
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
Query: 557 SSAISDKTDVYSYGMVLLEIIS 578
+ S +DV+S+G++L E+++
Sbjct: 193 NKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 389 PIGSGGFGTV--YKGILQDKSVVAVKKI-NSFG--IQGKKEFCTEITIIGNIHHVNLVRL 443
P+G G FG V + L ++V A+KKI F + K+ + E+ ++ ++ H N++ L
Sbjct: 17 PVGMGAFGLVCSARDQLTGQNV-AIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISL 74
Query: 444 KG-FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
F + + V E + L R L ++ + F RGL Y+H+
Sbjct: 75 SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYF--LYQILRGLKYVHSA---G 128
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE-WLTSSAIS 561
++H D+KP NIL+++ +KI DFGL+++ Q T TR Y APE LT
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 562 DKTDVYSYGMVLLEIISGR 580
+ D++S G + E++ G+
Sbjct: 185 VEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 386 FNTPIGSGGFGTVYK----GILQDKSV--VAVKKINSFGIQGKKE-FCTEITIIGNI-HH 437
F +G+G FG V + G+ + +V VAVK + ++E +E+ I+ ++ +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLH 496
N+V L G C G ++ EY G L L S L + + A+G+A+L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 497 T-GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAP 552
+ C IH D+ N+LL VKI DFGL++ + S + R ++AP
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIM--NDSNYVVKGNARLPVKWMAP 212
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIIS 578
E + + + ++DV+SYG++L EI S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 68/204 (33%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFC---TEITIIGNIHHVNLVRL 443
+G G FG V ++++K+ A+K + I K E TE ++ N H L L
Sbjct: 3 LGKGTFGKVI--LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 444 K-GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGC 499
K F R F V EY N G L L E R RF EI L YLH+
Sbjct: 61 KYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LGYLHSC- 114
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR---GTRGYLAPEWLT 556
+++ D+K EN++L +KI+DFGL K E S TM+ GT YLAPE L
Sbjct: 115 --DVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
+ D + G+V+ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 390 IGSGGFGTVYKGILQDK-SVVAVKKINSFGIQGKKEF---CTEITIIGNIHHVNLVRLKG 445
+G GGFG V ++ + A KK+N ++ +K + E I+ +H +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFG----NGSVLEWRERFEIALGTARGLAYLHTGCDH 501
LV MN G L ++ N E R F A GL +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA-QIISGLEHLH---QR 116
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
+II+ D+KPEN+LL + V+ISD GL+ L QS GT G++APE L
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGTPGFMAPELLQGEEYD 175
Query: 562 DKTDVYSYGMVLLEIISGR 580
D ++ G+ L E+I+ R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 65/257 (25%), Positives = 118/257 (45%), Gaps = 44/257 (17%)
Query: 390 IGSGGFGTVYKG--ILQDKSVVAVKKINSFGIQGKKEFCTEITI--------IGNIHHVN 439
IG G +G V+K + VA+K++ +Q +E TI + H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 440 LVRLKGFCAQGR-----QRFLVYEYMNKGSLDRTLFGN-----GSVLEWRERFEIALGTA 489
+VRL C R + LV+E++++ D T + + G E + ++
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIK--DMMFQLL 120
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549
RGL +LH+ H+++H D+KP+NIL+ Q+K++DFGL+++ + + T++ T Y
Sbjct: 121 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWY 175
Query: 550 LAPEWLTSSAISDKTDVYSYGMVLLEIISG----RKNSSL-------KIQSRSTEKDSSG 598
APE L S+ + D++S G + E+ R +S + + E+D
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235
Query: 599 DGNGPSSSSSPRESQRV 615
D P + + +Q +
Sbjct: 236 DVALPRQAFHSKSAQPI 252
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 66/198 (33%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFC---TEITIIGNIHHVNLVRL 443
+G G FG V ++++K+ A+K + I K E TE ++ N H L L
Sbjct: 3 LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 444 KGFCAQGRQRF-LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
K + Q + R V EY+N G L L E R RF A L YLH+G K
Sbjct: 61 K-YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG---K 115
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
I++ D+K EN++L +KI+DFGL K + +++ T GT YLAPE L +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM-KTFCGTPEYLAPEVLEDNDYGR 174
Query: 563 KTDVYSYGMVLLEIISGR 580
D + G+V+ E++ GR
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRL 443
T +G GG+G V+ +D +VA+K++ + E TE I+ LV+L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 444 KGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRE-RFEI-----ALGTARGLAYLH 496
+ Q + +L EY+ G RTL N VL RF + A+ L Y
Sbjct: 67 L-YAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY-- 122
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
IH D+KPEN L+ +K++DFGLSK + ++ G+ Y+APE L
Sbjct: 123 -------IHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLR 171
Query: 557 SSAISDKTDVYSYGMVLLEIISG 579
D +S G +L E + G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKE-----FCTEITIIGNIHHVNLVRLK 444
+G G FG VYK ++ +A K+ I+ K E + EI I+ +H +V+L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKV----IETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + +++ E+ G++D + L + I L YLH+ KII
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 505 HCDVKPENILLHDKLQVKISDFGLS--KLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
H D+K N+LL +K++DFG+S + T ++ F GT ++APE + + D
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAPEVVMCETMKD 189
Query: 563 -----KTDVYSYGMVLLEI 576
K D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 389 PIGSGGFGTVYKGI--LQDKSVVAVKKINSFGIQGKKEFCT---EITIIGNIHHVNLVRL 443
+G G + TVYKG L + +VA+K+I +G T E +++ ++ H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQ-LVALKEIRLEHEEGAP--FTAIREASLLKDLKHANIVTL 68
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+ LV+EY++ L + + G L RGLAY H ++
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRV 124
Query: 504 IHCDVKPENILLHDKLQVKISDFGL-------SKLLTPEQSSLFTTMRGTRGYLAPE-WL 555
+H D+KP+N+L+ ++ ++K++DFGL SK + E +L+ Y P+ L
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW--------YRPPDVLL 176
Query: 556 TSSAISDKTDVYSYGMVLLEIISGR 580
S+ S D++ G + E+ +GR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 14/195 (7%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKK-INSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G FG VYK ++ V+A K I++ + +++ EI I+ + H N+V+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+++ E+ G++D + L + + T L YLH ++KIIH D+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 509 KPENILLHDKLQVKISDFGLS--KLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD---- 562
K NIL +K++DFG+S T ++ F GT ++APE + D
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPYWMAPEVVMCETSKDRPYD 186
Query: 563 -KTDVYSYGMVLLEI 576
K DV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 46/226 (20%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN----SFGIQGKKE--------FCT--EITIIGN 434
+G G +G V K +VA+KK+ S + ++ F T E+ I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 435 IHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFE------IALGT 488
I H N++ L +G LV + M L + V++ + R I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKK-------VVDRKIRLTESQVKCILLQI 128
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL-------------SKLLTPE 535
GL LH +H D+ P NI ++ K KI+DFGL SK T +
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 536 QSSLFTTMRGTRGYLAPEWLT-SSAISDKTDVYSYGMVLLEIISGR 580
+ T+ T Y APE L + D++S G + E+++G+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 390 IGSGGFGTVYKGIL-QDKSV---VAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG+V +G L QD VAVK K++ +EF +E + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 444 KGFCAQGRQR------FLVYEYMNKGSLDRTLF-----GNGSVLEWRERFEIALGTARGL 492
G C + ++ +M G L L G L + + + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
YL IH D+ N +L + + V ++DFGLSK + R R P
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-----DYYRQGRIAKMP 178
Query: 553 -EWLTSSAISD-----KTDVYSYGMVLLEIIS 578
+W+ +++D K+DV+++G+ + EI +
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN---------SFGIQGKKEFCTEITIIGNIHHVN 439
IG G +G VYKG + +VA+KKI S I+ EI+++ + H N
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-------EISLLKELQHPN 60
Query: 440 LVRLKGFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLH 496
+V L+ Q + +L++E+++ K LD G ++ +G+ + H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCH 118
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL-TPEQSSLFTTMRGTRGYLAPEWL 555
+ +++H D+KP+N+L+ +K +K++DFGL++ P + ++T T Y APE L
Sbjct: 119 S---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVL 173
Query: 556 TSSA-ISDKTDVYSYGMVLLEIISGR 580
S S D++S G + E+ + +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQ---GKKEFCTEITIIGNIHHVNLVRL 443
+G GGFG V +Q K+ + A KK++ ++ G+K E I+ ++ +V L
Sbjct: 1 LGKGGFGEVCA--VQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL 58
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSV-LEWRERFEIALGTARGLAYLHTGCDHK 502
LV MN G L ++ G LE + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
I++ D+KPEN+LL D+ ++SD GL+ L + ++ T GT GY+APE L S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTI-TQRAGTNGYMAPEILKEEPYSY 173
Query: 563 KTDVYSYGMVLLEIISGR 580
D ++ G + E+++GR
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 45/194 (23%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKG 445
IG G F VY+ L D VA+KK+ F + + + + EI ++ ++H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLF---GNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
+ + +V E + G L R + ++ + ++ + L ++H+ +
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RR 126
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
++H D+KP N+ + VK+ D GL + + + ++ + + GT Y++PE + + +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185
Query: 563 KTDVYSYGMVLLEI 576
K+D++S G +L E+
Sbjct: 186 KSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 385 NFNTPIGSGGFGTVY------------KGILQDKSV-----VAVKKIN-SFGIQGKKEFC 426
NF +G G FG V+ K ++ + VAVK + +++F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 427 TEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL----------DRTLFGNGSVL 476
E+ I+ + N+ RL G C ++ EYM G L L N L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 477 EWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ 536
+ +A A G+ YL + +H D+ N L+ +KI+DFG+S+ L
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---Y 181
Query: 537 SSLFTTMRGTRGYLAPEWLTSSAI-----SDKTDVYSYGMVLLEIIS 578
SS + ++G R L W+ ++ + K+DV+++G+ L EI++
Sbjct: 182 SSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 390 IGSGGFGTVYKGIL-QDKSV--VAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
+G G FG+V +G L QD S+ VAVK KI ++F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 445 GFCAQGRQR------FLVYEYMNKGSLDRTLF----GNGSV-LEWRERFEIALGTARGLA 493
G C Q + ++ +M G L L G+ L + + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 494 YLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYL 550
YL + IH D+ N +L++ + V ++DFGLSK + + R + ++
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIY--NGDYYRQGRIAKMPVKWI 181
Query: 551 APEWLTSSAISDKTDVYSYGMVLLEI 576
A E L + K+DV+S+G+ + EI
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 36/207 (17%)
Query: 389 PIGSGGFGTVYKGILQDKSVV----AVKKINSFGIQGKKEFCTEITIIGNIHHV-----N 439
PI G FG+VY L K A+K + + K + T + I +
Sbjct: 3 PISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQV-TNVKAERAIMMIQGESPY 58
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKG---SLDRTLFGNGSVLEWRERF--EIALGTARGLAY 494
+ +L +LV EY+N G SL +TL G +W +++ E+ LG +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLG----VED 112
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK--LLTPEQSSLFTTMRGTRGYLAP 552
LH IIH D+KPEN+L+ +K++DFGLS+ L + GT YLAP
Sbjct: 113 LH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTPDYLAP 162
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIISG 579
E + +D +S G V+ E + G
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 63/198 (31%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 390 IGSGGFGTVYKGILQDKSV---VAVKKINSFGIQGKKEFC---TEITIIGNIHHVNLVRL 443
+G G FG V ++++K+ A+K + I K E TE ++ N H L L
Sbjct: 3 LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 444 KGFCAQGRQRF-LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
K + Q R V EY N G L L E R RF A L YLH+
Sbjct: 61 K-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHS---RD 115
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
+++ D+K EN++L +KI+DFGL K + +++ T GT YLAPE L +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLEDNDYGR 174
Query: 563 KTDVYSYGMVLLEIISGR 580
D + G+V+ E++ GR
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 51/212 (24%), Positives = 101/212 (47%), Gaps = 45/212 (21%)
Query: 390 IGSGGFGTVYKGILQDK-SVVAVKKIN---------SFGIQGKKEFCTEITIIGNIHHVN 439
IG G +GTV+K ++ +VA+K++ S ++ EI ++ + H N
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-------EICLLKELKHKN 60
Query: 440 LVRLKGFCAQGRQRFLVYEYMNK----------GSLDRTLFGNGSVLEWRERFEIALGTA 489
+VRL ++ LV+EY ++ G +D + + F L
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV---------KSFMFQL--L 109
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL-TPEQSSLFTTMRGTRG 548
+GLA+ H+ H ++H D+KP+N+L++ ++K++DFGL++ P + ++ T
Sbjct: 110 KGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLW 164
Query: 549 YLAPEWLTSSAISDKT-DVYSYGMVLLEIISG 579
Y P+ L + + + D++S G + E+ +
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 389 PIGSGGFGTVYK----GILQDKS----VVAVKKINSFGIQGK-KEFCTEITIIGNI-HHV 438
P+G G FG V GI +DK VAVK + + + +E+ ++ I H
Sbjct: 22 PLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGN---------------GSVLEWRERFE 483
N++ L G C Q +++ EY +KG+L L + +++
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 484 IALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543
ARG+ YL + K IH D+ N+L+ + +KI+DFGL++ + +++
Sbjct: 142 CTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYK 194
Query: 544 RGTRGYLAPEWLTSSAISDK-----TDVYSYGMVLLEIIS 578
+ T G L +W+ A+ D+ +DV+S+G+++ EI +
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 390 IGSGGFGTV----YKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVR-LK 444
+G+G FG V +KG + ++ +KK ++ + E +I+ + H +V +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDH 501
F + R FL+ E++ G L L G +F E+ L YLH+ D
Sbjct: 86 SFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEYLHS-KD- 138
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
II+ D+KPEN+LL +K VK++DFG +K + T+ GT YLAPE + S
Sbjct: 139 -IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHG 193
Query: 562 DKTDVYSYGMVLLEIISG 579
D ++ G++L E I+G
Sbjct: 194 KAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/234 (25%), Positives = 114/234 (48%), Gaps = 20/234 (8%)
Query: 384 DNFNTPIGSGGFGTVYKGILQDKSV---VAVKKINSFGIQGKKEFCTEITIIGNIHHVNL 440
+N+ IG G G V I ++K VAVK ++ Q ++ E+ I+ + H N+
Sbjct: 24 ENY-IKIGEGSTGIVC--IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
V + G + +++ E++ G+L T + + L + + + L YLH+
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGAL--TDIVSQTRLNEEQIATVCESVLQALCYLHS--- 135
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLT---PEQSSLFTTMRGTRGYLAPEWLTS 557
+IH D+K ++ILL +VK+SDFG ++ P++ SL GT ++APE ++
Sbjct: 136 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVISR 191
Query: 558 SAISDKTDVYSYGMVLLEIISGRKN--SSLKIQSRSTEKDSSGDGNGPSSSSSP 609
+ + D++S G++++E++ G S +Q+ +DS + SP
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISP 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 46/146 (31%), Positives = 67/146 (45%), Gaps = 14/146 (9%)
Query: 455 LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENIL 514
L+ +Y+N G L L+ E R IA L +LH II+ D+K ENIL
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137
Query: 515 LHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT--SSAISDKTDVYSYGMV 572
L + V ++DFGLSK E+ + GT Y+APE + S D +S G++
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197
Query: 573 LLEI--------ISGRKNSSLKIQSR 590
E+ + G +NS +I R
Sbjct: 198 TFELLTGASPFTVDGEQNSQSEISRR 223
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 58/236 (24%)
Query: 369 GLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSV-VAVKKINS-F--GIQGKKE 424
+P R Y+ L +P+GSG +G V VA+KK++ F I K+
Sbjct: 12 EVPDR--YQNL--------SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT 61
Query: 425 FCTEITIIGNIHHVNLV----------RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGS 474
+ E+ ++ ++ H N++ L+ F + +LV M L +
Sbjct: 62 Y-RELRLLKHMDHENVIGLLDVFTPASSLEDF----QDVYLVTHLM-----GADL---NN 108
Query: 475 VLEWRE------RFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL 528
+++ ++ +F + RGL Y+H+ IIH D+KP NI +++ ++KI DFGL
Sbjct: 109 IVKCQKLSDDHIQF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164
Query: 529 SKLLTPEQSSLFTTMRGTRGYLAPE----WLTSSAISDKTDVYSYGMVLLEIISGR 580
++ T TR Y APE W+ + D++S G ++ E+++G+
Sbjct: 165 ARHT----DDEMTGYVATRWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
IG G +G V I VA+KKIN + EI ++ + H ++V +K
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 447 CAQGRQR-----FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL-GTARGLAYLHTGCD 500
+R ++V+E M + L + + N + E + L R L Y+HT
Sbjct: 68 MLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLT--PEHHQFFLYQLLRALKYIHTA-- 122
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS--LFTTMRGTRGYLAPEWLTS- 557
+ H D+KP+NIL + ++KI DFGL+++ + + +T TR Y APE S
Sbjct: 123 -NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 181
Query: 558 -SAISDKTDVYSYGMVLLEIISGR 580
S + D++S G + E+++G+
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 44/194 (22%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKG 445
IG G F VY+ L D+ VA+KK+ F + + +++ EI ++ ++H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLF---GNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
+ + +V E + G L + + ++ R ++ + + ++H+ +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RR 126
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
++H D+KP N+ + VK+ D GL + + + ++ ++ GT Y++PE + + +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPERIHENGYNF 185
Query: 563 KTDVYSYGMVLLEI 576
K+D++S G +L E+
Sbjct: 186 KSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 18/198 (9%)
Query: 390 IGSGGFGTVYKGILQDKSVVA-----VKKINSFGIQGKKEFC---TEITIIGNIHHVNLV 441
+G G FGTVY +++DK VA V K G E E ++ + H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLD---RTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
+ + ++ EY LD L G L + E + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
+I+H D+K +NI L + L +KI DFG+S+LL L TT GT Y++PE L
Sbjct: 124 -QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSPEALKHQ 180
Query: 559 AISDKTDVYSYGMVLLEI 576
K+D++S G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 390 IGSGGFGTVYKGILQD-KSVVAVKKI-NSFGIQGKKEFC-TEITIIGNIHHVNLVRLKGF 446
+G G +G V K ++ K +VA+KK +S + KE E+ ++ + N+V LK
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 447 CAQGRQRFLVYEYMNKGSLDR-TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ + +LV+EY+ K L+ NG E + L A +H + I+H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA-----IHWCHKNDIVH 123
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
D+KPEN+L+ +K+ DFG ++ L+ ++ +T TR Y +PE L + D
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183
Query: 566 VYSYGMVLLEIISGR 580
++S G +L E+ G+
Sbjct: 184 MWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 60/231 (25%), Positives = 90/231 (38%), Gaps = 54/231 (23%)
Query: 390 IGSGGFGTVYKGIL----QDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVR 442
IG G FG V+ L V A+K + + + + E I+ + +V+
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 443 LKGFCAQGRQRFL--VYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHT 497
L + + + L V EYM G L L E RF E+ L L +H
Sbjct: 66 L--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA----LDSVHK 119
Query: 498 -GCDHKIIHCDVKPENILLHDKLQVKISDFGLSK----------LLTPEQSSLFTTMR-- 544
G IH D+KP+NIL+ +K++DFGL K L + LF
Sbjct: 120 LGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 545 ----------------GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
GT Y+APE L + + D +S G++L E++ G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 484 IALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543
+ + + L YL H +IH DVKP NILL VK+ DFG+S L ++ T
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRS 174
Query: 544 RGTRGYLAPEWLTSSAISDK----TDVYSYGMVLLEIISGR 580
G Y+APE + + K DV+S G+ L+E+ +G+
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 388 TPIGSGGFGTVYKGI-LQDKSVVAVKKIN---SFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+GSG +G+V I + VA+KK++ I K+ + E+T++ ++ H N++ L
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGL 79
Query: 444 KG-FCAQ----GRQRF-LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
F + Q F LV YM + L + + G L + + GL Y+H+
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
IIH D+KP N+ +++ ++KI DFGL++ E + TR Y APE + +
Sbjct: 136 A---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILN 188
Query: 558 SAISDKT-DVYSYGMVLLEIISGR 580
++T D++S G ++ E+++G+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 390 IGSGGFGTVY---KGILQDK-SVVAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG V+ K D + A+K K + ++ + E I+ ++H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 444 K-GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
F +G+ +L+ +++ G L L E +F +A A L +LH+
Sbjct: 64 HYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS---LG 118
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
II+ D+KPENILL ++ +K++DFGLSK + + + GT Y+APE + +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQ 177
Query: 563 KTDVYSYGMVLLEIISG 579
D +S+G+++ E+++G
Sbjct: 178 SADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 37/220 (16%)
Query: 389 PIGSGGFGTVYK----GILQDK----SVVAVKKINSFGIQGK-KEFCTEITIIGNI-HHV 438
P+G G FG V G+ ++K + VAVK + S + + +E+ ++ I H
Sbjct: 25 PLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGN---------------GSVLEWRERFE 483
N++ L G C Q +++ EY +KG+L L L +++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 484 IALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543
A ARG+ YL + K IH D+ N+L+ + +KI+DFGL++ + +
Sbjct: 145 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 197
Query: 544 RGTRGYLAPEWLTSSAISDK-----TDVYSYGMVLLEIIS 578
+ T G L +W+ A+ D+ +DV+S+G++L EI +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/198 (31%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 390 IGSGGFGTVYKGILQDKSV---VAVKKINSFGIQGKKEFC---TEITIIGNIHHVNLVRL 443
+G G FG V ++++K+ A+K + I K E TE ++ N H L L
Sbjct: 3 LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 444 KGFCAQGRQRF-LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
K + Q R V EY N G L L E R RF A L YLH+ +
Sbjct: 61 K-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHS--EKN 116
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
+++ D+K EN++L +KI+DFGL K + +++ T GT YLAPE L +
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KTFCGTPEYLAPEVLEDNDYGR 175
Query: 563 KTDVYSYGMVLLEIISGR 580
D + G+V+ E++ GR
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 39/225 (17%)
Query: 386 FNTPIGSGGFGTVY----KGILQ-----------DKSVVAVKKINS-FGIQGKKEFCTEI 429
+G G FG V+ +G+ + +VAVK + + + +F EI
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 430 TIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR-----------TLFGNGSVLEW 478
I+ + + N++RL G C ++ EYM G L++ T N +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 479 RERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538
+A+ A G+ YL + +H D+ N L+ + +KI+DFG+S+ L S
Sbjct: 129 ANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNL---YSG 182
Query: 539 LFTTMRGTRGYLAPEWLTSSAI-----SDKTDVYSYGMVLLEIIS 578
+ ++G R L W+ +I + +DV+++G+ L E+ +
Sbjct: 183 DYYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 390 IGSGGFGTVYKGILQDKS-VVAVKKI--NSFGIQGKKEFCT---EITIIGNIHHVNLVRL 443
+G G FG VY D +AVK++ + + KE EI ++ N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 444 KGFCAQGRQRFL--VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
G +R L E+M GS+ L G++ E R + G++YLH+ +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHS---N 125
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTP--EQSSLFTTMRGTRGYLAPEWLTSSA 559
I+H D+K NIL VK+ DFG SK L + ++ GT +++PE ++
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 560 ISDKTDVYSYGMVLLEIISGR 580
K D++S G ++E+++ +
Sbjct: 186 YGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 428 EITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF---EI 484
E I+ + H +V L G + +L+ EY++ G L L G +E F EI
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 485 ALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544
+L L +LH II+ D+KPENILL + VK++DFGL K + + ++ T
Sbjct: 110 SLA----LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFC 161
Query: 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
GT Y+APE L S D +S G ++ ++++G
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 46/131 (35%), Positives = 70/131 (53%), Gaps = 13/131 (9%)
Query: 454 FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDHKIIHCDVKP 510
F V EY+N G L + +G E R RF EI G L +LH II+ D+K
Sbjct: 72 FFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHK---KGIIYRDLKL 124
Query: 511 ENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSY 569
+N+LL +KI+DFG+ K + E + +T GT Y+APE L ++ D +S+
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKYNESVDWWSF 182
Query: 570 GMVLLEIISGR 580
G++L E++ G+
Sbjct: 183 GVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 44/214 (20%)
Query: 390 IGSGGFGTVYKGILQDKS-VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF-- 446
IG+G FG VY+ I D S VA+KK+ +Q + E+ I+ N++H+N++ LK +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 447 --CAQGRQR--FL----------VYEYM-----NKGSLDRTLFGNGSVLEWRERFEIALG 487
C + ++ FL V++YM N +L L + + L
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV---------KLYSYQL- 179
Query: 488 TARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ-VKISDFGLSKLLTPEQSSLFTTMRGT 546
R LAY+H+ I H D+KP+N+L+ +K+ DFG +K L Q S+ + +
Sbjct: 180 -CRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICS 233
Query: 547 RGYLAPE-WLTSSAISDKTDVYSYGMVLLEIISG 579
R Y APE L ++ + D++S G ++ E+I G
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 40/227 (17%)
Query: 389 PIGSGGFGTVYKGILQDKSVV-AVKKINSFGIQGKKEF---CTEITIIGNIHHVNLVRLK 444
+G G G V+ L+ + A+K ++ + + + TE I+ + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTL-FGNGSVL-EWRERFEIALGTARGLAYLHT-GCDH 501
LV +Y G L R L G L E RF A L YLH G
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG--- 123
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE-----QSSLFTTMR------------ 544
I++ D+KPENILLH+ + +SDF LSK E ++ + R
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 545 -----------GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
GT Y+APE ++ D ++ G++L E++ G
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP---EQSSLFTTMRGT 546
GL Y+H+ ++H D+KP N+L++ ++KI DFGL++ + E + T T
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 547 RGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGR 580
R Y APE + S + + DV+S G +L E++ +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 43/210 (20%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEF--------CTEITIIGNI-HHVN 439
IG G F V K + A+K + KK F EI + + H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 440 LVRLKGFC---AQGRQRFL-------VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA 489
++RL GR + +YE + KG + V + +++
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELI-KGR--KRPLPEKRVKSYM--YQLL---- 110
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549
+ L ++H + I H D+KPENIL+ D + +K++DFG + + + +T TR Y
Sbjct: 111 KSLDHMHR---NGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP--YTEYISTRWY 164
Query: 550 LAPE-WLTSSAISDKTDVYSYGMVLLEIIS 578
APE LT K D+++ G V EI+S
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 9e-11
Identities = 19/42 (45%), Positives = 22/42 (52%)
Query: 4 SRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLR 45
LQ+ GNLVL D LWQSFD PTD ++ GQ
Sbjct: 48 GSGCVAVLQDDGNLVLYDNSGKVLWQSFDHPTDTLLPGQKDG 89
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 32/211 (15%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKK----INSFGIQGKKEFCTEITIIG----NIHHV 438
IG G +G VYK +DK+ +VA+KK ++ GI EI+++ +I+ V
Sbjct: 9 IGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIV 64
Query: 439 NLVRLKGFCAQG--RQRFLVYEYMN---KGSLDRTLFGNGSVLEWR--ERFEIALGTARG 491
L+ ++ + +LV+EY++ K +D G G L + + F L +G
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LKG 122
Query: 492 LAYLHTGCDHKIIHCDVKPENILL-HDKLQVKISDFGLSKLLT-PEQSSLFTTMRGTRGY 549
+A+ H H ++H D+KP+N+L+ K +KI+D GL + + P +S +T T Y
Sbjct: 123 VAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWY 177
Query: 550 LAPE-WLTSSAISDKTDVYSYGMVLLEIISG 579
APE L S+ S D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 46/131 (35%), Positives = 68/131 (51%), Gaps = 14/131 (10%)
Query: 455 LVYEYMNKGSLDRTLF--GNGSVLEWRERF---EIALGTARGLAYLHTGCDHKIIHCDVK 509
LV MN G L ++ GN E R F EI G L LH +I++ D+K
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LEDLHR---ERIVYRDLK 129
Query: 510 PENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSY 569
PENILL D ++ISD GL+ + PE ++ + GT GY+APE + + + D +
Sbjct: 130 PENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKNERYTFSPDWWGL 187
Query: 570 GMVLLEIISGR 580
G ++ E+I G+
Sbjct: 188 GCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 66/251 (26%), Positives = 108/251 (43%), Gaps = 58/251 (23%)
Query: 390 IGSGGFGTVYKGILQDKS----------VVAVKKINSFGIQGKKEFCTEITIIGNIHHVN 439
+G G F +YKG+L+ +S V V K+ + F +++ + H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 440 LVRLKGFC-AQGRQRFLVYEYMNKGSLDRTL--FGNGSVLEWRERFEIALGTARGLAYLH 496
LV+L G C +V EY+ G LD L N L W + ++A A L YL
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 497 TGCDHKIIHCDVKPENILL--HD-----KLQVKISDFGLSK-LLTPEQSSLFTTMRGTRG 548
D K++H +V +NIL+ + +K+SD G+ +L+ E+ R R
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-------RVERI 168
Query: 549 -YLAPEWL--TSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSS 605
++APE + ++++ D +S+G LLEI S +G P S
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICS--------------------NGEEPLS 208
Query: 606 SSSPRESQRVY 616
+ S E +R Y
Sbjct: 209 TLSSSEKERFY 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 389 PIGSGGFGTVYK----GILQDK----SVVAVKKINSFGI-QGKKEFCTEITIIGNI-HHV 438
P+G G FG V + GI + + VAVK + + + +E+ ++ I H
Sbjct: 19 PLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSL------------DRTLFGNGS---VLEWRERFE 483
N++ L G C Q +++ EY KG+L D T L +++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 484 IALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543
A ARG+ YL + + IH D+ N+L+ + +KI+DFGL++ + +
Sbjct: 139 CAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGV--HDIDYYKKT 193
Query: 544 RGTR---GYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
R ++APE L + ++DV+S+G+++ EI +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 379 LAAATDNFN-TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKK-EFCTEITIIGNI 435
AAT N +G G + TVYKGI + + +VA+K I+ +G E +++ +
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 436 HHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYL 495
H N+V L V+EYM+ + G + + R RGLAY+
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYI 119
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEW 554
H I+H D+KP+N+L+ ++K++DFGL++ + P Q+ +++ T Y P+
Sbjct: 120 H---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDV 174
Query: 555 LT-SSAISDKTDVYSYGMVLLEIISGR 580
L ++ S D++ G + +E++ G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSF---GIQGKKEFCT---EITIIGNIHHVNLVRL 443
+G G FG VY D K F + KE EI ++ N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 444 KGFCAQGRQRFLV--YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
G ++ L EYM GS+ L G++ E R + G++YLH+ +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHS---N 125
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTP--EQSSLFTTMRGTRGYLAPEWLTSSA 559
I+H D+K NIL VK+ DFG SK L + ++ GT +++PE ++
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 560 ISDKTDVYSYGMVLLEIISGR 580
K DV+S G ++E+++ +
Sbjct: 186 YGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 390 IGSGGFGTVYKGILQD--------KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLV 441
+G G F ++KGI ++ K+ V +K ++ + F +++ + H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
G C G + +V EY+ GSLD L N +++ + E+A A L +L D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119
Query: 502 KIIHCDVKPENILL---HDKLQ-----VKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 553
+ H +V +N+LL D+ +K+SD G+S + P++ + ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-----ILLERIPWVPPE 174
Query: 554 WLTSS-AISDKTDVYSYGMVLLEIISG 579
+ + +S D +S+G L EI SG
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 390 IGSGGFGTVYK-GILQDKSVVAVKKINSFGIQ---GKKEFCTEITIIGNIHHVNLVRLKG 445
+G GGFG V + + A KK+ I+ G+ E I+ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLF--GNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
LV MN G L ++ G E R F A GL LH +I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQ---ERI 123
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
++ D+KPENILL D ++ISD GL+ + PE ++ + GT GY+APE + + +
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS 181
Query: 564 TDVYSYGMVLLEIISGR---KNSSLKIQSRSTEK 594
D ++ G +L E+I+G+ + KI+ E+
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 15/194 (7%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFC---TEITIIGNIHHVNLVRLKG 445
+GSG +G VYK L + AVK I ++ +F EI ++ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ ++ EY GSL G + E + + + T +GLAYLH+ +H
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLHSKGK---MH 129
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT---SSAISD 562
D+K NILL D VK++DFG++ +T + + GT ++APE + +
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKR-KSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 563 KTDVYSYGMVLLEI 576
D+++ G+ +E+
Sbjct: 189 LCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 26/206 (12%)
Query: 388 TPIGSGGFGTVYKGILQDKSV-VAVKKINS-FG--IQGKKEFCTEITIIGNIHHVNLVRL 443
+P+GSG +G+V + VAVKK++ F I K+ + E+ ++ ++ H N++ L
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGL 81
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGN--GSVLEWRE------RFEIALGTARGLAYL 495
R E N L L G ++++ ++ +F I RGL Y+
Sbjct: 82 LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYI 136
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H+ IIH D+KP N+ +++ ++KI DFGL++ E T TR Y APE +
Sbjct: 137 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIM 189
Query: 556 TSSAISDKT-DVYSYGMVLLEIISGR 580
+ ++T D++S G ++ E+++GR
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 28/154 (18%)
Query: 437 HVNLVRLKGFCAQGRQR-FLVYEYMNKGSL----DRTLFGNGSVLEWRERF---EIALGT 488
H LV L C Q V EY G L +F E R F + LG
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-----EPRAVFYAACVVLG- 113
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ---SSLFTTMRG 545
L YLH ++KI++ D+K +N+LL + VKI+DFGL K E +T G
Sbjct: 114 ---LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCG 163
Query: 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
T +LAPE LT ++ + D + G+++ E++ G
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 45/219 (20%)
Query: 390 IGSGGFGTVYKGILQ---DKSVVAVKKINSFGIQG---KKEFCTEITIIGNIHHVNLVRL 443
IG G +G VYK + D A+KK Q + C EI ++ + H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 444 KGFCAQGRQR--FLVYEYMNKGSLDRTLFGNGSVLEWR---ERFEIALGTAR-------- 490
+ + +L+++Y + L+ ++++ +R I +
Sbjct: 68 VEVFLEHADKSVYLLFDYA-----EHDLWQ---IIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 491 GLAYLHTGCDHKIIHCDVKPENILL----HDKLQVKISDFGLSKLLTPEQSSLFTTMRG- 545
G+ YLH+ + ++H D+KP NIL+ ++ VKI D GL++L L
Sbjct: 120 GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 546 -TRGYLAPEWLTSS-----AISDKTDVYSYGMVLLEIIS 578
T Y APE L + AI D+++ G + E+++
Sbjct: 177 VTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 31/202 (15%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKI----NSFGIQGKKEFCTEITIIGNIHHVNLVR 442
+G G FG ++Q + A+K+I +S ++ ++ E ++ + H N+V
Sbjct: 8 VGEGSFGRAL--LVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVA 62
Query: 443 LK-GFCAQGRQRFLVYEYMNKGSLDRT-------LFGNGSVLEWRERFEIALGTARGLAY 494
K F A G ++V EY + G L + LF ++L+W ++ LG + +
Sbjct: 63 FKESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCLG----VQH 115
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
+H + +++H D+K +NI L +VK+ DFG ++LLT + T GT Y+ PE
Sbjct: 116 IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEI 171
Query: 555 LTSSAISDKTDVYSYGMVLLEI 576
+ ++K+D++S G +L E+
Sbjct: 172 WENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 50/221 (22%)
Query: 385 NFNTPIGSGGFGTVY----KG--------------ILQDKSV--VAVKKINSFGIQGKKE 424
NF +G G FG V KG I+QD V V+K + GK
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEK-RVLALPGKPP 61
Query: 425 FCTEITIIGNIHHVNLVRLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERFE 483
F T++ H C Q R + V EY+N G L ++ V +++E
Sbjct: 62 FLTQL------HS---------CFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHA 103
Query: 484 I--ALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK--LLTPEQSSL 539
+ A A GL +LH+ II+ D+K +N++L + +KI+DFG+ K + + +
Sbjct: 104 VFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
Query: 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
F GT Y+APE + D +++G++L E+++G+
Sbjct: 161 FC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 69/223 (30%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 384 DNFNTP---------IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIG 433
D+F P IG G +G V+K + ++ S AVK ++ +E E I+
Sbjct: 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILK 69
Query: 434 NIH-HVNLVRLKGF-----CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFE---- 483
+ H N+V+ G G Q +LV E N GS+ + G L+ ER E
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPII 126
Query: 484 --IALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541
I GL +LH +K IH DVK NILL + VK+ DFG+S LT + T
Sbjct: 127 AYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183
Query: 542 TMRGTRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISG 579
++ GT ++APE + S + DV+S G+ +E+ G
Sbjct: 184 SV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 390 IGSGGFGTVYK-GILQDKSVVAVKKINSFGIQ---GKKEFCTEITIIGNIHHVNLVRLKG 445
+G GGFG V + + A K++ I+ G+ E I+ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLF--GNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
LV MN G L ++ GN E R F A GL LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGLEDLHR---ENT 123
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
++ D+KPENILL D ++ISD GL+ + PE S+ + GT GY+APE L + +
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-GTVGYMAPEVLNNQRYTLS 181
Query: 564 TDVYSYGMVLLEIISGR 580
D + G ++ E+I G+
Sbjct: 182 PDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-10
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 42/224 (18%)
Query: 390 IGSGGFGTVYKGILQDKSV---VAVKKINSFGIQG---KKEFCTEITIIGNIHHVNLVRL 443
IG GG G VY D VA+KKI + KK F E I ++ H +V +
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARG--LAYLHTG 498
C+ G + Y+ +L L SV W++ E+A T+ G L+ H
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLL---KSV--WQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 499 CD-----HK--IIHCDVKPENILLHDKLQVKISDFGLSK-----------LLTPEQSSLF 540
C H ++H D+KP+NILL +V I D+G + + E++ +
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 541 TTMR------GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
++M GT Y+APE L S+ TD+Y+ G++L ++++
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 6/135 (4%)
Query: 447 CAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
C Q + R F V EY+N G L + + E R RF A T L +LH H +I+
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHR---HGVIY 119
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
D+K +NILL + K++DFG+ K TT GT Y+APE L D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEILQELEYGPSVD 178
Query: 566 VYSYGMVLLEIISGR 580
++ G+++ E+++G+
Sbjct: 179 WWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 390 IGSGGFGTVYK-GILQDKSVVAVKKINSFGIQ---GKKEFCTEITIIGNIHHVNLVRLKG 445
+G GGFG V + + A KK+ I+ G+ E I+ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 446 FCAQGRQRF-LVYEYMNKGSLDRTLF--GNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
+ + + LV MN G L ++ GN E R F A GL L +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-YAAELCCGLEDLQR---ER 122
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
I++ D+KPENILL D+ ++ISD GL+ + PE ++ + GT GY+APE + + +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGYMAPEVINNEKYTF 180
Query: 563 KTDVYSYGMVLLEIISGR 580
D + G ++ E+I G+
Sbjct: 181 SPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 19/196 (9%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCT---EITIIGNIHHVNLVRLKGF 446
IGSG +G VYK ++ + + I ++ ++F EI ++ + H N+V G
Sbjct: 17 IGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
+ + ++ E+ GSL G + E + + ++ T +GL YLH+ +H
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHSKGK---MHR 130
Query: 507 DVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK--- 563
D+K NILL D VK++DFG+S +T + + GT ++APE +A+ K
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKR-KSFIGTPYWMAPE---VAAVERKGGY 186
Query: 564 ---TDVYSYGMVLLEI 576
D+++ G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-09
Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 43/227 (18%)
Query: 390 IGSGGFGTVYKGILQDKSVVAV---KKINSFGIQG--KKEFCTEITIIGNIHHVNLVR-L 443
IG+G FG V+ +++ K K I+ G++ K + E+ ++ + H N+VR +
Sbjct: 21 IGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 444 KGFCAQGRQR-FLVYEYMNKGSLDRT------LFGNGSVLEWRERFEIALGTARGLAYLH 496
F + Q+ +++ E+ + G L R +FG +E +I LAY H
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK---IEEHAIVDITRQLLHALAYCH 135
Query: 497 TGCD----HKIIHCDVKPENILLHDKLQ-----------------VKISDFGLSKLLTPE 535
D +++H D+KP+NI L ++ KI DFGLSK + E
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195
Query: 536 QSSLFTTMRGTRGYLAPEWL--TSSAISDKTDVYSYGMVLLEIISGR 580
S+ + GT Y +PE L + + DK+D+++ G ++ E+ SG+
Sbjct: 196 --SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 34/188 (18%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKI------NSFGIQGKKEFCTEITIIGNIHHVNLVR 442
IG G FG V+K + K +VA+KK+ F I +E I I+ + H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE----IKILQLLKHENVVN 75
Query: 443 LKGFC-----AQGRQR---FLVYEYMNKGSLDRTLFG---NGSV-LEWRERFEIALGTAR 490
L C R + +LV+E+ + L G N +V E ++
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 491 GLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK---LLTPEQSSLFTTMRGTR 547
GL Y+H +KI+H D+K NIL+ +K++DFGL++ L + + +T T
Sbjct: 131 GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 548 GYLAPEWL 555
Y PE L
Sbjct: 188 WYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 46/140 (32%), Positives = 72/140 (51%), Gaps = 16/140 (11%)
Query: 447 CAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDHK 502
C Q R F V EY+N G L + + E RF EI+L L YLH +
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ERG 116
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSK--LLTPEQSSLFTTMRGTRGYLAPEWLTSSAI 560
II+ D+K +N+LL + +K++D+G+ K L + +S F GT Y+APE L
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRGEDY 173
Query: 561 SDKTDVYSYGMVLLEIISGR 580
D ++ G+++ E+++GR
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 375 SYEELAAATDNFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKK-EFCTEITII 432
SYE+L +G G + TVYKG + + +VA+K I +G E +++
Sbjct: 6 SYEKLEK--------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLL 57
Query: 433 GNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGL 492
+ H N+V L LV+EY++ L + + + L RGL
Sbjct: 58 KGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGL 116
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
+Y+H I+H D+KP+N+L+ D ++K++DFGL++ + S ++ T Y P
Sbjct: 117 SYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPP 172
Query: 553 E-WLTSSAISDKTDVYSYGMVLLEIISG 579
+ L S+ S D++ G + +E+I G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 48/199 (24%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 386 FNTPIGSGGFGTV----YKGILQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVN 439
F +G G +G V ++ D +KK+N + + +K E ++ + H N
Sbjct: 4 FVRVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 440 LVRLK-GFCAQGRQRFLVYEYMNKGSLDRTLF-GNGSVLEWRERFEIALGTARGLAYLHT 497
+V + + + ++V + G L L G +L + E + A L YLH
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH- 119
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
+ I+H D+K +N+ L +K+ D G++++L Q + +T+ GT Y++PE ++
Sbjct: 120 --EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSN 176
Query: 558 SAISDKTDVYSYGMVLLEI 576
+ K+DV++ G + E+
Sbjct: 177 KPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 389 PIGSGGFGTV---YKGILQDKSVVAVKKINS-FGIQ--GKKEFCTEITIIGNIHHVNLVR 442
PIGSG G V Y + VA+KK++ F K+ + E+ ++ ++H N++
Sbjct: 23 PIGSGAQGIVCAAYDTVTGQN--VAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIG 79
Query: 443 -LKGFCAQG-----RQRFLVYEYMNKG-------SLDRTLFGNGSVLEWRERFEIALGTA 489
L F Q + +LV E M+ LD ER L
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH------------ERMSYLLYQM 127
Query: 490 R-GLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG 548
G+ +LH+ IIH D+KP NI++ +KI DFGL++ T S + T TR
Sbjct: 128 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 182
Query: 549 YLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
Y APE + + D++S G ++ E+I G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 390 IGSGGFGTVYKGILQ---DKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
IG+G FG V G + + V VK++ S +Q + +F E ++ H NL++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTL----FGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
C + LV E+ G L L + +A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---N 119
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKL-------LTPEQSSLFTTMRGTRGYLAPEW 554
IH D+ N LL L VKI D+GLS +TP+Q L+ +R ++APE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ--LWVPLR----WIAPEL 173
Query: 555 L----TSSAISDKT---DVYSYGMVLLEI 576
+ + + D+T +V+S G+ + E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 28/207 (13%)
Query: 388 TPIGSGGFGTV---YKGILQDKSVVAVKKINS-FG--IQGKKEFCTEITIIGNIHHVNLV 441
TP+GSG +G+V Y L+ K VAVKK++ F I ++ + E+ ++ ++ H N++
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVI 77
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFG---NGSVLEWRERFE----IALGTARGLAY 494
L E N+ L L G N V + E + RGL Y
Sbjct: 78 GLLDVFTPATS----IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
+H+ IIH D+KP N+ +++ +++I DFGL++ E T TR Y APE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEI 186
Query: 555 LTSSAISDKT-DVYSYGMVLLEIISGR 580
+ + ++T D++S G ++ E++ G+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 8/136 (5%)
Query: 447 CAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
C Q R FLV EY+N G L + + E RF A L +LH + II+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGIIY 119
Query: 506 CDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
D+K +N+LL +K++D+G+ K L P ++ +T GT Y+APE L
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STFCGTPNYIAPEILRGEEYGFSV 177
Query: 565 DVYSYGMVLLEIISGR 580
D ++ G+++ E+++GR
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 34/220 (15%)
Query: 373 RFSYEELAAATDNFNTPIGSGGFGTV----YKGILQDKSVVAVKKINSFGIQGKKEF--- 425
+ YE+ NF +G+G FG V YK +D VA+K+ I +K+
Sbjct: 26 KMKYEDF-----NFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 426 CTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIA 485
+E I+ I+H V L G +LV E++ G + L +RF
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF-------FTFLRRNKRFPND 131
Query: 486 LGTARG------LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539
+G YL + I++ D+KPEN+LL +K++DFG +K++
Sbjct: 132 VGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--- 185
Query: 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
T+ GT Y+APE L + D ++ G+ + EI+ G
Sbjct: 186 -YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 389 PIGSGGFGTV---YKGILQDKSVVAVKKINS-FGIQGK-KEFCTEITIIGNIHHVNLVRL 443
PIGSG G V Y IL+ VA+KK++ F Q K E+ ++ ++H N++ L
Sbjct: 31 PIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 444 KG-FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR-GLAYLHTGCDH 501
F Q Y+ +D L + ER L G+ +LH+
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA--- 145
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
IIH D+KP NI++ +KI DFGL++ T S + T TR Y APE +
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 562 DKTDVYSYGMVLLEIISGR 580
+ D++S G ++ E+I G
Sbjct: 204 ENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 7e-09
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 389 PIGSGGFGTV---YKGILQDKSVVAVKKINS-FGIQGK-KEFCTEITIIGNIHHVNLVRL 443
PIGSG G V Y +L D++V A+KK++ F Q K E+ ++ ++H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVL-DRNV-AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 444 KG-FCAQG-----RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR-GLAYLH 496
F Q + +LV E M D L + ER L G+ +LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
+ IIH D+KP NI++ +KI DFGL++ T S + T TR Y APE +
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 557 SSAISDKTDVYSYGMVLLEII 577
+ D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 21/135 (15%)
Query: 454 FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGT------ARGLAYLHTGCDHKIIHCD 507
F V EY+N G L +F S +F++ T GL +LH+ I++ D
Sbjct: 72 FFVMEYLNGGDL---MFHIQSC----HKFDLPRATFYAAEIICGLQFLHS---KGIVYRD 121
Query: 508 VKPENILLHDKLQVKISDFGLSK--LLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
+K +NILL +KI+DFG+ K +L ++ F GT Y+APE L + D
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---GTPDYIAPEILLGQKYNTSVD 178
Query: 566 VYSYGMVLLEIISGR 580
+S+G++L E++ G+
Sbjct: 179 WWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 390 IGSGGFGTVYKGILQDKS-VVAVKKI--NSFGIQGKKEFCT---EITIIGNIHHVNLVRL 443
+G G FG VY D +AVK++ + + KE EI ++ N+ H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 444 KGFCAQGRQRFL--VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
G ++ L EYM GS+ L G++ E R +G++YLH+ +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHS---N 125
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTP--EQSSLFTTMRGTRGYLAPEWLTSSA 559
I+H D+K NIL VK+ DFG SK + + ++ GT +++PE ++
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185
Query: 560 ISDKTDVYSYGMVLLEIIS 578
K DV+S ++E+++
Sbjct: 186 YGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 383 TDNFNTPIGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKEFCT--EITIIGNIH 436
NF +G G FG V KG + ++ +KK IQ CT E ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKK--DVVIQDDDVECTMVEKRVLALQD 58
Query: 437 HVNLVRLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYL 495
+ C Q R + V EY+N G L + G E + F A + GL +L
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-YAAEISVGLFFL 117
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H II+ D+K +N++L + +KI+DFG+ K + + T GT Y+APE +
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT-RTFCGTPDYIAPEII 173
Query: 556 TSSAISDKTDVYSYGMVLLEIISGR 580
D ++YG++L E+++G+
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 27/207 (13%)
Query: 390 IGSGGFGTVYKG---ILQDKSVVAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
IG+G FG V G K+ V VK++ S + F E+ ++H N+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVL----EWRERFEIALGTARGLAYLHTGCDH 501
C + LV E+ G L L N ++ + +A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE-----QSSLFTTMRGTRGYLAPEWLT 556
IH D+ N L L VKI D+GL+ PE + +R +LAPE +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPELVE 175
Query: 557 S-------SAISDKTDVYSYGMVLLEI 576
+ K++++S G+ + E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-08
Identities = 60/197 (30%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 454 FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENI 513
+LV EY+ G + L G E I+ A L YLH H IIH D+KP+N+
Sbjct: 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHR---HGIIHRDLKPDNM 135
Query: 514 LLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSY--GM 571
L+ ++ +K++DFGLSK+ T+ R + LT+ +++ + YS G
Sbjct: 136 LISNEGHIKLTDFGLSKV----------TLN--RELNMMDILTTPSMAKPKNDYSRTPGQ 183
Query: 572 VLLEIISGRKNSSLKIQSRSTEKD----SSGDGNGPSSSSSPRESQRVYFPLLALELHEQ 627
VL I SSL + EKD +SG NG SS PLL +
Sbjct: 184 VLSLI------SSLGFNTPVGEKDQGSVNSGQNNGTSSV-----RTGTSHPLLMINKESL 232
Query: 628 RRYLELADSRIEGQVSD 644
L+L+ S +E S
Sbjct: 233 PMSLKLSKSCLETSESS 249
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRL 443
IG G FG V +++ KS V A+K ++ F + + + F E I+ + + +V+L
Sbjct: 51 IGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 444 KGFCAQGRQRFL--VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
A ++L V EYM G L L N + E RF A L +H+
Sbjct: 109 --HYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTA-EVVLALDAIHS---M 161
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
IH DVKP+N+LL +K++DFG + T GT Y++PE L S
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 562 D----KTDVYSYGMVLLEIISG 579
+ D +S G+ L E++ G
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 31/195 (15%)
Query: 408 VVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466
+VAVK + + + +F E+ I+ + N++RL G C ++ EYM G L+
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 467 RTLF------------------GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+ L + + +AL A G+ YL + +H D+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDL 164
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAI-----SDK 563
N L+ + L +KI+DFG+S+ L + + ++G R L W+ I +
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNL---YAGDYYRIQG-RAVLPIRWMAWECILMGKFTTA 220
Query: 564 TDVYSYGMVLLEIIS 578
+DV+++G+ L EI+
Sbjct: 221 SDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK---KEFCTEITIIGNIHHVNLVRLK 444
+GSG +GTV + + + VA+KK+ Q + K E+ ++ ++ H N++ L
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 445 G-FCA-QGRQRF----LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
F RF LV +M G+ L + + E R +F + +GL Y+H
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF-LVYQMLKGLKYIHAA 137
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
IIH D+KP N+ +++ ++KI DFGL++ + S T TR Y APE + +
Sbjct: 138 ---GIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILNW 190
Query: 559 AISDKT-DVYSYGMVLLEIISGR 580
+T D++S G ++ E+++G+
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 41/129 (31%), Positives = 67/129 (51%), Gaps = 9/129 (6%)
Query: 454 FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENI 513
F V E++N G L + G +R F A GL +LH+ II+ D+K +N+
Sbjct: 72 FFVMEFLNGGDLMFHIQDKGRFDLYRATF-YAAEIVCGLQFLHS---KGIIYRDLKLDNV 127
Query: 514 LLHDKLQVKISDFGLSK--LLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGM 571
+L +KI+DFG+ K + ++S F GT Y+APE L + D +S+G+
Sbjct: 128 MLDRDGHIKIADFGMCKENVFGDNRASTFC---GTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 572 VLLEIISGR 580
+L E++ G+
Sbjct: 185 LLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 389 PIGSGGFGTVYKGILQDKSV-VAVKKI-NSFGIQGK-KEFCTEITIIGNIHHVNLVRLKG 445
PIGSG G V + VAVKK+ F Q K E+ ++ ++H N++ L
Sbjct: 28 PIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 87
Query: 446 -FCAQG-----RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR-GLAYLHTG 498
F Q + +LV E M+ +L + + ER L G+ +LH+
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD----HERMSYLLYQMLCGIKHLHSA 142
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
IIH D+KP NI++ +KI DFGL++ T + + T TR Y APE +
Sbjct: 143 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 559 AISDKTDVYSYGMVLLEIISG 579
+ D++S G ++ E++ G
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 12/146 (8%)
Query: 436 HHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYL 495
+ N ++L + L+ +Y+ G L L G + E + I L L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKK-IIRQLVEALNDL 125
Query: 496 HTGCDHKIIHCDVKPENILLHD-KLQVKISDFGLSKLL-TPEQSSLFTTMRGTRGYLAPE 553
H H IIH D+K EN+L K ++ + D+GL K++ TP + GT Y +PE
Sbjct: 126 HK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPE 176
Query: 554 WLTSSAISDKTDVYSYGMVLLEIISG 579
+ D ++ G++ E+++G
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 390 IGSGGFGTVYKGIL--QDKSV--VAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG+V + L +D S VAVK K + F +EF E + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 444 KGFCAQGRQR------FLVYEYMNKGSLDRTLFG-----NGSVLEWRERFEIALGTARGL 492
G + R + ++ +M G L L L + + A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
YL + IH D+ N +L++ + V ++DFGLSK + S +G L
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIY----SGDYYRQGCASKLPV 179
Query: 553 EWLTSSAISD-----KTDVYSYGMVLLEIIS 578
+WL +++D +DV+++G+ + EI++
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 62/196 (31%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 390 IGSGGFGTVYKGIL-QDKSVVAVKKINSFGI-QGKKEFCT--EITIIGNIH-HVNLVRLK 444
+G G FG V L + + AVK + I Q CT E I+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 445 GFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
C Q R F V E++N G L + + E R RF A T+ L +LH D I
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITS-ALMFLH---DKGI 117
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
I+ D+K +N+LL + K++DFG+ K +T GT Y+APE L
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 564 TDVYSYGMVLLEIISG 579
D ++ G++L E++ G
Sbjct: 177 VDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 52/222 (23%)
Query: 385 NFNTPIGSGGFGTVY----KG--------------ILQDKSV--VAVKKINSFGIQGKKE 424
NF +G G FG V KG ++QD V V+K + GK
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEK-RVLALSGKPP 61
Query: 425 FCTEITIIGNIHHVNLVRLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF- 482
F T++ H C Q R + V EY+N G L + G E F
Sbjct: 62 FLTQL------HS---------CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY 106
Query: 483 --EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK--LLTPEQSS 538
EIA+G L +LH+ II+ D+K +N++L + +KI+DFG+ K + +
Sbjct: 107 AAEIAIG----LFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159
Query: 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
F GT Y+APE + D +++G++L E+++G+
Sbjct: 160 TFC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 42/129 (32%), Positives = 65/129 (50%), Gaps = 14/129 (10%)
Query: 455 LVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDHKIIHCDVKPE 511
+ + MN G L L +G E RF EI LG L ++H + +++ D+KP
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----LEHMH---NRFVVYRDLKPA 126
Query: 512 NILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT-DVYSYG 570
NILL + V+ISD GL+ + ++ GT GY+APE L D + D +S G
Sbjct: 127 NILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYDSSADWFSLG 183
Query: 571 MVLLEIISG 579
+L +++ G
Sbjct: 184 CMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRL 443
IG G FG V +++ KS V A+K ++ F + + + F E I+ + +V+L
Sbjct: 51 IGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 444 KGFCA--QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
FCA + ++V EYM G L L N V E +F A L +H+
Sbjct: 109 --FCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTA-EVVLALDAIHS---M 161
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA-- 559
+IH DVKP+N+LL +K++DFG + T GT Y++PE L S
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 560 --ISDKTDVYSYGMVLLEIISG 579
+ D +S G+ L E++ G
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 44/199 (22%)
Query: 430 TIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGN-GSV-LEWRERFEIALG 487
+++ + H++L + G C +G + +V E++ G LD L G V + W + +A
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQ 125
Query: 488 TARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQ------VKISDFGLS-KLLTPEQSSL 539
A L+YL D ++H +V +NILL L +K+SD G+S L+ E+
Sbjct: 126 LASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE--- 179
Query: 540 FTTMRGTR-GYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSS 597
R R ++APE + +++S D +S+G LLEI
Sbjct: 180 ----RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF------------------- 216
Query: 598 GDGNGPSSSSSPRESQRVY 616
DG P +P E +R Y
Sbjct: 217 -DGEVPLKERTPSEKERFY 234
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRL 443
IG G FG V +++ KS V A+K ++ F + + + F E I+ + +V+L
Sbjct: 51 IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
R ++V EYM G L L N V E RF A L +H+
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTA-EVVLALDAIHS---MGF 163
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA---- 559
IH DVKP+N+LL +K++DFG + E T GT Y++PE L S
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 560 ISDKTDVYSYGMVLLEIISG 579
+ D +S G+ L E++ G
Sbjct: 224 YGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 42/129 (32%), Positives = 65/129 (50%), Gaps = 14/129 (10%)
Query: 455 LVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDHKIIHCDVKPE 511
+ + MN G L L +G E RF EI LG L ++H + +++ D+KP
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG----LEHMH---NRFVVYRDLKPA 126
Query: 512 NILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT-DVYSYG 570
NILL + V+ISD GL+ + ++ GT GY+APE L D + D +S G
Sbjct: 127 NILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLG 183
Query: 571 MVLLEIISG 579
+L +++ G
Sbjct: 184 CMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 42/139 (30%), Positives = 72/139 (51%), Gaps = 14/139 (10%)
Query: 447 CAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDHK 502
C Q R F V E+++ G L + + E RF EI+L L +LH
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHER---G 116
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
II+ D+K +N+LL + +K++D+G+ K + P ++ +T GT Y+APE L
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--STFCGTPNYIAPEILRGEDYG 174
Query: 562 DKTDVYSYGMVLLEIISGR 580
D ++ G+++ E+++GR
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 49/233 (21%)
Query: 390 IGSGGFGTVYKGILQDK---SVVAVKKINSFGIQGKKEFC---TEITIIGNIHHVNLVRL 443
IG G FG V ++Q K + A+KK+ + K++ E I+ + +V+L
Sbjct: 9 IGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+L+ EY+ G + L + E RF IA T + +H
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHK---LGY 122
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSK-----------------LLTPEQSSLFTTMR-- 544
IH D+KP+N+LL K +K+SDFGL L + + M
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 545 ------------------GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
GT Y+APE + + + D +S G+++ E++ G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 390 IGSGGFGTVYKGILQD---KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL-KG 445
+G G +G VYK +D A+K+I GI C EI ++ + H N++ L K
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 446 FCAQG-RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYLH 496
F + R+ +L+++Y F S ++ ++ G + G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 497 TGCDHKIIHCDVKPENILLH----DKLQVKISDFGLSKLLTPEQSSL--FTTMRGTRGYL 550
+ ++H D+KP NIL+ ++ +VKI+D G ++L L + T Y
Sbjct: 126 A---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 551 APEWLTSSAISDKT-DVYSYGMVLLEIIS 578
APE L + K D+++ G + E+++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 40/226 (17%)
Query: 386 FNTPIGSGGFGTVY----KGILQ-------------DKSVVAVKKINSFGIQ-GKKEFCT 427
F +G G FG V+ +G+ + +VAVK + + + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 428 EITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTL----------FGNGSVLE 477
EI I+ + N++RL C ++ EYM G L++ L + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 478 WRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537
+ +A A G+ YL + +H D+ N L+ +KI+DFG+S+ L S
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---YS 182
Query: 538 SLFTTMRGTRGYLAPEWLTSSAI-----SDKTDVYSYGMVLLEIIS 578
+ ++G R L W++ +I + +DV+++G+ L EI++
Sbjct: 183 GDYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 17/160 (10%)
Query: 427 TEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRER----- 481
TE I+ I+H ++++LKG Y L R L +
Sbjct: 132 TEAHILRAINHPSIIQLKGT--------FTYNKFTCLILPRYKTDLYCYLAAKRNIAICD 183
Query: 482 -FEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540
I R + YLH +++IIH D+K ENI ++ V + DFG + ++ +
Sbjct: 184 ILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
GT APE L D++S G+VL E+ +
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 390 IGSGGFGTVYKGILQDKSV---VAVKKINSFGI----QGKKEFCTE--ITIIGNIHHVNL 440
I +G +G VY +++ K A+KKIN + Q ++ F +T N V++
Sbjct: 9 ISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 441 VRLKGFCAQGRQRFL--VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
FC+ +R L V EY+ G L G++ R A T L YLH
Sbjct: 67 -----FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEYLH-- 118
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLF-------------TTMR 544
++ I+H D+KP+N+L+ +K++DFGLSK+ L ++L+ +
Sbjct: 119 -NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
GT Y+APE + D ++ G++L E + G
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT-TMRGTR 547
ARG+ +L + K IH D+ NILL + VKI DFGL++ + + + R
Sbjct: 183 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
++APE + + ++DV+S+G++L EI S
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 26/157 (16%)
Query: 455 LVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTAR---GLAYLHTGCDHKIIHCDV 508
L+ +Y+N G L F + L RERF E+ + + L +LH II+ D+
Sbjct: 82 LILDYINGGEL----FTH---LSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDI 131
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT--SSAISDKTDV 566
K ENILL V ++DFGLSK ++ + GT Y+AP+ + D
Sbjct: 132 KLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW 191
Query: 567 YSYGMVLLEIIS--------GRKNSSLKIQSRSTEKD 595
+S G+++ E+++ G KNS +I R + +
Sbjct: 192 WSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 45/147 (30%), Positives = 76/147 (51%), Gaps = 12/147 (8%)
Query: 455 LVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDHKIIHCDVKPE 511
L+ +Y++ G + L+ + E RF EI L L +LH I++ D+K E
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLHK---LGIVYRDIKLE 134
Query: 512 NILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK-TDVYSYG 570
NILL + V ++DFGLSK E+ + GT Y+APE + K D +S G
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG 194
Query: 571 MVLLEIISGRKNSSLKIQSRSTEKDSS 597
+++ E+++G +L+ + R+T+ + S
Sbjct: 195 ILIFELLTGASPFTLEGE-RNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 34/210 (16%)
Query: 390 IGSGGFGTVYKG-ILQDKSV--VAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
IG+G FG V I D V V VK++ + + + EF + + H N+++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 446 FCAQGRQRFLVYEYMNKGSL------DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
C + LV+EY G L ++ N +L + +A A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHK-- 117
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGL------SKLLTPEQSSLFTTMRGTRGYLAPE 553
H +H D+ N L L VK+ D+G+ + E +R +LAPE
Sbjct: 118 -HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLR----WLAPE 171
Query: 554 WLTS------SAISDK-TDVYSYGMVLLEI 576
+ +A K ++V++ G+ L E+
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 428 EITIIGNIHHVNLVRLK--------GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWR 479
EI +G ++H N+++++ + + F +Y +M + D L +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQ 268
Query: 480 ERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539
R I + Y+H D K+IH D+K ENI L+ ++ + DFG + E+ +
Sbjct: 269 TR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
GT +PE L + TD++S G++LL+++S
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 29/83 (34%), Positives = 44/83 (53%), Gaps = 6/83 (7%)
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
+H D+KPEN+L+ +K++DFG + LT + GT Y+APE LT+ K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 564 T------DVYSYGMVLLEIISGR 580
D +S G++ E+I GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 390 IGSGGFGTVYKGILQD---KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL-KG 445
+G G +G VYK +D + A+K+I GI C EI ++ + H N++ L K
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 446 FCAQG-RQRFLVYEYMNKG-----SLDRTLFGNGSVLEWRERFEIAL--GTARGLAYLHT 497
F + R+ +L+++Y R N ++ +L G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 498 GCDHKIIHCDVKPENILLH----DKLQVKISDFGLSKLLTPEQSSL--FTTMRGTRGYLA 551
+ ++H D+KP NIL+ ++ +VKI+D G ++L L + T Y A
Sbjct: 127 ---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 552 PEWLTSSAISDKT-DVYSYGMVLLEIIS 578
PE L + K D+++ G + E+++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 17/192 (8%)
Query: 398 VYKGILQDKSVVAVKKINSFGIQGKK---EFCTEITIIGNIHHVNLVRLKGF----CAQG 450
+YKGI +K V+ ++ F K EI + I N++++ GF
Sbjct: 36 IYKGIFNNKEVI-IRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 451 RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKP 510
+ L+ EY +G L R + L ++ + ++A+ +GL L+ + ++
Sbjct: 95 PRLSLILEYCTRGYL-REVLDKEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTS 151
Query: 511 ENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS--SAISDKTDVYS 568
+ L+ + ++KI GL K+L+ M Y + + L S + K D+YS
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDDIYS 207
Query: 569 YGMVLLEIISGR 580
G+VL EI +G+
Sbjct: 208 LGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 2/91 (2%)
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS-SLFTTMRGTRGYL 550
LA H H +IH D+K NILL VK+ DFG SK+ S + T GT Y+
Sbjct: 154 LAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 551 APEWLTSSAISDKTDVYSYGMVLLEIISGRK 581
APE S K D++S G++L E+++ ++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 39/213 (18%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIH------------- 436
+G G +Y GIL K G +KE + ++ H
Sbjct: 3 LGRGTRTQIYAGILNYK-----DDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASM 57
Query: 437 -----HVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARG 491
H ++V L G C + + +V E++ G LD + VL +F++A A
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASA 117
Query: 492 LAYLHTGCDHKIIHCDVKPENILL-HDKLQ------VKISDFGLSKLLTPEQSSLFTTMR 544
L+YL D ++H +V +NILL + + +K+SD G+ + Q +
Sbjct: 118 LSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI-- 172
Query: 545 GTRGYLAPEWLTSSA-ISDKTDVYSYGMVLLEI 576
++APE + S +S D +S+G L EI
Sbjct: 173 ---PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG 548
A+G+ +L + K IH D+ NILL + VKI DFGL++ + + + R
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKGDA 241
Query: 549 YLAPEWLTSSAISDK-----TDVYSYGMVLLEIIS 578
L +W+ I D+ +DV+S+G++L EI S
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 12/95 (12%)
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG 548
ARG+ +L + K IH D+ NILL + VKI DFGL++ + + + R
Sbjct: 184 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKGSA 236
Query: 549 YLAPEWLTSSAISDK-----TDVYSYGMVLLEIIS 578
L +W+ +I DK +DV+S+G++L EI S
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 57/195 (29%), Positives = 76/195 (38%), Gaps = 19/195 (9%)
Query: 405 DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464
+ V VK + G K EI I+ I H ++ L R + V M K
Sbjct: 118 QRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINL---IHAYRWKSTVCMVMPKYK 169
Query: 465 LDR-TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKI 523
D T L + I LAYLH IIH DVK ENI L + +
Sbjct: 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVL 226
Query: 524 SDFGLS-KLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEI------ 576
DFG + KL + GT +PE L KTD++S G+VL E+
Sbjct: 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
Query: 577 ISGRKNSSLKIQSRS 591
+ G++ S Q RS
Sbjct: 287 LFGKQVKSSSSQLRS 301
|
Length = 392 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR- 547
A+G+ +L + IH DV N+LL D KI DFGL++ + S + R
Sbjct: 222 AQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDI--MNDSNYVVKGNARL 276
Query: 548 --GYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKN 582
++APE + + ++DV+SYG++L EI S K+
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTSSAI 560
K++H D+K NI L +K+ DFG SK + S + ++ GT YLAPE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 561 SDKTDVYSYGMVLLEIIS 578
S K D++S G++L E+++
Sbjct: 249 SKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 42/163 (25%), Positives = 65/163 (39%), Gaps = 38/163 (23%)
Query: 451 RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKP 510
R +L+ E++ G + L ++ E +F IA T + +H IH D+KP
Sbjct: 74 RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH---QLGFIHRDIKP 129
Query: 511 ENILLHDKLQVKISDFGLSKLL--------------TPEQSSLFTTMR------------ 544
+N+LL K VK+SDFGL L P F M
Sbjct: 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189
Query: 545 --------GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
GT Y+APE + + D +S G+++ E++ G
Sbjct: 190 RQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 14/32 (43%), Positives = 18/32 (56%)
Query: 3 DSRVSSMQLQESGNLVLLDARNVSLWQSFDSP 34
+ + L + GNLVL D+ LWQSFD P
Sbjct: 85 VNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 13/128 (10%)
Query: 457 YEYMNKGSLDRTLFGNGSV-LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILL 515
Y+ N + L +GS L + ARG+ +L + +H D+ N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270
Query: 516 HDKLQVKISDFGLSKLLTPE-----QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYG 570
VKI DFGL++ + + + S F ++ ++APE + + + +DV+SYG
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSYG 326
Query: 571 MVLLEIIS 578
++L EI S
Sbjct: 327 ILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 38/160 (23%)
Query: 454 FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENI 513
+L+ E++ G + L ++ E +F IA T + +H IH D+KP+N+
Sbjct: 77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH---QLGFIHRDIKPDNL 132
Query: 514 LLHDKLQVKISDFGLSKLLTPEQSSLFT-------------------------------- 541
LL K VK+SDFGL L + F
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 542 --TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
+ GT Y+APE + + D +S G+++ E++ G
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-05
Identities = 15/70 (21%), Positives = 27/70 (38%), Gaps = 5/70 (7%)
Query: 225 NGVDYFANDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSD 284
V N + L +C++ C NCSC +++ S C + N L + S
Sbjct: 18 PDVKLPDNAS---AITAISLEECREACLSNCSCTAYAYNNGSGGCL-LWNGLLNNLRSLS 73
Query: 285 NERVRLGYIK 294
+ Y++
Sbjct: 74 SG-GGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 31/128 (24%), Positives = 61/128 (47%), Gaps = 13/128 (10%)
Query: 457 YEYMNKGSLDR-TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILL 515
Y R TL L + + + A G+ +L + +H D+ N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272
Query: 516 HDKLQVKISDFGLSKLLTPE-----QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYG 570
+ VKI DFGL++ + + + S F ++ ++APE + ++ + +DV+S+G
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFG 328
Query: 571 MVLLEIIS 578
++L EI +
Sbjct: 329 ILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 29/91 (31%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT-TMRGTR 547
A+G+++L + IH D+ NILL KI DFGL++ + + + + R
Sbjct: 224 AKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
++APE + + + ++DV+SYG++L EI S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 41/169 (24%), Positives = 64/169 (37%), Gaps = 46/169 (27%)
Query: 454 FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENI 513
+ V +Y+ G + L G E RF IA T + +H IH D+KP+NI
Sbjct: 77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC-AIESVH---KMGFIHRDIKPDNI 132
Query: 514 LLHDKLQVKISDFGL-----------------------------------SKLLTPEQSS 538
L+ +K++DFGL +L E+
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192
Query: 539 LFTTMR-------GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
R GT Y+APE L + + D +S G++L E++ G+
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 12/29 (41%), Positives = 17/29 (58%)
Query: 4 SRVSSMQLQESGNLVLLDARNVSLWQSFD 32
+ + L + GNLV+ D+ LWQSFD
Sbjct: 85 NGNYVLVLLDDGNLVIYDSDGNFLWQSFD 113
|
Length = 114 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 44/175 (25%), Positives = 67/175 (38%), Gaps = 54/175 (30%)
Query: 454 FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI--IHCDVKPE 511
+ V +Y+ G + L E RF IA T L HK+ IH D+KP+
Sbjct: 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELT------LAIESVHKMGFIHRDIKPD 130
Query: 512 NILLHDKLQVKISDFGL---------------------------------------SKLL 532
NIL+ +K++DFGL +L
Sbjct: 131 NILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK 190
Query: 533 TPEQSS-------LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
T EQ + L ++ GT Y+APE L + D +S G++L E++ G+
Sbjct: 191 TLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 32/127 (25%), Positives = 46/127 (36%), Gaps = 48/127 (37%)
Query: 501 HKI--IHCDVKPENILLHDKLQVKISDFGLS-------------KLLTPEQSSLFTTMR- 544
HK+ IH D+KP+NIL+ +K+SDFGLS KLL + + R
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 545 --------------------------------GTRGYLAPEWLTSSAISDKTDVYSYGMV 572
GT Y+APE + D +S G +
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 573 LLEIISG 579
+ E + G
Sbjct: 238 MFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 22/118 (18%)
Query: 479 RERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH----------------DKLQVK 522
R +I T L Y HT + ++H D+KPENIL+ D +V+
Sbjct: 231 RHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVR 288
Query: 523 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
I D G E+ S T + TR Y +PE + TD++S G ++ E+ +G+
Sbjct: 289 ICDLGGC---CDERHSR-TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 3/93 (3%)
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT-TMRGTRGYLAPEWLTSSAIS 561
IIH D+K EN+L++ + + DFG + S+ F + GT APE L +
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 562 DKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEK 594
D++S G+V+ E + +SL SR E+
Sbjct: 341 PSVDIWSAGLVIFE--AAVHTASLFSASRGDER 371
|
Length = 461 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 30/208 (14%)
Query: 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRLKG 445
IG G FG V L++ V A+K +N + + + E F E ++ N + + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGN--GSVLEWRERFE-----IALGTARGLAYLHTG 498
+LV +Y G L TL + E RF IA+ + L Y+H
Sbjct: 69 AFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR- 126
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
D+KP+NIL+ ++++DFG L + + + GT Y++PE L
Sbjct: 127 --------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL--Q 176
Query: 559 AISD-------KTDVYSYGMVLLEIISG 579
A+ D + D +S G+ + E++ G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 58/248 (23%), Positives = 96/248 (38%), Gaps = 40/248 (16%)
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLH-TGCDHKII 504
F A G L+ Y +G + L GN I G RGL YLH G I
Sbjct: 80 FMAYGSANSLLKTYFPEG-MSEALIGN-----------ILFGALRGLNYLHQNGY----I 123
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLT----PEQSSL------FTTMRGTRGYLAPEW 554
H ++K +IL+ V +S GLS L + +++ + F+T +L+PE
Sbjct: 124 HRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFST--SVLPWLSPEL 179
Query: 555 LTS--SAISDKTDVYSYGMVLLEIISGR------KNSSLKIQSRSTEKDSSGDGNGPSSS 606
L + K+D+YS G+ E+ +GR + + +Q S D
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239
Query: 607 SSP-RESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLR 665
S + SQ + + + R+ S + C+Q++P R
Sbjct: 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKR 299
Query: 666 PSMANVVS 673
PS ++++S
Sbjct: 300 PSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 44/173 (25%), Positives = 67/173 (38%), Gaps = 50/173 (28%)
Query: 454 FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENI 513
+ V +Y+ G + L G E RF IA T + +H IH D+KP+NI
Sbjct: 77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC-AVESVHK---MGFIHRDIKPDNI 132
Query: 514 LLHDKLQVKISDFGL---------SKL-----------------------------LTP- 534
L+ +K++DFGL SK L P
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 535 -------EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
Q L ++ GT Y+APE L + + D +S G++L E++ G+
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 745 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.87 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.86 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.54 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.05 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.05 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.98 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.9 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.87 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.72 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.56 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.54 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.5 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.44 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.37 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.3 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.15 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.14 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.07 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.97 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.88 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.85 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.84 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.83 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.35 | |
| PLN02236 | 344 | choline kinase | 96.16 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.64 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 95.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.37 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.2 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.98 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.9 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.81 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.77 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.58 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.51 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.47 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.42 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.26 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.96 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-57 Score=482.87 Aligned_cols=286 Identities=48% Similarity=0.823 Sum_probs=253.2
Q ss_pred CCCccCHHHHHHhhhcCC--CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEE
Q 004565 370 LPRRFSYEELAAATDNFN--TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447 (745)
Q Consensus 370 ~~~~~~~~el~~at~~f~--~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~ 447 (745)
..+.|++.||..||++|+ +.||+|+||.||+|.++++..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999999 799999999999999999999999988765433156699999999999999999999999
Q ss_pred EeCC-eeEEEEeecCCCChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEcc
Q 004565 448 AQGR-QRFLVYEYMNKGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525 (745)
Q Consensus 448 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~D 525 (745)
.+.+ +++||||||++|+|.++|+.... .|+|.+|++||.++|+||+|||+.+.+.|||||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 59999999999999999998776 899999999999999999999999888999999999999999999999999
Q ss_pred CCCcccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCC
Q 004565 526 FGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSS 605 (745)
Q Consensus 526 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 605 (745)
||+|+..+.......+...||.+|+||||+..+..|.|+|||||||+|+||+||+++.+...
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~------------------ 282 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR------------------ 282 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC------------------
Confidence 99997665411111111189999999999999999999999999999999999998765421
Q ss_pred CCCCcccccccHHHHHHHHHhhcccccccccccc-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 606 SSSPRESQRVYFPLLALELHEQRRYLELADSRIE-GQVSD-EDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
......+..|++....++++.+++|+.+. ..++. +++.++..++.+|++.+|.+||+|.||+++|+..
T Consensus 283 -----~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 283 -----PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred -----CcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 11333489999999999999999999997 66665 7899999999999999999999999999999653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=389.69 Aligned_cols=250 Identities=36% Similarity=0.532 Sum_probs=210.3
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcch--HHHHHHHHHHHccCCCCceeeEEEEEEeCC-eeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQG--KKEFCTEITIIGNIHHVNLVRLKGFCAQGR-QRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~gs 464 (745)
+.||+|+||+||+|.+.+...||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ...+|||||++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 4499999999999999887779999998543222 568999999999999999999999999988 7899999999999
Q ss_pred hhhhhcC-CCcccCHHHHHHHHHHHHHHHHHhhhCCCCc-eeecCCCCCCeeecCCC-CeEEccCCCcccCCCCCccccc
Q 004565 465 LDRTLFG-NGSVLEWRERFEIALGTARGLAYLHTGCDHK-IIHCDVKPENILLHDKL-QVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 465 L~~~l~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~dik~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
|.++++. ....+++..+++||.+||+||.|||+ .+ |||||||++||||+.++ ++||+|||+++...... ...+
T Consensus 127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~ 202 (362)
T KOG0192|consen 127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMT 202 (362)
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cccc
Confidence 9999998 36689999999999999999999999 66 99999999999999997 99999999998765432 2234
Q ss_pred ccccccCccCccccc--CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 542 TMRGTRGYLAPEWLT--SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~--~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
...||+.|||||++. ...++.|+|||||||+||||+||+.||.... ...
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~-----------------------------~~~ 253 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA-----------------------------PVQ 253 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC-----------------------------HHH
Confidence 478999999999999 5699999999999999999999999997543 111
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGM 679 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 679 (745)
.+..... ...+..++......+..++.+||+.||..||++.+++.+|+...
T Consensus 254 ~~~~v~~---------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 254 VASAVVV---------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HHHHHHh---------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 1222221 22223334445567889999999999999999999999999743
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=389.25 Aligned_cols=252 Identities=31% Similarity=0.470 Sum_probs=220.4
Q ss_pred hcCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 384 DNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
..+.+.||+|-||.||.|.+++...||||.++... ...+.|.+|+.+|.+|+|+|||+++|+|..+...+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34557799999999999999999899999998653 34678999999999999999999999999988999999999999
Q ss_pred ChhhhhcC-CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFG-NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.++|.. .+..++..+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||||+....+.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999997 55689999999999999999999999 999999999999999999999999999999666666555566
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
..-+..|.|||.+..+.++.|+|||||||+||||+| |+.|+.... ..
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------------------n~--- 411 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------------------NE--- 411 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------------------HH---
Confidence 677889999999999999999999999999999999 776665432 11
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
++.+.++...+-..|..++..+.+||..||+.+|++|||++.+...|+..
T Consensus 412 -------ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 412 -------EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred -------HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 23344455555566777888899999999999999999999999998763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=350.38 Aligned_cols=256 Identities=30% Similarity=0.434 Sum_probs=208.1
Q ss_pred cCHHHHHHhhhcCCCCccccCceeEEEEEEC-CCcEEEEEEec-cCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC
Q 004565 374 FSYEELAAATDNFNTPIGSGGFGTVYKGILQ-DKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR 451 (745)
Q Consensus 374 ~~~~el~~at~~f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~ 451 (745)
.++.||+. .+.||+|..|+|||++++ .+..+|+|++. .......+++.+|++++.+.+||+||.++|.|....
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 55556553 356999999999999996 57889999995 334455788999999999999999999999999988
Q ss_pred -eeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcc
Q 004565 452 -QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK 530 (745)
Q Consensus 452 -~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~ 530 (745)
...++||||++|+|++++...+ .+++...-+|+.+|++||.|||+ .++||||||||+|||++..|.+||+|||++.
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 5999999999999999997663 59999999999999999999996 3999999999999999999999999999998
Q ss_pred cCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCc
Q 004565 531 LLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPR 610 (745)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (745)
.+-.. .....+||..|||||.+.+..|+.++||||||+.|+|+.+|+.|+.... +
T Consensus 228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-----------------~----- 282 (364)
T KOG0581|consen 228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-----------------P----- 282 (364)
T ss_pred Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-----------------C-----
Confidence 77655 3467899999999999999999999999999999999999999986431 0
Q ss_pred ccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 611 ESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
............ -.+.. |.+... ....++..++..||++||.+||++.|+++
T Consensus 283 --~~~~~~~Ll~~I-v~~pp-----P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 283 --PYLDIFELLCAI-VDEPP-----PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred --CCCCHHHHHHHH-hcCCC-----CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000011111111 11111 111111 24567899999999999999999999974
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=389.91 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=215.9
Q ss_pred hhcCCCCccccCceeEEEEEEC------CCcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEE
Q 004565 383 TDNFNTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 383 t~~f~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l 455 (745)
.-.|...||+|.||.||+|+.. +.+.||||.++..... ...+|++|+++++.++|+|||+|+|.|.+++..+|
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3445578999999999999963 3567999999976655 78899999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCC---------c----ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeE
Q 004565 456 VYEYMNKGSLDRTLFGNG---------S----VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVK 522 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~---------~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~k 522 (745)
|+|||..|+|.+||.... . +|+..+.+.||.|||.||+||-+ +.+|||||..+|+||.++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEE
Confidence 999999999999997432 1 38899999999999999999999 9999999999999999999999
Q ss_pred EccCCCcccCCCCCccccc-ccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCC
Q 004565 523 ISDFGLSKLLTPEQSSLFT-TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDG 600 (745)
Q Consensus 523 l~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 600 (745)
|+||||++.....+.+... .-.-+.+||+||.+..+++|.++|||||||+|||+++ |+.|+....
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS------------- 710 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS------------- 710 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-------------
Confidence 9999999988766554432 3345779999999999999999999999999999998 888886543
Q ss_pred CCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 601 NGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
+ .-+.+....+++ -+.+..+..++..||+.||+.+|++||+++||-..|+..
T Consensus 711 ------------n-----~EVIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 711 ------------N-----QEVIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ------------h-----HHHHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 1 112233333333 245666778899999999999999999999999999863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=363.35 Aligned_cols=249 Identities=28% Similarity=0.395 Sum_probs=209.3
Q ss_pred CCCccccCceeEEEEEE-CCCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGIL-QDKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|||..||.++. ..|..||+|++.+. .....+...+|+++-++|+|||||+++++|++.+..|||.|+|++
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 47799999999999998 88999999999752 344567789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|..++. .++.+++.++..+..||+.||.|||+ .+|+|||||..|+||++++++||+|||||..+..+... ..+
T Consensus 103 ~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er-k~T 177 (592)
T KOG0575|consen 103 GSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER-KKT 177 (592)
T ss_pred ccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcccc-cce
Confidence 99999887 55689999999999999999999999 99999999999999999999999999999988765333 366
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||++.....+..+||||+||+||-||.|++||+.... ..- .
T Consensus 178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-----------------------------ket-y 227 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-----------------------------KET-Y 227 (592)
T ss_pred ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----------------------------HHH-H
Confidence 8999999999999999999999999999999999999999986541 110 1
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHh-ccCCC
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVV--SML-EGGMP 680 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~--~~L-~~~~~ 680 (745)
...... +. ..|........+|+..+|+.+|.+|||+++|+ .++ .+..+
T Consensus 228 ~~Ik~~------~Y----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 228 NKIKLN------EY----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred HHHHhc------Cc----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 111111 11 11222334567888899999999999999999 455 44443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=344.52 Aligned_cols=194 Identities=33% Similarity=0.509 Sum_probs=176.1
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
...||+|+|++||+|++. ++..||||.+... .....+.+..|+.+|+.++|+|||++++++...+..+||||||.+|
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 466999999999999985 4789999999765 4455677889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC------CCeEEccCCCcccCCCCCc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK------LQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~------~~~kl~Dfgl~~~~~~~~~ 537 (745)
+|.+||+..+ .+++.+...++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|+.+....
T Consensus 95 DLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~- 169 (429)
T KOG0595|consen 95 DLSDYIRRRG-RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS- 169 (429)
T ss_pred CHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh-
Confidence 9999998876 59999999999999999999999 999999999999999875 458999999999887432
Q ss_pred ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
...+..|++.|||||++...+|+.|+|+||.|++||++++|+.||...
T Consensus 170 -~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 170 -MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred -HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 336788999999999999999999999999999999999999999754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=376.93 Aligned_cols=264 Identities=29% Similarity=0.479 Sum_probs=223.5
Q ss_pred CccCHHHHHHhhhcCC-----------CCccccCceeEEEEEECC----CcEEEEEEeccC-CcchHHHHHHHHHHHccC
Q 004565 372 RRFSYEELAAATDNFN-----------TPIGSGGFGTVYKGILQD----KSVVAVKKINSF-GIQGKKEFCTEITIIGNI 435 (745)
Q Consensus 372 ~~~~~~el~~at~~f~-----------~~lG~G~fg~Vy~g~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l 435 (745)
..++|++--.|-..|. ++||.|.||.|++|+++- ...||||.|+.. ....+.+|+.|..+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 4577777666666553 569999999999999852 457999999854 456678999999999999
Q ss_pred CCCceeeEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeee
Q 004565 436 HHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILL 515 (745)
Q Consensus 436 ~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll 515 (745)
+||||++|.|+.......++|.|||+||+|+.||+.+...+++.++..+..+||.||.||.+ .++|||||.++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheee
Confidence 99999999999999999999999999999999999998899999999999999999999998 999999999999999
Q ss_pred cCCCCeEEccCCCcccCCCCCcccccc--cccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCcccccccc
Q 004565 516 HDKLQVKISDFGLSKLLTPEQSSLFTT--MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRST 592 (745)
Q Consensus 516 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~ 592 (745)
+.+..+||+||||++.+..+.....+. ..-+.+|.|||.+...++|..+|||||||++||.++ |.+|+=...
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----- 839 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----- 839 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----
Confidence 999999999999999876655333333 234579999999999999999999999999999997 878764332
Q ss_pred ccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 004565 593 EKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVV 672 (745)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~ 672 (745)
+.++...++...+-..+.++...|.+||+.|||+|-.+||++.||+
T Consensus 840 ----------------------------------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV 885 (996)
T KOG0196|consen 840 ----------------------------------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIV 885 (996)
T ss_pred ----------------------------------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHH
Confidence 1112223333344455566778899999999999999999999999
Q ss_pred HHhcc
Q 004565 673 SMLEG 677 (745)
Q Consensus 673 ~~L~~ 677 (745)
.+|.+
T Consensus 886 ~~lDk 890 (996)
T KOG0196|consen 886 STLDK 890 (996)
T ss_pred HHHHH
Confidence 99987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=344.71 Aligned_cols=249 Identities=31% Similarity=0.430 Sum_probs=201.3
Q ss_pred hcCCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcc-------hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEE
Q 004565 384 DNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQ-------GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l 455 (745)
+-.++.||+|+||.|-+|.. ++++.||||.+++.... ......+|+++|++++|||||++.+++...+..||
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 34458899999999999997 56999999999742211 12334689999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC---CCeEEccCCCcccC
Q 004565 456 VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLL 532 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~---~~~kl~Dfgl~~~~ 532 (745)
|+|||.+|.|.+.+..++ .+.+..-..++.|++.|+.|||+ .+|+||||||+|||+..+ ..+||+|||+|+..
T Consensus 254 VlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999998775 47788888999999999999999 999999999999999766 78999999999987
Q ss_pred CCCCcccccccccccCccCcccccCCCC---CCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCC
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLTSSAI---SDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSP 609 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (745)
. ....+.+..||+.|.|||++.+... ..+.|+||+||+||-+++|..||......
T Consensus 330 g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-------------------- 387 (475)
T KOG0615|consen 330 G--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-------------------- 387 (475)
T ss_pred c--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--------------------
Confidence 6 3445678899999999999987653 34889999999999999999999765411
Q ss_pred cccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 610 RESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
+.. .+....++... ....-.+..++..+++.+||+.||++|||+.|+++
T Consensus 388 --------~sl-~eQI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 388 --------PSL-KEQILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --------ccH-HHHHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111 11122222211 11122345578889999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=329.51 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=207.4
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEec--cCCcchHHHHHHHHHHHccCCCCceeeEEE-EEEeCCe-eEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKG-FCAQGRQ-RFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~g-~~~~~~~-~~lV~e~~~~ 462 (745)
++||+|.||.|||+.. .+|..||.|.+. ....+.......|+.+|++|+|||||++++ .+.+.++ ..|||||+..
T Consensus 25 ~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~ 104 (375)
T KOG0591|consen 25 KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDA 104 (375)
T ss_pred HHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcc
Confidence 5699999999999984 789999999987 334455677889999999999999999999 4555555 7899999999
Q ss_pred CChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCC-ceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 463 GSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDH-KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 463 gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+|...+.. ..+.+++..+++++.|++.||..+|....+ -|+||||||.||+|+++|.+||+||||++.+.....
T Consensus 105 GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t- 183 (375)
T KOG0591|consen 105 GDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT- 183 (375)
T ss_pred cCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH-
Confidence 999988863 445799999999999999999999985533 389999999999999999999999999998876543
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....+||+.||+||.+...+|+.|+||||+||++|||+..+.||.... +.
T Consensus 184 fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----------------------------~~ 234 (375)
T KOG0591|consen 184 FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----------------------------LL 234 (375)
T ss_pred HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----------------------------HH
Confidence 3466899999999999999999999999999999999999999998654 22
Q ss_pred HHHHHHHhhccccccccccccCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 004565 619 LLALELHEQRRYLELADSRIEGQVS-DEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMP 680 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 680 (745)
.+- .....+.. ...+ .-....+.+|+..|+..||+.||+...++..+...++
T Consensus 235 ~L~-~KI~qgd~---------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~ 287 (375)
T KOG0591|consen 235 SLC-KKIEQGDY---------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD 287 (375)
T ss_pred HHH-HHHHcCCC---------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence 221 11122221 1223 4456788899999999999999997777766665433
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=376.59 Aligned_cols=258 Identities=29% Similarity=0.444 Sum_probs=213.3
Q ss_pred HhhhcCCCCccccCceeEEEEEECC--Cc----EEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCee
Q 004565 381 AATDNFNTPIGSGGFGTVYKGILQD--KS----VVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQR 453 (745)
Q Consensus 381 ~at~~f~~~lG~G~fg~Vy~g~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~ 453 (745)
...-.+...||+|+||.||.|.+.+ +. .||||.+... +.+...+|++|..+|+.++|||||+++|+|.+...+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3444456789999999999999754 33 4999999865 456678999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCC------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCC
Q 004565 454 FLVYEYMNKGSLDRTLFGN------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFG 527 (745)
Q Consensus 454 ~lV~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfg 527 (745)
++++|||++|+|..||++. ...|.....+.++.+||+|+.|||+ +++|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999987 5579999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCcccccc-cccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCC
Q 004565 528 LSKLLTPEQSSLFTT-MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSS 605 (745)
Q Consensus 528 l~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 605 (745)
+|+.+...+...... ..-+..|||||.+..+.+|.|+|||||||+||||+| |..|+....
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~------------------ 909 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS------------------ 909 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc------------------
Confidence 999665544333222 245679999999999999999999999999999999 667775433
Q ss_pred CCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 004565 606 SSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMP 680 (745)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 680 (745)
+ ........+.+++ +.+..+.+.+.+||..||+.+|++||++..|++.+.....
T Consensus 910 -------n----~~v~~~~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 910 -------N----FEVLLDVLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred -------h----HHHHHHHHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 0 0111112223322 3445566789999999999999999999999998887543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=322.93 Aligned_cols=266 Identities=24% Similarity=0.296 Sum_probs=210.3
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.++|+|+||.|||.+.++ |+.||||++.... ..-.+-.++|+++|++++|+|+|.++.+|......+||+||++..-
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 469999999999999865 9999999997433 2335667899999999999999999999999999999999998744
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
| +-|......++.....+++.|+++|+.|+|+ +++|||||||+||||+.++.+||+|||+|+.+.. .....+..+
T Consensus 88 L-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYV 162 (396)
T KOG0593|consen 88 L-HELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYV 162 (396)
T ss_pred H-HHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhhh
Confidence 4 4455555568999999999999999999999 9999999999999999999999999999998874 233457788
Q ss_pred cccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 545 GTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 545 gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
.|..|.|||.+.+ .+|....|||+.||++.||++|..-|-+....+....+....|..++.. ...
T Consensus 163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh--------------q~i 228 (396)
T KOG0593|consen 163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH--------------QSI 228 (396)
T ss_pred hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH--------------HHH
Confidence 9999999999987 6899999999999999999999998877765555555555555443321 111
Q ss_pred HHhhccccccccccccC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 004565 624 LHEQRRYLELADSRIEG-----QVSDEDVEKLVRIALCCVQEEPMLRPSMANVV 672 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~ 672 (745)
+........+.-|.... ..-+.....+++++..|++.||++|++-+|++
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11222222222222111 11122345789999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=345.49 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=204.1
Q ss_pred CCCCccccCceeEEEEEECCCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
....||+|.||+||+|.+.+. ||||+++.. ..+..+.|++|+..+++-+|.||+-+.|+|..... .+|+.++++-
T Consensus 396 l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 346799999999999999764 999999843 44567889999999999999999999999998887 9999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC-Ccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE-QSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~-~~~~~~~ 542 (745)
+|..+|+-....|+..+.++||.|||+||.|||. ++|||||||..||||.+++.+||+||||+..-..- .......
T Consensus 473 SLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~q 549 (678)
T KOG0193|consen 473 SLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQ 549 (678)
T ss_pred hhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCC
Confidence 9999999888899999999999999999999999 99999999999999999999999999999654321 1112233
Q ss_pred cccccCccCcccccC---CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 543 MRGTRGYLAPEWLTS---SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~---~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
..|...|||||++.. .+|+..+||||||+++|||++|..|+........+-..
T Consensus 550 p~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV------------------------ 605 (678)
T KOG0193|consen 550 PHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV------------------------ 605 (678)
T ss_pred CccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe------------------------
Confidence 457889999999864 47899999999999999999999999743311111110
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGM 679 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 679 (745)
++-....|.. .....+.+.|.+|+..||..++++||.+.+|+.+|+...
T Consensus 606 --------GrG~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 606 --------GRGYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred --------cccccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 1100011110 111234567888999999999999999999999887644
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=332.90 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=200.8
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC--eeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR--QRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~~~~ 462 (745)
..+.||+|.||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|...... .+.++|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 34779999999999999865 8899999987543333667899999999999999999999854444 68899999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-CCCeEEccCCCcccCCC--CCccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-KLQVKISDFGLSKLLTP--EQSSL 539 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~~~~--~~~~~ 539 (745)
|+|.+++...+..|++..+..++.||++||+|||+ ++|+||||||+||||+. ++.+||+|||+++.... .....
T Consensus 101 GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~ 177 (313)
T KOG0198|consen 101 GSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDS 177 (313)
T ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccccccc
Confidence 99999999876679999999999999999999998 99999999999999999 79999999999987764 22223
Q ss_pred ccccccccCccCcccccCCC-CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 540 FTTMRGTRGYLAPEWLTSSA-ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~-~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
....+||+.|||||++..+. ...++|||||||++.||+||+.||.... ...
T Consensus 178 ~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~----------------------------~~~ 229 (313)
T KOG0198|consen 178 ELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF----------------------------EEA 229 (313)
T ss_pred cccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc----------------------------chH
Confidence 34578999999999999643 3459999999999999999999986421 001
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
.+......... ...++........+++..|++.+|++|||++++++-.
T Consensus 230 ~~~~~ig~~~~---------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 230 EALLLIGREDS---------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHHhccCC---------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11111111111 1133334455678899999999999999999998654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=336.04 Aligned_cols=271 Identities=24% Similarity=0.313 Sum_probs=214.7
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~ 462 (745)
.+||+|.||.||+|+. .+|+.||+|++.... ..-..-..+|+.+|++|.||||++|.+...+. ...|||+|||+.
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 4599999999999996 679999999997443 34456678899999999999999999999876 678999999977
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.-++...+-.++..++.-++.||+.||+|+|. ++|+|||||.+|||||.+|.+||+|||||+++........+.
T Consensus 203 -DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~ 278 (560)
T KOG0600|consen 203 -DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTS 278 (560)
T ss_pred -hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCccccc
Confidence 8988888887789999999999999999999999 999999999999999999999999999999988877776788
Q ss_pred cccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
.+-|..|.|||++.+. .|+...|+||.||||.||+.|+..|....+.+..+.++...|...... +. ...+| ++
T Consensus 279 rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~----W~-~~kLP-~~ 352 (560)
T KOG0600|consen 279 RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY----WP-VSKLP-HA 352 (560)
T ss_pred ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc----cc-cccCC-cc
Confidence 8889999999998875 799999999999999999999999999887777777776666443221 00 00111 00
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..+.........+... ...++ ...++|+..+|..||.+|.|+.++++
T Consensus 353 ~~~kp~~~y~r~l~E~-~~~~~----~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRET-FKDFP----ASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccchHHHH-hccCC----HHHHHHHHHHhccCccccccHHHHhc
Confidence 0000000000011000 11222 34667777889999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=306.00 Aligned_cols=270 Identities=22% Similarity=0.282 Sum_probs=217.7
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
++||+|.||.||+|+. ..|+.||||+++.... .-.....+|++.|+.++|+||+.+++++.......||+|||+. +
T Consensus 8 ~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-d 86 (318)
T KOG0659|consen 8 EKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-D 86 (318)
T ss_pred hhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-c
Confidence 5699999999999996 5689999999984322 2245678999999999999999999999999999999999976 9
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|+..+......++...+..++.++++||+|||+ +.|+||||||.|+|++.++.+||+|||+++.+....... +..+
T Consensus 87 Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-~~~V 162 (318)
T KOG0659|consen 87 LEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-THQV 162 (318)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-ccce
Confidence 999999888899999999999999999999999 999999999999999999999999999999987655433 3337
Q ss_pred cccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 545 GTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 545 gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
-|..|.|||.+.+. .|+...||||.||++.||+-|.+-|.+..+.+....++...|...+.. +.+...++.+..-
T Consensus 163 ~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~----WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 163 VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ----WPEMTSLPDYVKI 238 (318)
T ss_pred eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc----CccccccccHHHH
Confidence 79999999988775 689999999999999999999887777776666666666666543322 2344445555443
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
....... +.. .-+......++++..++..||.+|.|+.|.+++
T Consensus 239 ~~~P~~~-------~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 239 QQFPKPP-------LNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred hcCCCCc-------ccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 3221111 111 112233446899999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=321.25 Aligned_cols=195 Identities=29% Similarity=0.402 Sum_probs=175.9
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
++||+|+||.||.++-. .++.+|+|++++.. ....+....|..+|.+++||.||.++-.|++....|||+||+.+|
T Consensus 31 kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GG 110 (357)
T KOG0598|consen 31 KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGG 110 (357)
T ss_pred eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCc
Confidence 78999999999999975 48899999997532 234667889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
.|..+|...+ .+++..+.-++..|+.||.|||+ .+||||||||+|||||++|+++|+||||++...... ..+..+
T Consensus 111 eLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t~tf 185 (357)
T KOG0598|consen 111 ELFYHLQREG-RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DATRTF 185 (357)
T ss_pred cHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-Cccccc
Confidence 9999998765 58899888999999999999999 999999999999999999999999999998654432 334568
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
.||+.|||||++....++..+|.||+|+++|||++|.+||....
T Consensus 186 cGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 186 CGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred cCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 99999999999999999999999999999999999999997654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=322.72 Aligned_cols=256 Identities=25% Similarity=0.318 Sum_probs=202.5
Q ss_pred cCCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 385 NFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+..+||.|..++||+|.. +.+..||||++.-.... ..+.+..|+..++.++||||++++..|..+...|+||.||..
T Consensus 29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~ 108 (516)
T KOG0582|consen 29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAG 108 (516)
T ss_pred eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcC
Confidence 3447799999999999996 55799999999844333 358889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc---
Q 004565 463 GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS--- 538 (745)
Q Consensus 463 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--- 538 (745)
||+.+.+...- ..+++..+..|..++++||.|||+ ++.||||||+.||||+.+|.+||+|||+...+......
T Consensus 109 GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 109 GSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred CcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 99999987532 259999999999999999999999 99999999999999999999999999988766543322
Q ss_pred cccccccccCccCcccccCC--CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 539 LFTTMRGTRGYLAPEWLTSS--AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~--~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
.....+||+.|||||++... .|+.|+|||||||...||.+|..||.....-..+....
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-------------------- 245 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-------------------- 245 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--------------------
Confidence 12567899999999996543 68999999999999999999999998664211111111
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.+......-..+..+-.......+.+++..||+.||.+|||++++++
T Consensus 246 ----------qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 246 ----------QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ----------cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111111001111111122346888999999999999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.12 Aligned_cols=253 Identities=32% Similarity=0.429 Sum_probs=205.5
Q ss_pred cCCCCccccCceeEEEEEECC--C--cE-EEEEEecc---CCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQD--K--SV-VAVKKINS---FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLV 456 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~--~--~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV 456 (745)
.+.++||+|+||.||+|++.. + .. ||||..+. ......++|+.|.+++++++|+|||+++|++......++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345789999999999999843 2 23 89999874 3456688999999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC
Q 004565 457 YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~ 536 (745)
||++++|+|.++|......++..+++.++.+.|.||+|||+ .++|||||.++|+|++.++.+||+|||+++.-....
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999999999999988789999999999999999999999 999999999999999999999999999987544111
Q ss_pred cccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 537 SSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 537 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
.......-+..|+|||.+..+.++.++|||||||++||+++ |..|+....
T Consensus 317 -~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~---------------------------- 367 (474)
T KOG0194|consen 317 -MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK---------------------------- 367 (474)
T ss_pred -eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC----------------------------
Confidence 11112245789999999999999999999999999999998 777775433
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGM 679 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 679 (745)
........... ..+...+......+..++..|+..+|++||+|.+|.+.|+...
T Consensus 368 -~~~v~~kI~~~---------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 368 -NYEVKAKIVKN---------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred -HHHHHHHHHhc---------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 11111111011 1112223334456777888999999999999999999998733
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=335.35 Aligned_cols=243 Identities=29% Similarity=0.410 Sum_probs=207.9
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
.+||+|+.|.||.+.- ..++.||||++.......++-+.+|+.+|+..+|+|||.++..+...++.++|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 5699999999999985 568899999998777777788899999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
+.+... .+++.++..|+.+++.||+|||. ++|+|||||.+||||+.++.+||+|||++..+..... .....+||
T Consensus 359 DvVt~~--~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGT 432 (550)
T KOG0578|consen 359 DVVTKT--RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGT 432 (550)
T ss_pred hhhhcc--cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCC
Confidence 999765 49999999999999999999999 9999999999999999999999999999998876654 33678899
Q ss_pred cCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 547 ~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
+.|||||++....|..|.||||||++++||+.|..||-... +..+..+..
T Consensus 433 PYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------------------------------PlrAlyLIa 482 (550)
T KOG0578|consen 433 PYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------------------------------PLRALYLIA 482 (550)
T ss_pred CCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------------------------------hHHHHHHHh
Confidence 99999999999999999999999999999999999986432 111222222
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..-..++ ..+......+.+++.+||+.|+++||++.|+|+
T Consensus 483 ~ng~P~l-------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 483 TNGTPKL-------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred hcCCCCc-------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1111111 122334567889999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=342.37 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=197.6
Q ss_pred cCCCCccccCceeEEEEEE------CCCcEEEEEEeccCC-cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCC-eeEE
Q 004565 385 NFNTPIGSGGFGTVYKGIL------QDKSVVAVKKINSFG-IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGR-QRFL 455 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~-~~~l 455 (745)
.+.++||+|+||.||+|.. ..+..||||++.... ....+.+..|++++..+ +||||++++++|...+ ..++
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (338)
T cd05102 10 RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMV 89 (338)
T ss_pred eeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEE
Confidence 3457899999999999975 234679999987433 23356789999999999 8999999999987644 5789
Q ss_pred EEeecCCCChhhhhcCCC-------------------------------------------------------------c
Q 004565 456 VYEYMNKGSLDRTLFGNG-------------------------------------------------------------S 474 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~-------------------------------------------------------------~ 474 (745)
||||+++|+|.+++.... .
T Consensus 90 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (338)
T cd05102 90 IVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKS 169 (338)
T ss_pred EEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccC
Confidence 999999999999886432 2
Q ss_pred ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-cccccccccCccCcc
Q 004565 475 VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPE 553 (745)
Q Consensus 475 ~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE 553 (745)
.+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 47888999999999999999999 99999999999999999999999999999865433221 122345678899999
Q ss_pred cccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccc
Q 004565 554 WLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLE 632 (745)
Q Consensus 554 ~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (745)
++.+..++.++||||||++||||++ |..||..... ..... .....+...
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----------------------------~~~~~-~~~~~~~~~- 296 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----------------------------NEEFC-QRLKDGTRM- 296 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----------------------------cHHHH-HHHhcCCCC-
Confidence 9999999999999999999999997 9888864320 00011 111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 633 LADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 633 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
..+......+.+++.+||+.+|++|||+.||+++|+..
T Consensus 297 --------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 297 --------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11112234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.43 Aligned_cols=244 Identities=20% Similarity=0.283 Sum_probs=197.0
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcch---HHHHHHHHHHHccCCCCceeeEEEEEEe----CCeeEEEEeec
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQG---KKEFCTEITIIGNIHHVNLVRLKGFCAQ----GRQRFLVYEYM 460 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~ 460 (745)
..||+|++|.||+|.+ +++.||||++....... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4599999999999999 57889999997543333 4678899999999999999999999877 34678999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
++|+|.+++.... .+++..++.++.+++.||.|||+ ..+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 9999999997653 68999999999999999999997 2478899999999999999999999999998654322
Q ss_pred cccccccCccCcccccC--CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 541 TTMRGTRGYLAPEWLTS--SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~--~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----------------------------~~ 228 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----------------------------TK 228 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-----------------------------HH
Confidence 23457899999999976 688999999999999999999999996432 11
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.........+. +...+......+.+++.+||+.||++||||.||++.|+.
T Consensus 229 ~~~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 229 EIYDLIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11111111110 011122234568899999999999999999999999975
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=331.39 Aligned_cols=236 Identities=31% Similarity=0.470 Sum_probs=198.1
Q ss_pred ccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhhhh
Q 004565 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTL 469 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 469 (745)
||.|+.|.||+|++.+ +.||||+++... ..+++-|++|+|+||+.+.|+|.....++||||||+.|-|...|
T Consensus 132 lGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL 203 (904)
T KOG4721|consen 132 LGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL 203 (904)
T ss_pred hccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH
Confidence 9999999999999965 569999875322 24788899999999999999999999999999999999999999
Q ss_pred cCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccccCc
Q 004565 470 FGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549 (745)
Q Consensus 470 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 549 (745)
...+ .++.....+|..+||.||.|||. +.|||||||.-||||..+..+||+|||-++..... .....+.||..|
T Consensus 204 ka~~-~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaW 277 (904)
T KOG4721|consen 204 KAGR-PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAW 277 (904)
T ss_pred hccC-ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhh
Confidence 8764 58888899999999999999999 99999999999999999999999999999876544 223457899999
Q ss_pred cCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhcc
Q 004565 550 LAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRR 629 (745)
Q Consensus 550 ~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (745)
||||++.+.+.++|.|||||||||||||||..|+..-.. -+++-+
T Consensus 278 MAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwG------------------------------- 322 (904)
T KOG4721|consen 278 MAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWG------------------------------- 322 (904)
T ss_pred hCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEe-------------------------------
Confidence 999999999999999999999999999999999865321 011111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 630 YLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 630 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.-...+.-..+..+.+-+.-|+++||+-.|..||++++++.-|+-
T Consensus 323 ---VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 323 ---VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ---ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 111112223444556678889999999999999999999998875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=379.08 Aligned_cols=268 Identities=26% Similarity=0.487 Sum_probs=214.8
Q ss_pred ccCHHHHHHhhhcCCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC
Q 004565 373 RFSYEELAAATDNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR 451 (745)
Q Consensus 373 ~~~~~el~~at~~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~ 451 (745)
.++++++..+. ...+.||+|+||.||+|+. .++..||||++...... ...|++.+++++|||||+++|+|.+..
T Consensus 682 ~~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 682 SITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 45566655432 2346799999999999997 57889999998643322 234688899999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 452 QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 452 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
..++||||+++|+|.++++ .++|..+.+|+.|||+||+|||.++.++|+||||||+||+++.++.+++. |+....
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999999999999995 38999999999999999999997666899999999999999999988875 665543
Q ss_pred CCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcc
Q 004565 532 LTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
.... ....++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 832 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~------------------------ 882 (968)
T PLN00113 832 LCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF------------------------ 882 (968)
T ss_pred cccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc------------------------
Confidence 3221 22367899999999999999999999999999999999999985321
Q ss_pred cccccHHHHHHHHHhhccccccccccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEG--QVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGM 679 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 679 (745)
........|+............+|+.+.. ..+.++..++.+++.+|++.+|++||||+||+++|+...
T Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 883 GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 01123555555544444555566776644 345667788999999999999999999999999998643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.13 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=201.7
Q ss_pred hcCCCCccccCceeEEEEEEC----CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 384 DNFNTPIGSGGFGTVYKGILQ----DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
..+.+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+..+.+++|+||+++++++...+..++|||
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence 445578999999999999864 35689999987543 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++|+|.+++......+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+|++|||.+.........
T Consensus 87 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 87 YMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred eCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 999999999998766679999999999999999999998 99999999999999999999999999987654322211
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
......++..|+|||.+.+..++.++||||||+++||+++ |+.||.... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~-----------------------------~ 214 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS-----------------------------G 214 (266)
T ss_pred cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC-----------------------------H
Confidence 1123345678999999999999999999999999999875 998886432 0
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
...... ..++.. ...+......+.+++..||+.+|++||++++|++.|+.
T Consensus 215 ~~~~~~-~~~~~~---------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 215 QDVIKA-VEDGFR---------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HHHHHH-HHCCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 111111 111110 01122234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.63 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=214.3
Q ss_pred HHHHHHhhhcCCCCccccCceeEEEEEECCCcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeE
Q 004565 376 YEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRF 454 (745)
Q Consensus 376 ~~el~~at~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~ 454 (745)
++|.....-.|.++||+|-||.|......++..||||+++.... ...++|..|+++|.+++|||||+++|+|..++..+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 34444444556688999999999999999999999999986544 44589999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCcc-cCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCC
Q 004565 455 LVYEYMNKGSLDRTLFGNGSV-LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT 533 (745)
Q Consensus 455 lV~e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~ 533 (745)
+|+|||++|+|..+|.++..+ +.-....+|+.|||.||+||.+ .++|||||.++|+|+|.++++||+|||+++-+.
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999999876443 3556677899999999999999 999999999999999999999999999999776
Q ss_pred CCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh--CCCCCCccccccccccCCCCCCCCCCCCCCCc
Q 004565 534 PEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS--GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPR 610 (745)
Q Consensus 534 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (745)
..+... ....+-+.+|||||.+..+++|.++|||+||+.|||+++ ..+|+......
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--------------------- 747 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--------------------- 747 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---------------------
Confidence 655443 234566889999999999999999999999999999864 66777543210
Q ss_pred ccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 611 ESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
....-+..+...+. ...--..+.-+...+.++++.||..+-++||++++|...|+.
T Consensus 748 -----~vven~~~~~~~~~------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 748 -----QVVENAGEFFRDQG------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred -----HHHHhhhhhcCCCC------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 11111111111111 111112344456778899999999999999999999998875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=328.78 Aligned_cols=270 Identities=24% Similarity=0.339 Sum_probs=212.8
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHH--HHHHHHHHccCC-CCceeeEEEEEEeCC-eeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKE--FCTEITIIGNIH-HVNLVRLKGFCAQGR-QRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~g~~~~~~-~~~lV~e~~~~ 462 (745)
++||.|.||.||+|+- ..+..||||++++.-.. .++ =++|+..|+++. ||||++|..++.+.+ ..++|||||+.
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~ 94 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC 94 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh
Confidence 6699999999999996 46889999999754322 333 357999999998 999999999998888 89999999965
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++..+++.+++..+..|+.||.+||+|+|+ +|+.|||+||+|||+.....+||+|||+|+....... .+.
T Consensus 95 -NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP--YTe 168 (538)
T KOG0661|consen 95 -NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP--YTE 168 (538)
T ss_pred -hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccCCC--cch
Confidence 8999999888899999999999999999999999 9999999999999999999999999999998776543 477
Q ss_pred cccccCccCccccc-CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLT-SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~-~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
.+.|..|.|||++. .+.|+.+.|||++|++++||.+-+.-|-+..+.+...++-...|..-... .++ ....+
T Consensus 169 YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~-~~e------g~~La 241 (538)
T KOG0661|consen 169 YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS-WPE------GYNLA 241 (538)
T ss_pred hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc-chh------HHHHH
Confidence 88999999999765 56799999999999999999999999988877766666655555432111 000 00111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
..+ .-++.......+..-.+ ......++++..|+..||.+|||+.|.++.
T Consensus 242 ~~m--nf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAM--NFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHh--ccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 11122222222221122 256678899999999999999999999874
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.14 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=201.6
Q ss_pred CCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
+.+.||+|+||.||++.+.++..+|+|.+.... .....|..|++++++++|+||+++++++......++||||+++|+|
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 86 (256)
T cd05114 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86 (256)
T ss_pred EeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence 346799999999999999888889999886433 3356789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++......+++..++.++.+++.||+|||+ .+++|+||||+||++++++.+||+|||++...............+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05114 87 LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF 163 (256)
T ss_pred HHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCC
Confidence 99997655578999999999999999999999 999999999999999999999999999998654433222233345
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
+..|+|||++.+..++.++||||||+++|||++ |+.||.... ........
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----------------------------~~~~~~~i 214 (256)
T cd05114 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----------------------------NYEVVEMI 214 (256)
T ss_pred chhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----------------------------HHHHHHHH
Confidence 678999999998889999999999999999999 888875432 11111111
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
..... ... +......+.+++.+|++.+|++||+|.+|++.|.
T Consensus 215 ~~~~~---~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 215 SRGFR---LYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HCCCC---CCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111 001 1112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=339.99 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=198.7
Q ss_pred hcCCCCccccCceeEEEEEE------CCCcEEEEEEeccCC-cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEE
Q 004565 384 DNFNTPIGSGGFGTVYKGIL------QDKSVVAVKKINSFG-IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l 455 (745)
..+.++||+|+||.||+|+. ..+..||||+++... ....+.+.+|++++..+ +||||++++++|......++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 34458899999999999974 235689999987432 33456788999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhcCCC--------------------------------------------------------------
Q 004565 456 VYEYMNKGSLDRTLFGNG-------------------------------------------------------------- 473 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~-------------------------------------------------------------- 473 (745)
||||+++|+|.+++....
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 999999999998886432
Q ss_pred ------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc-c
Q 004565 474 ------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL-F 540 (745)
Q Consensus 474 ------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~ 540 (745)
..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......... .
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 147889999999999999999999 999999999999999999999999999998665433211 1
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
....++..|+|||.+.+..++.++||||||+++|||++ |..||.... . ..
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~-------------------------~----~~ 324 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP-------------------------V----DS 324 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC-------------------------c----hH
Confidence 22345678999999999999999999999999999998 777775322 0 00
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
........+.. ...+......+.+++.+|++.||++||+|.||+++|+.
T Consensus 325 ~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 325 KFYKMIKEGYR---------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHHhCcc---------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 01111111110 00111112468899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=328.48 Aligned_cols=247 Identities=35% Similarity=0.558 Sum_probs=194.3
Q ss_pred CCCccccCceeEEEEEEC-----CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQ-----DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++|+||++++|+|......++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 356999999999999987 25679999996533 334788999999999999999999999999888899999999
Q ss_pred CCCChhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc-c
Q 004565 461 NKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS-S 538 (745)
Q Consensus 461 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~ 538 (745)
++|+|.++|... ...+++..++.|+.|||+||+|||+ .+++|++|+++||++++++.+||+|||++........ .
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 999999999887 5579999999999999999999999 8999999999999999999999999999987733222 2
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
..........|+|||.+....++.++||||||+++|||++ |+.|+.... .
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----------------------------~ 211 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----------------------------N 211 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----------------------------H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-----------------------------c
Confidence 2234457789999999999889999999999999999999 677764322 1
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
...........+ . ..+......+.+++..||+.+|++||+|.+|++.|
T Consensus 212 ~~~~~~~~~~~~-~---------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 212 EEIIEKLKQGQR-L---------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHTTEE-T---------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccccc-c---------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 222222211111 1 11112235688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.39 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=197.5
Q ss_pred cCCCCccccCceeEEEEEECC-----------------CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQD-----------------KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGF 446 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~ 446 (745)
.+.++||+|+||.||++.+++ +..||||.+.... .....+|.+|++++.+++|+||++++++
T Consensus 8 ~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 87 (304)
T cd05096 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGV 87 (304)
T ss_pred eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence 445789999999999998643 3369999987543 3345679999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhhhhcCCC------------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCC
Q 004565 447 CAQGRQRFLVYEYMNKGSLDRTLFGNG------------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508 (745)
Q Consensus 447 ~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~di 508 (745)
+.+.+..++||||+++++|.+++.... ..++|..++.++.||+.||.|||+ .+|+||||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dl 164 (304)
T cd05096 88 CVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDL 164 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCc
Confidence 999999999999999999999885421 247889999999999999999999 89999999
Q ss_pred CCCCeeecCCCCeEEccCCCcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhC--CCCCCc
Q 004565 509 KPENILLHDKLQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG--RKNSSL 585 (745)
Q Consensus 509 k~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg--~~p~~~ 585 (745)
||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||+++ ..||..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 999999999999999999999865443221 12234467899999999988999999999999999999974 455543
Q ss_pred cccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCC
Q 004565 586 KIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLR 665 (745)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R 665 (745)
.. .. ............... ......++.....+.+++.+|++.+|++|
T Consensus 245 ~~-------------------------~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 245 LT-------------------------DE-QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred CC-------------------------HH-HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhC
Confidence 21 00 011111111111100 00001111233568899999999999999
Q ss_pred CCHHHHHHHhcc
Q 004565 666 PSMANVVSMLEG 677 (745)
Q Consensus 666 Pt~~ev~~~L~~ 677 (745)
|||.+|+++|+.
T Consensus 293 Ps~~~i~~~l~~ 304 (304)
T cd05096 293 PSFSDIHAFLTE 304 (304)
T ss_pred cCHHHHHHHHhC
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=323.35 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=201.6
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeec
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
|.+.||+|+|++|++|+.. .++.+|||++.+. .....+....|-+.|.+| .||.|++|+-.|.+...+|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 5678999999999999974 5889999998642 222344566788888888 8999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc--
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-- 538 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-- 538 (745)
++|+|.++|...+ .|++.....++.+|+.||+|||+ .+||||||||+|||||.++++||+|||-|+.+......
T Consensus 157 ~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 157 PNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred CCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 9999999998875 59999999999999999999999 99999999999999999999999999999988654322
Q ss_pred -------c-c--cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCC
Q 004565 539 -------L-F--TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSS 608 (745)
Q Consensus 539 -------~-~--~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (745)
. . ..++||..|.+||++..+..+..+|+|+|||+||+|+.|.+||...++
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------------------- 292 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-------------------- 292 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--------------------
Confidence 1 1 348899999999999999999999999999999999999999987541
Q ss_pred CcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 609 PRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
++.. +.. .-+|..+...++ +.+.+|+.+.|..||.+|+|..||.+
T Consensus 293 -------yliF---qkI------~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 293 -------YLIF---QKI------QALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred -------HHHH---HHH------HHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence 1110 100 012222323333 45677888889999999999988875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.86 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=220.3
Q ss_pred CHHHHHHhhhcCCCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCee
Q 004565 375 SYEELAAATDNFNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQR 453 (745)
Q Consensus 375 ~~~el~~at~~f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~ 453 (745)
.-+|++...-...++||-|-||.||.|.++. .-.||||.++... ...++|+.|..+|+.++|||+|+|+|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4456666656667999999999999999976 4579999998544 4578999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccC
Q 004565 454 FLVYEYMNKGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 454 ~lV~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
|||+|||.+|+|.+||+...+ .++....+.+|.||+.||+||.. +++|||||.++|+|+.++..+||+||||++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999987554 67888889999999999999999 99999999999999999999999999999999
Q ss_pred CCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcc
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
..+.........-+..|.|||-+....++.|+|||+|||+||||.| |-.|+-...
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------------------------ 471 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------------------------ 471 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------------------------
Confidence 8776555455556789999999999999999999999999999998 555553221
Q ss_pred cccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
+. . +.+++....+.+-+..+...+.+||+.||+.+|.+||++.|+-+.+|.
T Consensus 472 -----lS-q---------VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 472 -----LS-Q---------VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred -----HH-H---------HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 11 1 223444445555666777889999999999999999999999877664
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.49 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=203.8
Q ss_pred hhcCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 383 TDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 383 t~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
...+.+.||+|+||.||+|...++..||||.+.... ...+++.+|++++++++|+|++++++++...+..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 344558899999999999998888889999987543 3467799999999999999999999999999999999999999
Q ss_pred CChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 463 GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
++|.+++.... ..+++..+..++.+++.||.|||+ .+++|+||||+||++++++.+||+|||++............
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence 99999997644 468999999999999999999999 99999999999999999999999999999876533222112
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....+..|+|||++.+..++.++||||||++++||++ |+.||.... ....
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----------------------------~~~~ 213 (261)
T cd05068 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----------------------------NAEV 213 (261)
T ss_pred CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----------------------------HHHH
Confidence 2233468999999999899999999999999999999 888875322 0000
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
........ ....+......+.+++.+|++.+|++||+|.+|++.|+.
T Consensus 214 -~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 214 -LQQVDQGY---------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -HHHHHcCC---------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11111100 001112234568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=326.58 Aligned_cols=245 Identities=27% Similarity=0.380 Sum_probs=202.4
Q ss_pred hhcCCCCccccCceeEEEEEE-CCCcEEEEEEeccC----Cc-chHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEE
Q 004565 383 TDNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSF----GI-QGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 383 t~~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~l 455 (745)
.+.+.+.||+|.||+|+.|.. ..+..||||.+... .. ...+.+.+|+.++++++ ||||++++.++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 344558899999999999986 46799999977643 11 23456668999999998 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC-CCeEEccCCCcccCCC
Q 004565 456 VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDFGLSKLLTP 534 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~-~~~kl~Dfgl~~~~~~ 534 (745)
||||+.+|.|.+++.. ..++.+.....++.|++.|++|||+ ++|+||||||+|||||.+ +++||+|||++....
T Consensus 98 vmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 9999999999999998 5578999999999999999999999 999999999999999999 999999999999874
Q ss_pred CCcccccccccccCccCcccccCCC-CC-CccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccc
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTSSA-IS-DKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (745)
..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||....
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------------------------- 227 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------------------------- 227 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------------------------
Confidence 2233456789999999999999977 75 79999999999999999999997543
Q ss_pred ccccHHHHHHHHHhhccccccccccccCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHH
Q 004565 613 QRVYFPLLALELHEQRRYLELADSRIEGQVSDED-VEKLVRIALCCVQEEPMLRPSMANVV 672 (745)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~cl~~~p~~RPt~~ev~ 672 (745)
.+..... ...++. .++... ...+..++.+|++.+|.+|+|+.+|+
T Consensus 228 ----~~~l~~k-i~~~~~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 228 ----VPNLYRK-IRKGEF----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----HHHHHHH-HhcCCc----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111111 111110 111111 45688999999999999999999998
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.28 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=202.4
Q ss_pred CCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
+.++||+|+||.||+|...++..||+|.+.... ...+.+..|+.++++++|+||+++++.+...+..++|+||+++++|
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05072 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88 (261)
T ss_pred EeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence 347899999999999999888899999986433 3467899999999999999999999999999999999999999999
Q ss_pred hhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 466 DRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 466 ~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...............
T Consensus 89 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 165 (261)
T cd05072 89 LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 165 (261)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCc
Confidence 9998753 3468999999999999999999999 99999999999999999999999999999876543332223345
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
++..|+|||++....++.++||||||+++|||++ |+.||.... .......
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----------------------------~~~~~~~ 216 (261)
T cd05072 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-----------------------------NSDVMSA 216 (261)
T ss_pred cceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-----------------------------HHHHHHH
Confidence 6778999999998899999999999999999998 888885322 0001111
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
...... ...... ....+.+++.+|++.+|++||++++|+++|+.
T Consensus 217 ~~~~~~------~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 217 LQRGYR------MPRMEN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHcCCC------CCCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111100 011111 22457899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.07 Aligned_cols=249 Identities=28% Similarity=0.432 Sum_probs=202.1
Q ss_pred cCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.+.||+|+||.||+|...++..+|||.+.... ....+|.+|+.++.+++||||+++++++......++||||+++++
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 4457799999999999998887789999887433 335679999999999999999999999998888999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++......+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||+++..............
T Consensus 86 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05113 86 LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK 162 (256)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence 999997765579999999999999999999999 99999999999999999999999999999866443322222334
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----------------------------~~~~~~~ 213 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-----------------------------NSETVEK 213 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-----------------------------HHHHHHH
Confidence 5678999999998889999999999999999998 888875332 0111111
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
....... ..+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 214 ~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 214 VSQGLRL----------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HhcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1111110 011112356889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=318.33 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=201.8
Q ss_pred cCCCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.+.||+|+||.||+|... .+..||+|++... .....++..|++++++++|+||+++++++......++||||++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 34578999999999999975 4788999998743 334667899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++.... ..+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++.............
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 9999987543 368999999999999999999998 999999999999999999999999999998765433222222
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
..++..|+|||++.+..++.++||||||+++|||++ |..||.... .....
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----------------------------~~~~~ 215 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------------------LSQVY 215 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----------------------------HHHHH
Confidence 334678999999999999999999999999999998 888875322 11111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.. .... .....+......+.+++.+|++.+|++||++.+|+++|+.
T Consensus 216 ~~-~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 216 EL-LEKG---------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred HH-HHCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11 1110 1111122223568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=313.66 Aligned_cols=246 Identities=29% Similarity=0.386 Sum_probs=200.2
Q ss_pred CccccCceeEEEEEECCCcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhh
Q 004565 389 PIGSGGFGTVYKGILQDKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 467 (745)
+||+|+||.||+|...++..+|+|.+..... .....+.+|++++++++|+||+++++++......++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6999999999999998899999999875433 334568899999999999999999999999999999999999999999
Q ss_pred hhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccccc
Q 004565 468 TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR 547 (745)
Q Consensus 468 ~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~ 547 (745)
++......+++..++.++.+++.||.|||+ .+++|+||||+||++++++.+||+|||++...............++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 997666678999999999999999999998 99999999999999999999999999998754433222222234467
Q ss_pred CccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 548 ~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
.|+|||++.+..++.++||||||+++||+++ |..||.... ..... ....
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-----------------------------~~~~~-~~~~ 208 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-----------------------------NQQAR-EQVE 208 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-----------------------------HHHHH-HHHH
Confidence 8999999998899999999999999999998 888885432 00000 1111
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
... ....+......+.+++.+|++.+|++||++.||++.|.
T Consensus 209 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 209 KGY---------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 110 11112223457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.63 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=197.9
Q ss_pred hcCCCCccccCceeEEEEEEC------CCcEEEEEEeccCC-cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEE
Q 004565 384 DNFNTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFG-IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l 455 (745)
..+.+.||+|+||.||+|... ++..||||++.... ......+..|+++++.+ +|+||++++++|......++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 344588999999999998842 34579999997533 23356688999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhcCCC--------------------------------------------------------------
Q 004565 456 VYEYMNKGSLDRTLFGNG-------------------------------------------------------------- 473 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~-------------------------------------------------------------- 473 (745)
||||+++|+|.+++....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 999999999999885321
Q ss_pred -------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-ccccccc
Q 004565 474 -------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-LFTTMRG 545 (745)
Q Consensus 474 -------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~g 545 (745)
..+++..+++|+.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........ ......+
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 147889999999999999999999 99999999999999999999999999999865443221 1122345
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
+..|+|||++....++.++||||||+++|||++ |+.||.... .. .. ....
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~-------------------------~~---~~-~~~~ 327 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL-------------------------VN---SK-FYKM 327 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc-------------------------cc---HH-HHHH
Confidence 678999999998899999999999999999997 999886432 00 00 0011
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
...+. ....+......+.+++.+|++.+|++|||+.+|+++|+.
T Consensus 328 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 328 VKRGY---------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred HHccc---------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11110 000111112468899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=316.74 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=201.6
Q ss_pred CCCCccccCceeEEEEEECC----CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 386 FNTPIGSGGFGTVYKGILQD----KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
+.+.||+|+||.||+|.+.. ...||||.+.... ......|..|+.++++++|+||+++++++......++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 45789999999999999743 4579999887433 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-c
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-L 539 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~ 539 (745)
++++|.+++......+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++......... .
T Consensus 88 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (266)
T cd05033 88 ENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT 164 (266)
T ss_pred CCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccccccee
Confidence 9999999998766679999999999999999999999 99999999999999999999999999999877522221 1
Q ss_pred ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....++..|+|||.+.+..++.++||||||++++||++ |..||.... ..
T Consensus 165 ~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----------------------------~~ 215 (266)
T cd05033 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----------------------------NQ 215 (266)
T ss_pred ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----------------------------HH
Confidence 122345678999999998899999999999999999998 888875322 01
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
............ ..+......+.+++.+|++.+|++||++.||++.|+.
T Consensus 216 ~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 216 DVIKAVEDGYRL----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred HHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111111110000 1111223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=315.45 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=200.0
Q ss_pred CCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
+.+.||+|+||.||+|...++..+|+|.+.... .....|.+|++++++++|+||+++++++...+..++|+||+++++|
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 457799999999999998877789999986433 2345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++......+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++..............+
T Consensus 87 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05059 87 LNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163 (256)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCC
Confidence 99998766679999999999999999999999 999999999999999999999999999997654332222122234
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
+..|+|||++.+..++.++||||||+++|||++ |+.||.... . .......
T Consensus 164 ~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------------------------~----~~~~~~~ 214 (256)
T cd05059 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-------------------------N----SEVVESV 214 (256)
T ss_pred CccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-------------------------H----HHHHHHH
Confidence 568999999999999999999999999999999 788875322 0 0001111
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
. .. . ....+......+.+++.+|++.+|++||||.||+++|.
T Consensus 215 ~-~~-----~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 215 S-AG-----Y----RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred H-cC-----C----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1 10 0 01111123456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.82 Aligned_cols=244 Identities=27% Similarity=0.445 Sum_probs=206.8
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
..||+|.||.||||+-+. .+.||+|.+.+.. ....+.+.+|+++++.++|||||.++++|+...+.++|.||+.+ +
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 569999999999999864 7889999987543 33456788999999999999999999999999999999999977 9
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|..+|...+ .++++.+..|+.+++.||.|||+ .+|+|||+||.||||+.++.+|++|||+|+.+... ....+.+.
T Consensus 87 L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsik 161 (808)
T KOG0597|consen 87 LFTILEQDG-KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSIK 161 (808)
T ss_pred HHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-ceeeeecc
Confidence 999997765 59999999999999999999999 99999999999999999999999999999987654 34457789
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
||+.|||||.+.+.+|+..+|+||+||+|||++.|++||.... +...+...
T Consensus 162 GtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----------------------------i~~Lv~~I 212 (808)
T KOG0597|consen 162 GTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----------------------------ITQLVKSI 212 (808)
T ss_pred CcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----------------------------HHHHHHHH
Confidence 9999999999999999999999999999999999999997543 22222222
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhcc
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEG 677 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~--~L~~ 677 (745)
..+.. ..+......+..++.-.+++||..|-|..+++. +.++
T Consensus 213 ~~d~v-----------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 213 LKDPV-----------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred hcCCC-----------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 22111 123344567888889999999999999999983 4555
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=313.27 Aligned_cols=246 Identities=30% Similarity=0.412 Sum_probs=197.1
Q ss_pred CccccCceeEEEEEEC-CCcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 389 PIGSGGFGTVYKGILQ-DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5999999999999985 6889999987643 2344567999999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc-ccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF-TTMRG 545 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~~g 545 (745)
+++......+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........... .....
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9997766678999999999999999999998 9999999999999999999999999999876543211111 11223
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
+..|+|||.+.++.++.++||||||+++|||++ |..||.... . ......
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~-------------------------~-----~~~~~~ 208 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS-------------------------N-----QQTREA 208 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC-------------------------H-----HHHHHH
Confidence 467999999999899999999999999999998 777774321 0 000111
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
... ......+......+.+++.+|++.+|++|||+.+|+++|+
T Consensus 209 ~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 209 IEQ---------GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHc---------CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111 0111122223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=310.68 Aligned_cols=266 Identities=29% Similarity=0.404 Sum_probs=199.7
Q ss_pred CCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHcc--CCCCceeeEEEEEEeCC----eeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGN--IHHVNLVRLKGFCAQGR----QRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~g~~~~~~----~~~lV~e~~ 460 (745)
...||+|.||.||||.+.+ +.||||++. .+..+.|++|-++++. ++|+||+++++.-.... +++||++|.
T Consensus 215 ~eli~~Grfg~V~KaqL~~-~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDN-RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhccC-ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 3569999999999999976 789999985 3667889999888776 48999999999876665 889999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhC------CCCceeecCCCCCCeeecCCCCeEEccCCCcccCCC
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG------CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
++|+|.+||..+ .++|....+|+..+++||+|||+. ..+.|+|||||++||||.+++++.|+|||+|..+..
T Consensus 291 ~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 291 PKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred cCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 999999999776 699999999999999999999973 346799999999999999999999999999998876
Q ss_pred CCcc-cccccccccCccCcccccCCC-CC-----CccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCC
Q 004565 535 EQSS-LFTTMRGTRGYLAPEWLTSSA-IS-----DKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSS 607 (745)
Q Consensus 535 ~~~~-~~~~~~gt~~y~aPE~~~~~~-~t-----~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (745)
.... .....+||.+|||||++.+.. +. .+.||||+|.|||||++.-.-+.... +++-.
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~---------------vp~Yq 433 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP---------------VPEYQ 433 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC---------------CCccc
Confidence 5433 234478999999999997752 22 47999999999999999775443210 00111
Q ss_pred CCccc---ccccHHHHHHHHHhhccccccccccccCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 608 SPRES---QRVYFPLLALELHEQRRYLELADSRIEGQ-VSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 608 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
.|.+. ....+...-.-...++. .|.+... .....+..+.+.+..||..||+.|-|+.=|.+.+...
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~-----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQ-----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhcc-----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 11111 11111111111111111 1111111 0124567888999999999999999999998888763
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=315.96 Aligned_cols=250 Identities=27% Similarity=0.438 Sum_probs=205.8
Q ss_pred cCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.++||.|+||.||+|...++..+++|.+.........++..|+.+++.++|+||+++++++......++||||+++++
T Consensus 9 ~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (261)
T cd05148 9 TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGS 88 (261)
T ss_pred HHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCC
Confidence 34477999999999999998899999999986665567789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 465 LDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 465 L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+||++++++.+||+|||++......... ....
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 164 (261)
T cd05148 89 LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSDK 164 (261)
T ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccCC
Confidence 999997643 468999999999999999999999 99999999999999999999999999999876443222 2234
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
.++..|+|||.+....++.++||||||+++++|++ |+.||.... ......
T Consensus 165 ~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----------------------------~~~~~~ 215 (261)
T cd05148 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----------------------------NHEVYD 215 (261)
T ss_pred CCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----------------------------HHHHHH
Confidence 46778999999988899999999999999999998 788885422 000001
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.... ......+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 216 ~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 216 QITA----------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHh----------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111 01111122334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.48 Aligned_cols=245 Identities=25% Similarity=0.327 Sum_probs=195.8
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||++.. .+++.||||.+.... ......+.+|++++.+++|+|++++++++.+.+..++|+||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g 85 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence 6799999999999997 568999999986432 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|..++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++........ ...
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 160 (285)
T cd05631 86 DLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRG 160 (285)
T ss_pred cHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--ecC
Confidence 9998886433 368999999999999999999999 9999999999999999999999999999987543221 234
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||..|+|||++.+..++.++|||||||++|||++|+.||..... .. ......
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-------------------------~~-~~~~~~ 214 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE-------------------------RV-KREEVD 214 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc-------------------------ch-hHHHHH
Confidence 5689999999999999999999999999999999999999975320 00 000000
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS-----MANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~ev~~ 673 (745)
...... ...++......+.+|+..||+.||++||+ ++++++
T Consensus 215 ~~~~~~----------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 215 RRVKED----------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHhhcc----------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 000000 01112222346788999999999999997 777774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=318.30 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=200.7
Q ss_pred CCCCccccCceeEEEEEECCC------cEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 386 FNTPIGSGGFGTVYKGILQDK------SVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
+.+.||+|+||.||+|..... ..||+|.+.... ......|.+|++++.+++|+||+++++++......+++||
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEe
Confidence 347799999999999987432 579999986433 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEE
Q 004565 459 YMNKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKI 523 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl 523 (745)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEEE
Confidence 999999999986431 358899999999999999999999 99999999999999999999999
Q ss_pred ccCCCcccCCCCCc-ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCC
Q 004565 524 SDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGN 601 (745)
Q Consensus 524 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 601 (745)
+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-------------- 231 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-------------- 231 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--------------
Confidence 99999986543322 12234456788999999998899999999999999999998 998886432
Q ss_pred CCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 602 GPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.... ......+.. ...+......+.+|+.+||+.+|++||++.||++.|++
T Consensus 232 ---------------~~~~-~~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 232 ---------------NQEV-IEMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---------------HHHH-HHHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0000 111111111 11223344678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.12 Aligned_cols=242 Identities=23% Similarity=0.307 Sum_probs=194.6
Q ss_pred ccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
||+|+||.||++... ++..||+|++... .......+..|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999985 4788999998642 233456788899999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++...+ .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 99997653 58999999999999999999999 999999999999999999999999999997543322 22244679
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
|+.|+|||.+.+..++.++|||||||++|||++|+.||.... .........
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----------------------------~~~~~~~~~ 206 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----------------------------VNEMYRKIL 206 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----------------------------HHHHHHHHH
Confidence 999999999999999999999999999999999999986432 111111111
Q ss_pred hhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
.. . . .++......+.+++..||+.||++||++..+.+.|+
T Consensus 207 ~~-~------~----~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 207 QE-P------L----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cC-C------C----CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 10 0 0 111222345778999999999999986544444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=317.68 Aligned_cols=238 Identities=31% Similarity=0.467 Sum_probs=202.8
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
..||+|.||.||||... .++.||+|++... .....+++++|+.+|.+++++||.+++|.+..+...+++|||+.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 55999999999999975 4889999999743 344567889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+.|.... .+++..+.-|..++..||.|||. .+.+|||||+.|||+.+++.+||+|||++..+....... .+++|
T Consensus 99 ~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvG 173 (467)
T KOG0201|consen 99 LDLLKSGN-ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVG 173 (467)
T ss_pred hhhhccCC-CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccccc
Confidence 99997653 45788888899999999999999 999999999999999999999999999998877655444 67899
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
|+.|||||++....|+.|+||||||++.+||++|.+|+.....
T Consensus 174 TPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------------------------- 216 (467)
T KOG0201|consen 174 TPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------------------------- 216 (467)
T ss_pred cccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-------------------------------------
Confidence 9999999999988999999999999999999999999865431
Q ss_pred hhccccccc----cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 626 EQRRYLELA----DSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 626 ~~~~~~~~~----d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.++.-++ .|.+.+ .....+.+++..||+.+|+.||++.++++
T Consensus 217 --mrvlflIpk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 217 --MRVLFLIPKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --ceEEEeccCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 0111111 223333 33345888999999999999999999984
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=317.88 Aligned_cols=251 Identities=28% Similarity=0.465 Sum_probs=201.7
Q ss_pred hcCCCCccccCceeEEEEEECC------CcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEE
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD------KSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLV 456 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV 456 (745)
..+.+.||+|+||.||+|...+ +..||||.+...... ..+.+.+|+++++.++|+|++++++++......++|
T Consensus 7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 86 (280)
T cd05049 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMV 86 (280)
T ss_pred hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEE
Confidence 3445779999999999998743 478999998765444 467899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCC-------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEE
Q 004565 457 YEYMNKGSLDRTLFGNG-------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKI 523 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl 523 (745)
|||+++++|.+++...+ ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEEE
Confidence 99999999999997542 258899999999999999999998 89999999999999999999999
Q ss_pred ccCCCcccCCCCCc-ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCC
Q 004565 524 SDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGN 601 (745)
Q Consensus 524 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 601 (745)
+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-------------- 229 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-------------- 229 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--------------
Confidence 99999976533221 11223345788999999999999999999999999999998 998885432
Q ss_pred CCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 602 GPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
..... .....+... ..+......+.+++..||+.+|++||++.||+++|+
T Consensus 230 ---------------~~~~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 230 ---------------NEEVI-ECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---------------HHHHH-HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00111 111111111 111122356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.45 Aligned_cols=241 Identities=23% Similarity=0.261 Sum_probs=195.3
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||++... +++.||||++... .......+..|++++++++|+||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 35999999999999974 6889999998743 2233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 9999887653 68999999999999999999999 999999999999999999999999999987533221 122445
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .......
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----------------------------~~~~~~~ 206 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----------------------------HEKLFEL 206 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----------------------------HHHHHHH
Confidence 79999999999999999999999999999999999999986432 0000001
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
. .... . .++......+.+++.+||+.||++|| ++.++++
T Consensus 207 ~-~~~~------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 207 I-LMEE------I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred H-HcCC------C----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1 1000 0 11122234578899999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=323.80 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=197.8
Q ss_pred CCCccccCceeEEEEEEC-CCc----EEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKS----VVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.||+|+||.||+|++. ++. .||||+++... ....+++..|+.+++.++|+||++++|+|... ..++|+||+
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~ 90 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 90 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence 477999999999999864 333 38999987433 34467889999999999999999999999764 567999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc-
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL- 539 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~- 539 (745)
++|+|.+++......+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 91 ~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (316)
T cd05108 91 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167 (316)
T ss_pred CCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCCccee
Confidence 9999999998776679999999999999999999999 999999999999999999999999999998765433221
Q ss_pred ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 168 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----------------------------~~ 218 (316)
T cd05108 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----------------------------AS 218 (316)
T ss_pred ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----------------------------HH
Confidence 122334678999999999999999999999999999998 888885422 01
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
... ........ ...+......+.+++..|++.+|++||++.+|+..|...
T Consensus 219 ~~~-~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 219 EIS-SILEKGER---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred HHH-HHHhCCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 11111100 001111224578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.78 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=200.2
Q ss_pred cCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||+++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (260)
T cd05070 9 QLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (260)
T ss_pred hhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence 44578999999999999998888899999875433 3567999999999999999999999885 456789999999999
Q ss_pred hhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 465 LDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 465 L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
|.+++.... ..+++..++.++.+++.||+|||+ .+++|+||||+||++++++.+||+|||++..+...........
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 87 LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence 999997643 358999999999999999999999 8999999999999999999999999999987654332222233
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
.++..|+|||++.+..++.++||||||++++||++ |..||.... ......
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----------------------------~~~~~~ 214 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----------------------------NREVLE 214 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----------------------------HHHHHH
Confidence 45678999999988899999999999999999999 888875322 001111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.. ... .....+......+.+++.+|++.+|++|||+.+++++|+.
T Consensus 215 ~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 215 QV-ERG---------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HH-HcC---------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 110 0111122233568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.56 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=203.6
Q ss_pred HhhhcCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 381 AATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 381 ~at~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
..+..+.++||+|+||.||+|...+++.||+|.+.... .....+..|+.++++++|+|++++++++. ....++|+||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 44556678899999999999999899999999987543 34567899999999999999999999874 45689999999
Q ss_pred CCCChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc
Q 004565 461 NKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 461 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 9999999986543 468999999999999999999998 999999999999999999999999999998765333222
Q ss_pred ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....++..|+|||++....++.++||||||++++||++ |+.||.... .+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----------------------------~~ 210 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----------------------------NP 210 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----------------------------hH
Confidence 233456788999999998889999999999999999999 998885332 11
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
...... ..... ...+......+.+++.+|++.+|++||++++|+++|+.
T Consensus 211 ~~~~~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 211 EVIQNL-ERGYR---------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHH-HcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111 11100 01111123468899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.05 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=206.4
Q ss_pred CCCccccCceeEEEEEE-CCC----cEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGIL-QDK----SVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.++||+|+||+||||.+ +.+ -+||||++... ..+...++++|+-.|.+++|+|+++|+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 47799999999999997 333 47999998754 4455788999999999999999999999998766 78999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
+.|+|.+|++..+..+--+..+.|..|||+||.|||. +.++||||.++|||+..-..+||.|||+++.+..+.....
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9999999999988899999999999999999999998 9999999999999999999999999999998877654322
Q ss_pred -cccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 541 -TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 541 -~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
....-.+.|||-|.+....+|.++|||||||.+||++| |.+|.+... ..
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----------------------------~~ 907 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----------------------------AE 907 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----------------------------HH
Confidence 23344678999999999999999999999999999998 888876543 11
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
+ +.+++....+-..++-+...+..++..||..|++.||+++++.+.+..
T Consensus 908 e----------I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 908 E----------IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred H----------hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 1 111111111223445556678899999999999999999999877655
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=292.87 Aligned_cols=193 Identities=27% Similarity=0.385 Sum_probs=176.3
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||.|+||.|.+++.+ +|..+|+|++.+.. ....+...+|-.+|+.+.||.++++.+.+.+.+..+|||||+++
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 467999999999999985 47899999997532 33456677899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|.|..+|+..+ +++...+.-+|.+|+.||+|||+ ..|++||+||+|||||.+|.+||+|||+|+..... +-+
T Consensus 129 GElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~T 200 (355)
T KOG0616|consen 129 GELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TWT 200 (355)
T ss_pred ccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc----EEE
Confidence 99999998765 59999999999999999999999 99999999999999999999999999999977654 367
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
..||+.|+|||.+....+...+|.|+|||++|||+.|..||....
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 899999999999999999999999999999999999999998665
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.55 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=195.9
Q ss_pred CccccCceeEEEEEEC---CCcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 389 PIGSGGFGTVYKGILQ---DKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.||+|+||.||+|.+. .+..||+|.+..... ...+.|.+|+.++++++|+||+++++++. ....++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 355799999875432 33467899999999999999999999885 456799999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc--ccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL--FTT 542 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--~~~ 542 (745)
|.+++......+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999998766679999999999999999999999 899999999999999999999999999998654433221 122
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
..++..|+|||.+....++.++||||||+++|||++ |..||.... .....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----------------------------~~~~~ 208 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-----------------------------GPEVM 208 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-----------------------------HHHHH
Confidence 234578999999988889999999999999999996 998886432 01111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.....+. ....+......+.+++..|++.+|++||++.+|.+.|+.
T Consensus 209 -~~~~~~~---------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 209 -SFIEQGK---------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred -HHHHCCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 1111111 111222334567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=319.04 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=215.1
Q ss_pred cCCCCccccCceeEEEEEECC---C--cEEEEEEecc-CCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 385 NFNTPIGSGGFGTVYKGILQD---K--SVVAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~---~--~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
..+..||.|-||.||+|.+.+ | -.||||..+. ......+.|+.|..+++.++||||++++|+|.+. ..++|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 344679999999999999743 2 3588998875 4455678899999999999999999999999874 4689999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
.++.|.|..||..+...|+......++.||..||+|||+ ...|||||.++|||+.....+||+|||+++.+......
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 999999999999988899999999999999999999999 99999999999999999999999999999999887777
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
..+...-+..|||||.+...++|..+|||.|||++||++. |.+||..-...
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------------------- 599 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------------------- 599 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------------------
Confidence 6677777889999999999999999999999999999986 99999765411
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.+..-+...-+-..++.+...|..++.+||..+|.+||++.|+...|+.
T Consensus 600 -----------DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 600 -----------DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred -----------ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 1122222223335566777889999999999999999999999887765
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.80 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=197.7
Q ss_pred CCCCccccCceeEEEEEECC------CcEEEEEEeccCC-cchHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEE
Q 004565 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKINSFG-IQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 457 (745)
+.++||+|+||.||+|+... +..||||++.... ....+.+..|+++++++. ||||++++++|.+....++||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 44789999999999998632 3469999997433 233567899999999995 999999999999999999999
Q ss_pred eecCCCChhhhhcCCC----------------------------------------------------------------
Q 004565 458 EYMNKGSLDRTLFGNG---------------------------------------------------------------- 473 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~---------------------------------------------------------------- 473 (745)
||+++|+|.++|....
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 9999999998876421
Q ss_pred -------------------------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeE
Q 004565 474 -------------------------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVK 522 (745)
Q Consensus 474 -------------------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~k 522 (745)
..+++..++.++.||++||+|||+ .+|+|+||||+|||++.++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEE
Confidence 247888899999999999999999 9999999999999999999999
Q ss_pred EccCCCcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCC
Q 004565 523 ISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDG 600 (745)
Q Consensus 523 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 600 (745)
|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~------------ 345 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV------------ 345 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch------------
Confidence 9999999865433221 1123346788999999999899999999999999999997 8888754320
Q ss_pred CCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 601 NGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
..........+. ....+......+.+++.+||+.+|++||++.+|+++|+.
T Consensus 346 -----------------~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 346 -----------------DSTFYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred -----------------hHHHHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 000001111110 011112234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=319.51 Aligned_cols=196 Identities=25% Similarity=0.382 Sum_probs=170.1
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 467999999999999986 57889999987432 233567889999999999999999999999999999999999988
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
.|..+.. ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++..............
T Consensus 86 ~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (287)
T cd07848 86 MLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161 (287)
T ss_pred HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccccc
Confidence 7765543 33468999999999999999999999 9999999999999999999999999999987654433333455
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 7899999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=309.86 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=195.4
Q ss_pred CccccCceeEEEEEEC---CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 389 PIGSGGFGTVYKGILQ---DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+||+|+||.||+|.+. ++..+|+|+++... ....+++..|+.+++.++|+||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57789999986433 234567899999999999999999999885 45678999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc--cc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL--FT 541 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--~~ 541 (745)
+|.+++.... .+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999986543 68999999999999999999999 999999999999999999999999999998765443221 12
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
...++..|+|||.+....++.++||||||+++|||++ |+.||.... ....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----------------------------~~~~ 207 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----------------------------GNEV 207 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----------------------------HHHH
Confidence 2334678999999988889999999999999999998 888886432 0011
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
. .....+. ....+......+.+++.+|++.+|++||+|.+|++.|++
T Consensus 208 ~-~~i~~~~---------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 208 T-QMIESGE---------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred H-HHHHCCC---------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1 1111111 111122233567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.42 Aligned_cols=250 Identities=28% Similarity=0.467 Sum_probs=202.2
Q ss_pred CCCccccCceeEEEEEEC------CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++......++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 467999999999999853 34568999987666566678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEcc
Q 004565 461 NKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525 (745)
Q Consensus 461 ~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~D 525 (745)
++++|.+++.... ..+++..++.++.||+.||+|||+ ++++||||||+||+++.++.+||+|
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~d 166 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGD 166 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEECC
Confidence 9999999986432 248999999999999999999998 9999999999999999999999999
Q ss_pred CCCcccCCCCCc-ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCC
Q 004565 526 FGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGP 603 (745)
Q Consensus 526 fgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 603 (745)
||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---------------- 230 (291)
T cd05094 167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS---------------- 230 (291)
T ss_pred CCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----------------
Confidence 999976544322 12233456788999999999999999999999999999999 888875432
Q ss_pred CCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 604 SSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
... .......+.... .+......+.+++.+|++.+|++||++.+|+++|+..
T Consensus 231 -------------~~~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 231 -------------NTE-VIECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -------------HHH-HHHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 000 111111111111 1111234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.78 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=200.5
Q ss_pred hcCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 384 DNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
..+.++||+|+||.||+|+..+...||+|++.... ...+.|..|++++++++|+||+++++++.+ ...++||||++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~ 85 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 85 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCC
Confidence 44567899999999999998877789999987533 235678999999999999999999998754 5578999999999
Q ss_pred ChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 9999997543 368999999999999999999999 999999999999999999999999999998665443322233
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
..++..|+|||+..+..++.++||||||+++|||++ |..||.... . .. .
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-------------------------~----~~-~ 212 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------------------N----RE-V 212 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------------------------h----HH-H
Confidence 456778999999998899999999999999999999 777775321 0 00 0
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
........ ....+......+.+++.+|++.+|++||++.+++++|+.
T Consensus 213 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 213 LDQVERGY---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred HHHHhcCC---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 11111100 011122344568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.76 Aligned_cols=241 Identities=24% Similarity=0.273 Sum_probs=195.1
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||++... ++..||||++... .......+..|+++++.++|+||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999975 5889999998743 2334567888999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 9998886543 68999999999999999999999 999999999999999999999999999987543222 122345
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----------------------------~~~~~~ 206 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------------------------EKLFEL 206 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----------------------------HHHHHH
Confidence 799999999999998999999999999999999999999864320 000000
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
. ... +..+ +......+.+++.+||+.||++|| ++.|+++
T Consensus 207 ~-~~~------~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 207 I-LME------DIKF----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred h-ccC------CccC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 0 000 0111 112234577899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.01 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=200.5
Q ss_pred CCCCccccCceeEEEEEEC------CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 386 FNTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+.+.||+|+||.||++... ++..+|+|.+........+.+..|++++++++|+||+++++++......++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 3477999999999999852 3456899998766656677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCC
Q 004565 460 MNKGSLDRTLFGNG------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFG 527 (745)
Q Consensus 460 ~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfg 527 (745)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccCC
Confidence 99999999986432 258999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCC
Q 004565 528 LSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSS 605 (745)
Q Consensus 528 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 605 (745)
++......... ......++..|+|||.+.+..++.++||||||++++||++ |..||....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~------------------ 227 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------------------ 227 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------------------
Confidence 99865433221 1223345778999999998899999999999999999998 888875432
Q ss_pred CCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 606 SSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.... ......+.... ..... ...+.+++.+|++.+|.+|||+.||++.|+.
T Consensus 228 -----------~~~~-~~~i~~~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 228 -----------NNEV-IECITQGRVLQ-----RPRTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278 (288)
T ss_pred -----------HHHH-HHHHHcCCcCC-----CCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 0000 01111111100 11112 2458899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.07 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=198.6
Q ss_pred cCCCCccccCceeEEEEEE-----CCCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 385 NFNTPIGSGGFGTVYKGIL-----QDKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
.+.+.||+|+||.||+|.+ ..+..|++|.+.... ......+..|++++++++|+||+++++++......++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 87 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE 87 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence 3457899999999999985 245789999987433 3344678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCC----------------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeE
Q 004565 459 YMNKGSLDRTLFGN----------------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVK 522 (745)
Q Consensus 459 ~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~k 522 (745)
|+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+|||+++++.+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEE
Confidence 99999999998532 1257899999999999999999999 8999999999999999999999
Q ss_pred EccCCCcccCCCCCc-ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCC
Q 004565 523 ISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDG 600 (745)
Q Consensus 523 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 600 (745)
|+|||+++....... .......++..|+|||++.+..++.++||||||++++||++ |..||....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~------------- 231 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS------------- 231 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-------------
Confidence 999999986644322 12233445778999999988889999999999999999998 887875321
Q ss_pred CCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 601 NGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.............. ..+......+.+++.+|++.+|++||++.+|+++|.+
T Consensus 232 -----------------~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 -----------------NQEVIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----------------HHHHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00011111111111 0111123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=313.20 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=195.4
Q ss_pred CCCccccCceeEEEEEEC-CCc----EEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKS----VVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.||+|+||.||+|.+. ++. .+++|++..... ....++..|+..++++.|+||+++++++.. ...++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeC
Confidence 467999999999999974 344 477787754322 234567788889999999999999998864 4577899999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-c
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-L 539 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~ 539 (745)
++|+|.+++......+++..++.|+.||+.||+|||+ .+++|+||||+|||+++++.+||+|||+++........ .
T Consensus 91 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T cd05111 91 PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167 (279)
T ss_pred CCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccc
Confidence 9999999998766679999999999999999999999 99999999999999999999999999999876443221 2
Q ss_pred ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....++..|+|||++.++.++.++||||||+++|||++ |+.||.... +
T Consensus 168 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~------------------------------~ 217 (279)
T cd05111 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR------------------------------P 217 (279)
T ss_pred cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC------------------------------H
Confidence 234557789999999998899999999999999999998 888885432 0
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
....+....+... ..+. . ....+.+++..|++.+|++|||+.|+++.|...
T Consensus 218 ~~~~~~~~~~~~~--~~~~---~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 218 HEVPDLLEKGERL--AQPQ---I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred HHHHHHHHCCCcC--CCCC---C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0011111111110 1111 1 123467888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=320.83 Aligned_cols=248 Identities=22% Similarity=0.266 Sum_probs=198.3
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|++++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 367999999999999986 48899999987432 23456788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..... ....
T Consensus 86 ~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~ 157 (333)
T cd05600 86 GDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANS 157 (333)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCC
Confidence 99999997543 58899999999999999999999 9999999999999999999999999999986543 2245
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----------------------------~~~~~ 208 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-----------------------------NETWE 208 (333)
T ss_pred cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-----------------------------HHHHH
Confidence 5789999999999999999999999999999999999999864320 00000
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
....... .+...............+.+++..|++.+|.+||++.+|++.
T Consensus 209 ~i~~~~~---~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 209 NLKYWKE---TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHhccc---cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1110000 000000000001223567788899999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.70 Aligned_cols=250 Identities=27% Similarity=0.475 Sum_probs=200.2
Q ss_pred CCCccccCceeEEEEEECC-C---cEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 387 NTPIGSGGFGTVYKGILQD-K---SVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
.+.||+|+||.||+|++.. + ..+|+|++... .....+.+..|++++++++|+|++++.+++...+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 4779999999999999853 3 37999988644 23345678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+++|.+++......+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++............
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 166 (268)
T cd05063 90 NGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166 (268)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccccccee
Confidence 999999998766679999999999999999999999 89999999999999999999999999999866543222111
Q ss_pred --ccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 542 --TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 542 --~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
....+..|+|||++....++.++||||||+++|||++ |+.||.... ..
T Consensus 167 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-----------------------------~~ 217 (268)
T cd05063 167 TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-----------------------------NH 217 (268)
T ss_pred ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-----------------------------HH
Confidence 1223457999999998889999999999999999997 999885322 01
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
........... ..........+.+++.+|++.+|++||+|.+|++.|++.
T Consensus 218 ~~~~~i~~~~~----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 218 EVMKAINDGFR----------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHhcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111111100 011112235688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.43 Aligned_cols=193 Identities=26% Similarity=0.376 Sum_probs=171.2
Q ss_pred cCCCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 34478999999999999985 5889999998642 2234567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
++++|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 172 (329)
T PTZ00263 101 VGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---- 172 (329)
T ss_pred CCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----
Confidence 9999999997654 58899999999999999999999 999999999999999999999999999998664332
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 235689999999999999999999999999999999999999864
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=318.82 Aligned_cols=241 Identities=24% Similarity=0.272 Sum_probs=194.2
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||++... ++..||+|++... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 35999999999999974 5889999998743 2234556778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 9998886543 68999999999999999999999 999999999999999999999999999987543222 122345
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----------------------------~~~~~~~ 206 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----------------------------HERLFEL 206 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-----------------------------HHHHHHH
Confidence 68999999999999999999999999999999999999986432 0000001
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
... .. .. ++......+.+++..||+.||++|| ++.++++
T Consensus 207 ~~~-~~------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 207 ILM-EE------IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred Hhc-CC------CC----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 100 00 01 1112234577899999999999998 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.02 Aligned_cols=197 Identities=27% Similarity=0.442 Sum_probs=169.3
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.++||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~- 87 (288)
T cd07871 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS- 87 (288)
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence 3477999999999999975 57899999986432 23345678999999999999999999999999999999999975
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++...+..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 88 ~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~~ 163 (288)
T cd07871 88 DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNE 163 (288)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cccCc
Confidence 8999887766678999999999999999999999 9999999999999999999999999999976543221 12345
Q ss_pred ccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 544 RGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 544 ~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
.++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 67999999998865 568999999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.26 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=197.0
Q ss_pred cCCCCccccCceeEEEEEEC------CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 457 (745)
.+.+.||+|+||.||+|... .+..||||++.... .....+|.+|+.+++.++|+||+++++++..+...++|+
T Consensus 9 ~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 88 (277)
T cd05062 9 TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 88 (277)
T ss_pred eeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEE
Confidence 34578999999999999863 24679999886432 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCC---------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCC
Q 004565 458 EYMNKGSLDRTLFGNG---------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL 528 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl 528 (745)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 89 ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCCC
Confidence 9999999999986532 246788999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCC
Q 004565 529 SKLLTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSS 606 (745)
Q Consensus 529 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 606 (745)
+.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~------------------- 226 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS------------------- 226 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-------------------
Confidence 87654332211 122345778999999998899999999999999999999 677775322
Q ss_pred CCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
..... ......... ..+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 227 ----------~~~~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 227 ----------NEQVL-RFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----------HHHHH-HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00111 111111110 1111223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.82 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=197.2
Q ss_pred cCCCCccccCceeEEEEEEC------CCcEEEEEEeccCC-cchHHHHHHHHHHHccC-CCCceeeEEEEEEeC-CeeEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFG-IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQG-RQRFL 455 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~-~~~~l 455 (745)
.+.++||+|+||.||+|... .++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... ...++
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~ 89 (337)
T cd05054 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMV 89 (337)
T ss_pred hhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEE
Confidence 34578999999999999743 24689999987433 23345678899999999 899999999988654 56789
Q ss_pred EEeecCCCChhhhhcCCC------------------------------------------------------------cc
Q 004565 456 VYEYMNKGSLDRTLFGNG------------------------------------------------------------SV 475 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~------------------------------------------------------------~~ 475 (745)
++||+++++|.+++.... ..
T Consensus 90 v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (337)
T cd05054 90 IVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEP 169 (337)
T ss_pred EEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcC
Confidence 999999999998885321 25
Q ss_pred cCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc-ccccccccCccCccc
Q 004565 476 LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL-FTTMRGTRGYLAPEW 554 (745)
Q Consensus 476 l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~ 554 (745)
++|..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++..+....... .....++..|+|||+
T Consensus 170 l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 170 LTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 8999999999999999999998 999999999999999999999999999998764433221 233456778999999
Q ss_pred ccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhcccccc
Q 004565 555 LTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLEL 633 (745)
Q Consensus 555 ~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (745)
+.+..++.++|||||||+|+||++ |..||.... .. .... .....+..
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~-------------------------~~---~~~~-~~~~~~~~--- 294 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-------------------------ID---EEFC-RRLKEGTR--- 294 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC-------------------------cc---HHHH-HHHhccCC---
Confidence 999999999999999999999998 888875321 00 0000 11111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 634 ADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 634 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
...+......+.+++.+|++.+|++||++.||+++|+..
T Consensus 295 ------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 295 ------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred ------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011122335688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=307.39 Aligned_cols=249 Identities=28% Similarity=0.418 Sum_probs=198.9
Q ss_pred cCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+...||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. ....++||||+++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05069 9 RLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS 86 (260)
T ss_pred eeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence 3456799999999999999887789999876433 33567889999999999999999999875 456789999999999
Q ss_pred hhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 465 LDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 465 L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++..............
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 87 LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 999997643 358999999999999999999998 8999999999999999999999999999987644332222334
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
.++..|+|||++.+..++.++||||||+++|||++ |+.||.... .... .
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----------------------------~~~~-~ 213 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----------------------------NREV-L 213 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----------------------------HHHH-H
Confidence 56778999999998899999999999999999999 888875322 0000 0
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
....... ....+......+.+++.+|++.+|++||++++|+++|+.
T Consensus 214 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 214 EQVERGY---------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHcCC---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111110 001122234568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=304.87 Aligned_cols=248 Identities=30% Similarity=0.411 Sum_probs=200.3
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
++||+|+||.||++...+++.|++|++...... ..+.+..|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999877999999998754433 5678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc-ccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF-TTMRG 545 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~~g 545 (745)
+++......+++..++.++.+++.||+|||+ ++++||||||+||+++.++.+||+|||++........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9997766678999999999999999999998 9999999999999999999999999999986543221111 12234
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
+..|+|||.+.++.++.++||||||++++||++ |..||.... ..... ..
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~-----------------------------~~~~~-~~ 207 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS-----------------------------NQQTR-ER 207 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC-----------------------------HHHHH-HH
Confidence 667999999998899999999999999999999 777775332 00000 11
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.... .....+......+.+++.+|++.+|++|||+.||++.|+.
T Consensus 208 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 208 IESG---------YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HhcC---------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 1100 0011122233568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=318.29 Aligned_cols=192 Identities=29% Similarity=0.414 Sum_probs=169.3
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (331)
T cd06649 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (331)
T ss_pred EeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcH
Confidence 67999999999999986 57889999887432 23356789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++....... .....|
T Consensus 91 ~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~g 164 (331)
T cd06649 91 DQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVG 164 (331)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cccCCC
Confidence 99987644 58999999999999999999997 2369999999999999999999999999997654322 234568
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred CcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.60 Aligned_cols=249 Identities=27% Similarity=0.466 Sum_probs=201.7
Q ss_pred cCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.+.||+|+||.||+|...++..+|+|.+.... .....|..|++++++++|+|++++++++......++|+||+++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 3457799999999999998778889999886433 335678999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++......+++..++.++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||++...............
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05112 86 LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK 162 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence 999998766678999999999999999999999 89999999999999999999999999998765433222222333
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
++.+|+|||++.++.++.++||||||+++|||++ |+.||.... .......
T Consensus 163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----------------------------~~~~~~~ 213 (256)
T cd05112 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----------------------------NSEVVET 213 (256)
T ss_pred cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----------------------------HHHHHHH
Confidence 5678999999998899999999999999999998 888886432 1111111
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
.... .....+.+ ....+.+++.+|++.+|++|||+.||+++|.
T Consensus 214 ~~~~---~~~~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 214 INAG---FRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HhCC---CCCCCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1111 01111111 2356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=311.98 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=199.7
Q ss_pred CCCCccccCceeEEEEEEC------CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 386 FNTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+..+||+|+||.||++... ++..+|+|.+..........+..|+++++.++|+||+++++++......++|+||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 3477999999999999742 3567999998766666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC--------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEcc
Q 004565 460 MNKGSLDRTLFGNG--------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525 (745)
Q Consensus 460 ~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~D 525 (745)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+|||+++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEECC
Confidence 99999999987543 258899999999999999999998 9999999999999999999999999
Q ss_pred CCCcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCC
Q 004565 526 FGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGP 603 (745)
Q Consensus 526 fgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 603 (745)
||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---------------- 229 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS---------------- 229 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC----------------
Confidence 9999765433221 1123345678999999999999999999999999999998 888875322
Q ss_pred CCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 604 SSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
....... ...+... ..+......+.+++.+||+.+|++||++.||++.|+.
T Consensus 230 -------------~~~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 230 -------------NTEAIEC-ITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -------------HHHHHHH-HHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0000111 1111100 1111123457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.85 Aligned_cols=240 Identities=22% Similarity=0.261 Sum_probs=195.7
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 3477999999999999985 58899999986422 2335668899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+++|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .
T Consensus 85 ~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----~ 156 (291)
T cd05612 85 GGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----W 156 (291)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc----c
Confidence 999999997654 58999999999999999999999 999999999999999999999999999998664321 2
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .....
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----------------------------~~~~~ 207 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----------------------------PFGIY 207 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------------------------HHHHH
Confidence 3568999999999999889999999999999999999999986432 00111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS-----MANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~ev~~ 673 (745)
... ..+.. .++......+.+++.+||+.||.+||+ ++|+++
T Consensus 208 ~~i-~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 208 EKI-LAGKL----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHH-HhCCc----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 111 11110 111122345788999999999999995 777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.03 Aligned_cols=237 Identities=26% Similarity=0.311 Sum_probs=187.2
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHH-HHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEI-TIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
++||+|+||.||+|+.. ++..||+|++.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999985 57899999986422 12234455555 467889999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|..++... ..+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9999888654 358888899999999999999998 999999999999999999999999999987543222 12244
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----------------------------~~~~~~ 206 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----------------------------VSQMYD 206 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----------------------------HHHHHH
Confidence 578999999999999899999999999999999999999986432 111111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA 669 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 669 (745)
.... .. ...+......+.+++.+|++.+|.+||++.
T Consensus 207 ~i~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 207 NILH-KP----------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHhc-CC----------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111 10 011222335688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=319.00 Aligned_cols=196 Identities=28% Similarity=0.424 Sum_probs=170.6
Q ss_pred cCCCCccccCceeEEEEEEC-CCcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
...++||+|+||.||++... ++..+|+|.+... .......+..|++++++++|+||+++++++...+..++||||+++
T Consensus 8 ~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (333)
T cd06650 8 EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (333)
T ss_pred heeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCC
Confidence 34478999999999999986 5788899987643 223456789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|.+++.... .+++..+..++.+++.||.|||+ ..+++|+||||+|||++.++.+||+|||++....... ...
T Consensus 88 ~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~~ 161 (333)
T cd06650 88 GSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 161 (333)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---ccc
Confidence 99999997643 58899999999999999999997 2479999999999999999999999999987653321 234
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 56899999999999888999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=307.58 Aligned_cols=250 Identities=29% Similarity=0.453 Sum_probs=202.6
Q ss_pred cCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.++||+|+||.||+|..+++..||||.+.... ...+++.+|+.++++++|+|++++++++......++||||+++++
T Consensus 9 ~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 9 KLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 3457899999999999999888899999987533 345779999999999999999999999999899999999999999
Q ss_pred hhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 465 LDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 465 L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
|.+++.... ..+++..+..++.+++.||.|||+ .+++|+||||+||++++++.+||+|||++..............
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 88 LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 999997654 478999999999999999999999 8999999999999999999999999999987654322222233
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..+..|+|||.+.+..++.++||||||++++||++ |+.||.... . .....
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-------------------------~----~~~~~ 215 (261)
T cd05034 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-------------------------N----REVLE 215 (261)
T ss_pred CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-------------------------H----HHHHH
Confidence 45678999999998899999999999999999998 888875322 0 00001
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
....... ...+......+.+++.+|++.+|++||++++|++.|+.
T Consensus 216 ~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 216 QVERGYR----------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHcCCC----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1110000 01111123468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.07 Aligned_cols=196 Identities=27% Similarity=0.397 Sum_probs=162.5
Q ss_pred CCCCccccCceeEEEEEEC--CCcEEEEEEeccCC--cchHHHHHHHHHHHccC---CCCceeeEEEEEEe-----CCee
Q 004565 386 FNTPIGSGGFGTVYKGILQ--DKSVVAVKKINSFG--IQGKKEFCTEITIIGNI---HHVNLVRLKGFCAQ-----GRQR 453 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~-----~~~~ 453 (745)
+.+.||+|+||.||+|+.. ++..||||++.... ......+..|+.+++.+ +||||++++++|.. ....
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 84 (290)
T cd07862 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84 (290)
T ss_pred eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence 4477999999999999873 46789999886432 22234566677666655 69999999999852 3457
Q ss_pred EEEEeecCCCChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccC
Q 004565 454 FLVYEYMNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 454 ~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
++|+||++ ++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred EEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 89999996 58988886543 358999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
... .......|+..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred cCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 433 22345568999999999988899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.65 Aligned_cols=241 Identities=24% Similarity=0.318 Sum_probs=193.6
Q ss_pred CCccccCceeEEEEEE----CCCcEEEEEEeccC----CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGIL----QDKSVVAVKKINSF----GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+.||+|+||.||+++. ..++.||||.+... .......+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999986 35788999998742 122345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
+++++|.+++...+ .+.+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 99999999987653 57888899999999999999999 9999999999999999999999999999875433221 2
Q ss_pred ccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----------------------------~~~ 207 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----------------------------RKK 207 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----------------------------HHH
Confidence 234578999999999998889999999999999999999999986432 001
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
...... .+.. ..+......+.+++.+|++.+|++|| +++++++
T Consensus 208 ~~~~~~-~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 208 TIDKIL-KGKL----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHH-cCCC----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111111 1110 11112234578999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=314.02 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=197.8
Q ss_pred CCCCccccCceeEEEEEECC------CcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
+.++||+|+||.||+|...+ +..||||++...... ..+.+..|+.++..++|+||+++++++......++++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEE
Confidence 34679999999999998743 468999999754332 34668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCC---------------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEE
Q 004565 459 YMNKGSLDRTLFGN---------------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKI 523 (745)
Q Consensus 459 ~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl 523 (745)
|+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceEe
Confidence 99999999998522 1258899999999999999999998 99999999999999999999999
Q ss_pred ccCCCcccCCCCCc-ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCC
Q 004565 524 SDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGN 601 (745)
Q Consensus 524 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 601 (745)
+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..||....
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------------- 231 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------------- 231 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------------
Confidence 99999886643322 12233456789999999988889999999999999999998 777765322
Q ss_pred CCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 602 GPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
..... ........ ...+......+.+++..|++.+|++||++.+|++.|+.
T Consensus 232 ---------------~~~~~-~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 232 ---------------NQDVI-EMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------------HHHHH-HHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 01111 11111111 01122234558899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=307.04 Aligned_cols=252 Identities=25% Similarity=0.442 Sum_probs=202.0
Q ss_pred hhhcCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 382 ATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 382 at~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
....+.+.||+|+||.||+|...++..+|+|.+.... .....+.+|++++++++|+|++++.+++.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 3445568899999999999998888889999886432 345678999999999999999999999887 77899999999
Q ss_pred CCChhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 462 KGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 462 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
+++|.+++... ...+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 99999999764 3468999999999999999999998 8999999999999999999999999999987654333222
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
....++..|+|||++....++.++||||||++++++++ |+.||.... ...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----------------------------~~~ 211 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----------------------------NPE 211 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----------------------------HHH
Confidence 33456678999999998889999999999999999999 888875422 000
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
. ......+... .........+.+++.+|++.+|++||++.+|+++|+.
T Consensus 212 ~-~~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 212 V-IRALERGYRM---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred H-HHHHhCCCCC---------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0111111100 1111223468899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=335.20 Aligned_cols=248 Identities=20% Similarity=0.243 Sum_probs=199.0
Q ss_pred hcCCCCccccCceeEEEEEEC-C-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 384 DNFNTPIGSGGFGTVYKGILQ-D-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.+.+.||+|+||.||+|... + +..||+|++..........+..|+++++.++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 344578999999999999864 3 56788887765554555678889999999999999999999999999999999999
Q ss_pred CCChhhhhcCC---CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc-
Q 004565 462 KGSLDRTLFGN---GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS- 537 (745)
Q Consensus 462 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 537 (745)
+|+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999888642 2368899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----------------------------~ 276 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----------------------------Q 276 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----------------------------H
Confidence 12345569999999999999999999999999999999999999986432 0
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
........ .+... ..+......+.+++..||+.+|++||++++++.
T Consensus 277 ~~~~~~~~-~~~~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 REIMQQVL-YGKYD---------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHH-hCCCC---------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01111111 11110 111122346889999999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.77 Aligned_cols=266 Identities=29% Similarity=0.413 Sum_probs=200.0
Q ss_pred CCCCccccCceeEEEEEEC-----CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEe--CCeeEEEEe
Q 004565 386 FNTPIGSGGFGTVYKGILQ-----DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ--GRQRFLVYE 458 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e 458 (745)
+.+.||+|+||.||++... ++..||||++........+.+..|++++++++|+||+++++++.. ....++|+|
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 3467999999999999853 477899999987666667789999999999999999999998754 346789999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++++|.+++......+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 88 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 164 (284)
T cd05081 88 YLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164 (284)
T ss_pred ecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCCCcc
Confidence 999999999997766679999999999999999999999 99999999999999999999999999999876543321
Q ss_pred c--ccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 539 L--FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 539 ~--~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
. .....++..|+|||++.+..++.++||||||++++||++|..++...... . ....+... .....
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~---~~~~~~~~--------~~~~~ 231 (284)
T cd05081 165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--F---MRMMGNDK--------QGQMI 231 (284)
T ss_pred eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--h---hhhccccc--------ccccc
Confidence 1 11223445699999999888999999999999999999987765432100 0 00000000 00000
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.... ....... .....+......+.+++.+|++.+|++||||.||++.|+.
T Consensus 232 ~~~~-~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 232 VYHL-IELLKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred hHHH-HHHHhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 0011 1111111 0001111223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=312.76 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=199.3
Q ss_pred CCCccccCceeEEEEEECC------CcEEEEEEeccC-CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGILQD------KSVVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 458 (745)
.+.||+|+||.||++...+ ...+|+|.+... ......++..|++++.++ +|+||+++++++......++|||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 4779999999999998743 357999988743 233456788999999999 89999999999999999999999
Q ss_pred ecCCCChhhhhcCC---------------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEE
Q 004565 459 YMNKGSLDRTLFGN---------------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKI 523 (745)
Q Consensus 459 ~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl 523 (745)
|+++|+|..++... ...+++..++.++.|++.||.|||+ .+|+|+||||+|||+++++.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeEEe
Confidence 99999999998632 2368999999999999999999998 99999999999999999999999
Q ss_pred ccCCCcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCC
Q 004565 524 SDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGN 601 (745)
Q Consensus 524 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 601 (745)
+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------------- 239 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------------- 239 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC--------------
Confidence 999999876543221 1223345678999999998899999999999999999998 888775322
Q ss_pred CCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 602 GPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
.... ......+. ....+......+.+++.+|++.+|++||||.||++.|+..
T Consensus 240 ---------------~~~~-~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 ---------------VEEL-FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---------------HHHH-HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111 11111111 1112222345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.49 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=200.8
Q ss_pred HHHhhhcCC--CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEE
Q 004565 379 LAAATDNFN--TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 379 l~~at~~f~--~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l 455 (745)
++.+++++. ..||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345566664 67999999999999965 577899999876666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccc--CHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-CCCeEEccCCCcccC
Q 004565 456 VYEYMNKGSLDRTLFGNGSVL--EWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-KLQVKISDFGLSKLL 532 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~~ 532 (745)
|+||+++++|.+++......+ ++..+..++.||+.||+|||+ .+|+|+||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998654445 888899999999999999998 99999999999999986 678999999999765
Q ss_pred CCCCcccccccccccCccCcccccCCC--CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCc
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLTSSA--ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPR 610 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (745)
..... ......++..|+|||++.... ++.++||||||+++|||++|+.||.....
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~---------------------- 216 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE---------------------- 216 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC----------------------
Confidence 43222 123345789999999986643 78899999999999999999999853210
Q ss_pred ccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 611 ESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.....+..... ......+......+.+++.+|++.+|.+|||+.||++
T Consensus 217 ----~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 217 ----PQAAMFKVGMF-----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----hhhhHhhhhhh-----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00000000000 0011122233456888999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.12 Aligned_cols=240 Identities=23% Similarity=0.289 Sum_probs=189.6
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|... .+..||||+++.. .....+.+..|..++..+ +|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999985 4788999998742 123344556677666654 899999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 99999887654 58999999999999999999999 999999999999999999999999999997654332 22345
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----------------------------~~~~~~ 206 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----------------------------EDELFD 206 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----------------------------HHHHHH
Confidence 678999999999999899999999999999999999999986432 001111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA-NVV 672 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-ev~ 672 (745)
..... .+ .++......+.+++..||+.+|++||++. +++
T Consensus 207 ~i~~~-------~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 207 SILND-------RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHcC-------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11110 01 11112234567888999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.86 Aligned_cols=239 Identities=23% Similarity=0.361 Sum_probs=189.7
Q ss_pred CccccCceeEEEEEECC-------------CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEE
Q 004565 389 PIGSGGFGTVYKGILQD-------------KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l 455 (745)
.||+|+||.||+|++.+ ...|++|.+..........|.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998642 22588898775554556678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCC-------eEEccCCC
Q 004565 456 VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ-------VKISDFGL 528 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~-------~kl~Dfgl 528 (745)
||||+++++|..++......+++..++.++.||++||+|||+ .+|+||||||+|||++.++. +|++|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 999999999999987766679999999999999999999999 99999999999999987664 89999999
Q ss_pred cccCCCCCcccccccccccCccCccccc-CCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCC
Q 004565 529 SKLLTPEQSSLFTTMRGTRGYLAPEWLT-SSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSS 606 (745)
Q Consensus 529 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 606 (745)
+...... ....++..|+|||.+. +..++.++||||||+++|||++ |+.|+....
T Consensus 159 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------------------- 214 (262)
T cd05077 159 PITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT------------------- 214 (262)
T ss_pred CccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-------------------
Confidence 8755332 2345788999999887 4668999999999999999984 776664321
Q ss_pred CCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
.... ..... ... . .... ....+.+++.+||+.||++||++.+|++.|+
T Consensus 215 ----------~~~~-~~~~~-~~~-~-----~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 215 ----------LAEK-ERFYE-GQC-M-----LVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ----------hhHH-HHHHh-cCc-c-----CCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 00000 000 0 0011 1245788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.52 Aligned_cols=263 Identities=25% Similarity=0.366 Sum_probs=198.4
Q ss_pred CCCCccccCceeEEEEEE-----CCCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEE
Q 004565 386 FNTPIGSGGFGTVYKGIL-----QDKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVY 457 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 457 (745)
+.+.||+|+||.||++.. .++..||+|.+.... ......|.+|++++++++|+||+++++++... ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 447799999999988763 357789999987543 23467788999999999999999999998654 3578999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+++++|.+++... .+++..++.++.|++.||.|||+ .+++|+||||+|||+++++.+||+|||++........
T Consensus 88 e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 88 EYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred cCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999654 59999999999999999999999 9999999999999999999999999999987654322
Q ss_pred c--cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 538 S--LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 538 ~--~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
. ......++..|+|||.+....++.++||||||++++||++|+.|+......-...... .....
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--------------~~~~~ 228 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP--------------KQGQM 228 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc--------------ccccc
Confidence 1 1122345667999999988889999999999999999999999875422000000000 00000
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
... .....++.......+......+.+++..|++.+|++|||+++|+++|+.
T Consensus 229 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 229 TVV----------RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred chh----------hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 000 0111111111111222234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.59 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=191.0
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||++... +++.||+|.+... .....+.+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 5789999998753 223345677888888776 899999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 99998886543 58999999999999999999999 9999999999999999999999999999875432221 2234
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||..|+|||++.+..++.++||||||+++|||++|+.||...... .. .......+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----------------~~----~~~~~~~~~~ 214 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS-----------------DN----PDQNTEDYLF 214 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCc-----------------CC----cccccHHHHH
Confidence 57899999999999999999999999999999999999999632100 00 0001111112
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSM 668 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 668 (745)
........ .++......+.+++.+||+.||++||++
T Consensus 215 ~~i~~~~~----------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 215 QVILEKQI----------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHhcCCC----------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 21111111 1222233457789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=315.00 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=208.1
Q ss_pred cCCCCccccCceeEEEEEE-CCCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 385 NFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.+.||.|+-|.|-.|++ ..|+.+|||.+.+.. ......+..|+-+|+-+.|||++++++++++..+.|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 3457799999999999998 469999999997542 223445678999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
++|-|.+++...+ .|++.+..+++.||+.|+.|+|. .+|+|||+||+|+|||..+++||+|||+|.+-..+. ..
T Consensus 95 ~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--lL 168 (786)
T KOG0588|consen 95 PGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--LL 168 (786)
T ss_pred CCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc--cc
Confidence 9999999998776 58899999999999999999999 999999999999999999999999999998654433 33
Q ss_pred cccccccCccCcccccCCCCC-CccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAIS-DKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t-~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
.+-+|.+-|.|||++.+.+|. .++||||.|||||.||+|+.||+..+ +..
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----------------------------ir~ 219 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----------------------------IRV 219 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----------------------------HHH
Confidence 566899999999999999985 79999999999999999999998554 222
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccCCCCCC
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEGGMPLGE 683 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~--~L~~~~~~~~ 683 (745)
...... .+.. +.+........+|+.+|+..||++|-|++||++ .|.+...++.
T Consensus 220 LLlKV~-~G~f----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 220 LLLKVQ-RGVF----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred HHHHHH-cCcc----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 222211 1111 112223345778888999999999999999996 5666554433
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=312.00 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=197.9
Q ss_pred CCCccccCceeEEEEEEC------CCcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 387 NTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
.+.||+|+||.||+|... ....+++|.+..... .....+..|+.+++.++|+||+++++.+...+..++|+||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 467999999999999863 235688888864432 3356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC-----------------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeec
Q 004565 460 MNKGSLDRTLFGNG-----------------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH 516 (745)
Q Consensus 460 ~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~ 516 (745)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill~ 161 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVA 161 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEEc
Confidence 99999999875321 258899999999999999999998 9999999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCcccccccccc
Q 004565 517 DKLQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEK 594 (745)
Q Consensus 517 ~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~ 594 (745)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------- 234 (290)
T cd05045 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA------- 234 (290)
T ss_pred CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-------
Confidence 9999999999999865433221 1123345678999999988889999999999999999998 888875321
Q ss_pred CCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 595 DSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
... ........ .....+......+.+++..|++.+|++||++.||++.
T Consensus 235 ----------------------~~~-~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 235 ----------------------PER-LFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred ----------------------HHH-HHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 001 11111111 1111122233568899999999999999999999999
Q ss_pred hccC
Q 004565 675 LEGG 678 (745)
Q Consensus 675 L~~~ 678 (745)
|+..
T Consensus 283 l~~~ 286 (290)
T cd05045 283 LEKM 286 (290)
T ss_pred HHHH
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=309.41 Aligned_cols=239 Identities=24% Similarity=0.385 Sum_probs=188.3
Q ss_pred CccccCceeEEEEEECC-------------------------CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeE
Q 004565 389 PIGSGGFGTVYKGILQD-------------------------KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 443 (745)
.||+|+||.||+|.+.. ...|++|.+..........|.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998521 13588998875444445678899999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC----
Q 004565 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL---- 519 (745)
Q Consensus 444 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~---- 519 (745)
+++|......++||||+++|+|..++......+++..++.++.||++||+|||+ .+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence 999999999999999999999999997766678999999999999999999998 9999999999999998643
Q ss_pred ---CeEEccCCCcccCCCCCcccccccccccCccCcccccC-CCCCCccceeehHHHHHHHH-hCCCCCCcccccccccc
Q 004565 520 ---QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEII-SGRKNSSLKIQSRSTEK 594 (745)
Q Consensus 520 ---~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~ell-tg~~p~~~~~~~~~~~~ 594 (745)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------ 227 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP------ 227 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh------
Confidence 3799999988644322 22346788999998875 56899999999999999995 68887753220
Q ss_pred CCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 595 DSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
. .. ........ .+... ....+.+++..|++.+|++||+|.+|++.
T Consensus 228 ------------------~--~~----~~~~~~~~-------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 228 ------------------S--EK----ERFYEKKH-------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ------------------H--HH----HHHHHhcc-------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 0 00 00000000 00011 12357889999999999999999999998
Q ss_pred hc
Q 004565 675 LE 676 (745)
Q Consensus 675 L~ 676 (745)
|+
T Consensus 273 L~ 274 (274)
T cd05076 273 LT 274 (274)
T ss_pred hC
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=313.24 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=196.5
Q ss_pred CCCCccccCceeEEEEEECC-Cc--EEEEEEeccC-CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeec
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KS--VVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
+.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|..|++++.++ +||||+++++++......++|+||+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (297)
T cd05089 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYA 85 (297)
T ss_pred eeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEec
Confidence 45789999999999999854 32 4788887643 333456789999999999 7999999999999999999999999
Q ss_pred CCCChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEcc
Q 004565 461 NKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525 (745)
Q Consensus 461 ~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~D 525 (745)
++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~d 162 (297)
T cd05089 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIAD 162 (297)
T ss_pred CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEECC
Confidence 9999999986532 258899999999999999999998 9999999999999999999999999
Q ss_pred CCCcccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCC
Q 004565 526 FGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPS 604 (745)
Q Consensus 526 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 604 (745)
||++....... .......+..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 163 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~----------------- 223 (297)
T cd05089 163 FGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT----------------- 223 (297)
T ss_pred cCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----------------
Confidence 99986432211 1112233567999999998899999999999999999997 988885432
Q ss_pred CCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 004565 605 SSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMP 680 (745)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 680 (745)
....... ...+ .....+......+.+++..|++.+|.+||++++|++.|+....
T Consensus 224 ------------~~~~~~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 224 ------------CAELYEK-LPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred ------------HHHHHHH-HhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 1111 1111111223467899999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.91 Aligned_cols=246 Identities=27% Similarity=0.397 Sum_probs=201.4
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.+.||+|+||.||+|... ++..|++|.+... .....+.+..|+++++.++|+|++++++++.+.+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 3467999999999999985 5888999988632 344567889999999999999999999999999999999999999
Q ss_pred CChhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 463 GSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
++|.+++... ...+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.+||+|||++......... ..
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~ 159 (256)
T cd08529 84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-AN 159 (256)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-hh
Confidence 9999999765 4578999999999999999999998 99999999999999999999999999999876543322 23
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...++..|+|||++.+..++.++||||||++++||++|+.||..... ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------------------~~~- 209 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----------------------------GAL- 209 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----------------------------HHH-
Confidence 45688999999999999999999999999999999999999864320 000
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
......+.. ...+......+.+++.+|++.+|++||++.+|++.
T Consensus 210 ~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 210 ILKIIRGVF---------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHcCCC---------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 011111111 11111233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=308.43 Aligned_cols=252 Identities=28% Similarity=0.456 Sum_probs=200.0
Q ss_pred hcCCCCccccCceeEEEEEECC-C---cEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD-K---SVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
..+.+.||+|+||.||+|.... + ..||||.+... .....++|..|+.++++++||||+++++++.++...++|+|
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 3455789999999999999753 2 36999998754 33446789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++++|.+++......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 999999999998766679999999999999999999999 99999999999999999999999999998766443221
Q ss_pred cc-c-cc--ccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccc
Q 004565 539 LF-T-TM--RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQ 613 (745)
Q Consensus 539 ~~-~-~~--~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (745)
.. . .. ..+..|+|||++.+..++.++||||||+++||+++ |..||....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-------------------------- 216 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-------------------------- 216 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--------------------------
Confidence 11 1 11 12457999999999999999999999999999886 988885432
Q ss_pred cccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 614 RVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
............. ...+.+....+.+++..|++.+|++||+|.+|+.+|+.
T Consensus 217 ---~~~~~~~i~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 217 ---NQDVINAIEQDYR----------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---HHHHHHHHHcCCc----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0000111111000 01111223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.72 Aligned_cols=243 Identities=23% Similarity=0.267 Sum_probs=196.3
Q ss_pred hcCCCCccccCceeEEEEEECC--CcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD--KSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
..+.+.||+|+||.||+|...+ +..||+|++... .....+.+..|+++++.++||||+++++++.+....++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 3445789999999999998643 368999998642 22345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 112 y~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--- 184 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--- 184 (340)
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC---
Confidence 999999999997654 58999999999999999999999 99999999999999999999999999999865432
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----------------------------~- 234 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----------------------------L- 234 (340)
T ss_pred -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----------------------------H-
Confidence 2345789999999999988899999999999999999999999964320 0
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVSM 674 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~~ 674 (745)
........+.. .++......+.+++.+|++.+|++|+ +++++++.
T Consensus 235 -~~~~~i~~~~~----------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 235 -LIYQKILEGII----------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -HHHHHHhcCCC----------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00111111110 01111224567899999999999995 88888753
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.69 Aligned_cols=196 Identities=26% Similarity=0.370 Sum_probs=167.8
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++|+||+++++++.+....++||||++ +
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 9 KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred EeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 3478999999999999986 688999999874332 234567889999999999999999999999999999999996 6
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++....... ......
T Consensus 88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 163 (303)
T cd07869 88 DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNE 163 (303)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCC
Confidence 8888887666678999999999999999999999 999999999999999999999999999987543322 122345
Q ss_pred ccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 544 RGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 544 ~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 68999999998865 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=283.52 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=204.2
Q ss_pred cCCCCccccCceeEEEEE-ECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeC-----CeeEEEEe
Q 004565 385 NFNTPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG-----RQRFLVYE 458 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e 458 (745)
.+.+.||+|||+.||.++ +.++..+|+|++.....++.+..++|++..++++|||++++++++..+ ...||+++
T Consensus 24 ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~P 103 (302)
T KOG2345|consen 24 RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLP 103 (302)
T ss_pred EEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEee
Confidence 345779999999999999 467888999999877777888999999999999999999999987543 34899999
Q ss_pred ecCCCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 459 YMNKGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 459 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
|...|+|.+.+.. .+..+++.+++.|+.+|.+||++||+. .++++||||||.|||+.+.+.++|.|||.+...+..
T Consensus 104 yy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 9999999999874 334799999999999999999999982 234999999999999999999999999999876543
Q ss_pred Cccc--------ccccccccCccCcccccC---CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCC
Q 004565 536 QSSL--------FTTMRGTRGYLAPEWLTS---SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPS 604 (745)
Q Consensus 536 ~~~~--------~~~~~gt~~y~aPE~~~~---~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 604 (745)
.... -....-|..|.|||.+.- ..+++++|||||||+||+|+.|..||+...+
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------------- 246 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------------- 246 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------------
Confidence 2111 123457899999998854 4578999999999999999999999975431
Q ss_pred CCCCCcccccccHHHHHHHHHhhccc-cccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 605 SSSSPRESQRVYFPLLALELHEQRRY-LELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
..+.+ .....+.+...-.....+.+.+++.+|+|.||.+||++.+++..++.
T Consensus 247 ---------------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 ---------------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ---------------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 01111 11112222211122255789999999999999999999999998865
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.74 Aligned_cols=247 Identities=32% Similarity=0.463 Sum_probs=196.3
Q ss_pred CCccccCceeEEEEEECC----CcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQD----KSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
++||+|+||.||+|++.. +..+|+|.+..... ...+++..|+.+++++.|+|++++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999998632 26899999875433 34667899999999999999999999876 4567999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc--
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF-- 540 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-- 540 (745)
++|.+++.... .+++..++.++.|++.||+|||. .+++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997654 68999999999999999999998 8999999999999999999999999999987654332211
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----------------------------~~~ 206 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----------------------------GAE 206 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----------------------------HHH
Confidence 12234568999999998899999999999999999998 888885422 011
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
..... ...... ..+......+.+++.+|++.+|++||++.+|++.|++.
T Consensus 207 ~~~~~-~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 207 VIAML-ESGERL---------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHH-HcCCcC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11111 111100 11112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.94 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=193.4
Q ss_pred ccccCceeEEEEEEC-CCcEEEEEEeccCCc---chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
||+|+||+||++... +++.+|||++..... ...+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999975 688999999864321 2335677899999999999999999999999999999999999999
Q ss_pred hhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 466 DRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 466 ~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
..++.. ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++..+...... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988753 23368999999999999999999999 99999999999999999999999999999766543322 234
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .........
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-------------------------~~~~~~~~~ 211 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-------------------------KVENKELKQ 211 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc-------------------------chhHHHHHH
Confidence 5789999999999999999999999999999999999999864320 000000000
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
. ...... ..+......+.+++..|++.+|++|| +++++++
T Consensus 212 ~---------~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 212 R---------ILNDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred h---------hcccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0 000000 11222345678899999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.23 Aligned_cols=247 Identities=28% Similarity=0.388 Sum_probs=195.2
Q ss_pred CCccccCceeEEEEEECC------CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 388 TPIGSGGFGTVYKGILQD------KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
+.||+|+||.||+|.+.+ +..|++|.+.... ......|..|+.+++.++|+||+++++++.+....++||||+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELM 91 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecC
Confidence 789999999999999854 5678899876433 333567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCC------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC---CeEEccCCCccc
Q 004565 461 NKGSLDRTLFGNG------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL---QVKISDFGLSKL 531 (745)
Q Consensus 461 ~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~---~~kl~Dfgl~~~ 531 (745)
++++|.+++...+ ..+++..++.++.||+.||+|||+ .+++|+||||+||+++.++ .+||+|||+++.
T Consensus 92 ~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~ 168 (277)
T cd05036 92 AGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168 (277)
T ss_pred CCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCccccc
Confidence 9999999987543 258999999999999999999999 8999999999999998754 599999999987
Q ss_pred CCCCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCC
Q 004565 532 LTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSP 609 (745)
Q Consensus 532 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (745)
........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~---------------------- 226 (277)
T cd05036 169 IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT---------------------- 226 (277)
T ss_pred cCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC----------------------
Confidence 63322111 112233568999999998899999999999999999997 888886432
Q ss_pred cccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 610 RESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
............+ ...+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 227 -------~~~~~~~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 227 -------NQEVMEFVTGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------HHHHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0111111111111 1112222356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.59 Aligned_cols=247 Identities=29% Similarity=0.428 Sum_probs=193.8
Q ss_pred CCccccCceeEEEEEECC-Cc--EEEEEEeccC-CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KS--VVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|.+.+ +. .+++|.+... .....+.+..|++++.++ +|+||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999854 33 4688888743 234456788999999999 899999999999999999999999999
Q ss_pred CChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCC
Q 004565 463 GSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFG 527 (745)
Q Consensus 463 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfg 527 (745)
++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 247899999999999999999998 999999999999999999999999999
Q ss_pred CcccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCC
Q 004565 528 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSS 606 (745)
Q Consensus 528 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 606 (745)
++....... .......+..|+|||++....++.++||||||++++||++ |..||....
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~------------------- 216 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------------------- 216 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-------------------
Confidence 986322111 1112234567999999988899999999999999999997 998885432
Q ss_pred CCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
.............. ..+......+.+++.+|++.+|.+|||+.++++.|+..
T Consensus 217 ----------~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 217 ----------CAELYEKLPQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ----------HHHHHHHHhCCCCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11111111110000 11111234578999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.59 Aligned_cols=247 Identities=31% Similarity=0.480 Sum_probs=202.9
Q ss_pred CCccccCceeEEEEEECC----CcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQD----KSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|.... +..|++|.+...... ..+.+..|++.+..++|+|++++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999864 778999998754433 367889999999999999999999999999999999999999
Q ss_pred CChhhhhcCC--------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCC
Q 004565 463 GSLDRTLFGN--------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 463 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 4679999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCc-ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCccc
Q 004565 535 EQS-SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612 (745)
Q Consensus 535 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (745)
... .......++..|+|||.+....++.++||||||++++||++ |..||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------------------------- 212 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS------------------------- 212 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-------------------------
Confidence 432 12234567889999999988889999999999999999999 588875432
Q ss_pred ccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 613 QRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
....... ...+. ....+......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 213 ----~~~~~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 213 ----NEEVLEY-LRKGY---------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----HHHHHHH-HHcCC---------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111111 11111 01112222456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.41 Aligned_cols=245 Identities=25% Similarity=0.405 Sum_probs=208.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEecc--CCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCe-eEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINS--FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQ-RFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-~~lV~e~~~~ 462 (745)
.++||+|+||.++..+.+ ++..+++|++.. ......+...+|+.++++++|||||.+.+.+.+++. .+|||+|+++
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 467999999999998875 467899998873 334445578899999999999999999999999888 8999999999
Q ss_pred CChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 463 GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
|+|.+.|.... ..++++.+..++.|++.|+.|||+ ..|+|||||+.|||++.+..+||+|||+|+.+..... ...
T Consensus 89 g~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~-~a~ 164 (426)
T KOG0589|consen 89 GDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS-LAS 164 (426)
T ss_pred CCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCchh-hhh
Confidence 99999998765 579999999999999999999998 9999999999999999999999999999999887653 336
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...||+.|+.||.+.+.+|..|+|||||||++|||++-+++|.... .....
T Consensus 165 tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----------------------------m~~Li 215 (426)
T KOG0589|consen 165 TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----------------------------MSELI 215 (426)
T ss_pred eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----------------------------hHHHH
Confidence 6889999999999999999999999999999999999999997654 22222
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
...... .....+......+..++..|++.+|+.||++.+++.+
T Consensus 216 ~ki~~~----------~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 216 LKINRG----------LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHhhc----------cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222211 1223444556778899999999999999999999865
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=323.48 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=197.6
Q ss_pred CCCCccccCceeEEEEEECC------CcEEEEEEeccCCc-chHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEE
Q 004565 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKINSFGI-QGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 457 (745)
..++||+|+||.||+|++.+ +..||||+++.... ...+.+..|++++.++. |+||++++++|......++|+
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 34789999999999999642 45799999975432 23457889999999997 999999999999999999999
Q ss_pred eecCCCChhhhhcCCC----------------------------------------------------------------
Q 004565 458 EYMNKGSLDRTLFGNG---------------------------------------------------------------- 473 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~---------------------------------------------------------------- 473 (745)
||+++|+|.++++...
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 9999999999986432
Q ss_pred ---------------------------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCC
Q 004565 474 ---------------------------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ 520 (745)
Q Consensus 474 ---------------------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~ 520 (745)
..+++..++.|+.||+.||+|||+ .+++||||||+|||+++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCE
Confidence 136788889999999999999998 99999999999999999999
Q ss_pred eEEccCCCcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCC
Q 004565 521 VKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSG 598 (745)
Q Consensus 521 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~ 598 (745)
+||+|||+++........ ......++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus 278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~----------- 346 (401)
T cd05107 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP----------- 346 (401)
T ss_pred EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-----------
Confidence 999999999865432211 1123356788999999998889999999999999999998 888875321
Q ss_pred CCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 599 DGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
...........+. ....+......+.+++..|++.+|.+||++.||++.|+..
T Consensus 347 ------------------~~~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 347 ------------------MNEQFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ------------------chHHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0000011111110 0011112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.78 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=202.3
Q ss_pred CCCCccccCceeEEEEEE-CCCcEEEEEEeccCCc---chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
|.+.||+|.||.|-++.. ..|+.||||.+++... +..-.+.+|+++|+.|+||||+.++.+|++.+..++||||..
T Consensus 57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS 136 (668)
T KOG0611|consen 57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYAS 136 (668)
T ss_pred HHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence 345699999999999986 6799999999986543 344567889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|.|.+|+...+ .|++.+...++.||..|+.|+|+ ++++|||||..|||||+++++||+||||+.++... ....
T Consensus 137 ~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kfLq 210 (668)
T KOG0611|consen 137 GGELYDYISERG-SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KFLQ 210 (668)
T ss_pred CccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc--cHHH
Confidence 999999998765 59999999999999999999999 99999999999999999999999999999876543 3347
Q ss_pred ccccccCccCcccccCCCCC-CccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAIS-DKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t-~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
++.|++.|.+||++.+.+|. +..|-|||||+||-|+.|..||++.. .-..
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----------------------------hk~l 261 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----------------------------HKRL 261 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----------------------------HHHH
Confidence 78999999999999999985 79999999999999999999998654 1111
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
+.+ ...+...+ ++......-|+.|||-.+|++|.|+++|..-
T Consensus 262 vrQ-Is~GaYrE-----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 262 VRQ-ISRGAYRE-----------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHH-hhcccccC-----------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 111 11111111 1112235567889999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.20 Aligned_cols=243 Identities=28% Similarity=0.447 Sum_probs=189.6
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||+++++
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 467999999999999975 58899999986433 2335678999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++..+..... ......
T Consensus 159 L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~ 229 (353)
T PLN00034 159 LEGTH-----IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSV 229 (353)
T ss_pred ccccc-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccc
Confidence 87543 35677888999999999999999 9999999999999999999999999999987643221 123457
Q ss_pred cccCccCcccccCC-----CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 545 GTRGYLAPEWLTSS-----AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 545 gt~~y~aPE~~~~~-----~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
||..|+|||++... ..+.++|||||||++|||++|+.||..... . ....
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~------------------------~--~~~~ 283 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ------------------------G--DWAS 283 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------------------------c--cHHH
Confidence 89999999987532 345689999999999999999999863210 0 0000
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
......... ....+......+.+++.+||+.+|++|||+.||++.
T Consensus 284 ~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 284 LMCAICMSQ----------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHhccC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 011112233568899999999999999999999863
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.29 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=194.7
Q ss_pred CCCccccCceeEEEEEE-CCCcEEEEEEeccCCc--------------chHHHHHHHHHHHccCCCCceeeEEEEEEe--
Q 004565 387 NTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGI--------------QGKKEFCTEITIIGNIHHVNLVRLKGFCAQ-- 449 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-- 449 (745)
...||+|.||.|-+|.. .+++.||||++.+... ...+...+|+.+|++++|+|||+|+.+..+
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 36799999999999996 5689999999864211 123578899999999999999999999865
Q ss_pred CCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCc
Q 004565 450 GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLS 529 (745)
Q Consensus 450 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~ 529 (745)
.+..|||+||+..|.+...=.. ...|+..++++++.+++.||+|||. ++||||||||+|+||++++++||+|||++
T Consensus 182 s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsDFGVs 257 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISDFGVS 257 (576)
T ss_pred cCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeecccee
Confidence 4578999999998877543221 1138999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCc----ccccccccccCccCcccccCCC----CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCC
Q 004565 530 KLLTPEQS----SLFTTMRGTRGYLAPEWLTSSA----ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGN 601 (745)
Q Consensus 530 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 601 (745)
..+..... .......||+.|+|||...++. .+.+.||||+||.||.|+.|+.||......+.
T Consensus 258 ~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l---------- 327 (576)
T KOG0585|consen 258 NEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL---------- 327 (576)
T ss_pred eecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH----------
Confidence 87743311 1224468999999999987743 35789999999999999999999976541110
Q ss_pred CCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 602 GPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
...++...+.-...++..+.+.+|++++|++||+.|.+..+|..-.
T Consensus 328 ----------------------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 328 ----------------------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ----------------------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1122222232222335567888999999999999999999997543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.73 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=199.9
Q ss_pred CCccccCceeEEEEEECC--C--cEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQD--K--SVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
++||+|++|.||+|.+.. + ..||||.+..... ...+.+..|++++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999743 3 3689999986555 557789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc--c
Q 004565 463 GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS--L 539 (745)
Q Consensus 463 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--~ 539 (745)
++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998765 478999999999999999999999 99999999999999999999999999999877543221 1
Q ss_pred ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....++..|+|||++.+..++.++||||||++++||++ |+.||.... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----------------------------~~ 207 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-----------------------------GS 207 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-----------------------------HH
Confidence 123457789999999999899999999999999999998 999885322 01
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
............ . ..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 208 ~~~~~~~~~~~~--~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 208 QILKKIDKEGER--L-------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHhcCCc--C-------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111111111100 0 111122356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.76 Aligned_cols=251 Identities=28% Similarity=0.461 Sum_probs=200.3
Q ss_pred cCCCCccccCceeEEEEEEC----CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 385 NFNTPIGSGGFGTVYKGILQ----DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
.+.+.||+|+||.||+|... .+..+|+|.+.... ....+.+..|+.++.+++||||+++++++...+..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 34578999999999999873 23479999886432 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
+++++|.+++......+++.+++.++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||++..+.......
T Consensus 87 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 87 MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 99999999998766678999999999999999999999 999999999999999999999999999998765443222
Q ss_pred c--cccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 540 F--TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 540 ~--~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
. ....++..|+|||++.+..++.++||||||++++|+++ |..||.....
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---------------------------- 215 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---------------------------- 215 (267)
T ss_pred eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----------------------------
Confidence 1 12233568999999998899999999999999999886 9988854320
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
...........+ ...+......+.+++.+|++.+|.+||+|.+|++.|+.
T Consensus 216 -~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 216 -QDVIKAIEEGYR----------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -HHHHHHHhCCCc----------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 000111111000 01111223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.98 Aligned_cols=241 Identities=24% Similarity=0.267 Sum_probs=192.8
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccC---CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSF---GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|+..+ ++.||||++... .....+.+..|.+++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 359999999999999854 789999998743 223445677888888866 899999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|..++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 99998886553 58999999999999999999999 9999999999999999999999999999875433221 2244
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----------------------------~~~~~ 206 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----------------------------DDLFE 206 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----------------------------HHHHH
Confidence 5789999999999998999999999999999999999999964320 01111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-------SMANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------t~~ev~~ 673 (745)
.... ... ..+......+.+++..|++.+|++|| ++.++++
T Consensus 207 ~i~~-~~~----------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 207 SILH-DDV----------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHc-CCC----------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1111 110 01111224577899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=313.15 Aligned_cols=237 Identities=27% Similarity=0.316 Sum_probs=188.0
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHH-HHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEIT-IIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|... +++.||||++.... ....+++..|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 35999999999999985 68899999986421 122344555544 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 99999887643 68899999999999999999999 999999999999999999999999999987543222 22345
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----------------------------~~~~~~ 206 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----------------------------TAEMYD 206 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----------------------------HHHHHH
Confidence 578999999999999999999999999999999999999986432 111111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA 669 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 669 (745)
.... .. ..+.... ...+.+++..|++.+|.+||++.
T Consensus 207 ~i~~-~~------~~~~~~~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 207 NILN-KP------LRLKPNI----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHc-CC------CCCCCCC----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 1111 10 0111122 34578899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.56 Aligned_cols=241 Identities=26% Similarity=0.401 Sum_probs=200.8
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|.||.||.|+.+ ++-.||+|++.+.. .+...++.+|+++-+.|+||||+++++++.+....||++||.+.
T Consensus 27 gr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~ 106 (281)
T KOG0580|consen 27 GRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPR 106 (281)
T ss_pred cccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCC
Confidence 488999999999999985 46789999987532 23356788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 463 GSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
|+|...|..... .++......++.|+|.||.|+|. ++|+||||||.|+|++..+..||+|||.+..-+ .....
T Consensus 107 gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~kR~ 180 (281)
T KOG0580|consen 107 GELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNKRK 180 (281)
T ss_pred chHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---CCCce
Confidence 999999985443 68999999999999999999999 999999999999999999999999999987554 22336
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...||..|++||...+...+...|+|++||+.||++.|.+||...... ..+
T Consensus 181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------------------etY- 231 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------------------ETY- 231 (281)
T ss_pred eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------------------HHH-
Confidence 678999999999999999999999999999999999999999754310 000
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.+. .-.++. ++........+++..|+..+|.+|.+..||+.
T Consensus 232 krI----~k~~~~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 232 KRI----RKVDLK-------FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHH----HHcccc-------CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 010 011111 12222345778999999999999999999975
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=321.94 Aligned_cols=247 Identities=22% Similarity=0.260 Sum_probs=198.3
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||+|... +++.||||++... .......+..|++++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 367999999999999986 6889999998743 224456788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC------
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ------ 536 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~------ 536 (745)
++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 161 (350)
T cd05573 86 GDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161 (350)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccc
Confidence 9999999766 468999999999999999999999 999999999999999999999999999998765433
Q ss_pred ----------------------cccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcccccccccc
Q 004565 537 ----------------------SSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEK 594 (745)
Q Consensus 537 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~ 594 (745)
........||+.|+|||.+.+..++.++|||||||+||||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~------- 234 (350)
T cd05573 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT------- 234 (350)
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-------
Confidence 112234568999999999999999999999999999999999999986432
Q ss_pred CCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 004565 595 DSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS-MANVVS 673 (745)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~ev~~ 673 (745)
............. .+.-.........+.+++..|++ +|.+||+ ++|+++
T Consensus 235 ----------------------~~~~~~~i~~~~~-------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 235 ----------------------LQETYNKIINWKE-------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred ----------------------HHHHHHHHhccCC-------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 0000111111000 00000000123457788889997 9999999 999986
Q ss_pred H
Q 004565 674 M 674 (745)
Q Consensus 674 ~ 674 (745)
.
T Consensus 285 h 285 (350)
T cd05573 285 H 285 (350)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=327.49 Aligned_cols=248 Identities=22% Similarity=0.245 Sum_probs=205.0
Q ss_pred CCCccccCceeEEEEEECCC-cEEEEEEeccCCcchHHHHHHHHHHHccCC-CCceeeEEEEE-Ee------CCeeEEEE
Q 004565 387 NTPIGSGGFGTVYKGILQDK-SVVAVKKINSFGIQGKKEFCTEITIIGNIH-HVNLVRLKGFC-AQ------GRQRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~-~~------~~~~~lV~ 457 (745)
.+.|.+|||+.||.+....+ ..+|+|++-...+...+.+.+|+++|++|+ |+|||.+++.. .. .-+.+|+|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 36799999999999998776 999999998778888899999999999996 99999999932 21 23678999
Q ss_pred eecCCCChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC
Q 004565 458 EYMNKGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~ 536 (745)
|||.+|.|-+++..+.. .|++.++++|+.++++|+++||. +..+|||||||.+||||..+++.||+|||.+.-.-...
T Consensus 122 EyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~ 200 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSP 200 (738)
T ss_pred hhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccccCCC
Confidence 99999999999975433 59999999999999999999997 55779999999999999999999999999997443322
Q ss_pred cc--cc------cccccccCccCcccc---cCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCC
Q 004565 537 SS--LF------TTMRGTRGYLAPEWL---TSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSS 605 (745)
Q Consensus 537 ~~--~~------~~~~gt~~y~aPE~~---~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 605 (745)
.. .. -...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+...
T Consensus 201 ~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------------ 262 (738)
T KOG1989|consen 201 TSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------------ 262 (738)
T ss_pred ccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------------
Confidence 11 00 112368999999976 56789999999999999999999999997542
Q ss_pred CCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 606 SSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
...+++....-...+....++.+|+..||+.+|.+||++-+|+..+..
T Consensus 263 ------------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 263 ------------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ------------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 123344443333335677899999999999999999999999988766
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=291.88 Aligned_cols=272 Identities=22% Similarity=0.251 Sum_probs=211.2
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcch--HHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQG--KKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~ 462 (745)
+.|++|.||.||+|+.. ++..||+|+++...... .-.-.+|+.+|.+++|||||.+-.+.... +..||||||++.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 56999999999999984 58899999997433221 23457899999999999999999988644 468999999976
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|...+....+++...+..-+..|+++|++|||. +.|+|||||++|+|+...|.+||+|||+|+.+.... ...+.
T Consensus 162 -DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~~T~ 236 (419)
T KOG0663|consen 162 -DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KPYTP 236 (419)
T ss_pred -hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc-ccCcc
Confidence 8999999888889999999999999999999999 999999999999999999999999999999887653 34567
Q ss_pred cccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
.+-|..|.|||.+.+. .|+...|+||+|||+.||+++++-|.+..+.+....++...|........ .-..++.|-
T Consensus 237 lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp----g~~~lp~~k 312 (419)
T KOG0663|consen 237 LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP----GYSELPAVK 312 (419)
T ss_pred eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC----Cccccchhh
Confidence 7789999999998775 68999999999999999999999998887777777776666654433211 111122221
Q ss_pred HHHHhhccccccccccccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDE-DVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.. ....-.-..+++.+... ..+.-.+++...+..||.+|-|++|-++
T Consensus 313 ~~-----~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 313 KM-----TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cc-----ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 00011111122222221 3355667788889999999999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=318.17 Aligned_cols=247 Identities=20% Similarity=0.222 Sum_probs=197.4
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||++... +++.||||+++... ....+.+.+|+.+++.++|+||+++++++.+....++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 467999999999999975 58899999987432 23456688899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+..........
T Consensus 86 ~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 162 (330)
T cd05601 86 GDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL 162 (330)
T ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeec
Confidence 99999998765679999999999999999999999 999999999999999999999999999998765544333344
Q ss_pred cccccCccCccccc------CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 543 MRGTRGYLAPEWLT------SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 543 ~~gt~~y~aPE~~~------~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
..||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~----------------------------- 213 (330)
T cd05601 163 PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT----------------------------- 213 (330)
T ss_pred ccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-----------------------------
Confidence 57899999999986 4567899999999999999999999986432
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.................. ........+.+++..|++ +|++||++.++++
T Consensus 214 ~~~~~~~i~~~~~~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 214 SAKTYNNIMNFQRFLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHHcCCCccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 001111111111111000 011123456778888998 9999999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.64 Aligned_cols=245 Identities=29% Similarity=0.462 Sum_probs=200.3
Q ss_pred cCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.+.||.|+||.||+|... ++.||||.+..... ..+++..|+.++++++|+|++++++++......++|+||+++++
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred cceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 34578999999999999876 67899999976543 56789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 465 LDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 465 L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
|.+++..... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++....... ...
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----~~~ 159 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSG 159 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc----ccC
Confidence 9999976543 68999999999999999999999 999999999999999999999999999998763322 123
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..+..|+|||++....++.++||||||++++||++ |+.||.... ......
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----------------------------~~~~~~ 210 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----------------------------LKDVVP 210 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----------------------------HHHHHH
Confidence 45678999999998899999999999999999997 888875321 111111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
....... ...+......+.+++.+|++.+|++||+++||+++|+.
T Consensus 211 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 211 HVEKGYR----------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHhcCCC----------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1111100 11111223568899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.85 Aligned_cols=193 Identities=24% Similarity=0.338 Sum_probs=168.2
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||++... ++..||||.++.. .....+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 35899999999999985 5789999999743 223345678899999888 799999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 9999888654 369999999999999999999999 999999999999999999999999999987532221 12244
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
..||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 6789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.06 Aligned_cols=257 Identities=21% Similarity=0.344 Sum_probs=195.3
Q ss_pred cCCCCccccCceeEEEEEECC---------------CcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQD---------------KSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~ 448 (745)
.+.+.||+|+||.||++...+ ...||+|.+... .......|.+|++++++++|+|++++++++.
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 87 (295)
T cd05097 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV 87 (295)
T ss_pred eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 345779999999999987643 225899998753 2334567899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhhhhcCCC-----------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC
Q 004565 449 QGRQRFLVYEYMNKGSLDRTLFGNG-----------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD 517 (745)
Q Consensus 449 ~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~ 517 (745)
.....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGN 164 (295)
T ss_pred CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEcC
Confidence 9999999999999999999886432 147899999999999999999999 99999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh--CCCCCCcccccccccc
Q 004565 518 KLQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS--GRKNSSLKIQSRSTEK 594 (745)
Q Consensus 518 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt--g~~p~~~~~~~~~~~~ 594 (745)
++.+||+|||++......... ......++..|+|||++..+.++.++||||||++++||++ +..||....
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~------- 237 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS------- 237 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-------
Confidence 999999999999765433221 1122345778999999998899999999999999999998 445554321
Q ss_pred CCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 595 DSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.. .............. .......+......+.+++.+|++.+|++||+|.+|+++
T Consensus 238 ------------------~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 238 ------------------DE-QVIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred ------------------hH-HHHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 00 00000011111000 000001111123578999999999999999999999999
Q ss_pred hc
Q 004565 675 LE 676 (745)
Q Consensus 675 L~ 676 (745)
|+
T Consensus 293 l~ 294 (295)
T cd05097 293 LR 294 (295)
T ss_pred Hh
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.87 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=194.5
Q ss_pred CCCCccccCceeEEEEEECCCc---EEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeC------CeeE
Q 004565 386 FNTPIGSGGFGTVYKGILQDKS---VVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG------RQRF 454 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~ 454 (745)
+.++||+|+||.||+|.+.+.. .||+|.++.. .....+.+..|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 3467999999999999986532 5899987643 234467788999999999999999999988532 2468
Q ss_pred EEEeecCCCChhhhhcC-----CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCc
Q 004565 455 LVYEYMNKGSLDRTLFG-----NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLS 529 (745)
Q Consensus 455 lV~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~ 529 (745)
+|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 22358999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCC
Q 004565 530 KLLTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSS 607 (745)
Q Consensus 530 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (745)
+......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------------------- 219 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-------------------- 219 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------------------
Confidence 8765433211 122345678999999999999999999999999999999 777775321
Q ss_pred CCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 608 SPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.... ......+... ..+......+.+++.+|++.+|++|||+.+|++.|+.
T Consensus 220 ---------~~~~-~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 220 ---------NSEI-YDYLRQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred ---------HHHH-HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0011 1111111110 0111223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.62 Aligned_cols=247 Identities=22% Similarity=0.276 Sum_probs=194.9
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.+.||+|+||.||+++.. ++..||+|++... .....+.+..|+.+++.++|+||+++++++.+....++||||++
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 47 VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCC
Confidence 3478999999999999985 5889999998642 22334557889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++............
T Consensus 127 gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~ 201 (370)
T cd05596 127 GGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201 (370)
T ss_pred CCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence 99999998654 47888889999999999999999 99999999999999999999999999999876543322234
Q ss_pred ccccccCccCcccccCC----CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 542 TMRGTRGYLAPEWLTSS----AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~----~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
...||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... .
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----------------------------~ 252 (370)
T cd05596 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----------------------------L 252 (370)
T ss_pred CCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----------------------------H
Confidence 56799999999998653 47899999999999999999999996432 1
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPML--RPSMANVVS 673 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~ev~~ 673 (745)
................ .........+.+++..||+.+|.+ ||+++|+++
T Consensus 253 ~~~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 253 VGTYSKIMDHKNSLTF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHHHHHHcCCCcCCC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1111111111000000 000112356778899999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.83 Aligned_cols=236 Identities=23% Similarity=0.261 Sum_probs=190.2
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|+.. +++.||||++... .....+.+..|.+++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999985 5789999998742 223456677888888876 799999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 99999887654 58999999999999999999999 999999999999999999999999999987543222 12244
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----------------------------~~~~~~ 206 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----------------------------EDDLFE 206 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----------------------------HHHHHH
Confidence 578999999999999899999999999999999999999996432 011111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSM 668 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 668 (745)
.. ..... ..+......+.+++..|++.||++||++
T Consensus 207 ~i-~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 207 AI-LNDEV----------VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HH-hcCCC----------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11 11110 0111123457889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.50 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=199.4
Q ss_pred CCCCccccCceeEEEEEECC------CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++|+||+++++++......++|||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 34779999999999999753 3679999986432 3445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCC---------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCc
Q 004565 459 YMNKGSLDRTLFGNG---------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLS 529 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~ 529 (745)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcccc
Confidence 999999999986432 247899999999999999999998 99999999999999999999999999999
Q ss_pred ccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCC
Q 004565 530 KLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSS 607 (745)
Q Consensus 530 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (745)
+........ ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-------------------- 226 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-------------------- 226 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--------------------
Confidence 865443221 2233456789999999988889999999999999999998 888875322
Q ss_pred CCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 608 SPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.... ......+... ..+......+.+++..|++.+|++|||+.+|++.|+.
T Consensus 227 ---------~~~~-~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 227 ---------NEEV-LKFVIDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---------HHHH-HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0000 1111111111 1111224568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.61 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=194.1
Q ss_pred CCCccccCceeEEEEEE----CCCcEEEEEEeccC----CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEE
Q 004565 387 NTPIGSGGFGTVYKGIL----QDKSVVAVKKINSF----GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 457 (745)
.+.||+|+||.||+++. ..+..||+|++... .....+.+..|+.++..+ +|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 46799999999999986 35789999998642 122345678899999999 5999999999999999999999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 85 DYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999987543 58999999999999999999999 9999999999999999999999999999987654433
Q ss_pred ccccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 538 SLFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
.......||..|+|||.+.+. .++.++|||||||++|||++|+.||.... ....
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------------------------~~~~ 215 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG-------------------------ERNT 215 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC-------------------------CCCC
Confidence 333456799999999998865 47899999999999999999999986432 0001
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
.......... .++.+... ....+.+++.+||+.||++|| +++++++
T Consensus 216 ~~~~~~~~~~-------~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 216 QSEVSRRILK-------CDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHHHhc-------CCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111111111 11112122 234577889999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.26 Aligned_cols=249 Identities=29% Similarity=0.432 Sum_probs=194.7
Q ss_pred cCCCCccccCceeEEEEEECC-Cc--EEEEEEeccC-CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEee
Q 004565 385 NFNTPIGSGGFGTVYKGILQD-KS--VVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
.+.+.||+|+||.||+|.... +. .+++|++... .......+..|++++.++ +|+||+++++++...+..++|+||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 345789999999999999743 43 4678877643 234456788999999999 899999999999999999999999
Q ss_pred cCCCChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEc
Q 004565 460 MNKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKIS 524 (745)
Q Consensus 460 ~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~ 524 (745)
+++++|.+++...+ ..+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeC
Confidence 99999999986432 258899999999999999999998 999999999999999999999999
Q ss_pred cCCCcccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCC
Q 004565 525 DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGP 603 (745)
Q Consensus 525 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 603 (745)
|||++....... ......++..|+|||++.+..++.++||||||++++||++ |..||....
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---------------- 228 (303)
T cd05088 167 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---------------- 228 (303)
T ss_pred ccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC----------------
Confidence 999986432111 1112234668999999988889999999999999999998 998885432
Q ss_pred CCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 604 SSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
........ ... .....+......+.+++.+|++.+|++||++.+++++|+.
T Consensus 229 -------------~~~~~~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 229 -------------CAELYEKL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred -------------hHHHHHHH-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00011111 100 0001111123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.90 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=190.5
Q ss_pred CccccCceeEEEEEECC---CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 389 PIGSGGFGTVYKGILQD---KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.||+|+||.||+|...+ +..+|+|+++... ......+.+|+.++++++|+|++++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 59999999999998754 3578999887543 2344578899999999999999999999999999999999999999
Q ss_pred hhhhhcCCC----cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc-
Q 004565 465 LDRTLFGNG----SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL- 539 (745)
Q Consensus 465 L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~- 539 (745)
|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986432 246788888999999999999999 999999999999999999999999999997544332211
Q ss_pred ccccccccCccCcccccCC-------CCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcc
Q 004565 540 FTTMRGTRGYLAPEWLTSS-------AISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~-------~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
.....++..|+|||++... .++.++||||||+++|||++ |+.||.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----------------------- 215 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD----------------------- 215 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----------------------
Confidence 1234567889999988642 35789999999999999996 9988854320
Q ss_pred cccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
. .... ...........++.+.... ...+.+++..|+ .+|++|||++||+..|+
T Consensus 216 --~---~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 216 --E---QVLT--YTVREQQLKLPKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --H---HHHH--HHhhcccCCCCCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 0000 0001111112222222112 234667888898 58999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.40 Aligned_cols=238 Identities=21% Similarity=0.286 Sum_probs=192.0
Q ss_pred CCccccCceeEEEEEE----CCCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 388 TPIGSGGFGTVYKGIL----QDKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.||+|+||.||+++. ..++.+|+|++.... ......+..|++++++++|+||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999875 357899999987432 2234567789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 999999986543 58999999999999999999999 9999999999999999999999999999986543321 223
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...|++.|+|||.+....++.++||||||+++|||++|+.||.... .....
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----------------------------~~~~~ 207 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----------------------------RKETM 207 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-----------------------------HHHHH
Confidence 4578999999999998889999999999999999999999986432 00011
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMAN 670 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e 670 (745)
.... .... ..+......+.+++.+||+.||++||++.+
T Consensus 208 ~~i~-~~~~----------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 208 TMIL-KAKL----------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHH-cCCC----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111 1110 111122345778999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.84 Aligned_cols=247 Identities=26% Similarity=0.328 Sum_probs=193.6
Q ss_pred ccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
||+|+||.||++... +++.+|+|++.... ....+.+..|++++++++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999975 58899999986321 12244566799999999999999999999999999999999999999
Q ss_pred hhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 466 DRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 466 ~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
.+++.... ..+++..+..++.||+.||+|||+ .+++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 98886543 368999999999999999999999 999999999999999999999999999998665432 223456
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
|+..|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~-------------------------~~~~~~~~~~~~ 210 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK-------------------------EKVAKEELKRRT 210 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc-------------------------chhhHHHHHHHh
Confidence 8999999999999889999999999999999999999986422 000000010000
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
. ... +.. . .......+.+++..||+.+|++||+++|+++.+.
T Consensus 211 ~-~~~----~~~--~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 211 L-EDE----VKF--E---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred h-ccc----ccc--c---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 0 000 000 0 0112345789999999999999999988764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.04 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=199.5
Q ss_pred cCCCCccccCceeEEEEEEC------CCcEEEEEEeccCC-cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFG-IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLV 456 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV 456 (745)
.+.+.||+|+||.||+|... .+..||||+++... ....+.+.+|+++++++ +|+||+++++++...+..++|
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 117 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence 34588999999999999752 24579999887543 23356789999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 457 YEYMNKGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
+||+++++|.+++..... .+++.+++.++.+++.||+|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 118 ~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 999999999999975433 48999999999999999999999 99999999999999999999999999999866543
Q ss_pred Ccc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccc
Q 004565 536 QSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQ 613 (745)
Q Consensus 536 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (745)
... ......++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~------------------------- 249 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV------------------------- 249 (302)
T ss_pred CceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------------------------
Confidence 221 1123346778999999999899999999999999999998 8888754220
Q ss_pred cccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 614 RVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
... .......+. ....+......+.+++.+|++.+|++|||+.||++.|+.
T Consensus 250 ---~~~-~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 250 ---DSK-FYKLIKEGY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---hHH-HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000 011111110 001111123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=304.73 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=195.7
Q ss_pred CCCccccCceeEEEEEECC----CcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCe------eE
Q 004565 387 NTPIGSGGFGTVYKGILQD----KSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQ------RF 454 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~------~~ 454 (745)
.+.||+|+||.||+|.+.. +..||||+++... ......+..|++.++.++|+|++++++++..... .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4679999999999999743 3679999987432 2335678999999999999999999999866554 79
Q ss_pred EEEeecCCCChhhhhcCC-----CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCc
Q 004565 455 LVYEYMNKGSLDRTLFGN-----GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLS 529 (745)
Q Consensus 455 lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~ 529 (745)
+|+||+++++|..++... ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccce
Confidence 999999999999888532 2368999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCC
Q 004565 530 KLLTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSS 607 (745)
Q Consensus 530 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (745)
+......... .....++..|+|||++....++.++||||||+++|||++ |..||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-------------------- 220 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-------------------- 220 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--------------------
Confidence 8765433221 122335678999999988899999999999999999999 777775321
Q ss_pred CCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 608 SPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
-........ .+... ..+......+.+++.+|++.+|++|||+.||++.|+.
T Consensus 221 ---------~~~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 221 ---------NHEIYDYLR-HGNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred ---------HHHHHHHHH-cCCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 001111111 11110 1122234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.42 Aligned_cols=242 Identities=24% Similarity=0.277 Sum_probs=193.7
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||++... ++..||+|.+... .......+..|++++..++|+||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999974 6889999998743 2233466788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|..++.... .+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 9998886543 68999999999999999999996 26899999999999999999999999999875432221 22345
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
.||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..... .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----------------------------~~~~~-~ 206 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----------------------------HEKLF-E 206 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----------------------------HHHHH-H
Confidence 69999999999999999999999999999999999999986432 00000 0
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
...... ..+ +......+.+++.+|++.||++|+ ++.++++
T Consensus 207 ~i~~~~------~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 207 LILMEE------IRF----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHhcCC------CCC----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 000000 011 111234577889999999999996 8999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.30 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=200.4
Q ss_pred hcCCCCccccCceeEEEEEECC----CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD----KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
..+.+.||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++|+|++++++++.+ ...++|+|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e 86 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME 86 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence 3345789999999999999743 2468999887544 3456789999999999999999999999875 45689999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++++|.+++......+++..++.++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 87 LAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred cCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 999999999998766679999999999999999999998 99999999999999999999999999999876544322
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
......++..|+|||.+....++.++||||||++++|+++ |..||.... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----------------------------~ 214 (270)
T cd05056 164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-----------------------------N 214 (270)
T ss_pred ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-----------------------------H
Confidence 2233345678999999988889999999999999999996 999886432 0
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
............. ..+......+.+++.+|+..+|++|||+.++++.|+..
T Consensus 215 ~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 215 NDVIGRIENGERL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred HHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111111111111 11112234688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=307.24 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=198.6
Q ss_pred cCCCCccccCceeEEEEEECC-----------------CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQD-----------------KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGF 446 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~ 446 (745)
.+.+.||+|+||.||++...+ +..||+|.+.... ....+.+..|++++++++|+|+++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05051 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV 87 (296)
T ss_pred cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 345789999999999998643 2458999987443 3446788999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhhhhcCCC----------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeec
Q 004565 447 CAQGRQRFLVYEYMNKGSLDRTLFGNG----------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH 516 (745)
Q Consensus 447 ~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~ 516 (745)
+..+...++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili~ 164 (296)
T cd05051 88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164 (296)
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceeec
Confidence 999999999999999999999987543 268999999999999999999998 9999999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCc-ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh--CCCCCCccccccccc
Q 004565 517 DKLQVKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS--GRKNSSLKIQSRSTE 593 (745)
Q Consensus 517 ~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt--g~~p~~~~~~~~~~~ 593 (745)
.++.++|+|||++........ .......++..|+|||++....++.++||||||+++|||++ +..||....
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~------ 238 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT------ 238 (296)
T ss_pred CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC------
Confidence 999999999999976543322 12233456788999999998889999999999999999998 555654321
Q ss_pred cCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 594 KDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.. ............. +.......+......+.+++.+|++.+|++|||+.||++
T Consensus 239 -------------------~~-~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 239 -------------------DQ-QVIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred -------------------hH-HHHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 00 0000111110000 000001111122356899999999999999999999999
Q ss_pred Hhc
Q 004565 674 MLE 676 (745)
Q Consensus 674 ~L~ 676 (745)
.|+
T Consensus 293 ~L~ 295 (296)
T cd05051 293 FLQ 295 (296)
T ss_pred Hhc
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.84 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=197.2
Q ss_pred CCCCccccCceeEEEEEEC-CCc----EEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKS----VVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+.++||+|+||.||+|++. ++. .||+|.+... .....+++..|+.++..++|+|++++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEc
Confidence 3477999999999999863 444 4899998743 33346678899999999999999999999975 456899999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
+++|+|.+++......+++..++.++.||+.||+|||+ .+++||||||+|||+++++.+||+|||+++.........
T Consensus 90 ~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~ 166 (279)
T cd05109 90 MPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY 166 (279)
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccccccee
Confidence 99999999998766679999999999999999999999 999999999999999999999999999998765433221
Q ss_pred -ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 540 -FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 540 -~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...+
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------------------------~~~~ 220 (279)
T cd05109 167 HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--------------------------AREI 220 (279)
T ss_pred ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------------------------HHHH
Confidence 122345678999999998899999999999999999998 888875322 0001
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
.. ....+.. ...+......+.+++..|++.||++||++.+++..|+..
T Consensus 221 ~~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 221 PD----LLEKGER---------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HH----HHHCCCc---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11 1111110 011112234678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=306.83 Aligned_cols=240 Identities=28% Similarity=0.432 Sum_probs=191.4
Q ss_pred CCccccCceeEEEEEECC--------CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQD--------KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++|+|++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998743 234888887655545567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCC--------eEEccCCCccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ--------VKISDFGLSKL 531 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~--------~kl~Dfgl~~~ 531 (745)
+++|+|..++...+..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999998776679999999999999999999999 99999999999999987765 59999998865
Q ss_pred CCCCCcccccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCC-CCCCccccccccccCCCCCCCCCCCCCCC
Q 004565 532 LTPEQSSLFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGR-KNSSLKIQSRSTEKDSSGDGNGPSSSSSP 609 (745)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (745)
.... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---------------------- 210 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---------------------- 210 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc----------------------
Confidence 4432 234578899999999874 5799999999999999999995 4443211
Q ss_pred cccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 610 RESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
... . ...... . ...+......+.+++..|++.+|++|||+++|++.|+
T Consensus 211 ------~~~-~-~~~~~~-~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 211 ------SQK-K-LQFYED-R----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------HHH-H-HHHHHc-c----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 001110 0 0111112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.40 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=199.9
Q ss_pred cCCCCccccCceeEEEEEECC-----CcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEe-CCeeEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQD-----KSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ-GRQRFLVY 457 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lV~ 457 (745)
.+.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+|++++++++.. ....++++
T Consensus 9 ~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 88 (280)
T cd05043 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLY 88 (280)
T ss_pred EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEE
Confidence 345789999999999999865 678999988743 33446678899999999999999999999876 46789999
Q ss_pred eecCCCChhhhhcCCC-------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcc
Q 004565 458 EYMNKGSLDRTLFGNG-------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK 530 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~ 530 (745)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++
T Consensus 89 ~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 9999999999986532 358999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCC
Q 004565 531 LLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSS 608 (745)
Q Consensus 531 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (745)
.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------------------- 224 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--------------------- 224 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---------------------
Confidence 66443322 1223446778999999998889999999999999999999 998886432
Q ss_pred CcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 609 PRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
...+.......... . .+......+.+++.+|++.+|++|||+.+|+++|+.
T Consensus 225 --------~~~~~~~~~~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 225 --------PFEMAAYLKDGYRL------A----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred --------HHHHHHHHHcCCCC------C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 01111111111110 0 011123467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=303.05 Aligned_cols=252 Identities=21% Similarity=0.392 Sum_probs=201.5
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.++||+|+||.||+|+.. ++..||||.+... .......+..|+++++.++|+|++++++++...+..++|+||++
T Consensus 6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence 3477999999999999974 6889999987632 23335578899999999999999999999999999999999999
Q ss_pred CCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 462 KGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 462 ~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
+++|.+++.. ....++...++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~- 161 (267)
T cd08228 86 AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT- 161 (267)
T ss_pred CCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH-
Confidence 9999988753 23358899999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---------------------------~~~~ 214 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---------------------------MNLF 214 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc---------------------------ccHH
Confidence 1234568889999999998889999999999999999999999985322 0011
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.+.... .... .+ ..........+.+++.+||+.+|++||++.+|++.|++
T Consensus 215 ~~~~~~-~~~~-----~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 215 SLCQKI-EQCD-----YP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred HHHHHH-hcCC-----CC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 111111 1100 00 01112234568899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.29 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=201.5
Q ss_pred hhcCCCCccccCceeEEEEEEC--------CCcEEEEEEeccC-CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCe
Q 004565 383 TDNFNTPIGSGGFGTVYKGILQ--------DKSVVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQ 452 (745)
Q Consensus 383 t~~f~~~lG~G~fg~Vy~g~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~ 452 (745)
...+.+.||+|+||.||++... ++..||+|.+... .....+.+..|+.+++.+ +|+||+++++++.....
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 3445588999999999999741 2457999988643 234457789999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC
Q 004565 453 RFLVYEYMNKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD 517 (745)
Q Consensus 453 ~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~ 517 (745)
.++||||+++++|.+++.... ..+++..++.++.||++||.|||+ .+++||||||+||++++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~ 172 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTE 172 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcC
Confidence 999999999999999987532 257899999999999999999999 99999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccC
Q 004565 518 KLQVKISDFGLSKLLTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKD 595 (745)
Q Consensus 518 ~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~ 595 (745)
++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------- 244 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------- 244 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--------
Confidence 9999999999998765433221 223446778999999998889999999999999999998 677664321
Q ss_pred CCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 596 SSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
.............. ..+......+.+++.+|++.+|++||+|.||++.|
T Consensus 245 ---------------------~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 245 ---------------------VEELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred ---------------------HHHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 11111111111110 11112335688899999999999999999999999
Q ss_pred ccCCC
Q 004565 676 EGGMP 680 (745)
Q Consensus 676 ~~~~~ 680 (745)
+....
T Consensus 294 ~~~~~ 298 (304)
T cd05101 294 DRILT 298 (304)
T ss_pred HHHHH
Confidence 87443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.20 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=192.7
Q ss_pred CCccccCceeEEEEEECC----CcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEE-eCCeeEEEEeecC
Q 004565 388 TPIGSGGFGTVYKGILQD----KSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCA-QGRQRFLVYEYMN 461 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~ 461 (745)
+.||+|+||.||+|.+.+ ...||+|++... .....+.+..|+.+++.++|+|++++++++. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 358999999999998632 357999988643 2344677889999999999999999999876 4556789999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc---
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS--- 538 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--- 538 (745)
+++|.+++......+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999998765567888899999999999999998 99999999999999999999999999999765432211
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCC-CCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKN-SSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
......++..|+|||++.+..++.++||||||+++|||++|+.| |.... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----------------------------~ 208 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----------------------------S 208 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----------------------------H
Confidence 11234467789999999888999999999999999999996544 43211 1
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
............. . .+......+.+++..|++.+|++||++.||++.|+.
T Consensus 209 ~~~~~~~~~~~~~------~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 209 FDITVYLLQGRRL------L----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred HHHHHHHhcCCCC------C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1111111111000 0 011112468899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=318.07 Aligned_cols=196 Identities=26% Similarity=0.322 Sum_probs=169.5
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 47 ~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05621 47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence 3477999999999999985 4788999998632 22334567889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++............
T Consensus 127 gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~ 201 (370)
T cd05621 127 GGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201 (370)
T ss_pred CCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecc
Confidence 99999998654 58889999999999999999999 99999999999999999999999999999876543322234
Q ss_pred ccccccCccCcccccCC----CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 542 TMRGTRGYLAPEWLTSS----AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~----~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
...||+.|+|||.+... .++.++|||||||+||||++|+.||...
T Consensus 202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 56799999999998754 3788999999999999999999999643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.04 Aligned_cols=249 Identities=27% Similarity=0.394 Sum_probs=208.8
Q ss_pred CccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhh
Q 004565 389 PIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 467 (745)
+||+|.+|+||-|+..+ ...+|||.+........+.+.+|+.+-++++|+|||+++|.|.+++..-+.||.+|+|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999765 55799999987666677788999999999999999999999999999999999999999999
Q ss_pred hhcCCCccc--CHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-CCCeEEccCCCcccCCCCCcccccccc
Q 004565 468 TLFGNGSVL--EWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-KLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 468 ~l~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
+|+..-+++ ++.++-.+..||++||.|||+ +.|||||||-+|||++- .|.+||+|||-++.+..- +..+.++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccc
Confidence 998877777 788888999999999999999 99999999999999964 688999999999876543 33456788
Q ss_pred cccCccCcccccCC--CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 545 GTRGYLAPEWLTSS--AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 545 gt~~y~aPE~~~~~--~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
||..|||||++..+ .|...+|||||||.+.||.||++||..... +.-
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-----------------------------pqA-- 786 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-----------------------------PQA-- 786 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-----------------------------hhH--
Confidence 99999999999876 488999999999999999999999964320 000
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccC
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEGG 678 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~--~L~~~ 678 (745)
. +...--.....+++.+...+...++++|+.++|.+||++.++++ +|+-.
T Consensus 787 A------MFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 787 A------MFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred h------hhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0 01111122345677788889999999999999999999999984 45443
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.42 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=200.0
Q ss_pred hhhcCCCCccccCceeEEEEEECC--------CcEEEEEEeccC-CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCC
Q 004565 382 ATDNFNTPIGSGGFGTVYKGILQD--------KSVVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGR 451 (745)
Q Consensus 382 at~~f~~~lG~G~fg~Vy~g~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~ 451 (745)
..+.+.+.||+|+||.||++...+ ...+|+|.+... ......++..|++++..+ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 345556889999999999998532 346999998753 233456788899999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeec
Q 004565 452 QRFLVYEYMNKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH 516 (745)
Q Consensus 452 ~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~ 516 (745)
..++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 9999999999999999997532 258999999999999999999998 9999999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCcccccccccc
Q 004565 517 DKLQVKISDFGLSKLLTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEK 594 (745)
Q Consensus 517 ~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~ 594 (745)
.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------- 247 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 247 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-------
Confidence 99999999999997654322111 122334578999999998889999999999999999998 777774321
Q ss_pred CCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 595 DSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
........ ..... ...+......+.+++..|++.+|++||+|.+|++.
T Consensus 248 ----------------------~~~~~~~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 ----------------------VEELFKLL-KEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred ----------------------HHHHHHHH-HcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 11111111 11110 11122233567889999999999999999999999
Q ss_pred hccC
Q 004565 675 LEGG 678 (745)
Q Consensus 675 L~~~ 678 (745)
|+..
T Consensus 296 l~~~ 299 (307)
T cd05098 296 LDRI 299 (307)
T ss_pred HHHH
Confidence 9763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.65 Aligned_cols=188 Identities=24% Similarity=0.322 Sum_probs=164.5
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
.+.||+|+||.||++... .++.||+|+.. ...+.+|++++++++||||+++++++......++|+|++. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 477999999999999974 57889999753 2457789999999999999999999999999999999985 688
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
..++.... .+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++...............|
T Consensus 170 ~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 245 (391)
T PHA03212 170 YCYLAAKR-NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245 (391)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccC
Confidence 88886543 58999999999999999999999 899999999999999999999999999997544333233345679
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
|+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 246 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 9999999999999999999999999999999999988753
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=308.65 Aligned_cols=238 Identities=29% Similarity=0.443 Sum_probs=200.8
Q ss_pred CccccCceeEEEEEE-CCCcEEEEEEeccCCcc---hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 389 PIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQ---GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.||.|.||.||-+.. .+..+||||++.....+ ...++..|++.|++++|||++.+-||+..+...+|||||| -|+
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGS 111 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGS 111 (948)
T ss_pred HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hcc
Confidence 499999999999997 46789999999854433 3567889999999999999999999999999999999999 458
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
-.++|.-..+++.+..+..|+.+.+.||+|||+ .+.||||||+.||||.+.+.+||+|||.|....+. ..++
T Consensus 112 AsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----nsFv 183 (948)
T KOG0577|consen 112 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----NSFV 183 (948)
T ss_pred HHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----hccc
Confidence 888887777789999999999999999999999 99999999999999999999999999999876654 5678
Q ss_pred cccCccCccccc---CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 545 GTRGYLAPEWLT---SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 545 gt~~y~aPE~~~---~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
||+.|||||++. .+.|+.|+|||||||...||...++|....+ ....+.
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN----------------------------AMSALY 235 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----------------------------AMSALY 235 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch----------------------------HHHHHH
Confidence 999999999875 4689999999999999999999999987654 122221
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
-...++. |.+. ..+....+.+++-.||++-|.+|||.++++.
T Consensus 236 HIAQNes-------PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 236 HIAQNES-------PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHhcCC-------CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111111 1111 4567788999999999999999999998875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.76 Aligned_cols=235 Identities=26% Similarity=0.314 Sum_probs=196.5
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCC---cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeec
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFG---IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
|.++||+|.||+|+++.++. ++.+|||.+++.. ....+..+.|-+++... +||-|+.++.++...++.++||||.
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 34889999999999999864 7799999998643 34466778888888777 5999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
.+|++..+.+ ...+++..+.-+|..|+.||.|||+ ++|||||||.+|||||.+|.+||+|||+++..-.. ...+
T Consensus 452 ~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~~T 525 (694)
T KOG0694|consen 452 AGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GDRT 525 (694)
T ss_pred CCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC-CCcc
Confidence 9999544443 2469999999999999999999999 99999999999999999999999999999865432 2345
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
+++.||+.|||||++.+..|+...|.|||||+|||||.|..||....+.+
T Consensus 526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------------------------------ 575 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------------------------------ 575 (694)
T ss_pred ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------------------------------
Confidence 78999999999999999999999999999999999999999998654211
Q ss_pred HHHHHhhcccccccccccc--CCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004565 621 ALELHEQRRYLELADSRIE--GQVSDEDVEKLVRIALCCVQEEPMLRPSM 668 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 668 (745)
+.|..+. ..+|.-...+.+.|+.+.+..+|++|--+
T Consensus 576 ------------~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 576 ------------VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------------HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111111 13444455678899999999999999766
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=308.86 Aligned_cols=240 Identities=23% Similarity=0.284 Sum_probs=190.4
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccCC---cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFG---IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|...+ +..||||.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 359999999999999854 7889999987431 23345566777777764 999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 9999998754 358999999999999999999999 9999999999999999999999999999875432221 2244
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||..|+|||++.+..++.++|||||||++|||++|+.||.... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----------------------------~~~~~~ 206 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----------------------------EEELFQ 206 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----------------------------HHHHHH
Confidence 578999999999999899999999999999999999999986432 000011
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA-NVV 672 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-ev~ 672 (745)
.. ... .+. ++......+.+++.+|++.+|++||++. ++.
T Consensus 207 ~i-~~~------~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 207 SI-RMD------NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HH-HhC------CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11 100 011 1111234577889999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=300.49 Aligned_cols=252 Identities=23% Similarity=0.417 Sum_probs=203.3
Q ss_pred cCCCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 34578999999999999986 7889999988632 2233667899999999999999999999999999999999999
Q ss_pred CCCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 461 NKGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 461 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
++++|..++.. ....+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999998864 23468999999999999999999999 9999999999999999999999999999876544322
Q ss_pred ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ...
T Consensus 162 ~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---------------------------~~~ 213 (267)
T cd08224 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---------------------------MNL 213 (267)
T ss_pred c-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---------------------------ccH
Confidence 1 233468889999999998889999999999999999999999985322 011
Q ss_pred HHHHHHHHhhccccccccccccCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSD-EDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
....... ..+. ....+. .....+.+++.+|++.+|++|||+.+|+++|+.
T Consensus 214 ~~~~~~~-~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 214 YSLCKKI-EKCD---------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred HHHHhhh-hcCC---------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 1111111 1111 011111 334568899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=301.25 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=197.5
Q ss_pred cCCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 385 NFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++|+||+++++++......++|+||++++
T Consensus 12 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~ 91 (267)
T cd06646 12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG 91 (267)
T ss_pred chhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence 3447799999999999997 567899999987655455667889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++........ .....
T Consensus 92 ~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 166 (267)
T cd06646 92 SLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSF 166 (267)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCcc
Confidence 9999886543 68999999999999999999998 9999999999999999999999999999986643221 12334
Q ss_pred ccccCccCccccc---CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 544 RGTRGYLAPEWLT---SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 544 ~gt~~y~aPE~~~---~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
.++..|+|||.+. ...++.++||||||++++||++|+.|+.............
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~------------------------ 222 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS------------------------ 222 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee------------------------
Confidence 6889999999884 3457889999999999999999999885332000000000
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
. .....+.... .......+.+++.+|++.+|++||++++|++.|
T Consensus 223 ------~---~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 223 ------K---SNFQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ------c---CCCCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 0000000000 011234688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.88 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=197.0
Q ss_pred cCCCCccccCceeEEEEEE-CCCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC--------ee
Q 004565 385 NFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR--------QR 453 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--------~~ 453 (745)
.+.+.||+|+||.||+|+. .+++.||||++... .......+..|+.++..++|+|++++...+.... ..
T Consensus 35 ~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i 114 (496)
T PTZ00283 35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI 114 (496)
T ss_pred EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence 3447899999999999986 46899999998643 3344567889999999999999999988775432 35
Q ss_pred EEEEeecCCCChhhhhcCC---CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcc
Q 004565 454 FLVYEYMNKGSLDRTLFGN---GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK 530 (745)
Q Consensus 454 ~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~ 530 (745)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 7999999999999998643 2368999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc-ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCC
Q 004565 531 LLTPEQS-SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSP 609 (745)
Q Consensus 531 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (745)
.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---------------------- 249 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---------------------- 249 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----------------------
Confidence 7654322 22245679999999999999999999999999999999999999986432
Q ss_pred cccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 610 RESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
......... .+.. ...+......+.+++..||+.+|.+||++.++++.
T Consensus 250 -------~~~~~~~~~-~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 250 -------MEEVMHKTL-AGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------HHHHHHHHh-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111111 1111 01122233568899999999999999999999863
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=303.37 Aligned_cols=201 Identities=25% Similarity=0.340 Sum_probs=174.4
Q ss_pred hhcCC--CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEE
Q 004565 383 TDNFN--TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLV 456 (745)
Q Consensus 383 t~~f~--~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV 456 (745)
.+.|. ++||+|+||.||+++-+ .|..+|+|++++.. ....+..+.|-.+|....++.||+|+-.|.+...+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 34555 78999999999999975 49999999998653 34466788899999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC-
Q 004565 457 YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE- 535 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~- 535 (745)
|||+++|++..+|...+ .|++.....++.+++.||.-||+ .++|||||||+|+|||..|++||+||||+.-+...
T Consensus 220 MEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999998765 69999999999999999999999 99999999999999999999999999999543210
Q ss_pred ----------------------Ccc----c-------------------ccccccccCccCcccccCCCCCCccceeehH
Q 004565 536 ----------------------QSS----L-------------------FTTMRGTRGYLAPEWLTSSAISDKTDVYSYG 570 (745)
Q Consensus 536 ----------------------~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~G 570 (745)
... . ....+||+.|||||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 000 0 0124599999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccc
Q 004565 571 MVLLEIISGRKNSSLKI 587 (745)
Q Consensus 571 vll~elltg~~p~~~~~ 587 (745)
||+||||.|-+||....
T Consensus 376 ~ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSET 392 (550)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999998654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=318.40 Aligned_cols=196 Identities=22% Similarity=0.309 Sum_probs=168.9
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||+|+.. ++..||||++.... ....+.+..|++++.+++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 367999999999999874 57899999986432 23456788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc-----
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS----- 537 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~----- 537 (745)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||++..+.....
T Consensus 86 g~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 86 GDMMSLLIRME-VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999987654 58899999999999999999999 9999999999999999999999999999864321100
Q ss_pred -----------------------------------------ccccccccccCccCcccccCCCCCCccceeehHHHHHHH
Q 004565 538 -----------------------------------------SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEI 576 (745)
Q Consensus 538 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~el 576 (745)
.......||..|+|||.+.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 001234699999999999988999999999999999999
Q ss_pred HhCCCCCCcc
Q 004565 577 ISGRKNSSLK 586 (745)
Q Consensus 577 ltg~~p~~~~ 586 (745)
++|+.||...
T Consensus 242 ltG~~Pf~~~ 251 (381)
T cd05626 242 LVGQPPFLAP 251 (381)
T ss_pred HhCCCCCcCC
Confidence 9999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=311.33 Aligned_cols=243 Identities=25% Similarity=0.288 Sum_probs=190.3
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHH-HHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEIT-IIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+++.. +++.+|||++... .......+..|.. +++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999974 6889999998642 2223345555554 56778999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 99998886543 68999999999999999999999 999999999999999999999999999987543222 12244
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||..|+|||++.+..++.++|||||||++|||++|+.||.... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----------------------------~~~~~~ 206 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----------------------------VAEMYD 206 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----------------------------HHHHHH
Confidence 579999999999999999999999999999999999999986432 011111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
... .... .+... ....+.+++..|++.+|.+||++.+.++.+
T Consensus 207 ~~~-~~~~------~~~~~----~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 207 NIL-HKPL------VLRPG----ASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHH-cCCc------cCCCC----CCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 111 1110 11111 234577889999999999999987544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=309.98 Aligned_cols=241 Identities=24% Similarity=0.286 Sum_probs=193.4
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccC---CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSF---GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|.... +..||||++... .......+..|.+++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 359999999999999864 788999998743 223455677888888887 799999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++....... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST 155 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence 99998887653 58999999999999999999999 999999999999999999999999999987532222 12234
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..|+..|+|||++.+..++.++|||||||++|||++|+.||.... ......
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----------------------------~~~~~~ 206 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----------------------------EDELFQ 206 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----------------------------HHHHHH
Confidence 568999999999999999999999999999999999999986432 000111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSM-----ANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~ev~~ 673 (745)
.. ..... .++......+.+++.+||+.||.+||++ .++++
T Consensus 207 ~i-~~~~~----------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 207 SI-LEDEV----------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HH-HcCCC----------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11 11110 1111223467899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.89 Aligned_cols=253 Identities=26% Similarity=0.437 Sum_probs=197.5
Q ss_pred cCCCCccccCceeEEEEEECC------CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQD------KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 457 (745)
.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+....++||
T Consensus 9 ~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (288)
T cd05061 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVM 88 (288)
T ss_pred eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 345789999999999997642 4579999876433 233456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCC---------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCC
Q 004565 458 EYMNKGSLDRTLFGNG---------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL 528 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl 528 (745)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||+
T Consensus 89 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~ 165 (288)
T cd05061 89 ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM 165 (288)
T ss_pred eCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCCc
Confidence 9999999999996421 245778889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCC
Q 004565 529 SKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSS 606 (745)
Q Consensus 529 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 606 (745)
++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~------------------- 226 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS------------------- 226 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-------------------
Confidence 9865433221 1122345678999999998899999999999999999998 677775322
Q ss_pred CCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 004565 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGM 679 (745)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 679 (745)
..... .....+... ..+......+.+++.+|++.+|++|||+.++++.|+..+
T Consensus 227 ----------~~~~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 227 ----------NEQVL-KFVMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----------HHHHH-HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00111 111111100 011122357889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=309.30 Aligned_cols=240 Identities=23% Similarity=0.261 Sum_probs=190.4
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|... ++..||||+++... ....+.+..|.+++... +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999986 57899999987431 23345567788777754 899999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 9999988764 358899999999999999999999 999999999999999999999999999987532222 12245
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||..|+|||++.+..++.++|||||||++|||++|+.||.... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----------------------------~~~~~~ 206 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----------------------------EDELFE 206 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----------------------------HHHHHH
Confidence 678999999999999999999999999999999999999996432 001111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA-NVV 672 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-ev~ 672 (745)
.. ... .+.+ +......+.+++..|++.||++||++. +++
T Consensus 207 ~~-~~~------~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 207 SI-RVD------TPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HH-HhC------CCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11 100 0111 111234577899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.63 Aligned_cols=264 Identities=25% Similarity=0.394 Sum_probs=200.4
Q ss_pred CCCccccCceeEEEEEE-----CCCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGIL-----QDKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e 458 (745)
.+.||+|+||.||++++ .++..||+|.+.... ....+.+.+|++++++++|+|++++.+++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 46799999999999985 347789999987443 33456789999999999999999999999775 56789999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++++|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05079 89 FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 165 (284)
T ss_pred ccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccccCccc
Confidence 999999999997665578999999999999999999999 99999999999999999999999999999876543221
Q ss_pred --cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 539 --LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 539 --~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
......++..|+|||++.+..++.++||||||++++||++++.|...... ...+ ..+ +.. ....
T Consensus 166 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~---~~~~--~~~--~~~-------~~~~ 231 (284)
T cd05079 166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT---LFLK--MIG--PTH-------GQMT 231 (284)
T ss_pred eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc---hhhh--hcc--ccc-------cccc
Confidence 12234567789999999888899999999999999999998766432110 0000 000 000 0111
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
...... ....+... ..+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 232 ~~~~~~-~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 232 VTRLVR-VLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHHH-HHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 111111 11111110 1111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=304.35 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=196.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.++||+|+||.||++... ++..||||++.... ......+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 367999999999999974 68899999986432 22245678899999999999999999999999999999999999
Q ss_pred CChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 463 GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
|+|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++........ ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 159 (285)
T cd05605 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IR 159 (285)
T ss_pred CcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--cc
Confidence 99998886543 368999999999999999999999 9999999999999999999999999999987543322 23
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...|+..|+|||++.+..++.++||||||+++|||++|+.||.... ....... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~-------------------------~~~~~~~-~ 213 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK-------------------------EKVKREE-V 213 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc-------------------------hhhHHHH-H
Confidence 4468999999999998899999999999999999999999996432 0000000 0
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
...... ....++......+.+++..|++.||++|| +++++++
T Consensus 214 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 214 ERRVKE----------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHHhhh----------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 000000 00112223345678999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=294.42 Aligned_cols=271 Identities=24% Similarity=0.282 Sum_probs=207.6
Q ss_pred CccccCceeEEEEEE-CCCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCc-eeeEEEEEEeCC------eeEEEEe
Q 004565 389 PIGSGGFGTVYKGIL-QDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVN-LVRLKGFCAQGR------QRFLVYE 458 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~------~~~lV~e 458 (745)
+||+|.||+||+|+. .+|+.||+|+++.... .......+|+.++.+++|+| ||++.+++...+ ..++|+|
T Consensus 18 klGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe 97 (323)
T KOG0594|consen 18 KLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFE 97 (323)
T ss_pred HhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEE
Confidence 499999999999997 4688999999985433 23455688999999999999 999999998877 7889999
Q ss_pred ecCCCChhhhhcCCC---cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 459 YMNKGSLDRTLFGNG---SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
|+.. +|..++.... ..++...+..++.||+.||+|||+ ++|+||||||.||||++++.+||+|||+|+.+...
T Consensus 98 ~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip 173 (323)
T KOG0594|consen 98 FLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP 173 (323)
T ss_pred eecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhcCC
Confidence 9965 8999998765 357778899999999999999999 99999999999999999999999999999966533
Q ss_pred CcccccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccc
Q 004565 536 QSSLFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614 (745)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (745)
. ...+..++|..|.|||++.+. .|+...||||+||++.||++++.-|....+.+....++.-.|.+.... +...
T Consensus 174 ~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~----Wp~v 248 (323)
T KOG0594|consen 174 M-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD----WPGV 248 (323)
T ss_pred c-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC----CCCc
Confidence 2 224667889999999999876 789999999999999999999988888776666666666655543322 1112
Q ss_pred ccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 615 VYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
..++.+............+. .. -+.......+++.+|++.+|.+|.|++..+++
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~-----~~-~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLS-----SI-LPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccccCcCCCCccchH-----Hh-ccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 22222211111000000000 00 00111357788889999999999999999875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=310.00 Aligned_cols=194 Identities=27% Similarity=0.336 Sum_probs=165.5
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHH---HccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITI---IGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~---l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
.+.||+|+||.||+|... +++.||||++.... ....+.+..|+++ ++.++|+||+++++++......++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 467999999999999975 58899999987432 2234456666554 4567899999999999999999999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
+++++|..++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....... ..
T Consensus 84 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05589 84 AAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DR 157 (324)
T ss_pred CCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-Cc
Confidence 999999988854 369999999999999999999999 999999999999999999999999999987543222 12
Q ss_pred ccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 24467899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=313.01 Aligned_cols=195 Identities=29% Similarity=0.457 Sum_probs=164.6
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC-----eeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR-----QRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e 458 (745)
.++||+|+||.||+|+.. ++..||||++... .......+.+|++++++++||||+++++++.... ..++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 467999999999999975 5889999998742 2234457889999999999999999999885432 4799999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc-
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS- 537 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 537 (745)
|+. ++|.+++.... .+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 85 LME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred cCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 996 68988886543 58999999999999999999999 9999999999999999999999999999986533221
Q ss_pred -ccccccccccCccCcccccC--CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 -SLFTTMRGTRGYLAPEWLTS--SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 -~~~~~~~gt~~y~aPE~~~~--~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 11234578999999999876 67899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=301.57 Aligned_cols=265 Identities=25% Similarity=0.317 Sum_probs=197.1
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC-----eeEEEEeecC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR-----QRFLVYEYMN 461 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~~ 461 (745)
+++|.|.||.||+|++.. +..||||+.-.... .--.|+++|+++.|||||+++-++.... ...+|+||||
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 679999999999999854 68999999854322 2345899999999999999999886433 2359999998
Q ss_pred CCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC-CCeEEccCCCcccCCCCCc
Q 004565 462 KGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 462 ~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~-~~~kl~Dfgl~~~~~~~~~ 537 (745)
. +|...++. .+..++...+.-+..||.+||+|||+ .+|+||||||.|+|+|.+ +.+||+|||.|+.+..+..
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 7 88888874 24467888888899999999999999 999999999999999977 8999999999998877655
Q ss_pred ccccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 538 SLFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
. ....-|..|.|||.+.+. .|+.+.||||.||++.||+-|+.-|.+....+....+....|.++..+.......
T Consensus 182 n--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~--- 256 (364)
T KOG0658|consen 182 N--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN--- 256 (364)
T ss_pred c--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc---
Confidence 4 334568899999998774 7999999999999999999999988876655555555555554432221000000
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..+.+...+.......-.........++++.++++.+|.+|.++.|++.
T Consensus 257 --------y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 257 --------YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred --------cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0001111111111101112223346788899999999999999999984
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=305.75 Aligned_cols=265 Identities=28% Similarity=0.424 Sum_probs=204.1
Q ss_pred CCCCccccCceeEEEEEEC-----CCcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEe--CCeeEEEE
Q 004565 386 FNTPIGSGGFGTVYKGILQ-----DKSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQ--GRQRFLVY 457 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 457 (745)
+.+.||+|+||.||+|++. .+..||||.+...... ..+.|..|+++++.++|+||+++++++.. ....++|+
T Consensus 8 ~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred hheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence 3477999999999999964 3678999999755443 46789999999999999999999999977 55789999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+++++|.+++......+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 88 EYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164 (284)
T ss_pred ecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence 9999999999998776679999999999999999999998 9999999999999999999999999999987763322
Q ss_pred c--cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 538 S--LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 538 ~--~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
. ......++..|+|||.+.+..++.++||||||++++||++|+.|+........ ...+.. ....
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-----~~~~~~---------~~~~ 230 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-----RMIGIA---------QGQM 230 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc-----cccccc---------cccc
Confidence 1 11223456679999999988999999999999999999999988754321000 000000 0001
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
....+........+ ...+......+.+++.+|++.+|++||||.||+++|+.
T Consensus 231 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 231 IVTRLLELLKEGER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred cHHHHHHHHHcCCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 12222111111111 11112223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=299.25 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=197.2
Q ss_pred CCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 387 NTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
.+.||+|+||.||+|.... +..+++|.+........+.+..|+++++.++|+|++++++++......++|+||+++++|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l 89 (282)
T cd06643 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 89 (282)
T ss_pred HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcH
Confidence 3669999999999999864 678889988765555677889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
..++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... .......+
T Consensus 90 ~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 165 (282)
T cd06643 90 DAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIG 165 (282)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccccccc
Confidence 99887655679999999999999999999999 999999999999999999999999999987654322 12234568
Q ss_pred ccCccCccccc-----CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 546 TRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 546 t~~y~aPE~~~-----~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
+..|+|||++. ...++.++|||||||++|||++|+.||.... ....
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----------------------------~~~~ 216 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-----------------------------PMRV 216 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-----------------------------HHHH
Confidence 99999999984 3457789999999999999999999885322 0000
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
....... ...... .+......+.+++..|++.+|.+||++.+|++.
T Consensus 217 ~~~~~~~-~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 217 LLKIAKS-EPPTLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHhhc-CCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 000000 111123467899999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=299.75 Aligned_cols=244 Identities=29% Similarity=0.409 Sum_probs=195.4
Q ss_pred cCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEE-eCCeeEEEEeecCCC
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA-QGRQRFLVYEYMNKG 463 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~~g 463 (745)
.+.+.||+|+||.||++... +..||+|.++.. ...+.|..|+.++++++|+|++++++++. .....++|+||++++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred eeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 34577999999999999875 667899988643 23567899999999999999999999764 456789999999999
Q ss_pred ChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++..... .+++..++.++.+++.||+|||+ .+++|+||||+||++++++.+||+|||++....... ..
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 158 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 158 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----CC
Confidence 99999976544 58999999999999999999998 999999999999999999999999999987554322 22
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...+..|+|||++....++.++||||||+++|||++ |+.||.... .....
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----------------------------~~~~~ 209 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----------------------------LKDVV 209 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----------------------------HHHHH
Confidence 344678999999998899999999999999999998 888875322 11111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
...... . ....+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 210 ~~~~~~-~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 210 PRVEKG-Y---------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHhcC-C---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111111 0 011112233567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.35 Aligned_cols=248 Identities=29% Similarity=0.429 Sum_probs=197.0
Q ss_pred CCCccccCceeEEEEEEC------CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 387 NTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
.+.||+|+||.||++... ++..||+|.+.... ....+++..|+.++++++|+|++++++++..+...++|+||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 477999999999999864 46789999987433 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC---------------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC
Q 004565 460 MNKGSLDRTLFGNG---------------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK 518 (745)
Q Consensus 460 ~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~ 518 (745)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++++
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~ 166 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 166 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCC
Confidence 99999999986321 247889999999999999999998 999999999999999999
Q ss_pred CCeEEccCCCcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCC
Q 004565 519 LQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDS 596 (745)
Q Consensus 519 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~ 596 (745)
+.+||+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--------- 237 (288)
T cd05050 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--------- 237 (288)
T ss_pred CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---------
Confidence 99999999998765433211 1122345678999999998899999999999999999997 777775321
Q ss_pred CCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 597 SGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
..... .....+... ..+......+.+++.+|++.+|++|||+.||++.|+
T Consensus 238 --------------------~~~~~-~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 238 --------------------HEEVI-YYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred --------------------HHHHH-HHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 01111 111111111 111122356889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.14 Aligned_cols=274 Identities=23% Similarity=0.286 Sum_probs=196.8
Q ss_pred CCCccccCceeEEEEEE-CCCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC-----eeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGIL-QDKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR-----QRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e 458 (745)
.++||+|+||.||++.. .+++.||||++... .....+.+.+|+++++.++|+||+++++++.... ..++|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 36799999999999997 46889999998643 2234567889999999999999999999998776 7899999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+. ++|...+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 85 LMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred ccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 997 5787777554 368999999999999999999999 99999999999999999999999999999876544333
Q ss_pred cccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 539 LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
......++..|+|||++.+. .++.++|||||||+++||++|+.||...........+....+..+. . .....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~-~------~~~~~ 232 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL-E------AMRSA 232 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH-H------HHHHh
Confidence 33445688999999998774 4789999999999999999999999754322111111111111100 0 00000
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
............ ...................+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGP-HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCC-CCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000000000 0000000000011112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=302.88 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=195.7
Q ss_pred CCccccCceeEEEEEECC-------CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQD-------KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+.||+|+||.||+|+..+ +..+|||.+.... ......+.+|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 359999999999999753 2578999876432 24467789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCC------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC-----CeEEccCCC
Q 004565 460 MNKGSLDRTLFGN------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-----QVKISDFGL 528 (745)
Q Consensus 460 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~-----~~kl~Dfgl 528 (745)
+++++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 2358899999999999999999998 8999999999999999887 899999999
Q ss_pred cccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCC
Q 004565 529 SKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSS 606 (745)
Q Consensus 529 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 606 (745)
+......... ......++..|+|||++.++.++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~------------------- 218 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN------------------- 218 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-------------------
Confidence 9765433221 1122345678999999999999999999999999999998 888875322
Q ss_pred CCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
........ ..+. ....+......+.+++.+|++.+|.+||++.+|++.|+
T Consensus 219 ----------~~~~~~~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 219 ----------NQEVLQHV-TAGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----------HHHHHHHH-hcCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00111111 1100 00111223456789999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.74 Aligned_cols=193 Identities=25% Similarity=0.329 Sum_probs=167.9
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||++... +++.||||++.... ....+.+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999985 57889999997532 23345678899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 99998886543 59999999999999999999999 999999999999999999999999999987533221 12244
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
..||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 6799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=301.10 Aligned_cols=252 Identities=21% Similarity=0.389 Sum_probs=201.0
Q ss_pred CCCCccccCceeEEEEEE-CCCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.+.||+|+||.||+|.. .++..++||.+.... .....++.+|+++++.++|+||+++++++...+..+++|||++
T Consensus 6 ~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecC
Confidence 346799999999999996 478899999876432 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 462 KGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 462 ~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
+++|.+++.. ....+++..++.++.+|+.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd08229 86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence 9999998863 23468999999999999999999998 99999999999999999999999999998866543221
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....++..|+|||++.+..++.++||||||+++|||++|..||..... ...
T Consensus 163 -~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------------------------~~~ 214 (267)
T cd08229 163 -AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------------------------NLY 214 (267)
T ss_pred -cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---------------------------hHH
Confidence 2345688999999999988899999999999999999999999853220 000
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
..... ......+.+ ........+.+++.+|++.+|++||||.+|+++++.
T Consensus 215 ~~~~~------~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 215 SLCKK------IEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred HHhhh------hhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 00000 000111111 111234568899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.68 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=198.5
Q ss_pred CCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 387 NTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
.+.||+|+||.||+|.. .++..|++|.+........+.+..|+.+++.++|+|++++++.+......++||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 46799999999999996 46889999999865555667889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++... .+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++......... .....+
T Consensus 105 ~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 178 (296)
T cd06654 105 TDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVG 178 (296)
T ss_pred HHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cCcccC
Confidence 9998643 58999999999999999999999 99999999999999999999999999998765433221 233468
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+.. ..
T Consensus 179 ~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----------------------------~~~~~~-~~ 229 (296)
T cd06654 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----------------------------LRALYL-IA 229 (296)
T ss_pred CccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----------------------------HHhHHH-Hh
Confidence 8999999999988899999999999999999999999864320 000000 00
Q ss_pred hhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.... +.+ ..+......+.+++.+|++.+|++||++.+|++
T Consensus 230 ~~~~------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 230 TNGT------PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cCCC------CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0000 000 111223356788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=308.52 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=197.8
Q ss_pred cCCCCccccCceeEEEEEEC--------CCcEEEEEEeccC-CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeE
Q 004565 385 NFNTPIGSGGFGTVYKGILQ--------DKSVVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRF 454 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~ 454 (745)
.+.++||+|+||.||+++.. ....+|+|.+... .......+..|+++++++ +|+||+++++++......+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 34588999999999999752 2456899988743 233456788999999999 6999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC
Q 004565 455 LVYEYMNKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519 (745)
Q Consensus 455 lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~ 519 (745)
+|+||+++|+|.+++.... ..+++..+..++.||+.||.|||+ .+++|+||||+|||+++++
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCC
Confidence 9999999999999986532 358999999999999999999998 9999999999999999999
Q ss_pred CeEEccCCCcccCCCCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCC
Q 004565 520 QVKISDFGLSKLLTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSS 597 (745)
Q Consensus 520 ~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~ 597 (745)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---------- 241 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---------- 241 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC----------
Confidence 99999999998665322211 122334568999999998899999999999999999999 777775322
Q ss_pred CCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 598 GDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
... ........... ..+......+.+++.+|++.+|++|||+.||++.|+.
T Consensus 242 -------------------~~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 242 -------------------VEE-LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred -------------------HHH-HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 001 11111111110 1111223467789999999999999999999999987
Q ss_pred C
Q 004565 678 G 678 (745)
Q Consensus 678 ~ 678 (745)
.
T Consensus 293 ~ 293 (314)
T cd05099 293 V 293 (314)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.78 Aligned_cols=238 Identities=25% Similarity=0.404 Sum_probs=189.7
Q ss_pred CCccccCceeEEEEEECCCc-----------EEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEE
Q 004565 388 TPIGSGGFGTVYKGILQDKS-----------VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLV 456 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV 456 (745)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++|+|++++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 35999999999999986533 4777876543332 6788999999999999999999999988 778999
Q ss_pred EeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC-------CeEEccCCCc
Q 004565 457 YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-------QVKISDFGLS 529 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~-------~~kl~Dfgl~ 529 (745)
+||+++++|.+++......+++..++.++.||+.||+|||+ .+|+|+||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998766579999999999999999999998 9999999999999999887 7999999999
Q ss_pred ccCCCCCcccccccccccCccCcccccCC--CCCCccceeehHHHHHHHHhC-CCCCCccccccccccCCCCCCCCCCCC
Q 004565 530 KLLTPEQSSLFTTMRGTRGYLAPEWLTSS--AISDKTDVYSYGMVLLEIISG-RKNSSLKIQSRSTEKDSSGDGNGPSSS 606 (745)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~Dv~S~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 606 (745)
...... ....++..|+|||++... .++.++||||||+++|||++| ..|+.....
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~------------------ 212 (259)
T cd05037 156 ITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS------------------ 212 (259)
T ss_pred cccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc------------------
Confidence 865431 233467789999999876 789999999999999999995 555543210
Q ss_pred CCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
..+. ........ .+......+.+++..|++.+|.+|||+.+|++.|+
T Consensus 213 -----------~~~~-~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 213 -----------SEKE-RFYQDQHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----------hhHH-HHHhcCCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00000000 00001156889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.89 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=187.8
Q ss_pred CccccCceeEEEEEECC---CcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 389 PIGSGGFGTVYKGILQD---KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.||+|+||.||+|...+ ...+++|.+.... ......|.+|++.++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999998643 3468888776432 3335678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCc----ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-c
Q 004565 465 LDRTLFGNGS----VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-L 539 (745)
Q Consensus 465 L~~~l~~~~~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~ 539 (745)
|.+++..... ..++...+.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 35688889999999999999999 99999999999999999999999999998754332211 1
Q ss_pred ccccccccCccCcccccC-------CCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcc
Q 004565 540 FTTMRGTRGYLAPEWLTS-------SAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~-------~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------------------------ 214 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS------------------------ 214 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC------------------------
Confidence 123345678999998743 356889999999999999999 677764321
Q ss_pred cccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
. . ......... ......++.+... ....+.+++..|+ .+|++|||+++|+++|.
T Consensus 215 -~---~-~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 215 -D---E-QVLKQVVRE-QDIKLPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -H---H-HHHHHHhhc-cCccCCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 0 000111111 1111222222222 2344566777888 59999999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=302.35 Aligned_cols=243 Identities=27% Similarity=0.404 Sum_probs=191.3
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeC------CeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQG------RQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~------~~~~lV~e~ 459 (745)
+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+|++++++++... ...++||||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 67999999999999975 47889999986543 4456788999999998 799999999998753 457899999
Q ss_pred cCCCChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 460 MNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 460 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++........
T Consensus 91 ~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~- 166 (272)
T cd06637 91 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG- 166 (272)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceecccccc-
Confidence 99999999987643 468999999999999999999999 8999999999999999999999999999986543221
Q ss_pred cccccccccCccCccccc-----CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccc
Q 004565 539 LFTTMRGTRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQ 613 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~-----~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (745)
......|+..|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 167 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------------------------- 221 (272)
T cd06637 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------------------------- 221 (272)
T ss_pred cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------------------------
Confidence 224456899999999986 33578899999999999999999999853210
Q ss_pred cccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 614 RVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.... ........ ..+ ........+.+++.+|++.+|.+|||+.||++
T Consensus 222 ---~~~~--~~~~~~~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 222 ---MRAL--FLIPRNPA-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---HHHH--HHHhcCCC-----CCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 00000000 000 01112245789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=315.14 Aligned_cols=195 Identities=25% Similarity=0.353 Sum_probs=169.9
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||+++.. +++.||||++... .......+..|++++..++|+||+++++++.+....++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG 86 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence 67999999999999985 5889999999742 1233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-----
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS----- 538 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~----- 538 (745)
+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+......
T Consensus 87 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 162 (364)
T cd05599 87 DMMTLLMKKD-TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162 (364)
T ss_pred HHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccc
Confidence 9999997654 58999999999999999999999 99999999999999999999999999998765322110
Q ss_pred --------------------------------cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 539 --------------------------------LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 539 --------------------------------~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~ 242 (364)
T cd05599 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242 (364)
T ss_pred ccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCC
Confidence 001245899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.40 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=200.3
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
+.+.||+|+||.||+|...+ +..+++|.+..... .+++.+|++++++++|+|++++++++......++++||+++++
T Consensus 7 ~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 34679999999999999865 78999999865432 6789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++......+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........ ......
T Consensus 85 L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 160 (256)
T cd06612 85 VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVI 160 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccccc
Confidence 999998766789999999999999999999998 8999999999999999999999999999987654332 223345
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
++..|+|||++.+..++.++||||||++++||++|+.||........ ...
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------------------------------~~~ 210 (256)
T cd06612 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------------------------------IFM 210 (256)
T ss_pred CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------------------------------hhh
Confidence 78899999999988999999999999999999999999864321000 000
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..... ...+ ..+......+.+++.+|++.+|++|||+.||++
T Consensus 211 ~~~~~-----~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 211 IPNKP-----PPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hccCC-----CCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00000 0000 111222356888999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.83 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=194.7
Q ss_pred hcCCCCccccCceeEEEEEE------CCCcEEEEEEeccCC-cchHHHHHHHHHHHccC-CCCceeeEEEEEEeC-CeeE
Q 004565 384 DNFNTPIGSGGFGTVYKGIL------QDKSVVAVKKINSFG-IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQG-RQRF 454 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~-~~~~ 454 (745)
..+.+.||+|+||.||+|.. ..++.||||+++... ......+..|+.++.++ +|+||+++++++... ...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 44568899999999999974 346789999997533 23356788999999999 789999999988654 4578
Q ss_pred EEEeecCCCChhhhhcCCC-------------------------------------------------------------
Q 004565 455 LVYEYMNKGSLDRTLFGNG------------------------------------------------------------- 473 (745)
Q Consensus 455 lV~e~~~~gsL~~~l~~~~------------------------------------------------------------- 473 (745)
+|+||+++|+|.+++....
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 9999999999999886421
Q ss_pred -----cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-ccccccccc
Q 004565 474 -----SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-LFTTMRGTR 547 (745)
Q Consensus 474 -----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~ 547 (745)
..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||++......... ......++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 136888899999999999999999 99999999999999999999999999999865433221 112334567
Q ss_pred CccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 548 ~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
.|+|||.+.+..++.++||||||+++|||++ |..|+.... .. ... .....
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------------------------~~---~~~-~~~~~ 296 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------------------------ID---EEF-CRRLK 296 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc-------------------------cc---HHH-HHHHh
Confidence 8999999998899999999999999999997 887774321 00 000 11111
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.+... .. +......+.+++..|++.+|++|||+.||++.|+.
T Consensus 297 ~~~~~-----~~----~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 297 EGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred ccCCC-----CC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11100 00 11112357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.09 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=190.4
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHH-HHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEI-TIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 35999999999999985 56789999986422 12233444444 456788999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|.+++.... .+.+..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 99999987643 57788888999999999999999 999999999999999999999999999997543222 12345
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----------------------------~~~~~~ 206 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----------------------------TAEMYD 206 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-----------------------------HHHHHH
Confidence 679999999999999999999999999999999999999986432 001111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
... .... .+.. .....+.+++..|++.+|.+||++.+.+..+..
T Consensus 207 ~i~-~~~~------~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 207 NIL-NKPL------QLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred HHH-hCCc------CCCC----CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 111 1100 1111 223457788899999999999998865544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=299.20 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=197.6
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
+.++||+|+||.||+|.... +..+++|.+........+.+..|+.+++.++|+|++++++.+......++||||+++++
T Consensus 16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 34679999999999999864 78999999986666667789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|..++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++....... .......
T Consensus 96 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 171 (292)
T cd06644 96 VDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFI 171 (292)
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cccceec
Confidence 998887666679999999999999999999998 999999999999999999999999999987543321 1123456
Q ss_pred cccCccCccccc-----CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 545 GTRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 545 gt~~y~aPE~~~-----~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
++..|+|||++. ...++.++||||||+++|||++|+.||.... ...
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----------------------------~~~ 222 (292)
T cd06644 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----------------------------PMR 222 (292)
T ss_pred CCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-----------------------------HHH
Confidence 788999999985 3456889999999999999999999885432 000
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
....... ... +.+ ..+......+.+++.+|++.+|++||++++|++
T Consensus 223 ~~~~~~~-~~~-----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 223 VLLKIAK-SEP-----PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHhc-CCC-----ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0111110 000 000 011122345788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.32 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=196.6
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc-----chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI-----QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.||+|++|.||++... ++..||+|.+..... ...+.+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 377999999999999974 588999998864321 22456888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++...........
T Consensus 87 ~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 162 (263)
T cd06625 87 PGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT 162 (263)
T ss_pred CCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccc
Confidence 9999999886543 58899999999999999999999 9999999999999999999999999999976543222111
Q ss_pred --cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 541 --TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 541 --~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----------------------------~~~ 214 (263)
T cd06625 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----------------------------AMA 214 (263)
T ss_pred cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----------------------------hHH
Confidence 33457889999999999889999999999999999999999985321 000
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.. ....... .....+......+.+++..|++.+|++|||+.|+++.
T Consensus 215 ~~-~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 215 AI-FKIATQP---------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HH-HHHhccC---------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 0100000 0111222233467889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.85 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=203.3
Q ss_pred HHHHhhhcCCCCccccCceeEEEEEEC--------CCcEEEEEEeccCC-cchHHHHHHHHHHHccC-CCCceeeEEEEE
Q 004565 378 ELAAATDNFNTPIGSGGFGTVYKGILQ--------DKSVVAVKKINSFG-IQGKKEFCTEITIIGNI-HHVNLVRLKGFC 447 (745)
Q Consensus 378 el~~at~~f~~~lG~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~ 447 (745)
++......+.+.||+|+||.||++... ....||+|.+.... ....+++..|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 334445566788999999999999752 12368999887432 33457889999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCC
Q 004565 448 AQGRQRFLVYEYMNKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPEN 512 (745)
Q Consensus 448 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~N 512 (745)
......++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 99999999999999999999986432 258899999999999999999999 999999999999
Q ss_pred eeecCCCCeEEccCCCcccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCcccccc
Q 004565 513 ILLHDKLQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSR 590 (745)
Q Consensus 513 Ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~ 590 (745)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--- 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--- 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---
Confidence 99999999999999999865443221 1122344578999999999999999999999999999998 777775321
Q ss_pred ccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 004565 591 STEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMAN 670 (745)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e 670 (745)
........ ..... ...+......+.+++..|++.+|++||+|.|
T Consensus 242 --------------------------~~~~~~~~-~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 285 (334)
T cd05100 242 --------------------------VEELFKLL-KEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQ 285 (334)
T ss_pred --------------------------HHHHHHHH-HcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 11111111 11111 0111122346889999999999999999999
Q ss_pred HHHHhccCCC
Q 004565 671 VVSMLEGGMP 680 (745)
Q Consensus 671 v~~~L~~~~~ 680 (745)
|++.|+....
T Consensus 286 ll~~l~~~~~ 295 (334)
T cd05100 286 LVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHhh
Confidence 9999987553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.68 Aligned_cols=238 Identities=22% Similarity=0.276 Sum_probs=189.7
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeec
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
+.+.||+|+||.||+|... ++..||||.+.... ....+.+..|..++..+ +|++|+++.+++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 3467999999999999986 46789999987432 22344566788888777 6899999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
++|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 84 ~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~~ 158 (323)
T cd05616 84 NGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TT 158 (323)
T ss_pred CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-cc
Confidence 9999999886553 58999999999999999999999 9999999999999999999999999999975432221 22
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----------------------------~~~~ 209 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----------------------------EDEL 209 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----------------------------HHHH
Confidence 34578999999999999999999999999999999999999996432 0011
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSM 668 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 668 (745)
..... .... .++......+.+++.+|++.+|.+|++.
T Consensus 210 ~~~i~-~~~~----------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 210 FQSIM-EHNV----------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHH-hCCC----------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11111 1110 1122233567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.06 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=202.9
Q ss_pred CCccccCceeEEEEEEC--CCc--EEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ--DKS--VVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
++||+|.||.|++|.+. +|+ .||||+++..... ...+|+.|+..|-+|+|+|+++|+|+..+ ....||+|.++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 56999999999999985 343 5899999866544 57889999999999999999999999988 677899999999
Q ss_pred CChhhhhcC-CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-cc
Q 004565 463 GSLDRTLFG-NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-LF 540 (745)
Q Consensus 463 gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~ 540 (745)
|+|.+.|++ ....|-....-.++.|||.||.||.. +++|||||.++|+||-..-.+||+||||.+.+...... .+
T Consensus 195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 999999988 33478888889999999999999999 99999999999999999999999999999988765433 22
Q ss_pred c-ccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 541 T-TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 541 ~-~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
. ...-.+.|+|||.+....++.++|||+|||.||||++ |..||.+.. .
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~------------------------------g 321 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR------------------------------G 321 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC------------------------------H
Confidence 2 2234678999999999999999999999999999999 667775543 1
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.. +.+.+|..-+-..+..+.+.+.++++.||..+|++|||+..|++.
T Consensus 322 ~q---------IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 322 IQ---------ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HH---------HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 11 122333322334556678899999999999999999999999743
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.28 Aligned_cols=257 Identities=22% Similarity=0.339 Sum_probs=195.9
Q ss_pred cCCCCccccCceeEEEEEEC-----------------CCcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-----------------DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGF 446 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~ 446 (745)
.+.++||+|+||.||++... +...||+|++... ......+|..|+++++.++|+||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV 87 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34578999999999998642 2346899998743 33345789999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhhhhcCCC----------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeec
Q 004565 447 CAQGRQRFLVYEYMNKGSLDRTLFGNG----------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH 516 (745)
Q Consensus 447 ~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~ 516 (745)
+...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili~ 164 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVG 164 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEEc
Confidence 999999999999999999999986532 247888999999999999999999 8999999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh--CCCCCCccccccccc
Q 004565 517 DKLQVKISDFGLSKLLTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS--GRKNSSLKIQSRSTE 593 (745)
Q Consensus 517 ~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt--g~~p~~~~~~~~~~~ 593 (745)
.++.++|+|||++..+....... .....++..|+|||....+.++.++||||||+++|||++ |..||....
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~------ 238 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS------ 238 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC------
Confidence 99999999999998654332211 122334678999999888889999999999999999998 556664321
Q ss_pred cCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 594 KDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.. ............... ... ...+......+.+++.+|++.+|++||+|.||++
T Consensus 239 -------------------~~-~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 239 -------------------DE-QVIENTGEFFRDQGR-QVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred -------------------hH-HHHHHHHHHHhhccc-ccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 000000111111000 000 0111122357889999999999999999999999
Q ss_pred Hhc
Q 004565 674 MLE 676 (745)
Q Consensus 674 ~L~ 676 (745)
.|+
T Consensus 293 ~l~ 295 (296)
T cd05095 293 TLL 295 (296)
T ss_pred HHh
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.22 Aligned_cols=248 Identities=31% Similarity=0.486 Sum_probs=200.5
Q ss_pred CCCCccccCceeEEEEEECC-----CcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 386 FNTPIGSGGFGTVYKGILQD-----KSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+.+.||.|+||.||++...+ +..||+|.+...... ..+.+..|++++..++|+|++++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 34679999999999999864 478999999755433 567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCcc-cCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 460 MNKGSLDRTLFGNGSV-LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
+++++|.+++...... +++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999765544 9999999999999999999999 89999999999999999999999999999876554322
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
......++..|+|||.+.+..++.++||||||++++||++ |+.||.... .
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----------------------------~ 210 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----------------------------N 210 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------------------------H
Confidence 2222347789999999988889999999999999999998 677765321 1
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
......... .... ..+......+.+++.+|++.+|++|||+.|++++|
T Consensus 211 ~~~~~~~~~-~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 211 EEVLEYLKK-GYRL---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHhc-CCCC---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111111111 1110 11111345688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.34 Aligned_cols=196 Identities=25% Similarity=0.331 Sum_probs=170.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||+||++... .++.||||++.... ......+..|+.++.+++|+||+++++.+.+....++||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 367999999999999875 58899999986422 23345678899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc-----
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS----- 537 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~----- 537 (745)
|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~ 161 (363)
T cd05628 86 GDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161 (363)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccc
Confidence 99999997653 68999999999999999999999 9999999999999999999999999999976532110
Q ss_pred -----------------------------ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 -----------------------------SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012357999999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.65 Aligned_cols=195 Identities=25% Similarity=0.336 Sum_probs=167.2
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccC---CcchHHHHHHHHHHHccCCC-CceeeEEEEEEeCCeeEEEEeec
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSF---GIQGKKEFCTEITIIGNIHH-VNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
+.+.||+|+||.||+|...+ ++.||||++... .....+.+..|.+++..++| ++|+++.+++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (324)
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence 34679999999999999864 678999998742 22345667889999999965 46888999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
++|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ..
T Consensus 84 ~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 158 (324)
T cd05587 84 NGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TT 158 (324)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-ce
Confidence 9999999886553 58999999999999999999999 9999999999999999999999999999875332211 22
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 345689999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=309.39 Aligned_cols=196 Identities=27% Similarity=0.458 Sum_probs=167.9
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++|+||+++++++...+..++||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 467999999999999975 57889999987433 23345678899999999999999999999999999999999975 8
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++...+..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 165 (309)
T cd07872 90 LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEV 165 (309)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cccccc
Confidence 888887766678999999999999999999999 9999999999999999999999999999976543322 123346
Q ss_pred cccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 545 GTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 545 gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
++..|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred ccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 7899999998865 468899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.04 Aligned_cols=247 Identities=27% Similarity=0.391 Sum_probs=193.7
Q ss_pred CCCCccccCceeEEEEEE-CCCcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.++||+|+||.||+|.. .++..||+|.+... .....+.+.+|++++++++|+|++++++++...+..++|+||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 346799999999999986 46888999998643 3344567899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++....... ....
T Consensus 85 ~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (279)
T cd06619 85 SLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTY 153 (279)
T ss_pred ChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCC
Confidence 997553 47888899999999999999999 999999999999999999999999999997654322 2345
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
.++..|+|||++.+..++.++||||||+++|+|++|+.||....... ......... .
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~----------------------~~~~~~~~~-~ 210 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ----------------------GSLMPLQLL-Q 210 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccc----------------------cccchHHHH-H
Confidence 78999999999999899999999999999999999999986422000 000000000 0
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
...... .+.+. .......+.+++.+|++.+|++||+++|+++.
T Consensus 211 ~~~~~~-----~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 211 CIVDED-----PPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHhccC-----CCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000 01110 11122457889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.92 Aligned_cols=197 Identities=22% Similarity=0.284 Sum_probs=171.0
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence 3477999999999999975 5889999998642 22334568889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.........
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (331)
T cd05597 85 GGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161 (331)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccc
Confidence 999999997655679999999999999999999999 99999999999999999999999999999766544333333
Q ss_pred ccccccCccCcccccC-----CCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 542 TMRGTRGYLAPEWLTS-----SAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~-----~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
...||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 4569999999999863 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=309.33 Aligned_cols=195 Identities=27% Similarity=0.324 Sum_probs=169.0
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 378999999999999986 5788999998632 223345678899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.............
T Consensus 128 g~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~ 202 (371)
T cd05622 128 GDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202 (371)
T ss_pred CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccC
Confidence 9999998654 47888899999999999999999 999999999999999999999999999998765443333345
Q ss_pred cccccCccCcccccCC----CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 543 MRGTRGYLAPEWLTSS----AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~----~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
..||+.|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 203 ~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred cccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 6799999999998754 3789999999999999999999999643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.45 Aligned_cols=188 Identities=22% Similarity=0.272 Sum_probs=164.3
Q ss_pred CCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 387 NTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
...||+|+||.||++.... ++.||||... ...+.+|++++++++|+|||++++++..+...++|||++. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 3779999999999999864 7789999642 2346789999999999999999999999999999999995 688
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-cccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-LFTTMR 544 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~ 544 (745)
..++......++|..++.|+.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++........ ......
T Consensus 247 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 323 (461)
T PHA03211 247 YTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323 (461)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence 88887665679999999999999999999999 99999999999999999999999999999876443222 123457
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCC
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSS 584 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~ 584 (745)
||..|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 9999999999999999999999999999999999887654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.56 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=196.8
Q ss_pred CCCccccCceeEEEEEECC--CcEEEEEEeccC----------CcchHHHHHHHHHHHcc-CCCCceeeEEEEEEeCCee
Q 004565 387 NTPIGSGGFGTVYKGILQD--KSVVAVKKINSF----------GIQGKKEFCTEITIIGN-IHHVNLVRLKGFCAQGRQR 453 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~~~~~ 453 (745)
.+.||+|+||.||+|.... +..+|+|.+... ......++..|+.++.+ ++|+||+++++++.+.+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 3679999999999999865 678999987532 12234557788888865 7999999999999999999
Q ss_pred EEEEeecCCCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcc
Q 004565 454 FLVYEYMNKGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK 530 (745)
Q Consensus 454 ~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~ 530 (745)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 162 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccccee
Confidence 999999999999988743 33468999999999999999999995 2679999999999999999999999999998
Q ss_pred cCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCc
Q 004565 531 LLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPR 610 (745)
Q Consensus 531 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (745)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 163 ~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~----------------------- 217 (269)
T cd08528 163 QKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----------------------- 217 (269)
T ss_pred eccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----------------------
Confidence 755433 2345568999999999998889999999999999999999999985432
Q ss_pred ccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 611 ESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
.......... .... +.... .....+.+++.+|++.||++||++.||.++|+
T Consensus 218 ------~~~~~~~~~~-~~~~----~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 218 ------MLSLATKIVE-AVYE----PLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------HHHHHHHHhh-ccCC----cCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111111 1100 00011 12245788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=295.97 Aligned_cols=245 Identities=23% Similarity=0.351 Sum_probs=198.3
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.++||+|+||.||++... ++..+|+|.++.. .....+.+..|+.+++.++|+|++++++.+...+..++|+||+++++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 467999999999999975 5788999988642 33445678899999999999999999999999999999999999999
Q ss_pred hhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 465 LDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 465 L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++........ .....
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 160 (255)
T cd08219 85 LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTY 160 (255)
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccccc
Confidence 99988653 3468899999999999999999999 9999999999999999999999999999976643322 12345
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
.++..|+|||++.+..++.++||||||+++++|++|+.||.... .......
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----------------------------~~~~~~~ 211 (255)
T cd08219 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----------------------------WKNLILK 211 (255)
T ss_pred cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----------------------------HHHHHHH
Confidence 68899999999998889999999999999999999999986432 1111111
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.. .+... ..+......+.+++.+||+.+|++||++.+|+..
T Consensus 212 ~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 212 VC-QGSYK---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred Hh-cCCCC---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 11110 1111223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.64 Aligned_cols=242 Identities=29% Similarity=0.429 Sum_probs=195.9
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
+.||+|+||.||+|... ++..||+|.+.... ....+.+..|++++++++|+||+++++++......++|+||+++++|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence 45999999999999875 57789999887432 34456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++.. ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++..+..... ......+
T Consensus 90 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 163 (277)
T cd06642 90 LDLLKP--GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVG 163 (277)
T ss_pred HHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcccC
Confidence 998864 368999999999999999999998 9999999999999999999999999999976654321 1233467
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
+..|+|||++.+..++.++||||||++++||++|+.|+..... . .. ....
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-------------------------~-~~----~~~~ 213 (277)
T cd06642 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-------------------------M-RV----LFLI 213 (277)
T ss_pred cccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-------------------------h-hH----Hhhh
Confidence 8899999999998999999999999999999999998753220 0 00 0000
Q ss_pred hhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.... .+.+ .......+.+++.+|++.+|++||+|.+|++.
T Consensus 214 ~~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 214 PKNS-----PPTL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hcCC-----CCCC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000 1111 12233567899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.08 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=197.6
Q ss_pred CCccccCceeEEEEEEC------CCcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 388 TPIGSGGFGTVYKGILQ------DKSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
..||+|+||.||+|+.. +...|++|.+...... ....+..|++++++++|+||+++++++.+....++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT 90 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence 56999999999999964 3467999988654433 4577999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCC--------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccC
Q 004565 461 NKGSLDRTLFGNG--------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 461 ~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++...
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~ 167 (275)
T cd05046 91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDV 167 (275)
T ss_pred CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccccccc
Confidence 9999999997544 158999999999999999999998 89999999999999999999999999998755
Q ss_pred CCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcc
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
............++..|+|||.+.+...+.++||||||+++++|++ |..||....
T Consensus 168 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~------------------------ 223 (275)
T cd05046 168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS------------------------ 223 (275)
T ss_pred CcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc------------------------
Confidence 4333222334456778999999988888999999999999999999 677774321
Q ss_pred cccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
..... .....+.... ..+......+.+++.+|++.+|++||++.|++++|.
T Consensus 224 -----~~~~~-~~~~~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 224 -----DEEVL-NRLQAGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----hHHHH-HHHHcCCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00111 1111111110 011122346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.81 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=199.5
Q ss_pred cCCCCccccCceeEEEEEECC-Cc----EEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEe
Q 004565 385 NFNTPIGSGGFGTVYKGILQD-KS----VVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 458 (745)
.+.+.||+|+||.||+|...+ +. .+|+|.+.... .....++.+|+.++++++|+|+++++++|.. ...++|+|
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 344789999999999999743 32 58999886543 2345678899999999999999999999987 78899999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++|+|.+++......+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 89 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 89 LMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 999999999998776679999999999999999999999 99999999999999999999999999999876543322
Q ss_pred cc-cccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 539 LF-TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 539 ~~-~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
.. ....++..|+|||.+....++.++||||||++++|+++ |+.||....
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----------------------------- 216 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP----------------------------- 216 (279)
T ss_pred eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----------------------------
Confidence 11 12224568999999988889999999999999999998 998886432
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
......... .+.. ...+......+.+++..|+..+|.+||++.++++.|+..
T Consensus 217 ~~~~~~~~~-~~~~---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 217 AVEIPDLLE-KGER---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred HHHHHHHHh-CCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111111 1110 011111224577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.73 Aligned_cols=191 Identities=28% Similarity=0.343 Sum_probs=161.3
Q ss_pred ccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccC---CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNI---HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
||+|+||.||+|+.. ++..||||++.... ......+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999975 58899999986422 12233455566666655 699999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 9999888754 358999999999999999999999 9999999999999999999999999999875433221 2244
Q ss_pred cccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 543 MRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
..||..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 6799999999998764 479999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.33 Aligned_cols=196 Identities=23% Similarity=0.335 Sum_probs=168.4
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.++||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|+||+++++.+.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 367999999999999974 57899999986432 23356788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC------
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ------ 536 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~------ 536 (745)
|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 86 g~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 86 GDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999987653 58889999999999999999999 999999999999999999999999999975432100
Q ss_pred ----------------------------------------cccccccccccCccCcccccCCCCCCccceeehHHHHHHH
Q 004565 537 ----------------------------------------SSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEI 576 (745)
Q Consensus 537 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~el 576 (745)
........||+.|+|||++.+..++.++|||||||+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0001234689999999999999999999999999999999
Q ss_pred HhCCCCCCcc
Q 004565 577 ISGRKNSSLK 586 (745)
Q Consensus 577 ltg~~p~~~~ 586 (745)
++|+.||...
T Consensus 242 ltG~~Pf~~~ 251 (382)
T cd05625 242 LVGQPPFLAQ 251 (382)
T ss_pred HhCCCCCCCC
Confidence 9999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.90 Aligned_cols=244 Identities=30% Similarity=0.435 Sum_probs=194.7
Q ss_pred hcCCCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 384 DNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
..+.+.||+|+||.||+|.. .+..||+|.+.... ....+.+|+.++++++|+|++++++++... ..++||||++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 34557899999999999985 56679999986432 346788999999999999999999998654 479999999999
Q ss_pred ChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++..... .+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ..
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~ 156 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DN 156 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----CC
Confidence 99999975443 68999999999999999999998 999999999999999999999999999987543221 22
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...+..|+|||++.+..++.++||||||++++||++ |+.||.... .....
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----------------------------~~~~~ 207 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----------------------------LKEVK 207 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----------------------------HHHHH
Confidence 334678999999998899999999999999999998 888875332 11111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.. ...+. ....+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 208 ~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 208 EC-VEKGY---------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HH-HhCCC---------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11 11110 111112223567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=294.00 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=188.7
Q ss_pred CCccccCceeEEEEEECCC---cEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQDK---SVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3599999999999986443 346677765433 334678999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC---cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC-ccc
Q 004565 464 SLDRTLFGNG---SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ-SSL 539 (745)
Q Consensus 464 sL~~~l~~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~-~~~ 539 (745)
+|.+++.... ..+++..++.++.||+.||+|||+ .+++|+||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997542 246777888999999999999998 899999999999999999999999999986432211 111
Q ss_pred ccccccccCccCcccccC-------CCCCCccceeehHHHHHHHHhC-CCCCCccccccccccCCCCCCCCCCCCCCCcc
Q 004565 540 FTTMRGTRGYLAPEWLTS-------SAISDKTDVYSYGMVLLEIISG-RKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~-------~~~t~k~Dv~S~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..||....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------------------------ 213 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS------------------------ 213 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC------------------------
Confidence 234567889999998753 2457899999999999999975 55654221
Q ss_pred cccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
.......... +......++.+...++ ..+.+++..|+ .+|++||+|++|++.|.
T Consensus 214 -----~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 214 -----DREVLNHVIK-DQQVKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -----HHHHHHHHHh-hcccccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0111111111 1222333444433333 45667888899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.26 Aligned_cols=196 Identities=21% Similarity=0.282 Sum_probs=170.9
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||+++.. +++.||+|.+... .......+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999985 5788999998642 222345578899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.............
T Consensus 86 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 162 (331)
T cd05624 86 GDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV 162 (331)
T ss_pred CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeecc
Confidence 99999998755678999999999999999999999 999999999999999999999999999998765443333344
Q ss_pred cccccCccCcccccC-----CCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 543 MRGTRGYLAPEWLTS-----SAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~-----~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
..||+.|+|||++.+ +.++.++||||||++||||++|+.||..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 579999999999875 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.45 Aligned_cols=197 Identities=23% Similarity=0.293 Sum_probs=170.4
Q ss_pred CCCccccCceeEEEEEECC-CcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQD-KSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.++||+|+||.||+++... +..+|+|.+... .......+..|+.++..++|+||+++++++.+....++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 4779999999999999864 678999998632 122344578899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.............
T Consensus 86 g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~ 162 (332)
T cd05623 86 GDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 162 (332)
T ss_pred CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecc
Confidence 99999998765679999999999999999999999 999999999999999999999999999997654433333344
Q ss_pred cccccCccCccccc-----CCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 543 MRGTRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 543 ~~gt~~y~aPE~~~-----~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
..||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred cccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 57999999999986 346789999999999999999999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=295.64 Aligned_cols=242 Identities=27% Similarity=0.414 Sum_probs=198.0
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
+.||.|+||.||+|... .+..||||.+.... ......+..|+.++++++|+|++++++++.+....++||||+++++|
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcH
Confidence 56999999999999975 57889999887432 34467788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 90 ~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 163 (277)
T cd06640 90 LDLLRAG--PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVG 163 (277)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccccC
Confidence 9998643 58899999999999999999998 9999999999999999999999999999976654322 1233467
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
+..|+|||++.+..++.++||||||+++|||++|..||...... ... ..
T Consensus 164 ~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----------------------------~~~-~~- 212 (277)
T cd06640 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----------------------------RVL-FL- 212 (277)
T ss_pred cccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----------------------------hHh-hh-
Confidence 88999999999888999999999999999999999988643200 000 00
Q ss_pred hhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
+...............+.+++..||+.+|++||++.+|++.
T Consensus 213 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 213 --------IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --------hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00001112233445678899999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.24 Aligned_cols=195 Identities=23% Similarity=0.297 Sum_probs=168.0
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||++... +++.||||++... .....+.+..|++++++++|+||+++++++.+....++||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 367999999999999874 6889999998642 223346688899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc----
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS---- 538 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~---- 538 (745)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 86 g~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 161 (377)
T cd05629 86 GDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161 (377)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 9999998754 358899999999999999999999 99999999999999999999999999999643211000
Q ss_pred ------------------------------------------cccccccccCccCcccccCCCCCCccceeehHHHHHHH
Q 004565 539 ------------------------------------------LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEI 576 (745)
Q Consensus 539 ------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~el 576 (745)
......||+.|+|||++.+..++.++|||||||+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (377)
T cd05629 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241 (377)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhh
Confidence 00124699999999999998999999999999999999
Q ss_pred HhCCCCCCc
Q 004565 577 ISGRKNSSL 585 (745)
Q Consensus 577 ltg~~p~~~ 585 (745)
++|+.||..
T Consensus 242 ltG~~Pf~~ 250 (377)
T cd05629 242 LIGWPPFCS 250 (377)
T ss_pred hcCCCCCCC
Confidence 999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=293.40 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=201.4
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
+.+.||.|+||.||+|... ++..+++|.+........+.+..|++++++++|+|++++++++......+++|||+++++
T Consensus 7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 3467999999999999975 577899999886555567889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++......+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........ ......
T Consensus 87 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 162 (262)
T cd06613 87 LQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSFI 162 (262)
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cccccc
Confidence 999988765679999999999999999999998 9999999999999999999999999999986554321 123456
Q ss_pred cccCccCcccccCC---CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 545 GTRGYLAPEWLTSS---AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 545 gt~~y~aPE~~~~~---~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
++..|+|||.+... .++.++||||||++++||++|+.||..... ... .
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~----------------------------~~~-~ 213 (262)
T cd06613 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----------------------------MRA-L 213 (262)
T ss_pred CCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH----------------------------HHH-H
Confidence 88899999999876 789999999999999999999999864320 000 0
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..... .. ...+.+ .........+.+++.+|++.+|.+|||+.+|+.
T Consensus 214 ~~~~~-~~---~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 214 FLISK-SN---FPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHh-cc---CCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 00 000111 112233456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=297.44 Aligned_cols=243 Identities=28% Similarity=0.384 Sum_probs=197.8
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.||.|+||.||+|... +++.||+|.+.... ......+..|+++++.++|+|++++++++.+....++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 467999999999999975 58899999987432 3445678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++... .+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++........ ......
T Consensus 86 L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 159 (274)
T cd06609 86 CLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTFV 159 (274)
T ss_pred HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cccccc
Confidence 99999765 68999999999999999999998 9999999999999999999999999999987754322 223456
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
++..|+|||++.+..++.++||||||+++|||++|+.||..... .... ..
T Consensus 160 ~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----------------------------~~~~-~~ 209 (274)
T cd06609 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----------------------------MRVL-FL 209 (274)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----------------------------HHHH-HH
Confidence 88899999999998899999999999999999999999864320 0000 00
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..... .+.+... .....+.+++..|++.+|++|||+++|++
T Consensus 210 ~~~~~-----~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 210 IPKNN-----PPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred hhhcC-----CCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01111 1111111 02345778899999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.93 Aligned_cols=197 Identities=25% Similarity=0.356 Sum_probs=168.4
Q ss_pred cCCCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEee
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
++.+.||+|+||.||++... ++..||||++... .....+.+..|.+++..+. |++|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45578999999999999975 5889999998742 2233456778888888885 67788899999999999999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
+++|+|..++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 83 ~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 83 VNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 99999999886543 58999999999999999999999 999999999999999999999999999987543222 12
Q ss_pred ccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 23456899999999999989999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.06 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=218.1
Q ss_pred hcCCCCccccCceeEEEEEE-CCCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 384 DNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
+.+.+.||+|.|..|-++++ -.|..||||++.+... -....+.+|++.|+.++|||||+|+.+.......|||.|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 44557799999999999985 5789999999975433 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-CCCeEEccCCCcccCCCCCccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-KLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
.+|+|.+||......+.+....+++.||+.|+.|+|+ ..+|||||||+||.+-+ -|-+||.|||++..+.++..
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-- 174 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-- 174 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch--
Confidence 9999999999888889999999999999999999999 99999999999998865 47799999999988876643
Q ss_pred ccccccccCccCcccccCCCCC-CccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 540 FTTMRGTRGYLAPEWLTSSAIS-DKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t-~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.+...|...|-|||++.+..|+ +..|||||||+||-|++|+.||+..+..+.+.+
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm------------------------ 230 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM------------------------ 230 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh------------------------
Confidence 4677899999999999999886 689999999999999999999987663322222
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHhccCCCCCCCCcccce
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVV--SMLEGGMPLGEPRIESLR 690 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~--~~L~~~~~~~~p~~p~~~ 690 (745)
++|-.. ..+.....++.+|+..||+.||.+|.+.+||+ ..|++.-.-....+|.++
T Consensus 231 --------------ImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvs 288 (864)
T KOG4717|consen 231 --------------IMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVS 288 (864)
T ss_pred --------------hhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCceee
Confidence 233222 34455667889999999999999999999998 456653333333455544
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=295.80 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=196.6
Q ss_pred cCCCCccccCceeEEEEEEC-CCcEEEEEEeccCCcc---------hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeE
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQ---------GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRF 454 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~ 454 (745)
.+...||+|+||.||+|... ++..+|+|.+...... ..+.+..|+.++++++|+||+++++++.+....+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 34577999999999999874 5788999988643221 1256788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCC
Q 004565 455 LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 455 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
+|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 83 IFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999765 358899999999999999999998 8999999999999999999999999999987653
Q ss_pred CCcc-----cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCC
Q 004565 535 EQSS-----LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSP 609 (745)
Q Consensus 535 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (745)
.... ......|+..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---------------------- 216 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---------------------- 216 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc----------------------
Confidence 2111 1123457889999999998889999999999999999999999986432
Q ss_pred cccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 610 RESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
. .. ...... ....+ ..+......+.+++.+||+.+|.+||++.||++
T Consensus 217 ---~---~~-~~~~~~------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 217 ---Q---LQ-AIFKIG------ENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---H---HH-HHHHHh------ccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 00 000000 01111 112223356788999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.16 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=194.7
Q ss_pred CCccccCceeEEEEEEC-CCc----EEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKS----VVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.||+|+||.||+|... ++. .||+|.+..... ....++..|+.+++.++|+||++++++|... ..++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~ 91 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP 91 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence 67999999999999863 343 478888864332 3345788999999999999999999998754 4679999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc-c
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL-F 540 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~ 540 (745)
+|+|.+++......+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++......... .
T Consensus 92 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 168 (303)
T cd05110 92 HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168 (303)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCccccccc
Confidence 999999998766678999999999999999999999 999999999999999999999999999998765432211 1
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----------------------------~~~ 219 (303)
T cd05110 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----------------------------TRE 219 (303)
T ss_pred CCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----------------------------HHH
Confidence 22345678999999998899999999999999999997 888875321 000
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
. ......+.. . ..+......+.+++..|+..+|++||+|.+|++.|+..
T Consensus 220 ~-~~~~~~~~~--~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 220 I-PDLLEKGER--L-------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred H-HHHHHCCCC--C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 111111110 0 00111224578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.57 Aligned_cols=196 Identities=23% Similarity=0.334 Sum_probs=168.5
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||+++.. .++.||||++.... ......+.+|++++++++|+||+++++.+.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999975 58899999986421 22346688899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc-----
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS----- 537 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~----- 537 (745)
|+|.+++...+ .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 86 g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 86 GDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 99999997654 58888999999999999999999 9999999999999999999999999999853321000
Q ss_pred -------------------------------------ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCC
Q 004565 538 -------------------------------------SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580 (745)
Q Consensus 538 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~ 580 (745)
.......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~ 241 (376)
T cd05598 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241 (376)
T ss_pred cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCC
Confidence 0012346999999999999999999999999999999999999
Q ss_pred CCCCcc
Q 004565 581 KNSSLK 586 (745)
Q Consensus 581 ~p~~~~ 586 (745)
.||...
T Consensus 242 ~Pf~~~ 247 (376)
T cd05598 242 PPFLAD 247 (376)
T ss_pred CCCCCC
Confidence 999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=293.07 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=201.1
Q ss_pred CCCCccccCceeEEEEEE-CCCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.+.||.|+||.||.++. .++..+++|++... .....+++.+|++++++++|+||+++++++.+....++||||+++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 347799999999999986 45888999987643 344567789999999999999999999999999999999999999
Q ss_pred CChhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 463 GSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........ ...
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~ 159 (256)
T cd08221 84 GTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAE 159 (256)
T ss_pred CcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-ccc
Confidence 9999999765 3468999999999999999999998 8999999999999999999999999999987654432 224
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...++..|+|||.+.+..++.++||||||++++||++|+.||.... .....
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----------------------------~~~~~ 210 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----------------------------PLNLV 210 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----------------------------HHHHH
Confidence 4568999999999988889999999999999999999999886432 11111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
.... .+... ..+......+.+++.+|++.+|++||+++++++.+
T Consensus 211 ~~~~-~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 211 VKIV-QGNYT---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHH-cCCCC---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111 11111 11122234678899999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=298.28 Aligned_cols=193 Identities=28% Similarity=0.389 Sum_probs=168.8
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||+||+|... +++.+|+|.+.... ......+..|++++++++|+|++++.+.+..++..++|+||++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 66999999999999984 58899999986432 122345788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++........ ...
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 160 (285)
T cd05632 86 DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRG 160 (285)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--ccC
Confidence 9998886543 369999999999999999999999 9999999999999999999999999999976543221 234
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
..|+..|+|||++.+..++.++||||||++++||++|+.||..
T Consensus 161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 5689999999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=299.28 Aligned_cols=194 Identities=28% Similarity=0.409 Sum_probs=168.7
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.||+|+||.||++... ++..+|+|.+.... .....++..|++++.+++|+||+++++++...+..++|+||+++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 367999999999999975 47788888886432 2334668899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++... ..+++..+..++.|+++||.|||+ ..+++|+||||+|||++.++.+||+|||++....... .....
T Consensus 86 L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 159 (308)
T cd06615 86 LDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFV 159 (308)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---cccCC
Confidence 99999765 458999999999999999999997 2589999999999999999999999999987553321 23456
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 889999999998888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=303.23 Aligned_cols=197 Identities=21% Similarity=0.222 Sum_probs=164.6
Q ss_pred CCCcccc--CceeEEEEEE-CCCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 387 NTPIGSG--GFGTVYKGIL-QDKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 387 ~~~lG~G--~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
..+||+| +|++||++.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 7899999987 468899999987432 2334567789999999999999999999999999999999999
Q ss_pred CCChhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc--
Q 004565 462 KGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-- 538 (745)
Q Consensus 462 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-- 538 (745)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999998653 2358999999999999999999999 99999999999999999999999999865443221110
Q ss_pred ----cccccccccCccCcccccC--CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 539 ----LFTTMRGTRGYLAPEWLTS--SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 539 ----~~~~~~gt~~y~aPE~~~~--~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
......++..|+|||++.+ ..++.++|||||||+++||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0122346778999999876 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=299.69 Aligned_cols=245 Identities=27% Similarity=0.363 Sum_probs=198.6
Q ss_pred CCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 386 FNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
+.+.||+|+||.||+|.. .+++.||+|.+........+.+..|+.+++.++|+|++++++++......++||||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 23 RFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 347799999999999997 4688999999976555556778899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++... .+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++......... .....
T Consensus 103 L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~ 176 (297)
T cd06656 103 LTDVVTET--CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (297)
T ss_pred HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCccc
Confidence 99998643 58899999999999999999999 99999999999999999999999999999765443221 23446
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
+++.|+|||.+.+..++.++||||||+++|+|++|+.||............
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~----------------------------- 227 (297)
T cd06656 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----------------------------- 227 (297)
T ss_pred CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-----------------------------
Confidence 888999999999988999999999999999999999999643210000000
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
...+ .+.+ ..+......+.+++.+|++.+|++||++++|++
T Consensus 228 ~~~~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 228 ATNG------TPEL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCC------CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000 011122345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.25 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=194.3
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||++... .++.||||.+.... ......+..|+.++++++|+|++++++.+...+..++||||++++
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 85 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence 67999999999999975 58899999986432 122356778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++.... ..+++..++.++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||++........ ...
T Consensus 86 ~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~ 160 (285)
T cd05630 86 DLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKG 160 (285)
T ss_pred cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--ccC
Confidence 9999886543 368999999999999999999998 9999999999999999999999999999876543322 133
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ..... ....
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~-------------------------~~~~~-~~~~ 214 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK-------------------------KKIKR-EEVE 214 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC-------------------------ccchH-HHHH
Confidence 468999999999999999999999999999999999999996432 00000 0000
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS-----MANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~ev~~ 673 (745)
...... .......+ ...+.+++..|++.+|++||| ++|+++
T Consensus 215 ~~~~~~------~~~~~~~~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 215 RLVKEV------QEEYSEKF----SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhhh------hhhcCccC----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000000 00111122 245778999999999999999 778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=307.16 Aligned_cols=187 Identities=27% Similarity=0.350 Sum_probs=162.0
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
+.+.||+|+||.||+|+... +..||+|..... ....|+.++++++|+||+++++++......++|+||+. ++
T Consensus 70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD 142 (357)
T ss_pred EEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence 34789999999999999864 678999975322 23568999999999999999999999999999999995 68
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++......+++..++.|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....... ......
T Consensus 143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~ 217 (357)
T PHA03209 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLA 217 (357)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc--cccccc
Confidence 888887766689999999999999999999999 899999999999999999999999999997543221 123456
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCC
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSS 584 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~ 584 (745)
||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 8999999999999999999999999999999999776653
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=295.38 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=196.4
Q ss_pred CCCccccCceeEEEEEECCCcEEEEEEeccCC------cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSFG------IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.||+|+||.||+|...+++.+|||.+.... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 46799999999999998889999999886432 122356888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC----
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ---- 536 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~---- 536 (745)
++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 85 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 85 PGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 9999999997543 58899999999999999999998 899999999999999999999999999987653211
Q ss_pred -cccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 537 -SSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 537 -~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
........++..|+|||++.+..++.++||||||++++||++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------------------------- 213 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--------------------------- 213 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh---------------------------
Confidence 1112345689999999999988899999999999999999999999864220
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..... ...... ...+.+ +......+.+++.+|++.+|++||++.||++
T Consensus 214 -~~~~~-~~~~~~----~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 214 -LAAMF-YIGAHR----GLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -HHHHH-Hhhhcc----CCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 000000 001111 1223356788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.55 Aligned_cols=250 Identities=33% Similarity=0.491 Sum_probs=196.7
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHH--HHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKK--EFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.+.||+|+||+||+++... ++.+|+|.+......... ....|+.++++++|+||+++++++.+....++||||+++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 34679999999999999865 568999999865543322 345699999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|.+++. ....+++..++.++.||++||++||+ .+++|+||||+||++++++.++|+|||.+.... ........
T Consensus 83 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~ 157 (260)
T PF00069_consen 83 GSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNP 157 (260)
T ss_dssp EBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSS
T ss_pred cccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99999998 23468999999999999999999999 999999999999999999999999999998652 22223355
Q ss_pred cccccCccCccccc-CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLT-SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~-~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
..++..|+|||.+. ....+.++||||+|+++++|++|+.|+.... .........
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-------------------------~~~~~~~~~ 212 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-------------------------SDDQLEIIE 212 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-------------------------HHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc-------------------------chhhhhhhh
Confidence 67899999999998 7889999999999999999999999986431 000011110
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..... .. ..... ........+.+++..||+.+|++||++.++++
T Consensus 213 ~~~~~--~~----~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 213 KILKR--PL----PSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHT--HH----HHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hcccc--cc----ccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00 00000 00001267899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.42 Aligned_cols=244 Identities=27% Similarity=0.395 Sum_probs=198.4
Q ss_pred CCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 387 NTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++++......++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 36799999999999986 56889999999765555667889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
..++... .+++..+..++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... .....+
T Consensus 104 ~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 177 (296)
T cd06655 104 TDVVTET--CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVG 177 (296)
T ss_pred HHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcCC
Confidence 9988643 58999999999999999999999 99999999999999999999999999998865443221 233568
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
+..|+|||.+.+..++.++|||||||++|+|++|+.||..... .... ....
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~----------------------------~~~~-~~~~ 228 (296)
T cd06655 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----------------------------LRAL-YLIA 228 (296)
T ss_pred CccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------------------HHHH-HHHH
Confidence 8999999999988899999999999999999999999864320 0000 0000
Q ss_pred hhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
... ... + ..+......+.+++.+||+.+|++||++.+|+.
T Consensus 229 ~~~-~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 229 TNG-TPE-----L--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred hcC-Ccc-----c--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 000 0 011112345778999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=316.48 Aligned_cols=266 Identities=22% Similarity=0.303 Sum_probs=186.1
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeC--------CeeEEE
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--------RQRFLV 456 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--------~~~~lV 456 (745)
+.+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++|+||+++++++... ...++|
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 3478999999999999985 57899999885432 2345799999999999999999886432 235689
Q ss_pred EeecCCCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC-CeEEccCCCcccC
Q 004565 457 YEYMNKGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLL 532 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~-~~kl~Dfgl~~~~ 532 (745)
|||+++ +|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++ .+||+|||+++.+
T Consensus 146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 999985 67666542 33468999999999999999999999 9999999999999999665 6999999999876
Q ss_pred CCCCcccccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcc
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
..... .....||+.|+|||++.+. .++.++|||||||+||||++|..||................+.. ...
T Consensus 222 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p-~~~----- 293 (440)
T PTZ00036 222 LAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP-TED----- 293 (440)
T ss_pred cCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-CHH-----
Confidence 54322 2345689999999988654 68999999999999999999999997543111111111000000 000
Q ss_pred cccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVV 672 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~ 672 (745)
.+.... ...............+...++......+.+++.+||+.+|.+|||+.|++
T Consensus 294 ----~~~~~~-~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 294 ----QLKEMN-PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred ----HHHHhc-hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000000 00000000000001111112222335688999999999999999999998
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=293.12 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=197.5
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC-----cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-----IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+.+.||+|+||.||+|... ++..|++|.+.... .+..+.+..|+++++.++|+|++++++++......++|+||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 3467999999999999986 78899999886432 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
+++++|.+++.... .+++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.+||+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 84 VPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 99999999997653 58999999999999999999999 999999999999999999999999999988654432 2
Q ss_pred ccccccccCccCcccccCCC-CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 540 FTTMRGTRGYLAPEWLTSSA-ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~-~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....++..|+|||.+.... ++.++|+||||+++++|++|+.||.... -.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----------------------------~~ 208 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----------------------------GV 208 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----------------------------HH
Confidence 24456889999999987776 8999999999999999999999986422 00
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
............ ...+......+.+++.+|++.+|.+||++.+++.
T Consensus 209 ~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 209 AAVFKIGRSKEL---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHHhcccC---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011111110111 1111222356778999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=289.84 Aligned_cols=263 Identities=26% Similarity=0.404 Sum_probs=195.1
Q ss_pred CCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccC--CCCceeeEEEEEEeCC----eeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI--HHVNLVRLKGFCAQGR----QRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~g~~~~~~----~~~lV~e~~ 460 (745)
.+.||+|.||.||+|.+.+ ..||||++.. .+++.+.+|.++++.+ +|+||+.+++.-..++ +.+||.+|.
T Consensus 216 ~e~IGkGRyGEVwrG~wrG-e~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWRG-EDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeeccccC-CceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 3679999999999999974 5699999864 3456788888888774 9999999999875543 579999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhh-----CCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT-----GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
++|||.+||.. ..++-...++++..+|.||++||. +..+.|.|||||++|||+..++.+.|+|+|||......
T Consensus 292 e~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 292 EHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred cCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 99999999976 479999999999999999999995 34578999999999999999999999999999876654
Q ss_pred Ccc---cccccccccCccCcccccCCC----C--CCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCC
Q 004565 536 QSS---LFTTMRGTRGYLAPEWLTSSA----I--SDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSS 606 (745)
Q Consensus 536 ~~~---~~~~~~gt~~y~aPE~~~~~~----~--t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 606 (745)
... ..+..+||.+|||||++.... + -..+||||||.++||+...-.--.... +...|-.+
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e-----------ey~~Pyyd 438 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE-----------EYQLPYYD 438 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh-----------hhcCCccc
Confidence 322 235678999999999986542 2 247999999999999975432110000 00000000
Q ss_pred CCCcccccccHHHHHHHHHhhccccccccccccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQV-----SDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
.-|.+.. +. ++ .+ -.-..++++.+ +.+.+..+.++|..||..+|..|-|+-.|-+.|...
T Consensus 439 ~Vp~DPs---~e----eM---rk--VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 439 VVPSDPS---FE----EM---RK--VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred CCCCCCC---HH----HH---hc--ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 0000000 00 00 00 01122333333 357788999999999999999999999998888763
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=287.00 Aligned_cols=276 Identities=23% Similarity=0.300 Sum_probs=204.3
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEecc--CCcchHHHHHHHHHHHccCCCCceeeEEEEEEe-----CCeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINS--FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ-----GRQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-----~~~~~lV~e~ 459 (745)
+.||+|++|.|..+... +|..||||++.. ...-..+.-.+|+++|+.++|+||+.+++.+.. -+..++|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 56999999999999974 589999999973 333446778899999999999999999998865 3467999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC-Ccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE-QSS 538 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~-~~~ 538 (745)
| ..+|...+..+. .|+......+..||++||.|+|+ .+|+|||+||+|+|++.+...||+|||+|+..... ...
T Consensus 108 M-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~ 182 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG 182 (359)
T ss_pred H-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence 9 458888886653 49999999999999999999999 99999999999999999999999999999987543 122
Q ss_pred cccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 539 LFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
..+..+.|..|.|||++.. ..||...||||.||+|.||++|+.-|.+.........+..-.|..++.. . ...-
T Consensus 183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~-l-----~~i~ 256 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED-L-----QKIR 256 (359)
T ss_pred chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH-H-----HHhc
Confidence 3467788999999998754 5799999999999999999999998877665554444444444332111 0 0000
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhcc
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEG 677 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~--~L~~ 677 (745)
...+........ ..........++ ......++++.+||..||.+|+|++|.++ .|+.
T Consensus 257 s~~ar~yi~slp--~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 257 SEKARPYIKSLP--QIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred cHHHHHHHHhCC--CCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 000111111100 000000000111 12245678888999999999999999984 5555
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=292.09 Aligned_cols=246 Identities=22% Similarity=0.367 Sum_probs=197.0
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEe-CCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ-GRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~ 461 (745)
+.+.||+|++|.||++... +++.||+|++... .....+.+..|++++++++|+|++++.+.+.. ....++||||++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence 3467999999999999975 4778999998643 23345678899999999999999999998764 446789999999
Q ss_pred CCChhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 462 KGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 462 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
+++|.+++... ...+++.+++.++.+++.||+|||+ .+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 84 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 159 (257)
T cd08223 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MA 159 (257)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC-cc
Confidence 99999998764 3468999999999999999999999 9999999999999999999999999999987644322 22
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....+++.|+|||.+.+..++.++||||||++++||++|+.||.... ....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----------------------------~~~~ 210 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----------------------------MNSL 210 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----------------------------HHHH
Confidence 34568899999999999999999999999999999999999886322 1111
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
..... .+.. ...+......+.+++.+|++.+|++||++.++++.
T Consensus 211 ~~~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 211 VYRII-EGKL---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHH-hcCC---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111 1111 11122233568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.79 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=197.5
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
+.||.|+||.||+|... ++..+|+|.+........+.|..|++++++++|+|++++++.+......++||||+++++|.
T Consensus 11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (280)
T cd06611 11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALD 90 (280)
T ss_pred HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHH
Confidence 56999999999999985 58899999987665566678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
+++......+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++........ ......++
T Consensus 91 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 166 (280)
T cd06611 91 SIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTFIGT 166 (280)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccceeecc
Confidence 9998766679999999999999999999999 9999999999999999999999999999876543322 12345688
Q ss_pred cCccCccccc-----CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 547 RGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 547 ~~y~aPE~~~-----~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
..|+|||.+. ...++.++||||||+++|||++|+.||..... ....
T Consensus 167 ~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----------------------------~~~~ 217 (280)
T cd06611 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----------------------------MRVL 217 (280)
T ss_pred hhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----------------------------HHHH
Confidence 9999999875 34567899999999999999999999864320 0000
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.... .... +.+ ..+......+.+++..|++.+|.+||++.+|++
T Consensus 218 ~~~~-~~~~-----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 218 LKIL-KSEP-----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHh-cCCC-----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1111 1100 000 011122345778899999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=326.16 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=195.3
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.++||+|+||.||+|... .++.||||++.... ....+.|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 367999999999999975 48899999987432 22356789999999999999999999999999999999999999
Q ss_pred CChhhhhcCC----------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccC
Q 004565 463 GSLDRTLFGN----------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 463 gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
++|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i 163 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcceec
Confidence 9999988632 1246678889999999999999999 89999999999999999999999999999876
Q ss_pred CCCCc-----------------ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccC
Q 004565 533 TPEQS-----------------SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKD 595 (745)
Q Consensus 533 ~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~ 595 (745)
..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||......
T Consensus 164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~------ 237 (932)
T PRK13184 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR------ 237 (932)
T ss_pred ccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh------
Confidence 21110 0112356999999999999999999999999999999999999998643200
Q ss_pred CCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHH
Q 004565 596 SSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-SMANVVSM 674 (745)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~ev~~~ 674 (745)
. . ... ... .++.-.. ........+.+++.+|++.||++|| +++++++.
T Consensus 238 ------------------k--i---~~~----~~i---~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 238 ------------------K--I---SYR----DVI---LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286 (932)
T ss_pred ------------------h--h---hhh----hhc---cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0 0 000 000 0000000 0011224577899999999999995 67777777
Q ss_pred hcc
Q 004565 675 LEG 677 (745)
Q Consensus 675 L~~ 677 (745)
|+.
T Consensus 287 Le~ 289 (932)
T PRK13184 287 LEP 289 (932)
T ss_pred HHH
Confidence 765
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.87 Aligned_cols=194 Identities=30% Similarity=0.403 Sum_probs=160.8
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccC---CCCceeeEEEEEEe-----CCeeEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNI---HHVNLVRLKGFCAQ-----GRQRFL 455 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~-----~~~~~l 455 (745)
.+.||+|+||.||+|... +++.||+|.+..... .....+..|+++++.+ +|+||+++++++.. ....++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 467999999999999975 588999998874321 2234456677766655 79999999998864 345789
Q ss_pred EEeecCCCChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCC
Q 004565 456 VYEYMNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
|+||+++ +|.+++.... ..+++..+..++.||+.||.|||+ .+++||||||+|||+++++.+||+|||++.....
T Consensus 85 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 85 VFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred EEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 9999985 8888886543 358999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.. ......++..|+|||.+.+..++.++|||||||+++||++|+.||...
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 161 QM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 32 123456889999999999889999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=297.13 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=198.9
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.||+|+||.||++... ++..||+|++.... ....+.+.+|+++++.++|+||+++++++......++||||+++++
T Consensus 10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (284)
T cd06620 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS 89 (284)
T ss_pred HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCC
Confidence 367999999999999975 58889999876432 3446788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++... ..+++..+..++.+++.||.|||+ ..+++|+||||+||++++++.++|+|||++....... .....
T Consensus 90 L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~~ 163 (284)
T cd06620 90 LDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFV 163 (284)
T ss_pred HHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cCccc
Confidence 99988664 368999999999999999999996 2579999999999999999999999999987543221 13456
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
|+..|+|||++.+..++.++||||||++++||++|+.||........ .. .....+..+....
T Consensus 164 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~----------------~~--~~~~~~~~~~~~~ 225 (284)
T cd06620 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD----------------GQ--DDPMGILDLLQQI 225 (284)
T ss_pred cCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh----------------hh--hhhhHHHHHHHHH
Confidence 89999999999888999999999999999999999999975331000 00 0000111111111
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
.... .+.+. .......+.+++.+|++.+|++|||+.||+++.
T Consensus 226 ~~~~------~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 226 VQEP------PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhcc------CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1110 01110 111334688899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=291.86 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=199.0
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.+.||+|+||.||++... +++.||+|++... .....+++.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 3467999999999999974 5789999998642 334456889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 463 GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 159 (256)
T cd08218 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LAR 159 (256)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhh
Confidence 99999987643 368899999999999999999998 9999999999999999999999999999986644322 123
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...|+..|+|||++.+...+.++||||||+++++|++|+.||.... .....
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----------------------------~~~~~ 210 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----------------------------MKNLV 210 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----------------------------HHHHH
Confidence 3457889999999998899999999999999999999999885322 11111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
...... .. ...+......+.+++.+|++.+|++||+|.+|++
T Consensus 211 ~~~~~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 211 LKIIRG-SY---------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHhcC-CC---------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 10 0112223456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.84 Aligned_cols=243 Identities=21% Similarity=0.336 Sum_probs=196.4
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
..||+|+||.||++... ++..||+|.+........+.+.+|+.++..++|+|++++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 35999999999999975 68899999987555555677889999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
.++.. ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........ ......++
T Consensus 107 ~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 180 (297)
T cd06659 107 DIVSQ--TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGT 180 (297)
T ss_pred HHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecC
Confidence 88754 358999999999999999999998 9999999999999999999999999999876543322 12345689
Q ss_pred cCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 547 ~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
..|+|||++.+..++.++||||||++++||++|+.||..... ... . ....
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----------------------------~~~-~-~~~~ 230 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----------------------------VQA-M-KRLR 230 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------------------HHH-H-HHHh
Confidence 999999999988899999999999999999999999864320 000 0 0010
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.... .... ........+.+++..|++.+|++||++++|++
T Consensus 231 ~~~~-----~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 231 DSPP-----PKLK--NAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ccCC-----CCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000 0000 00112245778999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=310.41 Aligned_cols=193 Identities=26% Similarity=0.285 Sum_probs=166.4
Q ss_pred hcCCCCccccCceeEEEEEECC---CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD---KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
+.+.+.||+|+||.||++...+ +..||||.+... +.+.+|++++++++|+||+++++++......++|||++
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 4445789999999999998643 567999987542 34567999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-c
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-L 539 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~ 539 (745)
. ++|..++.. ...+++..++.|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......... .
T Consensus 169 ~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 169 K-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred C-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 6 688888843 3469999999999999999999999 99999999999999999999999999999866543322 2
Q ss_pred ccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.....||..|+|||++....++.++|||||||++|||++|+.||...
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 23467999999999999999999999999999999999999999654
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.71 Aligned_cols=196 Identities=26% Similarity=0.433 Sum_probs=167.6
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++|+||++ +
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 3467999999999999975 57889999986432 2334567889999999999999999999999999999999997 5
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|..++......+++..+..++.||+.||+|||+ .+++|+||||+||++++++.+||+|||++........ .....
T Consensus 89 ~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 164 (301)
T cd07873 89 DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNE 164 (301)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-ccccc
Confidence 8999887766678999999999999999999999 9999999999999999999999999999976543221 12334
Q ss_pred ccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 544 RGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 578899999988654 5788999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.35 Aligned_cols=195 Identities=26% Similarity=0.387 Sum_probs=166.1
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-----cchHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-----IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e 458 (745)
.+.||+|+||.||+|... .+..|++|++.... ....+.+.+|+.++++++|+||+++++++.+. ...++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 377999999999999975 58899999886322 12345688899999999999999999988753 56789999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc-
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS- 537 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 537 (745)
|+++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 87 YMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999997644 58899999999999999999998 9999999999999999999999999999976543211
Q ss_pred -ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 538 -SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 538 -~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
.......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 112334588999999999988899999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.23 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=195.0
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
.++||+|+||.||+|... ++..||+|.++.........+.+|+.+++.++|+||+++++.+...+..++|+||+++++|
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 93 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcH
Confidence 366999999999999974 5889999998765545556788899999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++...+ .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... .......|
T Consensus 94 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 168 (267)
T cd06645 94 QDIYHVTG-PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFIG 168 (267)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccccccC
Confidence 99886554 68999999999999999999999 899999999999999999999999999987654322 12234568
Q ss_pred ccCccCccccc---CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 546 TRGYLAPEWLT---SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 546 t~~y~aPE~~~---~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
+..|+|||++. ...++.++|||||||++|||++|+.||...... ... .
T Consensus 169 ~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~----------------------------~~~-~ 219 (267)
T cd06645 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----------------------------RAL-F 219 (267)
T ss_pred cccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch----------------------------hhH-H
Confidence 99999999874 456889999999999999999999988532200 000 0
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..... . ...+..... ......+.+++..|++.+|++||++++|++
T Consensus 220 ~~~~~-~---~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 220 LMTKS-N---FQPPKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hhhcc-C---CCCCccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 0 000011000 011235778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.23 Aligned_cols=193 Identities=25% Similarity=0.430 Sum_probs=159.8
Q ss_pred CCccccCceeEEEEEEC---CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEe--CCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ---DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ--GRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~ 462 (745)
.+||+|+||.||+|+.. .+..+|+|.+.... ....+.+|++++++++|+||+++++++.. ....++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 67999999999999975 45789999986432 23557889999999999999999998854 4567899999865
Q ss_pred CChhhhhcCC--------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeee----cCCCCeEEccCCCcc
Q 004565 463 GSLDRTLFGN--------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILL----HDKLQVKISDFGLSK 530 (745)
Q Consensus 463 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll----~~~~~~kl~Dfgl~~ 530 (745)
+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||+ +..+.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 777766422 1258899999999999999999999 999999999999999 456789999999998
Q ss_pred cCCCCCcc--cccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 531 LLTPEQSS--LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 531 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
........ ......+|+.|+|||++.+. .++.++|||||||+++||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 76543221 22346789999999998764 5899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=297.99 Aligned_cols=195 Identities=26% Similarity=0.403 Sum_probs=166.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++.+++|+|++++++++.++...++|+||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 367999999999999985 58899999986432 2234678899999999999999999999999999999999997 6
Q ss_pred ChhhhhcCCC--cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 464 SLDRTLFGNG--SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 464 sL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|.+++.... ..+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++....... ....
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (285)
T cd07861 84 DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYT 159 (285)
T ss_pred CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cccc
Confidence 8888876433 468999999999999999999999 999999999999999999999999999997654332 1223
Q ss_pred ccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 542 TMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
...++..|+|||.+.+. .++.++||||||++++||++|+.||...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 34578899999988654 5789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=298.22 Aligned_cols=244 Identities=24% Similarity=0.375 Sum_probs=196.9
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
..||+|+||.||++... ++..||||++........+.+.+|+..++.++|+|++++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 45999999999999975 58899999987655556677899999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
+++... .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++........ ......++
T Consensus 108 ~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 108 DIVTHT--RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 988543 58999999999999999999999 8999999999999999999999999999876543322 12345688
Q ss_pred cCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 547 ~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
..|+|||.+.+..++.++||||||++++||++|+.||.... . ... .....
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------------------------~---~~~--~~~~~ 231 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-------------------------P---LQA--MRRIR 231 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------------------------H---HHH--HHHHH
Confidence 99999999988889999999999999999999999986322 0 000 00000
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
....+.+.. .......+..++..|++.+|.+|||++||++.
T Consensus 232 -----~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 232 -----DNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -----hcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011111111 01123357788889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=292.29 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=198.3
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEe--CCeeEEEEeec
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ--GRQRFLVYEYM 460 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~ 460 (745)
+.+.||.|+||.||++... ++..+|+|.+... .....+.+..|++++++++|+|++++++++.. +...+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 3467999999999999874 5788999988643 33445678899999999999999999998754 44678999999
Q ss_pred CCCChhhhhcCC---CcccCHHHHHHHHHHHHHHHHHhhhCC--CCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 461 NKGSLDRTLFGN---GSVLEWRERFEIALGTARGLAYLHTGC--DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 461 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
++++|.+++... ...+++..++.++.+|+.||.|||..+ ..+++|+||||+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 999999998653 347999999999999999999999321 289999999999999999999999999999876544
Q ss_pred CcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 536 QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
... .....++..|+|||.+....++.++||||||+++++|++|+.||....
T Consensus 164 ~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---------------------------- 214 (265)
T cd08217 164 SSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---------------------------- 214 (265)
T ss_pred ccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----------------------------
Confidence 321 234568999999999998889999999999999999999999986432
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
..... +....+.. ...+......+.+++.+|++.+|++||++.+|++.
T Consensus 215 -~~~~~-~~~~~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 215 -QLQLA-SKIKEGKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -HHHHH-HHHhcCCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 01111 11111111 11222334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.92 Aligned_cols=191 Identities=27% Similarity=0.377 Sum_probs=162.4
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC------eeEEEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR------QRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~~lV~ 457 (745)
.+.||+|+||.||++... .+..||||++... .......+.+|+.+++.++|+||+++++++.... ..++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 477999999999999974 5889999998643 2334567889999999999999999999986443 469999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+++ +|...+.. .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 106 e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 177 (359)
T cd07876 106 ELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF- 177 (359)
T ss_pred eCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccccccCc-
Confidence 99975 56665532 47889999999999999999999 999999999999999999999999999997543322
Q ss_pred ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
......||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 178 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 178 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred -cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 223457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=284.10 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=206.0
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
.+||+|.||.|||+.++ .|++||||++.. ....+++..|+.++++...+++|+++|.+......++|||||..|++.
T Consensus 39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiS 116 (502)
T KOG0574|consen 39 GKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSIS 116 (502)
T ss_pred HHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHH
Confidence 46999999999999986 589999999853 345788999999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
+.++.++++|++.++..++...++||+|||. ..-||||||+.||||+-+|.+||+|||++..+...- ....++.||
T Consensus 117 DI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVIGT 192 (502)
T KOG0574|consen 117 DIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVIGT 192 (502)
T ss_pred HHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCccccC
Confidence 9999999999999999999999999999998 888999999999999999999999999998765432 223567899
Q ss_pred cCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 547 ~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
+.|||||++..-.|..++||||||+...||..|++|+..-. ....+...-..|++.
T Consensus 193 PFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH----PMRAIFMIPT~PPPT-------------------- 248 (502)
T KOG0574|consen 193 PFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH----PMRAIFMIPTKPPPT-------------------- 248 (502)
T ss_pred cccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc----ccceeEeccCCCCCC--------------------
Confidence 99999999999999999999999999999999999986432 000011111111111
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
+ ..+.+....+.++++.||-+.|++|.|+.++++
T Consensus 249 -----------F--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 249 -----------F--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -----------C--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 1 234566778999999999999999999998875
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.76 Aligned_cols=196 Identities=28% Similarity=0.398 Sum_probs=171.2
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.+.||+|+||.||+|... ++..||||++.... ....+.+..|+.++++++|+||+++++++......++|+||+ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-C
Confidence 3467999999999999974 68899999987543 333567899999999999999999999999999999999999 9
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|.+++......+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++.............
T Consensus 83 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 83 SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 99999997766779999999999999999999999 899999999999999999999999999998775543323345
Q ss_pred cccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 543 MRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
..++..|+|||.+.+. .++.++||||||++++||++|+.+|..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 5789999999998654 468999999999999999999777754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=291.57 Aligned_cols=244 Identities=27% Similarity=0.398 Sum_probs=196.8
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.+.||+|+||.||+|... ++..||||.+.... ....+.+.+|++++.+++|+||+++++++..+...++|+||++++
T Consensus 8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred hheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 3467999999999999874 67899999876432 234567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|..++... .+++..+..++.+++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++..+..... .....
T Consensus 88 ~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06641 88 SALDLLEPG--PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhccc
Confidence 999998643 58999999999999999999998 9999999999999999999999999999876644321 12334
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
.++..|+|||.+.+..++.++||||||+++++|++|..|+.... .......
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----------------------------~~~~~~~ 212 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----------------------------PMKVLFL 212 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----------------------------hHHHHHH
Confidence 67889999999988889999999999999999999999885322 0000011
Q ss_pred HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
...... +.+ +......+.+++.+|++.+|.+||++.++++.
T Consensus 213 -~~~~~~-----~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 -IPKNNP-----PTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -HhcCCC-----CCC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111110 111 11223457789999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.52 Aligned_cols=191 Identities=26% Similarity=0.364 Sum_probs=162.3
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeC------CeeEEEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG------RQRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~lV~ 457 (745)
.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++|+||+++++++... ...++||
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 377999999999999874 5788999998743 223356778899999999999999999988643 3468999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+++ +|...+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 102 e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 173 (355)
T cd07874 102 ELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 173 (355)
T ss_pred hhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc-
Confidence 99975 66666643 48899999999999999999999 999999999999999999999999999998654322
Q ss_pred ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
......||..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 174 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred -ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223457899999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=308.22 Aligned_cols=195 Identities=25% Similarity=0.337 Sum_probs=169.7
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||++... .+..||||++... .......+..|+.++..++|+||+++++.+.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 86 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence 67999999999999985 5889999998642 2234567888999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc------
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS------ 537 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~------ 537 (745)
+|.+++...+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 87 ~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~ 162 (360)
T cd05627 87 DMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162 (360)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccc
Confidence 9999987653 58999999999999999999999 9999999999999999999999999999875532110
Q ss_pred ----------------------------ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 ----------------------------SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0012346999999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=289.81 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=197.5
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|+||.||+|... ++..|++|.+..... ...+.+..|+.++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 367999999999999975 688999999875444 35778999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc---
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF--- 540 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~--- 540 (745)
+|.+++.... .+++..+..|+.+++.||+|||+ .+++|+||+|+||++++++.+||+|||++...........
T Consensus 85 ~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 85 TLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred cHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9999987653 58899999999999999999999 9999999999999999999999999999987655433221
Q ss_pred cccccccCccCcccccCCC---CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 541 TTMRGTRGYLAPEWLTSSA---ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~---~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
....++..|+|||++.... .+.++||||||++++|+++|+.||.... .. .
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-------------------------~~--~ 213 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------------------------NE--F 213 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-------------------------ch--H
Confidence 2356788999999998766 8899999999999999999999986321 00 0
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
........ .. .+.+... ......+.+++.+|++.+|.+||++.+++.
T Consensus 214 -~~~~~~~~-~~-----~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 214 -QIMFHVGA-GH-----KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -HHHHHHhc-CC-----CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00 0111100 111345678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=324.62 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=193.0
Q ss_pred hcCCCCccccCceeEEEEEECC-CcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEe--CCeeEEEEe
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD-KSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ--GRQRFLVYE 458 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e 458 (745)
+.+.+.||+|+||.||++.... +..||+|.+... .......|..|+.++++++|||||++++++.. ....+||||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 3445789999999999999854 678899988643 33345678999999999999999999998854 356899999
Q ss_pred ecCCCChhhhhcCC---CcccCHHHHHHHHHHHHHHHHHhhhCC----CCceeecCCCCCCeeecCC-------------
Q 004565 459 YMNKGSLDRTLFGN---GSVLEWRERFEIALGTARGLAYLHTGC----DHKIIHCDVKPENILLHDK------------- 518 (745)
Q Consensus 459 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~----~~~ivH~dik~~NIll~~~------------- 518 (745)
|+++++|.++|... ...+++..++.|+.||+.||+|||+.. ..+|+||||||+||||+.+
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 99999999998653 236999999999999999999999832 1459999999999999642
Q ss_pred ----CCeEEccCCCcccCCCCCcccccccccccCccCcccccC--CCCCCccceeehHHHHHHHHhCCCCCCcccccccc
Q 004565 519 ----LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS--SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRST 592 (745)
Q Consensus 519 ----~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~ 592 (745)
..+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~----- 247 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN----- 247 (1021)
T ss_pred cCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-----
Confidence 348999999998664332 2234578999999999854 458899999999999999999999986432
Q ss_pred ccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 004565 593 EKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVV 672 (745)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~ 672 (745)
........... .. +..+ ......+.+|+..||+.+|.+||++.|++
T Consensus 248 -----------------------~~~qli~~lk~-~p-----~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 248 -----------------------NFSQLISELKR-GP-----DLPI-----KGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred -----------------------cHHHHHHHHhc-CC-----CCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 11111111111 10 0000 01134578899999999999999999998
Q ss_pred --HHhc
Q 004565 673 --SMLE 676 (745)
Q Consensus 673 --~~L~ 676 (745)
..+.
T Consensus 294 ~h~~ik 299 (1021)
T PTZ00266 294 GYQIIK 299 (1021)
T ss_pred ccHHHh
Confidence 4444
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.83 Aligned_cols=248 Identities=26% Similarity=0.371 Sum_probs=207.1
Q ss_pred hhcCCCCccccCceeEEEEEECC-CcEEEEEEeccCCcc---hHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEE
Q 004565 383 TDNFNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQ---GKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 383 t~~f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 457 (745)
.+.+.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.+.+++....++||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 34555889999999999999876 999999999765443 3468899999999998 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC----CCeEEccCCCcccCC
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK----LQVKISDFGLSKLLT 533 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~----~~~kl~Dfgl~~~~~ 533 (745)
|++.+|.|.+.+... .+++..+..++.|++.|+.|||+ .+|+||||||+|+|+... +.+|++|||++....
T Consensus 116 EL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 999999999999876 39999999999999999999999 999999999999999643 479999999999887
Q ss_pred CCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccc
Q 004565 534 PEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQ 613 (745)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (745)
. .......+||+.|+|||.+....++..+||||+||++|.|++|..||..........
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------------- 248 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------------- 248 (382)
T ss_pred C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------------------
Confidence 6 344577899999999999999999999999999999999999999998654211111
Q ss_pred cccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 614 RVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
....++. .+....-+.....+.+++..++..||.+|+|+.++++
T Consensus 249 ----------~i~~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 249 ----------AILRGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ----------HHHcCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111111 1111112233566788999999999999999999998
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.19 Aligned_cols=242 Identities=29% Similarity=0.410 Sum_probs=192.8
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
..+.||+|+||.||+|... +++.||+|++.... ....+++.+|+++++.++|+|++++.++|...+..++|+||++
T Consensus 19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 3467999999999999975 58899999886432 2334578899999999999999999999999999999999997
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
|+|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...... .
T Consensus 99 -g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~ 169 (307)
T cd06607 99 -GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----N 169 (307)
T ss_pred -CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-----C
Confidence 57777776555579999999999999999999998 99999999999999999999999999998765432 2
Q ss_pred ccccccCccCccccc---CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 542 TMRGTRGYLAPEWLT---SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~---~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
...++..|+|||.+. ...++.++||||||+++|||++|+.||..... .
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----------------------------~ 220 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------------------------M 220 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----------------------------H
Confidence 345788999999874 45688999999999999999999999864320 0
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
........ ... +.+ ........+.+++.+||+.+|++||+|.+|+..
T Consensus 221 ~~~~~~~~-~~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 221 SALYHIAQ-NDS-----PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHhc-CCC-----CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 000 001 011234568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.63 Aligned_cols=193 Identities=25% Similarity=0.434 Sum_probs=159.1
Q ss_pred CCccccCceeEEEEEECC---CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEe--CCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQD---KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ--GRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~ 462 (745)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++|+||+++++++.. ....++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 569999999999999753 4689999886432 23467889999999999999999998854 4567899999875
Q ss_pred CChhhhhcCC--------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeee----cCCCCeEEccCCCcc
Q 004565 463 GSLDRTLFGN--------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILL----HDKLQVKISDFGLSK 530 (745)
Q Consensus 463 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll----~~~~~~kl~Dfgl~~ 530 (745)
+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 676665421 1258899999999999999999999 999999999999999 566789999999998
Q ss_pred cCCCCCcc--cccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 531 LLTPEQSS--LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 531 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
........ ......+|..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 22345689999999998764 5799999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.37 Aligned_cols=249 Identities=28% Similarity=0.387 Sum_probs=194.5
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc----------chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI----------QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l 455 (745)
.+.||+|+||.||+|... +++.||||.+..... ...+.+..|+.+++.++|+|++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 367999999999999864 588999998753211 113467889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 456 VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
|+||+++++|.+++...+ .+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 86 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred EEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 999999999999997663 68999999999999999999998 89999999999999999999999999999865432
Q ss_pred Ccc-cccccccccCccCcccccCCC--CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccc
Q 004565 536 QSS-LFTTMRGTRGYLAPEWLTSSA--ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612 (745)
Q Consensus 536 ~~~-~~~~~~gt~~y~aPE~~~~~~--~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (745)
... ......++..|+|||.+.... ++.++||||||++++|+++|..||....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------------------------- 216 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE------------------------- 216 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-------------------------
Confidence 211 123456889999999987654 7899999999999999999999985322
Q ss_pred ccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 613 QRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..... ...... .....+.. .........+.+++..|++.+|++||++.+|++
T Consensus 217 ---~~~~~-~~~~~~-~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 217 ---AIAAM-FKLGNK-RSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ---hHHHH-HHhhcc-ccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000 010000 00111111 111223456888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.36 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=195.4
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.+.||+|+||.||++... .+..||+|.+... .......+.+|++++.+++|+||+++++.+...+..++|+||++++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (286)
T cd06622 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAG 84 (286)
T ss_pred hhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCC
Confidence 4467999999999999986 6889999988643 3334567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCC--CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 464 SLDRTLFGN--GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 464 sL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|..++... ...+++..+..++.+++.||.|||+ ..+++|+||||+||+++.++.+||+|||++..+.... ..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~ 159 (286)
T cd06622 85 SLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---AK 159 (286)
T ss_pred CHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---cc
Confidence 999988764 2368999999999999999999996 2589999999999999999999999999997654322 23
Q ss_pred ccccccCccCcccccCCC------CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 542 TMRGTRGYLAPEWLTSSA------ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~------~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
...++..|+|||.+.+.. ++.++|||||||++|||++|+.||.... ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------------------------~~- 213 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-------------------------YA- 213 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-------------------------hh-
Confidence 345788999999986543 4889999999999999999999985321 00
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.... .......+.. ...+......+.+++.+|++.+|++||++.+++.
T Consensus 214 ~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 214 NIFA-QLSAIVDGDP---------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hHHH-HHHHHhhcCC---------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0000 0000011110 1122234456788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.78 Aligned_cols=258 Identities=29% Similarity=0.401 Sum_probs=198.6
Q ss_pred cCHHHHHHhhhcCC--CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEe
Q 004565 374 FSYEELAAATDNFN--TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQ 449 (745)
Q Consensus 374 ~~~~el~~at~~f~--~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~ 449 (745)
+.+.++..++++|. +.||+|+||.||++... +++.+|+|.+.... .....+..|+.++.++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34455556666665 77999999999999984 58899999986432 2345677899999998 89999999999875
Q ss_pred C-----CeeEEEEeecCCCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCe
Q 004565 450 G-----RQRFLVYEYMNKGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQV 521 (745)
Q Consensus 450 ~-----~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~ 521 (745)
. ...++|+||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 4 357999999999999998863 33468999999999999999999998 899999999999999999999
Q ss_pred EEccCCCcccCCCCCcccccccccccCccCcccccCCC-----CCCccceeehHHHHHHHHhCCCCCCccccccccccCC
Q 004565 522 KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA-----ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDS 596 (745)
Q Consensus 522 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~ 596 (745)
||+|||++......... .....++..|+|||.+.... ++.++|||||||++|||++|+.||.....
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------- 238 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------- 238 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--------
Confidence 99999998865433221 13346889999999886543 68899999999999999999999864320
Q ss_pred CCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 597 SGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
... .... .......+. .+......+.+++.+|++.+|++||++.|+++
T Consensus 239 --------------------~~~-~~~~-~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 --------------------VKT-LFKI-PRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --------------------HHH-HHHH-hcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0011 011111111 11123346889999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.76 Aligned_cols=284 Identities=25% Similarity=0.320 Sum_probs=212.4
Q ss_pred cCCCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCC-CC-----ceeeEEEEEEeCCeeEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIH-HV-----NLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~g~~~~~~~~~lV~ 457 (745)
...+.||+|.||.|-++... .++.||||++++.. .-..+-..|+.+|..++ |. |+|++++++...++.+||+
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVf 267 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVF 267 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeee
Confidence 33478999999999999975 58999999998643 33566678999999986 43 7999999999999999999
Q ss_pred eecCCCChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC--CCeEEccCCCcccCCC
Q 004565 458 EYMNKGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK--LQVKISDFGLSKLLTP 534 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~--~~~kl~Dfgl~~~~~~ 534 (745)
|.+.. +|.++|..+.- .|+...+..|+.||+.||.+||+ .+|||+||||+||||.+- ..+||+|||.+.....
T Consensus 268 ELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 268 ELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred hhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 99955 99999986653 69999999999999999999998 999999999999999754 4699999999987654
Q ss_pred CCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccc
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (745)
.. .....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|-+..+.+....+++..|..|+..........
T Consensus 344 ~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~ 419 (586)
T KOG0667|consen 344 RV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH 419 (586)
T ss_pred cc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence 32 25567889999999999999999999999999999999988888887777766666666644432211111111
Q ss_pred ccHHH--HHHHHHhhcc-----------------ccccccc----cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 004565 615 VYFPL--LALELHEQRR-----------------YLELADS----RIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671 (745)
Q Consensus 615 ~~~~~--~~~~~~~~~~-----------------~~~~~d~----~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev 671 (745)
..+.. +......+.. ..+..-+ .+........-..+++++++|++.||.+|+|..|.
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa 499 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA 499 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence 11111 0000000000 0000011 01111122445678999999999999999999999
Q ss_pred HH--Hhcc
Q 004565 672 VS--MLEG 677 (745)
Q Consensus 672 ~~--~L~~ 677 (745)
++ .|.+
T Consensus 500 l~Hpfl~~ 507 (586)
T KOG0667|consen 500 LNHPFLTG 507 (586)
T ss_pred hcCccccc
Confidence 84 4443
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=288.56 Aligned_cols=244 Identities=25% Similarity=0.398 Sum_probs=197.0
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.+.||+|+||.||++... +++.+|||++... .....+.+..|++++++++|+|++++++.+...+..++|+||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 3467999999999999974 5788999998643 234467789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC-CCeEEccCCCcccCCCCCcccc
Q 004565 463 GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 463 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~-~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
++|.+++.... ..+++..++.++.+++.||.|||+ .+++|+||+|+||+++++ ..+||+|||++........ .
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~ 158 (256)
T cd08220 84 GTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--A 158 (256)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--c
Confidence 99999997643 358999999999999999999999 999999999999999865 4589999999987654322 2
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....++..|+|||.+....++.++||||||+++++|++|+.||.... ....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----------------------------~~~~ 209 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----------------------------LPAL 209 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----------------------------hHHH
Confidence 33568889999999998889999999999999999999999886432 1111
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
....... ... ..+......+.+++..|++.+|++|||+.|+++
T Consensus 210 ~~~~~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 210 VLKIMSG-TFA---------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHhc-CCC---------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111111 100 111122345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.83 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=194.7
Q ss_pred HHHHHhhhcCC--CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEE----
Q 004565 377 EELAAATDNFN--TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCA---- 448 (745)
Q Consensus 377 ~el~~at~~f~--~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~---- 448 (745)
..+..++++|. +.||+|+||.||++... .++.+|+|.+.... ....++..|+.++.++ +|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 34444555554 78999999999999974 57889999876432 2346688899999999 6999999999884
Q ss_pred -eCCeeEEEEeecCCCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEc
Q 004565 449 -QGRQRFLVYEYMNKGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKIS 524 (745)
Q Consensus 449 -~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~ 524 (745)
.+...++||||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEc
Confidence 34568999999999999988753 23468899999999999999999999 999999999999999999999999
Q ss_pred cCCCcccCCCCCcccccccccccCccCcccccC-----CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCC
Q 004565 525 DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS-----SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGD 599 (745)
Q Consensus 525 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~ 599 (745)
|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+......
T Consensus 167 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---------- 235 (286)
T cd06638 167 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---------- 235 (286)
T ss_pred cCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----------
Confidence 9999986643321 1234468999999998853 44788999999999999999999998643200
Q ss_pred CCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 600 GNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.... .. .........++ ......+.+++.+|++.+|++|||+.||++-
T Consensus 236 ------------------~~~~-~~-~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 236 ------------------RALF-KI-PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ------------------HHHh-hc-cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 00 00000001111 1112458889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.00 Aligned_cols=246 Identities=24% Similarity=0.286 Sum_probs=195.7
Q ss_pred CCCccccCceeEEEEEECC-CcEEEEEEeccCCcc---hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQ---GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||++...+ +..+|+|.+...... ..+.+..|+++++.++|+||+++++.+......++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 3679999999999999865 889999998754322 456788999999999999999999999999999999999999
Q ss_pred CChhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc---
Q 004565 463 GSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS--- 538 (745)
Q Consensus 463 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--- 538 (745)
++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (316)
T cd05574 86 GELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162 (316)
T ss_pred CCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccc
Confidence 9999998754 3468999999999999999999999 99999999999999999999999999998765332110
Q ss_pred -------------------------cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccc
Q 004565 539 -------------------------LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTE 593 (745)
Q Consensus 539 -------------------------~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~ 593 (745)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----- 237 (316)
T cd05574 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR----- 237 (316)
T ss_pred ccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch-----
Confidence 01134678899999999998899999999999999999999999864320
Q ss_pred cCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCC----HH
Q 004565 594 KDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS----MA 669 (745)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt----~~ 669 (745)
. ..+ .. +.+....-.........+.+++.+|++.+|++||| ++
T Consensus 238 --------------------~---~~~-~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 238 --------------------D---ETF-SN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred --------------------H---HHH-HH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 0 000 00 00111100111113467889999999999999999 55
Q ss_pred HHHH
Q 004565 670 NVVS 673 (745)
Q Consensus 670 ev~~ 673 (745)
|++.
T Consensus 285 ~ll~ 288 (316)
T cd05574 285 EIKQ 288 (316)
T ss_pred HHHc
Confidence 5554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=319.31 Aligned_cols=192 Identities=23% Similarity=0.339 Sum_probs=156.8
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCC------CCceeeEEEEEEeC-CeeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIH------HVNLVRLKGFCAQG-RQRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~g~~~~~-~~~~lV~e 458 (745)
.++||+|+||.||+|... .++.||||+++... ...+++..|++++..++ |.+++.+++++... .+.++|||
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~ 212 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP 212 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence 378999999999999975 57889999986432 22344556766666665 45689999988764 46889999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC----------------CeE
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL----------------QVK 522 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~----------------~~k 522 (745)
++ +++|.+++... ..+++..+..|+.||+.||.|||+ ..+|+||||||+|||++.++ .+|
T Consensus 213 ~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vk 288 (467)
T PTZ00284 213 KY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVR 288 (467)
T ss_pred cc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCCCCceEE
Confidence 88 66888888654 369999999999999999999996 14999999999999998765 499
Q ss_pred EccCCCcccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 523 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 523 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
|+|||++...... .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 289 l~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 289 ICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999988643222 245679999999999999999999999999999999999999997644
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.76 Aligned_cols=243 Identities=22% Similarity=0.367 Sum_probs=197.4
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
++||+|++|.||++.. .++..+++|++........+.+.+|+.+++.++|+|++++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 5799999999999997 468899999987555555677889999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......... .....|+
T Consensus 105 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 178 (285)
T cd06648 105 DIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVGT 178 (285)
T ss_pred HHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cccccCC
Confidence 99876 358999999999999999999999 99999999999999999999999999988765433221 2335688
Q ss_pred cCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 547 ~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
..|+|||.+.+..++.++||||||++++||++|+.||.... .. .......
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----------------------------~~-~~~~~~~- 228 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----------------------------PL-QAMKRIR- 228 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----------------------------HH-HHHHHHH-
Confidence 99999999988889999999999999999999999985322 00 0011111
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
... .+.+.. .......+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~-----~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 229 DNL-----PPKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred hcC-----CCCCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 110 011110 1112346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=291.53 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=193.3
Q ss_pred CCCccccCceeEEEEEEC----CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC------eeE
Q 004565 387 NTPIGSGGFGTVYKGILQ----DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR------QRF 454 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~~ 454 (745)
.++||+|+||.||+|.+. .+..||||.+... .....+++..|++++++++|+|++++++++.... ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 467999999999999864 3678999998643 2334667889999999999999999999886532 247
Q ss_pred EEEeecCCCChhhhhcCC-----CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCc
Q 004565 455 LVYEYMNKGSLDRTLFGN-----GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLS 529 (745)
Q Consensus 455 lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~ 529 (745)
+++||+++|+|..++... ...+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccccc
Confidence 889999999998887532 1257899999999999999999998 89999999999999999999999999999
Q ss_pred ccCCCCCcc-cccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCC
Q 004565 530 KLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSS 607 (745)
Q Consensus 530 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (745)
+........ ......++..|++||.+....++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-------------------- 220 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-------------------- 220 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--------------------
Confidence 866443221 1123345678999999998889999999999999999999 777775322
Q ss_pred CCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 608 SPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.............. ..+......+.+++.+|++.+|++||++.||++.|++
T Consensus 221 ---------~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 221 ---------NSEIYNYLIKGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred ---------HHHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00011111111110 0111233578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.19 Aligned_cols=193 Identities=24% Similarity=0.396 Sum_probs=165.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|+||.||+|... +|..+|+|++.... ......+..|++++++++|+|++++++++.+....++|+||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 467999999999999985 58899999986432 2234567889999999999999999999999999999999997 5
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++......+++..++.++.||++||.|||+ .+++|+||||+||+++.++.+||+|||++........ .....
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 159 (284)
T cd07839 84 DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAE 159 (284)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcCCC
Confidence 7888877655679999999999999999999999 9999999999999999999999999999986543322 12334
Q ss_pred ccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCC
Q 004565 544 RGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSS 584 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~ 584 (745)
.++..|+|||.+.+. .++.++||||||+++|||++|+.|+.
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 678899999988764 46899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=292.97 Aligned_cols=266 Identities=22% Similarity=0.272 Sum_probs=196.3
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCcc-----hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQ-----GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+.||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 467999999999999975 5889999999754322 3455778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
.++|.+++......+++..++.++.||++||+|||+ .+++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 85 -~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (298)
T cd07841 85 -ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KM 159 (298)
T ss_pred -CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-cc
Confidence 899999997765579999999999999999999999 9999999999999999999999999999987654322 12
Q ss_pred cccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 541 TTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
....++..|+|||.+.+ ..++.++||||||++++||++|..+|............... ...+... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~------------~ 226 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA-LGTPTEE------------N 226 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH-cCCCchh------------h
Confidence 33456788999998865 46789999999999999999997766533211000000000 0000000 0
Q ss_pred HHHHHHhhccccccccccccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 620 LALELHEQRRYLELADSRIEGQ-----VSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
|. ................ ........+.+++.+|++.+|++|||+.||++.
T Consensus 227 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WP----GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hh----hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 0000000000000000 111234678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=285.55 Aligned_cols=245 Identities=29% Similarity=0.426 Sum_probs=201.7
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
.+.||+|++|.||++... ++..+++|++........+.+.+|++++++++|+|++++++++......++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 367999999999999986 6889999999765555678899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++......+++..+..++.+++.||.|||. .+++|+||+|+||++++++.++|+|||.+........ .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 159 (253)
T cd05122 85 KDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVG 159 (253)
T ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccceec
Confidence 99997765679999999999999999999999 9999999999999999999999999999987665432 244568
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
+..|+|||++.....+.++||||||+++++|++|+.||.... ..... .. .
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----------------------------~~~~~-~~-~ 209 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP----------------------------PMKAL-FK-I 209 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc----------------------------hHHHH-HH-H
Confidence 899999999998889999999999999999999999886431 00000 00 0
Q ss_pred hhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
......... . .......+.+++..|++.+|++|||+.||++
T Consensus 210 ~~~~~~~~~-----~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 210 ATNGPPGLR-----N--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HhcCCCCcC-----c--ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 0 1111356889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.50 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=195.8
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEE--EEecc--CCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCe--eEEEEe
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAV--KKINS--FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQ--RFLVYE 458 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vav--K~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~--~~lV~e 458 (745)
|..+||+|+|-+||||... .|..||= +++.. ......+.|..|+++|+.|+|+||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4577999999999999984 3666762 12222 233445889999999999999999999999876654 779999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC-CCeEEccCCCcccCCCCCc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~-~~~kl~Dfgl~~~~~~~~~ 537 (745)
.|..|+|..|+...+ .++.+.+..|++||++||.|||++. ++|||||||-+||||+.+ |.+||+|+|||..+.....
T Consensus 124 L~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred cccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 999999999998765 4889999999999999999999854 799999999999999865 8899999999998766543
Q ss_pred ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
..+.||+.|||||... ..|++..||||||++++||+|+..|+.... -
T Consensus 202 ---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----------------------------n 248 (632)
T KOG0584|consen 202 ---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----------------------------N 248 (632)
T ss_pred ---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----------------------------C
Confidence 3478999999999988 789999999999999999999999986543 1
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHhccC
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVV--SMLEGG 678 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~--~~L~~~ 678 (745)
+.........+.....+ ..--+ ..+.+++..|+.. ..+|||+.|++ .+|...
T Consensus 249 ~AQIYKKV~SGiKP~sl----~kV~d----Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 249 PAQIYKKVTSGIKPAAL----SKVKD----PEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHcCCCHHHh----hccCC----HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11122222222211111 11111 3467888899999 99999999999 466553
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=287.39 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=199.0
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+......++|+|+++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 4577999999999999964 57889999986432 235678899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC--cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc---
Q 004565 464 SLDRTLFGNG--SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS--- 538 (745)
Q Consensus 464 sL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--- 538 (745)
+|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++..+......
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 85 SLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred cHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 9999997542 368999999999999999999998 99999999999999999999999999999876554322
Q ss_pred cccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 539 LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
......++..|+|||++... .++.++||||||++++||++|+.||...... ..+
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------------------------~~~ 216 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-------------------------KVL 216 (267)
T ss_pred ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-------------------------hhH
Confidence 12344688999999998877 7899999999999999999999998643200 000
Q ss_pred HHHHHHHHhhccccccccccccCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 618 PLLALELHEQRRYLELADSRIEGQV-SDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
...... ..+.+.... .......+.+++..|++.+|++||++++|++
T Consensus 217 ----~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 217 ----MLTLQN------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ----HHHhcC------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 001111110 0122356789999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.58 Aligned_cols=191 Identities=27% Similarity=0.367 Sum_probs=162.9
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeC------CeeEEEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG------RQRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~lV~ 457 (745)
.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++|+||+++++++... ...++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 377999999999999974 5788999998743 233456788999999999999999999987543 3579999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+++ +|...+.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 109 e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~- 180 (364)
T cd07875 109 ELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 180 (364)
T ss_pred eCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-
Confidence 99975 67666643 47889999999999999999999 999999999999999999999999999998654322
Q ss_pred ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
......+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 181 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred -cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 223457899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=290.98 Aligned_cols=244 Identities=27% Similarity=0.392 Sum_probs=198.5
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
+.||+|+||.||+|..+ ++..|++|++..... ..+.+..|+++++.++|+|++++++++......++|+||+++++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 67999999999999986 688899999875443 5677889999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
+++......+++..++.++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ......++
T Consensus 104 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 179 (286)
T cd06614 104 DIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGT 179 (286)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccccCC
Confidence 9998765579999999999999999999999 9999999999999999999999999999875543321 12334578
Q ss_pred cCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 547 ~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
..|+|||++.+..++.++||||||+++|+|++|+.|+.... .... .....
T Consensus 180 ~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~----------------------------~~~~-~~~~~- 229 (286)
T cd06614 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP----------------------------PLRA-LFLIT- 229 (286)
T ss_pred cccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC----------------------------HHHH-HHHHH-
Confidence 89999999988889999999999999999999999886432 0000 00000
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
........ ........+.+++.+|++.+|.+||++.+|++
T Consensus 230 ~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 230 TKGIPPLK-------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hcCCCCCc-------chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01110000 01112356888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=287.60 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=190.8
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-----cchHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-----IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e 458 (745)
.+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++++++|+||+++++++.+. ...++|+|
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 367999999999999975 48899999875321 12345788899999999999999999988763 46789999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc-
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS- 537 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 537 (745)
|+++++|.+++.... .+++..+++++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 87 HMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS 162 (265)
T ss_pred ecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccccccc
Confidence 999999999987543 57889999999999999999998 8999999999999999999999999999986543211
Q ss_pred -ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 538 -SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 538 -~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||.... .
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----------------------------~ 214 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----------------------------A 214 (265)
T ss_pred ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc----------------------------h
Confidence 11233568899999999988889999999999999999999999985321 0
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
... ....... ......+......+..++..|+. +|++||+++||++
T Consensus 215 ~~~-~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 215 MAA-IFKIATQ---------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHH-HHHHhcC---------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000 0000000 01112233444567778888884 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=294.56 Aligned_cols=244 Identities=29% Similarity=0.414 Sum_probs=193.7
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||+|+.. ++..||+|++.... ......+..|++++++++|+|++++++++.+....++|+||++
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence 366999999999999974 58899999986432 2334578889999999999999999999999999999999997
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|.+.+......+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 109 g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~ 180 (317)
T cd06635 109 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----NS 180 (317)
T ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----cc
Confidence 57877776655679999999999999999999999 99999999999999999999999999998754332 33
Q ss_pred cccccCccCccccc---CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 543 MRGTRGYLAPEWLT---SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 543 ~~gt~~y~aPE~~~---~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
..++..|+|||++. .+.++.++||||||++++||++|+.||.... ....
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----------------------------~~~~ 232 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----------------------------AMSA 232 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc----------------------------HHHH
Confidence 46888999999974 4568899999999999999999999875321 0000
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
......... +. .........+.+++.+|++.+|.+||++.+|++.+--
T Consensus 233 -~~~~~~~~~------~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 233 -LYHIAQNES------PT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -HHHHHhccC------CC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 001111100 00 0111233468899999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=289.47 Aligned_cols=196 Identities=31% Similarity=0.419 Sum_probs=168.3
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+...||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++||||+++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 3467999999999999986 58899999886432 22346688999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|..++.... .+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++........ ....
T Consensus 85 ~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07847 85 TVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTD 159 (286)
T ss_pred cHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccC
Confidence 88887765443 58999999999999999999999 9999999999999999999999999999987654332 1233
Q ss_pred cccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 543 MRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
..++..|+|||++.+ ..++.++||||||++++||++|+.||...
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 457889999999876 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.64 Aligned_cols=195 Identities=29% Similarity=0.423 Sum_probs=167.4
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.++||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++|+||+++++++......++|+||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 3477999999999999986 488999998764322 2356788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|..+..... .+++..++.++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++....... .....
T Consensus 85 ~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (286)
T cd07846 85 TVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD 159 (286)
T ss_pred cHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCc
Confidence 99888765443 48999999999999999999999 899999999999999999999999999998764433 22234
Q ss_pred cccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 543 MRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
..++..|+|||++.+ ..++.++||||||++++||++|+.||..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 567899999999875 4578899999999999999999988853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=289.41 Aligned_cols=243 Identities=27% Similarity=0.401 Sum_probs=194.9
Q ss_pred CCCccccCceeEEEEEE-CCCcEEEEEEeccC-CcchHHHHHHHHHHHccCC---CCceeeEEEEEEeCCeeEEEEeecC
Q 004565 387 NTPIGSGGFGTVYKGIL-QDKSVVAVKKINSF-GIQGKKEFCTEITIIGNIH---HVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
.+.||+|+||.||+|.. .++..||+|.+... .....+++.+|+.++++++ |+|++++++++..+...++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 36799999999999997 46889999998643 3344567889999999986 9999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+++|.+++... .+++..++.++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++......... ..
T Consensus 86 ~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~ 159 (277)
T cd06917 86 GGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-RS 159 (277)
T ss_pred CCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-cc
Confidence 99999998653 68999999999999999999999 99999999999999999999999999999876554322 23
Q ss_pred ccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 542 TMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
...|+..|+|||.+.++ .++.++||||||+++|+|++|+.||....... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----------------------------~ 210 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----------------------------A 210 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----------------------------h
Confidence 45688999999988754 46899999999999999999999986432100 0
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.. .... ...+.+... .....+.+++.+|++.+|++||++.|++.
T Consensus 211 ~~-~~~~-----~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 211 MM-LIPK-----SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred hh-cccc-----CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00 0000 001111111 12345788999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=270.68 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=195.9
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC----cch----HHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEE
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG----IQG----KKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~----~~~----~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 457 (745)
+.||.|..++|.+...+ .+...|+|++.... ... .+.-..|+.+|+++ -||+|+.+.+++......++|+
T Consensus 23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVF 102 (411)
T KOG0599|consen 23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVF 102 (411)
T ss_pred HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhh
Confidence 66999999999888874 57889999886321 111 23345789999998 6999999999999999999999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
|.|+.|.|.++|...- .++++...+|+.|+.+|++|||. ..||||||||+|||+|++.++||+|||+++.+..+..
T Consensus 103 dl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek 178 (411)
T KOG0599|consen 103 DLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK 178 (411)
T ss_pred hhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCCchh
Confidence 9999999999997643 69999999999999999999999 9999999999999999999999999999998876543
Q ss_pred ccccccccccCccCcccccC------CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcc
Q 004565 538 SLFTTMRGTRGYLAPEWLTS------SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~------~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
.....||++|+|||.+.. ..|+...|+|+.||++|.|+.|..||-...+--.
T Consensus 179 --LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM-------------------- 236 (411)
T KOG0599|consen 179 --LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM-------------------- 236 (411)
T ss_pred --HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH--------------------
Confidence 467889999999998854 3578899999999999999999999865442111
Q ss_pred cccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.++..+++.. ...+-=.+......+++.+||+.||.+|-|++|+++
T Consensus 237 ----------LR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 ----------LRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ----------HHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1222222210 000000123356778999999999999999999984
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=292.78 Aligned_cols=250 Identities=22% Similarity=0.252 Sum_probs=197.1
Q ss_pred CCCccccCceeEEEEEECC-CcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQD-KSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||+|+||.||++.... ++.|++|.+.... ......+.+|++++..++|+||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 3679999999999999854 7789999987543 23345788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC------
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ------ 536 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~------ 536 (745)
++|.+++...+ .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (305)
T cd05609 86 GDCATLLKNIG-ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161 (305)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccc
Confidence 99999997654 58999999999999999999999 999999999999999999999999999986421110
Q ss_pred --------cccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCC
Q 004565 537 --------SSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSS 608 (745)
Q Consensus 537 --------~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (745)
........++..|+|||++....++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------------------- 220 (305)
T cd05609 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------------------- 220 (305)
T ss_pred cccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------------
Confidence 001122457889999999988889999999999999999999999985322
Q ss_pred CcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 609 PRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.......... .. ...+.... .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 --------~~~~~~~~~~-~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 221 --------PEELFGQVIS-DD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --------HHHHHHHHHh-cc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0011111111 10 01111111 123457899999999999999998888888876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=298.55 Aligned_cols=190 Identities=27% Similarity=0.424 Sum_probs=161.4
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeC------CeeEEEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG------RQRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~lV~ 457 (745)
.+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++|+||+++++++... ...++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 367999999999999974 57899999986432 22345677899999999999999999987543 3468999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
|++ +++|..++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 100 ~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 171 (343)
T cd07878 100 NLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-- 171 (343)
T ss_pred ecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecCCC--
Confidence 988 7789887753 359999999999999999999999 99999999999999999999999999999865432
Q ss_pred ccccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 SLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.....||..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 172 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred --cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 234568999999999876 56899999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.61 Aligned_cols=195 Identities=26% Similarity=0.427 Sum_probs=166.3
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++|+||+++++++.+....++||||+++ +
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-D 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-C
Confidence 467999999999999985 678999999864322 2234577899999999999999999999999999999999985 8
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++......+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||++........ ......
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 164 (291)
T cd07844 89 LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNEV 164 (291)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-cccccc
Confidence 999887766678999999999999999999999 9999999999999999999999999999875432211 112334
Q ss_pred cccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 545 GTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 545 gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6889999998875 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=291.16 Aligned_cols=197 Identities=28% Similarity=0.423 Sum_probs=170.6
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.++||+|+||.||+|... +++.||||++... .....+.+..|++++++++|+||+++++++...+..++|+||+++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence 3467999999999999986 4789999988643 233457789999999999999999999999999999999999998
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+.|..++... ..+++..+..++.+|+.||.|||+ .+++|+||+|+||++++++.+||+|||++.............
T Consensus 85 ~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 85 TLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 7776655443 458999999999999999999999 999999999999999999999999999998776554333345
Q ss_pred cccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 543 MRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
..++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6688999999999888 7899999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=291.38 Aligned_cols=274 Identities=25% Similarity=0.304 Sum_probs=198.5
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEeecC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYEYMN 461 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~ 461 (745)
.+.||.|+||.||+|... ++..+|+|++.... ......+..|++++++++|+|++++++++... ...++|+||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 367999999999999986 47899999997542 33356788999999999999999999999888 78999999997
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+ +|..++......+++..++.++.||++||+|||+ .+++|+||+|+||++++++.+||+|||++............
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 84 H-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred c-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 5 8988887665679999999999999999999999 89999999999999999999999999999877654432234
Q ss_pred ccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 542 TMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
...++..|+|||.+.+ ..++.++||||||++++||++|+.||................+ .+.....+.. ..+..+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~ 235 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCG-SPTDENWPGV---SKLPWF 235 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCchhhcccc---ccchhh
Confidence 4557889999997765 4678999999999999999999999865431111000000000 0000000000 000000
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
............+...+...+...+.+++..|++.+|++||+++++++
T Consensus 236 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 -----ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred -----hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000011111111112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=290.61 Aligned_cols=243 Identities=26% Similarity=0.398 Sum_probs=189.3
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEe------CCeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQ------GRQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~------~~~~~lV~e~ 459 (745)
..||+|+||.||+|... +++.+|+|.+.... ....++..|+.++.++ +|+|++++++++.. ....+++|||
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 77999999999999984 57889999886433 3446788899999998 79999999999853 4578999999
Q ss_pred cCCCChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 460 MNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 460 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~- 176 (282)
T cd06636 101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG- 176 (282)
T ss_pred CCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc-
Confidence 99999999887543 358888999999999999999999 9999999999999999999999999999876543221
Q ss_pred cccccccccCccCccccc-----CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccc
Q 004565 539 LFTTMRGTRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQ 613 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~-----~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (745)
......|+..|+|||.+. ...++.++||||||+++|||++|+.||......
T Consensus 177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------------------------ 232 (282)
T cd06636 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------------------------ 232 (282)
T ss_pred CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------------------------
Confidence 123456889999999876 345788999999999999999999998542200
Q ss_pred cccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 614 RVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.. ...... ...+.+. .......+.+++..||+.+|.+||++.||++
T Consensus 233 ----~~-~~~~~~------~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 ----RA-LFLIPR------NPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----hh-hhhHhh------CCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000000 0000110 1112346889999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.15 Aligned_cols=194 Identities=27% Similarity=0.424 Sum_probs=165.2
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
+.||.|+||.||+|+.. ++..||||++.... ......+..|++++++++|+||+++++++.+....++||||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD 84 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence 67999999999999975 58899999886432 2234578899999999999999999999999999999999996 68
Q ss_pred hhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 465 LDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 465 L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
|..++... ...+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......... ....
T Consensus 85 l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 160 (284)
T cd07860 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHE 160 (284)
T ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-cccc
Confidence 88888653 3468999999999999999999998 89999999999999999999999999998765433211 2334
Q ss_pred ccccCccCcccccCCC-CCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 544 RGTRGYLAPEWLTSSA-ISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~-~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.++..|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 5688999999887644 688999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=289.62 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=192.7
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCC------eeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGR------QRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~------~~~lV~e 458 (745)
.+.||+|+||.||+|... +++.+++|.+.... ...+.+..|+++++++ .|+||+++++++.... ..++|||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 378999999999999985 57789999887543 3456789999999999 7999999999997644 4899999
Q ss_pred ecCCCChhhhhcCC---CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 459 YMNKGSLDRTLFGN---GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 459 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
|+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 99999999988653 2478999999999999999999998 99999999999999999999999999998765433
Q ss_pred CcccccccccccCccCcccccC-----CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCc
Q 004565 536 QSSLFTTMRGTRGYLAPEWLTS-----SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPR 610 (745)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (745)
.. ......++..|+|||++.. ..++.++||||||+++++|++|+.||....
T Consensus 167 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----------------------- 222 (275)
T cd06608 167 LG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH----------------------- 222 (275)
T ss_pred hh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-----------------------
Confidence 22 2234568899999998754 346789999999999999999999986322
Q ss_pred ccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 611 ESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
. ... ..+.. ... .+.+ ..+......+.+++.+|++.||++|||+.+|++
T Consensus 223 --~---~~~-~~~~~-~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 223 --P---MRA-LFKIP-RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --h---HHH-HHHhh-ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 000 00000 000 0011 112224457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=293.92 Aligned_cols=272 Identities=22% Similarity=0.268 Sum_probs=196.0
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEeecC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYEYMN 461 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~ 461 (745)
.+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++|+||+++++++... ...++|+||++
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 367999999999999986 578899999874332 2234577899999999999999999999877 88999999997
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+ +|.+++......+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++........ ...
T Consensus 90 ~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 164 (293)
T cd07843 90 H-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYT 164 (293)
T ss_pred c-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-ccc
Confidence 4 8988887665579999999999999999999999 8999999999999999999999999999987654321 123
Q ss_pred ccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 542 TMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
...++..|+|||.+.+. .++.++||||||++++||++|+.||................+ .|.+. ..+.+
T Consensus 165 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~---------~~~~~ 234 (293)
T cd07843 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG-TPTEK---------IWPGF 234 (293)
T ss_pred cccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCchH---------HHHHh
Confidence 34578899999998764 468999999999999999999999865331111000000000 00000 00000
Q ss_pred HH-HHHhhccccccccccccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 621 AL-ELHEQRRYLELADSRIEGQVSDE-DVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~-~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.. ...............+...++.. ....+.+++..|++.+|++|||+.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00000000111111111122221 2456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=290.12 Aligned_cols=246 Identities=27% Similarity=0.376 Sum_probs=198.2
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
+.+.||+|+||.||+|... ++..|++|.+........+.+..|+.+++.++|+|++++++.+...+..++|+||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 3477999999999999864 678899999875555556778999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.+||+|||++......... .....
T Consensus 103 L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 176 (293)
T cd06647 103 LTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (293)
T ss_pred HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-ccccc
Confidence 99998653 58899999999999999999999 99999999999999999999999999998765543322 23346
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
++..|+|||.+....++.++||||||+++|++++|+.||........... .
T Consensus 177 ~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-----------------------------~ 227 (293)
T cd06647 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----------------------------I 227 (293)
T ss_pred CChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-----------------------------h
Confidence 88899999999888899999999999999999999999964321000000 0
Q ss_pred HhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
...+. +.. ..+......+.+++..||+.+|++||++.+++..
T Consensus 228 ~~~~~------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 228 ATNGT------PEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred hcCCC------CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000 0111123457789999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=272.40 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=193.9
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEec--cCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+||+|.|+.||+... ..|+.+|+|.++ +.+..+.+++.+|+++-+.++|||||+|...+.+....+||+|+|.++.
T Consensus 17 e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~d 96 (355)
T KOG0033|consen 17 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 96 (355)
T ss_pred HHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchH
Confidence 5699999999999886 458888888775 3445567889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC---CCCeEEccCCCcccCCCCCccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD---KLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~---~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
|..-|-.+ -..++..+-..+.||++||.|+|. ++|||||+||.|++|-. .--+||+|||+|..+. ....-.
T Consensus 97 l~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~ 170 (355)
T KOG0033|consen 97 LFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWH 170 (355)
T ss_pred HHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC--Cccccc
Confidence 87655443 346777778899999999999999 99999999999999953 3458999999999887 333446
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...||++|||||++...+++..+|||+.||+||-|+.|..||....+.+.-+-+..+...
T Consensus 171 G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd-------------------- 230 (355)
T KOG0033|consen 171 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD-------------------- 230 (355)
T ss_pred cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC--------------------
Confidence 678999999999999999999999999999999999999999763311111111111111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
+++.-...+ .+...+++.+||..||.+|-|+.|.+.
T Consensus 231 ------------~~~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 ------------YPSPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ------------CCCcccCcC----CHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111111122 234668888999999999999998863
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=287.32 Aligned_cols=248 Identities=23% Similarity=0.404 Sum_probs=197.0
Q ss_pred CCCccccCceeEEEEEE-CCCcEEEEEEeccCCc------chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 387 NTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGI------QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
.+.||+|+||.||+|.. .++..||+|.+..... ...+.+..|++++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 36799999999999996 5688999999864321 1346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC-CeEEccCCCcccCCCCCcc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~ 538 (745)
+++++|.+++.... .+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++ .+||+|||++.........
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 85 MAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred cCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 99999999987543 68899999999999999999999 9999999999999998775 5999999999876543211
Q ss_pred ---cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 539 ---LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 539 ---~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
......++..|+|||.+.+..++.++||||+|+++++|++|+.||.... ..
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------------------------~~- 214 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK-------------------------HS- 214 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-------------------------Cc-
Confidence 1123467889999999988889999999999999999999999985322 00
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
........... .......+......+.+++.+|++.+|++||++.|++.
T Consensus 215 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 215 NHLALIFKIAS---------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred chHHHHHHHhc---------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011101000 00112233344567889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=286.02 Aligned_cols=252 Identities=29% Similarity=0.353 Sum_probs=194.7
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~g 463 (745)
+.||.|++|.||++... .++.+|+|.+.... ......+.+|++++++++|+||+++++++... ...++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 67999999999999985 57889999887432 24467789999999999999999999998654 4689999999999
Q ss_pred ChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 464 SLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 464 sL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
+|.+++.. ....+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 87 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--- 160 (287)
T cd06621 87 SLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--- 160 (287)
T ss_pred CHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc---
Confidence 99887653 33468899999999999999999999 9999999999999999999999999999876543221
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....++..|+|||.+.+..++.++||||||+++|||++|+.||..... + .. .....
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------------------~---~~-~~~~~ 216 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE--------------------P---PL-GPIEL 216 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC--------------------C---CC-ChHHH
Confidence 234578899999999998999999999999999999999999864320 0 00 00011
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
. ..........+.+ ... ........+.+++.+|++.+|.+|||+.||++
T Consensus 217 ~-~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 217 L-SYIVNMPNPELKD-EPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred H-HHHhcCCchhhcc-CCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1 1111111111110 000 00123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=293.09 Aligned_cols=195 Identities=26% Similarity=0.403 Sum_probs=164.7
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.||+|+||.||+|... ++..||+|++..... .....+.+|+++++.++|+||+++.+++..+...++|+||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 377999999999999874 588999999864332 234467889999999999999999999999999999999996 67
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++........ .....
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~ 164 (291)
T cd07870 89 LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YSSEV 164 (291)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-CCCcc
Confidence 777776555568889999999999999999999 89999999999999999999999999999764332211 23345
Q ss_pred cccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 545 GTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 545 gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
++..|+|||++.+. .++.++||||||++++||++|+.||...
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred ccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 78899999998754 5788999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=318.94 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=208.4
Q ss_pred HHHHhhhcCCCCccccCceeEEEEEECC--------CcEEEEEEeccC-CcchHHHHHHHHHHHccC-CCCceeeEEEEE
Q 004565 378 ELAAATDNFNTPIGSGGFGTVYKGILQD--------KSVVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFC 447 (745)
Q Consensus 378 el~~at~~f~~~lG~G~fg~Vy~g~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~ 447 (745)
|+....-.+.+.||+|.||.|++|.... ...||||.++.. .....+.+..|++++..+ +|+|++.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3333333455689999999999998631 457999999843 335578899999999999 799999999999
Q ss_pred EeCCeeEEEEeecCCCChhhhhcCCC---------------cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCC
Q 004565 448 AQGRQRFLVYEYMNKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPEN 512 (745)
Q Consensus 448 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~N 512 (745)
......++|.||+..|+|.++|+..+ ..|+....+.++.|||.|++||++ .+++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999999877 348999999999999999999999 999999999999
Q ss_pred eeecCCCCeEEccCCCcccCCCCCcccccccc--cccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccc
Q 004565 513 ILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR--GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQS 589 (745)
Q Consensus 513 Ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~ 589 (745)
||+.++..+||+|||+++.............. -+..|||||.+....++.|+|||||||+||||+| |..|+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 99999999999999999976665544333222 3556999999999999999999999999999999 555553210
Q ss_pred cccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004565 590 RSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA 669 (745)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 669 (745)
..... .+...++. +.+.|..+..++.++|+.||+.+|++||++.
T Consensus 527 --------------------------~~~~l-~~~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~ 570 (609)
T KOG0200|consen 527 --------------------------PTEEL-LEFLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFS 570 (609)
T ss_pred --------------------------cHHHH-HHHHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 01111 22333322 2233444456788999999999999999999
Q ss_pred HHHHHhcc
Q 004565 670 NVVSMLEG 677 (745)
Q Consensus 670 ev~~~L~~ 677 (745)
++++.++.
T Consensus 571 ~~~~~~~~ 578 (609)
T KOG0200|consen 571 ECVEFFEK 578 (609)
T ss_pred HHHHHHHH
Confidence 99999987
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=286.65 Aligned_cols=248 Identities=29% Similarity=0.395 Sum_probs=198.6
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.||+|+||.||++... +++.||+|++.... ....+++.+|++++++++|+||+++++.+......++|+||+++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS 85 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence 356999999999999986 58899999987543 3445678999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++......+++..+..++.|++.||+|||+ ..+++|+||||+||++++++.+||+|||.+........ ....
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~ 160 (265)
T cd06605 86 LDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFV 160 (265)
T ss_pred HHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---hccc
Confidence 999998765678999999999999999999996 47899999999999999999999999999876533221 1256
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
++..|+|||++.+..++.++||||||+++++|++|+.||..... ............
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------------------------~~~~~~~~~~~~ 216 (265)
T cd06605 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND------------------------PPDGIFELLQYI 216 (265)
T ss_pred CChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc------------------------ccccHHHHHHHH
Confidence 88899999999998999999999999999999999999864320 000011111111
Q ss_pred HhhccccccccccccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 625 HEQRRYLELADSRIEGQVSDE-DVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.. .. .+. .+.. ....+.+++..|++.+|++|||+.+++.
T Consensus 217 ~~-~~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 217 VN-EP-----PPR----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hc-CC-----CCC----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11 00 011 1111 3455889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=287.47 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=196.4
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.+++.++|+|++++++.+......++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 367999999999999985 4788999998643 2234567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC-CeEEccCCCcccCCCCCccccc
Q 004565 464 SLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 464 sL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|.+++..... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .+||+|||.+........ ...
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 160 (257)
T cd08225 85 DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LAY 160 (257)
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-ccc
Confidence 99999876433 68999999999999999999998 9999999999999999885 469999999987654322 223
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...|+..|+|||++.+..++.++||||||++++||++|+.||.... .....
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----------------------------~~~~~ 211 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----------------------------LHQLV 211 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------------------------HHHHH
Confidence 3468899999999988889999999999999999999999885322 11111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
...... ... ...+.....+.+++.+|++.+|++|||+.||++
T Consensus 212 ~~~~~~-~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 212 LKICQG-YFA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHhcc-cCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111111 110 111122346888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=288.24 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=187.1
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHH-HccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITI-IGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|+||.||+|... ++..||+|++.... .....++..|+.. ++.++|+|++++++++......++|+||++ +
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 367999999999999985 58999999987532 2334556666665 566799999999999999999999999996 6
Q ss_pred ChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCC-ceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc
Q 004565 464 SLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDH-KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 464 sL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
+|.+++.. ....+++..++.++.||+.||+|||+ + +++||||||+||+++.++.+||+|||++....... .
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~ 159 (283)
T cd06617 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--A 159 (283)
T ss_pred cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--c
Confidence 88777653 23468999999999999999999998 6 89999999999999999999999999998654321 1
Q ss_pred ccccccccCccCcccccC----CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 540 FTTMRGTRGYLAPEWLTS----SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~----~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
.+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------------------------~-- 212 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK-------------------------T-- 212 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc-------------------------c--
Confidence 233467889999998865 456889999999999999999999985321 0
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
...... .... .. .+.+. .......+.+++..|++.+|++||++.+|++
T Consensus 213 ~~~~~~-~~~~-~~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 213 PFQQLK-QVVE-EP-----SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CHHHHH-HHHh-cC-----CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111 0000 00 01110 0112345888999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=288.17 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=197.2
Q ss_pred ccccCceeEEEEEECC-CcEEEEEEeccCCc---chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
||.|+||.||+++... ++.+++|.+..... ...+.+.+|++++.+++|+|++++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 88999999865433 3456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc-------c
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS-------S 538 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~-------~ 538 (745)
.+++...+ .+++..++.++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997654 68999999999999999999998 9999999999999999999999999999876543321 1
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
......++..|+|||.+.....+.++||||||++++||++|+.||.... ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----------------------------~~ 207 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----------------------------PE 207 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----------------------------HH
Confidence 2234567889999999988889999999999999999999999986432 01
Q ss_pred HHHHHHHhhccccccccccccCCCCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDE--DVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~--~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
........ +.. ..+.. ....+.+++..|++.+|++|||+.+|.+.|+
T Consensus 208 ~~~~~~~~-~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 208 EIFQNILN-GKI----------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHhc-CCc----------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11111111 110 00111 1456789999999999999999977777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.61 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=201.3
Q ss_pred CCCccccCceeEEEEEECCCc-EEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 387 NTPIGSGGFGTVYKGILQDKS-VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~-~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
...||-|+||.||++..++.. ..|.|.+........++|+-|+++|+...||+||+|++.|...+..+++.|||.+|-+
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 356899999999999987644 4567888777777889999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
+..+..-+..|+..++.-++.+++.||.|||+ ..|||||||+.|||++.+|.++|+|||++....... .....+.|
T Consensus 117 DaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRDsFIG 192 (1187)
T KOG0579|consen 117 DAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRDSFIG 192 (1187)
T ss_pred hHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH-hhhccccC
Confidence 99998888899999999999999999999999 999999999999999999999999999986543321 22356789
Q ss_pred ccCccCccccc-----CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 546 TRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 546 t~~y~aPE~~~-----~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
|+.|||||+.. ..+|+.++|||||||.|.||.-+.+|-..-. -+.
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------------------------pMR----- 242 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------------------------PMR----- 242 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------------------------hHH-----
Confidence 99999999875 3578999999999999999999987754322 001
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
+.-.........++. +......+.+++..||..||..||++.++++
T Consensus 243 VllKiaKSePPTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 243 VLLKIAKSEPPTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHhhcCCCcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111111111112221 2345567889999999999999999999875
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.80 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=195.1
Q ss_pred ccccCceeEEEEEECC-CcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
||.|+||.||+++... +..+|+|++.... ....+.+..|+.+++.++|+||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999864 7899999986432 23456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++.... .+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.+||+|||++....... ......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 99997653 58999999999999999999999 999999999999999999999999999998765432 1233467
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
+..|+|||.+....++.++|+||||+++|||++|..||..... ..........
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------------------------~~~~~~~~~~ 207 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---------------------------DPMEIYNDIL 207 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---------------------------CHHHHHHHHh
Confidence 8899999999888899999999999999999999999864320 0011111111
Q ss_pred hhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS-----MANVVS 673 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~ev~~ 673 (745)
+......++......+.+++..|++.+|++||+ ++|+++
T Consensus 208 ---------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 208 ---------KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---------ccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 000111222222457889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=285.97 Aligned_cols=195 Identities=28% Similarity=0.419 Sum_probs=166.5
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||.|++|.||+|... ++..||||++.... ....+.+.+|+++++.++|+|++++++++.+....++||||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 367999999999999975 68999999987432 2334678899999999999999999999999999999999995 6
Q ss_pred ChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++.... ..+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~ 158 (283)
T cd07835 83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTH 158 (283)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cCc
Confidence 8999887654 368999999999999999999999 89999999999999999999999999999765433221 123
Q ss_pred cccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 543 MRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
..++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3568899999988664 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=284.80 Aligned_cols=243 Identities=22% Similarity=0.368 Sum_probs=195.8
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
.+||+|+||.||++... ++..||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 45999999999999984 68899999987555555677899999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
+++... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........ ......++
T Consensus 106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 106 DIVTHT--RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 987543 58999999999999999999999 8999999999999999999999999999876544322 12345688
Q ss_pred cCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 547 ~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
..|+|||++.+..++.++||||||++++||++|..||..... . .. .....
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----------------------------~-~~-~~~~~ 229 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----------------------------L-KA-MKMIR 229 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------------------H-HH-HHHHH
Confidence 999999999888899999999999999999999999864320 0 00 00000
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
. ...+.+.. .......+.+++.+|++.+|.+||++.+|++
T Consensus 230 ~-----~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 230 D-----NLPPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred h-----hCCcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0 00111100 0112235778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=284.84 Aligned_cols=266 Identities=22% Similarity=0.243 Sum_probs=192.1
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCC-CCceeeEEEEEEeC--CeeEEEEeec
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQG--RQRFLVYEYM 460 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e~~ 460 (745)
+.++||+|+||.||+|... ++..||+|++.... .........|+..+.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 3467999999999999974 58899999987532 222334557888888885 99999999999887 8899999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
+ ++|.+++......+++..++.++.|++.||+|||+ .+++|+||+|+||+++. +.+||+|||++........ .
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~ 155 (282)
T cd07831 83 D-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--Y 155 (282)
T ss_pred C-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC--c
Confidence 7 58888887655679999999999999999999999 99999999999999999 9999999999987644322 1
Q ss_pred cccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 541 TTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
....++..|+|||++.. ..++.++|||||||++|||++|..||......+.........+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~--------------~~~ 221 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP--------------DAE 221 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCC--------------CHH
Confidence 33457889999997654 557899999999999999999999986543111000000000000 000
Q ss_pred HHHHHHhhccccccccccccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 620 LALELHEQRRYLELADSRIEG----QVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
+ ..............+.... .........+.+++.+|++.+|++||+++++++
T Consensus 222 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 222 V-LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred H-HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 0000000000000000000 001123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.23 Aligned_cols=247 Identities=27% Similarity=0.373 Sum_probs=189.0
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+||+|+||.||++... +++.+|+|++.... ......+..|+.++.++. |+||+++++++......++++||+.. +
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-S 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-C
Confidence 56999999999999975 57899999987432 234567889999999996 99999999999999999999999864 5
Q ss_pred hhhhh---cC-CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 465 LDRTL---FG-NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 465 L~~~l---~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
|.++. .. ....+++..+..++.+++.||+|||+ ..+++||||||+||+++.++.+||+|||++........ .
T Consensus 89 l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 164 (288)
T cd06616 89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--K 164 (288)
T ss_pred HHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc--c
Confidence 54432 22 23468999999999999999999997 25899999999999999999999999999976543321 1
Q ss_pred cccccccCccCcccccCC---CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 541 TTMRGTRGYLAPEWLTSS---AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~---~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
....++..|+|||.+... .++.++||||||+++|||++|+.||..... .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------------------------~ 216 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------------------------V 216 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------------------------H
Confidence 334678899999998776 689999999999999999999999864210 0
Q ss_pred HHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.....+.. ....+.+...........+.+++.+|++.+|++|||+.+|++
T Consensus 217 ~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 217 FDQLTQVV------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHhhhc------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 000111111111223456889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.99 Aligned_cols=192 Identities=29% Similarity=0.389 Sum_probs=170.5
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
+.+.||+|+||.||++... +++.||+|.+.... ....+.+..|++++++++|+||+++++++.++...++||||++
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 3467999999999999985 58899999986432 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 85 ~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 156 (290)
T cd05580 85 GGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156 (290)
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CC
Confidence 99999998765 368999999999999999999999 99999999999999999999999999999876544 23
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
...+++.|+|||.+.+...+.++||||||+++++|++|+.||..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 44688999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=285.85 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=185.8
Q ss_pred CccccCceeEEEEEEC-CCcEEEEEEeccCCc---chHHHHHHHHHH---HccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 389 PIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI---QGKKEFCTEITI---IGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~---l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
.||+|+||.||++... +++.+|||.+..... .....+.+|..+ +...+|+|++.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 588999998864321 222334444433 344579999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+++|.+++...+ .+++..+..++.|++.||+|||+ .+++|+||||+|||+++++.++|+|||++........ .
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 153 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---c
Confidence 999999887554 59999999999999999999999 9999999999999999999999999999875543221 2
Q ss_pred ccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 542 TMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
...|+..|+|||.+.. ..++.++||||||++++||++|+.||..... . ... .
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------------------~--~~~-~ 206 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT------------------------K--DKH-E 206 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC------------------------c--CHH-H
Confidence 3468999999998864 5688999999999999999999999864320 0 000 0
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVSM 674 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~~ 674 (745)
...... ..+. ..+......+.+++..|++.+|++|| +++|+++.
T Consensus 207 ~~~~~~------~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 207 IDRMTL------TVNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHhh------cCCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000000 0111 12222345678889999999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=280.61 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=201.6
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEeecC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYEYMN 461 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~ 461 (745)
.+.||+|++|.||+|... ++..|++|++..... ...+.+.+|++.+++++|+||+++++.+... ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 367999999999999986 688999999875432 4567889999999999999999999999988 88999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-cc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-LF 540 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~ 540 (745)
+++|.+++.... .+++..++.++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 85 ~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 85 GGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 999999997665 79999999999999999999999 99999999999999999999999999999877654321 12
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....++..|+|||.+.....+.++||||||+++++|++|+.||.... .....
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----------------------------~~~~~ 212 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----------------------------NPMAA 212 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----------------------------chHHH
Confidence 34568899999999998889999999999999999999999986432 00111
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
...... .......+......+.+++.+|++.+|++||++.+++.
T Consensus 213 ~~~~~~---------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 213 LYKIGS---------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHhccc---------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111110 01111222233467889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=282.05 Aligned_cols=248 Identities=30% Similarity=0.398 Sum_probs=201.7
Q ss_pred CCCccccCceeEEEEEECC-CcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.+.||+|++|.||+++..+ +..|+||++..... .....+..|++.+.+++|+|++++++++......++|+||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 4779999999999999865 88999999875443 446789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++... ..+++..++.++.|+++||+|||+ ..+++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 86 L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~ 161 (264)
T cd06623 86 LADLLKKV-GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV 161 (264)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-cccee
Confidence 99999765 468999999999999999999996 288999999999999999999999999999876543322 13456
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHH
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (745)
++..|+|||.+....++.++||||||+++|||++|+.||..... ..........
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--------------------------~~~~~~~~~~ 215 (264)
T cd06623 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--------------------------PSFFELMQAI 215 (264)
T ss_pred ecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--------------------------cCHHHHHHHH
Confidence 78999999999998999999999999999999999999864420 0011111111
Q ss_pred HhhccccccccccccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 625 HEQRRYLELADSRIEGQVSDE-DVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 625 ~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.. . ..+ ..+.. ....+.+++..|++.+|++||++.|+++.
T Consensus 216 ~~-~-----~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 216 CD-G-----PPP----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred hc-C-----CCC----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 0 001 11111 34578899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=283.78 Aligned_cols=192 Identities=30% Similarity=0.417 Sum_probs=167.1
Q ss_pred ccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
||+|+||+||++... ++..+|+|.+.... ......+..|++++++++|+|++++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 58899999986432 22345677899999999999999999999999999999999999999
Q ss_pred hhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 466 DRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 466 ~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
.+++..... .+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 999876543 68999999999999999999999 999999999999999999999999999987654321 123345
Q ss_pred cccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
++..|+|||++.+..++.++||||||+++++|++|+.||...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 788999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=274.91 Aligned_cols=244 Identities=23% Similarity=0.275 Sum_probs=199.1
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccCCc---chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|.-|+||++.+.+ +..+|+|++.+... ........|-++|+.+.||-++.|++.++.....++|||||++|
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 459999999999999976 58899999976433 33455677999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC-------
Q 004565 464 SLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE------- 535 (745)
Q Consensus 464 sL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~------- 535 (745)
+|...++.+. +.++...+.-++..|+-||+|||- .|||+|||||+||||.++|++-|+||.|+......
T Consensus 163 dL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~ 239 (459)
T KOG0610|consen 163 DLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS 239 (459)
T ss_pred cHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence 9999988654 479999999999999999999998 99999999999999999999999999988543110
Q ss_pred --------------------------Cc----------------------ccccccccccCccCcccccCCCCCCcccee
Q 004565 536 --------------------------QS----------------------SLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567 (745)
Q Consensus 536 --------------------------~~----------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~ 567 (745)
.. .....++||-.|+|||++.+...+...|.|
T Consensus 240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWW 319 (459)
T KOG0610|consen 240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWW 319 (459)
T ss_pred CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHH
Confidence 00 001235699999999999999999999999
Q ss_pred ehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHH
Q 004565 568 SYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDV 647 (745)
Q Consensus 568 S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 647 (745)
+|||+||||+.|.-||.+.. ...++ ..++-..+.-.-.++..
T Consensus 320 tfGIflYEmLyG~TPFKG~~-------------------------~~~Tl-------------~NIv~~~l~Fp~~~~vs 361 (459)
T KOG0610|consen 320 TFGIFLYEMLYGTTPFKGSN-------------------------NKETL-------------RNIVGQPLKFPEEPEVS 361 (459)
T ss_pred HHHHHHHHHHhCCCCcCCCC-------------------------chhhH-------------HHHhcCCCcCCCCCcch
Confidence 99999999999999998765 22222 12222222212222445
Q ss_pred HHHHHHHHHccCCCCCCCCC----HHHHH
Q 004565 648 EKLVRIALCCVQEEPMLRPS----MANVV 672 (745)
Q Consensus 648 ~~l~~l~~~cl~~~p~~RPt----~~ev~ 672 (745)
..+.+|+...|.+||.+|-- +.||-
T Consensus 362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred hHHHHHHHHHhccChhhhhccccchHHhh
Confidence 67889999999999999988 77775
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=288.37 Aligned_cols=241 Identities=28% Similarity=0.398 Sum_probs=191.2
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||+|+.. ++..+|+|.+... .....+++..|+++++.++|+|++++.+++......++|+||+. +
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 99 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 99 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-C
Confidence 56999999999999975 5788999988632 22334578889999999999999999999999999999999996 6
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+.+......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 100 ~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~ 171 (308)
T cd06634 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXF 171 (308)
T ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----ccc
Confidence 8888776555678999999999999999999998 99999999999999999999999999998765432 234
Q ss_pred ccccCccCccccc---CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 544 RGTRGYLAPEWLT---SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 544 ~gt~~y~aPE~~~---~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
.++..|+|||.+. ...++.++||||||++++||++|+.|+..... ...
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------------------------~~~ 222 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------------------------MSA 222 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----------------------------HHH
Confidence 5788999999874 35678899999999999999999998753220 000
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
.... ..... +.. ........+.+++.+||+.+|++||++.+|+...
T Consensus 223 ~~~~-~~~~~-----~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 223 LYHI-AQNES-----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHHH-hhcCC-----CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0000 01110 000 0112335578899999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=291.14 Aligned_cols=197 Identities=30% Similarity=0.396 Sum_probs=166.0
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCC----------e
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR----------Q 452 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----------~ 452 (745)
+.+.||+|+||.||+|... +++.||||+++... ......+..|++++++++|+|++++++++.+.. .
T Consensus 11 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCc
Confidence 3478999999999999985 57899999987432 233456778999999999999999999987655 7
Q ss_pred eEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccC
Q 004565 453 RFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 453 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
.++|+||+++ +|...+......+++..+..++.||+.||+|||+ .+|+|+||||+||++++++.+||+|||++...
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred EEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 8999999986 7777776655579999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
............++..|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred cCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 5543322233456788999998765 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=287.27 Aligned_cols=244 Identities=26% Similarity=0.407 Sum_probs=198.5
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEecc--CCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINS--FGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
++||+||.+.||++...+.+.+|+|++.. ...+...-|++|+.+|.++ .|.+||+|++|-..++..||||||- ..+
T Consensus 367 k~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~D 445 (677)
T KOG0596|consen 367 KQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DID 445 (677)
T ss_pred HhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-ccc
Confidence 56999999999999999999999988753 3445567799999999999 5999999999999999999999987 458
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc-cccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL-FTTM 543 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~ 543 (745)
|...|......++.-.+..+..|++.|+.++|+ .+|||.||||.|.|+-. |.+||+|||+|..+..+.... ....
T Consensus 446 L~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQ 521 (677)
T KOG0596|consen 446 LNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQ 521 (677)
T ss_pred HHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccc
Confidence 999998776644433788899999999999999 99999999999999876 489999999999887765443 3456
Q ss_pred ccccCccCcccccCCC-----------CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccc
Q 004565 544 RGTRGYLAPEWLTSSA-----------ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~-----------~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (745)
+||+.||+||.+.... .+.++||||+||+||+|+.|+.||....
T Consensus 522 vGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------------------------- 576 (677)
T KOG0596|consen 522 VGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------------------------- 576 (677)
T ss_pred cCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------------------------
Confidence 8999999999885432 5679999999999999999999996432
Q ss_pred ccccHHHHHHHHHhhccccccccccccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 613 QRVYFPLLALELHEQRRYLELADSRIEGQVSDE-DVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
-. ..++..+.||...-+++.- .-..++++|+.||+.||.+|||+.||++
T Consensus 577 -----n~-------~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 -----NQ-------IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HH-------HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 01 1234456666443333311 1123899999999999999999999985
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=280.32 Aligned_cols=244 Identities=27% Similarity=0.453 Sum_probs=200.5
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||.|+||.||++... ++..+++|++..... ...+.+..|+++++.++|+|++++++.+......++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 367999999999999985 588999999875433 45677889999999999999999999999999999999999999
Q ss_pred ChhhhhcCC---CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 464 SLDRTLFGN---GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 464 sL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
+|.+++... ...+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++....... ...
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (258)
T cd08215 85 DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLA 160 (258)
T ss_pred cHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-cee
Confidence 999999765 3579999999999999999999999 899999999999999999999999999998765543 222
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....+++.|+|||.+....++.++||||||+++++|++|+.||.... ....
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----------------------------~~~~ 211 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----------------------------LLEL 211 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----------------------------HHHH
Confidence 34568889999999988889999999999999999999999885432 1111
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..... ..... ..+......+.+++.+|++.+|++|||+.||++
T Consensus 212 ~~~~~-~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 212 ALKIL-KGQYP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHh-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111 11111 111122356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=284.80 Aligned_cols=243 Identities=25% Similarity=0.302 Sum_probs=197.7
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+.||.|+||.||++... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+||+.+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 467999999999999986 58899999987432 23467889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|..++... ..+++..+..++.||++||.|||+ .+++|+||+|+||++++++.++|+|||++....... ....
T Consensus 85 ~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~ 158 (258)
T cd05578 85 GDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTS 158 (258)
T ss_pred CCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccc
Confidence 9999999765 468999999999999999999998 899999999999999999999999999998765432 2234
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||..... . ......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------------------------~--~~~~~~ 211 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR-------------------------T--IRDQIR 211 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc-------------------------c--HHHHHH
Confidence 5688899999999988899999999999999999999999864320 0 011111
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSM--ANVV 672 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~--~ev~ 672 (745)
..... .....+......+.+++.+|++.+|.+||++ +|++
T Consensus 212 ~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 AKQET----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHhcc----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11110 0011222233678899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=284.98 Aligned_cols=195 Identities=27% Similarity=0.367 Sum_probs=161.7
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCe-----eEEEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQ-----RFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~-----~~lV~ 457 (745)
.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.+ +|+|++++++++..... .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 367999999999999975 58899999876432 22346788899999999 56999999999977665 79999
Q ss_pred eecCCCChhhhhcCC----CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-CCCeEEccCCCcccC
Q 004565 458 EYMNKGSLDRTLFGN----GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-KLQVKISDFGLSKLL 532 (745)
Q Consensus 458 e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~~ 532 (745)
||+++ +|.+++... ...+++..++.++.||+.||.|||+ .+++||||||+||+++. ++.+||+|||++...
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99985 788887643 2358999999999999999999999 99999999999999999 889999999999765
Q ss_pred CCCCcccccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
...... .....+++.|+|||++.+ ..++.++||||||+++|||++|..||...
T Consensus 162 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 162 SIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred CCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 432211 123356788999998865 45789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=281.14 Aligned_cols=242 Identities=28% Similarity=0.432 Sum_probs=198.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|+||.||+++.. ++..+++|++... ......++..|++++++++|+||+++.+++.+....++|+||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 467999999999999864 6788999998743 2334567888999999999999999999999999999999999999
Q ss_pred ChhhhhcCC---CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccc
Q 004565 464 SLDRTLFGN---GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 464 sL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
+|.+++... ...+++..++.++.+++.||+|||+ .+++|+||+|+||++++++.+||+|||++...... ..
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~ 158 (256)
T cd08530 85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MA 158 (256)
T ss_pred CHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC---Cc
Confidence 999988652 2468999999999999999999998 99999999999999999999999999999876554 22
Q ss_pred cccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....++..|+|||++.+..++.++|+||||++++||++|+.||.... ....
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----------------------------~~~~ 209 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----------------------------MQDL 209 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------------------------HHHH
Confidence 33457889999999999899999999999999999999999986432 0111
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.... ..+.. ...+......+.+++..|++.+|++||++.||++
T Consensus 210 ~~~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 210 RYKV-QRGKY---------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHH-hcCCC---------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111 11111 1222344566899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=278.64 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=199.4
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.+.||+|++|.||++... +++.|++|.+..... .....+.+|++++++++|+|++++++++.+....++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 3467999999999999875 578899999976543 4567889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 84 ~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~ 158 (254)
T cd06627 84 GSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DAS 158 (254)
T ss_pred CcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccc
Confidence 9999998765 469999999999999999999998 99999999999999999999999999999876554322 234
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..++..|+|||.+.+...+.++||||||+++++|++|+.||.... ......
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----------------------------~~~~~~- 209 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----------------------------PMAALF- 209 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----------------------------HHHHHH-
Confidence 568889999999988888999999999999999999999885321 011110
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.... ... + ..+......+.+++.+|++.+|++||++.+++.
T Consensus 210 ~~~~-~~~-----~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 210 RIVQ-DDH-----P----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhc-cCC-----C----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1100 000 1 111222356789999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.20 Aligned_cols=195 Identities=29% Similarity=0.477 Sum_probs=166.6
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc-chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
.++||.|++|.||+|+.. ++..||||++..... .....+..|++++++++|+|++++++++.+.+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 467999999999999985 588999999875432 2346678899999999999999999999999999999999985 8
Q ss_pred hhhhhcCCC--cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 465 LDRTLFGNG--SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 465 L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++........ ....
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 159 (284)
T cd07836 84 LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSN 159 (284)
T ss_pred HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cccc
Confidence 888876544 468999999999999999999998 8999999999999999999999999999976543221 1233
Q ss_pred cccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 543 MRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
..++..|++||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4578899999988664 5688999999999999999999998643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=284.40 Aligned_cols=272 Identities=25% Similarity=0.317 Sum_probs=198.7
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|++|.||++... +++.+++|++..... .....+..|++++++++|+||+++++++..+...++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 356999999999999975 688899999874432 2456788899999999999999999999999999999999975
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++......+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.+||+|||.+....... ......
T Consensus 83 ~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~ 158 (283)
T cd05118 83 DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHY 158 (283)
T ss_pred CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCc
Confidence 8888887765679999999999999999999999 999999999999999999999999999998775543 122334
Q ss_pred ccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 544 RGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
.++..|+|||.+.+. .++.++||||||+++++|++|+.||......+.........+ .+.+. ....+..+..
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~ 231 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG-TPDPE------VWPKFTSLAR 231 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCchH------hcccchhhhh
Confidence 578899999998876 789999999999999999999988854331110000000000 00000 0000000000
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
... .......+... ..........+.+++..|++.+|.+||++++++.
T Consensus 232 ~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYK--FSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhh--hhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00000000000 0111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=286.22 Aligned_cols=240 Identities=30% Similarity=0.426 Sum_probs=190.3
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCc---chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.||+|+||.||+|+.. ++..|++|++..... ...+.+..|+++++.++|+|++++++++.+....++||||+. +
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 56999999999999974 578899999864322 234568889999999999999999999999999999999996 5
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++......+++..++.++.||+.||.|||+ .+++|+||+|+||+++.++.+||+|||++..... ....
T Consensus 106 ~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~~ 177 (313)
T cd06633 106 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANSF 177 (313)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCCc
Confidence 7878776666679999999999999999999998 8999999999999999999999999999864322 2345
Q ss_pred ccccCccCccccc---CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 544 RGTRGYLAPEWLT---SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 544 ~gt~~y~aPE~~~---~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
.|+..|+|||++. ...++.++||||||+++|||++|..|+.... ....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-----------------------------~~~~ 228 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------------------------AMSA 228 (313)
T ss_pred cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------------------------hHHH
Confidence 6889999999984 4568899999999999999999999986432 0000
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
....... ...... .......+.+++.+|++.+|.+||++.+++..
T Consensus 229 ~~~~~~~-~~~~~~--------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 229 LYHIAQN-DSPTLQ--------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHhc-CCCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111110 110000 11122357789999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=277.41 Aligned_cols=244 Identities=23% Similarity=0.267 Sum_probs=189.4
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCc---chHHHHHHHHHH-HccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI---QGKKEFCTEITI-IGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.||+|+||.||+|... +++.||||.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45899999999999974 578999999864322 222334455544 4455899999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 99999987543 58999999999999999999999 8999999999999999999999999999875433 233
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..++..|+|||.+.+..++.++||||||++++||++|..||.... .... .
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----------------------------~~~~-~ 202 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----------------------------PDAV-F 202 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----------------------------HHHH-H
Confidence 468889999999988888999999999999999999999986432 0000 0
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
......... ... .........+.+++.+|++.+|++||++.++.+.|+
T Consensus 203 ~~~~~~~~~--~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 203 DNILSRRIN--WPE----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHhcccC--CCC----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 111111100 000 111122356889999999999999998877777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=289.84 Aligned_cols=240 Identities=24% Similarity=0.372 Sum_probs=201.4
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCCcc--hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQ--GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
....||+|.|+.|..|+.. .+..||||.+.+.... ....+.+|++++..+.|||||+++.+.......++||||..+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 3478999999999999975 4889999998754332 345588999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|.+.++|.+.+. .....+..++.|+..|++|||+ +.|+|||||+.||||+.+.++||+|||++..+... .....
T Consensus 140 ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lqt 213 (596)
T KOG0586|consen 140 GELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQT 213 (596)
T ss_pred chhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc--ccccc
Confidence 999999998876 4448888999999999999999 99999999999999999999999999999988743 33467
Q ss_pred cccccCccCcccccCCCC-CCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAI-SDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~-t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
..|++.|.|||++.+..+ .+++|+||+|++||-|++|..||++..
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------------------------- 259 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------------------------- 259 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----------------------------------
Confidence 789999999999998876 589999999999999999999997543
Q ss_pred HHHHhhccccccccccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEG--QVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
+.++-++.+++ .++.-....+-+++++++-.+|.+|++++++.+
T Consensus 260 --------lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 260 --------LKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --------cccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11122222222 122223345778888999999999999999974
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.57 Aligned_cols=270 Identities=23% Similarity=0.300 Sum_probs=195.5
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCCc-chHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGI-QGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.+.||+|+||.||+|+..+ +..|+||++..... ........|+..+.+++ |+|++++++++...+..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 34679999999999999864 78899999864322 22334567899999998 999999999999999999999999 8
Q ss_pred CChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 463 GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
++|.+++.... ..+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 156 (283)
T cd07830 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YT 156 (283)
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cC
Confidence 89998887654 468999999999999999999999 9999999999999999999999999999986644322 23
Q ss_pred ccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 542 TMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
...++..|+|||.+.. ..++.++||||||++++||++|+.||......+........ ...+.. ..|
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~-~~~~~~------------~~~ 223 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV-LGTPTK------------QDW 223 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHh-cCCCCh------------hhh
Confidence 3467889999998754 45789999999999999999999888654311111000000 000000 001
Q ss_pred HHHHHhhcccccccccccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIE---GQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.............+..... ..........+.+++.+|++.+|++|||++||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1111000011000000000 00001113568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.68 Aligned_cols=193 Identities=32% Similarity=0.507 Sum_probs=163.5
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeC--CeeEEEEeec
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQG--RQRFLVYEYM 460 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~--~~~~lV~e~~ 460 (745)
.+.||+|+||.||+|... ++..+|||++... .......+..|+.+++++ +|+||+++++++... ...++|+||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 467999999999999975 5788999988532 223445677899999999 999999999998653 3679999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc---
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS--- 537 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~--- 537 (745)
+ ++|..++... .++|..++.++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 92 ~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~ 165 (337)
T cd07852 92 E-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165 (337)
T ss_pred c-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccccc
Confidence 7 5998888654 68999999999999999999999 9999999999999999999999999999987654332
Q ss_pred -ccccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 538 -SLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 538 -~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
.......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 12234568999999998765 4678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=278.82 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=192.9
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccC-----CcchHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEE
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF-----GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVY 457 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 457 (745)
+.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++|+||+++++++.+. ...++|+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 3478999999999999974 5889999987522 223456788999999999999999999998764 4578999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+++++|.+++.... .+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++.......
T Consensus 86 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 86 EYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999999987544 48899999999999999999998 9999999999999999999999999999986543211
Q ss_pred --ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 538 --SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 538 --~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
.......++..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---------------------------- 213 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE---------------------------- 213 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC----------------------------
Confidence 11234568899999999998889999999999999999999999986321
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.. ....+.. ........+......+.+++..|++ +|..||++.+++.
T Consensus 214 ~~-~~~~~~~---------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 214 AM-AAIFKIA---------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HH-HHHHHHH---------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00 0000110 0011122333344668889999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=288.77 Aligned_cols=282 Identities=21% Similarity=0.258 Sum_probs=194.9
Q ss_pred Ccccc--CceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 389 PIGSG--GFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 389 ~lG~G--~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.||+| +||+||++... .++.||||.+.... ....+.+.+|+.+++.++|+||+++++++..+...++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 36666 89999999974 68999999986432 233567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc---
Q 004565 464 SLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL--- 539 (745)
Q Consensus 464 sL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--- 539 (745)
+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+|++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999887643 358999999999999999999998 999999999999999999999999997654332211100
Q ss_pred ---ccccccccCccCcccccCC--CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCC-CCcccc
Q 004565 540 ---FTTMRGTRGYLAPEWLTSS--AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSS-SPRESQ 613 (745)
Q Consensus 540 ---~~~~~gt~~y~aPE~~~~~--~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 613 (745)
.....++..|+|||++.+. .++.++||||||++++||++|+.||...................|.... .+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 0112345679999999764 4789999999999999999999999754322221111111111000000 000000
Q ss_pred cc--cHHHHH----HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 614 RV--YFPLLA----LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 614 ~~--~~~~~~----~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.. ....+. .............+..+...........+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 000000 0000000000111112222223445677899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=289.84 Aligned_cols=191 Identities=27% Similarity=0.382 Sum_probs=163.0
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeC------CeeEEEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG------RQRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~lV~ 457 (745)
.+.||+|+||.||+|... ++..||||++... .......+..|+.++++++|+||+++++++... ...++|+
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 377999999999999974 6889999998642 233456678899999999999999999988643 3569999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+. ++|.+.+... +++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 101 e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 173 (353)
T cd07850 101 ELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173 (353)
T ss_pred eccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC
Confidence 9996 4888877543 8899999999999999999999 8999999999999999999999999999986543321
Q ss_pred ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||...
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 174 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred --CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 23346788999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=284.17 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=190.3
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCC-cchHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFG-IQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
+.+.||+|+||.||+|..++ ++.||||.+.... .....++..|+.++.+.+ |+||+++++++......++||||+++
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 98 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST 98 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc
Confidence 45789999999999999875 8899999987533 233456677887776764 99999999999999999999999854
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++......+++..+..++.+++.||+|||+ ..+|+||||+|+||++++++.+||+|||++..+...... ..
T Consensus 99 -~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~--~~ 173 (296)
T cd06618 99 -CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173 (296)
T ss_pred -CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--cC
Confidence 7777766545579999999999999999999996 258999999999999999999999999999765433221 23
Q ss_pred cccccCccCcccccCCC----CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 543 MRGTRGYLAPEWLTSSA----ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~----~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
..++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ..
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------------------------~~- 225 (296)
T cd06618 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---------------------------EF- 225 (296)
T ss_pred CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---------------------------HH-
Confidence 35788999999987654 78999999999999999999999864220 00
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
......... .... +.. .......+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~~~-~~~~-----~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 226 EVLTKILQE-EPPS-----LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHhcC-CCCC-----CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000111111 0000 000 00123468899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=283.66 Aligned_cols=195 Identities=28% Similarity=0.430 Sum_probs=163.0
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++|+||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 467999999999999985 68899999886432 2334678899999999999999999999999999999999996 5
Q ss_pred ChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-CCCeEEccCCCcccCCCCCccccc
Q 004565 464 SLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-KLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 464 sL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|.+++..... .+++..+..++.||+.||+|||+ .+++|+||+|+||+++. +..+||+|||++........ ...
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (294)
T PLN00009 86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFT 161 (294)
T ss_pred cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-ccc
Confidence 78777754433 46888899999999999999999 89999999999999985 55789999999976543321 123
Q ss_pred ccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 542 TMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 34578899999988664 5789999999999999999999998653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=262.41 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=193.2
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccC-CcchHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSF-GIQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
..||.|..|.|++.++.. |..+|||.+... ..+..+.++..++++.+-+ .|.||+.+|+|..+...++.||.|.. .
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 349999999999999864 889999998754 3445667777888777764 99999999999999999999999843 6
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
++.+|.....++++..+-++...+++||.||.+ .++|+|||+||+|||+|+.|++|++|||++-.+-... ..+...
T Consensus 177 ~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--AhtrsA 252 (391)
T KOG0983|consen 177 AEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHTRSA 252 (391)
T ss_pred HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--cccccc
Confidence 777777666678888888999999999999998 5899999999999999999999999999998765443 335667
Q ss_pred cccCccCcccccC---CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHH
Q 004565 545 GTRGYLAPEWLTS---SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 545 gt~~y~aPE~~~~---~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
|.+.|||||.+.- ..|+.++|||||||.|+||.||+.|+..... .+....
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---------------------------dFe~lt 305 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---------------------------DFEVLT 305 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---------------------------cHHHHH
Confidence 9999999999864 3688999999999999999999999976431 111111
Q ss_pred HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..+. .+. -.++.... + ...+.++...||++|+.+||...++++
T Consensus 306 kvln--~eP-P~L~~~~g--F----Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 306 KVLN--EEP-PLLPGHMG--F----SPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHh--cCC-CCCCcccC--c----CHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1111 111 11111111 2 345788899999999999999998875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=283.96 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=197.5
Q ss_pred CCCccccCceeEEEEEE----CCCcEEEEEEeccCC----cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEE
Q 004565 387 NTPIGSGGFGTVYKGIL----QDKSVVAVKKINSFG----IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 457 (745)
.+.||+|+||.||+++. .++..||||.+.... ....+.+..|++++.++ +|+||+++++.+......++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 36799999999999985 356789999986432 22345688999999999 6999999999999999999999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 85 DYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred ecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 999999999998754 358899999999999999999998 9999999999999999999999999999987654433
Q ss_pred ccccccccccCccCcccccCCC--CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSA--ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~--~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
.......++..|+|||.+.+.. .+.++||||||++++||++|..||.... ...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-------------------------~~~ 215 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG-------------------------EQN 215 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc-------------------------ccc
Confidence 3233456889999999987765 7889999999999999999999985321 000
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
............ .+.. +......+.+++.+|++.+|++|||+.+|.+.|+.
T Consensus 216 ~~~~~~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 216 SQSEISRRILKS-------KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred hHHHHHHHHHcc-------CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111111111110 1111 11122457788999999999999999999988865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=287.95 Aligned_cols=198 Identities=24% Similarity=0.367 Sum_probs=165.2
Q ss_pred CCCCccccCceeEEEEEECC---CcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEE
Q 004565 386 FNTPIGSGGFGTVYKGILQD---KSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVY 457 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 457 (745)
+.++||+|+||.||+|.... +..||+|.+.... ....+.+..|+.++.+++||||+++++++.+. ...++||
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 34679999999999999854 7899999987632 33356778899999999999999999999988 7899999
Q ss_pred eecCCCChhhhhcCC----CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC----CCCeEEccCCCc
Q 004565 458 EYMNKGSLDRTLFGN----GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD----KLQVKISDFGLS 529 (745)
Q Consensus 458 e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~----~~~~kl~Dfgl~ 529 (745)
||+++ +|.+++... ...++...++.++.||+.||.|||+ .+++||||||+||+++. ++.+||+|||++
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99975 666655422 2268899999999999999999999 99999999999999999 899999999999
Q ss_pred ccCCCCCc--ccccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 530 KLLTPEQS--SLFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 530 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
........ .......++..|+|||.+.+. .++.++||||||++++||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 87654322 112345678899999987664 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=288.11 Aligned_cols=193 Identities=23% Similarity=0.218 Sum_probs=160.7
Q ss_pred ccccCceeEEEEEECCCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhh
Q 004565 390 IGSGGFGTVYKGILQDKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 467 (745)
+|.|+++.||+++. +++.||||++... .....+.+..|+++++.++|+||+++++++.+....+++|||+++++|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44455555555554 6889999998743 34456789999999999999999999999999999999999999999999
Q ss_pred hhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc------ccc
Q 004565 468 TLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS------SLF 540 (745)
Q Consensus 468 ~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~------~~~ 540 (745)
++... ...+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||.+........ ...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 99754 2368899999999999999999999 9999999999999999999999999998875532211 111
Q ss_pred cccccccCccCcccccCC--CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 541 TTMRGTRGYLAPEWLTSS--AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~--~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
....++..|+|||++... .++.++||||||++++||++|+.||...
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 334577899999998763 5789999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=284.44 Aligned_cols=195 Identities=31% Similarity=0.385 Sum_probs=164.1
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeC--CeeEEEEeecC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYEYMN 461 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~ 461 (745)
.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++|+|++++++++.+. +..++|+||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 477999999999999985 588999999864322 2234567899999999999999999998765 46799999997
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+ +|.+++......+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||++........ ...
T Consensus 92 ~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~ 166 (309)
T cd07845 92 Q-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMT 166 (309)
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-CCC
Confidence 4 8888887655679999999999999999999999 9999999999999999999999999999987654321 123
Q ss_pred ccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 542 TMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred cccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3345788999999865 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=281.70 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=192.8
Q ss_pred CCCccccCceeEEEEEE----CCCcEEEEEEeccCC----cchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEE
Q 004565 387 NTPIGSGGFGTVYKGIL----QDKSVVAVKKINSFG----IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 457 (745)
.+.||+|+||.||++.. .++..||+|++.... ....+.+..|++++.++ +|+||+++.+++..+...++|+
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 46799999999999986 368899999987432 22346678899999999 6999999999999999999999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+|||+++++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 85 DYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999987653 58899999999999999999999 9999999999999999999999999999987654333
Q ss_pred ccccccccccCccCcccccCC--CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 538 SLFTTMRGTRGYLAPEWLTSS--AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~--~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
.......|+..|+|||.+... .++.++||||||+++|+|++|+.||.... ...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-------------------------~~~ 215 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG-------------------------EKN 215 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC-------------------------ccc
Confidence 223345688999999998753 46789999999999999999999985321 000
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
............. ..++......+.+++..|++.+|++|| ++++++.
T Consensus 216 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 216 SQAEISRRILKSE-----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cHHHHHHHhhccC-----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111111111110 111222335678999999999999997 5666643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=283.15 Aligned_cols=197 Identities=27% Similarity=0.371 Sum_probs=164.0
Q ss_pred CCCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCC--------eeE
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR--------QRF 454 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--------~~~ 454 (745)
..++||+|+||.||+|... +++.||||++.... ......+.+|++++++++|+||++++++|.... ..+
T Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 16 KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence 3477999999999999975 58899999886432 222345678999999999999999999987654 349
Q ss_pred EEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCC
Q 004565 455 LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 455 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
+|+||+.+ +|.+.+......+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 96 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 96 LVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSL 171 (310)
T ss_pred EEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence 99999975 8888887665578999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCcc---cccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 535 EQSS---LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 535 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.... ......++..|+|||.+.+. .++.++||||||++++||++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 3221 12334578899999988665 4688999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=278.27 Aligned_cols=194 Identities=32% Similarity=0.430 Sum_probs=162.9
Q ss_pred CCCccccCceeEEEEEECC-CcEEEEEEeccCCc--chHHHHHHHHHHHccC---CCCceeeEEEEEEeCCe-----eEE
Q 004565 387 NTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGI--QGKKEFCTEITIIGNI---HHVNLVRLKGFCAQGRQ-----RFL 455 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~~~-----~~l 455 (745)
.+.||+|+||.||+|+... +..+|+|++..... .....+..|+.++.++ .|+|++++++++..... .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 3679999999999999864 88999999874322 2234566777766655 69999999999988776 899
Q ss_pred EEeecCCCChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCC
Q 004565 456 VYEYMNKGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
+|||+++ +|.+++..... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.....
T Consensus 84 ~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred Eehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999974 88888865433 68999999999999999999999 8999999999999999999999999999987644
Q ss_pred CCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
... .....++..|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 160 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 160 EMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred Ccc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 322 12345788999999999989999999999999999999999888643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=278.56 Aligned_cols=241 Identities=24% Similarity=0.280 Sum_probs=186.1
Q ss_pred CccccCceeEEEEEEC-CCcEEEEEEeccCCc---chHHHHHHHHH---HHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 389 PIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI---QGKKEFCTEIT---IIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
.||+|+||.||++... .++.||+|.+..... .....+..|.. +++...|+|++++.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999974 578999999864321 12223444443 4445679999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+++|..++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..+..... .
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 99999888654 369999999999999999999999 9999999999999999999999999999876543221 2
Q ss_pred ccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHH
Q 004565 542 TMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
...|+..|+|||.+.++ .++.++||||||++++||++|+.||...... ....
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~--------------------------~~~~- 206 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------------------------DKHE- 206 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc--------------------------chHH-
Confidence 34689999999998754 6899999999999999999999998643200 0000
Q ss_pred HHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~ev~~ 673 (745)
...... ..+..+ +......+.+++..|++.+|.+|| ++.++++
T Consensus 207 ~~~~~~------~~~~~~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 207 IDRMTL------TMAVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHhh------ccCCCC----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 000000 011111 112235688889999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=306.64 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=180.7
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEe----------------
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ---------------- 449 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~---------------- 449 (745)
..||+||||.|||++.+ ||+.+|||++... +......+.+|+.++++|+|||+|+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 56999999999999985 8999999999744 33445668889999999999999998653210
Q ss_pred --------------------------------------------------------------------------------
Q 004565 450 -------------------------------------------------------------------------------- 449 (745)
Q Consensus 450 -------------------------------------------------------------------------------- 449 (745)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------C--------CeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeec
Q 004565 450 ---------------G--------RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506 (745)
Q Consensus 450 ---------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~ 506 (745)
+ ...|+=||||+..+|.++++.+...-.-...++++.+|++||+|+|+ .+||||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~giIHR 721 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QGIIHR 721 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---Cceeec
Confidence 0 11356677887777776665543211356788999999999999999 999999
Q ss_pred CCCCCCeeecCCCCeEEccCCCcccCC-----------------CCCcccccccccccCccCcccccCC---CCCCccce
Q 004565 507 DVKPENILLHDKLQVKISDFGLSKLLT-----------------PEQSSLFTTMRGTRGYLAPEWLTSS---AISDKTDV 566 (745)
Q Consensus 507 dik~~NIll~~~~~~kl~Dfgl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~k~Dv 566 (745)
||||.|||||++..+||+|||+|.... .......+..+||.-|+|||++.+. .|+.|+|+
T Consensus 722 DLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm 801 (1351)
T KOG1035|consen 722 DLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM 801 (1351)
T ss_pred cCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh
Confidence 999999999999999999999998721 0011133567899999999999765 49999999
Q ss_pred eehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHH
Q 004565 567 YSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDED 646 (745)
Q Consensus 567 ~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 646 (745)
||+||||+||+. ||....+. ..+......+.+..- ..+....
T Consensus 802 YSLGIVlFEM~y---PF~TsMER-----------------------------a~iL~~LR~g~iP~~------~~f~~~~ 843 (1351)
T KOG1035|consen 802 YSLGIVLFEMLY---PFGTSMER-----------------------------ASILTNLRKGSIPEP------ADFFDPE 843 (1351)
T ss_pred HHHHHHHHHHhc---cCCchHHH-----------------------------HHHHHhcccCCCCCC------ccccccc
Confidence 999999999984 45443211 111111111111111 1222334
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 647 VEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 647 ~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
...-.+++.++++.||.+|||+.|++.
T Consensus 844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 844 HPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 445668899999999999999999975
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=291.44 Aligned_cols=278 Identities=23% Similarity=0.308 Sum_probs=201.4
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCC-----eeEEEE
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR-----QRFLVY 457 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~ 457 (745)
+.+.||.|+||.||+|+... +..||||++.... ....+.+..|+++++.++|+||+++.+++.... ..++||
T Consensus 4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence 34779999999999999854 8899999987543 344567899999999999999999999998775 789999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||++ ++|.+++.... .+++..++.++.+|+.||+|||+ .+|+|+||||.|||++.++.++|+|||++........
T Consensus 84 e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 84 ELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred cchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 9998 48888886654 79999999999999999999999 9999999999999999999999999999987655431
Q ss_pred --ccccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccc
Q 004565 538 --SLFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614 (745)
Q Consensus 538 --~~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (745)
.......++..|+|||.+.+. .++.++||||||+++++|++|+.||................+. +.+...... ..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~-~~ 236 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT-PSEEDLKFI-TS 236 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC-CChhHhhhc-cc
Confidence 122345678899999999887 7899999999999999999999998654321111111111111 110000000 00
Q ss_pred ccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhcc
Q 004565 615 VYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEG 677 (745)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~--~L~~ 677 (745)
.....+.... ..... ..+ ....+.....+.+++.+||+.+|++||+++++++ .+++
T Consensus 237 ~~~~~~~~~~----~~~~~--~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 237 EKARNYLKSL----PKKPK--KPL-SKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred cchhhHHhhc----ccCCc--chh-HHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0000000000 00000 000 0011113456789999999999999999999996 3555
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=281.20 Aligned_cols=254 Identities=19% Similarity=0.223 Sum_probs=178.4
Q ss_pred cCCCCccccCceeEEEEEECCC----cEEEEEEeccCCcchH-----------HHHHHHHHHHccCCCCceeeEEEEEEe
Q 004565 385 NFNTPIGSGGFGTVYKGILQDK----SVVAVKKINSFGIQGK-----------KEFCTEITIIGNIHHVNLVRLKGFCAQ 449 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~----~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~g~~~~ 449 (745)
.+.+.||+|+||.||+|...+. ..+|+|+......... .....++..+..+.|+|++++++++..
T Consensus 15 ~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 94 (294)
T PHA02882 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSF 94 (294)
T ss_pred EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeE
Confidence 3457899999999999997653 4556665332211110 112233445667789999999997765
Q ss_pred CC----eeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEcc
Q 004565 450 GR----QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525 (745)
Q Consensus 450 ~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~D 525 (745)
.. ..++++|++.. ++.+.+... ...++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 95 KRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred ecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEEEE
Confidence 43 34677777643 555555432 236788899999999999999999 8999999999999999999999999
Q ss_pred CCCcccCCCCCc------ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCC
Q 004565 526 FGLSKLLTPEQS------SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGD 599 (745)
Q Consensus 526 fgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~ 599 (745)
||+++.+..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||.....
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~----------- 238 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH----------- 238 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc-----------
Confidence 999987643221 111334699999999999999999999999999999999999999975420
Q ss_pred CCCCCCCCCCcccccccHHHHH-HHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 600 GNGPSSSSSPRESQRVYFPLLA-LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
...+.... .+... .+....+.. ......+.+++..|++.+|++||++.+|++.|+
T Consensus 239 --------------~~~~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 --------------NGNLIHAAKCDFIK-----RLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred --------------chHHHHHhHHHHHH-----Hhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00000000 00000 000011100 111356889999999999999999999998873
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=279.39 Aligned_cols=195 Identities=29% Similarity=0.402 Sum_probs=176.1
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
++||+||||.|+-.... .|+.+|.|++.+.. .++....++|-.+|.+++.+-||.+--.+...+..+||+..|.+|
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 78999999999999875 58899999886432 344566788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.-||.+.+. .+++..+.-+|.+|+.||++||+ ..||+||+||.|||||+.|+++|+|+|||..+...... ..
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~--~~ 345 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI--RG 345 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc--cc
Confidence 99999987664 69999999999999999999999 99999999999999999999999999999988776543 34
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
.+||.+|||||++.++.|+...|.||+||+||||+.|+.||....
T Consensus 346 rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 489999999999999999999999999999999999999997654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=291.47 Aligned_cols=195 Identities=27% Similarity=0.428 Sum_probs=164.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEe----CCeeEEEEee
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ----GRQRFLVYEY 459 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~ 459 (745)
.+.||+|+||.||+|... ++..||+|++.... ....+.+..|+.++.+++|+||+++.+++.. ....++|+||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 367999999999999975 58899999987432 2345667889999999999999999998753 3467999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS- 538 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~- 538 (745)
+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++.........
T Consensus 90 ~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 90 ME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred hh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence 96 68988886554 59999999999999999999999 99999999999999999999999999999765443221
Q ss_pred --cccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 539 --LFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 539 --~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 1234578899999998865 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=285.45 Aligned_cols=188 Identities=28% Similarity=0.422 Sum_probs=158.6
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCC------eeEEEEe
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR------QRFLVYE 458 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e 458 (745)
+.||+|+||.||+|... +++.||||++.... ......+..|+++++.++|+||+++++++.... ..++|+|
T Consensus 21 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 100 (342)
T cd07879 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP 100 (342)
T ss_pred EEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence 67999999999999974 68899999986432 223456889999999999999999999986543 4689999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+.. +|..++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--- 170 (342)
T cd07879 101 YMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 170 (342)
T ss_pred cccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC---
Confidence 9964 6766552 358999999999999999999999 89999999999999999999999999998765322
Q ss_pred cccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 539 LFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 171 -MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred -CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 133467889999999876 46889999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=278.79 Aligned_cols=195 Identities=31% Similarity=0.435 Sum_probs=169.2
Q ss_pred CCCccccCceeEEEEEECC-CcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQD-KSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
...||+|+||.||+|+... ++.+|+|.+.... ....+.+..|+.++++++|+|++++++++.+....++|+||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 3569999999999999864 8899999987543 3335678889999999999999999999999999999999998 5
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++......+++..++.++.+++.||+|||+ .+++|+||+|+||++++++.+||+|||++........ .....
T Consensus 83 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 158 (282)
T cd07829 83 DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHE 158 (282)
T ss_pred CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCcc
Confidence 8999998764579999999999999999999999 8999999999999999999999999999987654322 12334
Q ss_pred ccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 544 RGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.++..|+|||.+.+. .++.++||||||++++||++|+.||...
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 457789999998776 7899999999999999999999888654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=287.93 Aligned_cols=196 Identities=29% Similarity=0.393 Sum_probs=162.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEeCC--------eeEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR--------QRFL 455 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--------~~~l 455 (745)
.++||+|+||.||+|... +++.+|||++..... .....+.+|++++++++|+||+++++++.... ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 367999999999999975 578899998864322 22346778999999999999999999875433 4689
Q ss_pred EEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 456 VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
|+||+.. +|...+......+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 93 v~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 168 (311)
T cd07866 93 VTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168 (311)
T ss_pred EEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchhccCC
Confidence 9999975 6777776665679999999999999999999999 99999999999999999999999999999865432
Q ss_pred Ccc----------cccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 536 QSS----------LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 536 ~~~----------~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
... ..+...++..|+|||.+.+. .++.++||||||++++||++|+.||...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred CcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 211 11234578889999987654 5789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=271.52 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=199.6
Q ss_pred CCCccccCceeEEEEEEC------CCcEEEEEEeccC-CcchHHHHHHHHHHHccCCCCceeeEEEEEEe-CCeeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGILQ------DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ-GRQRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e 458 (745)
+..+-+|.||.||+|.+. +.+.|.||.++.. +.-....+..|--++..++|||+.++.+++.+ ...++++|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 366889999999999654 4556788887643 33446678889999999999999999999865 457899999
Q ss_pred ecCCCChhhhhc-----C--CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 459 YMNKGSLDRTLF-----G--NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 459 ~~~~gsL~~~l~-----~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
++.-|+|..+|. + ..+.++..+...++.|++.|++|||. .++||.||.++|++||+..++||+|=.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence 999999999998 2 22367788888999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCccc-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCCCCCCCC
Q 004565 532 LTPEQSSL-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSP 609 (745)
Q Consensus 532 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (745)
+-+.+.+. ......+..||+||.+.+..++..+|||||||+||||+| |+.|+-.-
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI----------------------- 502 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI----------------------- 502 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-----------------------
Confidence 76655433 334456889999999999999999999999999999998 66665321
Q ss_pred cccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 610 RESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
.|.-.....+++. +-.-+..+..++..+|..||...|++||+++|++.-|..
T Consensus 503 -------DPfEm~~ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 503 -------DPFEMEHYLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------CHHHHHHHHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1222222223221 112234456789999999999999999999999998864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=272.29 Aligned_cols=234 Identities=20% Similarity=0.278 Sum_probs=181.7
Q ss_pred ccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCCCChhh
Q 004565 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 467 (745)
||+|+||.||++... ++..+|+|.+........ |+.....+ +|+|++++++.+...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999974 577899998764321111 22222222 79999999999999999999999999999999
Q ss_pred hhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC-CeEEccCCCcccCCCCCcccccccccc
Q 004565 468 TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 468 ~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
++.... .+++..+..++.|+++||.|||+ .+++|+||||+||+++.++ .++|+|||++...... ....++
T Consensus 99 ~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~ 169 (267)
T PHA03390 99 LLKKEG-KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGT 169 (267)
T ss_pred HHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCC
Confidence 997654 79999999999999999999999 8999999999999999998 9999999998765433 234578
Q ss_pred cCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHh
Q 004565 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626 (745)
Q Consensus 547 ~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (745)
..|+|||++.+..++.++||||||++++||++|+.||..... .......+....
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~------------------------~~~~~~~~~~~~-- 223 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED------------------------EELDLESLLKRQ-- 223 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc------------------------chhhHHHHHHhh--
Confidence 999999999998999999999999999999999999863320 000111111111
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 004565 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS-MANVVS 673 (745)
Q Consensus 627 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~ev~~ 673 (745)
.... .........+.+++..|++.+|.+||+ ++|+++
T Consensus 224 -~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 -QKKL---------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -cccC---------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 111123456888999999999999996 688873
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=284.01 Aligned_cols=205 Identities=27% Similarity=0.413 Sum_probs=170.0
Q ss_pred CCccCHHHHHHhhhcCC--CCccccCceeEEEEEE-CCCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEE
Q 004565 371 PRRFSYEELAAATDNFN--TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKG 445 (745)
Q Consensus 371 ~~~~~~~el~~at~~f~--~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g 445 (745)
+++....++...+++|. +.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++.+++|+||+++.+
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 34555667777777776 7799999999999986 468899999987432 223466888999999999999999999
Q ss_pred EEEeC------CeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC
Q 004565 446 FCAQG------RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519 (745)
Q Consensus 446 ~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~ 519 (745)
++... ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+ .+++||||||+||++++++
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCC
Confidence 88643 2357788776 77898877543 58999999999999999999999 9999999999999999999
Q ss_pred CeEEccCCCcccCCCCCcccccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 520 QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 520 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||..
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998764322 233467889999998866 5688999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=284.63 Aligned_cols=193 Identities=28% Similarity=0.443 Sum_probs=161.4
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCC-----eeEEEEee
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR-----QRFLVYEY 459 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~ 459 (745)
.+.||+|+||.||+|... +++.||||++.... ......+..|+.++++++|+||+++++++.... ..++|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 377999999999999874 68899999986432 234566888999999999999999999876543 57999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc-
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS- 538 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~- 538 (745)
+++ +|..++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 163 (336)
T cd07849 90 MET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163 (336)
T ss_pred ccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecccccccc
Confidence 975 78777754 368999999999999999999999 99999999999999999999999999999865432221
Q ss_pred -cccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 539 -LFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 539 -~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
......|+..|+|||.+.+ ..++.++||||||++++||++|+.||..
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1133568899999998754 4689999999999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=300.98 Aligned_cols=195 Identities=21% Similarity=0.358 Sum_probs=155.7
Q ss_pred hcCCCCccccCceeEEEEEECC--CcEEEEE------------------EeccCCcchHHHHHHHHHHHccCCCCceeeE
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD--KSVVAVK------------------KINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 443 (745)
+.+.+.||+|+||.||++.+.. +..+++| ++. ........+.+|++++++++|+||+++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 3444789999999999987642 2122222 111 112234568899999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhhhhcCCC----cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC
Q 004565 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNG----SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519 (745)
Q Consensus 444 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~ 519 (745)
++++...+..++|+|++. ++|..++.... .......+..|+.||+.||.|||+ .+|+||||||+||||+.++
T Consensus 229 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 229 EEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred eEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence 999999999999999985 46766664322 123456677899999999999999 9999999999999999999
Q ss_pred CeEEccCCCcccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCC
Q 004565 520 QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNS 583 (745)
Q Consensus 520 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~ 583 (745)
.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999877654433334567999999999999999999999999999999999988543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=292.39 Aligned_cols=195 Identities=31% Similarity=0.483 Sum_probs=171.1
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCC-cchHHHHHHHHHHHccCCCCceeeEEEEEEeCC------eeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR------QRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e~ 459 (745)
..||+|+||.||+|+.+ .|+.||||.++... ....+....|++++++++|+|||++++.-.+.. ..++||||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy 98 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY 98 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence 56999999999999964 59999999998533 445677889999999999999999999865543 67899999
Q ss_pred cCCCChhhhhcCCCc--ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC----CCCeEEccCCCcccCC
Q 004565 460 MNKGSLDRTLFGNGS--VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD----KLQVKISDFGLSKLLT 533 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~----~~~~kl~Dfgl~~~~~ 533 (745)
|.+|+|...|..... .|++.+.+.+..+++.||.|||+ ++|+||||||.||++-. .-..||+|||.|+.+.
T Consensus 99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 999999999986543 69999999999999999999998 99999999999999943 2347999999999876
Q ss_pred CCCcccccccccccCccCccccc-CCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 534 PEQSSLFTTMRGTRGYLAPEWLT-SSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
.+. ....++||..|++||.+. .+.++...|.|||||++||.+||..||....
T Consensus 176 d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 176 DNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred CCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 554 567889999999999998 4889999999999999999999999997654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=276.33 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=190.3
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccC-----CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSF-----GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+.++||+|+||.||++.... +..+++|.++.. ......++..|+.+++.++|||++++++++.+....++|+||
T Consensus 4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEe
Confidence 44779999999999998754 344555555422 223345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcC---CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC
Q 004565 460 MNKGSLDRTLFG---NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 460 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~ 536 (745)
+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++. +.+||+|||++.......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 84 CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred CCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999988863 33479999999999999999999999 99999999999999986 469999999997664332
Q ss_pred cccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccccc
Q 004565 537 SSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 537 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
. ......++..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus 160 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----------------------------- 209 (260)
T cd08222 160 D-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----------------------------- 209 (260)
T ss_pred c-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------------------------
Confidence 2 2234567889999999988888999999999999999999999885322
Q ss_pred HHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
......... .+. .+ ..+......+.+++.+|++.+|++||++.|+++
T Consensus 210 ~~~~~~~~~-~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 210 FLSVVLRIV-EGP-----TP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHHH-cCC-----CC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111111111 111 11 122233456888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-33 Score=313.06 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=197.0
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEec--cCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
..||.|.||.||-+.. +.|...|+|-++ .......+...+|+.++..+.|||+|+++|+-.+.+..+|.||||.+|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 6799999999999986 558889999775 2234445678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc---cccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS---SLFT 541 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~---~~~~ 541 (745)
|.+.+...+ .+++.....+..|++.|++|||+ .+||||||||.||+|+.++.+|++|||.|..+..... ....
T Consensus 1321 La~ll~~gr-i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1321 LASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred HHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 999997653 46666667788999999999999 9999999999999999999999999999998866532 2235
Q ss_pred ccccccCccCcccccCCC---CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 542 TMRGTRGYLAPEWLTSSA---ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~---~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
...||+.|||||.+.+.. ...++||||+|||++||+||++||.... .
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-------------------------n----- 1446 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-------------------------N----- 1446 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-------------------------c-----
Confidence 678999999999997643 4578999999999999999999996432 1
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.|+.-. + +...-.+.+|......-.+++.+|++.||++|-++.|+++.
T Consensus 1447 e~aIMy-~-------V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1447 EWAIMY-H-------VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhHHHh-H-------HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111111 0 11111134444455667789999999999999888877654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=283.75 Aligned_cols=195 Identities=27% Similarity=0.353 Sum_probs=163.4
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCcch--------------HHHHHHHHHHHccCCCCceeeEEEEEEeCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQG--------------KKEFCTEITIIGNIHHVNLVRLKGFCAQGR 451 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~g~~~~~~ 451 (745)
.+.||.|+||.||+|... +++.||||++....... ...+.+|+++++.++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 356999999999999975 58899999986432211 124778999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 452 QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 452 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
..++||||+. ++|.+++... ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccceee
Confidence 9999999997 6898888654 358999999999999999999998 9999999999999999999999999999986
Q ss_pred CCCCC-------------cccccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 532 LTPEQ-------------SSLFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 532 ~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
..... ........++..|+|||++.+. .++.++||||||++++||++|+.||...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 65111 1111223467889999998764 4689999999999999999999998654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=280.04 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=197.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEeecC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
.+.||+|+||.||+|... +++.||+|++... .....+.+..|++++++++ |+||+++++++......++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 467999999999999985 6889999998642 2233567888999999998 9999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc----
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS---- 537 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~---- 537 (745)
+++|.+++...+ .+++..++.|+.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (280)
T cd05581 86 NGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161 (280)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccC
Confidence 999999997654 69999999999999999999998 9999999999999999999999999999986654321
Q ss_pred ---------------ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCC
Q 004565 538 ---------------SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNG 602 (745)
Q Consensus 538 ---------------~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 602 (745)
.......++..|+|||.+....++.++||||||++++++++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------------- 226 (280)
T cd05581 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--------------- 226 (280)
T ss_pred CCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---------------
Confidence 12233467899999999988889999999999999999999999986432
Q ss_pred CCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 004565 603 PSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSM----ANVVS 673 (745)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~----~ev~~ 673 (745)
. ... ..... . .....+....+.+.+++..|++.+|.+||++ +++++
T Consensus 227 ----------~---~~~-~~~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 227 ----------E---YLT-FQKIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----------H---HHH-HHHHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 000 00000 0 0111222224568899999999999999999 77653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=287.25 Aligned_cols=275 Identities=22% Similarity=0.289 Sum_probs=193.7
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeC-----CeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG-----RQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~ 459 (745)
+.||+|+||.||+|... ++..||||++... .......+..|+.+++.++|+||+++++++... ...++|+||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 67999999999999974 5889999998643 233355678899999999999999999988654 347999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... ..
T Consensus 91 ~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 164 (337)
T cd07858 91 MD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DF 164 (337)
T ss_pred CC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-cc
Confidence 96 6888888654 369999999999999999999999 999999999999999999999999999998664432 22
Q ss_pred ccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 540 FTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....++..|+|||.+.. ..++.++||||||+++++|++|+.||................+..+....... ......
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 242 (337)
T cd07858 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI--RNEKAR 242 (337)
T ss_pred ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc--Cchhhh
Confidence 234467889999998765 46889999999999999999999998643210000000000000000000000 000000
Q ss_pred HHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcc
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM--LEG 677 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~--L~~ 677 (745)
.+.. ......+..... ..+.....+.+++.+|++.+|++|||++|+++- ++.
T Consensus 243 ~~~~------~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 243 RYIR------SLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHHH------hcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000 000000010000 011234567899999999999999999999865 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=280.66 Aligned_cols=194 Identities=29% Similarity=0.444 Sum_probs=163.2
Q ss_pred hhhcCC--CCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEe-CCeeEE
Q 004565 382 ATDNFN--TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ-GRQRFL 455 (745)
Q Consensus 382 at~~f~--~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~l 455 (745)
.+++|. +.||.|+||.||++... ++..||||++... .....+.+..|++++..++|||++++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 445554 78999999999999865 6889999988532 22345678899999999999999999998865 567889
Q ss_pred EEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 456 VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
|+||+ +++|..++... .+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 88 VTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred Eeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 99998 46898887543 57888899999999999999999 99999999999999999999999999998754322
Q ss_pred CcccccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 536 QSSLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||..
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 133457889999998766 5689999999999999999999998854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=271.08 Aligned_cols=236 Identities=28% Similarity=0.341 Sum_probs=192.6
Q ss_pred ccccCceeEEEEEEC-CCcEEEEEEeccCCc---chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 390 IGSGGFGTVYKGILQ-DKSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
||+|+||.||++... +++.+++|.+..... .....+..|++++++++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999986 488999999875332 2456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccccc
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 99997654 58999999999999999999999 999999999999999999999999999998765432 12244568
Q ss_pred ccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
+..|+|||.+.+...+.++|+||||++++||++|+.||..... ........
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----------------------------~~~~~~~~ 206 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----------------------------KEIYEKIL 206 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----------------------------HHHHHHHh
Confidence 8899999999888899999999999999999999999864320 00001110
Q ss_pred hhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMAN 670 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e 670 (745)
. . . ...+......+.+++..|++.+|++||++.+
T Consensus 207 ~-~------~----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 207 K-D------P----LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred c-C------C----CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0 0 0 0112222356789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=261.12 Aligned_cols=248 Identities=29% Similarity=0.358 Sum_probs=191.1
Q ss_pred CccccCceeEEEEEEC-CCcEEEEEEeccCCc-chHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 389 PIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI-QGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
.||.|+||+|+|-.++ .|+..|||+++.... ...++++.|++...+- ..||||+++|.+..++..++.||.|. .||
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhH
Confidence 4999999999999985 589999999986544 4567788888765554 89999999999999999999999995 476
Q ss_pred hhhhc---C-CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 466 DRTLF---G-NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 466 ~~~l~---~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+.+.. . ....+++..+-.|+...+.||.||.+ ...||||||||+|||||..|.+||+|||++-.+-.. ...+
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iAkT 225 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IAKT 225 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH--HHhh
Confidence 65443 1 22368888888999999999999998 588999999999999999999999999999765433 2345
Q ss_pred ccccccCccCcccccCC--CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHH
Q 004565 542 TMRGTRGYLAPEWLTSS--AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~--~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
...|...|||||.+... .++.++||||||+.|+|+.||+.|+.... ..+..
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~---------------------------svfeq 278 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD---------------------------SVFEQ 278 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH---------------------------HHHHH
Confidence 66799999999998643 48899999999999999999999986543 01111
Q ss_pred HHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
.. +. ..+....+..+. -..+....+..++..|+.+|-.+||...++.++
T Consensus 279 l~-~V-v~gdpp~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 LC-QV-VIGDPPILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HH-HH-HcCCCCeecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 11 111111111111 012234568899999999999999999998764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=284.28 Aligned_cols=194 Identities=28% Similarity=0.445 Sum_probs=161.6
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeC--------------C
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--------------R 451 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--------------~ 451 (745)
.+.||.|+||.||+|... .+..||+|++........+.+.+|++++++++|+||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 477999999999999975 5889999998766556677889999999999999999999776543 3
Q ss_pred eeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeec-CCCCeEEccCCCcc
Q 004565 452 QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH-DKLQVKISDFGLSK 530 (745)
Q Consensus 452 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~-~~~~~kl~Dfgl~~ 530 (745)
..++|+||++ ++|.+++... .+++..+..++.||+.||.|||+ .+++||||||+||+++ ++..+||+|||++.
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~dfg~~~ 163 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCcccce
Confidence 5789999997 5888877543 58899999999999999999999 8999999999999997 45678999999997
Q ss_pred cCCCCCcc--cccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 531 LLTPEQSS--LFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 531 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred ecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65432211 1123457889999998754 46788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=279.13 Aligned_cols=190 Identities=26% Similarity=0.386 Sum_probs=161.2
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCC------eeEEEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR------QRFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~~lV~ 457 (745)
.+.||+|+||.||+|... ++..||||++.... ....+.+..|++++++++|+||+++++++.... ..++|+
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 367999999999999864 68899999986422 223456889999999999999999999986543 358999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+ +++|..++.. ..+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 100 e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~- 172 (343)
T cd07880 100 PFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM- 172 (343)
T ss_pred ecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccccCc-
Confidence 998 6789888754 358999999999999999999999 999999999999999999999999999998654321
Q ss_pred ccccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 SLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
....++..|+|||.+.+ ..++.++||||||+++++|++|+.||...
T Consensus 173 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 173 ---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 33467889999998876 45889999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=281.17 Aligned_cols=195 Identities=26% Similarity=0.379 Sum_probs=160.5
Q ss_pred CCCccccCceeEEEEEECC---CcEEEEEEeccC--CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeC----CeeEEE
Q 004565 387 NTPIGSGGFGTVYKGILQD---KSVVAVKKINSF--GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQG----RQRFLV 456 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~----~~~~lV 456 (745)
.+.||+|+||.||++.... +..||||++... .....+.+..|++++.++ +|+||+++++.+... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 4679999999999999753 678999998642 222356788899999999 599999999976432 346788
Q ss_pred EeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC
Q 004565 457 YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~ 536 (745)
+||+. ++|.+++... ..+++..++.++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 85 EELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred Eeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 88886 6898888654 368999999999999999999999 999999999999999999999999999998665332
Q ss_pred cc---cccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 537 SS---LFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 537 ~~---~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.. ......|+..|+|||++.+ ..++.++||||||+++++|++|+.||...
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 21 1234568999999998765 46899999999999999999999988653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=260.84 Aligned_cols=197 Identities=25% Similarity=0.381 Sum_probs=164.9
Q ss_pred CCCccccCceeEEEEEEC---C--CcEEEEEEeccCCc--chHHHHHHHHHHHccCCCCceeeEEEEEEe-CCeeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGILQ---D--KSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGFCAQ-GRQRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e 458 (745)
...||+|.+|.||+|.-. + ...+|||+++.... .-.....+|+.+++.++|+|++.|..++.. +...+|++|
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd 108 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD 108 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence 467999999999999753 2 23789999975422 224567899999999999999999998877 778899999
Q ss_pred ecCCCChhhhhcCCC----cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC----CCeEEccCCCcc
Q 004565 459 YMNKGSLDRTLFGNG----SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK----LQVKISDFGLSK 530 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~----~~~kl~Dfgl~~ 530 (745)
|.+. +|...|+..+ +.++-.+...|+.||+.|+.|||+ +-|+||||||.|||+..+ |.+||+|||+++
T Consensus 109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR 184 (438)
T KOG0666|consen 109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLGLAR 184 (438)
T ss_pred hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence 9977 7777775322 368899999999999999999999 999999999999999877 899999999999
Q ss_pred cCCCCCcc--cccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 531 LLTPEQSS--LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 531 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
.+...-.. ....++-|..|.|||.+.+. .||...|||+.||++.||++..+-|....
T Consensus 185 ~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 185 LFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred HhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 88664322 23556789999999998875 58999999999999999999988776654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=280.57 Aligned_cols=190 Identities=27% Similarity=0.426 Sum_probs=161.9
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCe------eEEEE
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQ------RFLVY 457 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~------~~lV~ 457 (745)
...||+|+||.||+|... ++..||||++... .....+.+..|+.++++++|+|++++.+++..... .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 377999999999999985 5789999998642 22334667789999999999999999988765554 89999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||++......
T Consensus 100 e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-- 171 (343)
T cd07851 100 HLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-- 171 (343)
T ss_pred ecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccccc--
Confidence 998 5689888865 368999999999999999999999 99999999999999999999999999999865432
Q ss_pred ccccccccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 538 SLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 234467889999998865 36789999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=263.60 Aligned_cols=179 Identities=21% Similarity=0.206 Sum_probs=153.8
Q ss_pred cCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhhhhcC
Q 004565 393 GGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFG 471 (745)
Q Consensus 393 G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 471 (745)
|.||.||++... +++.+|+|++.... .+..|...+....|||++++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999974 57899999986532 234455555566799999999999999999999999999999999865
Q ss_pred CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccccCccC
Q 004565 472 NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551 (745)
Q Consensus 472 ~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~a 551 (745)
.. .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||.+....... ....++..|+|
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 43 58999999999999999999999 999999999999999999999999999886554321 23345778999
Q ss_pred cccccCCCCCCccceeehHHHHHHHHhCCCCCC
Q 004565 552 PEWLTSSAISDKTDVYSYGMVLLEIISGRKNSS 584 (745)
Q Consensus 552 PE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~ 584 (745)
||.+....++.++||||+|++++||++|+.|+.
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 999988889999999999999999999997764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=250.89 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=201.0
Q ss_pred HHHHHHhhhcCCCCccccCceeEEEEE-ECCCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCee
Q 004565 376 YEELAAATDNFNTPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQR 453 (745)
Q Consensus 376 ~~el~~at~~f~~~lG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~ 453 (745)
++++-+-|.. .||+|+++.|--.+ +..+..+|||++.+.....+....+|++++.+. .|+||++|+.+|+++...
T Consensus 75 F~d~YkLt~e---~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSE---LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHH---HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4555555554 49999999998776 578999999999988878888999999999998 599999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCC---eEEccCCCcc
Q 004565 454 FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ---VKISDFGLSK 530 (745)
Q Consensus 454 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~---~kl~Dfgl~~ 530 (745)
|||||-|.+|+|..+|+... .+++.++.++..+||.||.|||. ++|.|||+||+|||-..... +||+||.|..
T Consensus 152 YLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecccccc
Confidence 99999999999999998764 59999999999999999999999 99999999999999976543 7999998876
Q ss_pred cCCCCC------cccccccccccCccCccccc-----CCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCC
Q 004565 531 LLTPEQ------SSLFTTMRGTRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGD 599 (745)
Q Consensus 531 ~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~ 599 (745)
-+.... .......+|+..|||||+.. ...|+.++|.||||||||-|++|..||.+.-
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C------------ 295 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC------------ 295 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc------------
Confidence 543221 11223467899999999763 2357899999999999999999999998765
Q ss_pred CCCCCCCCCCccccccc--HHHHHHHHHhhccccccccccccCCCCHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 600 GNGPSSSSSPRESQRVY--FPLLALELHEQRRYLELADSRIEGQVSDE----DVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 600 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..++..+..+.- =.....+-+.++.. +++.+ ...+..+++...+..++..|-++.+|+.
T Consensus 296 -----g~dCGWdrGe~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 296 -----GADCGWDRGEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -----CCcCCccCCCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111111 11111111122221 23322 2334556666677799999999999876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=260.39 Aligned_cols=238 Identities=30% Similarity=0.413 Sum_probs=193.5
Q ss_pred CceeEEEEEECC-CcEEEEEEeccCCcch-HHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhhhhcC
Q 004565 394 GFGTVYKGILQD-KSVVAVKKINSFGIQG-KKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFG 471 (745)
Q Consensus 394 ~fg~Vy~g~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 471 (745)
+||.||+|...+ +..+++|++....... .+.+..|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8899999997655444 68899999999999999999999999999999999999999999999876
Q ss_pred CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccccCccC
Q 004565 472 NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551 (745)
Q Consensus 472 ~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~a 551 (745)
... +++..++.++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 543 8999999999999999999999 899999999999999999999999999998765542 2344568889999
Q ss_pred cccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhcccc
Q 004565 552 PEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYL 631 (745)
Q Consensus 552 PE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (745)
||.+....++.++||||||+++++|++|..||.... . .... .+........
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------------------------~---~~~~-~~~~~~~~~~ 205 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------------------------Q---LLEL-FKKIGKPKPP 205 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------------------------c---HHHH-HHHHhccCCC
Confidence 999998889999999999999999999999886421 0 0011 1111111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 632 ELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 632 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
. . .........+.+++.+|+..+|++||++.++++
T Consensus 206 ~----~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 206 F----P---PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred C----c---cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 0 000002356889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=287.22 Aligned_cols=191 Identities=24% Similarity=0.320 Sum_probs=138.3
Q ss_pred CCCccccCceeEEEEEECC-----CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEE------EEeCCeeEE
Q 004565 387 NTPIGSGGFGTVYKGILQD-----KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF------CAQGRQRFL 455 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~------~~~~~~~~l 455 (745)
.++||+|+||.||+|++.+ +..||||++..... .+.+..+ .+....+.+++.++.. +......++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 3789999999999999854 68899998864321 1111111 1222222222222211 345667899
Q ss_pred EEeecCCCChhhhhcCCCcc-------------------cCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeec
Q 004565 456 VYEYMNKGSLDRTLFGNGSV-------------------LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH 516 (745)
Q Consensus 456 V~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~ 516 (745)
|+||+++++|.+++...... .....+..|+.||+.||+|||+ .+|+||||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEe
Confidence 99999999999988654311 1233456799999999999999 8999999999999999
Q ss_pred C-CCCeEEccCCCcccCCCCCcccccccccccCccCcccccCC----------------------CCCCccceeehHHHH
Q 004565 517 D-KLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS----------------------AISDKTDVYSYGMVL 573 (745)
Q Consensus 517 ~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~k~Dv~S~Gvll 573 (745)
+ ++.+||+|||+++.+............+++.|+|||.+... .++.++|||||||+|
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 6 57899999999987655444444566789999999965322 234567999999999
Q ss_pred HHHHhCCCCCC
Q 004565 574 LEIISGRKNSS 584 (745)
Q Consensus 574 ~elltg~~p~~ 584 (745)
|||+++..++.
T Consensus 370 ~el~~~~~~~~ 380 (566)
T PLN03225 370 LQMAFPNLRSD 380 (566)
T ss_pred HHHHhCcCCCc
Confidence 99999776543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=268.20 Aligned_cols=194 Identities=32% Similarity=0.501 Sum_probs=171.9
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEecc--CCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINS--FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
++||.|-||+||-|+. +.|+.||||++.+ .......++.+|+.+|+.++||.||.+...|+..+..++|||-+.+-=
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 6799999999999997 5699999999974 455667889999999999999999999999999999999999996655
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC---CCeEEccCCCcccCCCCCccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~---~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
|+-.|.....+|++..-..++.||+.||.|||. .+|+|+||||+||||... -.+||+|||+|+.++.... ..
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--Rr 724 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--RR 724 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh--hh
Confidence 555555555689999989999999999999999 999999999999999654 4699999999998865432 35
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.++||+.|+|||++.++.|...-|+||.||++|--++|..||...
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 678999999999999999999999999999999999999999754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=291.60 Aligned_cols=140 Identities=30% Similarity=0.437 Sum_probs=125.9
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.++||+|+||.||+|... +++.||||++.... ......+..|+.++..++|+||+++++++......++||||+++
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 477999999999999986 58899999987432 22346788899999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK 530 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~ 530 (745)
++|.+++...+ .+++..++.|+.||+.||.|||. .+|+||||||+||||+.++.+||+|||+++
T Consensus 89 ~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999987543 58899999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=254.02 Aligned_cols=195 Identities=29% Similarity=0.328 Sum_probs=172.0
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccCCcc---hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQ---GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
-++||+|.||.|-+.+-+ .++.+|+|++++...- ....-..|-++|+..+||.+..|--.+...+..++||||..+
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 378999999999999875 5889999999865433 334456788999999999999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|.|.-+|... +.+++....-+...|+.||.|||+ ++||.||||..|.|||.+|++||+|||+++.--. ....+..
T Consensus 253 GeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~t~kT 327 (516)
T KOG0690|consen 253 GELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGDTTKT 327 (516)
T ss_pred ceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc-ccceecc
Confidence 9999998664 368888888899999999999999 9999999999999999999999999999985432 2334577
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
+.||+.|+|||++....|....|.|.+||++|||++|+.||...
T Consensus 328 FCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 328 FCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred ccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 89999999999999999999999999999999999999999754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=275.26 Aligned_cols=234 Identities=25% Similarity=0.334 Sum_probs=187.8
Q ss_pred CCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
|...+|.|+|+.|-++.. ..++..+||++.+. ..+-.+|+.++... +|+|++++.+.+.+..+.++|||.+.++
T Consensus 326 ~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 326 FREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG 401 (612)
T ss_pred cccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence 445699999999998886 45788999998754 23345577665555 7999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeee-cCCCCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILL-HDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll-~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
-|.+.+..... .. ..+..|+.+|+.|+.|||+ +++||||+||+|||+ ++.++++|+|||.++..... ...
T Consensus 402 ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~t 472 (612)
T KOG0603|consen 402 ELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDT 472 (612)
T ss_pred HHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcc
Confidence 88888876543 22 7778899999999999999 999999999999999 58899999999999987665 233
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
.+-|..|.|||++....+++.+|+||||++||+|++|+.||..... .
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-------------------------~-------- 519 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-------------------------G-------- 519 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-------------------------h--------
Confidence 4568899999999999999999999999999999999999975430 0
Q ss_pred HHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.++......+.+.........+|+.+|||.||.+||+|.++..
T Consensus 520 --------~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 520 --------IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred --------HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 0000011112222334456778888999999999999999963
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-31 Score=261.44 Aligned_cols=242 Identities=24% Similarity=0.313 Sum_probs=193.5
Q ss_pred HHhhhcCCCCccccCceeEEEEEECC-CcEEEEEEeccCCc---chHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeE
Q 004565 380 AAATDNFNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGI---QGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRF 454 (745)
Q Consensus 380 ~~at~~f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~ 454 (745)
..+.-||..+||+|+||.|.+|.-++ ...+|||++++... ...+--+.|-++|+.. +-|-++++..++...+.++
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 33445777999999999999999875 56799999875322 2233345677777776 6778899999999999999
Q ss_pred EEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCC
Q 004565 455 LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 455 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
+||||+.+|+|--+++.-+ .+.+..+.-+|..||-||-+||+ ++||+||||..|||||.++++||+|||+++.---
T Consensus 427 FVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999999998765 47788889999999999999999 9999999999999999999999999999985322
Q ss_pred CCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccccc
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (745)
. ...+.+..||+.|+|||++...+|....|.|||||+||||+.|+.||+...+ .
T Consensus 503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-------------------------~ 556 (683)
T KOG0696|consen 503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------------------------D 556 (683)
T ss_pred C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-------------------------H
Confidence 2 2334678999999999999999999999999999999999999999986541 1
Q ss_pred ccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 004565 615 VYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP 666 (745)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP 666 (745)
..+ ..+.+..+ .++.....+.+.+....+.+.|.+|-
T Consensus 557 elF-------------~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 557 ELF-------------QAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHH-------------HHHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 111 11111111 34555556677888888889999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=276.01 Aligned_cols=199 Identities=25% Similarity=0.352 Sum_probs=151.0
Q ss_pred hhcCC--CCccccCceeEEEEEE-----------------CCCcEEEEEEeccCCcchHHHH--------------HHHH
Q 004565 383 TDNFN--TPIGSGGFGTVYKGIL-----------------QDKSVVAVKKINSFGIQGKKEF--------------CTEI 429 (745)
Q Consensus 383 t~~f~--~~lG~G~fg~Vy~g~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e~ 429 (745)
+++|. ++||+|+||.||+|.+ .+++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 34554 7899999999999974 2356799999875433333333 3466
Q ss_pred HHHccCCCCce-----eeEEEEEEe--------CCeeEEEEeecCCCChhhhhcCCC-----------------------
Q 004565 430 TIIGNIHHVNL-----VRLKGFCAQ--------GRQRFLVYEYMNKGSLDRTLFGNG----------------------- 473 (745)
Q Consensus 430 ~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------- 473 (745)
.++.+++|.++ ++++++|.. ....+|||||+++++|.++++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777766654 677888753 356899999999999999886421
Q ss_pred cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccccCccCcc
Q 004565 474 SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 553 (745)
Q Consensus 474 ~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE 553 (745)
..++|..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 134678899999999999999999 89999999999999999999999999999765443322222234578999999
Q ss_pred cccCCCC----------------------CCccceeehHHHHHHHHhCCC-CCC
Q 004565 554 WLTSSAI----------------------SDKTDVYSYGMVLLEIISGRK-NSS 584 (745)
Q Consensus 554 ~~~~~~~----------------------t~k~Dv~S~Gvll~elltg~~-p~~ 584 (745)
.+..... ..+.||||+||+++||++|.. |+.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 8754321 135799999999999999875 553
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=247.23 Aligned_cols=250 Identities=21% Similarity=0.242 Sum_probs=193.1
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEe----CCeeEEEEeecC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQ----GRQRFLVYEYMN 461 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e~~~ 461 (745)
++||-|-.|.|.....+ .++.+|+|++... ....+|+++--.. .|+|||++++++.+ ....++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 67999999999988875 5788999988642 3456788765554 69999999998854 446789999999
Q ss_pred CCChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC---CCCeEEccCCCcccCCCCCc
Q 004565 462 KGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD---KLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 462 ~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~---~~~~kl~Dfgl~~~~~~~~~ 537 (745)
+|.|...+...+. .+++.++-.|+.||..|+.|||+ .+|.||||||+|+|... |-.+||+|||+|+.-.. .
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~ 217 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--P 217 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCC--C
Confidence 9999999987765 79999999999999999999999 99999999999999964 45689999999986543 2
Q ss_pred ccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccH
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
.......-|+.|.|||++...+|+...|+||+||++|-|++|-+||....- ..+. + +
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~ais--------p-------g---- 274 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAIS--------P-------G---- 274 (400)
T ss_pred ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCC--------h-------h----
Confidence 333556789999999999999999999999999999999999999975430 0000 0 0
Q ss_pred HHHHHHHHhhccccccccccccCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccCCCCCC
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVS----DEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEGGMPLGE 683 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~--~L~~~~~~~~ 683 (745)
.......+. -+++ .+..+...++++..|..+|.+|-|++|++. .+.+...++.
T Consensus 275 ---Mk~rI~~gq----------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 275 ---MKRRIRTGQ----------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ 333 (400)
T ss_pred ---HHhHhhccC----------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence 000000000 0122 133566778888999999999999999984 4444444433
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=287.42 Aligned_cols=206 Identities=26% Similarity=0.320 Sum_probs=182.5
Q ss_pred HHHHhhhcCC--CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCC
Q 004565 378 ELAAATDNFN--TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR 451 (745)
Q Consensus 378 el~~at~~f~--~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~ 451 (745)
+++-...+|. ++||+|+||.|..++.. .++++|.|+++++ ......-|.+|-.+|..-..+=|+.+.-.|.+.+
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3333344554 78999999999999985 4889999999863 3344567889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 452 QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 452 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
+.|+|||||++|+|-.++.... .+++..+..++..|+.||.-||+ .|+|||||||+|||||..|++||+|||-+..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHh
Confidence 9999999999999999998877 79999999999999999999999 9999999999999999999999999999999
Q ss_pred CCCCCcccccccccccCccCcccccC-----CCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 532 LTPEQSSLFTTMRGTRGYLAPEWLTS-----SAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 532 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
+..+........+|||.|++||++.. +.|...+|.||+||++|||+.|..||....
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 88777666778899999999999853 568999999999999999999999997554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=227.71 Aligned_cols=195 Identities=25% Similarity=0.400 Sum_probs=167.0
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
++||+|.+|+||||+..+ ++.||+|+++.. ...-.....+|+.+++.++|+|||++++....+...-+|+||+.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 459999999999999754 788999998732 333356788999999999999999999999999999999999955 7
Q ss_pred hhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccc
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|..+...-...++.+....++.|+++||.++|+ +++.|||+||.|.||+.++..|++|||+++.+..... ..+..+
T Consensus 87 lkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr-cysaev 162 (292)
T KOG0662|consen 87 LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSAEV 162 (292)
T ss_pred HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeecee
Confidence 888887777789999999999999999999999 9999999999999999999999999999998765432 224455
Q ss_pred cccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCC-CCccc
Q 004565 545 GTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKN-SSLKI 587 (745)
Q Consensus 545 gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p-~~~~~ 587 (745)
-|..|.+|.++.+. -|+...|+||-|+++.|+....+| |....
T Consensus 163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 68999999998876 478999999999999999985555 44443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=252.97 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=189.3
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEec---cCCcc----hHHHHHHHHHHHccCCCCceeeEEEEEE-eCCeeEEEEe
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKIN---SFGIQ----GKKEFCTEITIIGNIHHVNLVRLKGFCA-QGRQRFLVYE 458 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~---~~~~~----~~~~~~~e~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e 458 (745)
+.||+|||+.|||+.. ...+.||||+-. .+..+ -.+..++|.++-+.|.||.||++++++. +.+..+-|.|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 5699999999999985 567889999753 22211 1345678999999999999999999996 4556789999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC---CCCeEEccCCCcccCCCC
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD---KLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~---~~~~kl~Dfgl~~~~~~~ 535 (745)
|+++.+|+.||.... .++++++..|+.||+.||.||.+ ...+|||.||||.||||-. -|.+||+||||++.+..+
T Consensus 549 YceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd 626 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD 626 (775)
T ss_pred ecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence 999999999997654 68999999999999999999996 4588999999999999954 478999999999998764
Q ss_pred Ccc------cccccccccCccCcccccCC----CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCC
Q 004565 536 QSS------LFTTMRGTRGYLAPEWLTSS----AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSS 605 (745)
Q Consensus 536 ~~~------~~~~~~gt~~y~aPE~~~~~----~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 605 (745)
... .++...||..|++||.+.-+ .++.|.||||.||++|..+.|++||......
T Consensus 627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---------------- 690 (775)
T KOG1151|consen 627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---------------- 690 (775)
T ss_pred ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----------------
Confidence 332 23557899999999977433 5789999999999999999999999764310
Q ss_pred CCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 004565 606 SSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVV 672 (745)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~ 672 (745)
.+...+..+...- .+.-..-+....+...++.+||+..-++|-...++.
T Consensus 691 ----------------QdILqeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 ----------------QDILQENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----------------HHHHhhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 0111111111111 111111122334567888999999999997665553
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=252.54 Aligned_cols=269 Identities=22% Similarity=0.251 Sum_probs=203.5
Q ss_pred CCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCC-CC-----ceeeEEEEEEeCCeeEEEEee
Q 004565 387 NTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIH-HV-----NLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~g~~~~~~~~~lV~e~ 459 (745)
-..+|+|.||.|-...... +..||||+++.... -.+..+-|+++++++. +. -+|.+.+++...++.++|+|.
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfel 172 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFEL 172 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEec
Confidence 3679999999999998754 68899999976543 3455677999999993 22 278888999999999999999
Q ss_pred cCCCChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC--------------------C
Q 004565 460 MNKGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD--------------------K 518 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~--------------------~ 518 (745)
+ +-|+.++|.+++- +++...+..|+.|+.++++|||+ .+++|.||||+|||+-+ +
T Consensus 173 l-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks 248 (415)
T KOG0671|consen 173 L-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKS 248 (415)
T ss_pred c-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccceeccCCC
Confidence 8 5589999987654 79999999999999999999999 99999999999999942 3
Q ss_pred CCeEEccCCCcccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCC
Q 004565 519 LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSG 598 (745)
Q Consensus 519 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~ 598 (745)
..+||+|||.|....... +.++.|.-|.|||++.+-.++.++||||+||||.|+.+|..-|......+++......
T Consensus 249 ~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI 324 (415)
T KOG0671|consen 249 TAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI 324 (415)
T ss_pred cceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence 458999999998654443 5667899999999999999999999999999999999999999887755555454445
Q ss_pred CCCCCCCCCCCcccccccHHHHHHHHHhhcccc-----------cccccc--c--cCCCCHHHHHHHHHHHHHccCCCCC
Q 004565 599 DGNGPSSSSSPRESQRVYFPLLALELHEQRRYL-----------ELADSR--I--EGQVSDEDVEKLVRIALCCVQEEPM 663 (745)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~d~~--l--~~~~~~~~~~~l~~l~~~cl~~~p~ 663 (745)
.|+.|..... ...+......+++. ...++. + .......+...|.+|+..+|..||.
T Consensus 325 lGp~P~~mi~---------r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 325 LGPIPSRMIK---------KTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred hCCCcHHHhh---------hhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 5533322110 00011111111110 000000 0 0122345667899999999999999
Q ss_pred CCCCHHHHHH
Q 004565 664 LRPSMANVVS 673 (745)
Q Consensus 664 ~RPt~~ev~~ 673 (745)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=265.72 Aligned_cols=248 Identities=27% Similarity=0.384 Sum_probs=200.3
Q ss_pred hcCCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEE-----eCCeeEEE
Q 004565 384 DNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCA-----QGRQRFLV 456 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~-----~~~~~~lV 456 (745)
..|..+||.|.+|.||+++. ++++.+|||++.... ...++...|.++++.. .|||++.++|++. .++.++||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 34457899999999999996 568888999886443 4456778899999988 7999999999985 35679999
Q ss_pred EeecCCCChhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 457 YEYMNKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
||||.+||..+++.+- +..+.|..+..|+..++.||.+||. +.++|||||-.||||+.++.+||.|||++..+...
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 9999999999998753 4479999999999999999999999 99999999999999999999999999999877654
Q ss_pred CcccccccccccCccCcccccCC-----CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCc
Q 004565 536 QSSLFTTMRGTRGYLAPEWLTSS-----AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPR 610 (745)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (745)
... ..+..||+.|||||++... .|+.++|+||||++-.||.-|.+|+-....
T Consensus 177 ~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---------------------- 233 (953)
T KOG0587|consen 177 VGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---------------------- 233 (953)
T ss_pred ccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----------------------
Confidence 332 2557899999999998654 367899999999999999999999865430
Q ss_pred ccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 611 ESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..+.-.... .|...-..+....+.+.+++..||.+|.+.||++.++++
T Consensus 234 --------mraLF~IpR-------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 234 --------MRALFLIPR-------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------hhhhccCCC-------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 001110000 111111234567788999999999999999999998874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-30 Score=243.07 Aligned_cols=275 Identities=21% Similarity=0.283 Sum_probs=198.1
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEecc--CCcchHHHHHHHHHHHccCCCCceeeEEEEEEe--------CCeeEEE
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINS--FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ--------GRQRFLV 456 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--------~~~~~lV 456 (745)
.+||+|.||.||+|+.. .++.||+|++-. ....-.....+|+++|..+.|+|++.++..|.. ....+||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 46999999999999975 477788876542 222224556789999999999999999998843 2346899
Q ss_pred EeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCC
Q 004565 457 YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~ 536 (745)
+.+++. +|...|.+....++..++.+++.++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||+++.+....
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~ 178 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFSTSK 178 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccceeccc
Confidence 999976 8888888777789999999999999999999999 999999999999999999999999999998775443
Q ss_pred ccc---ccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCccc
Q 004565 537 SSL---FTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612 (745)
Q Consensus 537 ~~~---~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (745)
... .+..+-|..|.+||.+.+. .++++.|||.-||++.||.++.+-+....+......+..-.|.-.+.. +.
T Consensus 179 n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev----WP 254 (376)
T KOG0669|consen 179 NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV----WP 254 (376)
T ss_pred ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc----CC
Confidence 322 3445669999999988765 689999999999999999999988776655544444443333322211 12
Q ss_pred ccccHHHHHHHHHh--hccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 613 QRVYFPLLALELHE--QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 613 ~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
+...++-|.....+ ...-...+...++.-.- ....++++..++..||.+|+++.+++.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~k---d~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVK---DDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccC---ChhHHHHHHHHhccCcccCcchHhhhc
Confidence 22223333221000 00000111111111000 124567777888899999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=226.14 Aligned_cols=194 Identities=30% Similarity=0.412 Sum_probs=163.9
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEecc-CCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINS-FGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
..||+|++|.|-+-++ .+|+..|+|++.. ...+..++...|+.+..+. .+|.+|.++|....+...++.||.|.. |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 4599999999998887 5799999999974 3445566778888876655 899999999999999999999999954 7
Q ss_pred hhhhhc---CCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 465 LDRTLF---GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 465 L~~~l~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
|+.+.. ..+..+++..+=+||..+.+||.|||+ ...+||||+||+||||+.+|++||+|||++-.+.+. -..+
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS--iAkt 206 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS--IAKT 206 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh--hHHH
Confidence 776554 455678999999999999999999998 478999999999999999999999999999766543 2234
Q ss_pred ccccccCccCcccccC----CCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 542 TMRGTRGYLAPEWLTS----SAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~----~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
...|...|||||.+.. ..|+.|+||||||+.+.||.+++.|+...
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 4678999999998753 36889999999999999999999998653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=253.65 Aligned_cols=209 Identities=24% Similarity=0.340 Sum_probs=174.3
Q ss_pred CHHHHHHhhhcCC-----CCccccCceeEEEEEE-CCCcEEEEEEeccCC---cchHHHHHHHHHHHccCCCCceeeEEE
Q 004565 375 SYEELAAATDNFN-----TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKG 445 (745)
Q Consensus 375 ~~~el~~at~~f~-----~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g 445 (745)
.|--|+.|.-.-+ +.||-|+||.|-++.- +....+|.|.|++.. .......+.|-.+|+....+=||+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 3445555544332 6699999999999875 446778999887543 234556778999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEcc
Q 004565 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525 (745)
Q Consensus 446 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~D 525 (745)
.|.+.+.+|+||+|+++|++-.+|...+ .+.+..+..++..++.|+++.|. .++|||||||+|||||.+|++||+|
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeee
Confidence 9999999999999999999999998765 58888888899999999999999 9999999999999999999999999
Q ss_pred CCCcccCCCC---------C-----------------c---------------ccccccccccCccCcccccCCCCCCcc
Q 004565 526 FGLSKLLTPE---------Q-----------------S---------------SLFTTMRGTRGYLAPEWLTSSAISDKT 564 (745)
Q Consensus 526 fgl~~~~~~~---------~-----------------~---------------~~~~~~~gt~~y~aPE~~~~~~~t~k~ 564 (745)
|||+.-+.-. . . ......+||..|+|||++....++..+
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 9999755210 0 0 001134699999999999999999999
Q ss_pred ceeehHHHHHHHHhCCCCCCccc
Q 004565 565 DVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 565 Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
|.||.||||+||+.|+.||-...
T Consensus 853 dwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCC
Confidence 99999999999999999996543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=267.28 Aligned_cols=239 Identities=28% Similarity=0.398 Sum_probs=185.3
Q ss_pred CCccccCcee-EEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 388 TPIGSGGFGT-VYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 388 ~~lG~G~fg~-Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
+.+|.|.-|+ ||+|.+. ++.||||++-. +...-..+|+.+|+.- .|||||++++.-.+....|+..|.|.. +|
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 4589999876 7999995 56899999753 3344567899999988 699999999999999999999999955 99
Q ss_pred hhhhcCCCc---ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-----CCCeEEccCCCcccCCCCCc
Q 004565 466 DRTLFGNGS---VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-----KLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 466 ~~~l~~~~~---~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-----~~~~kl~Dfgl~~~~~~~~~ 537 (745)
.+++...+. ...-...+.+..|+++||++||+ .+||||||||.||||+. ..+++|+|||+++.+..+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999987422 11113456788999999999999 99999999999999976 25799999999999887665
Q ss_pred cc--ccccccccCccCcccccCCCCCCccceeehHHHHHHHHhC-CCCCCccccccccccCCCCCCCCCCCCCCCccccc
Q 004565 538 SL--FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG-RKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614 (745)
Q Consensus 538 ~~--~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (745)
.. .....||.||+|||.+....-+...||||+||++|+.++| ..||......+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~------------------------ 722 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------------------------ 722 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh------------------------
Confidence 43 3457799999999999998889999999999999999996 78987654111
Q ss_pred ccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 615 VYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
+..+.....+..+ +...++ ...+|+..|+..+|..||++.+|+.
T Consensus 723 ------~NIl~~~~~L~~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 723 ------ANILTGNYTLVHL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ------hhhhcCccceeee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0011111111111 011111 5778889999999999999999973
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=234.43 Aligned_cols=194 Identities=24% Similarity=0.329 Sum_probs=169.4
Q ss_pred CCccccCceeEEEEEEC-CCcEEEEEEeccC---CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
.+||+|.+..|..+++. ..+.+|+|++++. ..+...-.+.|-.+..+. +||.+|.+..++..+...++|.||+++
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 78999999999999985 4778999988743 223344456677676666 799999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|--++...+ .|+++.+..+...|.-||.|||+ ++||.||||..|||||..+++||+|||+++.--.. ...+++
T Consensus 336 gdlmfhmqrqr-klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~-gd~tst 410 (593)
T KOG0695|consen 336 GDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTTST 410 (593)
T ss_pred cceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC-Cccccc
Confidence 99988887654 58999999999999999999999 99999999999999999999999999999864332 334577
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
+.||+.|+|||++.+..|....|.|++||+++||+.|+.||+.-
T Consensus 411 fcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 411 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred ccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 89999999999999999999999999999999999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=228.88 Aligned_cols=211 Identities=40% Similarity=0.610 Sum_probs=184.7
Q ss_pred ccccCceeEEEEEECC-CcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhh
Q 004565 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 467 (745)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999998754432 35779999999999999999999999999999999999999999999
Q ss_pred hhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-CCCeEEccCCCcccCCCCCcccccccccc
Q 004565 468 TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-KLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 468 ~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
++......+++..+..++.++++++.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 997654468999999999999999999999 89999999999999999 89999999999987654421 12345578
Q ss_pred cCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHH
Q 004565 547 RGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 547 ~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
..|++||.+... ..+.+.|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 899999999887 788999999999999988
Q ss_pred hhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 ----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2367888999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=255.04 Aligned_cols=194 Identities=24% Similarity=0.341 Sum_probs=173.8
Q ss_pred CCccccCceeEEEEEECCCc-EEEEEEecc---CCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQDKS-VVAVKKINS---FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~-~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
..||-||||.|=++..+... .+|+|.+++ ......+....|-++|...+.+.||+++-.+.+....|++||-|-+|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 45999999999999987654 378887764 34455677888999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
.|...|..++ .++..+...++..+++|++|||+ ++||+|||||+|.+||.+|-+||.|||+|+.+.... .+-++
T Consensus 506 ElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTF 579 (732)
T KOG0614|consen 506 ELWTILRDRG-SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTF 579 (732)
T ss_pred hhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC--ceeee
Confidence 9999998776 48888888899999999999999 999999999999999999999999999999887654 34678
Q ss_pred ccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
.||+.|.|||++.+...+..+|.||||++++||++|++||....
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 99999999999999999999999999999999999999997643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-29 Score=235.62 Aligned_cols=196 Identities=27% Similarity=0.407 Sum_probs=167.0
Q ss_pred CCCccccCceeEEEEEE-CCCcEEEEEEeccCC--cchHHHHHHHHHHHccCCCCceeeEEEEEEeCC-----eeEEEEe
Q 004565 387 NTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR-----QRFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e 458 (745)
.+.||.|+||.||..+. ++|+.||+|++.+.- ....+.+..|+++|..++|.|++..+++..-.. +.|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 36799999999999997 579999999986432 234577889999999999999999998775433 4578888
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
.|.. +|...|-.. +.|+-..+.-+..||++||.|||+ .+|.||||||.|.|++.|...||+|||+++.-..++..
T Consensus 138 LmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 8854 777777554 468888888899999999999999 99999999999999999999999999999987777766
Q ss_pred cccccccccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 539 LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
.++..+-|..|.|||++++. .|+...||||.|+++.||+..+.-|....
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 66777789999999999875 58999999999999999999887776544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=227.02 Aligned_cols=197 Identities=34% Similarity=0.517 Sum_probs=173.0
Q ss_pred CCCCccccCceeEEEEEECC-CcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+..|++.+++++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 34679999999999999976 889999999865544 6778999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++......+++..+..++.+++.++.+||+ .+++|+||+++||+++.++.++|+|||++..............
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 83 DLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 9999997654338999999999999999999999 8999999999999999999999999999987765431122345
Q ss_pred ccccCccCcccc-cCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 544 RGTRGYLAPEWL-TSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 544 ~gt~~y~aPE~~-~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
.++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 678899999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=237.01 Aligned_cols=131 Identities=28% Similarity=0.370 Sum_probs=106.1
Q ss_pred hhhcCCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCC-----C---CceeeEEEEEEe---
Q 004565 382 ATDNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIH-----H---VNLVRLKGFCAQ--- 449 (745)
Q Consensus 382 at~~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~g~~~~--- 449 (745)
+.+-..++||.|.|++||++.. .+.+.||+|+.+.. ..-.+..+.|+++|++++ | ..||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 3344448899999999999996 56788999998743 233566788999999984 2 369999999964
Q ss_pred -CCeeEEEEeecCCCChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeec
Q 004565 450 -GRQRFLVYEYMNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH 516 (745)
Q Consensus 450 -~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~ 516 (745)
+.+.+||+|++.. +|..+|.... +-++...+.+|+.||+.||.|||.. .+|||.||||+||||-
T Consensus 157 NG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 5689999999944 6666665443 4699999999999999999999994 6899999999999994
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=235.93 Aligned_cols=190 Identities=25% Similarity=0.353 Sum_probs=163.0
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccCCc--------chHHHHHHHHHHHccCC---CCceeeEEEEEEeCCeeEE
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFGI--------QGKKEFCTEITIIGNIH---HVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~l 455 (745)
+++|.|+||.|+.+.++. ...|+||.+.+... ...-..-.|+.+|..++ |+||++++++|++.+..+|
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 679999999999999965 56788898764321 11122456899999997 9999999999999999999
Q ss_pred EEeec-CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCC
Q 004565 456 VYEYM-NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 456 V~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
++|-. ++.+|.++|.... .+++.+...|+.||+.|+++||+ .+|||||||-+||.++.+|-+||+|||.+.....
T Consensus 647 ~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa~~ks 722 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS 722 (772)
T ss_pred EecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchhhhcC
Confidence 99975 5678999997654 59999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcccccccccccCccCcccccCCCC-CCccceeehHHHHHHHHhCCCCCC
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTSSAI-SDKTDVYSYGMVLLEIISGRKNSS 584 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~Dv~S~Gvll~elltg~~p~~ 584 (745)
+ ....++||.+|.|||++.+.+| ...-|||++||+||.++....|+.
T Consensus 723 g---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 723 G---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred C---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 4 3467899999999999999887 467899999999999998887764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=211.88 Aligned_cols=251 Identities=19% Similarity=0.303 Sum_probs=189.0
Q ss_pred hcCCCCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEE-EEeCCeeEEEEeec
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGF-CAQGRQRFLVYEYM 460 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~e~~ 460 (745)
++..+.||+|.||.+-++.++. .+.+++|.+.... ...++|.+|..---.| .|.||+.-+.. +...+.+++++||+
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 3445779999999999999865 6788888876433 3467899998755555 69999988764 66777889999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeec--CCCCeEEccCCCcccCCCCCcc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH--DKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~--~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|.|+|.+-+...+ +.+.....++.|++.||.|+|+ .++||||||.+||||- +..++||+|||+....+..
T Consensus 105 P~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--- 176 (378)
T KOG1345|consen 105 PRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--- 176 (378)
T ss_pred ccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce---
Confidence 9999999887654 7788888999999999999999 9999999999999993 3357999999998755432
Q ss_pred cccccccccCccCcccccCC-----CCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccc
Q 004565 539 LFTTMRGTRGYLAPEWLTSS-----AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQ 613 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~-----~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (745)
.....-+-.|.+||..... ...+.+|||+|||+++.++||+.||+...
T Consensus 177 -V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-------------------------- 229 (378)
T KOG1345|consen 177 -VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-------------------------- 229 (378)
T ss_pred -ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--------------------------
Confidence 2233456789999976432 34678999999999999999999998542
Q ss_pred cccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004565 614 RVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
...-+.|.+..+..+..... |..-..+. +++.++.++-+..+|++|-.+.++..+..
T Consensus 230 ~~d~~Y~~~~~w~~rk~~~~--P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 230 IMDKPYWEWEQWLKRKNPAL--PKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ccCchHHHHHHHhcccCccC--chhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 12234555555555544322 11112222 45667777889999999977777766653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=265.86 Aligned_cols=195 Identities=19% Similarity=0.183 Sum_probs=139.9
Q ss_pred cCCC-CceeeEEEEE-------EeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceee
Q 004565 434 NIHH-VNLVRLKGFC-------AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505 (745)
Q Consensus 434 ~l~h-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 505 (745)
.++| +||++++++| .+....++++||+ .++|.++|......+++..++.++.||++||.|||+ ++|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence 4455 6888888877 2233567778887 559999998766679999999999999999999999 99999
Q ss_pred cCCCCCCeeecC-------------------CCCeEEccCCCcccCCCCCc---------------ccccccccccCccC
Q 004565 506 CDVKPENILLHD-------------------KLQVKISDFGLSKLLTPEQS---------------SLFTTMRGTRGYLA 551 (745)
Q Consensus 506 ~dik~~NIll~~-------------------~~~~kl~Dfgl~~~~~~~~~---------------~~~~~~~gt~~y~a 551 (745)
|||||+||||+. ++.+||+|||+++....... .......||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 44566777777654221000 00112357889999
Q ss_pred cccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhcccc
Q 004565 552 PEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYL 631 (745)
Q Consensus 552 PE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (745)
||++.+..++.++|||||||+||||++|..|+.... ..+.... .
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------------------------~~~~~~~-----~---- 227 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------------------------RTMSSLR-----H---- 227 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------------------------HHHHHHH-----H----
Confidence 999999999999999999999999999887654211 0000000 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 632 ELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 632 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
..+.+.. .........++.+||+.+|.+||+|.||++
T Consensus 228 ~~~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 228 RVLPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhcChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0011111 111234567888999999999999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=203.68 Aligned_cols=186 Identities=23% Similarity=0.417 Sum_probs=157.9
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCC-CCceeeEEEEEEeC--CeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQG--RQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e~~~~g 463 (745)
+++|+|.++.||.|.. .+.+.++||.++.. ..+.+.+|+.+|..++ |+||+++++...+. ..+.||+||+.+.
T Consensus 44 rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~ 120 (338)
T KOG0668|consen 44 RKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT 120 (338)
T ss_pred HHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence 6799999999999984 56788999999754 3567889999999997 99999999998764 4578999999998
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC-CCeEEccCCCcccCCCCCcccccc
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~-~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+...+. ..|+...+...+.++++||.|+|+ .||.|||+||.||+||.. -..+|+|+|+|.+..+.... ..
T Consensus 121 Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY--nV 191 (338)
T KOG0668|consen 121 DFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NV 191 (338)
T ss_pred cHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCcee--ee
Confidence 776554 257778888999999999999999 999999999999999975 45899999999887665432 33
Q ss_pred cccccCccCcccccC-CCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 543 MRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
.+.+..|--||.+.. ..++..-|+|||||+|..|+..+.||..
T Consensus 192 RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 192 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 456777889998865 4678999999999999999999999865
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=216.45 Aligned_cols=269 Identities=25% Similarity=0.269 Sum_probs=187.2
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEeccC--CcchHHHHHHHHHHHccCCCCceeeEEEEEEeC------CeeEEEEe
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG------RQRFLVYE 458 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e 458 (745)
..+|.|.- .|-.+.. -.++.||+|++... .....+...+|+.++..+.|+|+++++.++.-. .+.++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 34666766 3333332 24788999988632 233456778899999999999999999998643 35689999
Q ss_pred ecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcc
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
+|. .+|...+.. .++-+++..|..|+..|+.|||+ .+|+||||||+||++..+..+||.|||+++.-... -
T Consensus 102 ~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~ 172 (369)
T KOG0665|consen 102 LMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--F 172 (369)
T ss_pred hhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc--c
Confidence 995 488877763 47778888999999999999999 99999999999999999999999999999865443 3
Q ss_pred cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHH
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+....+.-..+....|+.- +. -...+.
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd-~~------F~~qL~ 245 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD-PS------FMKQLQ 245 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC-HH------HHHHhh
Confidence 45677889999999999998899999999999999999999987765432222222222222210 00 000011
Q ss_pred HHHHHHHhh------ccccccc-cccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 619 LLALELHEQ------RRYLELA-DSRIEG--QVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 619 ~~~~~~~~~------~~~~~~~-d~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.-+...... ....+.+ |..... +.++........++.+||-.+|++|-++.++++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 111111100 0011111 111111 112223445778888999999999999999985
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=225.25 Aligned_cols=193 Identities=26% Similarity=0.368 Sum_probs=161.2
Q ss_pred CCccccCceeEEEEEEC----CCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ----DKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
++||+|.|++||++.+. ....||+|.+...+ ......+|+++|..+ -+.||+++.+++..++...+|+||++.
T Consensus 42 ~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 42 NKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred ccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 78999999999999964 36789999986543 345688999999999 599999999999999999999999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC-CCeEEccCCCcccCCCCC-----
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDFGLSKLLTPEQ----- 536 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~-~~~kl~Dfgl~~~~~~~~----- 536 (745)
-...+++.. ++...+..++..+..||+++|+ ++||||||||+|+|.+.. +.-.|.|||+|.......
T Consensus 120 ~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 120 DRFRDLYRS----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred cCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 888888854 6688899999999999999999 999999999999999854 678999999997211000
Q ss_pred ---------c-----------------------------ccccccccccCccCcccccC-CCCCCccceeehHHHHHHHH
Q 004565 537 ---------S-----------------------------SLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEII 577 (745)
Q Consensus 537 ---------~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~k~Dv~S~Gvll~ell 577 (745)
. .......||+||.|||++.. ..-+.+.||||-||+++-++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 0 00012459999999998865 45689999999999999999
Q ss_pred hCCCCCCccccc
Q 004565 578 SGRKNSSLKIQS 589 (745)
Q Consensus 578 tg~~p~~~~~~~ 589 (745)
+++.||.....+
T Consensus 273 s~~~PFf~a~dd 284 (418)
T KOG1167|consen 273 SRRYPFFKAKDD 284 (418)
T ss_pred ccccccccCccc
Confidence 999999776544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=237.67 Aligned_cols=245 Identities=25% Similarity=0.327 Sum_probs=197.5
Q ss_pred CCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
..+|.|.+|.|||++. ..+...|||.++........-.+.|+-+++..+|+|||.++|.+......++.|||+.+|+|.
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ 100 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ 100 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence 5699999999999997 458889999998777777778889999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
+.-+..+ ++++.++...++...+||+|||+ .+-+|||||-.|||+++.+.+|++|||.+..+..... ....+.||
T Consensus 101 diy~~Tg-plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-KrksfiGt 175 (829)
T KOG0576|consen 101 DIYHVTG-PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRKSFIGT 175 (829)
T ss_pred ceeeecc-cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhh-hhhcccCC
Confidence 9887654 68899999999999999999998 8889999999999999999999999999976654321 23567899
Q ss_pred cCccCcccc---cCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHH
Q 004565 547 RGYLAPEWL---TSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 547 ~~y~aPE~~---~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
+.|||||+. ..+.|..++|||+.|+...|+-..+.|..... +..+..
T Consensus 176 pywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh------------------------------pmr~l~ 225 (829)
T KOG0576|consen 176 PYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH------------------------------PMRALF 225 (829)
T ss_pred ccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc------------------------------hHHHHH
Confidence 999999976 45678999999999999999988776643221 111111
Q ss_pred HHhhcccccccc-ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 624 LHEQRRYLELAD-SRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 624 ~~~~~~~~~~~d-~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
+... ...+ +.++. .....+.+.++++.|+..+|++||+++.+++
T Consensus 226 LmTk----S~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 226 LMTK----SGFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Hhhc----cCCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1110 0111 11111 1234567999999999999999999987653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-26 Score=231.54 Aligned_cols=208 Identities=25% Similarity=0.293 Sum_probs=175.0
Q ss_pred ccCHHHHHHhhhcCCCCccccCceeEEEEEEC-CCcEEEEEEeccCCcchHHHHHHHHHHHccCC------CCceeeEEE
Q 004565 373 RFSYEELAAATDNFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIH------HVNLVRLKG 445 (745)
Q Consensus 373 ~~~~~el~~at~~f~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~g 445 (745)
++.+.|+....+......|+|-|++|-+|... -++.||||++.+... ..+.=+.|+++|.+|+ ..|+++++-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 45677888777777778999999999999974 477999999985432 2344567999999985 458999999
Q ss_pred EEEeCCeeEEEEeecCCCChhhhhcCCCc--ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC-CCeE
Q 004565 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGS--VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVK 522 (745)
Q Consensus 446 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~-~~~k 522 (745)
.|...++++||+|-+ ..+|.+.|...+. .|....+..++.|+.-||..|.. .+|+|.||||.|||+++. ..+|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceee
Confidence 999999999999987 4489999987665 58888999999999999999998 999999999999999987 4589
Q ss_pred EccCCCcccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcccc
Q 004565 523 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQ 588 (745)
Q Consensus 523 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~ 588 (745)
|+|||.|........ +...-+..|.|||++.+-+|+...|+||.||.||||.||+..|.+...
T Consensus 578 LCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 578 LCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred eccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 999999987665432 333345689999999999999999999999999999999988866543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=206.40 Aligned_cols=166 Identities=23% Similarity=0.258 Sum_probs=125.3
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|.+++...+..+++..++.|+.||+.||.|||+ .+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence 68999998766679999999999999999999998 44 999999999999999 99998654422
Q ss_pred cccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHH
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~----------------------------~~~~~~ 115 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE----------------------------LSAILE 115 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch----------------------------hcHHHH
Confidence 2588999999999999999999999999999999999999854320 001111
Q ss_pred HHHhhccccccccccccCCCCHHHH--HHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDV--EKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~--~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
........ .++.. ...+.... ..+.+++.+|++.+|++||++.|+++.+..
T Consensus 116 ~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 116 ILLNGMPA---DDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhcc---CCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11110000 00000 00111122 258999999999999999999999988753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=210.26 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=192.3
Q ss_pred hcCCCCccccCceeEEEEEECCCcEEEEEEec--cCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 384 DNFNTPIGSGGFGTVYKGILQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
-+|..+|.+...|..|+|+++++..| +|++. .......++|.+|.-.|+.+.||||++++|.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34567788999999999999877644 45544 3444556789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCc-ccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEc--cCCCcccCCCCCcc
Q 004565 462 KGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKIS--DFGLSKLLTPEQSS 538 (745)
Q Consensus 462 ~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~--Dfgl~~~~~~~~~~ 538 (745)
.|+|...|++... ..+-.++.+++.+||+|++|||+ .++-|.---+.+..|++|++.+++|+ |--++.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeee--------
Confidence 9999999998765 67888999999999999999998 23445555689999999999998875 221111
Q ss_pred cccccccccCccCcccccCCCCC---CccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAIS---DKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t---~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
......-.+.|++||.++..+.+ ..+|+|||+++||||.|...||.... +. +
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls-----------------pm----e---- 396 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS-----------------PM----E---- 396 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC-----------------ch----h----
Confidence 01122346789999999887643 57999999999999999999996432 00 0
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~ 677 (745)
. -..+.-..++..+++.....+.+++.-|+..||.+||.+..|+-.||.
T Consensus 397 -----------c--gmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 397 -----------C--GMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred -----------h--hhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 0 011112234455666667789999999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=206.87 Aligned_cols=169 Identities=20% Similarity=0.182 Sum_probs=129.5
Q ss_pred cCCCCccccCceeEEEEEEC--CCcEEEEEEeccC-----CcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQ--DKSVVAVKKINSF-----GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 457 (745)
.+.+.||+|+||.||+|.+. +++.||||++... .....+.|.+|++++++++|+|+++.+.. ....++||
T Consensus 21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVm 97 (365)
T PRK09188 21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVR 97 (365)
T ss_pred eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEE
Confidence 34578999999999999875 5778899987532 12235668999999999999999864432 24579999
Q ss_pred eecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCC-CCCCeeecCCCCeEEccCCCcccCCCCC
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV-KPENILLHDKLQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~di-k~~NIll~~~~~~kl~Dfgl~~~~~~~~ 536 (745)
||+++++|... .... ...++.++++||.|||+ .+|+|||| ||+|||++.++.+||+|||+++.+....
T Consensus 98 E~~~G~~L~~~-~~~~-------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 98 GWTEGVPLHLA-RPHG-------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred EccCCCCHHHh-Cccc-------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 99999999632 1111 14678899999999999 99999999 9999999999999999999999775432
Q ss_pred cc-------cccccccccCccCcccccCCC------CCCcccee
Q 004565 537 SS-------LFTTMRGTRGYLAPEWLTSSA------ISDKTDVY 567 (745)
Q Consensus 537 ~~-------~~~~~~gt~~y~aPE~~~~~~------~t~k~Dv~ 567 (745)
.. ..+...+++.|+|||++...+ .+..+|-|
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 11 124567889999999986543 22346666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=196.33 Aligned_cols=198 Identities=22% Similarity=0.278 Sum_probs=161.6
Q ss_pred cCCCCccccCceeEEEEEECCC--cEEEEEEeccCCcchHHHHHHHHHHHccCCC----CceeeEEEEE-EeCCeeEEEE
Q 004565 385 NFNTPIGSGGFGTVYKGILQDK--SVVAVKKINSFGIQGKKEFCTEITIIGNIHH----VNLVRLKGFC-AQGRQRFLVY 457 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~g~~-~~~~~~~lV~ 457 (745)
....+||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..+++.. ......++||
T Consensus 21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM 100 (322)
T KOG1164|consen 21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVM 100 (322)
T ss_pred EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEE
Confidence 3457899999999999997654 4788888765433333367788888888863 5888888888 4777889999
Q ss_pred eecCCCChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC-----CCeEEccCCCcc-
Q 004565 458 EYMNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-----LQVKISDFGLSK- 530 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~-----~~~kl~Dfgl~~- 530 (745)
+.+ +.+|.++..... +.++..+.+.|+.|++.+|++||+ .+++||||||.|+++... ..+.|.|||+++
T Consensus 101 ~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 101 SLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred ecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 988 669999886554 689999999999999999999999 999999999999999865 468999999998
Q ss_pred -cCCCCCcc------c-ccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCcc
Q 004565 531 -LLTPEQSS------L-FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 531 -~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
.+...... . ....+||..|.++..+.+...+.+.|+||++.++.|++.|..||...
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 33222211 1 23467999999999999999999999999999999999999998543
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=164.42 Aligned_cols=105 Identities=16% Similarity=0.286 Sum_probs=86.9
Q ss_pred eecccccccccCCCCCeeeEEecccceEEEccCCceEEEEEccCccceEEEEecCCceEEEEEEc--CCceeEEEecccc
Q 004565 83 WKLSMYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFVLKVSLDAAGFRIAKLEPSGRLIVSKLV--GDNLVQELAIPVE 160 (745)
Q Consensus 83 w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~l~~~G~l~~~~~~--~~~w~~~~~~p~~ 160 (745)
||+|+|++..+.+.+++...... ...++.++++.++++...+.+.++|++||++|+++.+.|. ..+|...|.+|.+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~--~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d 78 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLY--NYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKD 78 (110)
T ss_pred CCccccCCeEECCccccccccee--EEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEeccc
Confidence 89999999999998876522211 1234456667777777778888999999999999999994 5789999999999
Q ss_pred CccCCCCCCCCcccCC---CCCCCCCCCcccC
Q 004565 161 NCRIPFFCKEIGLCSG---GSCSCPSGFHAEL 189 (745)
Q Consensus 161 ~Cd~~~~CG~~g~C~~---~~C~Cl~GF~~~~ 189 (745)
+||+|+.||+||+|+. +.|+||+||+|++
T Consensus 79 ~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 79 QCDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999974 5699999999863
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-18 Score=185.27 Aligned_cols=256 Identities=31% Similarity=0.395 Sum_probs=194.4
Q ss_pred CCCccccCceeEEEEEECCCcEEEEEEeccCCcc---hHHHHHHHHHHHccCCCC-ceeeEEEEEEeCCeeEEEEeecCC
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQ---GKKEFCTEITIIGNIHHV-NLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
...||.|+||.||++... ..+++|.+...... ....+..|+.+++.+.|+ +++++.+++......+++++++.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 356899999999999988 77899988744332 367899999999999888 799999999777778999999999
Q ss_pred CChhhhhcCCC--cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC-CeEEccCCCcccCCCCCcc-
Q 004565 463 GSLDRTLFGNG--SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLLTPEQSS- 538 (745)
Q Consensus 463 gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~- 538 (745)
++|.+++.... ..+.......++.|++.++.|+|+ .+++|||+||.||+++... .++++|||++..+......
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 99997776554 268899999999999999999999 8899999999999999998 7999999999866544322
Q ss_pred ----cccccccccCccCcccccC---CCCCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcc
Q 004565 539 ----LFTTMRGTRGYLAPEWLTS---SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 539 ----~~~~~~gt~~y~aPE~~~~---~~~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
......|+..|+|||.+.. ...+...|+||+|++++++++|..|+......
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---------------------- 217 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---------------------- 217 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----------------------
Confidence 2366789999999999987 57889999999999999999999986543200
Q ss_pred cccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~ 674 (745)
................ .................+.+++..|+..+|..|.++.+....
T Consensus 218 ----~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 218 ----SATSQTLKIILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----ccHHHHHHHHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000111111110000 000001111002223567788889999999999999987754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-19 Score=174.62 Aligned_cols=198 Identities=20% Similarity=0.272 Sum_probs=170.0
Q ss_pred hcCCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 384 DNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
....++||+|.||.++.|+. -++++||||.-... ...-++..|.+..+.| ..++|..++-|-.++.+-.||+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 34468899999999999994 67899999976433 2345678888888888 6889999998888888899999998
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-----CCCeEEccCCCcccCCCCC
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-----KLQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-----~~~~kl~Dfgl~~~~~~~~ 536 (745)
+-||++++.-.++.++.++...||+|++.-++|+|+ +.+|.|||||+|.||.. ...+.|+|||+|+......
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 669999998888899999999999999999999999 99999999999999964 3458999999999887654
Q ss_pred cc------cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 537 SS------LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 537 ~~------~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
.. ......||.+||+-.-+.+..-+.+.|+-|+|-+++..|-|..||..-.
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 32 2245679999999999999999999999999999999999999998644
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=193.57 Aligned_cols=217 Identities=26% Similarity=0.378 Sum_probs=163.9
Q ss_pred HccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCC
Q 004565 432 IGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPE 511 (745)
Q Consensus 432 l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~ 511 (745)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+......++|.....++.+|++||+|||. ++...|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 457899999999999999999999999999999999999877789999999999999999999998 233399999999
Q ss_pred CeeecCCCCeEEccCCCcccCCCC-CcccccccccccCccCcccccCC-------CCCCccceeehHHHHHHHHhCCCCC
Q 004565 512 NILLHDKLQVKISDFGLSKLLTPE-QSSLFTTMRGTRGYLAPEWLTSS-------AISDKTDVYSYGMVLLEIISGRKNS 583 (745)
Q Consensus 512 NIll~~~~~~kl~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~k~Dv~S~Gvll~elltg~~p~ 583 (745)
|+++|....+||+|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999876431 11111223345689999998764 1467899999999999999999999
Q ss_pred CccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCC
Q 004565 584 SLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPM 663 (745)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~ 663 (745)
........ -...+..... .......|.+... .+....+..++..||..+|+
T Consensus 159 ~~~~~~~~-------------------------~~eii~~~~~--~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~ 209 (484)
T KOG1023|consen 159 DLRNLVED-------------------------PDEIILRVKK--GGSNPFRPSIELL--NELPPELLLLVARCWEEIPE 209 (484)
T ss_pred ccccccCC-------------------------hHHHHHHHHh--cCCCCcCcchhhh--hhcchHHHHHHHHhcccChh
Confidence 76431100 0111111111 0111122222111 02333688999999999999
Q ss_pred CCCCHHHHHHHhccCC
Q 004565 664 LRPSMANVVSMLEGGM 679 (745)
Q Consensus 664 ~RPt~~ev~~~L~~~~ 679 (745)
+||++++|-..++...
T Consensus 210 ~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 210 KRPSIEQIRSKLLTIN 225 (484)
T ss_pred hCccHHHHHhhhhhhc
Confidence 9999999998887633
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-20 Score=174.32 Aligned_cols=200 Identities=22% Similarity=0.273 Sum_probs=168.2
Q ss_pred hhhcCCCCccccCceeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCC-CceeeEEEEEEeCCeeEEEEee
Q 004565 382 ATDNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHH-VNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 382 at~~f~~~lG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~ 459 (745)
..+...++||.|+||.+|.|.. .+|..||||.-.... ...++..|.++...++| ..|..+..+..+...-.|||+.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 3445568899999999999995 779999999875432 24567788999999864 5677778888888899999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC---CCeEEccCCCcccCCCCC
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~---~~~kl~Dfgl~~~~~~~~ 536 (745)
+ +.+|++++.-..+.++.++.+-+|-|++.-++|+|. +++|||||||+|.|+.-+ ..+.++|||+++.+....
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 8 669999888777789999999999999999999999 999999999999999654 568999999999876543
Q ss_pred cc------cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 537 SS------LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 537 ~~------~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
.. ......||..|.+-..+.+...+.+.|+-|+|.+|....-|..||+.-.
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 32 1245679999999988888888999999999999999999999998643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=173.51 Aligned_cols=139 Identities=17% Similarity=0.179 Sum_probs=108.2
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcc--h-------HHH-----------------HHHHHHHHccCCCCcee
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQ--G-------KKE-----------------FCTEITIIGNIHHVNLV 441 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~niv 441 (745)
..||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 469999999999999988999999999743211 1 112 23489999999887764
Q ss_pred eEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHh-hhCCCCceeecCCCCCCeeecCCCC
Q 004565 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYL-HTGCDHKIIHCDVKPENILLHDKLQ 520 (745)
Q Consensus 442 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~dik~~NIll~~~~~ 520 (745)
....+.. ...+|||||+++++|....... ..++......++.|++.+|.|| |+ .+|+||||||+|||+++ +.
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~~-~~ 155 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYHD-GK 155 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEEC-Cc
Confidence 4333222 2238999999988776553322 3688999999999999999999 67 89999999999999984 78
Q ss_pred eEEccCCCcccCC
Q 004565 521 VKISDFGLSKLLT 533 (745)
Q Consensus 521 ~kl~Dfgl~~~~~ 533 (745)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-20 Score=209.22 Aligned_cols=251 Identities=21% Similarity=0.238 Sum_probs=185.1
Q ss_pred CCCccccCceeEEEEEEC-CCcEEEEEEeccC--CcchH----HHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGK----KEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~----~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
...+|.|++|.|+..... .....+.|..... ..... ..+..|+.+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 467999999977777643 3333444432210 11111 2255677888889999998888877777666666999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc--
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS-- 537 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~-- 537 (745)
++. +|..++... ..++...+-.++.|+..|+.|||+ .+|.|||+|++|++++.++.+||+|||.+..+.....
T Consensus 403 ~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred ccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 999 999998765 358888899999999999999999 9999999999999999999999999999988766544
Q ss_pred -ccccccccccCccCcccccCCCCCC-ccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccc
Q 004565 538 -SLFTTMRGTRGYLAPEWLTSSAISD-KTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 538 -~~~~~~~gt~~y~aPE~~~~~~~t~-k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
.......|+..|+|||.+....|.+ -.||||.||++..|++|+.||......+...
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------------------- 535 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------------------- 535 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----------------------
Confidence 4456788999999999999999875 6999999999999999999998654211100
Q ss_pred cHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~ 673 (745)
.........-...-..........+...++.++|+.+|.+|-||++|++
T Consensus 536 ---------~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 536 ---------KTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---------hhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000000000000112234567788999999999999999999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-20 Score=207.01 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=180.6
Q ss_pred cCCCCccccCceeEEEEEECCCcEEEEEEeccCC-cchHHHHHHHHHH--HccCCCCceeeEEEEEEeCCeeEEEEeecC
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFG-IQGKKEFCTEITI--IGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
.+.+.||.+.|=.|.+++.++|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-.-......|||-+|..
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 34577999999999999999988 8888875433 3344555554433 455689999999888777777889999986
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCC--CCCcc-
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT--PEQSS- 538 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~--~~~~~- 538 (745)
+ +|.+.|..+ ..|...+...|+.|++.||..+|. .+|+|||||.+||||+.-+-+.|+||..-+... .+...
T Consensus 105 h-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 105 H-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred h-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 5 888888543 357888889999999999999999 999999999999999999999999997765432 22222
Q ss_pred ---cccccccccCccCcccccCC-----------CCCCccceeehHHHHHHHHh-CCCCCCccccccccccCCCCCCCCC
Q 004565 539 ---LFTTMRGTRGYLAPEWLTSS-----------AISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGP 603 (745)
Q Consensus 539 ---~~~~~~gt~~y~aPE~~~~~-----------~~t~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 603 (745)
.+.+.+.-..|+|||.+... ..+++.||||.||++.||++ |+++|..+.
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---------------- 243 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---------------- 243 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----------------
Confidence 12334455689999977431 26789999999999999998 677776543
Q ss_pred CCCCCCcccccccHHHHHHH--HHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 004565 604 SSSSSPRESQRVYFPLLALE--LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 678 (745)
+..+... ...+.-+.++-| ..+.++++.|+|.||.+|-+++++++.-.|.
T Consensus 244 -------------L~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 244 -------------LLAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -------------HHhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1111000 000001111111 1466899999999999999999999875553
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.2e-19 Score=172.90 Aligned_cols=165 Identities=13% Similarity=0.097 Sum_probs=127.3
Q ss_pred CCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHH---------HHHHHHHHccCCCCceeeEEEEEEeC-------
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKE---------FCTEITIIGNIHHVNLVRLKGFCAQG------- 450 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~g~~~~~------- 450 (745)
.++||.|+||.||.... ++..+|||.+........+. +.+|++.+.+++|++|..+..++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 47899999999999666 56679999997443322222 57899999999999999999886533
Q ss_pred -CeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCc
Q 004565 451 -RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLS 529 (745)
Q Consensus 451 -~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~ 529 (745)
...+|||||+++.+|.++.. ++. ....+++.+|..||+ .+++||||||+||+++.++ ++|+|||..
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~liDfg~~ 181 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRIIDLSGK 181 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEEEECCCc
Confidence 35789999999999987642 222 345699999999999 9999999999999999988 999999988
Q ss_pred ccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh
Q 004565 530 KLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578 (745)
Q Consensus 530 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt 578 (745)
......... . .++....+..++|+|+||+.+.-+..
T Consensus 182 ~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 182 RCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred ccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHHH
Confidence 755322211 0 13344456679999999999887653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-18 Score=165.10 Aligned_cols=141 Identities=18% Similarity=0.151 Sum_probs=111.1
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcc---------------------h-----HHHHHHHHHHHccCCCCcee
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQ---------------------G-----KKEFCTEITIIGNIHHVNLV 441 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~niv 441 (745)
..||+|+||.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 469999999999999888999999998754211 0 11235788999999999875
Q ss_pred eEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCe
Q 004565 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQV 521 (745)
Q Consensus 442 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~ 521 (745)
....+... ..+|||||++++++....... ..++......++.+++.++.+||+ ..+|+||||||.||+++ ++.+
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCCE
Confidence 54444333 248999999988654432222 357788899999999999999997 47999999999999999 7899
Q ss_pred EEccCCCcccCCC
Q 004565 522 KISDFGLSKLLTP 534 (745)
Q Consensus 522 kl~Dfgl~~~~~~ 534 (745)
+|+|||++.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=156.70 Aligned_cols=183 Identities=15% Similarity=0.080 Sum_probs=136.1
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcc----hHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQ----GKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
..|++|+||+||.+.- ++..++.+.+.....- ....|..|+++|++++ |+++.+++++ ...+++|||+.+
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 5699999999997766 5667777777643321 1225789999999994 5889999886 346899999999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCC-CCCCeeecCCCCeEEccCCCcccCCCCCcc---
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV-KPENILLHDKLQVKISDFGLSKLLTPEQSS--- 538 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~di-k~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--- 538 (745)
.+|...+.. ....++.+++.+|.++|+ .+|+|||| ||.|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 83 AAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred ccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 888654321 123577899999999999 99999999 799999999999999999999865443210
Q ss_pred -c--------ccccccccCccCcccccCC-CCC-CccceeehHHHHHHHHhCCCCCCcc
Q 004565 539 -L--------FTTMRGTRGYLAPEWLTSS-AIS-DKTDVYSYGMVLLEIISGRKNSSLK 586 (745)
Q Consensus 539 -~--------~~~~~gt~~y~aPE~~~~~-~~t-~k~Dv~S~Gvll~elltg~~p~~~~ 586 (745)
. ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-.+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0112357778888743321 223 5678889999999999999876443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=159.49 Aligned_cols=133 Identities=18% Similarity=0.225 Sum_probs=104.8
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccC-----CCCceeeEEEEEEeCC---e-eEEEEe
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-----HHVNLVRLKGFCAQGR---Q-RFLVYE 458 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lV~e 458 (745)
..||+|+||.||. ++.....+||++........+.+.+|+++++.+ .||||++++|++.+.. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5699999999996 443333478988755445567899999999999 5799999999998864 3 337899
Q ss_pred e--cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHH-HHhhhCCCCceeecCCCCCCeeecC----CCCeEEccCCCc
Q 004565 459 Y--MNKGSLDRTLFGNGSVLEWRERFEIALGTARGL-AYLHTGCDHKIIHCDVKPENILLHD----KLQVKISDFGLS 529 (745)
Q Consensus 459 ~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~ivH~dik~~NIll~~----~~~~kl~Dfgl~ 529 (745)
| ++.++|.+++... .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +..++|+||+-+
T Consensus 86 ~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 6689999999653 35555 35677888777 99999 99999999999999974 347999994433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-17 Score=166.06 Aligned_cols=226 Identities=21% Similarity=0.246 Sum_probs=146.4
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccCC---cchHHHHHHHHHHHccCCC----------CceeeEEEEEE-----
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFG---IQGKKEFCTEITIIGNIHH----------VNLVRLKGFCA----- 448 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~g~~~----- 448 (745)
..||.|+|+.||.++..+ ++.+|||.+.... ....+++.+|.-.+..+.+ -.++-.++...
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~ 97 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence 569999999999999965 8999999876322 3345677777655555432 22333333221
Q ss_pred ----eCC--------eeEEEEeecCCCChhhhhcC---C---CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCC
Q 004565 449 ----QGR--------QRFLVYEYMNKGSLDRTLFG---N---GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKP 510 (745)
Q Consensus 449 ----~~~--------~~~lV~e~~~~gsL~~~l~~---~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~ 510 (745)
... ..+++|+-+ .++|..++.. . ...+....++.+..|+++.+++||+ .+++|+||+|
T Consensus 98 ~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~~ 173 (288)
T PF14531_consen 98 PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIKP 173 (288)
T ss_dssp SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-SG
T ss_pred cceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccce
Confidence 111 236778777 4578776541 1 1246667788888999999999999 9999999999
Q ss_pred CCeeecCCCCeEEccCCCcccCCCCCcccccccccccCccCcccccCC--------CCCCccceeehHHHHHHHHhCCCC
Q 004565 511 ENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS--------AISDKTDVYSYGMVLLEIISGRKN 582 (745)
Q Consensus 511 ~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~t~k~Dv~S~Gvll~elltg~~p 582 (745)
+|++++++|.++|+||+.....+.... ....+..|.+||..... .+|.+.|.|++|+++|.|.+|+.|
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred eeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999999987765443211 13345789999976432 478899999999999999999999
Q ss_pred CCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHHHHccCCCC
Q 004565 583 SSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEP 662 (745)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p 662 (745)
|........ .. + .-..+. +..+.+..|+..+|+.+|
T Consensus 250 f~~~~~~~~---------------------~~-----~-----------------~f~~C~-~~Pe~v~~LI~~lL~~~~ 285 (288)
T PF14531_consen 250 FGLSSPEAD---------------------PE-----W-----------------DFSRCR-DMPEPVQFLIRGLLQRNP 285 (288)
T ss_dssp TCCCGGGST---------------------SG-----G-----------------GGTTSS----HHHHHHHHHHT-SSG
T ss_pred CCCCCcccc---------------------cc-----c-----------------cchhcC-CcCHHHHHHHHHHccCCc
Confidence 975431000 00 0 112334 455678889999999999
Q ss_pred CCC
Q 004565 663 MLR 665 (745)
Q Consensus 663 ~~R 665 (745)
++|
T Consensus 286 ~~R 288 (288)
T PF14531_consen 286 EDR 288 (288)
T ss_dssp GGS
T ss_pred ccC
Confidence 988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-16 Score=155.49 Aligned_cols=134 Identities=21% Similarity=0.290 Sum_probs=113.2
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcc--------hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQ--------GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
+.||+|++|.||+|.. .+..|+||+....... ....+..|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999988 5567888876532211 124577899999999999998888888778888999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
+++++|.+++.... + .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885432 2 888999999999999999 9999999999999999 78899999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=181.19 Aligned_cols=188 Identities=21% Similarity=0.274 Sum_probs=151.9
Q ss_pred CCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCC---CCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIH---HVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
.+.||+|+||+||+|...+++.||+|.-+....- +|.--.+++.+|+ -+-|..+...+.-.+..+||+||.+.|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 4779999999999999988999999987654332 2333334444444 223334444445567789999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeec-------CCCCeEEccCCCcccCCCC-
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH-------DKLQVKISDFGLSKLLTPE- 535 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~-------~~~~~kl~Dfgl~~~~~~~- 535 (745)
+|.+++.. .+.++|...+.++.|+++.++.||. .+|||+||||+|.||. ++..++|+|||.+-.+..-
T Consensus 780 tlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp 855 (974)
T KOG1166|consen 780 TLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP 855 (974)
T ss_pred cHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcC
Confidence 99999984 3469999999999999999999999 9999999999999995 3456899999999766432
Q ss_pred CcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCC
Q 004565 536 QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRK 581 (745)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~ 581 (745)
+........+|-++-.+|...+.+++.++|-|.|+-+++-||.|+.
T Consensus 856 ~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 856 DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 2235577889999999999999999999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.5e-17 Score=177.50 Aligned_cols=186 Identities=25% Similarity=0.322 Sum_probs=154.8
Q ss_pred CccccCceeEEEEE----ECCCcEEEEEEeccCCcc--hHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEeecC
Q 004565 389 PIGSGGFGTVYKGI----LQDKSVVAVKKINSFGIQ--GKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~----~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 461 (745)
++|+|.||.|+... .+.+...|.|.+.+.... .......|..++..++ |+.+|++.-.+......+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999998755 344667788877643221 1224556788888886 9999999999999999999999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccccc
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|.|...+.... .++..........+|-|++++|+ .+|+|||+|++||+++.+|.+|+.|||+.+..-.....
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 999998886654 46666666777889999999999 99999999999999999999999999999876543322
Q ss_pred ccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCc
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSL 585 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~ 585 (745)
.||..|||||++. .....+|-||||++.+||++|-.||..
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7899999999998 567899999999999999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.9e-16 Score=154.29 Aligned_cols=140 Identities=21% Similarity=0.204 Sum_probs=108.3
Q ss_pred CCCCccccCceeEEEEE--ECCCcEEEEEEeccCCcc------------------------hHHHHHHHHHHHccCCCCc
Q 004565 386 FNTPIGSGGFGTVYKGI--LQDKSVVAVKKINSFGIQ------------------------GKKEFCTEITIIGNIHHVN 439 (745)
Q Consensus 386 f~~~lG~G~fg~Vy~g~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~n 439 (745)
+.+.||+|+||.||+|. ..+|+.||||++...... ....+..|++.+.++.+.+
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34779999999999998 568999999998743210 0123567999999997533
Q ss_pred --eeeEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCc-eeecCCCCCCeeec
Q 004565 440 --LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK-IIHCDVKPENILLH 516 (745)
Q Consensus 440 --iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~dik~~NIll~ 516 (745)
+.+++++ ...++||||+++.+|....... ..+.......++.||+.+|++||+ .+ ++|+||||+||+++
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILVH 183 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEEE
Confidence 3444443 2358999999998887665333 245566678999999999999999 88 99999999999999
Q ss_pred CCCCeEEccCCCcccCCC
Q 004565 517 DKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 517 ~~~~~kl~Dfgl~~~~~~ 534 (745)
++.++|+|||.+.....
T Consensus 184 -~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 -DGKVVIIDVSQSVELDH 200 (237)
T ss_pred -CCCEEEEEChhhhccCC
Confidence 88999999999875443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.6e-16 Score=151.13 Aligned_cols=130 Identities=18% Similarity=0.264 Sum_probs=107.0
Q ss_pred CccccCceeEEEEEECCCcEEEEEEeccCCc--c------hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 389 PIGSGGFGTVYKGILQDKSVVAVKKINSFGI--Q------GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.||+|+||.||+|.+ ++..|++|....... . ....+..|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 456788888653221 1 1355778999999999988766666666777789999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
++++|.+.+..... .++.+++.+|.+||+ .+++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754321 789999999999999 9999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=150.02 Aligned_cols=138 Identities=20% Similarity=0.189 Sum_probs=108.3
Q ss_pred hcCCCCccccCceeEEEEEECCCcEEEEEEeccCCcc----------------------hHHHHHHHHHHHccCCCCc--
Q 004565 384 DNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQ----------------------GKKEFCTEITIIGNIHHVN-- 439 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n-- 439 (745)
+...++||+|+||.||++...+++.||||++...... ....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 3345789999999999999988999999987532200 1123567888888887774
Q ss_pred eeeEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC
Q 004565 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519 (745)
Q Consensus 440 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~ 519 (745)
+...++. ...++||||+++++|...... .....++.+++.++.++|+ .+++|+||||.||++++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCC
Confidence 4444442 345899999999998765431 3356788999999999999 9999999999999999999
Q ss_pred CeEEccCCCcccCCCC
Q 004565 520 QVKISDFGLSKLLTPE 535 (745)
Q Consensus 520 ~~kl~Dfgl~~~~~~~ 535 (745)
.++|+|||++......
T Consensus 163 ~~~liDfg~~~~~~~~ 178 (198)
T cd05144 163 KIYIIDWPQMVSTDHP 178 (198)
T ss_pred cEEEEECCccccCCCc
Confidence 9999999999765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.6e-16 Score=154.27 Aligned_cols=196 Identities=21% Similarity=0.282 Sum_probs=135.3
Q ss_pred CCCceeeEEEEEEe---------------------------CCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHH
Q 004565 436 HHVNLVRLKGFCAQ---------------------------GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGT 488 (745)
Q Consensus 436 ~h~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 488 (745)
+|||||+++++|.+ ....|+||.-.+. +|..++..+ ..+...+.-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 69999998887642 2345888887754 888888765 46677777899999
Q ss_pred HHHHHHhhhCCCCceeecCCCCCCeee--cCCC--CeEEccCCCcccCCCCC-----cccccccccccCccCcccccCCC
Q 004565 489 ARGLAYLHTGCDHKIIHCDVKPENILL--HDKL--QVKISDFGLSKLLTPEQ-----SSLFTTMRGTRGYLAPEWLTSSA 559 (745)
Q Consensus 489 a~~l~yLH~~~~~~ivH~dik~~NIll--~~~~--~~kl~Dfgl~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~ 559 (745)
++|+.|||+ ++|.|||+|++|||| |++. ...|+|||.+---.... .......-|...-||||+....+
T Consensus 351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999 999999999999999 4443 46889999885432211 11112345788899999876432
Q ss_pred ------CCCccceeehHHHHHHHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhcccccc
Q 004565 560 ------ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLEL 633 (745)
Q Consensus 560 ------~t~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (745)
.-.|+|.|+.|.+-||+++...||.... +..+..-. ..+..+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--------------------------em~L~~r~---Yqe~qL--- 475 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--------------------------EMLLDTRT---YQESQL--- 475 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccc--------------------------hheechhh---hhhhhC---
Confidence 1359999999999999999999997632 00110000 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004565 634 ADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675 (745)
Q Consensus 634 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev~~~L 675 (745)
|.+...++ ..+.+++...++.||.+||+..=....|
T Consensus 476 --Palp~~vp----p~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 476 --PALPSRVP----PVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred --CCCcccCC----hHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 12222233 3466777788999999999876554444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=172.26 Aligned_cols=133 Identities=19% Similarity=0.256 Sum_probs=110.0
Q ss_pred CCCccccCceeEEEEEECCCcEEEEEEeccC-Cc------chHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEee
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSF-GI------QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~-~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
.+.||+|+||.||+|.+.+...++.+++... .. ...+.+..|++++..++|++++....++......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 4779999999999999876654443333221 11 1235688999999999999999988888887788999999
Q ss_pred cCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccC
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
+++++|.+++. .+..++.+++++|.|||+ .+++||||||+|||+ +++.++|+|||+++..
T Consensus 418 ~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999998874 457899999999999999 999999999999999 5778999999999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.5e-16 Score=165.11 Aligned_cols=121 Identities=28% Similarity=0.443 Sum_probs=107.5
Q ss_pred eeEEEEeecCCCChhhhhcCCC--cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCc
Q 004565 452 QRFLVYEYMNKGSLDRTLFGNG--SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLS 529 (745)
Q Consensus 452 ~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~ 529 (745)
..++.|+++...+|.++|..+. ...++...+.++.|++.|+.| ++.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 4689999999999999996443 378899999999999999999 67899999999999999999999999999
Q ss_pred ccCCCCC-----cccccccccccCccCcccccCCCCCCccceeehHHHHHHHHh
Q 004565 530 KLLTPEQ-----SSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578 (745)
Q Consensus 530 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ellt 578 (745)
....... ....+...||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8776554 223456789999999999999999999999999999999997
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.9e-16 Score=135.50 Aligned_cols=56 Identities=46% Similarity=0.668 Sum_probs=45.1
Q ss_pred ccceeEEeccccEEEEeCCCCceeeccCCCCcccccCCccCCCC------eeeeccccCCCC
Q 004565 5 RVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGK------SLAASVSENDLS 60 (745)
Q Consensus 5 ~~~~~~lld~GNlvl~~~~~~~lWqSFd~PTDtllpg~~l~~~~------~L~S~~s~~dps 60 (745)
.+..|+|+|+|||||+|..+..+||||||||||+||||+|+.+. .|+||++.+|||
T Consensus 53 ~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 53 SGCYLVLQDDGNLVLYDSSGNVLWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSEEEEEETTSEEEEEETTSEEEEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred cCeEEEEeCCCCEEEEeecceEEEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 47889999999999999999999999999999999999998733 599999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.8e-14 Score=131.77 Aligned_cols=134 Identities=22% Similarity=0.175 Sum_probs=114.2
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCC--CceeeEEEEEEeCCeeEEEEeecCCCCh
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHH--VNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
+.||+|.++.||++...+ ..++||....... ...+..|+.++..++| .++.+++++....+..++++||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 458999999999999866 6789998764332 5678899999999976 5899999988888889999999998877
Q ss_pred hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccC
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
..+ +......++.+++++|++||.....+++|+|++|.||++++.+.+++.|||.+...
T Consensus 81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 654 56677889999999999999854467999999999999999899999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.4e-14 Score=137.47 Aligned_cols=139 Identities=19% Similarity=0.217 Sum_probs=98.5
Q ss_pred CCCccccCceeEEEEEECCCcEEEEEEeccCCcc--hHHHH----------------------HHHHHHHccCCCCc--e
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQ--GKKEF----------------------CTEITIIGNIHHVN--L 440 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~e~~~l~~l~h~n--i 440 (745)
.+.||+|+||.||+|...+++.||||++...... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999888999999988743211 11111 24555555554332 4
Q ss_pred eeEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCC
Q 004565 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ 520 (745)
Q Consensus 441 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~ 520 (745)
.+++++ ...++||||++++.+........ ... .....++.+++.++.++|. ..+|+|+||||+||+++ ++.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCc
Confidence 444443 24689999999955432111110 011 5678899999999999996 37899999999999999 889
Q ss_pred eEEccCCCcccCCC
Q 004565 521 VKISDFGLSKLLTP 534 (745)
Q Consensus 521 ~kl~Dfgl~~~~~~ 534 (745)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.2e-13 Score=137.00 Aligned_cols=135 Identities=17% Similarity=0.148 Sum_probs=105.2
Q ss_pred CCcc-ccCceeEEEEEECCCcEEEEEEeccCC-------------cchHHHHHHHHHHHccCCCCce--eeEEEEEEeCC
Q 004565 388 TPIG-SGGFGTVYKGILQDKSVVAVKKINSFG-------------IQGKKEFCTEITIIGNIHHVNL--VRLKGFCAQGR 451 (745)
Q Consensus 388 ~~lG-~G~fg~Vy~g~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~g~~~~~~ 451 (745)
..|| .||.|+||++... +..++||++.... ......+.+|++++.+++|+++ ++++++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 8999999999886 5568888774311 1223567889999999998885 67777654332
Q ss_pred ----eeEEEEeecCC-CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccC
Q 004565 452 ----QRFLVYEYMNK-GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDF 526 (745)
Q Consensus 452 ----~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Df 526 (745)
..++|+|++++ .+|.+++... .++.. .+.+|+.+|.+||+ .+|+|+||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 6898887543 34433 35689999999999 99999999999999999889999999
Q ss_pred CCcccC
Q 004565 527 GLSKLL 532 (745)
Q Consensus 527 gl~~~~ 532 (745)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.2e-15 Score=164.54 Aligned_cols=200 Identities=26% Similarity=0.336 Sum_probs=160.7
Q ss_pred cCCCCccccCceeEEEEEECC--CcEEEEEEeccCC--cchHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEee
Q 004565 385 NFNTPIGSGGFGTVYKGILQD--KSVVAVKKINSFG--IQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 385 ~f~~~lG~G~fg~Vy~g~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 459 (745)
.+.+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++.+|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 344669999999998887643 4456666665433 222333445776767776 99999999999999999999999
Q ss_pred cCCCChhhhh-cCCCcccCHHHHHHHHHHHHHHHHHhh-hCCCCceeecCCCCCCeeecCCC-CeEEccCCCcccCCC--
Q 004565 460 MNKGSLDRTL-FGNGSVLEWRERFEIALGTARGLAYLH-TGCDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLLTP-- 534 (745)
Q Consensus 460 ~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH~dik~~NIll~~~~-~~kl~Dfgl~~~~~~-- 534 (745)
..++++.+-+ +......+....-.+..|+..++.|+| . .++.|+||||+|.+++..+ ..+++|||+|..+..
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999999988 444335666777889999999999999 6 9999999999999999999 999999999998876
Q ss_pred CCccccccccc-ccCccCcccccCC-CCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 535 EQSSLFTTMRG-TRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 535 ~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 23333345667 9999999999885 44678999999999999999999887544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9e-14 Score=156.09 Aligned_cols=159 Identities=28% Similarity=0.406 Sum_probs=114.1
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
+.|..|++|.||..+++. .+.+|.| +++... +.+- ++.....| ++| |+-.
T Consensus 89 klisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~np---------------fvv------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNP---------------FVV------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCc---------------cee------chhh
Confidence 668999999999999875 5677774 332110 0000 12222222 222 3333
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCc---------
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS--------- 537 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~--------- 537 (745)
..+...+ .++.. ++.+++|||+ .+|+|||+||+|.+|+.-|++|+.|||+.+.......
T Consensus 140 tllk~~g-~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~ 207 (1205)
T KOG0606|consen 140 TLLKNIG-PLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE 207 (1205)
T ss_pred hhcccCC-CCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence 4443332 23322 2789999999 9999999999999999999999999999976432111
Q ss_pred ---c--cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 538 ---S--LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 538 ---~--~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
+ ....++||+.|+|||++....|....|.|++|+|+||.+-|..||....
T Consensus 208 k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 208 KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 0 1134679999999999999999999999999999999999999998763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-12 Score=141.74 Aligned_cols=141 Identities=21% Similarity=0.227 Sum_probs=100.1
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchH----------------------------------------HHHHH
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGK----------------------------------------KEFCT 427 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 427 (745)
+.||.|++|.||+|++.+|+.||||+.+....... -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999864321110 02334
Q ss_pred HHHHHccC----CCCceeeEEEEE-EeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHH-HHHHhhhCCCC
Q 004565 428 EITIIGNI----HHVNLVRLKGFC-AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR-GLAYLHTGCDH 501 (745)
Q Consensus 428 e~~~l~~l----~h~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-~l~yLH~~~~~ 501 (745)
|.+.+.++ +|.+-+.+-..+ ......+|||||+++++|.+......... .+..++..++. .+..+|. .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~---~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR---D 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh---C
Confidence 44444443 233333333333 23445799999999999988764321112 24557777766 4678888 9
Q ss_pred ceeecCCCCCCeeecCCCCeEEccCCCcccCCC
Q 004565 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 502 ~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
+++|+|+||.||+++.++.+++.|||++..+..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.7e-13 Score=131.86 Aligned_cols=151 Identities=24% Similarity=0.375 Sum_probs=118.2
Q ss_pred HHHHccCCCCceeeEEEEEEeC-----CeeEEEEeecCCCChhhhhcCCC---cccCHHHHHHHHHHHHHHHHHhhhCCC
Q 004565 429 ITIIGNIHHVNLVRLKGFCAQG-----RQRFLVYEYMNKGSLDRTLFGNG---SVLEWRERFEIALGTARGLAYLHTGCD 500 (745)
Q Consensus 429 ~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~ 500 (745)
..-|-++.|.|||++..|+.+. .+..++.|||..|+|..+|+... ..+....-.+|+-||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3455666799999999887543 35689999999999999997543 367788888999999999999997 77
Q ss_pred CceeecCCCCCCeeecCCCCeEEccCCCcccCCC----CCcccccccccccCccCcccccCCCCCCccceeehHHHHHHH
Q 004565 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP----EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEI 576 (745)
Q Consensus 501 ~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~el 576 (745)
+.|+|+++..+.|++..++-+||.-- ....... ..........+-++|.|||+-.....+..+|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 99999999999999999998888532 1111111 111122334578899999998888889999999999999999
Q ss_pred HhCCC
Q 004565 577 ISGRK 581 (745)
Q Consensus 577 ltg~~ 581 (745)
.-+..
T Consensus 276 ailEi 280 (458)
T KOG1266|consen 276 AILEI 280 (458)
T ss_pred HHhee
Confidence 88763
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.7e-12 Score=98.82 Aligned_cols=61 Identities=28% Similarity=0.434 Sum_probs=49.4
Q ss_pred cceeEEEeccccccccccccccccCCcChhhhHhhcccCCccceeeecC--CCCceEEeecCccc
Q 004565 216 SSITYLKLGNGVDYFANDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDD--SSESCYFIENHLGT 278 (745)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~--~~~~C~~~~~~l~~ 278 (745)
..+.|+++++ +++|+++.. .+..++++++|+..|++||||+||+|.+ ++++|++|.++|.+
T Consensus 3 ~~d~F~~l~~-~~~p~~~~~-~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 3 SGDGFLKLPN-MKLPDFDNA-IVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CCCEEEEECC-eeCCCCcce-eeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 3468999975 788777543 3335689999999999999999999986 67899999987754
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-11 Score=132.82 Aligned_cols=200 Identities=26% Similarity=0.255 Sum_probs=157.7
Q ss_pred HHhhhcCCCCccc--cCceeEEEEEE---CCCcEEEEEEeccC--CcchHHHHHHHHHHHccC-CCCceeeEEEEEEeCC
Q 004565 380 AAATDNFNTPIGS--GGFGTVYKGIL---QDKSVVAVKKINSF--GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGR 451 (745)
Q Consensus 380 ~~at~~f~~~lG~--G~fg~Vy~g~~---~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~ 451 (745)
....-+..+.+|. |.+|.||.+.. .++..+|+|+-+.. .......=.+|+..-.++ .|+|.++....+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3334455677999 99999999997 35678888874322 222333334566666666 5999999888888888
Q ss_pred eeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHH----HHHHhhhCCCCceeecCCCCCCeeecCC-CCeEEccC
Q 004565 452 QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR----GLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDF 526 (745)
Q Consensus 452 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~ivH~dik~~NIll~~~-~~~kl~Df 526 (745)
..++=+|++. .+|..+.+.....++....+.+..+... ||..+|. ..++|-|+||.||++..+ ...+++||
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence 8888888885 6888888877777888888888888888 9999999 999999999999999999 89999999
Q ss_pred CCcccCCCCCcc----cccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCC
Q 004565 527 GLSKLLTPEQSS----LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSS 584 (745)
Q Consensus 527 gl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~ 584 (745)
|+...+...... ......|...|++||...+ .++...|||++|.++++..++.....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 999988765422 1123367889999998764 67899999999999999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=8e-11 Score=112.44 Aligned_cols=130 Identities=18% Similarity=0.082 Sum_probs=95.0
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceee-EEEEEEeCCeeEEEEeecCCCChh
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVR-LKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~g~~~~~~~~~lV~e~~~~gsL~ 466 (745)
+.|+.|.++.||++... +..+++|....... ....+..|++.+..+.+.++++ ++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 45888999999999976 66799998754321 2334678888888886666544 44433 33468999999998876
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCC--CCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGC--DHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
..- .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 431 111345678999999999822 22369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.7e-10 Score=125.95 Aligned_cols=140 Identities=19% Similarity=0.218 Sum_probs=91.8
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEeccCCcch----------------------------------HH------HHH
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQG----------------------------------KK------EFC 426 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~----------------------------------~~------~~~ 426 (745)
+.||.|++|.||+|++.+ |+.||||+++..-... .+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999987431100 11 133
Q ss_pred HHHHHHccC----CCCceeeEEEEEEe-CCeeEEEEeecCCCChhhh--hcCCCcccCHHHHHHHHHHHHHH-HHHhhhC
Q 004565 427 TEITIIGNI----HHVNLVRLKGFCAQ-GRQRFLVYEYMNKGSLDRT--LFGNGSVLEWRERFEIALGTARG-LAYLHTG 498 (745)
Q Consensus 427 ~e~~~l~~l----~h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~~~l~~~~~~~i~~~ia~~-l~yLH~~ 498 (745)
.|+..+.++ .+.+.+.+-..+.+ ....+|||||++++.+.+. +...+ .+ +..++...++. +.-++.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d---~~~la~~~v~~~~~Qif~- 278 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TD---MKLLAERGVEVFFTQVFR- 278 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CC---HHHHHHHHHHHHHHHHHh-
Confidence 344444443 24444544444433 4567899999999999764 22222 11 11222222221 122233
Q ss_pred CCCceeecCCCCCCeeecCCC----CeEEccCCCcccCCCC
Q 004565 499 CDHKIIHCDVKPENILLHDKL----QVKISDFGLSKLLTPE 535 (745)
Q Consensus 499 ~~~~ivH~dik~~NIll~~~~----~~kl~Dfgl~~~~~~~ 535 (745)
.+++|+|+||.||+++.++ .+++.|||++..+...
T Consensus 279 --~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 279 --DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred --CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 8999999999999999988 8999999999877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=8.6e-10 Score=119.76 Aligned_cols=166 Identities=15% Similarity=0.168 Sum_probs=123.6
Q ss_pred ECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHH
Q 004565 403 LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF 482 (745)
Q Consensus 403 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~ 482 (745)
-.++.+|.|...+...........+-++.|+.++||||++++.........|||+|-+. .|..++... .....-
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence 34677888888876555445566778899999999999999999999999999999874 345555432 244455
Q ss_pred HHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccccCccCcccccCCCCCC
Q 004565 483 EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562 (745)
Q Consensus 483 ~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 562 (745)
-.+.||+.||.|||. ..+++|++|....|++++.|..||++|.++........ ......--..|..|+.+.... -
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence 567899999999986 48899999999999999999999999988865433221 011112223456665443221 3
Q ss_pred ccceeehHHHHHHHHhC
Q 004565 563 KTDVYSYGMVLLEIISG 579 (745)
Q Consensus 563 k~Dv~S~Gvll~elltg 579 (745)
..|.|.||++++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 46999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.7e-09 Score=108.21 Aligned_cols=142 Identities=19% Similarity=0.263 Sum_probs=111.2
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCc-chHHHHHHHHHHHccCCCC--ceeeEEEEEEeCC---eeEEEEeecC
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHV--NLVRLKGFCAQGR---QRFLVYEYMN 461 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~g~~~~~~---~~~lV~e~~~ 461 (745)
..|+.|..+.||++...+|..+++|....... .....+..|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 35899999999999988777899998764322 2356788999999999764 4577787776543 5689999999
Q ss_pred CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCC------------------------------------------
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC------------------------------------------ 499 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------------------ 499 (745)
+.+|...+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988876642 24777888889999999999998521
Q ss_pred -----------CCceeecCCCCCCeeecC--CCCeEEccCCCccc
Q 004565 500 -----------DHKIIHCDVKPENILLHD--KLQVKISDFGLSKL 531 (745)
Q Consensus 500 -----------~~~ivH~dik~~NIll~~--~~~~kl~Dfgl~~~ 531 (745)
...++|+|+++.||+++. +..+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.8e-09 Score=100.71 Aligned_cols=137 Identities=17% Similarity=0.159 Sum_probs=98.9
Q ss_pred CCccccCceeEEEEEECC-------CcEEEEEEeccCC----------------------cchHHHHH----HHHHHHcc
Q 004565 388 TPIGSGGFGTVYKGILQD-------KSVVAVKKINSFG----------------------IQGKKEFC----TEITIIGN 434 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~~ 434 (745)
..||.|.-+.||.|.-.+ +..+|||..+... ....+.+. .|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4789999765210 01122333 78888888
Q ss_pred CCC--CceeeEEEEEEeCCeeEEEEeecCCCChhh-hhcCCCcccCHHHHHHHHHHHHHHHHHh-hhCCCCceeecCCCC
Q 004565 435 IHH--VNLVRLKGFCAQGRQRFLVYEYMNKGSLDR-TLFGNGSVLEWRERFEIALGTARGLAYL-HTGCDHKIIHCDVKP 510 (745)
Q Consensus 435 l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~dik~ 510 (745)
+.. -++..++++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|..| |+ .+++|+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 853 355666654 45689999997654422 2221 1344556677889999999999 77 8999999999
Q ss_pred CCeeecCCCCeEEccCCCcccCCC
Q 004565 511 ENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 511 ~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
.||++++ +.+.|+|||.+....+
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCCC
Confidence 9999974 5799999999876654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.3e-10 Score=92.46 Aligned_cols=72 Identities=26% Similarity=0.451 Sum_probs=54.0
Q ss_pred eeEEEeccccccccccccccccCCcChhhhHhhcccCCccceeeecCCCCceEEeecCccccccCCCccccccceeee
Q 004565 218 ITYLKLGNGVDYFANDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENHLGTLMSSSDNERVRLGYIKA 295 (745)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~~C~~~~~~l~~~~~~~~~~~~~~~~ik~ 295 (745)
..|++++ ++.++++.+. . .++++++|++.|++||+|.||+|.+++++|++|...+......... ....|+|+
T Consensus 12 ~~f~~~~-~~~~~~~~~~--~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~--~~~~yiKv 83 (84)
T cd01098 12 DGFLKLP-DVKLPDNASA--I-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSG--GGTLYLRL 83 (84)
T ss_pred CEEEEeC-CeeCCCchhh--h-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCC--CcEEEEEe
Confidence 5788886 4777765432 2 6789999999999999999999998788999998877665543322 34566664
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.2e-09 Score=98.00 Aligned_cols=130 Identities=20% Similarity=0.241 Sum_probs=103.5
Q ss_pred CccccCceeEEEEEECCCcEEEEEEeccCC--cc------hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 389 PIGSGGFGTVYKGILQDKSVVAVKKINSFG--IQ------GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
.+++|+-+.+|.+.+.+.. +++|.-.... .. ....-.+|.+++.+++--.+....-+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4789999999999876555 5555332211 11 1234567999999998778877777788888899999999
Q ss_pred CCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
++-.|.+.+... +..++..+-.-+.-||. .+|+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888654 35678888888999999 9999999999999998875 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.8e-09 Score=96.85 Aligned_cols=141 Identities=18% Similarity=0.216 Sum_probs=105.6
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCC-------cchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeec
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFG-------IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 460 (745)
..|-+|+-+.|+++.+.+...++-+++.+.- .-..+...+|.+++.+++--.|.-..-++.+...-.|+|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 4578999999999999765544333333211 112456778999999998777777777777777788999999
Q ss_pred CC-CChhhhhcCCCcccCHHHH-HHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCC---eEEccCCCccc
Q 004565 461 NK-GSLDRTLFGNGSVLEWRER-FEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ---VKISDFGLSKL 531 (745)
Q Consensus 461 ~~-gsL~~~l~~~~~~l~~~~~-~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~---~kl~Dfgl~~~ 531 (745)
++ .++.+++......-..... ..++..|-+.+.-||. +.|+|+||..+||+|..++. +.++|||++..
T Consensus 93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 77 4788888765443333333 7889999999999999 99999999999999976543 58999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.5e-08 Score=105.12 Aligned_cols=165 Identities=20% Similarity=0.289 Sum_probs=126.8
Q ss_pred eeEEEEEE-CCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEE----eCCeeEEEEeecCC-CChhhhh
Q 004565 396 GTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA----QGRQRFLVYEYMNK-GSLDRTL 469 (745)
Q Consensus 396 g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~----~~~~~~lV~e~~~~-gsL~~~l 469 (745)
.+.||+.. -||..+++|++.....+.......-++.++++.|.|+|++..++. .....++||+|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899986 478889999995433333333445688999999999999999876 34467899999986 5676655
Q ss_pred cCC--------------CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 470 FGN--------------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 470 ~~~--------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
..+ +..+++..+|.++.|++.||.++|+ .|+.-+-|.+++|+++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 422 1257789999999999999999999 99999999999999999999999988887655443
Q ss_pred CcccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCC
Q 004565 536 QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRK 581 (745)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~ 581 (745)
.. |-+.. -.+-|.-.||.+++.|.||..
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 21 11111 236788889999999999964
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.7e-09 Score=116.65 Aligned_cols=187 Identities=24% Similarity=0.309 Sum_probs=139.5
Q ss_pred CCccccCceeEEEEEEC--CCcEEEEEEeccCCcchHHH--HHHHHHHHccC-CCCceeeEEEEEEeCCeeEEEEeecCC
Q 004565 388 TPIGSGGFGTVYKGILQ--DKSVVAVKKINSFGIQGKKE--FCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 462 (745)
..||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+-+...+ .|.+.++....+...+..++=-||+.+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 66999999999987754 57788888876543332222 13455555555 688888887777777777788899999
Q ss_pred CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC-CCeEEccCCCcccCCCCCccccc
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~-~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+++...+ .-...++...++++..+++.++.++|+ ..++|+|+||+||++..+ +..+++|||....+..... .
T Consensus 351 ~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~---~ 423 (524)
T KOG0601|consen 351 GSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG---V 423 (524)
T ss_pred cchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceecc---c
Confidence 9887666 222357888899999999999999998 999999999999999886 8889999999864322111 1
Q ss_pred ccccccCc-cCcccccCCCCCCccceeehHHHHHHHHhCCC
Q 004565 542 TMRGTRGY-LAPEWLTSSAISDKTDVYSYGMVLLEIISGRK 581 (745)
Q Consensus 542 ~~~gt~~y-~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~ 581 (745)
....+..| .+++......+-.+.|++|||.-+.|.+++..
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcc
Confidence 11122333 35556666778899999999999999999864
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.2e-09 Score=82.90 Aligned_cols=67 Identities=12% Similarity=0.136 Sum_probs=46.7
Q ss_pred eeEEEeccccccccccccccccCCcChhhhHhhccc---CCccceeeecCCCCceEEeecCc-cccccCCCcccccccee
Q 004565 218 ITYLKLGNGVDYFANDFIQPVKRGVGLSDCQDLCSW---NCSCLGIFHDDSSESCYFIENHL-GTLMSSSDNERVRLGYI 293 (745)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~A~~~~~~~~~C~~~~~~l-~~~~~~~~~~~~~~~~i 293 (745)
..|+++.+ +..+.. ...++++|+++|++ ||||+||+|.+.+.+|.+|.+++ .++...... +...|+
T Consensus 9 g~fl~~~~-~klpd~-------~~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~--g~~Ly~ 78 (80)
T cd00129 9 GTTLIKIA-LKIKTT-------KANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSH--GFDLYE 78 (80)
T ss_pred CeEEEeec-ccCCcc-------cccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCC--CceeEe
Confidence 35666643 343333 33689999999999 99999999987667899999988 665543322 344555
Q ss_pred e
Q 004565 294 K 294 (745)
Q Consensus 294 k 294 (745)
+
T Consensus 79 r 79 (80)
T cd00129 79 N 79 (80)
T ss_pred E
Confidence 3
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.7e-07 Score=95.42 Aligned_cols=132 Identities=18% Similarity=0.118 Sum_probs=96.2
Q ss_pred eeEEEEEECCCcEEEEEEeccCCcc-----------hHHHHHHHHHHHccCCCCce--eeEEEEEEe-----CCeeEEEE
Q 004565 396 GTVYKGILQDKSVVAVKKINSFGIQ-----------GKKEFCTEITIIGNIHHVNL--VRLKGFCAQ-----GRQRFLVY 457 (745)
Q Consensus 396 g~Vy~g~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni--v~l~g~~~~-----~~~~~lV~ 457 (745)
..|.+..+ +|+.+.||+....... ....+..|.+.+.++...+| ..++++... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34667766 4567999976432211 11147789998888854444 444555543 23578999
Q ss_pred eecCCC-ChhhhhcCC-CcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecC-------CCCeEEccCCC
Q 004565 458 EYMNKG-SLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-------KLQVKISDFGL 528 (745)
Q Consensus 458 e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~-------~~~~kl~Dfgl 528 (745)
|++++. +|.+++... ....+...+..++.+++..+.-||. .+|+|+|++++|||++. +..+.++||+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999986 798887532 2245566778999999999999999 99999999999999985 46789999998
Q ss_pred ccc
Q 004565 529 SKL 531 (745)
Q Consensus 529 ~~~ 531 (745)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.8e-07 Score=89.54 Aligned_cols=127 Identities=24% Similarity=0.230 Sum_probs=83.6
Q ss_pred eEEEEEECCCcEEEEEEeccCCc-------------c-------------hHHHHHHHHHHHccCCCC--ceeeEEEEEE
Q 004565 397 TVYKGILQDKSVVAVKKINSFGI-------------Q-------------GKKEFCTEITIIGNIHHV--NLVRLKGFCA 448 (745)
Q Consensus 397 ~Vy~g~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~l~g~~~ 448 (745)
.||.|...++..+|||..+.... . .......|.+.|.++... ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999997652100 0 013356799999999766 455665442
Q ss_pred eCCeeEEEEeecC--CCChhhhhcCCCcccCHHHHHHHHHHHHHHHHH-hhhCCCCceeecCCCCCCeeecCCCCeEEcc
Q 004565 449 QGRQRFLVYEYMN--KGSLDRTLFGNGSVLEWRERFEIALGTARGLAY-LHTGCDHKIIHCDVKPENILLHDKLQVKISD 525 (745)
Q Consensus 449 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~ivH~dik~~NIll~~~~~~kl~D 525 (745)
..+|||||++ +..+..+.... ++......++.+++..+.. +|. .+|+|+|+.+.||+++++ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence 3479999998 54444333221 2244556777888886665 467 999999999999999998 999999
Q ss_pred CCCcccCCC
Q 004565 526 FGLSKLLTP 534 (745)
Q Consensus 526 fgl~~~~~~ 534 (745)
||.+.....
T Consensus 150 f~qav~~~~ 158 (188)
T PF01163_consen 150 FGQAVDSSH 158 (188)
T ss_dssp GTTEEETTS
T ss_pred cCcceecCC
Confidence 999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.2e-08 Score=111.42 Aligned_cols=100 Identities=25% Similarity=0.417 Sum_probs=80.0
Q ss_pred HHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCccc--------ccccccccCccCccc
Q 004565 483 EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL--------FTTMRGTRGYLAPEW 554 (745)
Q Consensus 483 ~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--------~~~~~gt~~y~aPE~ 554 (745)
.=+.+++.|+.|+|. ..++||++|.|++|.+++++..||+.|+.+.......... ..-......|.|||+
T Consensus 103 ~nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence 334566699999998 5899999999999999999999999999887654422111 112235668999999
Q ss_pred ccCCCCCCccceeehHHHHHHHHhCCCCCC
Q 004565 555 LTSSAISDKTDVYSYGMVLLEIISGRKNSS 584 (745)
Q Consensus 555 ~~~~~~t~k~Dv~S~Gvll~elltg~~p~~ 584 (745)
+.....+.++|+||+|++++.+..|+++..
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~ 210 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSII 210 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchh
Confidence 999888999999999999999997666543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.5e-08 Score=113.19 Aligned_cols=196 Identities=21% Similarity=0.237 Sum_probs=133.5
Q ss_pred CCccccCceeEEEEEECC-CcEEEEEEecc---CCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINS---FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~-~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.+-.|.|+.++.+.-.. +...++|.... ......+....+-.++-..+||-+++..--+.-.....||++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 456778888887665322 32233332221 11111122222222222234455554444444556678999999999
Q ss_pred ChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC--------
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE-------- 535 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~-------- 535 (745)
+|...|+..+ .++.+.....+..+..+++|||. ..+.|+|++|.|+++..++..+++||+........
T Consensus 890 ~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 890 DLPSKLHNSG-CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred CchhhhhcCC-CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 9999998776 34555555566678889999998 77999999999999999999999999844322110
Q ss_pred -------------C---------cccccccccccCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCCccc
Q 004565 536 -------------Q---------SSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKI 587 (745)
Q Consensus 536 -------------~---------~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~~~~ 587 (745)
. ........+|+.|.+||.+.+......+|.|++|++++|.++|..||....
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 001123568999999999999999999999999999999999999997644
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.3e-06 Score=85.67 Aligned_cols=191 Identities=16% Similarity=0.168 Sum_probs=122.6
Q ss_pred CCCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccC-CCCceeeEEEE----EE--eCCe-eEEEEe
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGF----CA--QGRQ-RFLVYE 458 (745)
Q Consensus 387 ~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~----~~--~~~~-~~lV~e 458 (745)
+..||+|+-+.+|-.---.+ .| .|+..........+. ++.|... .||-+-.-+.+ .. ++.. .-++|+
T Consensus 16 gr~LgqGgea~ly~l~e~~d-~V-AKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD-QV-AKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchhhc-hh-heeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 46699999999985432112 23 355544333322222 2333333 45543321111 11 1122 446666
Q ss_pred ecCCCC-hhhhhcC-----CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccC
Q 004565 459 YMNKGS-LDRTLFG-----NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 459 ~~~~gs-L~~~l~~-----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
.+++.- ...++.. .-...+|...++.+..+|.+.+-||. .+.+-+|+.++|+|+.++..+.|.|=..-..-
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 665532 2222221 11258899999999999999999999 88899999999999999999999874433221
Q ss_pred CCCCcccccccccccCccCccccc-----CCCCCCccceeehHHHHHHHHhC-CCCCCccc
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISG-RKNSSLKI 587 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~Dv~S~Gvll~elltg-~~p~~~~~ 587 (745)
.........+|...|.+||.-. +-.-+...|-|.+||++++++.| +.||.+-.
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 1222234457889999999754 23456789999999999999986 89987643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.2e-06 Score=86.18 Aligned_cols=138 Identities=20% Similarity=0.171 Sum_probs=95.3
Q ss_pred hcCCCCccccCceeEEEEEECCCcEEEEEEeccCC----------------------cchHHHHHHHHHHHccCCCC--c
Q 004565 384 DNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFG----------------------IQGKKEFCTEITIIGNIHHV--N 439 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--n 439 (745)
+.+.++||-|.-+.||.|..+.|..+|||.=+... .-......+|.+.|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34457899999999999999999999999533110 01123456788889888655 6
Q ss_pred eeeEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC
Q 004565 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519 (745)
Q Consensus 440 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~ 519 (745)
+.+.+++ +...+||||+++-.|...- ++-+..-.|+..|++-+.-+-. .+|||+|+++-||++++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence 6666654 3447999999886664322 1222233333444444433334 8999999999999999999
Q ss_pred CeEEccCCCcccCCC
Q 004565 520 QVKISDFGLSKLLTP 534 (745)
Q Consensus 520 ~~kl~Dfgl~~~~~~ 534 (745)
.+.++||--+.....
T Consensus 240 ~~~vIDwPQ~v~~~h 254 (304)
T COG0478 240 DIVVIDWPQAVPISH 254 (304)
T ss_pred CEEEEeCcccccCCC
Confidence 999999977765443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.6e-06 Score=81.97 Aligned_cols=137 Identities=16% Similarity=0.133 Sum_probs=104.1
Q ss_pred ccccCceeEEEEEECCCcEEEEEEeccC-----C-cchHHHHHHHHHHHccCCCCc--eeeEEEEEEe-----CCeeEEE
Q 004565 390 IGSGGFGTVYKGILQDKSVVAVKKINSF-----G-IQGKKEFCTEITIIGNIHHVN--LVRLKGFCAQ-----GRQRFLV 456 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~~~~vavK~~~~~-----~-~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~~-----~~~~~lV 456 (745)
-|+||-+.|++-.+.+. .+-+|+-... . +.+...|.+|...|.++...+ +.+++ ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46799999999888665 5888876511 1 346788999999999985333 44444 3321 1246899
Q ss_pred EeecCC-CChhhhhcCCC-cccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCC--eEEccCCCccc
Q 004565 457 YEYMNK-GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ--VKISDFGLSKL 531 (745)
Q Consensus 457 ~e~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~--~kl~Dfgl~~~ 531 (745)
+|-+++ -+|.+++.... .+.+...+..+..+++.++.-||+ .++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 57888885532 256778888999999999999999 99999999999999986666 99999977654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.4e-06 Score=84.03 Aligned_cols=108 Identities=19% Similarity=0.231 Sum_probs=85.2
Q ss_pred HHHHHHHHHHHccCCCC--ceeeEEEEEEeCC----eeEEEEeecCCC-ChhhhhcCCCcccCHHHHHHHHHHHHHHHHH
Q 004565 422 KKEFCTEITIIGNIHHV--NLVRLKGFCAQGR----QRFLVYEYMNKG-SLDRTLFGNGSVLEWRERFEIALGTARGLAY 494 (745)
Q Consensus 422 ~~~~~~e~~~l~~l~h~--niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~y 494 (745)
......|.+.+..+... ...+++++..... ..++|+|++++. +|.+++..... ++...+..++.++++.++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 44577888888777533 3456666665532 458999999874 79988875332 5667788999999999999
Q ss_pred hhhCCCCceeecCCCCCCeeecCCC---CeEEccCCCcccCC
Q 004565 495 LHTGCDHKIIHCDVKPENILLHDKL---QVKISDFGLSKLLT 533 (745)
Q Consensus 495 LH~~~~~~ivH~dik~~NIll~~~~---~~kl~Dfgl~~~~~ 533 (745)
||. .+|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999 9999999999999999887 89999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.3e-06 Score=93.12 Aligned_cols=147 Identities=22% Similarity=0.259 Sum_probs=95.5
Q ss_pred hcCC-CCccccCceeEEEEEECCCcEEEEEEeccCCcch------------------------------HHH--------
Q 004565 384 DNFN-TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQG------------------------------KKE-------- 424 (745)
Q Consensus 384 ~~f~-~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~------------------------------~~~-------- 424 (745)
..|+ +.|+.++-|.||+|++++|+.||||+.+..-... .++
T Consensus 126 ~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 126 SEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 4566 7899999999999999999999999876422111 011
Q ss_pred --HHHHHHHHccC----CCCceeeEEEEEE-eCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhh
Q 004565 425 --FCTEITIIGNI----HHVNLVRLKGFCA-QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497 (745)
Q Consensus 425 --~~~e~~~l~~l----~h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~ 497 (745)
+..|...+.++ +...-+++=..+. -....+|+|||+++..+.+........++ +..|+..++++. +.+
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f--~~q 280 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAF--LRQ 280 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHH--HHH
Confidence 12222222222 2222333334443 35678999999999988887532223344 233333333321 111
Q ss_pred CCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCC
Q 004565 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 498 ~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~ 535 (745)
-...+++|.|.+|.||+++.++.+.+.|||+...+...
T Consensus 281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 11278999999999999999999999999999877654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.4e-05 Score=75.52 Aligned_cols=138 Identities=17% Similarity=0.174 Sum_probs=84.0
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCc--eeeEEEEEEeCCeeEEEEeecCCCC-
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVN--LVRLKGFCAQGRQRFLVYEYMNKGS- 464 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gs- 464 (745)
.+||+|..+.||+. .+..+++|...... ......+|.+.++.+..-. +.+++++....+...+|||++++..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 45899999999984 23456677765422 2345688999998886444 4677788777777889999998863
Q ss_pred hhhhh---------------------cCCC-cccCHHHHHH-HHH----------HHHH-HHHHhhhC-CCCceeecCCC
Q 004565 465 LDRTL---------------------FGNG-SVLEWRERFE-IAL----------GTAR-GLAYLHTG-CDHKIIHCDVK 509 (745)
Q Consensus 465 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~ia~-~l~yLH~~-~~~~ivH~dik 509 (745)
+...+ +.-. .......+.. +.. .+.+ ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111 1100 0011111000 000 0011 12222211 12457899999
Q ss_pred CCCeeecCCCCeEEccCCCccc
Q 004565 510 PENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 510 ~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999988 99999988763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.4e-05 Score=76.93 Aligned_cols=103 Identities=26% Similarity=0.318 Sum_probs=82.3
Q ss_pred HHHHHHHccCCC-CceeeEEEEEEeCCeeEEEEeecCCCChhhhhcC--CCcccCHHHHHHHHHHHHHHHHHhhhCCCCc
Q 004565 426 CTEITIIGNIHH-VNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFG--NGSVLEWRERFEIALGTARGLAYLHTGCDHK 502 (745)
Q Consensus 426 ~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 502 (745)
..|.-+++.+++ +++.+++|+|-. ++|.||.+.+++...-.. .-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347778888866 699999999944 789999987766422100 0114789999999999999999999866666
Q ss_pred eeecCCCCCCeeecCCCCeEEccCCCcccC
Q 004565 503 IIHCDVKPENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 503 ivH~dik~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.9e-06 Score=92.03 Aligned_cols=181 Identities=21% Similarity=0.167 Sum_probs=132.6
Q ss_pred CccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCc-eeeEEEEEEeCCeeEEEEeecCCC-Chh
Q 004565 389 PIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVN-LVRLKGFCAQGRQRFLVYEYMNKG-SLD 466 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~~~g-sL~ 466 (745)
-+++|+++.++|.+-...+...++.+.. .....-++++|.+++||| .++.++-+..+...+++++++..+ +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 3688999999998864444444555432 244566889999999999 777777788888889999999877 222
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccc
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 546 (745)
.........+...+...+...-+++++|||+ ..-+|+| ||+..+ ...|..||+.+..+.... ......++
T Consensus 324 ~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~ 393 (829)
T KOG0576|consen 324 LEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGT 393 (829)
T ss_pred ccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccccCCCC
Confidence 2221111134444455666777889999998 4457888 777776 578999999988766543 33566789
Q ss_pred cCccCcccccCCCCCCccceeehHHHHHHHHhCCCCCC
Q 004565 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSS 584 (745)
Q Consensus 547 ~~y~aPE~~~~~~~t~k~Dv~S~Gvll~elltg~~p~~ 584 (745)
+.++|||......+..+.|+|+.|+--.++--|-.|-.
T Consensus 394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 99999999999999999999999987777777766643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.97 E-value=8.3e-05 Score=72.73 Aligned_cols=138 Identities=22% Similarity=0.183 Sum_probs=91.7
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchH-------------------HH-----HHHHHHHHccCC--CCcee
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGK-------------------KE-----FCTEITIIGNIH--HVNLV 441 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~-------------------~~-----~~~e~~~l~~l~--h~niv 441 (745)
-.|.+|.-..||+|.-.++..+|||+......... ++ ...|+.-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 35788999999999998999999999864322111 11 124555555552 34445
Q ss_pred eEEEEEEeCCeeEEEEeecCCCCh-hhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCC
Q 004565 442 RLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ 520 (745)
Q Consensus 442 ~l~g~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~ 520 (745)
+.+++.. -.|||||+....+ .-.|... .+.......+..++++.+.-|-. ..++||+||+.=|||+. ++.
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCe
Confidence 5555443 3799999865421 1122111 22233456666777777776654 37899999999999999 789
Q ss_pred eEEccCCCcccCCC
Q 004565 521 VKISDFGLSKLLTP 534 (745)
Q Consensus 521 ~kl~Dfgl~~~~~~ 534 (745)
+.|+|++-+....+
T Consensus 205 p~iID~~QaV~~~h 218 (268)
T COG1718 205 PYIIDVSQAVTIDH 218 (268)
T ss_pred EEEEECccccccCC
Confidence 99999999876553
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.2e-05 Score=81.91 Aligned_cols=147 Identities=20% Similarity=0.235 Sum_probs=91.6
Q ss_pred hcCC-CCccccCceeEEEEEECCCcEEEEEEeccCCcch-------------------------------HH------HH
Q 004565 384 DNFN-TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQG-------------------------------KK------EF 425 (745)
Q Consensus 384 ~~f~-~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~ 425 (745)
..|. +.||....|.||+|++++|+.||||+-+..-... .+ +|
T Consensus 162 ~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 162 SEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred HhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 3455 6799999999999999999999999865321111 01 12
Q ss_pred HHHHHHHcc----CCCCce---eeEEEEEE-eCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhh
Q 004565 426 CTEITIIGN----IHHVNL---VRLKGFCA-QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497 (745)
Q Consensus 426 ~~e~~~l~~----l~h~ni---v~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~ 497 (745)
..|.+-..+ +.|-++ |.+=.++. -...++|+||||++..+.+.-.-....++-. .|+..+.++. ++.
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~~--~~q 316 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEAY--LEQ 316 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHHH--HHH
Confidence 233322222 235551 22333333 2346899999999988776543222234433 3333333332 221
Q ss_pred CCCCceeecCCCCCCeeecC----CCCeEEccCCCcccCCCC
Q 004565 498 GCDHKIIHCDVKPENILLHD----KLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 498 ~~~~~ivH~dik~~NIll~~----~~~~kl~Dfgl~~~~~~~ 535 (745)
-...|++|+|-+|.||+++. ++.+.+-|||+...+...
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 11277999999999999994 678999999999876544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00013 Score=74.07 Aligned_cols=137 Identities=15% Similarity=0.067 Sum_probs=83.8
Q ss_pred ccccCc-eeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCC-CCceeeEEEEEEeCCeeEEEEeecCCCChhh
Q 004565 390 IGSGGF-GTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467 (745)
Q Consensus 390 lG~G~f-g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 467 (745)
|..|.. ..||+....+ ..++||...... ......|++++..+. +--+.+++++....+..++|||++++.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 7889997754 678888775432 345667888888773 4445677777776667899999999887764
Q ss_pred hhc-------------------CCC---cccC--HHHHHHHHH--------------------HHHHHHHHhhh----CC
Q 004565 468 TLF-------------------GNG---SVLE--WRERFEIAL--------------------GTARGLAYLHT----GC 499 (745)
Q Consensus 468 ~l~-------------------~~~---~~l~--~~~~~~i~~--------------------~ia~~l~yLH~----~~ 499 (745)
... ... ..+. ...++.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 100 0000 001110000 01111222211 11
Q ss_pred CCceeecCCCCCCeeecCCCCeEEccCCCcc
Q 004565 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSK 530 (745)
Q Consensus 500 ~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~ 530 (745)
...++|+|+.|.|||++++....|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2558999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00018 Score=72.32 Aligned_cols=140 Identities=20% Similarity=0.207 Sum_probs=83.3
Q ss_pred CccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCC--ceeeEEEEEEe---CCeeEEEEeecCCC
Q 004565 389 PIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHV--NLVRLKGFCAQ---GRQRFLVYEYMNKG 463 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~g~~~~---~~~~~lV~e~~~~g 463 (745)
.|+.|..+.||+....+ ..+++|..... .....+..|+.+++.+... .+.+++.++.. ....+++|+++++.
T Consensus 4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred cCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 47889999999999988 57889987543 4456778888888887533 35566765533 33468999999998
Q ss_pred Chhh----------------hh---cCC---CcccCHHH---------HHHH------------HHHHHH-HHHHhhh--
Q 004565 464 SLDR----------------TL---FGN---GSVLEWRE---------RFEI------------ALGTAR-GLAYLHT-- 497 (745)
Q Consensus 464 sL~~----------------~l---~~~---~~~l~~~~---------~~~i------------~~~ia~-~l~yLH~-- 497 (745)
.+.. .+ +.. ...+.+.. .... ...+.+ .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7776 11 011 00111100 0000 112222 3333332
Q ss_pred --CCCCceeecCCCCCCeeec-CCCCeEEccCCCccc
Q 004565 498 --GCDHKIIHCDVKPENILLH-DKLQVKISDFGLSKL 531 (745)
Q Consensus 498 --~~~~~ivH~dik~~NIll~-~~~~~kl~Dfgl~~~ 531 (745)
.....++|+|+.+.||+++ +++.+-|.||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2347799999999999999 555567999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00039 Score=67.43 Aligned_cols=128 Identities=16% Similarity=0.131 Sum_probs=78.2
Q ss_pred ccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHH---------HHHHHHccCCC---CceeeEEEEEE-----eCCe
Q 004565 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFC---------TEITIIGNIHH---VNLVRLKGFCA-----QGRQ 452 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~---------~e~~~l~~l~h---~niv~l~g~~~-----~~~~ 452 (745)
+-......|.+-..+ +...++|..+.......+.|. +++..+.+++. .....++.+.. -...
T Consensus 39 ~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~ 117 (229)
T PF06176_consen 39 FKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSS 117 (229)
T ss_pred ecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeE
Confidence 333444555555554 456777876543322222222 23333333322 22333333222 2234
Q ss_pred eEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 453 RFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 453 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
.+|||||+++..|.++.. ++. .++..+++++.-||+ .|++|+|++|.|+++++++ +++.||+..+.
T Consensus 118 ~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 118 YVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 579999999988766542 222 355677888999999 9999999999999999654 99999977653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00079 Score=80.54 Aligned_cols=78 Identities=13% Similarity=0.272 Sum_probs=56.1
Q ss_pred CCccccCceeEEEEEECCC---cEEEEEEeccCC-cchHHHHHHHHHHHccCC-CCce--eeEEEEEEeC---CeeEEEE
Q 004565 388 TPIGSGGFGTVYKGILQDK---SVVAVKKINSFG-IQGKKEFCTEITIIGNIH-HVNL--VRLKGFCAQG---RQRFLVY 457 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV~ 457 (745)
..|+.|.+..+|+....++ ..+++|+..... ......+..|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4478898999999887654 356677654322 123456889999999985 6665 7888888764 4678999
Q ss_pred eecCCCCh
Q 004565 458 EYMNKGSL 465 (745)
Q Consensus 458 e~~~~gsL 465 (745)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99987654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00015 Score=58.84 Aligned_cols=56 Identities=23% Similarity=0.475 Sum_probs=39.7
Q ss_pred eEEEeccccccccccccccccCCcChhhhHhhccc-CCccceeeecCCCCceEEee-cCcc
Q 004565 219 TYLKLGNGVDYFANDFIQPVKRGVGLSDCQDLCSW-NCSCLGIFHDDSSESCYFIE-NHLG 277 (745)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~A~~~~~~~~~C~~~~-~~l~ 277 (745)
.|+++++ +.++.... ......++++|++.|+. +|+|.||.|..+++.|++|. +.+.
T Consensus 5 ~f~~~~~-~~l~~~~~--~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~ 62 (78)
T smart00473 5 CFVRLPN-TKLPGFSR--IVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLG 62 (78)
T ss_pred eeEEecC-ccCCCCcc--eeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccc
Confidence 4566644 44442222 12356799999999999 99999999987667999998 4443
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0014 Score=63.34 Aligned_cols=131 Identities=21% Similarity=0.254 Sum_probs=89.6
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCC----------------cchHHHHHHHHHHHccCC------CCceeeEEE
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFG----------------IQGKKEFCTEITIIGNIH------HVNLVRLKG 445 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l~g 445 (745)
..||+|+.-.||.= ++.....||+..... ....++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 56999999998854 444556778776544 223456666766555554 889999999
Q ss_pred EEEeCCeeEEEEeecCC------CChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC
Q 004565 446 FCAQGRQRFLVYEYMNK------GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519 (745)
Q Consensus 446 ~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~ 519 (745)
+....-..-+|+|.+.+ -+|.+++... .++. .. ...+-+-..||-+ ..|+.+|++|.||++....
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~---~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-EL---RQALDEFKRYLLD---HHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HH---HHHHHHHHHHHHH---cCCeecCCCcccEEEEecC
Confidence 99999999999998643 3577777544 2444 33 3333344556666 8899999999999996432
Q ss_pred ----CeEEcc-CCCc
Q 004565 520 ----QVKISD-FGLS 529 (745)
Q Consensus 520 ----~~kl~D-fgl~ 529 (745)
.+.|+| ||-.
T Consensus 156 ~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEK 170 (199)
T ss_pred CCceEEEEEeCCCCc
Confidence 466666 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0022 Score=66.97 Aligned_cols=75 Identities=12% Similarity=0.068 Sum_probs=55.7
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCC---CceeeEEEEEEeC---CeeEEEEeecC
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHH---VNLVRLKGFCAQG---RQRFLVYEYMN 461 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~g~~~~~---~~~~lV~e~~~ 461 (745)
+.||.|..+.||+....+++ +++|..+.. .....|..|.+.++.+.- -.+.+++++|..+ +..+||||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 45999999999999877765 556664321 123578889999988843 3678888888643 56899999999
Q ss_pred CCCh
Q 004565 462 KGSL 465 (745)
Q Consensus 462 ~gsL 465 (745)
+.++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0013 Score=60.93 Aligned_cols=128 Identities=20% Similarity=0.229 Sum_probs=85.7
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhh
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 467 (745)
..|++|.+|.||+|.+.++ .+|+|+-... .....+..|.++|..+.-.++.+=+-++.. -++.|||+.+-.|.+
T Consensus 28 ~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~~ 101 (201)
T COG2112 28 KELAKGTTSVVYLGEWRGG-EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhcccccEEEEeeccCc-eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchhh
Confidence 5599999999999999766 6888876543 346778899999999877666544333322 245599998877765
Q ss_pred hhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCC-CCCeeecCCCCeEEccCCCcccC
Q 004565 468 TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVK-PENILLHDKLQVKISDFGLSKLL 532 (745)
Q Consensus 468 ~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik-~~NIll~~~~~~kl~Dfgl~~~~ 532 (745)
.-... + .+-...++++-.-|-. .+|-|+.|. |..++|-.+..+.|+||.-|..-
T Consensus 102 ~~~~~----~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 102 LEIGG----D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhcc----c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 54321 1 1223345555444444 788888876 44444444448999999998743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0011 Score=66.71 Aligned_cols=137 Identities=17% Similarity=0.185 Sum_probs=74.8
Q ss_pred CccccCce-eEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCC---ceeeEEEEEEeC---CeeEEEEeecC
Q 004565 389 PIGSGGFG-TVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHV---NLVRLKGFCAQG---RQRFLVYEYMN 461 (745)
Q Consensus 389 ~lG~G~fg-~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~g~~~~~---~~~~lV~e~~~ 461 (745)
.|+.|+.. .||+. +..+++|.... ......+..|.+.+..+... .+.++++..... ...++||++++
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 46777765 58875 22466676433 12345788899988887532 234444433322 23588999999
Q ss_pred CCChhhhh------------------cCCCc---cc-------------CHHHHH--HHH-------HHHHHH-HHH-hh
Q 004565 462 KGSLDRTL------------------FGNGS---VL-------------EWRERF--EIA-------LGTARG-LAY-LH 496 (745)
Q Consensus 462 ~gsL~~~l------------------~~~~~---~l-------------~~~~~~--~i~-------~~ia~~-l~y-LH 496 (745)
+.++.... +.-.. .. .|.... .+. .+.+.. ++. ++
T Consensus 78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 157 (235)
T cd05155 78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR 157 (235)
T ss_pred CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence 87774321 11000 00 011110 000 011111 111 11
Q ss_pred h--CCCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 497 T--GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 497 ~--~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
. .....++|+|+.+.||+++++...-|.||+.+..
T Consensus 158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 1 1234589999999999999876667999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0022 Score=64.52 Aligned_cols=138 Identities=17% Similarity=0.156 Sum_probs=78.9
Q ss_pred CccccCceeEEEEEECC--CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCcee-eEEEEEEeCCeeEEEEeecCCCCh
Q 004565 389 PIGSGGFGTVYKGILQD--KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLV-RLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gsL 465 (745)
.|..|-...+|+....+ +..+++|........ ......|+.++..+...+++ ++++... ..+||||+++.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 36667778999998764 567888876532211 12234688888887544444 3433332 2489999998776
Q ss_pred hhh-----------------hcCCCcc----------c-CHHHHHHHHH----------------------HHHHHHHHh
Q 004565 466 DRT-----------------LFGNGSV----------L-EWRERFEIAL----------------------GTARGLAYL 495 (745)
Q Consensus 466 ~~~-----------------l~~~~~~----------l-~~~~~~~i~~----------------------~ia~~l~yL 495 (745)
... ++..... . -|..+..+.. .+...+..|
T Consensus 80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 159 (235)
T cd05157 80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL 159 (235)
T ss_pred CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence 321 0110001 1 1222112111 111111122
Q ss_pred ----hhC-CCCceeecCCCCCCeeecC-CCCeEEccCCCccc
Q 004565 496 ----HTG-CDHKIIHCDVKPENILLHD-KLQVKISDFGLSKL 531 (745)
Q Consensus 496 ----H~~-~~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~ 531 (745)
... ....++|+|+.+.|||+++ +..+.|+||..+..
T Consensus 160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 111 2356999999999999998 57899999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0033 Score=64.22 Aligned_cols=136 Identities=13% Similarity=0.100 Sum_probs=76.6
Q ss_pred ccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCcee-eEEEEEEeCCeeEEEEeecCCCChhhh
Q 004565 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLV-RLKGFCAQGRQRFLVYEYMNKGSLDRT 468 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gsL~~~ 468 (745)
+..|-...+|+... ++..+++|........-.-....|.++++.+....++ ++++... ..+|+||+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 4556778875432221112356788888888644443 3444332 3689999998766421
Q ss_pred -----------------hcCCC---cccCHHHHH-HHHHH---------HHHHHHHhhhC-----CCCceeecCCCCCCe
Q 004565 469 -----------------LFGNG---SVLEWRERF-EIALG---------TARGLAYLHTG-----CDHKIIHCDVKPENI 513 (745)
Q Consensus 469 -----------------l~~~~---~~l~~~~~~-~i~~~---------ia~~l~yLH~~-----~~~~ivH~dik~~NI 513 (745)
||... ..++...++ ....+ +...+..+... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 112221111 11111 11112222111 124689999999999
Q ss_pred eecCCCCeEEccCCCccc
Q 004565 514 LLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 514 ll~~~~~~kl~Dfgl~~~ 531 (745)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00044 Score=55.26 Aligned_cols=47 Identities=21% Similarity=0.487 Sum_probs=36.7
Q ss_pred cccccccccccccCCcChhhhHhhcccCCccceeeecCCCCceEEeecC
Q 004565 227 VDYFANDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYFIENH 275 (745)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~~C~~~~~~ 275 (745)
++++.++.... ...+.++|++.|+.+|+|.||.|....+.|+++...
T Consensus 12 ~~~~g~d~~~~--~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~ 58 (73)
T cd01100 12 VDFRGGDLSTV--FASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE 58 (73)
T ss_pred CccccCCccee--ecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence 55555554322 255889999999999999999998878899998653
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0033 Score=65.79 Aligned_cols=140 Identities=16% Similarity=0.131 Sum_probs=85.0
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCc--eeeEEEE------EEeCCeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVN--LVRLKGF------CAQGRQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e~ 459 (745)
..|..|....+|+....++ .+++|+... ........|++++..+++.+ +.+++.. ....+..++|++|
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred ecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 3477777789999887655 577787754 23455667777777775433 4444432 1234456899999
Q ss_pred cCCCChhh----hh----------cCC----C------cccCHHHHH----------HHHHHHHHHHHHhhh----CCCC
Q 004565 460 MNKGSLDR----TL----------FGN----G------SVLEWRERF----------EIALGTARGLAYLHT----GCDH 501 (745)
Q Consensus 460 ~~~gsL~~----~l----------~~~----~------~~l~~~~~~----------~i~~~ia~~l~yLH~----~~~~ 501 (745)
+++..+.. .. +.. . ....|.... .....+..++.++.+ ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876532 00 100 0 012222211 011223344455443 2235
Q ss_pred ceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 502 KIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 502 ~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
.++|+|+.|.||+++++..+.|.||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 799999999999999987778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0092 Score=64.22 Aligned_cols=75 Identities=15% Similarity=0.135 Sum_probs=52.3
Q ss_pred CCccccCceeEEEEEECCC-cEEEEEEeccC----C---cchHHHHHHHHHHHccCC---CCceeeEEEEEEeCCeeEEE
Q 004565 388 TPIGSGGFGTVYKGILQDK-SVVAVKKINSF----G---IQGKKEFCTEITIIGNIH---HVNLVRLKGFCAQGRQRFLV 456 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~-~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~lV 456 (745)
+.||.|.+..||++...+| +.|+||.-... . .-..+.+..|.+.|..+. ..++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4589999999999999887 47999974311 0 123456677887777752 2346666666 44567899
Q ss_pred EeecCCCC
Q 004565 457 YEYMNKGS 464 (745)
Q Consensus 457 ~e~~~~gs 464 (745)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.002 Score=75.49 Aligned_cols=196 Identities=22% Similarity=0.197 Sum_probs=132.8
Q ss_pred HHHHHHHccCCCCceeeEEEEEEeCCee----EEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCC
Q 004565 426 CTEITIIGNIHHVNLVRLKGFCAQGRQR----FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501 (745)
Q Consensus 426 ~~e~~~l~~l~h~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~ 501 (745)
..|++.+.++.|+|++.++++-.+.... .+..+++..-++...+...+ .++....+.+..++.+||+|+|+ .
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~---~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHS---L 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHH---h
Confidence 3467788889999999999987654433 24457777777777776554 57888888999999999999998 4
Q ss_pred ceeecCCCCC---CeeecCCCCeEEc--cCCCcccCCCCCcccccccccccCccCcccccCCCCCC--ccceeehHHHHH
Q 004565 502 KIIHCDVKPE---NILLHDKLQVKIS--DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD--KTDVYSYGMVLL 574 (745)
Q Consensus 502 ~ivH~dik~~---NIll~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--k~Dv~S~Gvll~ 574 (745)
.+.|.-+..+ +.-.+..+...++ ||+..+.+...... ....-+..+.|||......+.. ..|+|.+|.++.
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 4445444444 4555666667777 88888766543322 2223455677888777665544 479999999999
Q ss_pred HHHhCCCCCCccccccccccCCCCCCCCCCCCCCCcccccccHHHHHHHHHhhccccccccccccCCCCHHHHHHHHHHH
Q 004565 575 EIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIA 654 (745)
Q Consensus 575 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 654 (745)
.+..|..+-.... ....+++.. ... .+....
T Consensus 384 ~~~~~~~i~~~~~-----------------------------------------~~~~~l~~~----~~~----~~~d~~ 414 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA-----------------------------------------VPVSLLDVL----STS----ELLDAL 414 (1351)
T ss_pred hhhhcCccccccc-----------------------------------------chhhhhccc----cch----hhhhhh
Confidence 9998875432111 000011110 000 355666
Q ss_pred HHccCCCCCCCCCHHHHHHHhc
Q 004565 655 LCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 655 ~~cl~~~p~~RPt~~ev~~~L~ 676 (745)
..|+..++++|+++.+++...-
T Consensus 415 ~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 415 PKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhcchhhhhccchhhhhhchh
Confidence 7899999999999999987653
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.026 Score=59.72 Aligned_cols=140 Identities=14% Similarity=0.142 Sum_probs=76.9
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCc--eeeEEE------EEEeCCeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVN--LVRLKG------FCAQGRQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g------~~~~~~~~~lV~e~ 459 (745)
+.|+.|....+|+....++ .+++|+..... .+....|+.++..+...+ +.+++. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 3466777789999987766 47788775222 233334555555443222 333332 12234567899999
Q ss_pred cCCCChhh-----------hh---cCCC----------cccCH-HHHHH------------HH-HHHHHHHHHhhhC---
Q 004565 460 MNKGSLDR-----------TL---FGNG----------SVLEW-RERFE------------IA-LGTARGLAYLHTG--- 498 (745)
Q Consensus 460 ~~~gsL~~-----------~l---~~~~----------~~l~~-~~~~~------------i~-~~ia~~l~yLH~~--- 498 (745)
+++..+.. .| +... ..+.| ...+. .. ..+...+..+.+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 98875421 11 1000 01112 11111 11 1111122333211
Q ss_pred -CCCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 499 -CDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 499 -~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
...+++|+|+++.||+++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 346899999999999999776668999998853
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.006 Score=64.02 Aligned_cols=137 Identities=21% Similarity=0.239 Sum_probs=80.4
Q ss_pred ccccCceeEEEEEECC-------CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCcee-eEEEEEEeCCeeEEEEeecC
Q 004565 390 IGSGGFGTVYKGILQD-------KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLV-RLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~ 461 (745)
|..|-...+|+....+ +..+++|+..... ........|.+++..+...++. ++++++.. .+|+||++
T Consensus 6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 4455567899988765 4678888865432 2233456787777777543343 45555432 35899998
Q ss_pred CCChhhh-h----------------cCCCcc----------cCHHHHHH--------------------------HHHHH
Q 004565 462 KGSLDRT-L----------------FGNGSV----------LEWRERFE--------------------------IALGT 488 (745)
Q Consensus 462 ~gsL~~~-l----------------~~~~~~----------l~~~~~~~--------------------------i~~~i 488 (745)
+..+... + |..... .-|..+.. +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8766431 1 110000 00111111 11122
Q ss_pred HHHHHHhhh------CCCCceeecCCCCCCeeecCC----CCeEEccCCCccc
Q 004565 489 ARGLAYLHT------GCDHKIIHCDVKPENILLHDK----LQVKISDFGLSKL 531 (745)
Q Consensus 489 a~~l~yLH~------~~~~~ivH~dik~~NIll~~~----~~~kl~Dfgl~~~ 531 (745)
...+..|.. .....++|+|+.+.||+++++ +.++++||..+..
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 222334432 134678999999999999985 7899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.011 Score=56.76 Aligned_cols=125 Identities=24% Similarity=0.314 Sum_probs=86.8
Q ss_pred hhhcCCCCccccCc-eeEEEEEECCCcEEEEEEeccCC---c------------------chHHHHHHHHHHHccCC---
Q 004565 382 ATDNFNTPIGSGGF-GTVYKGILQDKSVVAVKKINSFG---I------------------QGKKEFCTEITIIGNIH--- 436 (745)
Q Consensus 382 at~~f~~~lG~G~f-g~Vy~g~~~~~~~vavK~~~~~~---~------------------~~~~~~~~e~~~l~~l~--- 436 (745)
+.-.|-..||.|.- |.|||+++.+ ..+|+|.+.... . .....|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g-~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDG-RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECC-eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 34445578999999 9999999964 589999943210 0 11235778888877774
Q ss_pred CCce--eeEEEEEEeC------------------CeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhh
Q 004565 437 HVNL--VRLKGFCAQG------------------RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLH 496 (745)
Q Consensus 437 h~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH 496 (745)
+.++ |+.+||..-. ..+.+|.||++... ....+-+.+|.+-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIRDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchhHHHHHHHHHHHHH
Confidence 5566 8999987321 12357888776532 112234556777788899
Q ss_pred hCCCCceeecCCCCCCeeecCCCCeEEccCCCc
Q 004565 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLS 529 (745)
Q Consensus 497 ~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~ 529 (745)
. .+|+-+|+++.|.. .-||+|||.+
T Consensus 182 k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 K---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H---CCeeeccCcccccc-----CCEEEecccC
Confidence 8 99999999999976 4589999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0012 Score=66.76 Aligned_cols=136 Identities=14% Similarity=0.175 Sum_probs=88.2
Q ss_pred hcCCCCccccCceeEEEEEECCCcEEEEEEecc--CC--------------cc------hHHHHHHHHHHHccCCC--Cc
Q 004565 384 DNFNTPIGSGGFGTVYKGILQDKSVVAVKKINS--FG--------------IQ------GKKEFCTEITIIGNIHH--VN 439 (745)
Q Consensus 384 ~~f~~~lG~G~fg~Vy~g~~~~~~~vavK~~~~--~~--------------~~------~~~~~~~e~~~l~~l~h--~n 439 (745)
..+.++||-|.-+.||.+...+|.+.++|.-+. .+ .. ..-....|...|+.+.- --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 345588999999999999999999988874221 00 00 01123456677777642 23
Q ss_pred eeeEEEEEEeCCeeEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCC
Q 004565 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519 (745)
Q Consensus 440 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~ 519 (745)
+.+.++++ ..++|||++.+-.|...-+-...+--...++.++..+| . +++||+|..-=||+++++.
T Consensus 174 VPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la-------~---~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPIDHN----RHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLA-------N---HGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCccccc----ceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHH-------H---cCceecccchheeEEecCC
Confidence 44555543 34899999988777654422221111223333333333 3 9999999999999999999
Q ss_pred CeEEccCCCcccCC
Q 004565 520 QVKISDFGLSKLLT 533 (745)
Q Consensus 520 ~~kl~Dfgl~~~~~ 533 (745)
.++++||--.....
T Consensus 240 ~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 240 KIVVIDFPQMVSTS 253 (465)
T ss_pred CEEEeechHhhccC
Confidence 99999997655443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.086 Score=55.39 Aligned_cols=140 Identities=15% Similarity=0.169 Sum_probs=81.5
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCc--eeeEEEEE------EeCCeeEEEEee
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVN--LVRLKGFC------AQGRQRFLVYEY 459 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~e~ 459 (745)
+.++.|....+|+....++. +++|+..... .......|++++..|.... +.+++... ...+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~-~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGR-YILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCCc-EEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 44677777899998876664 6677764321 2334556667776664322 34444321 223557899999
Q ss_pred cCCCChhhh--------------hcCCCc-----------ccCHHHHHH------------HHHHHHHHHHHhhh----C
Q 004565 460 MNKGSLDRT--------------LFGNGS-----------VLEWRERFE------------IALGTARGLAYLHT----G 498 (745)
Q Consensus 460 ~~~gsL~~~--------------l~~~~~-----------~l~~~~~~~------------i~~~ia~~l~yLH~----~ 498 (745)
+++..+... ++.... .-.|..... ....+.+.++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 988654211 111000 112221110 11223344555542 2
Q ss_pred CCCceeecCCCCCCeeecCCCCeEEccCCCcc
Q 004565 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSK 530 (745)
Q Consensus 499 ~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~ 530 (745)
...+++|+|+++.||+++++....|.||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 35789999999999999998777899998875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.041 Score=58.71 Aligned_cols=137 Identities=16% Similarity=0.144 Sum_probs=79.0
Q ss_pred ccccCceeEEEEEECC-----CcEEEEEEeccCCcchHHHHHHHHHHHccCCCCcee-eEEEEEEeCCeeEEEEeecCCC
Q 004565 390 IGSGGFGTVYKGILQD-----KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLV-RLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~g 463 (745)
|-.|-.-.+|+..+.+ +..+++|......... -.-..|..++..+...++. ++++++..+ .|+||+++.
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 4346667888887643 3578888775443222 2235688888888655554 555655332 589999876
Q ss_pred Chhhh-----------------hcCCC---c--ccCHHHHHHHHHH-----------------HHHHHHHhh----h-CC
Q 004565 464 SLDRT-----------------LFGNG---S--VLEWRERFEIALG-----------------TARGLAYLH----T-GC 499 (745)
Q Consensus 464 sL~~~-----------------l~~~~---~--~l~~~~~~~i~~~-----------------ia~~l~yLH----~-~~ 499 (745)
+|... +|... . ...|..+.++..+ +...+..|. . ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 66421 11111 0 1123333233211 111222222 1 12
Q ss_pred CCceeecCCCCCCeeecC-CCCeEEccCCCccc
Q 004565 500 DHKIIHCDVKPENILLHD-KLQVKISDFGLSKL 531 (745)
Q Consensus 500 ~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~ 531 (745)
...++|+|+++.||++++ +..+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 357899999999999986 46799999988864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.096 Score=53.97 Aligned_cols=32 Identities=22% Similarity=0.456 Sum_probs=26.1
Q ss_pred CceeecCCCCCCeeecCCCC-eEEccCCCcccC
Q 004565 501 HKIIHCDVKPENILLHDKLQ-VKISDFGLSKLL 532 (745)
Q Consensus 501 ~~ivH~dik~~NIll~~~~~-~kl~Dfgl~~~~ 532 (745)
..++|+|+++.||++++++. .-|.||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997554 569999988643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.039 Score=48.40 Aligned_cols=57 Identities=32% Similarity=0.503 Sum_probs=0.0
Q ss_pred CCccceeEEeccccEEEEeCCCCceeeccCCCCcccccCCccCCCCeeeeccccCCCCcccEEEEEEcCCcceec---cc
Q 004565 3 DSRVSSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYSFVVTDGDGVLQW---NQ 79 (745)
Q Consensus 3 ~~~~~~~~lld~GNlvl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~~~~~~~---~~ 79 (745)
......+.|.++|||||++.++..+|+| ... ...|.|.+.+ ..+|.+.. .+
T Consensus 52 ~~~~~~l~l~~dGnLvl~~~~g~~vW~S------------------------~t~-~~~~~~~~~L-~ddGnlvl~~~~~ 105 (114)
T smart00108 52 VSDSCTLTLQSDGNLVLYDGDGRVVWSS------------------------NTT-GANGNYVLVL-LDDGNLVIYDSDG 105 (114)
T ss_pred CCCCEEEEEeCCCCEEEEeCCCCEEEEe------------------------ccc-CCCCceEEEE-eCCCCEEEECCCC
Q ss_pred cceeec
Q 004565 80 MTYWKL 85 (745)
Q Consensus 80 ~~yw~~ 85 (745)
.+.|.+
T Consensus 106 ~~~W~S 111 (114)
T smart00108 106 NFLWQS 111 (114)
T ss_pred CEEeCC
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.26 Score=51.88 Aligned_cols=137 Identities=21% Similarity=0.299 Sum_probs=82.2
Q ss_pred ccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccCCCCc------eeeEEE----EEEeCCeeEEEEee
Q 004565 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVN------LVRLKG----FCAQGRQRFLVYEY 459 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~g----~~~~~~~~~lV~e~ 459 (745)
|.+ .-..+|+....+|.. ++|..... ....+...|+..+..+.-.. +..+=| ....+...+.|++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789999888887 77776653 44566677777777763222 111112 11222377899999
Q ss_pred cCCCChhh-hh--------------c----C----CC---cccCHHH-------------HHHHHHHHHHHHHHhhh---
Q 004565 460 MNKGSLDR-TL--------------F----G----NG---SVLEWRE-------------RFEIALGTARGLAYLHT--- 497 (745)
Q Consensus 460 ~~~gsL~~-~l--------------~----~----~~---~~l~~~~-------------~~~i~~~ia~~l~yLH~--- 497 (745)
+++..+.. -. + . .. ....|.. ......++...+..+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988773 11 0 0 00 1234431 01122333444444443
Q ss_pred -CCCCc---eeecCCCCCCeeecCCCC-eEEccCCCcc
Q 004565 498 -GCDHK---IIHCDVKPENILLHDKLQ-VKISDFGLSK 530 (745)
Q Consensus 498 -~~~~~---ivH~dik~~NIll~~~~~-~kl~Dfgl~~ 530 (745)
..... +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22333 999999999999999885 8999999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.18 Score=52.97 Aligned_cols=32 Identities=9% Similarity=0.183 Sum_probs=28.8
Q ss_pred CCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 500 ~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
..+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 46799999999999999999999999988864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.28 Score=51.88 Aligned_cols=74 Identities=15% Similarity=0.010 Sum_probs=45.4
Q ss_pred CccccCceeEEEEEECCC-cEEEEEEecc-------CCcchHHHHHHHHHHHccCC--CCceeeEEEEEEeCCeeEEEEe
Q 004565 389 PIGSGGFGTVYKGILQDK-SVVAVKKINS-------FGIQGKKEFCTEITIIGNIH--HVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 389 ~lG~G~fg~Vy~g~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~~lV~e 458 (745)
.||-|....||++..+++ ..|+||.-.. .-+-.......|.+.|.... -|..|+-+- +.+.....+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence 489999999999998765 5788886431 11222344456666665542 343333322 234455679999
Q ss_pred ecCCC
Q 004565 459 YMNKG 463 (745)
Q Consensus 459 ~~~~g 463 (745)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 98654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.12 Score=49.81 Aligned_cols=154 Identities=16% Similarity=0.203 Sum_probs=97.2
Q ss_pred cCceeEEEEEECCCcEEEEEEeccCCcc-hHHHHHHHHHHHccCCCCceeeEEEEEEeCCeeEEEEeecCCCChhhhhcC
Q 004565 393 GGFGTVYKGILQDKSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFG 471 (745)
Q Consensus 393 G~fg~Vy~g~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 471 (745)
++-.+.-+|+-+-|. ..+|++...... ...-|..+.+++++++ .|+++..= +....-++.|++.....
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 344555555544443 556777655555 5677888999999885 56666622 33345688888743211
Q ss_pred CCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccccCccC
Q 004565 472 NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551 (745)
Q Consensus 472 ~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~a 551 (745)
.. ..++..=+.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+.... .+..|.-
T Consensus 142 ----~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~vN 199 (308)
T PF07387_consen 142 ----NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMVN 199 (308)
T ss_pred ----ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEEe
Confidence 00 11222224677888852 47899999999999999999999998553321 1122222
Q ss_pred cccccCCCCCCccceeehHHHHHHHHhCCCC
Q 004565 552 PEWLTSSAISDKTDVYSYGMVLLEIISGRKN 582 (745)
Q Consensus 552 PE~~~~~~~t~k~Dv~S~Gvll~elltg~~p 582 (745)
-| ....|.++.+-+|=.-++++....+.
T Consensus 200 ~~---Y~~lT~~aE~~~fv~s~l~~v~~~~~ 227 (308)
T PF07387_consen 200 IE---YESLTQEAEVKVFVKSCLKLVEKQRS 227 (308)
T ss_pred ee---ccccChHHHHHHHHHHHHHHHHHHhc
Confidence 11 13457788888888888888876543
|
The function of this family is unknown. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.34 Score=50.50 Aligned_cols=128 Identities=18% Similarity=0.322 Sum_probs=74.8
Q ss_pred CcEEEEEEec--cCCcchHHHHHHHHHHHccCC--CCceeeEEEEEEeCC--eeEEEEeecCCCChhhhhcCCC------
Q 004565 406 KSVVAVKKIN--SFGIQGKKEFCTEITIIGNIH--HVNLVRLKGFCAQGR--QRFLVYEYMNKGSLDRTLFGNG------ 473 (745)
Q Consensus 406 ~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~------ 473 (745)
++..+++ .. ............|+++|+.+. ---....++.|.++. ..+.||+|.++..+...+....
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 5666666 22 122233445567788877774 234456677787766 6799999998743322221100
Q ss_pred -------------------------------cccCHHHHHHHH--------HHHHHHHHHhhhCC-----CCceeecCCC
Q 004565 474 -------------------------------SVLEWRERFEIA--------LGTARGLAYLHTGC-----DHKIIHCDVK 509 (745)
Q Consensus 474 -------------------------------~~l~~~~~~~i~--------~~ia~~l~yLH~~~-----~~~ivH~dik 509 (745)
+.-.|...++.+ -....-..+|++.. ...++|+|++
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 011122222110 11122344554321 2458999999
Q ss_pred CCCeeecCCCCeEEccCCCcccCCC
Q 004565 510 PENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 510 ~~NIll~~~~~~kl~Dfgl~~~~~~ 534 (745)
+.||+++.+.-+=|.||+++..-.+
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccCCc
Confidence 9999999998899999999875443
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.091 Score=55.34 Aligned_cols=62 Identities=19% Similarity=0.113 Sum_probs=45.5
Q ss_pred eEEEEeecCCCChhhhhcCCCcccCHHHHHHHHHHHHHHHHHhhhCCCCceeecCCCCCCeeecCC
Q 004565 453 RFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK 518 (745)
Q Consensus 453 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~dik~~NIll~~~ 518 (745)
.+|+-+|+++.++..++.... .++..+.+++.-.+.|+.-+-- -.+.+|.|++|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEec
Confidence 467778889999988886654 3445666777766777665543 2679999999999999644
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.0034 Score=75.30 Aligned_cols=159 Identities=12% Similarity=0.047 Sum_probs=113.1
Q ss_pred HHHHHHHHccCCCCceeeEEEEEE--eCCeeEEEEeecCCCChhhhhcCCCc---ccCHHHHHHHHHHHHHHHHHhhhCC
Q 004565 425 FCTEITIIGNIHHVNLVRLKGFCA--QGRQRFLVYEYMNKGSLDRTLFGNGS---VLEWRERFEIALGTARGLAYLHTGC 499 (745)
Q Consensus 425 ~~~e~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~---~l~~~~~~~i~~~ia~~l~yLH~~~ 499 (745)
...|...++...|+++.....-.. +..+.+.+++|+..|.+.+.|.+... .++.........+...+..-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555666678888776655443 23456788999999999998875433 3333333333333345555555422
Q ss_pred --CCceeecCCCCCCeeecCCCCeEEccCCCcccCCCCCcccccccccccCccCcccccCCCCCCccceeehHHHHHHHH
Q 004565 500 --DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEII 577 (745)
Q Consensus 500 --~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~Dv~S~Gvll~ell 577 (745)
..-.+|+++|+-|.+|+.+.++|++++|+.+...+ .........+++-|++|+....-.++.++|+|..|..+|++-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 24478999999999999999999999999983332 223334556788899999888888899999999999999998
Q ss_pred hCCCCCC
Q 004565 578 SGRKNSS 584 (745)
Q Consensus 578 tg~~p~~ 584 (745)
-|..+|.
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 8877664
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.23 Score=52.27 Aligned_cols=30 Identities=33% Similarity=0.380 Sum_probs=26.1
Q ss_pred CCceeecCCCCCCeeecCCCCeEEccCCCcc
Q 004565 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSK 530 (745)
Q Consensus 500 ~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~ 530 (745)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 367899999999999998 578899998765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.24 Score=52.59 Aligned_cols=137 Identities=15% Similarity=0.210 Sum_probs=76.9
Q ss_pred ccccCceeEEEEEECCC----cEEEEEEeccCCcchHHHHHHHHHHHccCCCCcee-eEEEEEEeCCeeEEEEeecCCCC
Q 004565 390 IGSGGFGTVYKGILQDK----SVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLV-RLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 390 lG~G~fg~Vy~g~~~~~----~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gs 464 (745)
|..|-...+|+....+. ..+++|........ .-.-.+|..+++.+...++. ++++++.. . +|.+|+++..
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~~ 96 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINART 96 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCCC
Confidence 44455677888876542 36888877543322 22235688888888665554 55555532 2 5899997766
Q ss_pred hhhh-----------------hcCCC----c-ccCHHHHHHHHHHH----------------------HHHHHHhhh---
Q 004565 465 LDRT-----------------LFGNG----S-VLEWRERFEIALGT----------------------ARGLAYLHT--- 497 (745)
Q Consensus 465 L~~~-----------------l~~~~----~-~l~~~~~~~i~~~i----------------------a~~l~yLH~--- 497 (745)
|... +|... . .--|..+.++..++ ..-+..+..
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 5311 11111 0 11233332222221 111111111
Q ss_pred --CCCCceeecCCCCCCeeecC-CCCeEEccCCCccc
Q 004565 498 --GCDHKIIHCDVKPENILLHD-KLQVKISDFGLSKL 531 (745)
Q Consensus 498 --~~~~~ivH~dik~~NIll~~-~~~~kl~Dfgl~~~ 531 (745)
.....++|.|+.+.|||+++ ++.++++||..+..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11235799999999999975 57899999998854
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.059 Score=58.30 Aligned_cols=50 Identities=18% Similarity=0.217 Sum_probs=38.9
Q ss_pred HHHHHHHHHHHccCCCCceeeEEEEEEeCCe-eEEEEeecCCCChhhhhcCC
Q 004565 422 KKEFCTEITIIGNIHHVNLVRLKGFCAQGRQ-RFLVYEYMNKGSLDRTLFGN 472 (745)
Q Consensus 422 ~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-~~lV~e~~~~gsL~~~l~~~ 472 (745)
..++......++.+.|+|+...+.+...... ..+|+|++ +.||++.+...
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 4556677888999999999999998876554 56888887 56888887544
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.26 Score=50.93 Aligned_cols=72 Identities=18% Similarity=0.334 Sum_probs=47.0
Q ss_pred CCccccCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccC---CCCceeeEEEEEEeCCeeEEEEeecCCC
Q 004565 388 TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI---HHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 388 ~~lG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~~~~~lV~e~~~~g 463 (745)
+.|+.|....+|+.. .++..+.||.-. ......|..|.+-|+.| .--.+.+++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 458888889999988 667789999876 23345678888777776 3556788899888888889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.96 E-value=1 Score=47.68 Aligned_cols=136 Identities=15% Similarity=0.087 Sum_probs=0.0
Q ss_pred cCceeEEEEEECCCcEEEEEEeccCCcchHHHHHHHHHHHccC--CCCceeeEEE-----EEEeCCeeEEEEeecCCCCh
Q 004565 393 GGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI--HHVNLVRLKG-----FCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 393 G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~g-----~~~~~~~~~lV~e~~~~gsL 465 (745)
+.-..||+....++..+++|.. ........+...|++.+..+ +.-.++..+. ....++..+.|++++++..+
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~-r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFY-RPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEc-CcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Q ss_pred hh--------------hhcC--------CCcccCHHHHH----------------------HHHHHHHHHHHHhhhC--C
Q 004565 466 DR--------------TLFG--------NGSVLEWRERF----------------------EIALGTARGLAYLHTG--C 499 (745)
Q Consensus 466 ~~--------------~l~~--------~~~~l~~~~~~----------------------~i~~~ia~~l~yLH~~--~ 499 (745)
.. .++. .+..+++.... .++.++...++-.-.. .
T Consensus 115 ~~~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 194 (325)
T PRK11768 115 ELDNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIPSDLRPAYLAAADQLLAAVEACWARGDV 194 (325)
T ss_pred CCCCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHHHhcCCC
Q ss_pred CCceeecCCCCCCeeecCCCCeEEccCCCccc
Q 004565 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 500 ~~~ivH~dik~~NIll~~~~~~kl~Dfgl~~~ 531 (745)
..+++|+|+.+.|||+++ .+.|.||+-+..
T Consensus 195 ~~~liHgD~h~~NvL~~d--~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWRD--GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhccccC--CcEEEeCCCCCC
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 745 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 408 bits (1052), Expect = e-138
Identities = 128/315 (40%), Positives = 184/315 (58%), Gaps = 27/315 (8%)
Query: 369 GLPRRFSYEELAAATDNFNTP--IGSGGFGTVYKGILQDKSVVAVKKINSFGIQG-KKEF 425
G +RFS EL A+DNF+ +G GGFG VYKG L D ++VAVK++ QG + +F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 426 CTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFG---NGSVLEWRERF 482
TE+ +I H NL+RL+GFC +R LVY YM GS+ L + L+W +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 483 EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542
IALG+ARGLAYLH CD KIIH DVK NILL ++ + + DFGL+KL+ + + + T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNG 602
+RGT G++APE+L++ S+KTDV+ YG++LLE+I+G++
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR--------------------- 233
Query: 603 PSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEP 662
+ V L ++++ L D ++G DE+VE+L+++AL C Q P
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293
Query: 663 MLRPSMANVVSMLEG 677
M RP M+ VV MLEG
Sbjct: 294 MERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-120
Identities = 114/342 (33%), Positives = 169/342 (49%), Gaps = 36/342 (10%)
Query: 353 GSRNSSSEELELTSIAGLPRRFSYEELAAATDNFN--TPIGSGGFGTVYKGILQDKSVVA 410
+ + + + R +L AT+NF+ IG G FG VYKG+L+D + VA
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 411 VKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLF 470
+K+ QG +EF TEI + H +LV L GFC + + L+Y+YM G+L R L+
Sbjct: 68 LKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
Query: 471 GNGS---VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFG 527
G+ + W +R EI +G ARGL YLHT IIH DVK NILL + KI+DFG
Sbjct: 128 GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184
Query: 528 LSKLLTPEQSSLFTTM-RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLK 586
+SK T + +T+ +GT GY+ PE+ +++K+DVYS+G+VL E++ R
Sbjct: 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS----- 239
Query: 587 IQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL--ALELHEQRRYLELADSRIEGQVSD 644
S PRE L A+E H + ++ D + ++
Sbjct: 240 ----------------AIVQSLPREMVN----LAEWAVESHNNGQLEQIVDPNLADKIRP 279
Query: 645 EDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEPRI 686
E + K A+ C+ RPSM +V+ LE + L E I
Sbjct: 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-111
Identities = 105/336 (31%), Positives = 150/336 (44%), Gaps = 51/336 (15%)
Query: 360 EELELTSIAGLPRRFSYEELAAATDNFNTP--------IGSGGFGTVYKGILQDKSVVAV 411
E L FS+ EL T+NF+ +G GGFG VYKG + + VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAV 59
Query: 412 KKINSF----GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDR 467
KK+ + + K++F EI ++ H NLV L GF + G LVY YM GSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 468 TLFG--NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525
L L W R +IA G A G+ +LH IH D+K NILL + KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 526 FGLSKLLTPEQSSLFTTM-RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSS 584
FGL++ ++ T+ GT Y+APE L I+ K+D+YS+G+VLLEII+G
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV- 234
Query: 585 LKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL--ALELH-EQRRYLELADSRIEGQ 641
D + LL E+ E++ + D ++
Sbjct: 235 --------------DEHREPQL------------LLDIKEEIEDEEKTIEDYIDKKM-ND 267
Query: 642 VSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677
VE + +A C+ E+ RP + V +L+
Sbjct: 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 3e-71
Identities = 76/327 (23%), Positives = 117/327 (35%), Gaps = 50/327 (15%)
Query: 374 FSYEELAAATDNFN--TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITI 431
E L + G FG V+K L ++ V AVK Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSW-QNEYEVYS 71
Query: 432 IGNIHHVNLVRLKGFCAQGR----QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALG 487
+ + H N+++ G +G +L+ + KGSL L N V+ W E IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129
Query: 488 TARGLAYLHT-------GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540
ARGLAYLH G I H D+K +N+LL + L I+DFGL+ +S+
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 541 TTMR-GTRGYLAPEWL-----TSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEK 594
T + GTR Y+APE L + D+Y+ G+VL E+ S
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA------------ 237
Query: 595 DSSGDGNGPSSSSSPRESQRVYFPLLALEL-HEQRRYL---ELADSRIEGQV-SDEDVEK 649
+ E + + E + + + + +
Sbjct: 238 ----------ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287
Query: 650 LVRIALCCVQEEPMLRPSMANVVSMLE 676
L C + R S V +
Sbjct: 288 LCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-60
Identities = 79/342 (23%), Positives = 124/342 (36%), Gaps = 69/342 (20%)
Query: 374 FSYEELAAATDNFN--TPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTE--I 429
+ E + DN IG G +G VYKG L ++ V AVK F ++ F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKV---FSFANRQNFINEKNI 58
Query: 430 TIIGNIHHVNLVRLKGFCAQG-----RQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEI 484
+ + H N+ R + + LV EY GSL + L + +W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116
Query: 485 ALGTARGLAYLHT------GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP---- 534
A RGLAYLHT I H D+ N+L+ + ISDFGLS LT
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 535 ---EQSSLFTTMRGTRGYLAPEWLTSS-------AISDKTDVYSYGMVLLEIISGRKNSS 584
E+ + + GT Y+APE L + + + D+Y+ G++ EI +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL- 235
Query: 585 LKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL----------ALELHEQRRYLELA 634
S E Q + + L E++R +
Sbjct: 236 -------------------FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR-PKFP 275
Query: 635 DSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
++ E ++ V L C ++ R + +
Sbjct: 276 EAWKENSLA---VRSLKETIEDCWDQDAEARLTAQXAEERMA 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-60
Identities = 90/351 (25%), Positives = 144/351 (41%), Gaps = 54/351 (15%)
Query: 376 YEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI 435
Y+E+ +G G FG V K + K V A+K+I S +K F E+ + +
Sbjct: 7 YKEI-----EVEEVVGRGAFGVVCKAKWRAKDV-AIKQIES--ESERKAFIVELRQLSRV 58
Query: 436 HHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSV--LEWRERFEIALGTARGLA 493
+H N+V+L G C LV EY GSL L G + L ++G+A
Sbjct: 59 NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 494 YLHTGCDHKIIHCDVKPENILLHDKLQV-KISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
YLH+ +IH D+KP N+LL V KI DFG + + + T +G+ ++AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAP 172
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612
E S S+K DV+S+G++L E+I+ RK P
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRK---------------------PFDEIGGPAF 211
Query: 613 QRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVV 672
+ + +H R L + + +E L+ C ++P RPSM +V
Sbjct: 212 R------IMWAVHNGTR-PPLIKN------LPKPIESLMT---RCWSKDPSQRPSMEEIV 255
Query: 673 SMLEGGMPLGEPRIESLRFLRFYGQRFNEASTIEESNELNLQFILQSETNG 723
++ M E L++ + E +E + + L S +G
Sbjct: 256 KIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDHG 306
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-59
Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 376 YEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGK--KEFCTEITIIG 433
+ +L N IG+G FGTV++ VAVK + + EF E+ I+
Sbjct: 36 WCDL-----NIKEKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 434 NIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGS--VLEWRERFEIALGTARG 491
+ H N+V G Q +V EY+++GSL R L +G+ L+ R R +A A+G
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551
+ YLH + I+H ++K N+L+ K VK+ DFGLS+L S + GT ++A
Sbjct: 150 MNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMA 207
Query: 552 PEWLTSSAISDKTDVYSYGMVLLEIISGR 580
PE L ++K+DVYS+G++L E+ + +
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-57
Identities = 73/316 (23%), Positives = 130/316 (41%), Gaps = 63/316 (19%)
Query: 376 YEELAAATDNFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGK-------KEFCT 427
E+ + IG GGFG V+KG L DKSVVA+K + +G+ +EF
Sbjct: 18 DNEI-----EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 428 EITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALG 487
E+ I+ N++H N+V+L G +V E++ G L L ++W + + L
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 488 TARGLAYLHTGCDHKIIHCDVKPENILL-----HDKLQVKISDFGLSKLLTPEQSSLFTT 542
A G+ Y+ + I+H D++ NI L + + K++DFGLS+ + +
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSG 185
Query: 543 MRGTRGYLAPEWLT--SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDG 600
+ G ++APE + + ++K D YS+ M+L I++G
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG------------------- 226
Query: 601 NGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQE 660
P S + + + + E R + + + ++ C
Sbjct: 227 --PFDEYSYGKIK-----FINMIREEGLR-PTIPED------CPPRLRNVIE---LCWSG 269
Query: 661 EPMLRPSMANVVSMLE 676
+P RP + +V L
Sbjct: 270 DPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-56
Identities = 81/293 (27%), Positives = 135/293 (46%), Gaps = 46/293 (15%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNLVRLKGFC 447
IGSG FGTVYKG VAVK +N + + F E+ ++ HVN++ G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
Q +V ++ SL L + + E ++ +IA TARG+ YLH IIH D
Sbjct: 90 TAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRD 145
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTP-EQSSLFTTMRGTRGYLAPEWL---TSSAISDK 563
+K NI LH+ VKI DFGL+ + S F + G+ ++APE + S+ S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 564 TDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623
+DVY++G+VL E+++G+ P S+ + R ++ +
Sbjct: 206 SDVYAFGIVLYELMTGQL---------------------PYSNINNR--DQIIEMV---- 238
Query: 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
R L S++ + R+ C++++ RPS +++ +E
Sbjct: 239 ---GRGSLSPDLSKVRSNCPKR----MKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-55
Identities = 66/301 (21%), Positives = 116/301 (38%), Gaps = 54/301 (17%)
Query: 390 IGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G FG K + V+ +K++ F + ++ F E+ ++ + H N+++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+ ++ + EY+ G+L + S W +R A A G+AYLH IIH D+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLF-------------TTMRGTRGYLAPEWL 555
N L+ + V ++DFGL++L+ E++ T+ G ++APE +
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 556 TSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615
+ +K DV+S+G+VL EII PR
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVN---------------------ADPDYLPR--TMD 231
Query: 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675
+ L + + + CC +P RPS + L
Sbjct: 232 F----GLNVRGFLD-RYCPPN------CPPSFFPI--TVRCC-DLDPEKRPSFVKLEHWL 277
Query: 676 E 676
E
Sbjct: 278 E 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-55
Identities = 75/299 (25%), Positives = 120/299 (40%), Gaps = 56/299 (18%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQ----GKKEFCTEITIIGNIHHVNLVRLKG 445
IG GGFG VY+ V AVK + + E + + H N++ L+G
Sbjct: 15 IGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
C + LV E+ G L+R L +G + A+ ARG+ YLH IIH
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 506 CDVKPENILLHDKLQ--------VKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
D+K NIL+ K++ +KI+DFGL++ + + G ++APE + +
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAAGAYAWMAPEVIRA 188
Query: 558 SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617
S S +DV+SYG++L E+++G P
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEV---------------------PFRGIDGLA------ 221
Query: 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
+A + + L + + E KL+ C +P RPS N++ L
Sbjct: 222 --VAYGVAMNKLALPIPST------CPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-54
Identities = 58/250 (23%), Positives = 93/250 (37%), Gaps = 38/250 (15%)
Query: 358 SSEELELTSIAGLPRRFS------------YEELAAATDNFNTPIGSGGFGTVYKGILQD 405
L L S PR+ S +E+L IG G FG VY G
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQL-----EIGELIGKGRFGQVYHGRWHG 56
Query: 406 KSVVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463
+ VA++ I+ K F E+ H N+V G C ++
Sbjct: 57 E--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114
Query: 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKI 523
+L + VL+ + +IA +G+ YLH I+H D+K +N+ D +V I
Sbjct: 115 TLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFY-DNGKVVI 170
Query: 524 SDFGLSKLLT----PEQSSLFTTMRGTRGYLAPEWLTSSAI---------SDKTDVYSYG 570
+DFGL + + G +LAPE + + S +DV++ G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 571 MVLLEIISGR 580
+ E+ +
Sbjct: 231 TIWYELHARE 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 8e-54
Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 59/309 (19%)
Query: 376 YEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKIN--SFGIQGKKEFCTEITIIG 433
+++L NF T + G ++KG Q + VK + + + ++F E +
Sbjct: 9 FKQL-----NFLTKLNENHSGELWKGRWQGNDI-VVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 434 NIHHVNLVRLKGFCAQ--GRQRFLVYEYMNKGSLDRTLF-GNGSVLEWRERFEIALGTAR 490
H N++ + G C L+ +M GSL L G V++ + + AL AR
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 491 GLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL 550
G+A+LHT + I + ++++ + + +IS + ++
Sbjct: 123 GMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWV 175
Query: 551 APEWLT---SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSS 607
APE L D++S+ ++L E+++ P +
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREV---------------------PFADL 214
Query: 608 SPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS 667
S E + E R + V KL++I C+ E+P RP
Sbjct: 215 SNME-------IGMKVALEGLR-PTIPPG------ISPHVSKLMKI---CMNEDPAKRPK 257
Query: 668 MANVVSMLE 676
+V +LE
Sbjct: 258 FDMIVPILE 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-50
Identities = 74/344 (21%), Positives = 126/344 (36%), Gaps = 44/344 (12%)
Query: 353 GSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVK 412
G E +S +G + A IG G +G V+ G + + V AVK
Sbjct: 8 GESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKV-AVK 66
Query: 413 KINSFGIQGKKEFC--TEITIIGNIHHVNLVRLKGFCAQGR----QRFLVYEYMNKGSLD 466
+ + + TEI + H N++ +G Q +L+ +Y GSL
Sbjct: 67 VFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123
Query: 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHT---GCDHK--IIHCDVKPENILLHDKLQV 521
L + L+ + ++A + GL +LHT K I H D+K +NIL+
Sbjct: 124 DYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181
Query: 522 KISDFGLSKLLTPEQSSLFTTM---RGTRGYLAPEWLTSSAISD------KTDVYSYGMV 572
I+D GL+ + + + GT+ Y+ PE L S + D+YS+G++
Sbjct: 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241
Query: 573 LLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLE 632
L E+ R + P P S Y + + ++ R
Sbjct: 242 LWEVA-----------RRCVSGGIVEEYQLPYHDLVP--SDPSYEDMREIVCIKKLR-PS 287
Query: 633 LADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
+ SDE + ++ ++ C P R + V L
Sbjct: 288 FPNRWS----SDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-50
Identities = 72/307 (23%), Positives = 123/307 (40%), Gaps = 44/307 (14%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFC--TEITIIGNIHHVNLVRLKGFC 447
+G G +G V++G Q ++V AVK +S + +K + TE+ + H N++
Sbjct: 16 VGKGRYGEVWRGSWQGENV-AVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 448 AQGR----QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT-----G 498
R Q +L+ Y GSL L + L+ I L A GLA+LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM---RGTRGYLAPEWL 555
I H D+K +NIL+ Q I+D GL+ + + + L GT+ Y+APE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 556 TSSAISD------KTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSP 609
+ D + D++++G+VL E+ R D P P
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVA-----------RRMVSNGIVEDYKPPFYDVVP 238
Query: 610 RESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA 669
+ + + + +Q+R + + SD + L ++ C + P R +
Sbjct: 239 --NDPSFEDMRKVVCVDQQR-PNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTAL 291
Query: 670 NVVSMLE 676
+ L
Sbjct: 292 RIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 73/307 (23%), Positives = 117/307 (38%), Gaps = 44/307 (14%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTE--ITIIGNIHHVNLVRLKGFC 447
IG G FG V++G + + V AVK +S + ++ + E I + H N++
Sbjct: 50 IGKGRFGEVWRGKWRGEEV-AVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 448 AQGR----QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT---GCD 500
+ Q +LV +Y GSL L N + ++AL TA GLA+LH G
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 501 HK--IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM---RGTRGYLAPEWL 555
K I H D+K +NIL+ I+D GL+ ++ GT+ Y+APE L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 556 TSSAISD------KTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSP 609
S + D+Y+ G+V EI R + D P P
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIA-----------RRCSIGGIHEDYQLPYYDLVP 272
Query: 610 RESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA 669
S + + ++ R + + S E + + +I C R +
Sbjct: 273 --SDPSVEEMRKVVCEQKLR-PNIPNRWQ----SCEALRVMAKIMRECWYANGAARLTAL 325
Query: 670 NVVSMLE 676
+ L
Sbjct: 326 RIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 61/195 (31%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 390 IGSGGFGTVYKGILQDKSV-VAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
IG G FG V+ G L+ + VAVK + K +F E I+ H N+VRL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
Q + ++V E + G L G+ L + ++ A G+ YL IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY----LAPEWLTSSAISDK 563
+ N L+ +K +KISDFG+S+ ++ G R APE L S +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREE---ADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 564 TDVYSYGMVLLEIIS 578
+DV+S+G++L E S
Sbjct: 296 SDVWSFGILLWETFS 310
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+GSG FG V G + + VAVK I G + EF E + + H LV+ G C++
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 450 GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVK 509
++V EY++ G L L +G LE + E+ G+A+L H+ IH D+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 510 PENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTDV 566
N L+ L VK+SDFG+++ + + + GT+ + APE S K+DV
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 567 YSYGMVLLEIIS-GRK 581
+++G+++ E+ S G+
Sbjct: 189 WAFGILMWEVFSLGKM 204
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
IGSG FG V+ G +K VA+K I G +++F E ++ + H LV+L G C +
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 450 GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVK 509
LV E+M G L L + + L G+AYL + +IH D+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 131
Query: 510 PENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTDV 566
N L+ + +K+SDFG+++ + +T+ GT+ + +PE + S S K+DV
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 567 YSYGMVLLEIIS-GRK 581
+S+G+++ E+ S G+
Sbjct: 189 WSFGVLMWEVFSEGKI 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 58/192 (30%), Positives = 98/192 (51%), Gaps = 10/192 (5%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G+G FG V G + + VA+K I G + EF E ++ N+ H LV+L G C +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 450 GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVK 509
R F++ EYM G L L + ++ E+ + YL + +H D+
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 510 PENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTDV 566
N L++D+ VK+SDFGLS+ + +T+ G++ + PE L S S K+D+
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 567 YSYGMVLLEIIS 578
+++G+++ EI S
Sbjct: 205 WAFGVLMWEIYS 216
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 389 PIGSGGFGTVYKGIL-----QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG+V ++VAVK++ G +++F EI I+ +H +V+
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 444 KGFCAQGRQR--FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
+G ++ LV EY+ G L L + + L+ + +G+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SR 146
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLTSS 558
+ +H D+ NIL+ + VKI+DFGL+KLL P + + + APE L+ +
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 559 AISDKTDVYSYGMVLLEIIS 578
S ++DV+S+G+VL E+ +
Sbjct: 206 IFSRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 390 IGSGGFGTVYKGIL-----QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
+G G FG+V VVAVKK+ + ++F EI I+ ++ H N+V+ K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 445 GFCAQGRQR--FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
G C +R L+ EY+ GSL L + ++ + + +G+ YL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLTSSA 559
IH D+ NIL+ ++ +VKI DFGL+K+L P+ F + APE LT S
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 560 ISDKTDVYSYGMVLLEIIS 578
S +DV+S+G+VL E+ +
Sbjct: 194 FSVASDVWSFGVVLYELFT 212
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 64/284 (22%), Positives = 116/284 (40%), Gaps = 12/284 (4%)
Query: 390 IGSGGFGTVYKGIL-QDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
+G+G G V+K V+A K I+ + + E+ ++ + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ + E+M+ GSLD+ L G + E + ++++ +GL YL HKI+H D
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRD 157
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
VKP NIL++ + ++K+ DFG+S L S+ + GTR Y++PE L + S ++D++
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 214
Query: 568 SYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQ 627
S G+ L+E+ GR + + + ++
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274
Query: 628 RRYLELADSRIEGQVSDEDVEK----LVRIALCCVQEEPMLRPS 667
EL D + C+ + P R
Sbjct: 275 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-38
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 389 PIGSGGFGTVYKGILQDKSV-VAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
+G G +G VY+G+ + S+ VAVK + +EF E ++ I H NLV+L G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 448 AQGRQRFLVYEYMNKGSLDRTL-FGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
+ +++ E+M G+L L N + +A + + YL IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 342
Query: 507 DVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDK 563
++ N L+ + VK++DFGLS+L+ +T G + + APE L + S K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 564 TDVYSYGMVLLEIIS 578
+DV+++G++L EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 386 FNTPIGSGGFGTVYKGIL-----QDKSVVAVKKI-NSFGIQGKKEFCTEITIIGNIHHVN 439
+G G FG V VAVK + G + EI I+ N++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 440 LVRLKGFCAQGRQR--FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
+V+ KG C + L+ E++ GSL L N + + +++ + A+ +G+ YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG- 143
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEW 554
+ +H D+ N+L+ + QVKI DFGL+K + +T + APE
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 555 LTSSAISDKTDVYSYGMVLLEIIS-GRKNSS 584
L S +DV+S+G+ L E+++ +SS
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 390 IGSGGFGTVYKGILQDKS----VVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLK 444
IGSG G V G L+ VA+K + + + +++F +E +I+G H N++RL+
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G +GR +V EYM GSLD L + + + G G+ YL D +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYV 173
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG------TRGYLAPEWLTSS 558
H D+ N+L+ L K+SDFGLS++L + + +TT G T APE +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFR 229
Query: 559 AISDKTDVYSYGMVLLEIIS-GRK 581
S +DV+S+G+V+ E+++ G +
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGER 253
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 20/205 (9%)
Query: 390 IGSGGFGTVYKGILQDKSV-----VAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVRL 443
IG+G FG VYKG+L+ S VA+K + + + + + +F E I+G H N++RL
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+G ++ + ++ EYM G+LD+ L + + G A G+ YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNY 168
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG------TRGYLAPEWLTS 557
+H D+ NIL++ L K+SDFGLS++L + + +TT G T APE ++
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISY 224
Query: 558 SAISDKTDVYSYGMVLLEIIS-GRK 581
+ +DV+S+G+V+ E+++ G +
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 390 IGSGGFGTVYKGIL-----QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
+G G FG+V VVAVKK+ + ++F EI I+ ++ H N+V+ K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 445 GFCAQGRQR--FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
G C +R L+ EY+ GSL L + ++ + + +G+ YL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLTSSA 559
IH D+ NIL+ ++ +VKI DFGL+K+L P+ + + APE LT S
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 560 ISDKTDVYSYGMVLLEIIS 578
S +DV+S+G+VL E+ +
Sbjct: 225 FSVASDVWSFGVVLYELFT 243
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-37
Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 6/190 (3%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G G FG V+ G + VA+K + G + F E ++ + H LV+L ++
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 450 GRQRFLVYEYMNKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
++V EYM+KGSL L G G L + ++A A G+AY+ +H D+
Sbjct: 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
+ NIL+ + L K++DFGL++L+ + + + + APE + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 569 YGMVLLEIIS 578
+G++L E+ +
Sbjct: 367 FGILLTELTT 376
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-37
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 389 PIGSGGFGTVYKGILQDKS-----VVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVR 442
+GSG FGTVYKG+ + VA+K++ + + KE E ++ ++ + ++ R
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
L G C L+ + M G L + + + + + A+G+ YL D +
Sbjct: 82 LLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRR 137
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSA 559
++H D+ N+L+ VKI+DFGL+KLL E+ G + ++A E +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESILHRI 195
Query: 560 ISDKTDVYSYGMVLLEIIS-GRK 581
+ ++DV+SYG+ + E+++ G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 390 IGSGGFGTVYKGILQDKSV---VAVKKI-NSFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
+G G FG+V +G+ + + VA+K + +E E I+ + + +VRL G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
C Q LV E G L + L G + E+ + G+ YL + +H
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 133
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISD 562
D+ N+LL ++ KISDFGLSK L S +T + + APE + S
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 563 KTDVYSYGMVLLEIIS-GRK 581
++DV+SYG+ + E +S G+K
Sbjct: 193 RSDVWSYGVTMWEALSYGQK 212
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF- 446
IGSGGFG V+K D +K++ ++ E+ + + HVN+V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 447 ---------------CAQGRQRFLVYEYMNKGSLDRTLFG-NGSVLEWRERFEIALGTAR 490
++ + F+ E+ +KG+L++ + G L+ E+ +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 491 GLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL 550
G+ Y+H K+I+ D+KP NI L D QVKI DFGL L + T +GT Y+
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGTLRYM 188
Query: 551 APEWLTSSAISDKTDVYSYGMVLLEIISGRK 581
+PE ++S + D+Y+ G++L E++
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 19/204 (9%)
Query: 390 IGSGGFGTVYKGILQ----DKSVVAVKKINSFGI-QGKKEFCTEITIIGNIHHVNLVRLK 444
+G+G FG V G L+ + VA+K + + +++F E +I+G H N++RL+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + + +V EYM GSLD L + + + + G A G+ YL D +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYV 169
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG------TRGYLAPEWLTSS 558
H D+ NIL++ L K+SDFGL ++L + + +TT G T +PE +
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYR 225
Query: 559 AISDKTDVYSYGMVLLEIIS-GRK 581
+ +DV+SYG+VL E++S G +
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGER 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G+G FG V+ G + VAVK + G F E ++ + H LVRL Q
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 450 GRQRFLVYEYMNKGSLDRTL-FGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+++ EYM GSL L +G L + ++A A G+A++ + IH D+
Sbjct: 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTSSAISDK 563
+ NIL+ D L KI+DFGL++L+ + + +T G + APE + + K
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAK--FPIKWTAPEAINYGTFTIK 190
Query: 564 TDVYSYGMVLLEIIS 578
+DV+S+G++L EI++
Sbjct: 191 SDVWSFGILLTEIVT 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-36
Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 6/190 (3%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G G FG V+ G + VA+K + G + F E ++ + H LV+L ++
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 450 GRQRFLVYEYMNKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
++V EYM+KGSL L G G L + ++A A G+AY+ +H D+
Sbjct: 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
+ NIL+ + L K++DFGL++L+ + + + + APE + K+DV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 569 YGMVLLEIIS 578
+G++L E+ +
Sbjct: 450 FGILLTELTT 459
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 12/194 (6%)
Query: 390 IGSGGFGTVYKGILQDKSV-VAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G +G VY+G+ + S+ VAVK + +EF E ++ I H NLV+L G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 449 QGRQRFLVYEYMNKGSLDRTL-FGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ +++ E+M G+L L N + +A + + YL IH D
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKT 564
+ N L+ + VK++DFGLS+L+T + +T G + + APE L + S K+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 565 DVYSYGMVLLEIIS 578
DV+++G++L EI +
Sbjct: 194 DVWAFGVLLWEIAT 207
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-36
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 12/194 (6%)
Query: 389 PIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G+G FG V+ + VAVK + G + F E ++ + H LV+L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ +++ E+M KGSL L + GS + + + A G+A++ IH D
Sbjct: 254 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 309
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLTSSAISDKT 564
++ NIL+ L KI+DFGL++++ + +T G + + APE + + + K+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 565 DVYSYGMVLLEIIS 578
DV+S+G++L+EI++
Sbjct: 367 DVWSFGILLMEIVT 380
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-36
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 26/205 (12%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCT----EITIIGNI-HHVNLVRLK 444
+G G GT+ + D VAVK+I E + E+ ++ H N++R
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEHPNVIRYF 84
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
+ +++ E +L + E + T GLA+LH I+
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140
Query: 505 HCDVKPENILLHDK-----LQVKISDFGLSKLLTPEQSSL--FTTMRGTRGYLAPEWLTS 557
H D+KP NIL+ ++ ISDFGL K L + S + + GT G++APE L+
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 558 SAI---SDKTDVYSYGMVLLEIISG 579
+ D++S G V +IS
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 385 NFNTPIGSGGFGTVYKGILQDKS----VVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVN 439
+FN IG G FG VY G L D AVK +N I +F TE I+ + H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 440 LVRLKGFCAQGR-QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
++ L G C + +V YM G L + ++ L A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 145
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APE 553
K +H D+ N +L +K VK++DFGL++ + ++ T L A E
Sbjct: 146 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALE 202
Query: 554 WLTSSAISDKTDVYSYGMVLLEIIS 578
L + + K+DV+S+G++L E+++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 43/215 (20%), Positives = 85/215 (39%), Gaps = 35/215 (16%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGF- 446
+G G V++G + + A+K N+ + E ++ ++H N+V+L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 447 -CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYLHT 497
R + L+ E+ GSL L + E G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES------EFLIVLRDVVGGMNHLR- 129
Query: 498 GCDHKIIHCDVKPENILLH----DKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 553
++ I+H ++KP NI+ + K++DFG ++ L ++ F ++ GT YL P+
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPD 185
Query: 554 WLTSSAISD--------KTDVYSYGMVLLEIISGR 580
+ + D++S G+ +G
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 390 IGSGGFGTVYKGILQDKSV---VAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
+GSG FGTV KG Q K V VAVK K + K E E ++ + + +VR+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G C + LV E G L++ L N ++ + E+ + G+ YL + +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFV 139
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAIS 561
H D+ N+LL + KISDFGLSK L ++ + + + + APE + S
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 562 DKTDVYSYGMVLLEIIS-GRK 581
K+DV+S+G+++ E S G+K
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQK 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 390 IGSGGFGTVYKGILQDKS-----VVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+GSG FGTV+KG+ + V +K I G Q + + IG++ H ++VRL
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
G C LV +Y+ GSL + + L + + A+G+ YL +H +
Sbjct: 81 LGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAI 560
+H ++ N+LL QV+++DFG++ LL + ++A E +
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLL--PPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 561 SDKTDVYSYGMVLLEIIS-GRK 581
+ ++DV+SYG+ + E+++ G +
Sbjct: 195 THQSDVWSYGVTVWELMTFGAE 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 389 PIGSGGFGTVYKGILQDKS-----VVAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVR 442
+GSG FGTVYKG+ + VA+K++ + KE E ++ ++ + ++ R
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
L G C L+ + M G L + + + + + A+G+ YL D +
Sbjct: 82 LLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRR 137
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSA 559
++H D+ N+L+ VKI+DFGL+KLL E+ G + ++A E +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESILHRI 195
Query: 560 ISDKTDVYSYGMVLLEIIS-GRK 581
+ ++DV+SYG+ + E+++ G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 385 NFNTPIGSGGFGTVYKGILQDKS----VVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVN 439
+FN IG G FG VY G L D AVK +N I +F TE I+ + H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 440 LVRLKGFCAQGR-QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
++ L G C + +V YM G L + ++ L A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 209
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APE 553
K +H D+ N +L +K VK++DFGL++ + + T L A E
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTGAKLPVKWMALE 266
Query: 554 WLTSSAISDKTDVYSYGMVLLEIIS 578
L + + K+DV+S+G++L E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 48/205 (23%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRLKG 445
IG G F VY+ L D VA+KK+ F + K EI ++ ++H N+++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 446 FCAQGRQRFLVYEYMNKGSL---------DRTLFGNGSVLEWRERF-EIALGTARGLAYL 495
+ + +V E + G L + L +V ++ F ++ L ++
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY---FVQLCSA----LEHM 152
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H +++H D+KP N+ + VK+ D GL + + +++ ++ GT Y++PE +
Sbjct: 153 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208
Query: 556 TSSAISDKTDVYSYGMVLLEIISGR 580
+ + K+D++S G +L E+ + +
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 390 IGSGGFGTVYKGILQDKS----VVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
IG G FG V++GI VA+K +++F E + H ++V+L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + +++ E G L L L+ A + LAYL + +
Sbjct: 83 GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAIS 561
H D+ N+L+ VK+ DFGLS+ + + S + + ++APE + +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 562 DKTDVYSYGMVLLEIIS-GRK 581
+DV+ +G+ + EI+ G K
Sbjct: 196 SASDVWMFGVCMWEILMHGVK 216
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 390 IGSGGFGTVYKGILQDKSV----VAVKKINS---FGIQGKKEFCTEITIIGNIHHVNLVR 442
+G G FG V +G S VAVK + + +F E+ + ++ H NL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
L G +V E GSL L + A+ A G+ YL +
Sbjct: 86 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSA 559
IH D+ N+LL + VKI DFGL + L P+ + + + APE L +
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 560 ISDKTDVYSYGMVLLEIIS-GRK 581
S +D + +G+ L E+ + G++
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQE 223
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 55/196 (28%), Positives = 83/196 (42%), Gaps = 11/196 (5%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK--KEFCTEITIIGNI-HHVNLVRLKG 445
+G G +G V+K +D + AVK+ S K E+ + H VRL+
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+G +L E SL + G+ L + + T LA+LH ++H
Sbjct: 125 AWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVH 180
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
DVKP NI L + + K+ DFGL L + G Y+APE L S D
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQEGDPRYMAPELLQGSY-GTAAD 237
Query: 566 VYSYGMVLLEIISGRK 581
V+S G+ +LE+ +
Sbjct: 238 VFSLGLTILEVACNME 253
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 390 IGSGGFGTVYKGILQDKSV--------VAVKKINSFGIQGKKEFCTEITIIGNIHHVNLV 441
+G G F ++KG+ ++ V +K ++ + F +++ + H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
G C G + LV E++ GSLD L N + + + E+A A + +L ++
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---EN 132
Query: 502 KIIHCDVKPENILL--------HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY---- 549
+IH +V +NILL + +K+SD G+S + P+
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQERI 181
Query: 550 --LAPEWLTSSAI-SDKTDVYSYGMVLLEIIS-GRK 581
+ PE + + + TD +S+G L EI S G K
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 390 IGSGGFGTVYKGILQDKSV----VAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
+G G FG VY+G+ + VAVK + K++F +E I+ N+ H ++V+L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + +++ E G L L N + L+ +L + +AYL +
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAIS 561
H D+ NIL+ VK+ DFGLS+ + + + TR +++PE + +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 562 DKTDVYSYGMVLLEIIS-GRK 581
+DV+ + + + EI+S G++
Sbjct: 193 TASDVWMFAVCMWEILSFGKQ 213
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNL--VRLKG 445
IGSGG V++ + + K + A+K +N + + EI + + + +RL
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ + ++V E N L+ L S+ W + + +H H I+H
Sbjct: 96 YEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIH---QHGIVH 150
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF-TTMRGTRGYLAPE----------- 553
D+KP N L+ D +K+ DFG++ + P+ +S+ + GT Y+ PE
Sbjct: 151 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 554 WLTSSAISDKTDVYSYGMVLLEIISGR 580
+ S IS K+DV+S G +L + G+
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 386 FNTPIGSGGFGTVYKGIL------QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVN 439
+G G FG V+ +DK +VAVK + + +K+F E ++ N+ H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTL---------------FGNGSVLEWRERFEI 484
+V+ G C G +V+EYM G L++ L L + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 485 ALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544
A A G+ YL +H D+ N L+ L VKI DFG+S+ +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----YYRV 191
Query: 545 GTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
G L PE + + ++DV+S+G++L EI +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 386 FNTPIGSGGFGTVYKGILQDKS----VVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNL 440
+ IG G FG VY G D++ A+K ++ +Q + F E ++ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 441 VRLKGFCAQGR-QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+ L G ++ YM G L + + ++ L ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEW 554
+ K +H D+ N +L + VK++DFGL++ + ++ + L A E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKWTALES 199
Query: 555 LTSSAISDKTDVYSYGMVLLEIIS 578
L + + K+DV+S+G++L E+++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 60/214 (28%), Positives = 85/214 (39%), Gaps = 28/214 (13%)
Query: 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHV 438
+G G FG VY+G + VAVK + Q + +F E II +H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLD------RTLFGNGSVLEWRERFEIALGTARGL 492
N+VR G Q RF++ E M G L R S L + +A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 493 AYLHTGCDHKIIHCDVKPENILLH---DKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549
YL ++ IH D+ N LL KI DFG+++ + +G
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAM 206
Query: 550 L-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
L PE + KTD +S+G++L EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 30/215 (13%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQ-GKKEFCTEITIIGNIHHVNLVRLKGFC 447
+G GGFG V++ D A+K+I + +++ E+ + + H +VR
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 448 AQGRQR------------FLVYEYMNKGSLDRTLFGNGSVLEWRERF--EIALGTARGLA 493
+ ++ + K +L + G ++ E I L A +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 494 YLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT-----------PEQSSLFTT 542
+LH ++H D+KP NI VK+ DFGL + + T
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEII 577
GT+ Y++PE + ++ S K D++S G++L E++
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 27/211 (12%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGF- 446
+G G V++G + + A+K N+ + E ++ ++H N+V+L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 447 -CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR----GLAYLHTGCDH 501
R + L+ E+ GSL L + E L R G+ +L ++
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLR---EN 131
Query: 502 KIIHCDVKPENILLH----DKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
I+H ++KP NI+ + K++DFG ++ L E F ++ GT YL P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLHPDMYER 189
Query: 558 SAISD--------KTDVYSYGMVLLEIISGR 580
+ + D++S G+ +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-34
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 13/219 (5%)
Query: 371 PRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSV---VAVKKI-NSFGIQGKKEFC 426
+ + +G G FG+V +G+ + + VA+K + +E
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 427 TEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL 486
E I+ + + +VRL G C Q LV E G L + L G + E+
Sbjct: 385 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 487 GTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546
+ G+ YL + +H ++ N+LL ++ KISDFGLSK L S +T
Sbjct: 444 QVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAG 499
Query: 547 R---GYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRK 581
+ + APE + S ++DV+SYG+ + E +S G+K
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 386 FNTPIGSGGFGTVYKGIL------QDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVN 439
+G G FG V+ QDK +VAVK + +++F E ++ + H +
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTL--------------FGNGSVLEWRERFEIA 485
+VR G C +GR +V+EYM G L+R L L + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 486 LGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545
A G+ YL +H D+ N L+ L VKI DFG+S+ + G
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVG 217
Query: 546 TRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
R L PE + + ++DV+S+G+VL EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 18/198 (9%)
Query: 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
IG G FG V G + V AVK I + + F E +++ + H NLV+L G
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 446 FCAQGRQRF-LVYEYMNKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+ + +V EYM KGSL L SVL + +L + YL +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAI 560
+H D+ N+L+ + K+SDFGL+K +T + + APE L
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 561 SDKTDVYSYGMVLLEIIS 578
S K+DV+S+G++L EI S
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGK--KEFCTEITIIGNI--HHVNLVRLKG 445
IGSGG V++ + + K + A+K +N + + EI + + H ++RL
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ + ++V E N L+ L S+ W + + +H H I+H
Sbjct: 77 YEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIH---QHGIVH 131
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF-TTMRGTRGYLAPE----------- 553
D+KP N L+ D +K+ DFG++ + P+ +S+ + GT Y+ PE
Sbjct: 132 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 554 WLTSSAISDKTDVYSYGMVLLEIISGR 580
+ S IS K+DV+S G +L + G+
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G +G VY G L ++ +A+K+I + + EI + ++ H N+V+ G +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA---RGLAYLHTGCDHKIIH 505
+ + E + GSL L L+ E+ I T GL YLH D++I+H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEGLKYLH---DNQIVH 145
Query: 506 CDVKPENILLHDKL-QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAI--SD 562
D+K +N+L++ +KISDFG SK L T GT Y+APE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT-ETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 563 KTDVYSYGMVLLEIISGR 580
D++S G ++E+ +G+
Sbjct: 205 AADIWSLGCTIIEMATGK 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 64/243 (26%), Positives = 98/243 (40%), Gaps = 23/243 (9%)
Query: 354 SRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQD-----KSV 408
+ L G P F L +G G FG V +
Sbjct: 8 HHHHHGALEVLFQGPGDPTVFHKRYLK-----KIRDLGEGHFGKVSLYCYDPTNDGTGEM 62
Query: 409 VAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQR--FLVYEYMNKGSL 465
VAVK + + G Q + + EI I+ ++H ++++ KG C LV EY+ GSL
Sbjct: 63 VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525
L + + + A G+AYLH IH D+ N+LL + VKI D
Sbjct: 123 RDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGD 177
Query: 526 FGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRK 581
FGL+K + PE + + APE L +DV+S+G+ L E+++
Sbjct: 178 FGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS 236
Query: 582 NSS 584
+ S
Sbjct: 237 SQS 239
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-34
Identities = 52/246 (21%), Positives = 99/246 (40%), Gaps = 16/246 (6%)
Query: 341 NSKRARAKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYK 400
+ R+ + + + +E ++ +P YE + IG G FG V++
Sbjct: 350 EKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYE-IQRERIELGRCIGEGQFGDVHQ 408
Query: 401 GILQDKS----VVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFL 455
GI VA+K +++F E + H ++V+L G + ++
Sbjct: 409 GIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467
Query: 456 VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILL 515
+ E G L L L+ A + LAYL + +H D+ N+L+
Sbjct: 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLV 524
Query: 516 HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTSSAISDKTDVYSYGMV 572
VK+ DFGLS+ + + S + + ++APE + + +DV+ +G+
Sbjct: 525 SSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 581
Query: 573 LLEIIS 578
+ EI+
Sbjct: 582 MWEILM 587
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 9e-34
Identities = 64/210 (30%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRL---- 443
+G+GGFG V + I VA+K+ +E +C EI I+ ++H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 444 --KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLA 493
A L EY G L + L + +E R L
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG------PIRTLLSDISSALR 135
Query: 494 YLHTGCDHKIIHCDVKPENILLH---DKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL 550
YLH +++IIH D+KPENI+L +L KI D G +K L L T GT YL
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYL 190
Query: 551 APEWLTSSAISDKTDVYSYGMVLLEIISGR 580
APE L + D +S+G + E I+G
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 386 FNTPIGSGGFGTVYKGILQDKS----VVAVK--KINSFGIQGKKEFCTEITIIGNIHHVN 439
+G G FG+V +G L+ + VAVK K+++ + +EF +E + + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 440 LVRLKGFCAQGRQR-----FLVYEYMNKGSL-----DRTLFGNGSVLEWRERFEIALGTA 489
++RL G C + + ++ +M G L L + + + + A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549
G+ YL + +H D+ N +L D + V ++DFGLSK + + +G
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYR--QGRIAK 210
Query: 550 L-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ A E L + K+DV+++G+ + EI +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 60/214 (28%), Positives = 85/214 (39%), Gaps = 28/214 (13%)
Query: 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHV 438
+G G FG VY+G + VAVK + Q + +F E II +H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLD------RTLFGNGSVLEWRERFEIALGTARGL 492
N+VR G Q RF++ E M G L R S L + +A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 493 AYLHTGCDHKIIHCDVKPENILLH---DKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549
YL ++ IH D+ N LL KI DFG+++ + +G
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAM 247
Query: 550 L-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
L PE + KTD +S+G++L EI S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCTEITIIGNIHHVNLVR 442
P+G G FG VY Q K ++A+K ++ G++ + E+ I ++ H N++R
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHLRHPNILR 73
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
L G+ + +L+ EY G++ R L E R I A L+Y H+ +
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS---KR 129
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
+IH D+KPEN+LL ++KI+DFG S SS T + GT YL PE + +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLPPEMIEGRMHDE 186
Query: 563 KTDVYSYGMVLLEIISGR 580
K D++S G++ E + G+
Sbjct: 187 KVDLWSLGVLCYEFLVGK 204
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 32/219 (14%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF- 446
+G G FG V K D A+KKI + +E+ ++ +++H +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 447 ------------CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAY 494
+ F+ EY G+L + + E + + L+Y
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT-------------PEQSSLFT 541
+H IIH D+KP NI + + VKI DFGL+K + P S T
Sbjct: 132 IH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 542 TMRGTRGYLAPEWLTSSAISD-KTDVYSYGMVLLEIISG 579
+ GT Y+A E L + + K D+YS G++ E+I
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 49/195 (25%), Positives = 96/195 (49%), Gaps = 8/195 (4%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGF 446
IG G FG +D +K+IN + + ++E E+ ++ N+ H N+V+ +
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 447 CAQGRQRFLVYEYMNKGSLDRTL-FGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ ++V +Y G L + + G + + + + + L ++H D KI+H
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILH 148
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
D+K +NI L V++ DFG++++L L GT YL+PE + ++K+D
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENKPYNNKSD 207
Query: 566 VYSYGMVLLEIISGR 580
+++ G VL E+ + +
Sbjct: 208 IWALGCVLYELCTLK 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNL--VRLKG 445
IGSGG V++ + + K + A+K +N + + EI + + + +RL
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDHK 502
+ + ++V E N L+ L S+ W + + + +H H
Sbjct: 124 YEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLE----AVHTIH---QHG 175
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF-TTMRGTRGYLAPE-------- 553
I+H D+KP N L+ D +K+ DFG++ + P+ +S+ + G Y+ PE
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 554 ---WLTSSAISDKTDVYSYGMVLLEIISGR 580
+ S IS K+DV+S G +L + G+
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 27/203 (13%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G FG V++ Q AVKK+ ++ + E+ + +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVR---LEVFRV--EELVACAGLSSPRIVPLYGAVR 120
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFE---IALGTA---RGLAYLHTGCDHK 502
+G + E + GSL G +++ GL YLH +
Sbjct: 121 EGPWVNIFMELLEGGSL-------GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRR 170
Query: 503 IIHCDVKPENILL-HDKLQVKISDFGLSKLLTPEQSSLFT----TMRGTRGYLAPEWLTS 557
I+H DVK +N+LL D + + DFG + L P+ + GT ++APE +
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 558 SAISDKTDVYSYGMVLLEIISGR 580
K D++S ++L +++G
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCTEITIIGNIHHVNLVR 442
+G GGF ++ K V A K + + K EI+I ++ H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVG 105
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
GF F+V E + SL ++ E R+ G YLH ++
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 161
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
+IH D+K N+ L++ L+VKI DFGL+ + + + GT Y+APE L+ S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 563 KTDVYSYGMVLLEIISGR 580
+ DV+S G ++ ++ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 29/215 (13%)
Query: 386 FNTPIGSGGFGTVYKGILQDKS----VVAVK--KINSFGIQGKKEFCTEITIIGNIHHVN 439
+G G FG+V + L+ + VAVK K + +EF E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 440 LVRLKGFCAQGRQR------FLVYEYMNKGSL-----DRTLFGNGSVLEWRERFEIALGT 488
+ +L G + R + ++ +M G L + N L + +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRG 548
A G+ YL IH D+ N +L + + V ++DFGLS+ + + +G
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYYR--QGCAS 199
Query: 549 YL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
L A E L + + +DV+++G+ + EI++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 63/224 (28%), Positives = 90/224 (40%), Gaps = 45/224 (20%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCT----EITI-IGNIHHVNLVRLK 444
+G G GTV VAVK++ +FC EI + + H N++R
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF------EIALGTARGLAYLHTG 498
R ++ E N +L + E + + A G+A+LH
Sbjct: 76 CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 499 CDHKIIHCDVKPENILL-------------HDKLQVKISDFGLSKLLTPEQSSLFTTMR- 544
KIIH D+KP+NIL+ + L++ ISDFGL K L QSS T +
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 545 --GTRGYLAPEWLTSSAISD-------KTDVYSYGMVLLEIISG 579
GT G+ APE L S D++S G V I+S
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCTEITIIGNIHHVNLVR 442
+G GGF ++ K V A K + + K EI+I ++ H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVG 79
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
GF F+V E + SL ++ E R+ G YLH ++
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 135
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
+IH D+K N+ L++ L+VKI DFGL+ + + + GT Y+APE L+ S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 563 KTDVYSYGMVLLEIISGR 580
+ DV+S G ++ ++ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 34/220 (15%)
Query: 386 FNTPIGSGGFGTVYKGIL------QDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHV 438
F +G FG VYKG L + VA+K + ++EF E + + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLDRTL---------------FGNGSVLEWRERFE 483
N+V L G + + +++ Y + G L L S LE +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 484 IALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543
+ A G+ YL H ++H D+ N+L++DKL VKISD GL + + + +
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYKL- 186
Query: 544 RGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
L APE + S +D++SYG+VL E+ S
Sbjct: 187 -LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
IG G FG V G + V AVK I + + F E +++ + H NLV+L G
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNKV-AVKCIKN-DAT-AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 446 FCAQGRQR-FLVYEYMNKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+ + ++V EYM KGSL L SVL + +L + YL +
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTSS 558
+H D+ N+L+ + K+SDFGL+K +T + L APE L
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGK--LPVKWTAPEALREK 189
Query: 559 AISDKTDVYSYGMVLLEIIS-GRK 581
S K+DV+S+G++L EI S GR
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRV 213
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 63/233 (27%), Positives = 96/233 (41%), Gaps = 35/233 (15%)
Query: 371 PRRFSYEELAAATDNFNTPIGSGGFGTVYKGILQD---KSVVAVKKIN-SFGIQGKKEFC 426
P Y L F IG G FG V K ++ + A+K++ ++F
Sbjct: 14 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 427 TEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGSLD---------------RTLF 470
E+ ++ + HH N++ L G C +L EY G+L
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 471 GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSK 530
S L ++ A ARG+ YL + IH D+ NIL+ + KI+DFGLS+
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 531 LLTPEQSSLFTTMRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
++ T G L A E L S + +DV+SYG++L EI+S
Sbjct: 191 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCTEITIIGNIHHVNLVR 442
P+G G FG VY Q+K ++A+K ++ G++ + EI I ++ H N++R
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHLRHPNILR 78
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
+ + ++ +L+ E+ +G L + L +G E R + A L Y H K
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCHE---RK 134
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
+IH D+KPEN+L+ K ++KI+DFG S S TM GT YL PE + +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLDYLPPEMIEGKTHDE 191
Query: 563 KTDVYSYGMVLLEIISGR 580
K D++ G++ E + G
Sbjct: 192 KVDLWCAGVLCYEFLVGM 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCTEITIIGNIHHVNLVR 442
+G G F VY+ + VA+K + G+ + E+ I + H +++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQLKHPSILE 75
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVL-EWRERFEIALGTARGLAYLHTGCDH 501
L + +LV E + G ++R L E R + G+ YLH+ H
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHS---H 131
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
I+H D+ N+LL + +KI+DFGL+ L T+ GT Y++PE T SA
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-HEKHYTLCGTPNYISPEIATRSAHG 190
Query: 562 DKTDVYSYGMVLLEIISGR 580
++DV+S G + ++ GR
Sbjct: 191 LESDVWSLGCMFYTLLIGR 209
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 31/236 (13%)
Query: 357 SSSEELELTSIAGLPRRFSYEELAAATDNFN--------TPIGSGGFGTVYKGILQDKS- 407
S I P F + + A N +G G FG V+K + +
Sbjct: 56 SKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE--ETAT 113
Query: 408 --VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465
+A K I + G++ K+E EI+++ + H NL++L LV EY++ G L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 466 -DRTLFGNGSVLEWRERFEIALGTAR----GLAYLHTGCDHKIIHCDVKPENILLHDK-- 518
DR + + ++ E + + G+ ++H I+H D+KPENIL ++
Sbjct: 174 FDRIIDESYNLTELD-----TILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDA 225
Query: 519 LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLL 574
Q+KI DFGL++ P + GT +LAPE + +S TD++S G V+
Sbjct: 226 KQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG-VIA 278
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
IG G GTVY + + VA++++N K+ EI ++ + N+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL---GTARGLAYLHTGCDHKIIH 505
G + ++V EY+ GSL + + E +IA + L +LH+ +++IH
Sbjct: 88 VGDELWVVMEYLAGGSL-TDVVTETCMDE----GQIAAVCRECLQALEFLHS---NQVIH 139
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
D+K +NILL VK++DFG +TPEQS +TM GT ++APE +T A K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 566 VYSYGMVLLEIISG 579
++S G++ +E+I G
Sbjct: 199 IWSLGIMAIEMIEG 212
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHV 438
+ +G G FG VY+G+ + ++ VA+K +N + ++ + EF E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLD------RTLFGNGSVLEW---RERFEIALGTA 489
++VRL G +QG+ ++ E M +G L R N VL + ++A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGY 549
G+AYL+ +K +H D+ N ++ + VKI DFG+++ + +G +G
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGL 201
Query: 550 L-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
L +PE L + +DV+S+G+VL EI +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
+G GGF V L D A+K+I Q ++E E + +H N++RL +C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 448 AQGRQR----FLVYEYMNKGSLD---RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
+ R +L+ + +G+L L G+ L + + LG RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS--------LFTTMRGTRGYLAP 552
H D+KP NILL D+ Q + D G + R T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 553 E-WLTSS--AISDKTDVYSYGMVLLEIISGR 580
E + S I ++TDV+S G VL ++ G
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 26/237 (10%)
Query: 354 SRNSSSEELELTSIAGLP--RRFSYEELAAATDNFNTPIGSGGFGTVYKGI-LQDKSVVA 410
+ EELE ++ R ++ IG G F TVYKG+ + VA
Sbjct: 6 QQQDDIEELETKAVGMSNDGRFLKFDIE----------IGRGSFKTVYKGLDTETTVEVA 55
Query: 411 VKKINSFGIQGK--KEFCTEITIIGNIHHVNLVRLKGFC---AQGRQRFLVY-EYMNKGS 464
++ + + F E ++ + H N+VR +G++ ++ E M G+
Sbjct: 56 WCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115
Query: 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-QVKI 523
L +T V++ + +GL +LHT IIH D+K +NI + VKI
Sbjct: 116 L-KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKI 173
Query: 524 SDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
D GL+ L ++S + GT ++APE + DVY++GM +LE+ +
Sbjct: 174 GDLGLATLK---RASFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-32
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 33/219 (15%)
Query: 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNI-HH 437
F +G+G FG V + VAVK + + K+ +E+ I+ ++ H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMNKGSL-------------DRTLFGNGSVLEWRERFEI 484
N+V L G C G ++ EY G L D S R+
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 485 ALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544
+ A+G+A+L IH DV N+LL + KI DFGL++ + S +
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDSNYI--V 222
Query: 545 GTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
L APE + + ++DV+SYG++L EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 51/194 (26%), Positives = 96/194 (49%), Gaps = 13/194 (6%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
IG G G V VAVK ++ Q ++ E+ I+ + H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL---GTARGLAYLHTGCDHKIIH 505
G + +++ E++ G+L + + E +IA + LAYLH +IH
Sbjct: 113 VGEELWVLMEFLQGGALT-DIVSQVRLNE----EQIATVCEAVLQALAYLHA---QGVIH 164
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
D+K ++ILL +VK+SDFG ++ + ++ GT ++APE ++ S + + D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRSLYATEVD 223
Query: 566 VYSYGMVLLEIISG 579
++S G++++E++ G
Sbjct: 224 IWSLGIMVIEMVDG 237
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFG-IQGKKEFCTEITII-GNIHHVNLVRLKGF 446
IG G +G+V K + ++AVK+I S + +K+ ++ ++ + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWR--ERF--EIALGTARGLAYLHTGCDHK 502
+ ++ E M+ S D+ SVL+ E +I L T + L +L + K
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
IIH D+KP NILL +K+ DFG+S L S T G R Y+APE + SA
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 563 ----KTDVYSYGMVLLEIISGR 580
++DV+S G+ L E+ +GR
Sbjct: 205 GYDVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN-SFGIQGKKEFCTEITII-GNIHHVNLVRLKGF 446
+G G +G V K + ++AVK+I + Q +K ++ I + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFE------IALGTARGLAYLHTGCD 500
+ ++ E M+ SLD+ V++ + IA+ + L +LH+
Sbjct: 75 LFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHS--K 128
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAI 560
+IH DVKP N+L++ QVK+ DFG+S L G + Y+APE +
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELN 186
Query: 561 SD----KTDVYSYGMVLLEIISGR 580
K+D++S G+ ++E+ R
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILR 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 18/236 (7%)
Query: 353 GSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKGI-LQDKSVVAV 411
GS SS ++ +I G + +L + +GSG G V+K + V+AV
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGE-----MGSGTCGQVWKMRFRKTGHVIAV 55
Query: 412 KKIN-SFGIQGKKEFCTEITIIGN-IHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTL 469
K++ S + K ++ ++ +V+ G F+ E M +
Sbjct: 56 KQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK 115
Query: 470 FGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLS 529
G + E R ++ + + L YL H +IH DVKP NILL ++ Q+K+ DFG+S
Sbjct: 116 RMQGPIPE-RILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 530 KLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD-----KTDVYSYGMVLLEIISGR 580
L G Y+APE + + + DV+S G+ L+E+ +G+
Sbjct: 173 GRLV--DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 386 FNTPIGSGGFGTVYKGIL------QDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNI-HH 437
F +G+G FG V + VAVK + S + ++ +E+ ++ + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMNKGSL-----------------DRTLFGNGSVLEWRE 480
+N+V L G C G ++ EY G L + + L+ +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 481 RFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540
+ A+G+A+L IH D+ NILL KI DFGL++ + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---- 199
Query: 541 TTMRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ L APE + + + ++DV+SYG+ L E+ S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 14/190 (7%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
+GSG FG V++ + +K+ V K IN+ K EI+I+ +HH L+ L
Sbjct: 59 LGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ L+ E+++ G L DR + + E E GL ++H +H I+H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSE-AEVINYMRQACEGLKHMH---EHSIVH 172
Query: 506 CDVKPENILLHDK--LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
D+KPENI+ K VKI DFGL+ L P++ T + APE + +
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFY 230
Query: 564 TDVYSYGMVL 573
TD+++ G++
Sbjct: 231 TDMWAIGVLG 240
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKG- 445
IG+G +G K D ++ K+++ + K+ +E+ ++ + H N+VR
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 446 -FCAQGRQRFLVYEYMNKGSLD---RTLFGNGSVLEWRERFEIALGTARGLAYLHT--GC 499
++V EY G L L+ + L H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
H ++H D+KP N+ L K VK+ DFGL+++L + +S T GT Y++PE + +
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKTFVGTPYYMSPEQMNRMS 192
Query: 560 ISDKTDVYSYGMVLLEIISGR 580
++K+D++S G +L E+ +
Sbjct: 193 YNEKSDIWSLGCLLYELCALM 213
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHV 438
+G G FG V K + VAVK + + ++ +E ++ ++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSL-----------------------DRTLFGNGSV 475
++++L G C+Q L+ EY GSL +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 476 LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535
L + A ++G+ YL + K++H D+ NIL+ + ++KISDFGLS+ + E
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 536 QSSLFTTMRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ ++ ++G + A E L + ++DV+S+G++L EI++
Sbjct: 204 D----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 29/204 (14%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKIN--------SFGIQGKKE-FCTEITIIGNI-H 436
+G G V + I K AVK I+ + +Q +E E+ I+ +
Sbjct: 25 LGRGVSSVVRRCI--HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 437 HVNLVRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYL 495
H N+++LK FLV++ M KG L D L ++ E +E +I + L
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEKVTLSE-KETRKIMRALLEVICAL 140
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H I+H D+KPENILL D + +K++DFG S L P + + GT YLAPE +
Sbjct: 141 H---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEII 195
Query: 556 TSSAISDKT------DVYSYGMVL 573
S + D++S G+++
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 48/231 (20%)
Query: 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHV 438
+ IG G FG V++ ++VAVK + + +F E ++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSL-----------------------DRTLFGNGSV 475
N+V+L G CA G+ L++EYM G L R
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 476 LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535
L E+ IA A G+AYL + K +H D+ N L+ + + VKI+DFGLS+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR----- 222
Query: 536 QSSLFTT---MRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
++++ + PE + + + ++DV++YG+VL EI S
Sbjct: 223 --NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 35/213 (16%), Positives = 71/213 (33%), Gaps = 25/213 (11%)
Query: 390 IGSGGFGTVYKGI------LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G F VY+ ++K +K + + ++
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF 132
Query: 444 KGFCAQGRQRFLVYEYMNKGSL----DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
LV E + G+L + V+ A+ + +H
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--- 189
Query: 500 DHKIIHCDVKPENILLHDKLQ-----------VKISDFGLSKLLTP-EQSSLFTTMRGTR 547
D +IIH D+KP+N +L + + + D G S + + ++FT T
Sbjct: 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249
Query: 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
G+ E L++ + + D + + ++ G
Sbjct: 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKIN------SFGIQGKKEFCTEITIIGNIHHVNL 440
+GSG F V K +KS A K I S ++E E++I+ + H N+
Sbjct: 20 LGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+ L L+ E ++ G L D L S+ E E G+ YLH
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDF-LAQKESLSE-EEATSFIKQILDGVNYLH--- 132
Query: 500 DHKIIHCDVKPENILLHDK----LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
KI H D+KPENI+L DK +K+ DFGL+ + F + GT ++APE +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIV 190
Query: 556 TSSAISDKTDVYSYGMVL 573
+ + D++S G++
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 59/288 (20%), Positives = 104/288 (36%), Gaps = 54/288 (18%)
Query: 338 WRINSKRARAKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTP-------- 389
R + S +S + L I + + A + P
Sbjct: 20 LTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFP 79
Query: 390 ---------IGSGGFGTVYKGILQD--------KSVVAVKKIN-SFGIQGKKEFCTEITI 431
+G G FG V VAVK + + + +E+ +
Sbjct: 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 139
Query: 432 IGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGSL---------------DRTLFGNGSV 475
+ I H N++ L G C Q +++ EY +KG+L
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 476 LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535
+ +++ ARG+ YL K IH D+ N+L+ + +KI+DFGL++ +
Sbjct: 200 MTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 536 QSSLFTTMRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ T G L APE L + ++DV+S+G+++ EI +
Sbjct: 257 D----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 386 FNTPIGSGGFGTVYKGILQD--------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNI- 435
P+G G FG V VAVK + + + +E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 436 HHVNLVRLKGFCAQGRQRFLVYEYMNKGSL---------------DRTLFGNGSVLEWRE 480
H N++ L G C Q +++ EY +KG+L + +++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 481 RFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540
ARG+ YL K IH D+ N+L+ + +KI+DFGL++ +
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---- 211
Query: 541 TTMRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ T G L APE L + ++DV+S+G+++ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGFC 447
IG G FG V+KGI + + VVA+K I+ + + E EIT++ + + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL---GTARGLAYLHTGCDHKII 504
+ + +++ EY+ GS L G + E +IA +GL YLH+ K I
Sbjct: 90 LKDTKLWIIMEYLGGGSA-LDLLEPGPLDE----TQIATILREILKGLDYLHS---EKKI 141
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
H D+K N+LL + +VK++DFG++ LT Q T GT ++APE + SA K
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDSKA 200
Query: 565 DVYSYGMVLLEIISG 579
D++S G+ +E+ G
Sbjct: 201 DIWSLGITAIELARG 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G FG VYK + ++ A K I + + +++ EI I+ H +V+L G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL---GTARGLAYLHTGCDHKIIH 505
+ +++ E+ G++D + L E +I + L +LH+ +IIH
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLT--EP-QIQVVCRQMLEALNFLHS---KRIIH 140
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD--- 562
D+K N+L+ + ++++DFG+S + GT ++APE + + D
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 563 --KTDVYSYGMVLLEIISG 579
K D++S G+ L+E+
Sbjct: 200 DYKADIWSLGITLIEMAQI 218
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
+G+G FG V++ +++ A K + + K+ EI + + H LV L
Sbjct: 165 LGTGAFGVVHRVT--ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ ++YE+M+ G L ++ + + E E E +GL ++H ++ +H
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-DEAVEYMRQVCKGLCHMH---ENNYVH 278
Query: 506 CDVKPENILLHDKL--QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
D+KPENI+ K ++K+ DFGL+ L P+QS GT + APE +
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 564 TDVYSYGMVLLEII-SG 579
TD++S G VL I+ SG
Sbjct: 337 TDMWSVG-VLSYILLSG 352
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 51/202 (25%), Positives = 81/202 (40%), Gaps = 30/202 (14%)
Query: 389 PIGSGGFGTVYKGILQDKS---VVAVKKIN--SFGIQGKKEFCTEITIIGNI-HHVNLVR 442
+G G F V + I KS A K + G + E EI ++ ++
Sbjct: 36 ELGRGKFAVVRQCI--SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 443 LKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERF--EIALGTAR----GLAYL 495
L + L+ EY G + + E E + + G+ YL
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 496 HTGCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
H + I+H D+KP+NILL +KI DFG+S+ + + GT YLAP
Sbjct: 148 H---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAP 202
Query: 553 EWLTSSAISDKTDVYSYGMVLL 574
E L I+ TD+++ G ++
Sbjct: 203 EILNYDPITTATDMWNIG-IIA 223
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 24/201 (11%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKIN------SFGIQGKKEFCTEITIIGNIHHVNL 440
+GSG F V K K A K I S ++E E+ I+ I H N+
Sbjct: 13 LGSGQFAIVRKCR--QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+ L L+ E ++ G L D L S+ E E + G+ YLH
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDF-LAEKESLTE-DEATQFLKQILDGVHYLH--- 125
Query: 500 DHKIIHCDVKPENILLHDK----LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
+I H D+KPENI+L DK ++K+ DFG++ + F + GT ++APE +
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIV 183
Query: 556 TSSAISDKTDVYSYGMVLLEI 576
+ + D++S G V+ I
Sbjct: 184 NYEPLGLEADMWSIG-VITYI 203
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G +G+VYK I + +VA+K++ +E EI+I+ ++V+ G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+ ++V EY GS+ + L E I T +GL YLH + IH D+
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDI 151
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
K NILL+ + K++DFG++ LT + T+ GT ++APE + + D++S
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVIQEIGYNCVADIWS 210
Query: 569 YGMVLLEIISG 579
G+ +E+ G
Sbjct: 211 LGITAIEMAEG 221
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 42/228 (18%)
Query: 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNI-HH 437
F +GSG FG V VAVK + ++ +E+ ++ + H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMNKGSL----------------------DRTLFGNGSV 475
N+V L G C +L++EY G L + +V
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 476 LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535
L + + A A+G+ +L +H D+ N+L+ VKI DFGL++ + +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 536 QSSLFTTMRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ L APE L + K+DV+SYG++L EI S
Sbjct: 226 S----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 24/201 (11%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKIN------SFGIQGKKEFCTEITIIGNIHHVNL 440
+GSG F V K +KS A K I S ++E E++I+ + H N+
Sbjct: 20 LGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+ L L+ E ++ G L D L S+ E E G+ YLH
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDF-LAQKESLSE-EEATSFIKQILDGVNYLH--- 132
Query: 500 DHKIIHCDVKPENILLHDK----LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
KI H D+KPENI+L DK +K+ DFGL+ + F + GT ++APE +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIV 190
Query: 556 TSSAISDKTDVYSYGMVLLEI 576
+ + D++S G V+ I
Sbjct: 191 NYEPLGLEADMWSIG-VITYI 210
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 34/219 (15%)
Query: 389 PIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCT-----------------EITI 431
+ G F + +D A+KK ++ K++F E+ I
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 432 IGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR- 490
I +I + + +G + +++YEYM S+ + VL+ I + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF-VLDKNYTCFIPIQVIKC 155
Query: 491 -------GLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543
+Y+H + I H DVKP NIL+ +VK+SDFG S+
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEY---MVDKKIKGS 210
Query: 544 RGTRGYLAPEWLTSSAISD--KTDVYSYGMVLLEIISGR 580
RGT ++ PE+ ++ + + K D++S G+ L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 35/239 (14%), Positives = 68/239 (28%), Gaps = 55/239 (23%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKI----------------------------NSFGI 419
+G + + V N
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 420 QGKKEFCTEITIIGNIHHVNLVRLKGFCAQG--RQRFLVYEYM--NKGSLDRTLFGNGSV 475
+ F ++ + ++R++ RF +Y M N + L + S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 476 ---LEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532
L R ++ L R LA LH + ++H ++P +I+L + V ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 533 TPEQSSLFTTMRGTRGYLAPEWLTSSAISD-----------KTDVYSYGMVLLEIISGR 580
+ +RG+ PE A D ++ G+V+ I
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 22/266 (8%), Positives = 59/266 (22%), Gaps = 49/266 (18%)
Query: 357 SSSEELELTSIAGLPRRFSYEELAAATDNFNT-----PIGSGGFGTVYKGI-LQDKSVVA 410
+ +E + P+ + + P+ G V+ ++ A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 411 VKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRLKGFC-------------------- 447
+K + E + + +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 448 ------AQGRQRFLVYEYM-----NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLH 496
L+ S ++ + R A L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
++H P+N+ + ++ + D + + Y E+L
Sbjct: 212 ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAPREFLN 264
Query: 557 SSAI--SDKTDVYSYGMVLLEIISGR 580
+S + + + G+ + +
Sbjct: 265 ASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 16/193 (8%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
+G G FG V++ + + S K + G + EI+I+ H N++ L
Sbjct: 13 LGRGEFGIVHRCV--ETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ +++E+++ + +R + E RE L +LH H I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNE-REIVSYVHQVCEALQFLH---SHNIGH 125
Query: 506 CDVKPENILLHDK--LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDK 563
D++PENI+ + +KI +FG ++ L P + F + Y APE +S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 564 TDVYSYGMVLLEI 576
TD++S G L+ +
Sbjct: 184 TDMWSLG-TLVYV 195
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 35/218 (16%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNI-HHVNLVRLKG 445
IGSG FG+V+K + D + A+K+ G ++ E+ + H ++VR
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTL---FGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
A+ + EY N GSL + + S + E ++ L RGL Y+H
Sbjct: 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMS 135
Query: 503 IIHCDVKPENILL-------------------HDKLQVKISDFGLSKLLTPEQSSLFTTM 543
++H D+KP NI + +K+ KI D G ++ Q
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VE 190
Query: 544 RGTRGYLAPE-WLTSSAISDKTDVYSYGMVLLEIISGR 580
G +LA E + K D+++ + ++
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 389 PIGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLV 441
+G GG TVY +D VA+K I + K+E E+ + H N+V
Sbjct: 18 KLGGGGMSTVYLA--EDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
+ + +LV EY+ +L + L G+ + H D
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
+I+H D+KP+NIL+ +KI DFG++K L+ + + GT Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 562 DKTDVYSYGMVLLEIISGR 580
+ TD+YS G+VL E++ G
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 17/191 (8%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
+GSG F V+ + + A+K I EI ++ I H N+V L+
Sbjct: 17 LGSGAFSEVFLVK--QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+LV + ++ G L DR + G E ++ + + YLH ++ I+H
Sbjct: 75 YESTTHYYLVMQLVSGGELFDR-ILERGVYTE-KDASLVIQQVLSAVKYLH---ENGIVH 129
Query: 506 CDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
D+KPEN+L ++ I+DFGLSK+ +T GT GY+APE L S
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVLAQKPYSK 186
Query: 563 KTDVYSYGMVL 573
D +S G++
Sbjct: 187 AVDCWSIGVIT 197
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 37/223 (16%)
Query: 386 FNTPIGSGGFGTVYKGILQD--------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNI- 435
P+G G FG V + VAVK + + + +E+ ++ I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 436 HHVNLVRLKGFCAQGRQRFLVYEYMNKGSL---------------DRTLFGNGSVLEWRE 480
H N++ L G C Q +++ EY +KG+L L ++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 481 RFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540
A ARG+ YL K IH D+ N+L+ + +KI+DFGL++ +
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---- 245
Query: 541 TTMRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ T G L APE L + ++DV+S+G++L EI +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKIN------SFGIQGKKEFCTEITIIGNIHHVNL 440
+GSG F V K +KS A K I S +++ E++I+ I H N+
Sbjct: 19 LGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+ L L+ E + G L D L S+ E E E G+ YLH
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTE-EEATEFLKQILNGVYYLH--- 131
Query: 500 DHKIIHCDVKPENILLHDK----LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
+I H D+KPENI+L D+ ++KI DFGL+ + F + GT ++APE +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIV 189
Query: 556 TSSAISDKTDVYSYGMVLLEI 576
+ + D++S G V+ I
Sbjct: 190 NYEPLGLEADMWSIG-VITYI 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNLVRLK 444
+G G F V + + K+ A K IN+ + + ++ E I + H N+VRL
Sbjct: 14 LGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 445 GFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+ +LV++ + G L + + E + +AY H + I
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFED-IVAREFYSE-ADASHCIQQILESIAYCH---SNGI 126
Query: 504 IHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAI 560
+H ++KPEN+LL K VK++DFGL+ + ++ + GT GYL+PE L
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPY 184
Query: 561 SDKTDVYSYGMVL 573
S D+++ G++L
Sbjct: 185 SKPVDIWACGVIL 197
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 386 FNTPIGSGGFGTVYKGILQD------KSVVAVKKIN-SFGIQGKKEFCTEITIIGNI-HH 437
P+G G FG V + VAVK + + +E+ I+ +I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 438 VNLVRLKGFCAQ-GRQRFLVYEYMNKGSL---------------DRTLFGNGSVLEWRER 481
+N+V L G C + G ++ E+ G+L L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 482 FEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541
+ A+G+ +L K IH D+ NILL +K VKI DFGL++ + +
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--- 204
Query: 542 TMRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
+R L APE + + ++DV+S+G++L EI S
Sbjct: 205 -VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKIN--------SFGIQGKKEFCTEITIIGNIHHV 438
+GSG G V ++ VA++ I+ + TEI I+ ++H
Sbjct: 143 LGSGACGEVKLAF--ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
++++K F ++V E M G L D+ + GN + E + YLH
Sbjct: 201 CIIKIKNFF-DAEDYYIVLELMEGGELFDK-VVGNKRLKE-ATCKLYFYQMLLAVQYLH- 256
Query: 498 GCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
++ IIH D+KPEN+LL + +KI+DFG SK+L L T+ GT YLAPE
Sbjct: 257 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEV 312
Query: 555 LTSSAI---SDKTDVYSYGMVL 573
L S + D +S G++L
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVIL 334
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 25/203 (12%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCT-----EITIIGNIHHVNLV 441
IG G F V + I ++ AVK ++ T E +I + H ++V
Sbjct: 32 IGKGPFSVVRRCI--NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTAR----GLAYLH 496
L + ++V+E+M+ L + + + E +A R L Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA--VASHYMRQILEALRYCH 147
Query: 497 TGCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 553
D+ IIH DVKP +LL K VK+ FG++ L + GT ++APE
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPE 203
Query: 554 WLTSSAISDKTDVYSYGMVLLEI 576
+ DV+ G V+L I
Sbjct: 204 VVKREPYGKPVDVWGCG-VILFI 225
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFC--------TEITIIGNIH-H 437
IG G V + + ++ AVK + + E E I+ + H
Sbjct: 102 IGRGVSSVVRRCV--HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLH 496
+++ L FLV++ M KG L D L ++ E +E I +++LH
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDY-LTEKVALSE-KETRSIMRSLLEAVSFLH 217
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
+ I+H D+KPENILL D +Q+++SDFG S L P + + GT GYLAPE L
Sbjct: 218 ---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILK 272
Query: 557 SSAISDKT------DVYSYGMVL 573
S D+++ G++L
Sbjct: 273 CSMDETHPGYGKEVDLWACGVIL 295
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 389 PIGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLV 441
+G GG V+ +D VAVK + + + F E ++H +V
Sbjct: 19 ILGFGGMSEVHLA--RDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 442 RL----KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
+ + G ++V EY++ +L R + + + E+ + L + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH- 133
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT--MRGTRGYLAPEWL 555
+ IIH DVKP NI++ VK+ DFG+++ + +S+ T + GT YL+PE
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 556 TSSAISDKTDVYSYGMVLLEIISGR 580
++ ++DVYS G VL E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK---KEFCTEITIIGNIHHVNLVRLKG 445
IG G FG VY +++ VVA+KK++ G Q ++ E+ + + H N ++ +G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL---GTARGLAYLHTGCDHK 502
+ +LV EY + D + E EIA G +GLAYLH+ H
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQE----VEIAAVTHGALQGLAYLHS---HN 174
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE---WLTSSA 559
+IH DVK NILL + VK+ DFG + ++ P + GT ++APE +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQ 229
Query: 560 ISDKTDVYSYGMVLLEIISG 579
K DV+S G+ +E+
Sbjct: 230 YDGKVDVWSLGITCIELAER 249
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 28/202 (13%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFC--------TEITIIGNIHHV 438
+GSG G V ++ VA+K I+ TEI I+ ++H
Sbjct: 18 LGSGACGEVKLAF--ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
++++K F ++V E M G L D+ + GN + E + YLH
Sbjct: 76 CIIKIKNFF-DAEDYYIVLELMEGGELFDK-VVGNKRLKE-ATCKLYFYQMLLAVQYLH- 131
Query: 498 GCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
++ IIH D+KPEN+LL + +KI+DFG SK+L L T+ GT YLAPE
Sbjct: 132 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEV 187
Query: 555 LTSSAI---SDKTDVYSYGMVL 573
L S + D +S G++L
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVIL 209
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-28
Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 23/201 (11%)
Query: 389 PIGSGGFGTVYKG---ILQDKSVVAVKK-INSFGIQGKKEFCTEITIIGNIHHVNLVRL- 443
I GG G +Y + + V +K ++S + + E + + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 444 ----KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
++V EY+ SL R+ L E L L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
+++ D+KPENI+L ++ Q+K+ D G + + GT G+ APE + +
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN--SFG---YLYGTPGFQAPEIVRTGP 253
Query: 560 ISDKTDVYSYGMVLLEIISGR 580
+ TD+Y+ G L +
Sbjct: 254 -TVATDIYTVGRTLAALTLDL 273
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 385 NFNTPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNL 440
+G G FG V AVK I+ ++ K + E+ ++ + H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
++L F +LV E G L D + E + I G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDE-IISRKRFSE-VDAARIIRQVLSGITYMH--- 143
Query: 500 DHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
+KI+H D+KPEN+LL K ++I DFGLS + GT Y+APE L
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLH 201
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
+ +K DV+S G++L ++SG
Sbjct: 202 GT-YDEKCDVWSTGVILYILLSGC 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNLVRLK 444
+G G F V + + K+ A K IN+ + + ++ E I + H N+VRL
Sbjct: 37 LGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 445 GFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+ +LV++ + G L + + E + +AY H + I
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFED-IVAREFYSE-ADASHCIQQILESIAYCH---SNGI 149
Query: 504 IHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAI 560
+H ++KPEN+LL K VK++DFGL+ + ++ + GT GYL+PE L
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPY 207
Query: 561 SDKTDVYSYGMVL 573
S D+++ G++L
Sbjct: 208 SKPVDIWACGVIL 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE--FCTEITIIGNIHHVNLVRLKGF 446
+GSG +G V A+K I + E+ ++ + H N+++L F
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
R +LV E G L D + E + I G+ YLH H I+H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDE-IIHRMKFNE-VDAAVIIKQVLSGVTYLH---KHNIVH 159
Query: 506 CDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
D+KPEN+LL K +KI DFGLS + ++ GT Y+APE L +
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAYYIAPEVLRKK-YDE 216
Query: 563 KTDVYSYGMVLLEIISGR 580
K DV+S G++L +++G
Sbjct: 217 KCDVWSIGVILFILLAGY 234
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 18/194 (9%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGFC 447
+GSG FG V+ +K IN Q E EI ++ ++ H N++++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 448 AQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTAR----GLAYLHTGCDHK 502
++V E G L +R + E + LAY H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG--YVAELMKQMMNALAYFH---SQH 144
Query: 503 IIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
++H D+KPENIL D +KI DFGL++L ++ T GT Y+APE
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFKRD- 201
Query: 560 ISDKTDVYSYGMVL 573
++ K D++S G+V+
Sbjct: 202 VTFKCDIWSAGVVM 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-28
Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
+G G F V + + A IN + ++ E I + H N+VRL
Sbjct: 19 LGKGAFSVVRRCV--KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 445 GFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERF--EIALGTAR----GLAYLHT 497
++ +L+++ + G L + ++ RE + A + + + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFED-------IVA-REYYSEADASHCIQQILEAVLHCH- 127
Query: 498 GCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
++H ++KPEN+LL K VK++DFGL+ + EQ + GT GYL+PE
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEV 184
Query: 555 LTSSAISDKTDVYSYGMVL 573
L D+++ G++L
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 13/189 (6%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
IG G +G V + + A KKI + ++ F EI I+ ++ H N++RL
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 449 QGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+LV E G L +R + E + I +AY H + H D
Sbjct: 77 DNTDIYLVMELCTGGELFER-VVHKRVFRE-SDAARIMKDVLSAVAYCH---KLNVAHRD 131
Query: 508 VKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
+KPEN L +K+ DFGL+ P + + T GT Y++P+ L +
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEGL-YGPEC 188
Query: 565 DVYSYGMVL 573
D +S G+++
Sbjct: 189 DEWSAGVMM 197
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGFC 447
IGSG V K VA+K+IN Q + EI + HH N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 448 AQGRQRFLVYEYMNKGSLD---RTLFGNGSVLEWR-ERFEIAL---GTARGLAYLHTGCD 500
+ +LV + ++ GS+ + + G + IA GL YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLT----PEQSSLFTTMRGTRGYLAPEWLT 556
+ IH DVK NILL + V+I+DFG+S L ++ + T GT ++APE +
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 557 SSAISD-KTDVYSYGMVLLEIISGR 580
D K D++S+G+ +E+ +G
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGA 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKG-- 445
+G+G +G VYKG ++ + A+K ++ G ++E EI ++ HH N+ G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 446 ----FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL---GTARGLAYLHTG 498
Q +LV E+ GS+ L N +E IA RGL++LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEE-WIAYICREILRGLSHLH-- 146
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
HK+IH D+K +N+LL + +VK+ DFG+S L T GT ++APE +
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACD 204
Query: 559 AISD-----KTDVYSYGMVLLEIISG 579
D K+D++S G+ +E+ G
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 58/191 (30%), Positives = 83/191 (43%), Gaps = 15/191 (7%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE--FCTEITIIGNIHHVNLVRLKGF 446
+G G FG V K + AVK IN + K E+ ++ + H N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
++V E G L D + E + I G+ Y+H H I+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDE-IIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 506 CDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
D+KPENILL K +KI DFGLS GT Y+APE L + +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRGT-YDE 201
Query: 563 KTDVYSYGMVL 573
K DV+S G++L
Sbjct: 202 KCDVWSAGVIL 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 18/191 (9%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
+G G VY+ K A+K + KK TEI ++ + H N+++LK
Sbjct: 61 LGRGATSIVYRCK--QKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ LV E + G L DR + G E R+ + +AYLH ++ I+H
Sbjct: 117 FETPTEISLVLELVTGGELFDR-IVEKGYYSE-RDAADAVKQILEAVAYLH---ENGIVH 171
Query: 506 CDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
D+KPEN+L +KI+DFGLSK++ + L T+ GT GY APE L A
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGP 229
Query: 563 KTDVYSYGMVL 573
+ D++S G++
Sbjct: 230 EVDMWSVGIIT 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNLVRLKGF 446
+G G FG V K + AVK IN + K E+ ++ + H N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
++V E G L D + E + I G+ Y+H H I+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDE-IIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 506 CDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
D+KPENILL K +KI DFGLS GT Y+APE L + +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDE 201
Query: 563 KTDVYSYGMVLLEIISGR 580
K DV+S G++L ++SG
Sbjct: 202 KCDVWSAGVILYILLSGT 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 45/256 (17%)
Query: 353 GSRNSSSEELELTSIAGL--PRRFSYEELAAATDNFNT--------PIGSGGFGTVYKGI 402
GS S+ L + L P + + IG+G FG V++
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 403 LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKG-FCAQGRQR-----FLV 456
L + VA+KK+ +Q K+ E+ I+ + H N+V LK F + G ++ LV
Sbjct: 61 LVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 457 YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA----------RGLAYLHTGCDHKIIHC 506
EY+ T++ + + + R LAY+H+ I H
Sbjct: 117 LEYV-----PETVY---RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHR 165
Query: 507 DVKPENILLH-DKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW-LTSSAISDKT 564
D+KP+N+LL +K+ DFG +K+L + + +R Y APE ++ +
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNI 223
Query: 565 DVYSYGMVLLEIISGR 580
D++S G V+ E++ G+
Sbjct: 224 DIWSTGCVMAELMQGQ 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEF---CTEITIIGNIHHVNLVRL 443
+G G F TV + ++ + A+K + I + + E ++ + H V+L
Sbjct: 38 LGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 444 KGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGC 499
F Q ++ + Y G L + + GS E RF EI L YLH
Sbjct: 96 Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA----LEYLH--- 147
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT-TMRGTRGYLAPEWLTSS 558
IIH D+KPENILL++ + ++I+DFG +K+L+PE + GT Y++PE LT
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 559 AISDKTDVYSYGMVLLEIISGR 580
+ +D+++ G ++ ++++G
Sbjct: 208 SACKSSDLWALGCIIYQLVAGL 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 17/191 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIG-NIHHVNLVRLKGFC 447
IG G + + I AVK I+ + K++ EI I+ H N++ LK
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 448 AQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
G+ ++V E M G L D+ + E RE + + + YLH ++H
Sbjct: 86 DDGKYVYVVTELMKGGELLDK-ILRQKFFSE-REASAVLFTITKTVEYLH---AQGVVHR 140
Query: 507 DVKPENILLHDK----LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
D+KP NIL D+ ++I DFG +K L E L T T ++APE L
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLERQGYDA 199
Query: 563 KTDVYSYGMVL 573
D++S G++L
Sbjct: 200 ACDIWSLGVLL 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN-------------SFGIQGKKEFCTEITIIGNI 435
+GSG +G V S A+K I + +E EI+++ ++
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 436 HHVNLVRLKGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAY 494
H N+++L + +LV E+ G L ++ + E + I G+ Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ-IINRHKFDE-CDAANIMKQILSGICY 161
Query: 495 LHTGCDHKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551
LH H I+H D+KPENILL +K L +KI DFGLS + + GT Y+A
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIA 216
Query: 552 PEWLTSSAISDKTDVYSYGMVLLEIISGR 580
PE L ++K DV+S G+++ ++ G
Sbjct: 217 PEVLKKK-YNEKCDVWSCGVIMYILLCGY 244
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 17/192 (8%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFC-TEITIIGNI-HHVNLVRLKG 445
P+G G F K + + AVK I+ + + EIT + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 446 FCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
FLV E +N G L +R + E E I ++++H D ++
Sbjct: 74 VFHDQLHTFLVMELLNGGELFER-IKKKKHFSE-TEASYIMRKLVSAVSHMH---DVGVV 128
Query: 505 HCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
H D+KPEN+L D+ L++KI DFG ++L P+ T T Y APE L +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQNGYD 187
Query: 562 DKTDVYSYGMVL 573
+ D++S G++L
Sbjct: 188 ESCDLWSLGVIL 199
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 2e-26
Identities = 36/280 (12%), Positives = 74/280 (26%), Gaps = 54/280 (19%)
Query: 342 SKRARAKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFNTPIGSGGFGTVYKG 401
+ A ++ N+ + + PR +G +
Sbjct: 48 MQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGT----------VLGQEDPYAYLEA 97
Query: 402 I-LQDKSVVAVKKI----------------------------NSFGIQGKKEFCTEITII 432
+ V N + F ++
Sbjct: 98 TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157
Query: 433 GNIHHVNLVRLKGFCAQG--RQRFLVYEYM--NKGSLDRTLFGNGSV---LEWRERFEIA 485
+ ++R++ RF +Y M N + L + S L R ++
Sbjct: 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 217
Query: 486 LGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545
L R LA LH + ++H ++P +I+L + V ++ F S
Sbjct: 218 LQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFA 274
Query: 546 TRGYLAPEWLTSS-----AISDKTDVYSYGMVLLEIISGR 580
A L ++ D ++ G+ + I
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 14/199 (7%)
Query: 389 PIGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLV 441
+G GG G VY+ +D +VA+K ++ + F T E G + ++V
Sbjct: 41 LVGRGGMGDVYEA--EDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
+ F Q ++ +N L L G L I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAH---AA 153
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
H DVKPENIL+ + DFG++ T E+ + GT Y+APE + S +
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 562 DKTDVYSYGMVLLEIISGR 580
+ D+Y+ VL E ++G
Sbjct: 214 YRADIYALTCVLYECLTGS 232
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 56/304 (18%), Positives = 94/304 (30%), Gaps = 35/304 (11%)
Query: 390 IGSG--GFGTVYKGI-LQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
IG G TV V V++IN + + E+ + +H N+V +
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIAL---GTARGLAYLHTGCDH 501
+ ++V +M GS + L + E IA G + L Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNEL-AIAYILQGVLKALDYIH---HM 147
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR------GTRGYLAPEWL 555
+H VK +IL+ +V +S + + +L+PE L
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 556 TSSAI--SDKTDVYSYGMVLLEIISGRKNSS---------LKIQSRS-TEKDSSGDGNGP 603
+ K+D+YS G+ E+ +G K+ D+S
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267
Query: 604 SSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPM 663
+ S R + + S V C+Q P
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH-FHHFVE---QCLQRNPD 323
Query: 664 LRPS 667
RPS
Sbjct: 324 ARPS 327
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEF---CTEITIIGNIHHVNLVRL 443
IG G FG V I+Q + A+K +N + E E+ I+ + H LV L
Sbjct: 23 IGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 444 KGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGC 499
+ Q + F+V + + G L L N E + E+ + L YL
Sbjct: 81 W-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA----LDYLQ--- 132
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
+ +IIH D+KP+NILL + V I+DF ++ +L E TTM GT+ Y+APE +S
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFSSRK 190
Query: 560 IS--DKT-DVYSYGMVLLEIISGR 580
+ D +S G+ E++ GR
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGR 214
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 42/214 (19%)
Query: 389 PIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKG-F 446
IG+G FG VY+ L D +VA+KK+ +Q K+ E+ I+ + H N+VRL+ F
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 447 CAQGRQR-----FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALG----------TARG 491
+ G ++ LV +Y+ T++ V R + L R
Sbjct: 117 YSSGEKKDEVYLNLVLDYV-----PETVY---RVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 492 LAYLHTGCDHKIIHCDVKPENILLH-DKLQVKISDFGLSKLLTPEQSSLFTTMRG---TR 547
LAY+H+ I H D+KP+N+LL D +K+ DFG +K L + +R
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-----PNVSYICSR 220
Query: 548 GYLAPEW-LTSSAISDKTDVYSYGMVLLEIISGR 580
Y APE ++ + DV+S G VL E++ G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 41/211 (19%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEF------CT---EITIIGNIHH 437
IG G +G V+K +++ +VA+KK + EI ++ + H
Sbjct: 11 IGEGSYGVVFKC--RNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRMLKQLKH 61
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAY 494
NLV L + R+ LV+EY + LDR + I T + + +
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNF 117
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
H H IH DVKPENIL+ +K+ DFG ++LLT + TR Y +PE
Sbjct: 118 CH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-YDDEVATRWYRSPEL 173
Query: 555 LT-----SSAISDKTDVYSYGMVLLEIISGR 580
L + DV++ G V E++SG
Sbjct: 174 LVGDTQYGPPV----DVWAIGCVFAELLSGV 200
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEF-CT--EITIIGNIHHVNLVRLKG 445
+G GGFG V+ ++ + A KK+N ++ +K + E I+ +H +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 446 FCAQGRQR-FLVYEYMNKGSL----DRTLFGNGSVLEWRERF---EIALGTARGLAYLHT 497
+ + + LV MN G + N E R F +I G L +LH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLH- 306
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
II+ D+KPEN+LL D V+ISD GL+ L Q+ GT G++APE L
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT-KGYAGTPGFMAPELLLG 363
Query: 558 SAISDKTDVYSYGMVLLEIISGR 580
D ++ G+ L E+I+ R
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 30/206 (14%)
Query: 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEF-CT--EITIIGNIHHVNLVRLKG 445
+G GGFG V ++ + A KK+ I+ +K E I+ ++ +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 446 FCAQGRQR-FLVYEYMNKGSL-------DRTLFGNGSVLEWRERF---EIALGTARGLAY 494
+ + + LV MN G L + F E R F EI G L
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-----EARAVFYAAEICCG----LED 301
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
LH +I++ D+KPENILL D ++ISD GL+ + Q+ GT GY+APE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI--KGRVGTVGYMAPEV 356
Query: 555 LTSSAISDKTDVYSYGMVLLEIISGR 580
+ + + D ++ G +L E+I+G+
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 48/229 (20%), Positives = 94/229 (41%), Gaps = 30/229 (13%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFC 447
+ GGF VY+ + A+K++ S + + E+ + + H N+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 448 AQGRQR-------FLVYEYMNKGSL--DRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
+ G++ FL+ + KG L + L +I T R + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT-----------TMRGTR 547
IIH D+K EN+LL ++ +K+ DFG + ++ ++ T T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 548 GYLAPE---WLTSSAISDKTDVYSYGMVLLEIISGR----KNSSLKIQS 589
Y PE ++ I +K D+++ G +L + + + L+I +
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 43/216 (19%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN------SFGIQGKKEFCTEITII----GNIHHV 438
+G GGFGTV+ G L D+ VA+K I + E+ ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLF----GNGSVLEWRERFEIALGTAR---- 490
++RL + LV E + LF G + E G +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGE---------GPSRCFFG 146
Query: 491 ----GLAYLHTGCDHKIIHCDVKPENILL-HDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545
+ + H ++H D+K ENIL+ + K+ DFG LL +T G
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDG 200
Query: 546 TRGYLAPEWLTSSA-ISDKTDVYSYGMVLLEIISGR 580
TR Y PEW++ + V+S G++L +++ G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 390 IGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEF-CT--EITIIGNIHHVN---LVR 442
IG GGFG VY D + A+K ++ I+ K+ E ++ + + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 443 LKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTG 498
+ + + + + MN G L L +G E RF EI LG L ++H
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMH-- 309
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
+ +++ D+KP NILL + V+ISD GL+ + ++ GT GY+APE L
Sbjct: 310 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKG 365
Query: 559 AISDKT-DVYSYGMVLLEIISGR 580
D + D +S G +L +++ G
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGH 388
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 56/243 (23%), Positives = 88/243 (36%), Gaps = 55/243 (22%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN-----SFGIQGKKEFCTEITIIGNIHHVNLVRL 443
IG G +G V I Q +++ A+K +N + + TE+ ++ +HH N+ RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 444 KGFCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTAR------------ 490
+ LV E + G L D+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 491 --------------------------GLAYLHTGCDHKIIHCDVKPENILLHDK--LQVK 522
L YLH + I H D+KPEN L ++K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 523 ISDFGLSKLLT---PEQSSLFTTMRGTRGYLAPEWLTSSA--ISDKTDVYSYGMVLLEII 577
+ DFGLSK + TT GT ++APE L ++ K D +S G++L ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 578 SGR 580
G
Sbjct: 271 MGA 273
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCT-EITIIGNIHHV--NL 440
+GSGGFG+VY GI + D VA+K +I+ +G E+ ++ + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLF----GNGSVLEWRERFEIALGTAR------ 490
+RL + + L+ E + D LF G++ E AR
Sbjct: 111 IRLLDWFERPDSFVLILERP-EPVQD--LFDFITERGALQE---------ELARSFFWQV 158
Query: 491 --GLAYLHTGCDHKIIHCDVKPENILL-HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR 547
+ + H + ++H D+K ENIL+ ++ ++K+ DFG LL + +++T GTR
Sbjct: 159 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 212
Query: 548 GYLAPEWLTSSA-ISDKTDVYSYGMVLLEIISGR 580
Y PEW+ V+S G++L +++ G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 49/196 (25%), Positives = 76/196 (38%), Gaps = 23/196 (11%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIG-NIHHVNLVRLKGF 446
+G G G V + + A+K + + E+ ++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 447 C----AQGRQRFLVYEYMNKGSL-DR-TLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
R ++ E M G L R G+ + E RE EI + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE-REAAEIMRDIGTAIQFLH---S 146
Query: 501 HKIIHCDVKPENILLHDK---LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
H I H DVKPEN+L K +K++DFG +K T T T Y+APE L
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGP 203
Query: 558 SAISDKTDVYSYGMVL 573
D++S G+++
Sbjct: 204 EKYDKSCDMWSLGVIM 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 52/202 (25%), Positives = 79/202 (39%), Gaps = 22/202 (10%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGF 446
+G G V I L AVK I + E+ ++ H N++ L F
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 447 CAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ + +LV+E M GS+ + E E + A L +LH + I H
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSH-IHKRRHFNE-LEASVVVQDVASALDFLH---NKGIAH 134
Query: 506 CDVKPENILLHDKLQ---VKISDFGLSKLLTPEQSS------LFTTMRGTRGYLAPEWLT 556
D+KPENIL Q VKI DF L + T G+ Y+APE +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 557 SSAISDKT-----DVYSYGMVL 573
+ + D++S G++L
Sbjct: 195 AFSEEASIYDKRCDLWSLGVIL 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEF------CT---EITIIGNIHH 437
+G G +G V K ++K +VA+KK + EI ++ + H
Sbjct: 33 VGEGSYGMVMKC--RNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKLLKQLRH 83
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAY 494
NLV L C + ++ +LV+E+++ L+ + L+++ + G+ +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGF 139
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
H H IIH D+KPENIL+ VK+ DFG ++ L ++ TR Y APE
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPEL 195
Query: 555 LT-----SSAISDKTDVYSYGMVLLEIISGR 580
L A+ DV++ G ++ E+ G
Sbjct: 196 LVGDVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 36/209 (17%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT-EITIIGNIHHVNLVRLKGFC 447
+G G +G V + + VAVK ++ E EI I ++H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 448 AQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTAR--------GLAYLHTG 498
+G ++L EY + G L DR + + + E A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDR-IEPDIGMPEP---------DAQRFFHQLMAGVVYLHG- 123
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE-QSSLFTTMRGTRGYLAPEWLTS 557
I H D+KPEN+LL ++ +KISDFGL+ + + L M GT Y+APE
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE---- 177
Query: 558 SAISDK------TDVYSYGMVLLEIISGR 580
+ + DV+S G+VL +++G
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 54/210 (25%), Positives = 83/210 (39%), Gaps = 30/210 (14%)
Query: 390 IGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVR 442
IG G F V K V A+K +N + + + E F E ++ N + +
Sbjct: 69 IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 443 LKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVL-EWRERF---EIALGTARGLAYLHT 497
L F Q +LV EY G L L G + RF EI + + +H
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVH- 179
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
+H D+KP+NILL ++++DFG L + + GT YL+PE L +
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 558 SAISDKTDVY-------SYGMVLLEIISGR 580
T Y + G+ E+ G+
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 35/180 (19%), Positives = 68/180 (37%), Gaps = 16/180 (8%)
Query: 422 KKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRER 481
+I + N V + ++ + K +L + S+ +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 482 F--EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLT------ 533
I + A + +LH ++H D+KP NI VK+ DFGL +
Sbjct: 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 534 -----PEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQ 588
+ T GT+ Y++PE + + S K D++S G++L E++ +++
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 15/74 (20%), Positives = 28/74 (37%), Gaps = 2/74 (2%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
+G GGFG V++ D A+K+I +++ E+ + + H +VR
Sbjct: 14 MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 448 AQGRQRFLVYEYMN 461
+ E
Sbjct: 74 LETPPEKWQEEMDE 87
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 36/209 (17%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT-EITIIGNIHHVNLVRLKGFC 447
+G G +G V + + VAVK ++ E EI I ++H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 448 AQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWRERFEIALGTAR--------GLAYLHTG 498
+G ++L EY + G L DR + + + E A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDR-IEPDIGMPEP---------DAQRFFHQLMAGVVYLHG- 123
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE-QSSLFTTMRGTRGYLAPEWLTS 557
I H D+KPEN+LL ++ +KISDFGL+ + + L M GT Y+APE
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE---- 177
Query: 558 SAISDK------TDVYSYGMVLLEIISGR 580
+ + DV+S G+VL +++G
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 61/205 (29%), Positives = 110/205 (53%), Gaps = 25/205 (12%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEF-CT---EITIIGNIHHVNLVRLK 444
+G+G + TVYKG+ VA+K++ + ++ T EI+++ + H N+VRL
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRLY 69
Query: 445 GFCAQGRQRFLVYEYMN---KGSLD-RTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
+ LV+E+M+ K +D RT+ LE +GLA+ H +
Sbjct: 70 DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---E 126
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT---- 556
+KI+H D+KP+N+L++ + Q+K+ DFGL++ ++ F++ T Y AP+ L
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-FSSEVVTLWYRAPDVLMGSRT 185
Query: 557 -SSAISDKTDVYSYGMVLLEIISGR 580
S++I D++S G +L E+I+G+
Sbjct: 186 YSTSI----DIWSCGCILAEMITGK 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 28/204 (13%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKE-F-CT---EITIIGNIHHVNLVRLK 444
+G G +G VYK +VA+K+I + + E T EI+++ +HH N+V L
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 445 GFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
R LV+E+M K LD N + L+ + RG+A+ H H
Sbjct: 86 DVIHSERCLTLVFEFMEKDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCH---QH 138
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT----- 556
+I+H D+KP+N+L++ +K++DFGL++ S +T T Y AP+ L
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-YTHEVVTLWYRAPDVLMGSKKY 197
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
S+++ D++S G + E+I+G+
Sbjct: 198 STSV----DIWSIGCIFAEMITGK 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 4e-23
Identities = 48/207 (23%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-F-CT---EITIIGNIHHVNLVRL 443
IG G +GTV+K + +VA+K++ + E + EI ++ + H N+VRL
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 444 KGFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
++ LV+E+ + K D L+ +GL + H
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCH---S 119
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLT--- 556
++H D+KP+N+L++ ++K+++FGL++ P + ++ T Y P+ L
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK 177
Query: 557 --SSAISDKTDVYSYGMVLLEIISGRK 581
S++I D++S G + E+ + +
Sbjct: 178 LYSTSI----DMWSAGCIFAELANAGR 200
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 25/203 (12%)
Query: 386 FNTPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT-EITIIGNI-HHVNLVR 442
+ +G G G V + + + A+K + E+ + ++VR
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVR 119
Query: 443 LKGFC---AQGRQRF-LVYEYMNKGSL-DRTLF-GNGSVLEWRERFEIALGTARGLAYLH 496
+ GR+ +V E ++ G L R G+ + E RE EI + YLH
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH 178
Query: 497 TGCDHKIIHCDVKPENILLHDKLQ---VKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 553
I H DVKPEN+L K +K++DFG +K T S TT T Y+APE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPE 233
Query: 554 WLTSSAISDKTDVYSYGMVLLEI 576
L D++S G V++ I
Sbjct: 234 VLGPEKYDKSCDMWSLG-VIMYI 255
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 40/216 (18%)
Query: 389 PIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLVRL 443
G G FGTV G + VA+KK+ F + + +HH N+V+L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 444 K-GFCAQGRQRF------LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALG--------- 487
+ F G + +V EY+ TL R ++A
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYV-----PDTLH---RCCRNYYRRQVAPPPILIKVFLF 136
Query: 488 -TARGLAYLHTGCDHKIIHCDVKPENILL-HDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545
R + LH + H D+KP N+L+ +K+ DFG +K L+P + +
Sbjct: 137 QLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--VAYIC 193
Query: 546 TRGYLAPEW-LTSSAISDKTDVYSYGMVLLEIISGR 580
+R Y APE + + D++S G + E++ G
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 28/208 (13%)
Query: 390 IGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVR 442
IG G FG V K V A+K +N + + + E F E ++ N +
Sbjct: 82 IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 443 LKGFCAQGRQR-FLVYEYMNKGSLDRTLF-GNGSVLEWRERF---EIALGTARGLAYLHT 497
L + Q +LV +Y G L L + E RF E+ + + +H
Sbjct: 139 LH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA----IDSVH- 192
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
+H D+KP+NIL+ ++++DFG L + + + GT Y++PE L +
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 558 SAISDKT-----DVYSYGMVLLEIISGR 580
D +S G+ + E++ G
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 25/210 (11%)
Query: 389 PIGSGGFGTVYKGILQDKSVVAVKKINSFGIQG-------KKEFCT----EITIIGNIHH 437
I SG +G V G+ + VA+K++ + G C EI ++ + HH
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 438 VNLVRLKG-FCAQGRQRF----LVYEYMNKGSLDRTLFGNGSVL-EWRERFEIALGTARG 491
N++ L+ F LV E M L + + V+ ++ G
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY-FMYHILLG 146
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551
L LH ++H D+ P NILL D + I DF L++ T + + T R Y A
Sbjct: 147 LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRWYRA 201
Query: 552 PEWLTSSAISDKT-DVYSYGMVLLEIISGR 580
PE + K D++S G V+ E+ + +
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLVRL 443
IG G +G V +K VA+KKI+ F + +C EI I+ H N++ +
Sbjct: 34 YIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGI 90
Query: 444 KG-FCAQGRQRF----LVYEYMNKGSLDRTLFGNGSVLEWRERFEI--ALGTARGLAYLH 496
A ++ +V + M L + L + + + L RGL Y+H
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQIL---RGLKYIH 145
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ--SSLFTTMRGTRGYLAPEW 554
+ ++H D+KP N+LL+ +KI DFGL+++ P+ + T TR Y APE
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 555 LTSSAISDKT-DVYSYGMVLLEIISGR 580
+ +S K+ D++S G +L E++S R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-F-CT---EITIIGNIHHVNLVRL 443
+G G F TVYK +VA+KKI K+ T EI ++ + H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 444 KGFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
LV+++M + + N VL L T +GL YLH
Sbjct: 78 LDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLH---Q 130
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLT--- 556
H I+H D+KP N+LL + +K++DFGL+K P ++ +T TR Y APE L
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGAR 188
Query: 557 --SSAISDKTDVYSYGMVLLEIISGR 580
+ D+++ G +L E++
Sbjct: 189 MYGVGV----DMWAVGCILAELLLRV 210
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 35/212 (16%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLVRLK 444
+G G +G V + + + AVK + ++ EI ++ + H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 445 G--FCAQGRQRFLVYEYMNKGSLDRTLFG---NGSVLEWRERFEIALGTAR--------G 491
+ + ++ ++V EY G + + A G
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVC---------QAHGYFCQLIDG 121
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE-QSSLFTTMRGTRGYL 550
L YLH+ I+H D+KP N+LL +KIS G+++ L P T +G+ +
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 551 APEWLTSSAISD--KTDVYSYGMVLLEIISGR 580
PE K D++S G+ L I +G
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 390 IGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVR 442
IG G FG V K + V A+K ++ F + + + F E I+ + +V+
Sbjct: 77 IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 443 LKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTG 498
L + Q + ++V EYM G L L N V E RF E+ L L +H
Sbjct: 134 LF-YAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLA----LDAIH-- 185
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
IH DVKP+N+LL +K++DFG + E T GT Y++PE L S
Sbjct: 186 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 559 AISDK----TDVYSYGMVLLEIISGR 580
D +S G+ L E++ G
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 64/203 (31%), Positives = 88/203 (43%), Gaps = 24/203 (11%)
Query: 390 IGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKEF-CT--EITIIGNIHHVNLVR 442
+G G FG V K A+K + I K E T E ++ N H L
Sbjct: 156 LGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 443 LKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTG 498
LK + Q R V EY N G L L E R RF EI L YLH+
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LDYLHS- 266
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTS 557
+ +++ D+K EN++L +KI+DFGL K + + T GT YLAPE L
Sbjct: 267 -EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAPEVLED 323
Query: 558 SAISDKTDVYSYGMVLLEIISGR 580
+ D + G+V+ E++ GR
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKE-F-CT---EITIIGNIHHVNLVRLK 444
IG G +G VYK A+KKI ++ + E T EI+I+ + H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 445 GFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
++ LV+E+++ K LD LE L G+AY H D
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT----- 556
+++H D+KP+N+L++ + ++KI+DFGL++ +T T Y AP+ L
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSKKY 178
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
S+ I D++S G + E+++G
Sbjct: 179 STTI----DIWSVGCIFAEMVNGT 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 390 IGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKEFCT--EITIIGNIHHVNLVRL 443
+G G FG V+ + + A+K + ++ + T E I+ ++H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 444 KGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGC 499
+ Q + +L+ +++ G L L E +F E+AL L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA----LDHLH--- 143
Query: 500 DHKIIHCDVKPENILL----HDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEW 554
II+ D+KPENILL H +K++DFGLSK + E+ + + GT Y+APE
Sbjct: 144 SLGIIYRDLKPENILLDEEGH----IKLTDFGLSKESIDHEKKA--YSFCGTVEYMAPEV 197
Query: 555 LTSSAISDKTDVYSYGMVLLEIISGR 580
+ + D +S+G+++ E+++G
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLVRL 443
+G G +G V +VA+KKI F K F EI I+ + H N++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITI 74
Query: 444 KG-FCAQGRQRF----LVYEYMNKGSLDRTLFGNGSVL-EWRERFEI--ALGTARGLAYL 495
+ F ++ E M L R + +L + ++ I L R + L
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ--MLSDDHIQYFIYQTL---RAVKVL 128
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG---------T 546
H +IH D+KP N+L++ +K+ DFGL++++ + T
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 547 RGYLAPEWLTSSAISDKT-DVYSYGMVLLEIISGR 580
R Y APE + +SA + DV+S G +L E+ R
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 64/203 (31%), Positives = 87/203 (42%), Gaps = 25/203 (12%)
Query: 390 IGSGGFGTV----YKGILQDKSVVAVKKINSFGIQGKKEF-CT--EITIIGNIHHVNLVR 442
+G G FG V K A+K + I K E T E ++ N H L
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 443 LKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTG 498
LK + Q R V EY N G L L E R RF EI L YLH
Sbjct: 70 LK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA----LEYLH-- 122
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTS 557
+++ D+K EN++L +KI+DFGL K ++ + T GT YLAPE L
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLED 179
Query: 558 SAISDKTDVYSYGMVLLEIISGR 580
+ D + G+V+ E++ GR
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG V G VAVK KI S + GK + EI + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYL 495
+ F+V EY++ G L + +G V E AR + Y
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE---------MEARRLFQQILSAVDYC 127
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H H ++H D+KPEN+LL + KI+DFGLS +++ + T G+ Y APE
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPE-- 180
Query: 556 TSSAISDK------TDVYSYGMVLLEIISGR 580
IS + D++S G++L ++ G
Sbjct: 181 ---VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 56/205 (27%), Positives = 106/205 (51%), Gaps = 30/205 (14%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEF-CT---EITIIGNIHHVNLVRLK 444
+G G + TVYKG ++VA+K+I ++ ++ CT E++++ ++ H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 445 GFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
+ LV+EY++ K LD G+++ RGLAY H
Sbjct: 67 DIIHTEKSLTLVFEYLDKDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCH---RQ 119
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLT---- 556
K++H D+KP+N+L++++ ++K++DFGL++ + P ++ + T Y P+ L
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTD 177
Query: 557 -SSAISDKTDVYSYGMVLLEIISGR 580
S+ I D++ G + E+ +GR
Sbjct: 178 YSTQI----DMWGVGCIFYEMATGR 198
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 390 IGSGGFGTVY---KGILQD-KSVVAVKKIN-SFGIQGKKEF-CT--EITIIGNIHHVNLV 441
+G GG+G V+ K + + A+K + + ++ K+ T E I+ + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 442 RLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHT 497
L + Q + +L+ EY++ G L L G +E F EI++ L +LH
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA----LGHLH- 138
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLT 556
II+ D+KPENI+L+ + VK++DFGL K + + T GT Y+APE L
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--HTFCGTIEYMAPEILM 194
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
S + D +S G ++ ++++G
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 29/209 (13%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCT---EITIIGNIHHVN 439
P+GSG FG V+ + + V VK K+ + EI I+ + H N
Sbjct: 31 PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLF------GNGSVLEWRERF-EIALGTARGL 492
++++ LV E G LF F ++ +
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLV----SAV 143
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
YL IIH D+K ENI++ + +K+ DFG + L + LF T GT Y AP
Sbjct: 144 GYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIEYCAP 198
Query: 553 EWLTSSA-ISDKTDVYSYGMVLLEIISGR 580
E L + + +++S G+ L ++
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 58/208 (27%), Positives = 82/208 (39%), Gaps = 37/208 (17%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
IGSG FG K +VAVK I + EI ++ H N+VR K
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNIVRFKEVIL 86
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYLHTGCD 500
++ EY + G L + G E AR G++Y H+
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSE---------DEARFFFQQLLSGVSYCHS--- 134
Query: 501 HKIIHCDVKPENILL--HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
+I H D+K EN LL ++KI DFG SK S + GT Y+APE
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAYIAPE----- 187
Query: 559 AISDK------TDVYSYGMVLLEIISGR 580
+ + DV+S G+ L ++ G
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 44/220 (20%)
Query: 390 IGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
+G G +G VYK +D A+K+I GI C EI ++ + H N++ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 86
Query: 447 CAQGRQR--FLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTA--------RGLA 493
R +L+++Y + + ++ ++ G G+
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILDGIH 142
Query: 494 YLHTGCDHKIIHCDVKPENILLH----DKLQVKISDFGLSKLLT-PEQSSLFTTMRG--- 545
YLH + ++H D+KP NIL+ ++ +VKI+D G ++L P + +
Sbjct: 143 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LADLDPVVV 197
Query: 546 TRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGR 580
T Y APE L + AI D+++ G + E+++
Sbjct: 198 TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG V + + VA+K + + + E EI+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYL 495
+V EY G L + + E R + Y
Sbjct: 75 YDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTE---------DEGRRFFQQIICAIEYC 124
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H HKI+H D+KPEN+LL D L VKI+DFGLS ++T T G+ Y APE +
Sbjct: 125 HR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVI 179
Query: 556 TSSA-ISDKTDVYSYGMVLLEIISGR 580
+ DV+S G+VL ++ GR
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 42/225 (18%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT--------------------- 427
IG G +G V D + A+K ++ + + F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 428 -----EITIIGNIHHVNLVRLKG--FCAQGRQRFLVYEYMNKGSL-DRTLFGNGSVLEWR 479
EI I+ + H N+V+L ++V+E +N+G + + S + R
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 480 ERF-EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538
F ++ G + YLH KIIH D+KP N+L+ + +KI+DFG+S +
Sbjct: 141 FYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 539 LFTTMRGTRGYLAPEWLTSSAIS---DKTDVYSYGMVLLEIISGR 580
L T GT ++APE L+ + DV++ G+ L + G+
Sbjct: 194 LSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 26/242 (10%)
Query: 351 KLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFN--TPIGSGGFGTVY----KGILQ 404
K + S E L L + + + A D F+ +G+G FG V K
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE--- 64
Query: 405 DKSVVAVKKINSFGIQGKKEF---CTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461
+ A+K ++ + K+ E I+ ++ LV+L+ ++V EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 462 KGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK 518
G + L G E RF +I L YLH +I+ D+KPEN+L+ +
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH---SLDLIYRDLKPENLLIDQQ 177
Query: 519 LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS 578
++++DFG +K T+ GT LAPE + S + D ++ G+++ E+ +
Sbjct: 178 GYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 579 GR 580
G
Sbjct: 234 GY 235
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 32/206 (15%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
IG G F V + VA+K ++N +Q E+ I+ ++H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL 79
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYL 495
+ +L+ EY + G + L +G + E AR + Y
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---------KEARSKFRQIVSAVQYC 130
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H +I+H D+K EN+LL + +KI+DFG S T G Y APE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELF 185
Query: 556 TSSA-ISDKTDVYSYGMVLLEIISGR 580
+ DV+S G++L ++SG
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 390 IGSGGFGTVY---KGILQDKSVV-AVKKINSFGIQGKKE--FCT--EITIIGNI-HHVNL 440
+G+G +G V+ K D + A+K + I K + T E ++ +I L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 441 VRLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLH 496
V L + Q + L+ +Y+N G L L E + EI L L +LH
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA----LEHLH 176
Query: 497 TGCDHKIIHCDVKPENILL----HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
II+ D+K ENILL H V ++DFGLSK +++ GT Y+AP
Sbjct: 177 ---KLGIIYRDIKLENILLDSNGH----VVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 553 EWLTSSAIS-DKT-DVYSYGMVLLEIISGR 580
+ + DK D +S G+++ E+++G
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKIN-SFGIQGKKEF-CT---EITI---IGNIHHVNL 440
IG G +GTVYK VA+K + G G + E+ + + H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 441 VRLKGFCAQGRQR-----FLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGL 492
VRL CA R LV+E+++ + LD+ L ++ RGL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAETIKDLMRQFLRGL 133
Query: 493 AYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
+LH + I+H D+KPENIL+ VK++DFGL+++ + + + T + T Y AP
Sbjct: 134 DFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVVTLWYRAP 188
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIISGR 580
E L S + D++S G + E+ +
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKI-NSFGIQGKKEFCT----EITIIGNIHHVNLVR 442
PIGSG G V + VA+KK+ F + E+ ++ ++H N++
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 443 LKG-FCAQGRQR-----FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLH 496
L F Q ++V E M+ +L + + R + + G+ +LH
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELD--HERMSY-LLYQMLCGIKHLH 144
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
+ IIH D+KP NI++ +KI DFGL++ + T TR Y APE +
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVIL 199
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
+ D++S G ++ E+I G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 9e-21
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 390 IGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKEF-CT--EITIIGNIHHVNLVR 442
+G+G FG V+ + + A+K + + K+ T E ++ + H ++R
Sbjct: 14 LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 443 LKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTG 498
+ Q Q+ F++ +Y+ G L L + +F E+ L L YLH
Sbjct: 71 MW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEYLH-- 123
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
II+ D+KPENILL +KI+DFG +K + T+ GT Y+APE +++
Sbjct: 124 -SKDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIAPEVVSTK 178
Query: 559 AISDKTDVYSYGMVLLEIISGR 580
+ D +S+G+++ E+++G
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGY 200
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-21
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVK-----KINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+G G FG V G VAVK KI S + GK EI + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTAR--------GLAYL 495
+ F+V EY++ G L + NG + E +R G+ Y
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE---------KESRRLFQQILSGVDYC 132
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H H ++H D+KPEN+LL + KI+DFGLS +++ + T G+ Y APE
Sbjct: 133 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPE-- 185
Query: 556 TSSAISDK------TDVYSYGMVLLEIISGR 580
IS + D++S G++L ++ G
Sbjct: 186 ---VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 69/204 (33%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 390 IGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKEF-CT--EITIIG-NIHHVNLV 441
IG G FG V K ++ AVK + I KKE E ++ N+ H LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 442 RLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHT 497
L F Q + + V +Y+N G L L LE R RF EIA L YLH
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA----LGYLH- 156
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLT 556
I++ D+KPENILL + + ++DFGL K + ++ +T GT YLAPE L
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLAPEVLH 212
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
D + G VL E++ G
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 388 TPIGSGGFGTVYKGI-LQDKSVVAVKKI-NSFGIQGKKEFCT----EITIIGNIHHVNLV 441
T +GSG +G+V I + VA+KK+ F + F E+ ++ ++ H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKHMQHENVI 86
Query: 442 RLKG-FCAQGRQR-----FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYL 495
L F R +LV +M L + + S E + ++ + +GL Y+
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFS--EEKIQY-LVYQMLKGLKYI 142
Query: 496 HTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
H+ ++H D+KP N+ +++ ++KI DFGL++ E T TR Y APE +
Sbjct: 143 HSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVI 195
Query: 556 TSSAISDKT-DVYSYGMVLLEIISGR 580
S ++T D++S G ++ E+++G+
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 35/210 (16%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-F-CT---EITIIGNIHHVNLVRL 443
+G G +G VYK I VA+K+I ++ ++E T E++++ + H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 444 KGFCAQGRQRFLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
K + L++EY K +D+ + R G+ + H
Sbjct: 99 KSVIHHNHRLHLIFEYAENDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH---S 150
Query: 501 HKIIHCDVKPENILL-----HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 555
+ +H D+KP+N+LL + +KI DFGL++ FT T Y PE L
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ-FTHEIITLWYRPPEIL 209
Query: 556 T-----SSAISDKTDVYSYGMVLLEIISGR 580
S+++ D++S + E++
Sbjct: 210 LGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 51/222 (22%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-F-CT---EITIIGNIHHVNLVRL 443
IG G FG V+K + VA+KK+ ++ +KE F T EI I+ + H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 444 KGFCAQGRQR--------FLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIA------L 486
C +LV+++ G L +F ++
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----------LVKFTLSEIKRVMQ 131
Query: 487 GTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL---TPEQSSLFTTM 543
GL Y+H +KI+H D+K N+L+ +K++DFGL++ Q + +T
Sbjct: 132 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 544 RGTRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGR 580
T Y PE L I D++ G ++ E+ +
Sbjct: 189 VVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 390 IGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKEF-CT--EITIIGNI-HHVNLV 441
IG G + V K + A+K + + ++ E + +H LV
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 442 RLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHT 497
L C Q R F V EY+N G L + + E RF EI+L L YLH
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH- 127
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLT 556
+ II+ D+K +N+LL + +K++D+G+ K L P ++ +T GT Y+APE L
Sbjct: 128 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILR 183
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
D ++ G+++ E+++GR
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGF 446
+G G + V++ I + + V VK + KK+ EI I+ N+ N++ L
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADI 99
Query: 447 C--AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRE-RFEIALGTARGLAYLHTGCDHKI 503
R LV+E++N + L+ + + R +EI L + L Y H+ I
Sbjct: 100 VKDPVSRTPALVFEHVNNTDF-KQLYQTLTDYDIRFYMYEI-L---KALDYCHS---MGI 151
Query: 504 IHCDVKPENILL-HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
+H DVKP N+++ H+ ++++ D+GL++ P Q + +R + PE L + D
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYD 209
Query: 563 KT-DVYSYGMVLLEIISGRK 581
+ D++S G +L +I ++
Sbjct: 210 YSLDMWSLGCMLASMIFRKE 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 390 IGSGGFGTVYKG--ILQDKSVVAVKKINSFGIQGKKE-F-CT---EITI---IGNIHHVN 439
IG G +G V+K + VA+K++ +Q +E + E+ + + H N
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 440 LVRLKGFCAQGRQR-----FLVYEYMN---KGSLDRTLFGNGSVLEWRERFEIALGTARG 491
+VRL C R LV+E+++ LD+ + ++ RG
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRG 132
Query: 492 LAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551
L +LH H+++H D+KP+NIL+ Q+K++DFGL+++ + + + T++ T Y A
Sbjct: 133 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRA 187
Query: 552 PEWLTSSAISDKTDVYSYGMVLLEIISGR 580
PE L S+ + D++S G + E+ +
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 26/204 (12%)
Query: 390 IGSGGFGTV----YKGILQDKSVVAVKKINSFGIQGKKEF-CT--EITIIG-NIHHVNLV 441
+G G FG V +K A+K + + + CT E ++ H L
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 442 RLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHT 497
+ Q ++ F V EY+N G L + R F EI LG L +LH
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----LQFLH- 135
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLT 556
I++ D+K +NILL +KI+DFG+ K + + + T GT Y+APE L
Sbjct: 136 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILL 191
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
+ D +S+G++L E++ G+
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 390 IGSGGFGTV----YKGILQDKSVVAVKKINSFGIQGKKEF-CT--EITIIGNI-HHVNLV 441
+G G FG V KG + AVK + + + CT E ++ L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 442 RLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHT 497
+L C Q R + V EY+N G L + G E F EIA+G L +L
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ- 138
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLT 556
II+ D+K +N++L + +KI+DFG+ K + ++ T GT Y+APE +
Sbjct: 139 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTFCGTPDYIAPEIIA 194
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
D +++G++L E+++G+
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 28/245 (11%)
Query: 351 KLGSRNSSSEELELTSIAGLPRRFSYEELAAATDNFN--TPIGSGGFGTVY----KGILQ 404
L + + +E A R + +F+ IG G + V K
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK--- 75
Query: 405 DKSVVAVKKINSFGIQGKKEF-CT--EITIIGNI-HHVNLVRLKGFCAQGRQR-FLVYEY 459
+ A++ + + ++ E + +H LV L C Q R F V EY
Sbjct: 76 TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEY 134
Query: 460 MNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHTGCDHKIIHCDVKPENILLH 516
+N G L + + E RF EI+L L YLH + II+ D+K +N+LL
Sbjct: 135 VNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ERGIIYRDLKLDNVLLD 187
Query: 517 DKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLE 575
+ +K++D+G+ K L P ++ +T GT Y+APE L D ++ G+++ E
Sbjct: 188 SEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245
Query: 576 IISGR 580
+++GR
Sbjct: 246 MMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-20
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 390 IGSGGFGTVY----KGILQDKSVVAVKKINSFGIQGKKEF-CT--EITIIGNI-HHVNLV 441
+G G FG V K + AVK + I + CT E I+ +H L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 442 RLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHT 497
+L C Q R F V E++N G L + + E R RF EI L +LH
Sbjct: 88 QLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA----LMFLH- 141
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLT 556
D II+ D+K +N+LL + K++DFG+ K + ++ T GT Y+APE L
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPEILQ 197
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
D ++ G++L E++ G
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 1e-19
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 390 IGSGGFGTV----YKGILQDKSVVAVKKINSFGIQGKKEF-CT--EITIIGNI-HHVNLV 441
+G G FG V KG + AVK + + + CT E ++ L
Sbjct: 349 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 442 RLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERF---EIALGTARGLAYLHT 497
+L C Q R + V EY+N G L + G E F EIA+G L +L
Sbjct: 406 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ- 459
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLT 556
II+ D+K +N++L + +KI+DFG+ K + ++ T GT Y+APE +
Sbjct: 460 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTFCGTPDYIAPEIIA 515
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
D +++G++L E+++G+
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 33/215 (15%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLVRL 443
P+G GG G V+ + VA+KKI + EI II + H N+V++
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKI-VLT---DPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 444 K----------GFCAQGRQRF----LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA 489
+V EYM L L G +LE R
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARL-FMYQLL 130
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDFGLSKLLTPEQSS--LFTTMRGT 546
RGL Y+H+ ++H D+KP N+ ++ + L +KI DFGL++++ P S + T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 547 RGYLAPEWLTSSAISDKT-DVYSYGMVLLEIISGR 580
+ Y +P L S K D+++ G + E+++G+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKI-NSFGIQGKKEFCT----EITIIGNIHHVNLVR 442
PIGSG G V VA+KK+ F + E+ ++ ++H N++
Sbjct: 69 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 443 LKG-FCAQGRQR-----FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLH 496
L F Q +LV E M+ +L + + + R + + G+ +LH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSY-LLYQMLCGIKHLH 181
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
+ IIH D+KP NI++ +KI DFGL++ + T TR Y APE +
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVIL 236
Query: 557 SSAISDKTDVYSYGMVLLEIISGR 580
+ D++S G ++ E++ +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 54/235 (22%), Positives = 89/235 (37%), Gaps = 41/235 (17%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKI-NSFGIQGKKEFCT----EITIIGNIHHVNLVR 442
IG G +G VY + VA+KK+ F C EITI+ + ++R
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE---DLIDCKRILREITILNRLKSDYIIR 89
Query: 443 LKG-FCAQGRQRF----LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
L +F +V E + L + + E + I G ++H
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIHE 147
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG------------ 545
IIH D+KP N LL+ VK+ DFGL++ + E+ +
Sbjct: 148 S---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 546 ---------TRGYLAPEWLTSSAISDKT-DVYSYGMVLLEIISGRKNSSLKIQSR 590
TR Y APE + K+ D++S G + E+++ ++ +R
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKI-NSFGIQGKKEFCT----EITIIGNIHHVNLVR 442
P+GSG +G V + + + VA+KK+ F + F E+ ++ ++ H N++
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKHMRHENVIG 88
Query: 443 LKG-FCAQGRQR-----FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLH 496
L F +LV +M L + + L + +GL Y+H
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
IIH D+KP N+ +++ ++KI DFGL++ E T TR Y APE +
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVIL 198
Query: 557 SSAISDKT-DVYSYGMVLLEIISGR 580
+ +T D++S G ++ E+I+G+
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKI-NSFGIQGKKEFCT----EITIIGNIHHVNLVR 442
P+GSG +G+V + VAVKK+ F E+ ++ ++ H N++
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIG 92
Query: 443 LKG-FCAQGRQR-----FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLH 496
L F +LV M L+ + + + +F + RGL Y+H
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ-KLTDDHVQF-LIYQILRGLKYIH 149
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
+ IIH D+KP N+ +++ ++KI DFGL++ E T TR Y APE +
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIML 202
Query: 557 SSAISDKT-DVYSYGMVLLEIISGR 580
+ ++T D++S G ++ E+++GR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 53/244 (21%), Positives = 94/244 (38%), Gaps = 70/244 (28%)
Query: 389 PIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCT-EITIIGNIHHVNLVRLK-G 445
+G+G FG V + + A+KK+ + E+ I+ + HVN+++L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 446 FCAQGRQRF-------------------------------------LVYEYMNKGSLDRT 468
F G + ++ EY+ T
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-----PDT 123
Query: 469 LFGNGSVLEWRERFEIALG----------TARGLAYLHTGCDHKIIHCDVKPENILLH-D 517
L VL+ R ++ R + ++H+ I H D+KP+N+L++
Sbjct: 124 LH---KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 518 KLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE-WLTSSAISDKTDVYSYGMVLLEI 576
+K+ DFG +K L P + S +R Y APE L ++ + D++S G V E+
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 577 ISGR 580
I G+
Sbjct: 236 ILGK 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 6e-18
Identities = 52/249 (20%), Positives = 93/249 (37%), Gaps = 64/249 (25%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCT----EITIIGNIHHVNLVRL 443
IG+G +G V + +K VVA+KKI + C EI I+ ++H ++V++
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 444 KG-FCAQGRQRF----LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA--------- 489
+ ++F +V E + + R + L
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADS-DFKKLF-----------RTPVYLTELHIKTLLYNL 165
Query: 490 -RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG--- 545
G+ Y+H+ I+H D+KP N L++ VK+ DFGL++ + ++
Sbjct: 166 LVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 546 -----------------------TRGYLAPEWLTSSAISDKT-DVYSYGMVLLEIISGRK 581
TR Y APE + + DV+S G + E+++ K
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282
Query: 582 NSSLKIQSR 590
+ R
Sbjct: 283 ENVAYHADR 291
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 21/198 (10%), Positives = 48/198 (24%), Gaps = 42/198 (21%)
Query: 389 PIGSGGFGTVYKGILQDKS---VVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVR 442
G ++ D + VA+ ++ G+ +E + + I + R
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
+ +V E++ GSL + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISD 562
+ P + + V ++ + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NP 181
Query: 563 KTDVYSYGMVLLEIISGR 580
+ D+ G L ++ R
Sbjct: 182 QDDIRGIGASLYALLVNR 199
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 48/225 (21%), Positives = 91/225 (40%), Gaps = 53/225 (23%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINS---FGIQGKKE---------FCTEITIIGNIH 436
+G G F TV+ + + + VA+K + + + E +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86
Query: 437 HVNLVRLKG-FCAQGRQR---FLVYEYMNKGSLDRTLFGNGSVLEWRERFE--------- 483
H+ ++L F +G +V+E + + ++L +++E
Sbjct: 87 HI--LKLLDHFNHKGPNGVHVVMVFEVLGE-----------NLLALIKKYEHRGIPLIYV 133
Query: 484 --IALGTARGLAYLHTGCDHKIIHCDVKPENILL------HDKLQVKISDFGLSKLLTPE 535
I+ GL Y+H C IIH D+KPEN+L+ + +Q+KI+D G +
Sbjct: 134 KQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 536 QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
++ TR Y +PE L + D++S ++ E+I+G
Sbjct: 192 YTNSIQ----TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKI-NSFGIQGKKEFCT----EITIIGNIH-HVNLV 441
+G G +G V+K I + VVAVKKI ++F EI I+ + H N+V
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ---NSTDAQRTFREIMILTELSGHENIV 72
Query: 442 RLKG-FCAQGRQRF-LVYEYMNKGSLDRTLFGNGSVL-EWRERFEIALGTARGLAYLHTG 498
L A + LV++YM L + N +L +++ + + + YLH+G
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQY-VVYQLIKVIKYLHSG 128
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG------------- 545
++H D+KP NILL+ + VK++DFGLS+ +
Sbjct: 129 ---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 546 -------TRGYLAPEWLTSSAISDKT-DVYSYGMVLLEIISGR 580
TR Y APE L S K D++S G +L EI+ G+
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 40/159 (25%), Positives = 63/159 (39%), Gaps = 26/159 (16%)
Query: 386 FNTPIGSGGFGTVYKGILQDKS---VVAVKKINSFGIQGKKEFC-TEITIIGNI-HHVNL 440
+ +G G G V + +K A+K + E+ + ++
Sbjct: 22 TSQVLGLGINGKVLQIF--NKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHI 73
Query: 441 VRLKGFC----AQGRQRFLVYEYMNKGSL-DRTLF-GNGSVLEWRERFEIALGTARGLAY 494
VR+ A + +V E ++ G L R G+ + E RE EI + Y
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQY 132
Query: 495 LHTGCDHKIIHCDVKPENILLHDK---LQVKISDFGLSK 530
LH I H DVKPEN+L K +K++DFG +K
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 61/222 (27%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFC----TEITII--------GNIH 436
IG G FG V K + VA+K + + +K F EI I+ N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 437 HVNLVRLKGF-------CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF------- 482
+V + + C + +E L L+ +++ + +F
Sbjct: 160 NV--IHMLENFTFRNHIC-------MTFE-----LLSMNLY---ELIK-KNKFQGFSLPL 201
Query: 483 --EIALGTARGLAYLHTGCDHKIIHCDVKPENILL--HDKLQVKISDFGLSKLLTPEQSS 538
+ A + L LH ++IIHCD+KPENILL + +K+ DFG S E
Sbjct: 202 VRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQR 255
Query: 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
++T ++ +R Y APE + + D++S G +L E+++G
Sbjct: 256 VYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 9e-14
Identities = 46/269 (17%), Positives = 70/269 (26%), Gaps = 67/269 (24%)
Query: 371 PRRFSYEELAAATDNFNTP--IGSGGFGTVYKGILQDKSVVAVKKI--------NSFGIQ 420
P FS+ T+ IG G FG V++ I VA+K I N +
Sbjct: 10 PVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQK 65
Query: 421 GKKEFCTEITI---------IGNIHHVNLVRLKG-FCAQGR------------------- 451
+E EI I + L C QG
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 452 ----------QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
Q F+V E+ G + I LA
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEA--SL 181
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAIS 561
+ H D+ N+LL K+ K T L ++ T S +
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII---------DYTLSRLE 232
Query: 562 DKTDVYSYGMVL-LEIISGRKNSSLKIQS 589
V + + ++ +G + I
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYR 261
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINS---FGIQGKKEFCTEITII--------GNIHH 437
IG G FG V K ++ VA+K I + F Q + E + ++ ++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMKYY 117
Query: 438 VNLVRLKGF-------CAQGRQRFLVYEYMNKGSLDRTLFGNG----SVLEWRERFEIAL 486
+ V LK C LV+E ++ +L L S+ R+ A
Sbjct: 118 I--VHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLNLTRK---FAQ 164
Query: 487 GTARGLAYLHTGCDHKIIHCDVKPENILLHD--KLQVKISDFGLSKLLTPEQSSLFTTMR 544
L +L T + IIHCD+KPENILL + + +KI DFG S ++ ++
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQ 220
Query: 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR 580
+R Y +PE L D++S G +L+E+ +G
Sbjct: 221 -SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 12/111 (10%)
Query: 473 GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532
L + A+G+ +L K IH D+ NILL +K VKI DFGL++ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 533 TPEQSSLFTTMRGTRGYL-----APEWLTSSAISDKTDVYSYGMVLLEIIS 578
+ +R L APE + + ++DV+S+G++L EI S
Sbjct: 244 YKDP----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 42/199 (21%), Positives = 68/199 (34%), Gaps = 23/199 (11%)
Query: 386 FNTPIGSGGFGTVYKGIL------QDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNI-HH 437
P+G G FG V + VAVK + + +E+ I+ +I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 438 VNLVRLKGFCAQ-GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLH 496
+N+V L G C + G ++ E+ G+L L +R E +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEFVPYKTKGARFRQ 137
Query: 497 TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 556
I D+K + S F K L+ + + +L E L
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY-KDFLTLEHLI 196
Query: 557 SSAISDKTDVYSYGMVLLE 575
+ V + GM L
Sbjct: 197 CYSF----QV-AKGMEFLA 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 30/171 (17%), Positives = 61/171 (35%), Gaps = 41/171 (23%)
Query: 390 IGSGGFGTVYKGI---------LQDKSVVAVK----------KINSFGIQGKKEFCTEIT 430
G +Y+ K ++K + N F K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 431 IIGNIHHVNLVRLKGF-CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA 489
+ + + + GF Q + RFLV + + SL S L+ + ++ +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-------SALDVSPKHVLSERSV 161
Query: 490 RGLA--------YLHTGCDHKIIHCDVKPENILL--HDKLQVKISDFGLSK 530
+A +LH +++ +H +V ENI + D+ QV ++ +G +
Sbjct: 162 LQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 49/243 (20%), Positives = 83/243 (34%), Gaps = 87/243 (35%)
Query: 390 IGSGGFGTVYKGI--LQDKSVVAVKKI---NSFGIQGKKEFCTEITII--------GNIH 436
+G G FG V + + + KS VA+K I + + EI ++ N
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR----LEINVLKKIKEKDKENKF 82
Query: 437 HVNLVRLKGF-------CAQGRQRFLV--------YEYMNKGSLDRTLFGNGSVLEWRER 481
V + + C + +E++ + + L
Sbjct: 83 LC--VLMSDWFNFHGHMC-------IAFELLGKNTFEFLKENNF------QPYPLPHVRH 127
Query: 482 FEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-------------------KLQVK 522
L A L +LH ++++ H D+KPENIL + ++
Sbjct: 128 MAYQLCHA--LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 523 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE------WLTSSAISDKTDVYSYGMVLLEI 576
++DFG + T + T + TR Y PE W + DV+S G +L E
Sbjct: 183 VADFGSA---TFDHEHHTTIVA-TRHYRPPEVILELGW--AQPC----DVWSIGCILFEY 232
Query: 577 ISG 579
G
Sbjct: 233 YRG 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 8e-11
Identities = 98/646 (15%), Positives = 193/646 (29%), Gaps = 189/646 (29%)
Query: 2 LDSRVSSMQLQESGNLVL---------LDARNVSLWQSFDSP--------TDAIV----- 39
+D Q Q +++ D ++V D P D I+
Sbjct: 7 MDFETGEHQYQ-YKDILSVFEDAFVDNFDCKDVQ-----DMPKSILSKEEIDHIIMSKDA 60
Query: 40 TGQTLRVGKSLAASVSENDLSVGEYSFVVTDGDGVLQWNQMTY-WKLSMYSYAFKDSDAP 98
TLR+ +L + E FV + VL+ N Y + +S +
Sbjct: 61 VSGTLRLFWTLLSKQEE-----MVQKFV----EEVLRIN---YKFLMSPIKTEQRQPSMM 108
Query: 99 VSFLSVNRTGLYLLASDGSRFV------------LKVSLDAAGFRIAKLEPSGRLIV--- 143
R LY +D F L+ +L +L P+ +++
Sbjct: 109 TRMYIEQRDRLY---NDNQVFAKYNVSRLQPYLKLRQAL-------LELRPAKNVLIDGV 158
Query: 144 -----SKLVGDNLVQELAIPVENCRIPFFCKEIGLCSGGSCSCPSGFHAELNGDCVPINS 198
+ + D L+ V+ C++ F +I + +C+ P L I+
Sbjct: 159 LGSGKTWVALDVC---LSYKVQ-CKMDF---KIFWLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 199 SLSLPNGCSATNASGLNSSITYLKLGNGVDYFANDFIQPVKRG--VGLSDCQDLCSWNCS 256
+ + + S+ ++S L+ + +P + V L + N
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELR-----RLLKS---KPYENCLLV-LLNV-----QNAK 257
Query: 257 CLGIFHDDSSESCYFIENHLGTLMSSSDNERV-RLGYIKAMVLSSDGSKKA--EDENGSK 313
F + SC L+++ + L +S D DE S
Sbjct: 258 AWNAF----NLSCK-------ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 314 F------PVAGLVLIPS-----SLLAIAIVVGFL------W--WRINSKRARAKVIKLGS 354
L P + ++I+ + W W+ + +I+
Sbjct: 307 LLKYLDCRPQDL---PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE--- 360
Query: 355 RNSSSEELELTSIAGLPRRFSYEELAAATDNF--NTPIGSGGFGTVYKGILQDKSVVAVK 412
SS LE R ++ L+ F + I + ++ +++ +V V
Sbjct: 361 --SSLNVLEPAEY-----RKMFDRLSV----FPPSAHIPTILLSLIWFDVIKSDVMVVVN 409
Query: 413 KINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQ--RFLVYEYMNKGSLDR 467
K++ + + Q K+ + I + L LK R +V Y ++ +
Sbjct: 410 KLHKYSLVEKQPKESTIS-------IPSIYL-ELKVKLENEYALHRSIVDHY----NIPK 457
Query: 468 TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH--KIIHCDVKPE--NILLHDK-LQVK 522
T + + + Y H G H I H + + L + L+ K
Sbjct: 458 TFDSDDLIPPY----------LDQYFYSHIG-HHLKNIEHPERMTLFRMVFLDFRFLEQK 506
Query: 523 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
I + + + ++ + Y I D Y
Sbjct: 507 IRHDSTAWNASGSILNTLQQLKFYKPY----------ICDNDPKYE 542
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 3e-10
Identities = 88/645 (13%), Positives = 164/645 (25%), Gaps = 237/645 (36%)
Query: 214 LNSSITYLKLGNG--VDYFANDFIQPVKRGVGLSDCQDLCSWNCSCLGIFHDDSSESCYF 271
++ + + F + F+ DC+D+ I S E
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNF-------DCKDVQD---MPKSIL---SKEEIDH 53
Query: 272 IENHLGTLMSSSDNERVRLGYIKAMVLSSDGSKKAEDENGSKFPVAGLVLIPSSLLAIAI 331
I +MS + L S + + KF VL +
Sbjct: 54 I------IMSKDAVSGTLRLFW---TLLSKQEEMVQ-----KF--VEEVLRIN------- 90
Query: 332 VVGFLWWRI---NSKRARAKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAA----TD 384
FL I + + + + R+ + ++ + + R Y +L A
Sbjct: 91 -YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP 149
Query: 385 NFNTPI-GSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRL 443
N I G G G K+ VA+ S+ +Q K +F I +NL
Sbjct: 150 AKNVLIDGVLGSG---------KTWVALDVCLSYKVQCKMDF--------KIFWLNL--- 189
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLE-----WRERFEIALGTARGLAYLHTG 498
C V E + K L + N + + R R L
Sbjct: 190 -KNCNSPE---TVLEMLQK--LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-- 241
Query: 499 CDHKIIHC-----DVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 553
++ +C +V+ L KI LLT TR
Sbjct: 242 -PYE--NCLLVLLNVQNAKAWNAFNLSCKI-------LLT------------TR------ 273
Query: 554 WLTSSAISDKTDVYSYGMVLLEIISG--RKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611
++D + + L+ S + + + + PRE
Sbjct: 274 ---FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC---------RPQDLPRE 321
Query: 612 SQRVYFPLL----ALELHE--------------------------------QRRYLELA- 634
P A + + ++ + L+
Sbjct: 322 VLTT-NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 635 ---DSRIEGQV--------SDEDVE----KLVRIALCCVQEEPM----------LRPSMA 669
+ I + DV KL + +L Q + L+ +
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440
Query: 670 NVVSM---LEGGMPLGEPRIESLRFLR---------------FY---GQRFNEASTIEES 708
N ++ + ++ + FY G E
Sbjct: 441 NEYALHRSI----------VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERM 490
Query: 709 NE-----LNLQFI---LQSETNGTNTTGSYNSL--------SYIS 737
L+ +F+ ++ ++ N +GS + YI
Sbjct: 491 TLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC 535
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 71/369 (19%), Positives = 120/369 (32%), Gaps = 119/369 (32%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITII-----GNIHHVNLVRL 443
+G G F TV+ +Q K VA+K + S + EI ++ + + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPN---- 99
Query: 444 KGFCAQGRQRF-----------LVYEYMNKGSLDRTLFGNGSVLEWRERF---------- 482
+ Q F +V+E + G +L+W +
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL--GH---------HLLKWIIKSNYQGLPLPCV 148
Query: 483 -EIALGTARGLAYLHTGCDHKIIHCDVKPENILL-------------------------- 515
+I +GL YLHT C +IIH D+KPENILL
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 516 -----------------------HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 552
+KL+VKI+D G + + + TR Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSL 262
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGD----------GNG 602
E L S + D++S + E+ +G L + S E+ + + G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD---YL-FEPHSGEEYTRDEDHIALIIELLGKV 318
Query: 603 PSSSSSPRESQRVYF----PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCV 658
P + + +F L + + E+ + E S E+ L +
Sbjct: 319 PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEW--SQEEAAGFTDFLLPML 376
Query: 659 QEEPMLRPS 667
+ P R +
Sbjct: 377 ELIPEKRAT 385
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 53/250 (21%), Positives = 84/250 (33%), Gaps = 97/250 (38%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINS---FGIQGKKEFCTEITIIGNI-------HHV 438
+G G FG V + +K AVK + + + K E I+ I +++
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNNI 98
Query: 439 NLVRLKGF-------CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF--------- 482
V+ G C L++E + S+ E R
Sbjct: 99 --VKYHGKFMYYDHMC-------LIFEPLGP-----------SLYEIITRNNYNGFHIED 138
Query: 483 --EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD----------------------- 517
+ + L YL + H D+KPENILL D
Sbjct: 139 IKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 518 --KLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE------WLTSSAISDKTDVYSY 569
+K+ DFG + T + + + TR Y APE W + D++S+
Sbjct: 196 TKSTGIKLIDFGCA---TFKSDYHGSIIN-TRQYRAPEVILNLGW--DVSS----DMWSF 245
Query: 570 GMVLLEIISG 579
G VL E+ +G
Sbjct: 246 GCVLAELYTG 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 42/156 (26%), Positives = 63/156 (40%), Gaps = 29/156 (18%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
IG G FG + G L VA+K + S Q E+ + + ++ F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVYYF 73
Query: 447 CAQGRQRFLVYEYMNKGSL-------DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
G+ +V E + SL DRT F +VL IA+ + Y+H
Sbjct: 74 GPCGKYNAMVLELLGP-SLEDLFDLCDRT-FSLKTVLM------IAIQLISRMEYVH--- 122
Query: 500 DHKIIHCDVKPENILL-----HDKLQVKISDFGLSK 530
+I+ DVKPEN L+ + + I DF L+K
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 33/155 (21%), Positives = 61/155 (39%), Gaps = 27/155 (17%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
IG G FG +++G L + VA+K S Q + E ++ + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDE-YRTYKLLAGCTGI--PNVYYF 74
Query: 447 CAQGRQRFLVYEYMNKGSLDRTL------FGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
+G LV + + SL+ L F +V A + +H +
Sbjct: 75 GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAM------AAKQMLARVQSIH---E 124
Query: 501 HKIIHCDVKPENILL-----HDKLQVKISDFGLSK 530
+++ D+KP+N L+ + + + DFG+ K
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 53/245 (21%), Positives = 85/245 (34%), Gaps = 91/245 (37%)
Query: 390 IGSGGFGTVYKGI--LQDKSVVAVKKI---NSFGIQGKKEFCTEITII--------GNIH 436
+G G FG V + I VAVK + + + + E I ++ +
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPNSTF 77
Query: 437 HVNLVRLKGF-------CAQGRQRFLVYEYMNKGSLDRTLF----GNGSVLEWRERF--- 482
V++ + C +V+E L + + NG F
Sbjct: 78 RC--VQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKENG-----FLPFRLD 118
Query: 483 ---EIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-------------------KLQ 520
++A + + +LH +K+ H D+KPENIL
Sbjct: 119 HIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 521 VKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE------WLTSSAISDKTDVYSYGMVLL 574
+K+ DFG + T + T + TR Y APE W S DV+S G +L+
Sbjct: 176 IKVVDFGSA---TYDDEHHSTLVS-TRHYRAPEVILALGW--SQPC----DVWSIGCILI 225
Query: 575 EIISG 579
E G
Sbjct: 226 EYYLG 230
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 33/168 (19%), Positives = 59/168 (35%), Gaps = 38/168 (22%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKI--------------NSFGIQGKKEFCTEITIIGN 434
IGSGGFG +Y A + + KK+ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 435 IHHVNLVRLKGF----CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERF------EI 484
+ ++ + G RF+V E + L + F ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ-------KISGQNGTFKKSTVLQL 156
Query: 485 ALGTARGLAYLHTGCDHKIIHCDVKPENILLH--DKLQVKISDFGLSK 530
+ L Y+H +++ +H D+K N+LL + QV ++D+GLS
Sbjct: 157 GIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 37/147 (25%), Positives = 58/147 (39%), Gaps = 13/147 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
IGSG FG +Y G + VA+K + + Q E ++ + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVGI--PTIRWC 73
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
A+G +V E + SL+ + +A + Y+H IH
Sbjct: 74 GAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 507 DVKPENILLH---DKLQVKISDFGLSK 530
DVKP+N L+ V I DFGL+K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 31/164 (18%), Positives = 60/164 (36%), Gaps = 27/164 (16%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKK-----------------INSFGIQGKKEFCTEITII 432
IG GGFG +Y + V + + K E +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 433 GNIHHVNLVRLKGFCAQGRQ----RFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGT 488
+ ++ + + G + RF++ + L + N + +++L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 489 ARGLAYLHTGCDHKIIHCDVKPENILL--HDKLQVKISDFGLSK 530
L Y+H +H+ +H D+K N+LL + QV + D+GL+
Sbjct: 162 LDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 13/147 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVK--KINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGF 446
IGSG FG +Y G +Q VA+K + + Q E I+ + ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI-YRILQGGTGI--PNVRWF 71
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
+G LV + + SL+ L + +A + ++H +H
Sbjct: 72 GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127
Query: 507 DVKPENILL---HDKLQVKISDFGLSK 530
D+KP+N L+ QV I DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 745 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-04 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-04 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 4e-68
Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 42/291 (14%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
IGSG FGTVYKG V + + + Q + F E+ ++ HVN++ G+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 450 GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVK 509
Q +V ++ SL L + E + +IA TA+G+ YLH IIH D+K
Sbjct: 76 P-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 510 PENILLHDKLQVKISDFGLSKLLTP-EQSSLFTTMRGTRGYLAPEWLT---SSAISDKTD 565
NI LH+ L VKI DFGL+ + + S F + G+ ++APE + + S ++D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 566 VYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625
VY++G+VL E+++G+ P S+ + R+ +
Sbjct: 192 VYAFGIVLYELMTGQL---------------------PYSNINNRD---------QIIFM 221
Query: 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
R YL S++ + R+ C++++ RP +++ +E
Sbjct: 222 VGRGYLSPDLSKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-63
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 44/288 (15%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
+G+G FG V+ G + VAVK + G F E ++ + H LVRL Q
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 450 GRQRFLVYEYMNKGSLDRTLFGNGSV-LEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+++ EYM GSL L + L + ++A A G+A++ + IH D+
Sbjct: 80 E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
+ NIL+ D L KI+DFGL++L+ + + + + APE + + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 569 YGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQR 628
+G++L EI++ + P + E ++ E+
Sbjct: 196 FGILLTEIVTHGRI--------------------PYPGMTNPE---------VIQNLERG 226
Query: 629 RYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
+ D+ +E L ++ C +E P RP+ + S+LE
Sbjct: 227 YRMVRPDN-----CPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 9e-63
Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 14/298 (4%)
Query: 382 ATDNFNT--PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQG-KKEFCTEITIIGNIHH 437
D+F +G+G G V+K V+A K I+ + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 438 VNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
+V G + + E+M+ GSLD+ L G + + ++++ +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 122
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
HKI+H DVKP NIL++ + ++K+ DFG+S L + + GTR Y++PE L
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG 177
Query: 558 SAISDKTDVYSYGMVLLEIISGRK----NSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQ 613
+ S ++D++S G+ L+E+ GR + +++ + P +P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 614 RVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671
Y + + + S + C+ + P R + +
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-62
Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 42/292 (14%)
Query: 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
F +G+G FG V G + + VA+K I G + EF E ++ N+ H LV+L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G C + R F++ EYM G L L + ++ E+ + YL + +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
H D+ N L++D+ VK+SDFGLS+ + ++ + + + PE L S S K+
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 565 DVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624
D++++G+++ EI S K P + E+
Sbjct: 183 DIWAFGVLMWEIYSLGKM--------------------PYERFTNSET------------ 210
Query: 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
E + EK+ I C E+ RP+ ++S +
Sbjct: 211 ------AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 1e-61
Identities = 78/323 (24%), Positives = 133/323 (41%), Gaps = 61/323 (18%)
Query: 374 FSYEELAAATDNFNTP-----------IGSGGFGTVYKGIL----QDKSVVAVKKINS-F 417
F++E+ A F IG+G FG V G L + + VA+K + S +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 418 GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLE 477
+ +++F +E +I+G H N++ L+G + ++ E+M GSLD L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 478 WRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537
+ + G A G+ YL D +H D+ NIL++ L K+SDFGLS+ L + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 538 SLFTT----MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTE 593
T + + APE + + +DV+SYG+V+ E++S
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY-------------- 229
Query: 594 KDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRI 653
G P + ++ + EQ L + L ++
Sbjct: 230 ------GERPYWDMTNQD---------VINAIEQDYRLPP---------PMDCPSALHQL 265
Query: 654 ALCCVQEEPMLRPSMANVVSMLE 676
L C Q++ RP +V+ L+
Sbjct: 266 MLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-61
Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 42/292 (14%)
Query: 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLK 444
F IGSG FG V+ G +K VA+K I G +++F E ++ + H LV+L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G C + LV+E+M G L L + + L G+AYL + +I
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 123
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
H D+ N L+ + +K+SDFG+++ + +Q + T + + +PE + S S K+
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 565 DVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624
DV+S+G+++ E+ S K P + S E +
Sbjct: 184 DVWSFGVLMWEVFSEGKI--------------------PYENRSNSEV-----------V 212
Query: 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
+ L R+ + +I C +E P RP+ + ++ L
Sbjct: 213 EDISTGFRLYKPRLAS-------THVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-60
Identities = 71/309 (22%), Positives = 117/309 (37%), Gaps = 51/309 (16%)
Query: 377 EELAAATDNF---NTPIGSGGFGTVYKGILQDKS---VVAVKKINSFGIQG-KKEFCTEI 429
++L DN + +G G FG+V +G+ + + VA+K + + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 430 TIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTA 489
I+ + + +VRL G C Q LV E G L + L G + E+ +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 490 RGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS--SLFTTMRGTR 547
G+ YL + +H D+ N+LL ++ KISDFGLSK L + S + + +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSS 607
+ APE + S ++DV+SYG+ + E +S G P
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSY--------------------GQKPYKKM 216
Query: 608 SPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS 667
E + EQ + +E E L + C + RP
Sbjct: 217 KGPE---------VMAFIEQGKRMECPPE-----CPPE----LYALMSDCWIYKWEDRPD 258
Query: 668 MANVVSMLE 676
V +
Sbjct: 259 FLTVEQRMR 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-59
Identities = 73/313 (23%), Positives = 125/313 (39%), Gaps = 52/313 (16%)
Query: 368 AGLPR---RFSYEELAAATDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKE 424
GL + E L +G G FG V+ G + VA+K + G +
Sbjct: 5 QGLAKDAWEIPRESL-----RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEA 58
Query: 425 FCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFG-NGSVLEWRERFE 483
F E ++ + H LV+L ++ ++V EYM+KGSL L G G L + +
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 484 IALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543
+A A G+AY+ +H D++ NIL+ + L K++DFGL++L+ + +
Sbjct: 118 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174
Query: 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGP 603
+ + APE + K+DV+S+G++L E+ + + P
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV--------------------P 214
Query: 604 SSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPM 663
RE L+ + E E L + C ++EP
Sbjct: 215 YPGMVNRE------------------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 256
Query: 664 LRPSMANVVSMLE 676
RP+ + + LE
Sbjct: 257 ERPTFEYLQAFLE 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-57
Identities = 72/289 (24%), Positives = 115/289 (39%), Gaps = 50/289 (17%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
IG G FG V G + VAVK I + + F E +++ + H NLV+L G +
Sbjct: 15 IGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 450 GRQR-FLVYEYMNKGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ ++V EYM KGSL L G SVL + +L + YL + +H D
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 128
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
+ N+L+ + K+SDFGL+K + Q T + + APE L S K+DV+
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVW 184
Query: 568 SYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQ 627
S+G++L EI S + P ++ + E+
Sbjct: 185 SFGILLWEIYSFGRV--------------------PYPRIPLKD---------VVPRVEK 215
Query: 628 RRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
++ D + + C + +RPS + LE
Sbjct: 216 GYKMDAPDG-----CPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 3e-57
Identities = 71/310 (22%), Positives = 124/310 (40%), Gaps = 46/310 (14%)
Query: 371 PRRFSYEELAAATDNFN--TPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCT 427
P +Y++ + +G G +G VY+G+ + VAVK + ++ +EF
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62
Query: 428 EITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLF-GNGSVLEWRERFEIAL 486
E ++ I H NLV+L G C + +++ E+M G+L L N + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 487 GTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGT 546
+ + YL IH D+ N L+ + VK++DFGLS+L+T + + +
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 547 RGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSS 606
+ APE L + S K+DV+++G++L EI + + P
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------------PYPG 219
Query: 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP 666
+ EL + + + EK+ + C Q P RP
Sbjct: 220 IDLSQ------------------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 261
Query: 667 SMANVVSMLE 676
S A + E
Sbjct: 262 SFAEIHQAFE 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-56
Identities = 67/306 (21%), Positives = 109/306 (35%), Gaps = 42/306 (13%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ 449
IG G FG V++G + + VAVK +S + EI + H N++ +
Sbjct: 11 IGKGRFGEVWRGKWRGE-EVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 450 GR----QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH---- 501
Q +LV +Y GSL L + ++AL TA GLA+LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 502 -KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF---TTMRGTRGYLAPEWLTS 557
I H D+K +NIL+ I+D GL+ ++ GT+ Y+APE L
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 558 SA------ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611
S + D+Y+ G+V EI + + D
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD---------------- 230
Query: 612 SQRVYFPLLALELHEQRRYLELADSRIEGQV-SDEDVEKLVRIALCCVQEEPMLRPSMAN 670
+ ++E + + I + S E + + +I C R +
Sbjct: 231 ---LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 671 VVSMLE 676
+ L
Sbjct: 288 IKKTLS 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-56
Identities = 71/294 (24%), Positives = 112/294 (38%), Gaps = 50/294 (17%)
Query: 390 IGSGGFGTVYKGILQDKSV---VAVKKINSFGIQG--KKEFCTEITIIGNIHHVNLVRLK 444
+GSG FGTV KG Q K V VAVK + + K E E ++ + + +VR+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G C + LV E G L++ L N ++ + E+ + G+ YL + +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFV 129
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT--MRGTRGYLAPEWLTSSAISD 562
H D+ N+LL + KISDFGLSK L +++ + + APE + S
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 563 KTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622
K+DV+S+G+++ E S G P E
Sbjct: 190 KSDVWSFGVLMWEAFS--------------------YGQKPYRGMKGSE---------VT 220
Query: 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
+ E+ + E + + C + RP A V L
Sbjct: 221 AMLEKGERMGCPAG-----CPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-56
Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 50/301 (16%)
Query: 385 NFNTPIGSGGFGTVYKGILQDKS----VVAVKKINSFGIQGK-KEFCTEITIIGNIHHVN 439
+FN IG G FG VY G L D AVK +N G+ +F TE I+ + H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 440 LVRLKGFCAQGRQR-FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
++ L G C + +V YM G L + ++ L A+G+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFL 146
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ---SSLFTTMRGTRGYLAPEWL 555
K +H D+ N +L +K VK++DFGL++ + ++ T + ++A E L
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 556 TSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615
+ + K+DV+S+G++L E+++ P + +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP--------------------PYPDVNTFD---- 242
Query: 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675
+ + L + RR L+ + + L + L C + +RPS + +VS +
Sbjct: 243 ----ITVYLLQGRRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288
Query: 676 E 676
Sbjct: 289 S 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-55
Identities = 72/296 (24%), Positives = 133/296 (44%), Gaps = 49/296 (16%)
Query: 390 IGSGGFGTVYKGILQDKS-----VVAVKKINSFGIQG-KKEFCTEITIIGNIHHVNLVRL 443
IG+G FG VYKG+L+ S VA+K + + + + +F E I+G H N++RL
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
+G ++ + ++ EYM G+LD+ L + + G A G+ YL +
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNY 131
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT--MRGTRGYLAPEWLTSSAIS 561
+H D+ NIL++ L K+SDFGLS++L + + +TT + + APE ++ +
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 191
Query: 562 DKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621
+DV+S+G+V+ E+++ + P S E
Sbjct: 192 SASDVWSFGIVMWEVMTYGER--------------------PYWELSNHE---------- 221
Query: 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677
++ + + + ++ + C Q+E RP A++VS+L+
Sbjct: 222 --------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 2e-54
Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 54/292 (18%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK---KEFCTEITIIGNIHHVNLVRLK 444
IG G FG VY +++ VVA+KK++ G Q ++ E+ + + H N ++ +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + +LV EY + D L+ E + G +GLAYLH H +I
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH---SHNMI 137
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS---AIS 561
H DVK NILL + VK+ DFG + ++ P + GT ++APE + +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYD 192
Query: 562 DKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621
K DV+S G+ +E+ + P + + A
Sbjct: 193 GKVDVWSLGITCIELAERKP---------------------PLFNMNAMS---------A 222
Query: 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673
L Q L G S+ C+Q+ P RP+ ++
Sbjct: 223 LYHIAQNESPAL----QSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 4e-54
Identities = 71/335 (21%), Positives = 121/335 (36%), Gaps = 74/335 (22%)
Query: 375 SYEELAAATDNFNT--PIGSGGFGTVYKGIL------QDKSVVAVKKIN-SFGIQGKKEF 425
L +N IG G FG V++ + ++VAVK + + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 426 CTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGS----------- 474
E ++ + N+V+L G CA G+ L++EYM G L+ L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 475 ------------VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVK 522
L E+ IA A G+AYL + K +H D+ N L+ + + VK
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 523 ISDFGLSKLLTP-EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRK 581
I+DFGLS+ + + ++ PE + + + ++DV++YG+VL EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 582 NSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQ 641
P + E + L
Sbjct: 241 Q--------------------PYYGMAHEE---------VIYYVRDGNILAC-------- 263
Query: 642 VSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
+ +L + C + P RPS ++ +L+
Sbjct: 264 -PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 5e-54
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G FG VYK + + A K I++ + +++ EI I+ + H N+V+L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+++ E+ G++D + L + + T L YLH D+KIIH D+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 136
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL-----TSSAISDK 563
K NIL +K++DFG+S T + GT ++APE + K
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRR-DSFIGTPYWMAPEVVMCETSKDRPYDYK 195
Query: 564 TDVYSYGMVLLEIISGR 580
DV+S G+ L+E+
Sbjct: 196 ADVWSLGITLIEMAEIE 212
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 2e-53
Identities = 61/314 (19%), Positives = 114/314 (36%), Gaps = 66/314 (21%)
Query: 390 IGSGGFGTVYKGIL------QDKSVVAVKKINSFGIQG-KKEFCTEITIIGNI-HHVNLV 441
+G+G FG V + VAVK + ++ +E+ ++ + +H+N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGS-----------------VLEWRERFEI 484
L G C G ++ EY G L L L+ +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 485 ALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM- 543
+ A+G+A+L IH D+ NILL KI DFGL++ + + + +
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGP 603
R ++APE + + + ++DV+SYG+ L E+ S
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS---------------------S 246
Query: 604 SSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPM 663
P +S+ + ++ + ++ I C +P+
Sbjct: 247 PYPGMPVDSK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL 290
Query: 664 LRPSMANVVSMLEG 677
RP+ +V ++E
Sbjct: 291 KRPTFKQIVQLIEK 304
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-53
Identities = 64/301 (21%), Positives = 118/301 (39%), Gaps = 52/301 (17%)
Query: 384 DNFN--TPIGSGGFGTVYKGI-LQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHV 438
+++ IG+G +G K D ++ K+++ S K+ +E+ ++ + H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 439 NLVRLKGFC--AQGRQRFLVYEYMNKGSLDRTLFGNGS---VLEWRERFEIALGTARGLA 493
N+VR ++V EY G L + L+ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 494 YLH--TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 551
H + H ++H D+KP N+ L K VK+ DFGL+++L + S GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KAFVGTPYYMS 182
Query: 552 PEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611
PE + + ++K+D++S G +L E+ + P ++ S +E
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP---------------------PFTAFSQKE 221
Query: 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671
L + R RI + SDE L I + + RPS+ +
Sbjct: 222 -------LAGKIREGKFR-------RIPYRYSDE----LNEIITRMLNLKDYHRPSVEEI 263
Query: 672 V 672
+
Sbjct: 264 L 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 59/192 (30%), Positives = 98/192 (51%), Gaps = 7/192 (3%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
IG G GTVY + + VA++++N K+ EI ++ + N+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
G + ++V EY+ GSL + + + + + L +LH +++IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 509 KPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYS 568
K +NILL VK++DFG +TPEQS +TM GT ++APE +T A K D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 569 YGMVLLEIISGR 580
G++ +E+I G
Sbjct: 202 LGIMAIEMIEGE 213
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-52
Identities = 62/296 (20%), Positives = 110/296 (37%), Gaps = 51/296 (17%)
Query: 386 FNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVR 442
F+ IG G F TVYKG+ + VA ++ + ++ F E ++ + H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 443 LKGFCA----QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
+ LV E M G+L L V++ + +GL +LHT
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR 131
Query: 499 CDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
IIH D+K +NI + VKI D GL+ L + + GT ++APE
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEE 187
Query: 558 SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617
+ DVY++GM +LE+ +
Sbjct: 188 K-YDESVDVYAFGMCMLEMATSE------------------------------------- 209
Query: 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673
+ + + Y + + ++ I C+++ R S+ ++++
Sbjct: 210 YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 76/324 (23%), Positives = 122/324 (37%), Gaps = 68/324 (20%)
Query: 373 RFSYEELAAATDNFNTPIGSGGFGTVYKGILQD---KSVVAVKKINSFGI-QGKKEFCTE 428
+ ++ F IG G FG V K ++ + A+K++ + ++F E
Sbjct: 6 VLDWNDI-----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE 60
Query: 429 ITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGN--------------- 472
+ ++ + HH N++ L G C +L EY G+L L +
Sbjct: 61 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 473 GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLL 532
S L ++ A ARG+ YL + IH D+ NIL+ + KI+DFGLS+
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177
Query: 533 TPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRST 592
T R ++A E L S + +DV+SYG++L EI+S
Sbjct: 178 EVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------- 225
Query: 593 EKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVR 652
P + E E Q LE + DE +
Sbjct: 226 ----------PYCGMTCAE---------LYEKLPQGYRLEKPLN-----CDDE----VYD 257
Query: 653 IALCCVQEEPMLRPSMANVVSMLE 676
+ C +E+P RPS A ++ L
Sbjct: 258 LMRQCWREKPYERPSFAQILVSLN 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 5e-52
Identities = 57/292 (19%), Positives = 100/292 (34%), Gaps = 47/292 (16%)
Query: 390 IGSGGFGTVYKGILQDKS----VVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLK 444
IG G FG V++GI VA+K + +E F E + H ++V+L
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
G + +++ E G L L L+ A + LAYL + +
Sbjct: 75 GVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
H D+ N+L+ VK+ DFGLS+ + + + ++APE + + +
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 565 DVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALEL 624
DV+ +G+ + EI+ G P + +
Sbjct: 191 DVWMFGVCMWEILMH--------------------GVKPFQGVKNND---------VIGR 221
Query: 625 HEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
E L + + L + C +P RP + + L
Sbjct: 222 IENGERLPMPPN-----CPPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 6e-52
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 384 DNFN--TPIGSGGFGTVYKGI-LQDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVN 439
++++ +G G +G V + + VAVK ++ + + EI I ++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 440 LVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+V+ G +G ++L EY + G L + + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH--- 120
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP-EQSSLFTTMRGTRGYLAPEWLTSS 558
I H D+KPEN+LL ++ +KISDFGL+ + + L M GT Y+APE L
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 559 AISD-KTDVYSYGMVLLEIISGR 580
DV+S G+VL +++G
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 7e-52
Identities = 69/306 (22%), Positives = 121/306 (39%), Gaps = 56/306 (18%)
Query: 372 RRFSYEELAAATDNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGK---KEFCT 427
R+++ E+ P+G G FG VY Q K ++A+K + ++ +
Sbjct: 1 RQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55
Query: 428 EITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALG 487
E+ I ++ H N++RL G+ + +L+ EY G++ R L + +
Sbjct: 56 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITE 114
Query: 488 TARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR 547
A L+Y H ++IH D+KPEN+LL ++KI+DFG S SS TT+ GT
Sbjct: 115 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTL 168
Query: 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSS 607
YL PE + +K D++S G++ E + G+
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK--------------------------- 201
Query: 608 SPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS 667
P A E + + + V++ + ++ P RP
Sbjct: 202 ---------PPFEANTYQETYKRISRVEFTFPDFVTEG----ARDLISRLLKHNPSQRPM 248
Query: 668 MANVVS 673
+ V+
Sbjct: 249 LREVLE 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 68/318 (21%), Positives = 112/318 (35%), Gaps = 71/318 (22%)
Query: 390 IGSGGFGTVYKGILQDKS------VVAVKKINSFGIQG-KKEFCTEITIIGNI-HHVNLV 441
+GSG FG V S VAVK + ++ +E+ ++ + H N+V
Sbjct: 45 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104
Query: 442 RLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNG----------------------SVLEWR 479
L G C +L++EY G L L +VL +
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 480 ERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS-S 538
+ A A+G+ +L +H D+ N+L+ VKI DFGL++ + + +
Sbjct: 165 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221
Query: 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSG 598
+ R ++APE L + K+DV+SYG++L EI S
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL------------------- 262
Query: 599 DGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCV 658
G P + +L + + E++ I C
Sbjct: 263 -GVNPYPGIPVDA-----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCW 304
Query: 659 QEEPMLRPSMANVVSMLE 676
+ RPS N+ S L
Sbjct: 305 AFDSRKRPSFPNLTSFLG 322
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (455), Expect = 6e-51
Identities = 69/325 (21%), Positives = 123/325 (37%), Gaps = 47/325 (14%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G+G FG V++ + A K + + K+ EI + + H LV L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+ ++YE+M+ G L + + + E E +GL ++H ++ +H D+
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDL 150
Query: 509 KPENILLHDKL--QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDV 566
KPENI+ K ++K+ DFGL+ L P+QS GT + APE + TD+
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDM 208
Query: 567 YSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHE 626
+S G++ ++SG P + E L
Sbjct: 209 WSVGVLSYILLSGLS---------------------PFGGENDDE-------TLRNVKSC 240
Query: 627 QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS---MLEGGMPLGE 683
+ A S I ED + +R + +P R ++ + + G P +
Sbjct: 241 DWNMDDSAFSGI-----SEDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292
Query: 684 PRIESLRFLRFYGQRFNEASTIEES 708
+I S R+ + + E
Sbjct: 293 SQIPSSRYTKIRDSIKTKYDAWPEP 317
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 70/319 (21%), Positives = 129/319 (40%), Gaps = 61/319 (19%)
Query: 390 IGSGGFGTVYKGIL------QDKSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVR 442
+G G FG VY+G+ + ++ VA+K +N + ++ + EF E +++ + ++VR
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNG---------SVLEWRERFEIALGTARGLA 493
L G +QG+ ++ E M +G L L + + ++A A G+A
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 494 YLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT-MRGTRGYLAP 552
YL +K +H D+ N ++ + VKI DFG+++ + +++P
Sbjct: 148 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 553 EWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612
E L + +DV+S+G+VL EI + + P S +
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--------------------PYQGLSNEQ- 243
Query: 613 QRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVV 672
L + L+ D+ D L + C Q P +RPS ++
Sbjct: 244 --------VLRFVMEGGLLDKPDN-----CPDM----LFELMRMCWQYNPKMRPSFLEII 286
Query: 673 SMLEGGMPLGEPRIESLRF 691
S ++ M EP + F
Sbjct: 287 SSIKEEM---EPGFREVSF 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-50
Identities = 64/296 (21%), Positives = 104/296 (35%), Gaps = 50/296 (16%)
Query: 390 IGSGGFGTVYKGILQDKS----VVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVR 442
+G G FG V +G S VAVK + + + +F E+ + ++ H NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
L G +V E GSL L + A+ A G+ YL +
Sbjct: 76 LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 503 IIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS--LFTTMRGTRGYLAPEWLTSSAI 560
IH D+ N+LL + VKI DFGL + L + + + APE L +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 561 SDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620
S +D + +G+ L E+ + G P + + +L
Sbjct: 192 SHASDTWMFGVTLWEMFTY--------------------GQEPWIGLNGSQ-------IL 224
Query: 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
E R D + + + + C +P RP+ + L
Sbjct: 225 HKIDKEGERLPRPED------CPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 49/294 (16%)
Query: 390 IGSGGFGTVYKGILQD-----KSVVAVKKIN-SFGIQGKKEFCTEITIIGNIHHVNLVRL 443
+GSG FGTVYKG+ K VA+K++ + + KE E ++ ++ + ++ RL
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
G C L+ + M G L + + + + + A+G+ YL D ++
Sbjct: 77 LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRL 132
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT-MRGTRGYLAPEWLTSSAISD 562
+H D+ N+L+ VKI+DFGL+KLL E+ + ++A E + +
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192
Query: 563 KTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622
++DV+SYG+ + E+++ P E
Sbjct: 193 QSDVWSYGVTVWELMTFGSK--------------------PYDGIPASE---------IS 223
Query: 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
+ E+ L + I + C + RP ++
Sbjct: 224 SILEKGERLPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-48
Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 9/196 (4%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKG 445
+G G F TV L A+K + I E ++ + H V+L
Sbjct: 16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ + Y G L + + GS E TA ++ L IIH
Sbjct: 76 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIH 131
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTSSAISDKT 564
D+KPENILL++ + ++I+DFG +K+L+PE + + GT Y++PE LT + +
Sbjct: 132 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 191
Query: 565 DVYSYGMVLLEIISGR 580
D+++ G ++ ++++G
Sbjct: 192 DLWALGCIIYQLVAGL 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (434), Expect = 5e-48
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 8/194 (4%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+GSG FG V++ + V K IN+ K EI+I+ +HH L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 449 QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDV 508
+ L+ E+++ G L + + E GL ++H +H I+H D+
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 153
Query: 509 KPENILL--HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDV 566
KPENI+ VKI DFGL+ L P++ TT T + APE + + TD+
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDM 211
Query: 567 YSYGMVLLEIISGR 580
++ G++ ++SG
Sbjct: 212 WAIGVLGYVLLSGL 225
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 8e-46
Identities = 69/319 (21%), Positives = 121/319 (37%), Gaps = 67/319 (21%)
Query: 389 PIGSGGFGTVYKGIL--------QDKSVVAVKKINSFGIQ-GKKEFCTEITIIGNI-HHV 438
P+G G FG V + VAVK + S + + +E+ ++ I H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNG---------------SVLEWRERFE 483
N++ L G C Q +++ EY +KG+L L L ++
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 484 IALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT-T 542
A ARG+ YL K IH D+ N+L+ + +KI+DFGL++ + T
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNG 602
R ++APE L + ++DV+S+G++L EI + +
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-------------------- 236
Query: 603 PSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEP 662
P E +L ++ ++ + ++E L + C P
Sbjct: 237 PYPGVPVEE---------LFKLLKEGHRMDKPSN-----CTNE----LYMMMRDCWHAVP 278
Query: 663 MLRPSMANVVSMLEGGMPL 681
RP+ +V L+ + L
Sbjct: 279 SQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 5e-45
Identities = 71/313 (22%), Positives = 116/313 (37%), Gaps = 65/313 (20%)
Query: 389 PIGSGGFGTVYKGI------LQDKSVVAVKKINSFGIQG-KKEFCTEITIIGNI-HHVNL 440
P+G G FG V + VAVK + + +E+ I+ +I HH+N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 441 VRLKGFCAQ-GRQRFLVYEYMNKGSLDRTLFGNG---------------SVLEWRERFEI 484
V L G C + G ++ E+ G+L L L
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 485 ALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT-M 543
+ A+G+ +L + K IH D+ NILL +K VKI DFGL++ + + +
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGP 603
R ++APE + + ++DV+S+G++L EI S + P
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--------------------P 236
Query: 604 SSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPM 663
E L E R + D ++ + L C EP
Sbjct: 237 YPGVKIDE-------EFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPS 279
Query: 664 LRPSMANVVSMLE 676
RP+ + +V L
Sbjct: 280 QRPTFSELVEHLG 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 9/195 (4%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
+G G FG V++ + K K + G + EI+I+ H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
+ +++E+++ + + + L RE L +LH H I H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 508 VKPENILLHDK--LQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
++PENI+ + +KI +FG ++ L P + F + Y APE +S TD
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 566 VYSYGMVLLEIISGR 580
++S G ++ ++SG
Sbjct: 186 MWSLGTLVYVLLSGI 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 1e-43
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-FCTEITIIGNIHHVNLVRLKGFC 447
+G+G F V + + +VA+K I ++GK+ EI ++ I H N+V L
Sbjct: 17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 76
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
G +L+ + ++ G L + G R+ + + YL D I+H D
Sbjct: 77 ESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYL---HDLGIVHRD 132
Query: 508 VKPENILL---HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
+KPEN+L + ++ ISDFGLSK+ P S+ +T GT GY+APE L S
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPYSKAV 190
Query: 565 DVYSYGMVLLEIISGR 580
D +S G++ ++ G
Sbjct: 191 DCWSIGVIAYILLCGY 206
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (393), Expect = 3e-43
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGI---------QGKKEFCTEITIIGNIH-HV 438
+G G V + I AVK I+ G + ++ E+ I+ + H
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
N+++LK FLV++ M KG L L + L +E +I + LH
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALH-- 127
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
I+H D+KPENILL D + +K++DFG S L P + + GT YLAPE + S
Sbjct: 128 -KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIECS 184
Query: 559 ------AISDKTDVYSYGMVLLEIISGR 580
+ D++S G+++ +++G
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 1e-41
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 384 DNFNT--PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK------KEFCTEITIIGN 434
++F+ IG GGFG VY + A+K ++ I+ K ++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 435 IHHVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAY 494
+V + + + + MN G L L +G E RF A GL +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 122
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 554
+H + +++ D+KP NILL + V+ISD GL+ + ++ GT GY+APE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEV 176
Query: 555 L-TSSAISDKTDVYSYGMVLLEIISGR 580
L A D +S G +L +++ G
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 48/202 (23%), Positives = 84/202 (41%), Gaps = 17/202 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE------FCTEITIIGNIH--HVNL 440
+GSGGFG+VY GI + D VA+K + I E E+ ++ + +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 441 VRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
+RL + + L+ E L+ + + +
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---HN 128
Query: 501 HKIIHCDVKPENILL-HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
++H D+K ENIL+ ++ ++K+ DFG LL +T GTR Y PEW+
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHR 185
Query: 560 ISDK-TDVYSYGMVLLEIISGR 580
+ V+S G++L +++ G
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGD 207
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (383), Expect = 2e-41
Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRLKG 445
+G+G FG V+ + A+K + + K+ E ++ + H ++R+ G
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+Q F++ +Y+ G L L + +F A L YLH II+
Sbjct: 72 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 127
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
D+KPENILL +KI+DFG +K + + T+ GT Y+APE +++ + D
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYNKSID 183
Query: 566 VYSYGMVLLEIISGRK 581
+S+G+++ E+++G
Sbjct: 184 WWSFGILIYEMLAGYT 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (379), Expect = 2e-41
Identities = 62/290 (21%), Positives = 111/290 (38%), Gaps = 50/290 (17%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK---KEFCTEITIIGNIHHVNLVRLKG 445
+G GG V+ L+ VAVK + + + F E ++H +V +
Sbjct: 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74
Query: 446 FC----AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDH 501
G ++V EY++ +L + G + + E+ + L + +
Sbjct: 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFS---HQN 130
Query: 502 KIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL--FTTMRGTRGYLAPEWLTSSA 559
IIH DVKP NI++ VK+ DFG+++ + +S+ + GT YL+PE +
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 560 ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619
+ ++DVYS G VL E+++G P + SP
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEP---------------------PFTGDSPVS-------- 221
Query: 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA 669
++ R + S +S + L + L + + P R A
Sbjct: 222 ---VAYQHVREDPIPPSARHEGLSAD----LDAVVLKALAKNPENRYQTA 264
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 66/309 (21%), Positives = 115/309 (37%), Gaps = 22/309 (7%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQG-KKEFCTEITIIGNIHHVNLVRLKGFC 447
IG G +G V +K VA+KKI+ F Q + EI I+ H N++ +
Sbjct: 16 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 75
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFG--NGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ Y+ + L+ L RGL Y+H ++H
Sbjct: 76 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 132
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSS--LFTTMRGTRGYLAPEWLTSSAISD- 562
D+KP N+LL+ +KI DFGL+++ P+ T TR Y APE + +S
Sbjct: 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 192
Query: 563 KTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622
D++S G +L E++S R K G+ + + + LL
Sbjct: 193 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL-- 250
Query: 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS---MLEGGM 679
++ +R+ + + + + P R + ++ + +
Sbjct: 251 ---SLPHKNKVPWNRLFPNADSK----ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 680 PLGEPRIES 688
P EP E+
Sbjct: 304 PSDEPIAEA 312
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 67/289 (23%), Positives = 106/289 (36%), Gaps = 24/289 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE-----FCTEITIIGNIHHVNLVRL 443
+G G F TVYK +VA+KKI K+ EI ++ + H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 444 KGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKI 503
LV+++M L+ + N VL L T +GL YLH H I
Sbjct: 66 LDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 121
Query: 504 IHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL-TSSAISD 562
+H D+KP N+LL + +K++DFGL+K + +T TR Y APE L +
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARMYGV 180
Query: 563 KTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622
D+++ G +L E++ + G S Y +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671
A +D+ L++ P R +
Sbjct: 241 PGIPLHHIFSAA---------GDDLLDLIQ---GLFLFNPCARITATQA 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 10/196 (5%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE---FCTEITIIG-NIHHVNLVRLK 444
+G G FG V+ + A+K + + + E ++ H L +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 445 GFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKII 504
F V EY+N G L + + A GL +L I+
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFL---HSKGIV 125
Query: 505 HCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKT 564
+ D+K +NILL +KI+DFG+ K + T GT Y+APE L +
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQKYNHSV 184
Query: 565 DVYSYGMVLLEIISGR 580
D +S+G++L E++ G+
Sbjct: 185 DWWSFGVLLYEMLIGQ 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 147 bits (372), Expect = 2e-40
Identities = 58/284 (20%), Positives = 108/284 (38%), Gaps = 17/284 (5%)
Query: 390 IGSGGFGTVYKGILQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC 447
IG G +G VYK A+KKI EI+I+ + H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
++ LV+E++++ G LE L G+AY H D +++H D
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 508 VKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVY 567
+KP+N+L++ + ++KI+DFGL++ + + S S D++
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 568 SYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQ 627
S G + E+++G ++ + G S + Y P
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF------- 238
Query: 628 RRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671
Y L + + ++ L + ++ +P R +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSK----MLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 63/294 (21%), Positives = 116/294 (39%), Gaps = 30/294 (10%)
Query: 390 IGSGGFGTVYKG--ILQDKSVVAVKKINSFGIQGK--KEFCTEITI---IGNIHHVNLVR 442
IG G +G V+K + VA+K++ + E+ + + H N+VR
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 443 LKGFCAQGRQR-----FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHT 497
L C R LV+E++++ + ++ RGL +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 133
Query: 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTS 557
H+++H D+KP+NIL+ Q+K++DFGL+++ + + + T++ T Y APE L
Sbjct: 134 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVLLQ 189
Query: 558 SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617
S+ + D++S G + E+ + K G P PR+
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGEEDWPRDVALPRQ 248
Query: 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671
+ +++ DE + L+ C+ P R S +
Sbjct: 249 AFHSKSAQPIEKFVTDI---------DELGKDLLL---KCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-40
Identities = 61/294 (20%), Positives = 116/294 (39%), Gaps = 21/294 (7%)
Query: 384 DNFN--TPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHV 438
+NF IG G +G VYK VVA+KKI EI+++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 439 NLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
N+V+L + +LV+E++++ + + +GLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
H+++H D+KP+N+L++ + +K++DFGL++ + +T T Y APE L
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 177
Query: 559 -AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617
S D++S G + E+++ R + + G S Y
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671
P ++ S++ + ++ L + + +P R S
Sbjct: 238 PSF-------PKWARQDFSKVVPPLDEDGRSLLSQ----MLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 371 PRRFSYEELAAATDNFNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEI 429
P+ SY + IG+G FG VY+ L +VA+KK+ Q K+ E+
Sbjct: 17 PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNREL 64
Query: 430 TIIGNIHHVNLVRLKGFCAQGRQR------FLVYEYMNKGSLD--RTLFGNGSVLEWRER 481
I+ + H N+VRL+ F ++ LV +Y+ + R L
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 482 FEIALGTARGLAYLHTGCDHKIIHCDVKPENILL-HDKLQVKISDFGLSKLLTPEQSSLF 540
R LAY+H I H D+KP+N+LL D +K+ DFG +K L +
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPN 179
Query: 541 TTMRGTRGYLAP-EWLTSSAISDKTDVYSYGMVLLEIISGR 580
+ +R Y AP ++ + DV+S G VL E++ G+
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 3e-39
Identities = 51/298 (17%), Positives = 83/298 (27%), Gaps = 49/298 (16%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFC- 447
IGSG FG +Y G + VA+K + E I + + +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCD 507
A+G +V E + D F + + +A + Y+H IH D
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 508 VKPENILLHDK---LQVKISDFGLSKLLTPEQSSLF------TTMRGTRGYLAPEWLTSS 558
VKP+N L+ V I DFGL+K ++ + GT Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 559 AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618
S + D+ S G VL+ G
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGS----------------------------LPWQGLKAAT 220
Query: 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676
+ + + E C +P + + +
Sbjct: 221 KRQKYERISEKKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-39
Identities = 65/338 (19%), Positives = 121/338 (35%), Gaps = 54/338 (15%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFC 447
+G G G V + + + A+K + + E+ + ++VR+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74
Query: 448 ----AQGRQRFLVYEYMNKGSLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHK 502
A + +V E ++ G L + G RE EI + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 503 IIHCDVKPENILL---HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
I H DVKPEN+L +K++DFG +K T S TT T Y+APE L
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEK 189
Query: 560 ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619
D++S G+++ ++ G P S+ + +
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYP---------------------PFYSNHGLA---ISPGM 225
Query: 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM--LEG 677
Q + S + E+V+ L+R ++ EP R ++ ++ +
Sbjct: 226 KTRIRMGQYEFPNPEWSEV-----SEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQ 277
Query: 678 GMPLGEPRIESLRFLRFYGQRFNEASTIEESNELNLQF 715
+ + + + R L+ +R+ + S ++
Sbjct: 278 STKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRV 315
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (363), Expect = 5e-39
Identities = 43/301 (14%), Positives = 91/301 (30%), Gaps = 51/301 (16%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGF 446
IG G FG +++G L + VA+K + E + + + F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
+G LV + + D L G + A + +H + +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125
Query: 507 DVKPENILLHDKLQ-----VKISDFGLSKLLTPEQSS------LFTTMRGTRGYLAPEWL 555
D+KP+N L+ + + DFG+ K + + GT Y++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 556 TSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615
S + D+ + G V + + G G ++++ ++ +R+
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPW-----------------QGLKAATNKQKYERI 228
Query: 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSML 675
+ L E + +E + P + +
Sbjct: 229 GEKKQSTPLRE-----------LCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLF 273
Query: 676 E 676
Sbjct: 274 S 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQG------KKEFCTEITIIGNIHHVNLVR 442
+GSG F V K A K I + +++ E++I+ I H N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 443 LKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK 502
L L+ E + G L L S+ E + + L ++ +
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL----KQILNGVYYLHSLQ 133
Query: 503 IIHCDVKPENILLHD----KLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSS 558
I H D+KPENI+L D K ++KI DFGL+ + + F + GT ++APE +
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYE 191
Query: 559 AISDKTDVYSYGMVLLEIISGR 580
+ + D++S G++ ++SG
Sbjct: 192 PLGLEADMWSIGVITYILLSGA 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 27/297 (9%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGK--KEFCTEITIIGNIHHVNLVRLKGF 446
IG G FG V+K + VA+KK+ + EI I+ + H N+V L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 447 CAQGRQR--------FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTG 498
C +LV+++ E + GL Y+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYI--- 133
Query: 499 CDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS---LFTTMRGTRGYLAPEWL 555
+KI+H D+K N+L+ +K++DFGL++ + ++S +T T Y PE L
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 556 TSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614
D++ G ++ E+ + + S G+ + P
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-ITPEVWPNVDNY 252
Query: 615 VYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671
+ L L ++R+ + R++ V D L+ + +P R +
Sbjct: 253 ELYEKLELVKGQKRKVKD----RLKAYVRDPYALDLID---KLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 55/195 (28%), Positives = 81/195 (41%), Gaps = 9/195 (4%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRLKG 445
+G G FG V A+K + I K E TE ++ N H L LK
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 446 FCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIH 505
+ V EY N G L L E R A ++ L +++
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEER----ARFYGAEIVSALEYLHSRDVVY 128
Query: 506 CDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTD 565
D+K EN++L +KI+DFGL K + +++ T GT YLAPE L + D
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVD 187
Query: 566 VYSYGMVLLEIISGR 580
+ G+V+ E++ GR
Sbjct: 188 WWGLGVVMYEMMCGR 202
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 1e-36
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 15/241 (6%)
Query: 347 AKVIKLGSRNSSSEELELTSIAGLPRRFSYEELAAAT-DNFNT--PIGSGGFGTVYKGI- 402
A K GS S +E + +++ A D F+ +G+G FG V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 403 LQDKSVVAVKKINSFGIQGKKE---FCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEY 459
+ + A+K ++ + K+ E I+ ++ LV+L+ ++V EY
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL 519
+ G + L G A YLH +I+ D+KPEN+L+ +
Sbjct: 123 VAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQG 178
Query: 520 QVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISG 579
++++DFG +K T+ GT LAPE + S + D ++ G+++ E+ +G
Sbjct: 179 YIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 580 R 580
Sbjct: 235 Y 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-35
Identities = 62/293 (21%), Positives = 114/293 (38%), Gaps = 29/293 (9%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKG 445
P+GSG +G V + + + VA+KK+ K E+ ++ ++ H N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 446 FCAQGRQR------FLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+LV +M G+ L + L + +GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH--- 138
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
IIH D+KP N+ +++ ++KI DFGL++ E T TR Y APE + +
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWM 194
Query: 560 ISD-KTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618
D++S G ++ E+I+G+ ++ G P+ +S
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671
+ L E++ + + I S V L + + + R +
Sbjct: 255 MKGLPELEKKDF-----ASILTNASPLAVNLLEK----MLVLDAEQRVTAGEA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 39/195 (20%), Positives = 82/195 (42%), Gaps = 7/195 (3%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKGF 446
IG G +GTV+K + +VA+K++ EI ++ + H N+VRL
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 447 CAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHC 506
++ LV+E+ ++ NG + + + + L L ++H
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF----QLLKGLGFCHSRNVLHR 125
Query: 507 DVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDV 566
D+KP+N+L++ ++K+++FGL++ + + S D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 567 YSYGMVLLEIISGRK 581
+S G + E+ + +
Sbjct: 186 WSAGCIFAELANAGR 200
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 3e-34
Identities = 58/314 (18%), Positives = 114/314 (36%), Gaps = 29/314 (9%)
Query: 371 PRRFSYEELAAATDNFN-----TPIGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKE 424
+ YE N + +G G + V++ I + + V VK + KK+
Sbjct: 19 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKK 75
Query: 425 FCTEITIIGNI-HHVNLVRLKGFC--AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRER 481
EI I+ N+ N++ L R LV+E++N + L +
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDI 131
Query: 482 FEIALGTARGLAYLHTGCDHKIIHCDVKPENILL-HDKLQVKISDFGLSKLLTPEQSSLF 540
+ L Y H I+H DVKP N+++ H+ ++++ D+GL++ P Q +
Sbjct: 132 RFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--Y 186
Query: 541 TTMRGTRGYLAPE-WLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGD 599
+R + PE + D++S G +L +I ++ + +
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 600 GNGPSSSSSPRESQRVYFPLL--ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCC 657
+ P L H ++R+ S + VS E ++ L +
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK----L 302
Query: 658 VQEEPMLRPSMANV 671
++ + R +
Sbjct: 303 LRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 53/237 (22%), Positives = 94/237 (39%), Gaps = 24/237 (10%)
Query: 357 SSSEELELTSIAGLPRRFSYEELAAATDNFN--TPIGSGGFGTVYKGIL----QDKSVVA 410
+ EL ++ G + +NF +G+G +G V+ + A
Sbjct: 4 TVKHELRTANLTGHAEKVG-------IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 56
Query: 411 VKKINSFGI----QGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465
+K + I + + TE ++ +I LV L + L+ +Y+N G L
Sbjct: 57 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 116
Query: 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525
L E + + + L II+ D+K ENILL V ++D
Sbjct: 117 FTHLSQRERFTEHEVQIYVG----EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 172
Query: 526 FGLSKLLTPEQSSLFTTMRGTRGYLAPEWL--TSSAISDKTDVYSYGMVLLEIISGR 580
FGLSK +++ GT Y+AP+ + S D +S G+++ E+++G
Sbjct: 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 8e-31
Identities = 66/342 (19%), Positives = 126/342 (36%), Gaps = 35/342 (10%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKIN--SFGIQGKKEFCTEITIIGNIHHVNLVRLKG 445
P+GSG +G+V + VAVKK++ I K E+ ++ ++ H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 446 FCAQGR-----QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCD 500
R + ++ L+ + L + RGL Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH---S 139
Query: 501 HKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW-LTSSA 559
IIH D+KP N+ +++ ++KI DFGL++ E T TR Y APE L
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 195
Query: 560 ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619
+ D++S G ++ E+++GR + G + S+ +
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS---MLE 676
+L + + + + + V+ L + + + R + A ++ +
Sbjct: 256 QSLTQMPKMNF-----ANVFIGANPLAVDLLEK----MLVLDSDKRITAAQALAHAYFAQ 306
Query: 677 GGMPLGEPRIESLRFLRFYGQRFNEASTIEESNELNLQFILQ 718
P EP + + I+E L ++
Sbjct: 307 YHDPDDEPVADPYDQ-----SFESRDLLIDEWKSLTYDEVIS 343
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-30
Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 389 PIGSGGFGTVYKGI-LQDKSVVAVKKINSFGI--QGKKEFCTEITIIGNIHHVNLVRLKG 445
PIGSG G V VA+KK++ K E+ ++ ++H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 446 FCA------QGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC 499
+ + +LV E M+ + + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136
Query: 500 DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSA 559
IIH D+KP NI++ +KI DFGL++ T S + T TR Y APE +
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 560 ISDKTDVYSYGMVLLEIISGR 580
+ D++S G ++ E++ +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (296), Expect = 2e-29
Identities = 57/310 (18%), Positives = 113/310 (36%), Gaps = 37/310 (11%)
Query: 390 IGSGGFGTVYKGI-LQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCA 448
+G G F TV+ + + + VA+K + + + EI ++ ++ + + A
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 449 Q---------------GRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLA 493
G +V+E + + L + +I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 494 YLHTGCDHKIIHCDVKPENILL------HDKLQVKISDFGLSKLLTPEQSSLFTTMRGTR 547
Y+H IIH D+KPEN+L+ + +Q+KI+D G + +T TR
Sbjct: 140 YMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTR 193
Query: 548 GYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR------KNSSLKIQSRSTEKDSSGDGN 601
Y +PE L + D++S ++ E+I+G + S + G
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 602 GPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEG--QVSDEDVEKLVRIALCCVQ 659
PS + R +F L + + + + + S ++ +++ +Q
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313
Query: 660 EEPMLRPSMA 669
+P R
Sbjct: 314 LDPRKRADAG 323
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 3e-22
Identities = 24/163 (14%), Positives = 46/163 (28%), Gaps = 26/163 (15%)
Query: 389 PIGSGGFGTVYKGILQDKSVVAVK----------KINSFGIQGKKEFCTEITIIGNIHHV 438
+G G V+ + VK K+ G F
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 439 NLVRLKGFCAQGR----QRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAY 494
L +L+G ++ E ++ + E+ +A
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDEVLDMILEEVAK 118
Query: 495 LHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537
+ I+H D+ N+L+ ++ + I DF S + E
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW 157
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 39.0 bits (90), Expect = 3e-04
Identities = 7/33 (21%), Positives = 16/33 (48%)
Query: 4 SRVSSMQLQESGNLVLLDARNVSLWQSFDSPTD 36
+ + LQ N+V+ D N ++W + + +
Sbjct: 80 NGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 38.8 bits (90), Expect = 3e-04
Identities = 15/118 (12%), Positives = 37/118 (31%), Gaps = 19/118 (16%)
Query: 28 WQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYSFVV-TDGDGVLQWNQMTYWKLS 86
Q D+ + ++L + Y F++ TD + VL N W
Sbjct: 7 KQPDDNHPQILHATESLEILF-----------GTHVYRFIMQTDCNLVLYDNNNPIW--- 52
Query: 87 MYSYAFKDSDAPVSFLSVNRTGLYLLASDGSRFVLKVSLDAAGF-RIAKLEPSGRLIV 143
+ G+ ++ ++ + V + + + L+P +++
Sbjct: 53 ---ATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 36.4 bits (84), Expect = 0.002
Identities = 8/30 (26%), Positives = 16/30 (53%)
Query: 4 SRVSSMQLQESGNLVLLDARNVSLWQSFDS 33
LQ +G + +L +N+++W S +S
Sbjct: 65 GTGCRAVLQPNGRMDVLTNQNIAVWTSGNS 94
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 745 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.62 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.21 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.12 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.07 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 97.9 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 97.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.17 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 96.76 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 96.6 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 96.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.0 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 95.36 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 94.92 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=374.42 Aligned_cols=264 Identities=27% Similarity=0.434 Sum_probs=214.4
Q ss_pred CCCHHHHHHHHHCCC-----------CCCCCCCCEEEEEEEECC----CCEEEEEEECCC-CCCHHHHHHHHHHHHCCCC
Q ss_conf 548889999620479-----------875435751699999799----969999995158-9500889999999980179
Q 004565 373 RFSYEELAAATDNFN-----------TPIGSGGFGTVYKGILQD----KSVVAVKKINSF-GIQGKKEFCTEITIIGNIH 436 (745)
Q Consensus 373 ~~~~~el~~~t~~f~-----------~~ig~G~fg~Vy~g~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~ 436 (745)
.++|+++..++.+|. ++||+|+||.||+|.+.. ...||||++... .....+.|.+|++++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC
T ss_conf 88879899999604622080042785698027882999999957997889999999784459899999999999998579
Q ss_pred CCCEEEEEEEEEECCEEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 87113289999829833999950589992333007985448889999999999998886507999606267899983455
Q 004565 437 HVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH 516 (745)
Q Consensus 437 h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld 516 (745)
|||||+++|++.+....++||||+++|+|.+++......+++..++.|+.|||+||.|||+ ++|+||||||+|||++
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVN 162 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred CCCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEC
T ss_conf 9888618999962887799997227985300210456799999999999999998898852---7983576150448988
Q ss_pred CCCCEEECCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCC
Q ss_conf 99973990478863479997631----002345667558322367988876555414799999873-9989972000245
Q 004565 517 DKLQVKISDFGLSKLLTPEQSSL----FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRS 591 (745)
Q Consensus 517 ~~~~~kl~Dfgl~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~ 591 (745)
.++.+||+|||+++.+....... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---- 238 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---- 238 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----
T ss_pred CCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC----
T ss_conf 9991998884431575677776536502566688300387888369978612144535789999867999999999----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 55688999999999999966654328999999975034330123312389999999999999987027899999998899
Q 004565 592 TEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671 (745)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev 671 (745)
............ +...+......+.+++.+||+.||++||||.+|
T Consensus 239 -------------------------~~~~~~~i~~~~----------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei 283 (299)
T d1jpaa_ 239 -------------------------NQDVINAIEQDY----------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283 (299)
T ss_dssp -------------------------HHHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred -------------------------HHHHHHHHHCCC----------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf -------------------------999999997378----------899974226999999999758797689299999
Q ss_pred HHHHCCC
Q ss_conf 9985069
Q 004565 672 VSMLEGG 678 (745)
Q Consensus 672 l~~L~~~ 678 (745)
++.|+..
T Consensus 284 ~~~L~~~ 290 (299)
T d1jpaa_ 284 VNTLDKM 290 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
T ss_conf 9999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.59 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=208.5
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCCCH
Q ss_conf 79875435751699999799969999995158950088999999998017987113289999829833999950589992
Q 004565 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 465 (745)
+.++||+|+||.||+|.+.++..||||++.... ...++|.+|++++++++||||++++|+|......++||||+++|+|
T Consensus 9 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECCCCCH
T ss_conf 888982088829999998899999999987886-7689999999999966899756535243159933799983699918
Q ss_pred HHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 33300798544888999999999999888650799960626789998345599973990478863479997631002345
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++......+++..++.|+.|+|.||.|||+ ++|+||||||+|||+++++.+||+|||+++..............|
T Consensus 88 ~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~g 164 (263)
T d1sm2a_ 88 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 164 (263)
T ss_dssp HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred HHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEEECCEEC
T ss_conf 99752013478899999999999998776531---643104431532666688776865532100236887335043001
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 66755832236798887655541479999987399899720002455568899999999999996665432899999997
Q 004565 546 TRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELH 625 (745)
Q Consensus 546 t~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (745)
|..|+|||++.+..++.++|||||||++|||+|++.|+.... ..........
T Consensus 165 t~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----------------------------~~~~~~~~i~ 216 (263)
T d1sm2a_ 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----------------------------SNSEVVEDIS 216 (263)
T ss_dssp CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----------------------------CHHHHHHHHH
T ss_pred CCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCC----------------------------CHHHHHHHHH
T ss_conf 766678578607999840332105999999987898887789----------------------------9999999998
Q ss_pred HHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 5034330123312389999999999999987027899999998899998506
Q 004565 626 EQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 626 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
...+ ...+......+.+++..||+.||++||||++|++.|+.
T Consensus 217 ~~~~----------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 217 TGFR----------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp HTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HCCC----------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 0688----------89954367999999999765797689199999999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.53 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=205.3
Q ss_pred HCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCC
Q ss_conf 04798754357516999997999699999951589500889999999980179871132899998298339999505899
Q 004565 384 DNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 463 (745)
..+.++||+|+||.||+|.++++..||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||+++|
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEECCCC
T ss_conf 38867981079828999999999999999986476-888999999999986799988578731045-9769999957898
Q ss_pred CHHHHHCCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 92333007985-44888999999999999888650799960626789998345599973990478863479997631002
Q 004565 464 SLDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
+|.+++..... .+++..++.|+.||++||.|||+ ++|+||||||+|||+++++.+||+|||+++.+..........
T Consensus 93 ~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred CHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCCCCCC
T ss_conf 28888751478988788999999999999999974---895467564225156202440423410147735886442035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 34566755832236798887655541479999987399899720002455568899999999999996665432899999
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..|+..|+|||++.+..++.++|||||||++|||+||+.|+.... ..... .
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----------------------------~~~~~-~ 220 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----------------------------TNPEV-I 220 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----------------------------CHHHH-H
T ss_pred CCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC----------------------------CHHHH-H
T ss_conf 677444458289837999824564525799999996898888888----------------------------99999-9
Q ss_pred HHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 9975034330123312389999999999999987027899999998899998506
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
.....+. +...+......+.+++..||+.||++||||++|+++|+.
T Consensus 221 ~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 221 QNLERGY---------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHCC---------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 9997068---------888965571999999999758897689399999998611
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=367.44 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=212.1
Q ss_pred HHHHHHHCCCCCCCCCCCEEEEEEEECC-CCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 9999620479875435751699999799-969999995158950088999999998017987113289999829833999
Q 004565 378 ELAAATDNFNTPIGSGGFGTVYKGILQD-KSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLV 456 (745)
Q Consensus 378 el~~~t~~f~~~ig~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv 456 (745)
|+......+.++||+|+||.||+|.+.. +..||||+++... ...++|.+|++++++++|||||+++|++.+....++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEE
T ss_conf 745799398659820888089999999999699999977761-0399999999999867999882677527457854787
Q ss_pred EEECCCCCHHHHHCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCC
Q ss_conf 9505899923330079-854488899999999999988865079996062678999834559997399047886347999
Q 004565 457 YEYMNKGSLDRTLFGN-GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~ 535 (745)
|||+++|+|.+++... ...+++..++.|+.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf 631467606777530355415799999999999997888987---89305760457689989992898324454653788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 76310023456675583223679888765554147999998739989972000245556889999999999999666543
Q 004565 536 QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
.........|+..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---------------------------- 220 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---------------------------- 220 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----------------------------
T ss_pred CCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC----------------------------
T ss_conf 7221035566546669278727999810430217899999986799887742----------------------------
Q ss_pred CHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 2899999997503433012331238999999999999998702789999999889999850699
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGM 679 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 679 (745)
.... ..+.... ..+...+......+.+++..||+.||++||||.+|++.|+...
T Consensus 221 ~~~~-~~~~i~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 221 DLSQ-VYELLEK---------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CHHH-HHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHH-HHHHHHC---------CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 5999-9999855---------8888887433099999999975779768939999999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.34 Aligned_cols=253 Identities=30% Similarity=0.456 Sum_probs=203.0
Q ss_pred CCCCCCCCCCCEEEEEEEECCCCEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 479875435751699999799969999995158--950088999999998017987113289999829833999950589
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 462 (745)
.+.++||+|+||.||+|++++ .||||+++.. .....+.|.+|++++++++|||||+++|++.+ ...++|+||+++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEECCCC
T ss_conf 998898307885899999999--89999997346998999999999999984799878645679715-589999965899
Q ss_pred CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCC-CCCC
Q ss_conf 992333007985448889999999999998886507999606267899983455999739904788634799976-3100
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS-SLFT 541 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~-~~~~ 541 (745)
|+|.+++......+++..++.|+.|||+||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 88 g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~ 164 (276)
T d1uwha_ 88 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164 (276)
T ss_dssp EEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----------
T ss_pred CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCCCCCC
T ss_conf 88899985235789999999999999999888750---999516147899798189978875002213335567763125
Q ss_pred CCCCCCCCCCCCCCCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 2345667558322367---9888765554147999998739989972000245556889999999999999666543289
Q 004565 542 TMRGTRGYLAPEWLTS---SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
...||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... . ..
T Consensus 165 ~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-------------------------~---~~ 216 (276)
T d1uwha_ 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------------------N---RD 216 (276)
T ss_dssp -CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------------------------C---HH
T ss_pred CCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-------------------------H---HH
T ss_conf 6655743179999950568999953151635999999997889989989-------------------------6---99
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 99999975034330123312389999999999999987027899999998899998506
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
........+.. .+.+ ...+......+.+++..||+.||++||||.+|++.|+.
T Consensus 217 -~~~~~~~~~~~----~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 217 -QIIFMVGRGYL----SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp -HHHHHHHHTSC----CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHCCCC----CCCC-HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf -99999965888----9860-00365554999999999758897689299999999999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.31 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=211.5
Q ss_pred CCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCCC
Q ss_conf 47987543575169999979996999999515895008899999999801798711328999982983399995058999
Q 004565 385 NFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 464 (745)
.|.++||+|+||.||+|+++++..||||+++... ...++|.+|++++++++||||++++|+|.+....++|+||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCCCCC
T ss_conf 9968982078839999998899899999987475-778999999999996689860158899850781699997048993
Q ss_pred HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 23330079854488899999999999988865079996062678999834559997399047886347999763100234
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|..++......+++..++.|+.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++..............
T Consensus 86 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 162 (258)
T d1k2pa_ 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162 (258)
T ss_dssp HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred HHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEEECCCC
T ss_conf 888641024677689999999999999998754---68434665413588769984798861442023578722524657
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 5667558322367988876555414799999873-998997200024555688999999999999966654328999999
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
||..|+|||.+....++.++||||||+++|||+| |+.||.... .......
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-----------------------------~~~~~~~ 213 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----------------------------NSETAEH 213 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----------------------------HHHHHHH
T ss_pred CCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCC-----------------------------HHHHHHH
T ss_conf 88775780786379988521033643246739755999988999-----------------------------9999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 975034330123312389999999999999987027899999998899998506
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
. ..+. +...+......+.+++..||+.||++|||+.+|++.|..
T Consensus 214 i-~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 214 I-AQGL---------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp H-HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred H-HHCC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9-8079---------789965465999999999766897689399999987418
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.35 Aligned_cols=246 Identities=27% Similarity=0.398 Sum_probs=202.5
Q ss_pred CCCCCCCEEEEEEEEC---CCCEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCCC
Q ss_conf 7543575169999979---99699999951589-5008899999999801798711328999982983399995058999
Q 004565 389 PIGSGGFGTVYKGILQ---DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 389 ~ig~G~fg~Vy~g~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 464 (745)
+||+|+||.||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|++.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEEECCCCC
T ss_conf 87306080999999960897689999998820397899999999999986799888068656036-80799998078996
Q ss_pred HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCC--CCC
Q ss_conf 233300798544888999999999999888650799960626789998345599973990478863479997631--002
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL--FTT 542 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~--~~~ 542 (745)
|.+++......+++..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCCCCCCCCC
T ss_conf 899752125699999999999999998789986---88105767646604546885420331342115543432113562
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 345667558322367988876555414799999873-9989972000245556889999999999999666543289999
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
..||+.|+|||++....++.++|||||||++|||+| |+.||.... ....
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----------------------------~~~~- 221 (285)
T d1u59a_ 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----------------------------GPEV- 221 (285)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------------------------THHH-
T ss_pred CCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCC-----------------------------HHHH-
T ss_conf 1137433586887279999541232201789999938999999979-----------------------------9999-
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 99975034330123312389999999999999987027899999998899998506
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
......+.. ...+......+.+++..||+.+|++||||.+|++.|+.
T Consensus 222 ~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 222 MAFIEQGKR---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp HHHHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHCCCC---------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 999981899---------99997678999999999757797689099999999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.21 Aligned_cols=252 Identities=26% Similarity=0.457 Sum_probs=205.9
Q ss_pred CCCCCCCCCEEEEEEEECCC-----CEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 98754357516999997999-----69999995158-9500889999999980179871132899998298339999505
Q 004565 387 NTPIGSGGFGTVYKGILQDK-----SVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 460 (745)
.++||+|+||.||+|.++.. ..||||++... ......+|.+|++++.+++|||||+++|++.+....++|+||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEEC
T ss_conf 15981177909999999689987879999999884459689999999999998568987832367783388038999721
Q ss_pred CCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC--
Q ss_conf 899923330079854488899999999999988865079996062678999834559997399047886347999763--
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-- 538 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~-- 538 (745)
.+++|.+.+......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 ~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~ 168 (283)
T d1mqba_ 92 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168 (283)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred CCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCCCCCCE
T ss_conf 3574022210234542089999999999985412121---2342576564427888998499845510300357876526
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 10023456675583223679888765554147999998739989972000245556889999999999999666543289
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
......||..|+|||++.+..++.++||||||+++|||++++.|+.... ...
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----------------------------~~~ 220 (283)
T d1mqba_ 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----------------------------SNH 220 (283)
T ss_dssp -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----------------------------CHH
T ss_pred EECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC----------------------------CHH
T ss_conf 7426777734348888704999973556344898999996798865568----------------------------999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 9999997503433012331238999999999999998702789999999889999850699
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGM 679 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 679 (745)
.. ...... ..+...+......+.+++.+||+.||++||||.+|+++|+..+
T Consensus 221 ~~-~~~i~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 221 EV-MKAIND---------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp HH-HHHHHT---------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HH-HHHHHC---------CCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99-999863---------5789985045799999999977679768939999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.92 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=204.4
Q ss_pred HCCCCCCCCCCCEEEEEEEECCC------CEEEEEEECCC-CCCHHHHHHHHHHHHCCC-CCCCEEEEEEEEEECCEEEE
Q ss_conf 04798754357516999997999------69999995158-950088999999998017-98711328999982983399
Q 004565 384 DNFNTPIGSGGFGTVYKGILQDK------SVVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~~~------~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l 455 (745)
..+.++||+|+||.||+|+.... ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+..++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 39701983078819999998578855420499999966335878999999999999971589968687788862995899
Q ss_pred EEEECCCCCHHHHHCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf 995058999233300798----------------------5448889999999999998886507999606267899983
Q 004565 456 VYEYMNKGSLDRTLFGNG----------------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENI 513 (745)
Q Consensus 456 v~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NI 513 (745)
||||+++|+|.+++.... ..+++..++.|+.|++.||.|||+ ++|+||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGE
T ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHCC
T ss_conf 9972799959999986257775102210000122200125778999999999999999999973---9905052703214
Q ss_pred EECCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCC
Q ss_conf 4559997399047886347999763-1002345667558322367988876555414799999873-9989972000245
Q 004565 514 LLHDKLQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRS 591 (745)
Q Consensus 514 lld~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~ 591 (745)
|++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~---- 271 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP---- 271 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----
T ss_pred CCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC----
T ss_conf 4345982898514222204577861562343578765783887279999633030003999999838999999989----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 55688999999999999966654328999999975034330123312389999999999999987027899999998899
Q 004565 592 TEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671 (745)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev 671 (745)
.... .......+ .+...+......+.+|+..||+.||++||||+||
T Consensus 272 ---------------------~~~~----~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 272 ---------------------VDAN----FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp ---------------------CSHH----HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---------------------HHHH----HHHHHHCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf ---------------------8999----99998569---------9899887678999999999758896689399999
Q ss_pred HHHHCC
Q ss_conf 998506
Q 004565 672 VSMLEG 677 (745)
Q Consensus 672 l~~L~~ 677 (745)
++.|.-
T Consensus 318 ~~~L~~ 323 (325)
T d1rjba_ 318 TSFLGC 323 (325)
T ss_dssp HHHHHH
T ss_pred HHHHHC
T ss_conf 999748
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.58 Aligned_cols=246 Identities=28% Similarity=0.377 Sum_probs=200.8
Q ss_pred CCCCCCCCEEEEEEEECC---CCEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 875435751699999799---969999995158--950088999999998017987113289999829833999950589
Q 004565 388 TPIGSGGFGTVYKGILQD---KSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 388 ~~ig~G~fg~Vy~g~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 462 (745)
++||+|+||.||+|.+.+ +..||||+++.. .....++|.+|++++++++|||||+++|+|.. ...++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCC--C
Q ss_conf 99233300798544888999999999999888650799960626789998345599973990478863479997631--0
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL--F 540 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~--~ 540 (745)
|+|.+++.... .+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....... .
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCC
T ss_conf 96899975225-78999999999999999766874---795567776113102356751234134533134323443224
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 02345667558322367988876555414799999873-99899720002455568899999999999996665432899
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.... ...
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----------------------------~~~ 218 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----------------------------GSE 218 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----------------------------HHH
T ss_pred CCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC-----------------------------HHH
T ss_conf 456778420391665379998434430340313289658999999989-----------------------------999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 9999975034330123312389999999999999987027899999998899998506
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
. ......+. +...+......+.+++..||+.||++||||.+|+++|+.
T Consensus 219 ~-~~~i~~~~---------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 219 V-TAMLEKGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp H-HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred H-HHHHHCCC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9-99998289---------999986567999999999758897689098999998528
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.69 Aligned_cols=246 Identities=26% Similarity=0.352 Sum_probs=203.3
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCC
Q ss_conf 47987543575169999979-99699999951589500889999999980179871132899998298339999505899
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 463 (745)
.+.++||+|+||.||+|... ++..||||++........+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 102 (293)
T d1yhwa1 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (293)
T ss_dssp CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred EEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCCC
T ss_conf 88789812858299999998999899999984301727999999999998679998805857798899989999703798
Q ss_pred CHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 92333007985448889999999999998886507999606267899983455999739904788634799976310023
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..... .....
T Consensus 103 ~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~ 176 (293)
T d1yhwa1 103 SLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (293)
T ss_dssp BHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCC
T ss_pred CHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-CCCCC
T ss_conf 089886415--99999999999999999999998---7972267768886887899686425156413213666-44444
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 45667558322367988876555414799999873998997200024555688999999999999966654328999999
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----------------------------~~~~~~~ 227 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----------------------------PLRALYL 227 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----------------------------HHHHHHH
T ss_pred CCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCC-----------------------------HHHHHHH
T ss_conf 44777368266447998801203137299999804889989979-----------------------------9999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 97503433012331238999999999999998702789999999889999
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
....... .. ..+......+.+++..||+.||.+|||+.|+++
T Consensus 228 ~~~~~~~-~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 228 IATNGTP-EL-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHCSC-CC-------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHCCCC-CC-------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9857999-88-------885537999999999986699668909999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.12 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=210.1
Q ss_pred HHCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 20479875435751699999799969999995158950088999999998017987113289999829833999950589
Q 004565 383 TDNFNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 383 t~~f~~~ig~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 462 (745)
...+.+.||+|+||.||+|.++++..||||++.... ...+.|.+|+.++++++|+|||+++|++.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEECCC
T ss_conf 979846993079809999999999999999988044-888999999999986666788689999823-975999994479
Q ss_pred CCHHHHHCCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 99233300798-54488899999999999988865079996062678999834559997399047886347999763100
Q 004565 463 GSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 463 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
|+|..++.... ..++|..++.|+.||+.||+|||+ ++|+||||||+|||+|.++.+||+|||+++...........
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHH---HHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCEEEC
T ss_conf 943542000035530599999999999999998754---11433531230799989992998442555425688733524
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 23456675583223679888765554147999998739989972000245556889999999999999666543289999
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...||..|+|||++..+.++.++||||||+++|||++|+.|+.... ......
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----------------------------~~~~~~ 224 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----------------------------VNREVL 224 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----------------------------CHHHHH
T ss_pred CCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCC----------------------------CHHHHH
T ss_conf 5455665458089837998917741323589999986899999888----------------------------899999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCC
Q ss_conf 999750343301233123899999999999999870278999999988999985069999888
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMPLGEP 684 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~~~p 684 (745)
...... .+...+....+.+.+++.+||+.||++||+|++|+++|+.......|
T Consensus 225 ~~i~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 225 DQVERG----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp HHHHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHC----------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCC
T ss_conf 999826----------89999832379999999997566975891999999987666238999
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=342.87 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=205.1
Q ss_pred HCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 047987543575169999979-9969999995158950088999999998017987113289999829833999950589
Q 004565 384 DNFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 462 (745)
+.+.+.||+|+||.||+|... ++..||||++........+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCCC
T ss_conf 58988984076819999998899989999998452431699999999999867997999299999989999999985799
Q ss_pred CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 9923330079854488899999999999988865079996062678999834559--99739904788634799976310
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD--KLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~--~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
|+|.+++......+++..+..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.+..... .
T Consensus 108 g~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~ 182 (350)
T d1koaa2 108 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--V 182 (350)
T ss_dssp CBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--E
T ss_pred CCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---CCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCCC--C
T ss_conf 88999997623789999999999999999999975---697600015467364168898699954521044256543--2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 02345667558322367988876555414799999873998997200024555688999999999999966654328999
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----------------------------~~~~ 233 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----------------------------DDET 233 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----------------------------HHHH
T ss_pred CEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-----------------------------HHHH
T ss_conf 00068624218899758998726765546599999985989989979-----------------------------9999
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999975034330123312389999999999999987027899999998899998
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 674 (745)
...... ... ..+......+ ...+.+++..||+.||++|||+.|+++.
T Consensus 234 ~~~i~~-~~~--~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 234 LRNVKS-CDW--NMDDSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHH-TCC--CSCCGGGGGC----CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHH-CCC--CCCCCCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 999984-788--9894223589----9999999999756896679089998629
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.35 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=206.8
Q ss_pred HHCCCCCCCCCCCEEEEEEEECCC----CEEEEEEECC-CCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEE-CCEEEEE
Q ss_conf 204798754357516999997999----6999999515-895008899999999801798711328999982-9833999
Q 004565 383 TDNFNTPIGSGGFGTVYKGILQDK----SVVAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ-GRQRFLV 456 (745)
Q Consensus 383 t~~f~~~ig~G~fg~Vy~g~~~~~----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv 456 (745)
+.+|+++||+|+||+||+|.+.+. ..||||+++. ......++|.+|++++++++||||++++|++.. ....++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred EECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 55266698136880999999977998799999999884369789999999999998678999867867898069943899
Q ss_pred EEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCC
Q ss_conf 95058999233300798544888999999999999888650799960626789998345599973990478863479997
Q 004565 457 YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~ 536 (745)
|||+++|+|.+++......+++..++.++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 98740674144210134540489999999998876520033---676257766875767799988991065232255665
Q ss_pred CC---CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 63---100234566755832236798887655541479999987399899720002455568899999999999996665
Q 004565 537 SS---LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQ 613 (745)
Q Consensus 537 ~~---~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (745)
.. ......||..|+|||.+....++.++||||||+++|||++|+.||.....
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~------------------------- 239 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------------------------- 239 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------------------------
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-------------------------
T ss_conf 5531002565556455676887437999745746619999999978999988899-------------------------
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 43289999999750343301233123899999999999999870278999999988999985069
Q 004565 614 RVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGG 678 (745)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~ 678 (745)
............+. ..+......+.+++..||+.||++||+|.||++.|+..
T Consensus 240 ---~~~~~~~i~~g~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 240 ---TFDITVYLLQGRRL----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ------CHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHCCCCC----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ---99999999808988----------99644759999999997688976893999999999999
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=343.85 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=207.8
Q ss_pred HCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 047987543575169999979-9969999995158950088999999998017987113289999829833999950589
Q 004565 384 DNFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 462 (745)
+.+.++||+|+||.||+|... ++..||||++..........+.+|++++++++|||||++++++.+....++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCCC
T ss_conf 59989993177829999999899979999998872646799999999999867997989199999989999999982899
Q ss_pred CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 992333007985448889999999999998886507999606267899983455--999739904788634799976310
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH--DKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld--~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
|+|.+++......+++..+..|+.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++..+..... .
T Consensus 111 g~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--~ 185 (352)
T d1koba_ 111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--V 185 (352)
T ss_dssp CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--E
T ss_pred CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCCC--E
T ss_conf 80888898638998999999999999999999997---792651314455311346788489952563034378872--0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 02345667558322367988876555414799999873998997200024555688999999999999966654328999
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------------------------~~~ 236 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----------------------------LET 236 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------------------------HHH
T ss_pred EECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-----------------------------HHH
T ss_conf 100476453489997479989763338989999999968899899799-----------------------------999
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHCCC
Q ss_conf 99997503433012331238999999999999998702789999999889999--85069
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEGG 678 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~--~L~~~ 678 (745)
.... ..... .... .........+.+++..||+.||.+|||+.|+++ .+++.
T Consensus 237 ~~~i-~~~~~--~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 237 LQNV-KRCDW--EFDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHH-HHCCC--CCCS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHH-HHCCC--CCCC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9999-84788--9893----0024799999999999756996689189999609734888
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.74 Aligned_cols=246 Identities=23% Similarity=0.312 Sum_probs=201.4
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCCCH
Q ss_conf 987543575169999979-9969999995158950088999999998017987113289999829833999950589992
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGSL 465 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 465 (745)
.++||+|+||.||+|... ++..||||++........+.+.+|++++++++|||||++++++.+.+..++||||+++|+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred EEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCCCCH
T ss_conf 47993077819999999999939999998728999999999999999867999988498898009958999962799818
Q ss_pred HHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 33300798544888999999999999888650799960626789998345599973990478863479997631002345
Q 004565 466 DRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMRG 545 (745)
Q Consensus 466 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 545 (745)
.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 97 ~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~G 172 (288)
T d2jfla1 97 DAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIG 172 (288)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCCCS
T ss_pred HHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC-CCCCCCCC
T ss_conf 89998628999999999999999999999998---898871407003148789998997161230357786-41001025
Q ss_pred CCCCCCCCCCC-----CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 66755832236-----7988876555414799999873998997200024555688999999999999966654328999
Q 004565 546 TRGYLAPEWLT-----SSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 546 t~~y~aPE~~~-----~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
|+.|+|||++. ...++.++|||||||++|||++|+.||..... ...
T Consensus 173 t~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-------------------------~~~---- 223 (288)
T d2jfla1 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-------------------------MRV---- 223 (288)
T ss_dssp CCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-------------------------GGH----
T ss_pred CCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH-------------------------HHH----
T ss_conf 626479999832025788888066578789999998208899999899-------------------------999----
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99997503433012331238999999999999998702789999999889999
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
....... ....+ ..+......+.+++..||+.||.+|||+.|+++
T Consensus 224 ~~~i~~~-~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 224 LLKIAKS-EPPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHS-CCCCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHCC-CCCCC-------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9999707-99877-------765669999999999976699668919999962
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.06 Aligned_cols=242 Identities=26% Similarity=0.415 Sum_probs=201.0
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 47987543575169999979-9969999995158---9500889999999980179871132899998298339999505
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 460 (745)
.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 9 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~ 88 (263)
T d2j4za1 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 88 (263)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEEC
T ss_conf 99889851778589999998999499999981688567689999999999998568888885999999899989998504
Q ss_pred CCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 89992333007985448889999999999998886507999606267899983455999739904788634799976310
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLF 540 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~ 540 (745)
++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 89 ~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~ 161 (263)
T d2j4za1 89 PLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---R 161 (263)
T ss_dssp TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---C
T ss_pred CCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC---C
T ss_conf 7985898875048-99999999999999999999998---894652202344146689987115556335448885---2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 02345667558322367988876555414799999873998997200024555688999999999999966654328999
Q 004565 541 TTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 541 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----------------------------~~~~ 212 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----------------------------YQET 212 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------------------------HHHH
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-----------------------------HHHH
T ss_conf 35578876349999758998931440467599999832999988899-----------------------------9999
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99997503433012331238999999999999998702789999999889999
Q 004565 621 ALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
........ . .++......+.+++..|++.||++|||++|+++
T Consensus 213 -~~~i~~~~------~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 213 -YKRISRVE------F----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -HHHHHTTC------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHCCC------C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -99997189------9----998668999999999976479768909999971
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.56 Aligned_cols=272 Identities=23% Similarity=0.346 Sum_probs=201.1
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCCC
Q ss_conf 987543575169999979-9969999995158-95008899999999801798711328999982983399995058999
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 464 (745)
.++||+|+||.||+|... ++..||+|+++.. .......+.+|+++++.++|||||++++++.+....++||||+++|+
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCCCCC
T ss_conf 78971277809999999899969999998754097899999999999986799999949999998999999997679986
Q ss_pred HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 23330079854488899999999999988865079996062678999834559997399047886347999763100234
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
|.+++...+ .+++..+..++.|++.||.|||+ .++|+||||||+|||++.++.+||+|||+|+..... ..+..+
T Consensus 91 L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~ 164 (322)
T d1s9ja_ 91 LDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFV 164 (322)
T ss_dssp HHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC---C
T ss_pred HHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC---CCCCCC
T ss_conf 899874249-99999999999999999999998--599971445779946878998999548776256788---621113
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC-CCCC---CCCCCCCC---------C
Q ss_conf 566755832236798887655541479999987399899720002455568899-9999---99999996---------6
Q 004565 545 GTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSG-DGNG---PSSSSSPR---------E 611 (745)
Q Consensus 545 gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~---------~ 611 (745)
||+.|+|||++.+..++.++||||+||++|||++|+.||............... .+.. +.....+. .
T Consensus 165 GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T d1s9ja_ 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244 (322)
T ss_dssp CSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------------
T ss_pred CCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 77141194687589989488899899999999988899899887899999988751775457742123332211112223
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 65432899999997503433012331238999999999999998702789999999889999
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
................ . .+.+.. ......+.+++..|++.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~-~-----~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 245 RPPMAIFELLDYIVNE-P-----PPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -CCCCHHHHHHHHHTS-C-----CCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHCC-C-----CCCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 5413477887665026-8-----766764---448999999999986899467908999960
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.57 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=199.4
Q ss_pred CCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCC
Q ss_conf 7987543575169999979-99699999951589-500889999999980179871132899998298339999505899
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 463 (745)
+.++||+|+||.||+|... ++..||||++.... .+..+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECCCCC
T ss_conf 99897217480999999999997999999845664127999999999998579988846965404674367988645898
Q ss_pred CHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCC-CCCCC
Q ss_conf 92333007985448889999999999998886507999606267899983455999739904788634799976-31002
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS-SLFTT 542 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~-~~~~~ 542 (745)
+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+....... ...+.
T Consensus 89 ~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 89 ELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp EGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred CHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCCCCCC
T ss_conf 0899975379-99999999999999999999997---5983575468997887899879832314224046886531113
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 345667558322367988-8765554147999998739989972000245556889999999999999666543289999
Q 004565 543 MRGTRGYLAPEWLTSSAI-SDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
.+||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... . ....
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~-------------------------~--~~~~- 216 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-------------------------S--CQEY- 216 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST-------------------------T--SHHH-
T ss_pred EEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCH-------------------------H--HHHH-
T ss_conf 25574742872861899999710161737999999829978888985-------------------------9--9999-
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9997503433012331238999999999999998702789999999889999
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
... ....... .........+.+++.+|++.||++|||++|+++
T Consensus 217 ~~~-~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 217 SDW-KEKKTYL--------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHH-HTTCTTS--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHH-HCCCCCC--------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 998-6388878--------864469999999999976799668909999961
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.97 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=202.5
Q ss_pred CCCCCCCCCEEEEEEEECC-CC----EEEEEEECC-CCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 9875435751699999799-96----999999515-89500889999999980179871132899998298339999505
Q 004565 387 NTPIGSGGFGTVYKGILQD-KS----VVAVKKINS-FGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~~-~~----~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 460 (745)
.++||+|+||.||+|.+.. ++ .||+|++.. ...+..++|.+|++++++++|||||+++|+|.++ ..++++|++
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEEEEEEC
T ss_conf 3198208992999999958998898999999965134979999999999999867998881589999619-836999842
Q ss_pred CCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCC-
Q ss_conf 8999233300798544888999999999999888650799960626789998345599973990478863479997631-
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL- 539 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~- 539 (745)
.+++|.+++......+++..++.|+.|||.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 169 (317)
T d1xkka_ 93 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169 (317)
T ss_dssp TTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC---
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCCCCCCC
T ss_conf 6874010111334579999999999999999999987---6950476212031167998758602552223354445322
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 002345667558322367988876555414799999873-9989972000245556889999999999999666543289
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....||..|+|||++.++.++.++||||||+++|||+| |+.||.... .. .+
T Consensus 170 ~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-------------------------~~-~~- 222 (317)
T d1xkka_ 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------------------------AS-EI- 222 (317)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-------------------------GG-GH-
T ss_pred CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-------------------------HH-HH-
T ss_conf 3651058644670887469998356544079999999977999999999-------------------------89-99-
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 99999975034330123312389999999999999987027899999998899998506
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
......+ .+...+......+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 223 ---~~~i~~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 223 ---SSILEKG---------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ---HHHHHHT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ---9999759---------9899985568999999998478993469199999999999
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.34 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=194.3
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEE----CCEEEEEE
Q ss_conf 47987543575169999979-9969999995158--95008899999999801798711328999982----98339999
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ----GRQRFLVY 457 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 457 (745)
.|..+||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEECCCCCCCCCCC
Q ss_conf 505899923330079854488899999999999988865079996--06267899983455-999739904788634799
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHK--IIHCDVKPENILLH-DKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dik~~NIlld-~~~~~kl~Dfgl~~~~~~ 534 (745)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++ |+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 5789894899975135-54699999999999999999997---8997996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 97631002345667558322367988876555414799999873998997200024555688999999999999966654
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (745)
.. .....||+.|+|||++.+ .++.++|||||||++|||++|+.||....
T Consensus 168 ~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--------------------------- 216 (270)
T d1t4ha_ 168 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--------------------------- 216 (270)
T ss_dssp TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS---------------------------
T ss_pred CC---CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC---------------------------
T ss_conf 76---677553813008988478-99986711007999999987889998765---------------------------
Q ss_pred CCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32899999997503433012331238999999999999998702789999999889999
Q 004565 615 VYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
..... ......+.. ........+ ..+.+++..||+.||++|||+.|+++
T Consensus 217 -~~~~~-~~~i~~~~~----~~~~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 217 -NAAQI-YRRVTSGVK----PASFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -SHHHH-HHHHTTTCC----CGGGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CHHHH-HHHHHCCCC----CCCCCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -59999-999973899----865675578----99999999976379758929999967
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=349.06 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=205.4
Q ss_pred HHHCC--CCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCE
Q ss_conf 62047--987543575169999979------99699999951589-5008899999999801798711328999982983
Q 004565 382 ATDNF--NTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQ 452 (745)
Q Consensus 382 ~t~~f--~~~ig~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~ 452 (745)
..++| .++||+|+||.||+|++. ++..||||+++... .+..++|.+|++++++++|+|++++++++.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf 98893886798207883999999888765778829999998821085799999999999996689976552466605980
Q ss_pred EEEEEEECCCCCHHHHHCCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 399995058999233300798-----------------------544888999999999999888650799960626789
Q 004565 453 RFLVYEYMNKGSLDRTLFGNG-----------------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVK 509 (745)
Q Consensus 453 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik 509 (745)
.++|+||+++|+|.+++.... ..+++..++.|+.|++.||+|||+ ++++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC---CCEEEEEEC
T ss_conf 38999815899299999852755421000011100121034678898999999999999998554135---786854884
Q ss_pred CCCEEECCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCC-CCCCCC
Q ss_conf 99834559997399047886347999763-1002345667558322367988876555414799999873998-997200
Q 004565 510 PENILLHDKLQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRK-NSSLKI 587 (745)
Q Consensus 510 ~~NIlld~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~-p~~~~~ 587 (745)
|+|||+|.++.+||+|||+++.+...... ..+...|++.|+|||++.+..++.++|||||||++|||++|.. ||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCC
T ss_conf 01168989992898331442113677641115777767676798997268898056302523629999806899999989
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 02455568899999999999996665432899999997503433012331238999999999999998702789999999
Q 004565 588 QSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS 667 (745)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt 667 (745)
....... ...+... ..+...+..+.+|+..||+.+|++|||
T Consensus 248 -----------------------------~~e~~~~-v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 248 -----------------------------HEEVIYY-VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp -----------------------------HHHHHHH-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -----------------------------HHHHHHH-HHCCCCC---------CCCCCCHHHHHHHHHHHCCCCHHHCCC
T ss_conf -----------------------------9999999-9739978---------887325299999999974889657939
Q ss_pred HHHHHHHHCCCC
Q ss_conf 889999850699
Q 004565 668 MANVVSMLEGGM 679 (745)
Q Consensus 668 ~~evl~~L~~~~ 679 (745)
|.||+++|+...
T Consensus 289 ~~ev~~~L~~i~ 300 (301)
T d1lufa_ 289 FCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHHHC
T ss_conf 999999999842
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=342.34 Aligned_cols=240 Identities=28% Similarity=0.413 Sum_probs=195.0
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCC---CHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 987543575169999979-996999999515895---0088999999998017987113289999829833999950589
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI---QGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 462 (745)
.++||+|+||.||+|... ++..||||++..... ...+.+.+|++++++++|||||++++++.+....++||||+++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCC
T ss_conf 27970188809999999899939999998444435889999999999999977899982389999989988999980699
Q ss_pred CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 99233300798544888999999999999888650799960626789998345599973990478863479997631002
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...... ..
T Consensus 100 g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-----~~ 170 (309)
T d1u5ra_ 100 SASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NS 170 (309)
T ss_dssp EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----CC
T ss_pred CCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC-----CC
T ss_conf 94578997379-99999999999999999999986---89766678842179879997898443653346778-----73
Q ss_pred CCCCCCCCCCCCCCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 345667558322367---98887655541479999987399899720002455568899999999999996665432899
Q 004565 543 MRGTRGYLAPEWLTS---SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----------------------------~~~ 221 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------------------------AMS 221 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----------------------------HHH
T ss_pred CCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----------------------------HHH
T ss_conf 134766368899834678886721454558999999987889999979-----------------------------999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999997503433012331238999999999999998702789999999889999
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
....... +...... ...+ ...+.+++..||+.||.+|||+.|+++
T Consensus 222 ~~~~i~~-~~~~~~~----~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 222 ALYHIAQ-NESPALQ----SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHH-SCCCCCS----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHH-CCCCCCC----CCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999982-8999888----7888----999999999977379657918999971
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.42 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=198.7
Q ss_pred CCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEE--CCEEEEEEEEC
Q ss_conf 7987543575169999979-9969999995158--95008899999999801798711328999982--98339999505
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ--GRQRFLVYEYM 460 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~ 460 (745)
+.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|++++++++|||||++++++.+ ....++||||+
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred EEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEECC
T ss_conf 96798308891999999999997999999874657979999999999999977899982489999917899899999568
Q ss_pred CCCCHHHHHCCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCC
Q ss_conf 899923330079---854488899999999999988865079--996062678999834559997399047886347999
Q 004565 461 NKGSLDRTLFGN---GSVLEWRERFEIALGTARGLAYLHTGC--DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 461 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~ 535 (745)
++|+|.+++... ...+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 ~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 88 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEECCCC
T ss_conf 99938999985154578999999999999999999999971677887885867654257478885798001000322457
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 76310023456675583223679888765554147999998739989972000245556889999999999999666543
Q 004565 536 QSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 536 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---------------------------- 218 (269)
T d2java1 168 TS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---------------------------- 218 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----------------------------
T ss_pred CC-CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC----------------------------
T ss_conf 77-5566778823279999839999938988752789999801889989989----------------------------
Q ss_pred CHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 2899999997503433012331238999999999999998702789999999889999
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
.... ......+... .+...+ ...+.+++.+||+.||.+|||+.|+++
T Consensus 219 -~~~~-~~~i~~~~~~-----~~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 219 -QKEL-AGKIREGKFR-----RIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -HHHH-HHHHHHTCCC-----CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHH-HHHHHCCCCC-----CCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -9999-9999718998-----897435----999999999976799557918999972
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=341.01 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=203.1
Q ss_pred HCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf 047987543575169999979-99699999951589-5008899999999801798711328999982983399995058
Q 004565 384 DNFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 461 (745)
+.+.+.||+|+||.||+|... ++..||||++.... ......+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf 69988994065839999999999989999998157731289999999999986799899919899998998889885268
Q ss_pred CCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEECCCCCCCCCCCCCCC
Q ss_conf 9992333007985448889999999999998886507999606267899983455---9997399047886347999763
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH---DKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld---~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
+|+|.+++...+ .+++..+..++.|++.||.|||+ ++|+||||||+|||+. +++.+||+|||+++......
T Consensus 91 gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 91 GGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp SCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHH---CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCCC--
T ss_conf 984888653036-78878999999999999875241---305568704630011046888249983154358725897--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 10023456675583223679888765554147999998739989972000245556889999999999999666543289
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------------------------~ 215 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----------------------------A 215 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------------------H
T ss_pred EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-----------------------------H
T ss_conf 04400328422591887379998078734515999999859799999899-----------------------------9
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHCCC
Q ss_conf 9999997503433012331238999999999999998702789999999889999--85069
Q 004565 619 LLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEGG 678 (745)
Q Consensus 619 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~--~L~~~ 678 (745)
...... ..... .... .........+.+++..|++.||++|||+.|+++ .+.+.
T Consensus 216 ~~~~~i-~~~~~--~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 216 KLFEQI-LKAEY--EFDS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHH-HTTCC--CCCT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHH-HCCCC--CCCC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 999998-61687--7787----6666789999999999760897579189998629844799
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.67 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=204.9
Q ss_pred HCCCCCCCCCCCEEEEEEEECC----CCEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 0479875435751699999799----9699999951589-5008899999999801798711328999982983399995
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD----KSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 458 (745)
..+.+.||+|+||.||+|.+.. +..||||++.... ....+.|.+|++++++++||||++++|++. .+..++|+|
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEEEE
T ss_conf 6987799307882999999936996449999999365668799999999999998689999856988995-374799998
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 05899923330079854488899999999999988865079996062678999834559997399047886347999763
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++|+|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.+......
T Consensus 88 ~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCHHHEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf 406980776542247899999999999999877523022---67441410265532067896787650342133677623
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 1002345667558322367988876555414799999873-998997200024555688999999999999966654328
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
..+...||+.|+|||.+.+..++.++|||||||++|||++ |..||..... . .+
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-------------------------~-~~ 218 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------------------------N-DV 218 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------------------------G-GH
T ss_pred ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-------------------------H-HH
T ss_conf 305400583103266751699887452444247899998269999888999-------------------------9-99
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 999999975034330123312389999999999999987027899999998899998506
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
......+.. ...+......+.+++..||+.||++|||+.+|++.|+.
T Consensus 219 ----~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 219 ----IGRIENGER---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----HHHHHCCCC---------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ----999981899---------98987779999999999768797689299999999999
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.95 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=201.8
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 47987543575169999979-9969999995158---9500889999999980179871132899998298339999505
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 460 (745)
.+.+.||+|+||.||+|... ++..||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 11 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~ 90 (288)
T d1uu3a_ 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 90 (288)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEECC
T ss_conf 89889850879099999998999799999986577557778999999999998768888617999999899889999704
Q ss_pred CCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCC-CC
Q ss_conf 89992333007985448889999999999998886507999606267899983455999739904788634799976-31
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS-SL 539 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~-~~ 539 (745)
++|+|.+++...+ .+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++.+..... ..
T Consensus 91 ~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 91 KNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp TTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCCCC
T ss_conf 8987777653159-99999999999999999976216---5088476774123668885388603210242256776433
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 00234566755832236798887655541479999987399899720002455568899999999999996665432899
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------------------------~~~ 217 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----------------------------EYL 217 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----------------------------HHH
T ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCC-----------------------------HHH
T ss_conf 355567755258440026898966623045699999803889989959-----------------------------999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999997503433012331238999999999999998702789999999889999
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
. ......... .++......+.+++..||+.||.+|||++|++.
T Consensus 218 ~-~~~i~~~~~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 218 I-FQKIIKLEY----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp H-HHHHHTTCC----------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred H-HHHHHCCCC----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf 9-999971899----------998547999999999985579768919789737
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.49 Aligned_cols=243 Identities=24% Similarity=0.287 Sum_probs=200.9
Q ss_pred CCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf 7987543575169999979-9969999995158---95008899999999801798711328999982983399995058
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 461 (745)
+.++||+|+||.||+|+.. ++..||||++... .....+.+.+|+++++.++||||+++++++.+....++||||++
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCEECCC
T ss_conf 98898317684999999989998999999815654497999999999999986799988778764035642111000357
Q ss_pred CCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 99923330079854488899999999999988865079996062678999834559997399047886347999763100
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|+|.+++...+ .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 89 gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~~~ 163 (337)
T d1o6la_ 89 GGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 163 (337)
T ss_dssp TCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CBC
T ss_pred CCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCCC-CCC
T ss_conf 986055553256-77599999999999652113431---5962246477784765899888820565200356786-205
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 23456675583223679888765554147999998739989972000245556889999999999999666543289999
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....
T Consensus 164 ~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----------------------------~~~~- 213 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----------------------------HERL- 213 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----------------------------HHHH-
T ss_pred CCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCC-----------------------------HHHH-
T ss_conf 5100889966665048988833310223067889987899999969-----------------------------9999-
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 9997503433012331238999999999999998702789999999-----889999
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS-----MANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 673 (745)
......... .++......+.+++..||+.||.+||+ +.++++
T Consensus 214 ~~~i~~~~~----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 214 FELILMEEI----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHCCC----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHCCCC----------CCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 999852899----------89866899999999866638934422565234999972
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.41 Aligned_cols=259 Identities=23% Similarity=0.394 Sum_probs=206.9
Q ss_pred HHHHHHCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCC-CCHHHHHHHHHHHHCCC-CCCCEEEEEEEEEEC
Q ss_conf 99962047987543575169999979------99699999951589-50088999999998017-987113289999829
Q 004565 379 LAAATDNFNTPIGSGGFGTVYKGILQ------DKSVVAVKKINSFG-IQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQG 450 (745)
Q Consensus 379 l~~~t~~f~~~ig~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~ 450 (745)
+......+.++||+|+||.||+|++. .+..||||+++... ......+.+|+.++..+ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf 77899698549820688299999980664477886999999874248779999999999987626999887899898319
Q ss_pred CEEEEEEEECCCCCHHHHHCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf 83399995058999233300798-----------------5448889999999999998886507999606267899983
Q 004565 451 RQRFLVYEYMNKGSLDRTLFGNG-----------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENI 513 (745)
Q Consensus 451 ~~~~lv~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NI 513 (745)
...++||||+++|+|.++++... ..+++..++.++.||+.||+|||+ ++++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCC
T ss_conf 9789999737998799999853566544444533222334588999999999999999998875---7926662410210
Q ss_pred EECCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCC-CCCCCCC
Q ss_conf 4559997399047886347999763-1002345667558322367988876555414799999873998997-2000245
Q 004565 514 LLHDKLQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSS-LKIQSRS 591 (745)
Q Consensus 514 lld~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~-~~~~~~~ 591 (745)
+++.++.+|++|||+++........ ......||+.|+|||++....++.++||||||+++|||+|++.|+. ...
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~---- 252 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---- 252 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----
T ss_pred CCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC----
T ss_conf 0002575210234010233678861586201359687677886179999740010258999999858998877899----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 55688999999999999966654328999999975034330123312389999999999999987027899999998899
Q 004565 592 TEKDSSGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANV 671 (745)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev 671 (745)
. . .........+ .+...+......+.+|+.+||+.||++||||.+|
T Consensus 253 ---------------------~---~-~~~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 253 ---------------------V---D-SKFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp ---------------------S---S-HHHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---------------------H---H-HHHHHHHHCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf ---------------------8---9-9999998668---------9889854365999999999757796579299999
Q ss_pred HHHHCCC
Q ss_conf 9985069
Q 004565 672 VSMLEGG 678 (745)
Q Consensus 672 l~~L~~~ 678 (745)
+++|+..
T Consensus 299 l~~L~~~ 305 (311)
T d1t46a_ 299 VQLIEKQ 305 (311)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
T ss_conf 9999876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.65 Aligned_cols=243 Identities=30% Similarity=0.416 Sum_probs=199.3
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEEC-CEEEEEEEECCCCC
Q ss_conf 79875435751699999799969999995158950088999999998017987113289999829-83399995058999
Q 004565 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG-RQRFLVYEYMNKGS 464 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~~~~gs 464 (745)
+.++||+|+||.||+|.++ +..||||+++.. ...+.+.+|++++++++||||++++|+|.+. +..++|+||+++|+
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCCCCC
T ss_conf 8579820798089999999-909999998857--7799999999999867898985498788723892899996369998
Q ss_pred HHHHHCCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 2333007985-448889999999999998886507999606267899983455999739904788634799976310023
Q 004565 465 LDRTLFGNGS-VLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 465 L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
|.+++..... .++|..++.|+.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++...... ...
T Consensus 88 L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~~~ 160 (262)
T d1byga_ 88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTG 160 (262)
T ss_dssp HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCC---CCEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC----CCC
T ss_conf 9999874578888999999999999852321133---765536665676014689977632456003447877----655
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 45667558322367988876555414799999873-99899720002455568899999999999996665432899999
Q 004565 544 RGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
.++..|+|||++.+..++.++||||||+++|||+| |+.||.... .... ..
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--------------------------~~~~---~~ 211 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------------------------LKDV---VP 211 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--------------------------GGGH---HH
T ss_pred CCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------------------HHHH---HH
T ss_conf 666467781787279888588777579999999978999999999--------------------------9999---99
Q ss_pred HHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 9975034330123312389999999999999987027899999998899998506
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
.. .. ..+.+.+......+.+++.+||+.||.+||||.+|+++|+.
T Consensus 212 ~i-~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 212 RV-EK---------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp HH-TT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH-HC---------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 99-80---------89999976579999999999756697689399999999999
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.99 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=200.3
Q ss_pred HCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC------CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 047987543575169999979-99699999951589------50088999999998017987113289999829833999
Q 004565 384 DNFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG------IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLV 456 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv 456 (745)
+.+.+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++|||||++++++.+....++|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 79827981178959999999999989999998756632134068999999999999867998999388999979989999
Q ss_pred EEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEECCCCCCCCC
Q ss_conf 950589992333007985448889999999999998886507999606267899983455999----7399047886347
Q 004565 457 YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL----QVKISDFGLSKLL 532 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~----~~kl~Dfgl~~~~ 532 (745)
|||+++|+|.+++...+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||++...
T Consensus 92 ~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EECCCCCCCCCHHCCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHC
T ss_conf 98677864310010356-42155789999999999876662---542211333012798258986664696433442105
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99976310023456675583223679888765554147999998739989972000245556889999999999999666
Q 004565 533 TPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612 (745)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (745)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------------------ 221 (293)
T d1jksa_ 168 DFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------------------ 221 (293)
T ss_dssp TTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------------------
T ss_pred CCCCC--CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH------------------------
T ss_conf 77763--1224777743099998189999766522140999999708899889999------------------------
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 5432899999997503433012331238999999999999998702789999999889999
Q 004565 613 QRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
.... ........ .......... ...+.+++..||+.||.+|||++|+++
T Consensus 222 -----~~~~-~~i~~~~~--~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 -----QETL-ANVSAVNY--EFEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----HHHH-HHHHTTCC--CCCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----HHHH-HHHHHCCC--CCCCHHCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----9999-99981688--8870104788----999999999986389668919999961
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.76 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=202.1
Q ss_pred CCCCCCCCCCEEEEEEEECC-CC--EEEEEEECCC-CCCHHHHHHHHHHHHCCC-CCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 79875435751699999799-96--9999995158-950088999999998017-9871132899998298339999505
Q 004565 386 FNTPIGSGGFGTVYKGILQD-KS--VVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQRFLVYEYM 460 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 460 (745)
+.++||+|+||.||+|.+.+ +. .||||++... .....+.|.+|++++.++ +|||||+++|++.+.+..++|+||+
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEEC
T ss_conf 87798207882899999989996999999997823385799999999999986228998836788884187369999802
Q ss_pred CCCCHHHHHCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 899923330079---------------85448889999999999998886507999606267899983455999739904
Q 004565 461 NKGSLDRTLFGN---------------GSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISD 525 (745)
Q Consensus 461 ~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~D 525 (745)
++|+|.++++.. ...+++..++.++.|||.||.|||+ ++++||||||+|||++.++.+||+|
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECC
T ss_pred CCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCCEEECC
T ss_conf 8986999986403555551231012345789999999999999999876630---8954555052048986887638743
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCC-CCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 78863479997631002345667558322367988876555414799999873998-99720002455568899999999
Q 004565 526 FGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRK-NSSLKIQSRSTEKDSSGDGNGPS 604 (745)
Q Consensus 526 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~ 604 (745)
||+++....... .....||..|+|||.+....++.++||||||+++|||++|.. ||....
T Consensus 171 fG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~----------------- 231 (309)
T d1fvra_ 171 FGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----------------- 231 (309)
T ss_dssp TTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------------
T ss_pred CCCCCCCCCCCC--CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC-----------------
T ss_conf 443224442234--5530137755553875269999622153138899999836899999999-----------------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 999996665432899999997503433012331238999999999999998702789999999889999850699
Q 004565 605 SSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGM 679 (745)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 679 (745)
..... .....+ .+...+......+.+++.+||+.||++||||++|++.|+...
T Consensus 232 ------------~~~~~-~~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 232 ------------CAELY-EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp ------------HHHHH-HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------HHHHH-HHHHHC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ------------99999-999826---------888887667899999999976789668949999999999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.66 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=204.7
Q ss_pred CCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 47987543575169999979------9969999995158-9500889999999980179871132899998298339999
Q 004565 385 NFNTPIGSGGFGTVYKGILQ------DKSVVAVKKINSF-GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVY 457 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 457 (745)
.+.++||+|+||.||+|.+. .+..||||+++.. ..+....|.+|++++++++||||++++|++......++|+
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEE
T ss_conf 88359820788189999987864477896899999870128689999999999999769998841254784288106777
Q ss_pred EECCCCCHHHHHCCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 5058999233300798---------5448889999999999998886507999606267899983455999739904788
Q 004565 458 EYMNKGSLDRTLFGNG---------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGL 528 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl 528 (745)
||+++|+|.+++.... ..+++..+..++.|+|+||.|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECEECCCCEEECCCCEEEEEECCC
T ss_conf 6048998899987503321134446887999999999999999998764---7965432867754035996499942454
Q ss_pred CCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 6347999763-100234566755832236798887655541479999987399-89972000245556889999999999
Q 004565 529 SKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGR-KNSSLKIQSRSTEKDSSGDGNGPSSS 606 (745)
Q Consensus 529 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 606 (745)
++.+...... ......|++.|+|||.+.+..++.++||||||+++|||+||+ .||....
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------------------- 240 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------------------- 240 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------------------
T ss_pred CEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC-------------------
T ss_conf 2023577630313402316323788887369988333444378999999968999999989-------------------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 99966654328999999975034330123312389999999999999987027899999998899998506999
Q 004565 607 SSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEGGMP 680 (745)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 680 (745)
........ ..+.. ...+......+.+++.+||+.+|++||||++|+++|+..++
T Consensus 241 ----------~~~~~~~i-~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 241 ----------NEQVLRFV-MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----------HHHHHHHH-HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----------HHHHHHHH-HHCCC---------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf ----------99999999-80888---------88863353999999999757796589399999999787617
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=328.83 Aligned_cols=240 Identities=22% Similarity=0.296 Sum_probs=199.2
Q ss_pred CCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf 7987543575169999979-9969999995158---95008899999999801798711328999982983399995058
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 461 (745)
+.++||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEEEECC
T ss_conf 88897207680899999989997999999845775488999999999999986369675330356852880056765037
Q ss_pred CCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 99923330079854488899999999999988865079996062678999834559997399047886347999763100
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 88 gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~----~ 159 (316)
T d1fota_ 88 GGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----Y 159 (316)
T ss_dssp SCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB----C
T ss_pred CCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCC---CCEECCCCCCHHEEECCCCCEEEECCCCCEEECCCC----C
T ss_conf 863223432222-11100799999999876554124---767705568105038689988983175216712456----4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 23456675583223679888765554147999998739989972000245556889999999999999666543289999
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----------------------------~~~~~ 210 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----------------------------TMKTY 210 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------------------------HHHHH
T ss_pred CCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC-----------------------------HHHHH
T ss_conf 3457634359999838999804304653336899975989999969-----------------------------99999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 999750343301233123899999999999999870278999999-----9889999
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 673 (745)
... ..+.. .+++.....+.+++.+|++.||.+|| |++++++
T Consensus 211 ~~i-~~~~~----------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 211 EKI-LNAEL----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHH-HHCCC----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHH-HCCCC----------CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf 999-70898----------89977899999999999544997666431021999981
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.56 Aligned_cols=267 Identities=25% Similarity=0.297 Sum_probs=197.9
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHH--HHHHCCCCCCCEEEEEEEEEECC----EEEEEEEE
Q ss_conf 7987543575169999979996999999515895008899999--99980179871132899998298----33999950
Q 004565 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTE--ITIIGNIHHVNLVRLKGFCAQGR----QRFLVYEY 459 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e--~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e~ 459 (745)
+.+.||+|+||.||+|+++ +..||||++... ..+.+..| +..+..++||||++++|+|.+.. ..++||||
T Consensus 7 l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEECCCEEEEEEEEC-CEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEEC
T ss_conf 9889820788199999999-989999998720---046799999999996279986832688998379860489999964
Q ss_pred CCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCC
Q ss_conf 5899923330079854488899999999999988865079-----99606267899983455999739904788634799
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGC-----DHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~ 534 (745)
+++|+|.++++.. .++|..++.++.++|.||.|||+.. .++|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCC
T ss_conf 6698989998658--99989999999999999999887665204689866153173135786887768876386623467
Q ss_pred CCCC---CCCCCCCCCCCCCCCCCCCCC------CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9763---100234566755832236798------8876555414799999873998997200024555688999999999
Q 004565 535 EQSS---LFTTMRGTRGYLAPEWLTSSA------ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSS 605 (745)
Q Consensus 535 ~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 605 (745)
.... ......||+.|+|||++.... ++.++||||||+++|||+||..|+.............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~--------- 231 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL--------- 231 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT---------
T ss_pred CCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHC---------
T ss_conf 77620013552503547678221056545467776750122015999999962899887663112410122---------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 9999666543289999999750343301233123899-99999999999987027899999998899998506
Q 004565 606 SSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQV-SDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
.............. . ....++.+.... +.+....+.+++.+||+.||++||||.||++.|+.
T Consensus 232 -----~~~~~~~~~~~~~~-~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 232 -----VPSDPSVEEMRKVV-C----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp -----SCSSCCHHHHHHHH-T----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHH-H----CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf -----55643099999987-5----024688877655776899999999999760698589599999999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.76 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=205.0
Q ss_pred HCCCCCCCCCCCEEEEEEEECC--------CCEEEEEEECCCCC-CHHHHHHHHHHHHCCC-CCCCEEEEEEEEEECCEE
Q ss_conf 0479875435751699999799--------96999999515895-0088999999998017-987113289999829833
Q 004565 384 DNFNTPIGSGGFGTVYKGILQD--------KSVVAVKKINSFGI-QGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGRQR 453 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~ 453 (745)
..+.+.||+|+||.||+|+... +..||||+++.... ....++..|+..+.++ +|||||+++++|.+....
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCCEE
T ss_conf 69700985167828999998578755566754999999881128688999999999999813999697346522018868
Q ss_pred EEEEEECCCCCHHHHHCCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf 99995058999233300798---------------544888999999999999888650799960626789998345599
Q 004565 454 FLVYEYMNKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK 518 (745)
Q Consensus 454 ~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~ 518 (745)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTT
T ss_pred EEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCEEECCC
T ss_conf 99997369990999998606776432223345743467999999999999999987663---797863022102245478
Q ss_pred CCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCCCC
Q ss_conf 97399047886347999763-1002345667558322367988876555414799999873-998997200024555688
Q 004565 519 LQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDS 596 (745)
Q Consensus 519 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~ 596 (745)
+.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |+.||....
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--------- 242 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------- 242 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---------
T ss_pred CCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC---------
T ss_conf 97676221110113555554314667888466326675179888255547758888874017989899999---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 99999999999996665432899999997503433012331238999999999999998702789999999889999850
Q 004565 597 SGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 676 (745)
.. ........+.. ...+......+.+++.+||+.||++||||.||+++|+
T Consensus 243 --------------------~~-~~~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 243 --------------------VE-ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp --------------------HH-HHHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --------------------HH-HHHHHHHCCCC---------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf --------------------99-99999972888---------8987435299999999976679767939999999998
Q ss_pred CCC
Q ss_conf 699
Q 004565 677 GGM 679 (745)
Q Consensus 677 ~~~ 679 (745)
..+
T Consensus 293 ~i~ 295 (299)
T d1fgka_ 293 RIV 295 (299)
T ss_dssp HHH
T ss_pred HHH
T ss_conf 886
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.38 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=199.7
Q ss_pred HHCCCCCCCCCCCEEEEEEEECC------CCEEEEEEECCC-CCCHHHHHHHHHHHHCCC-CCCCEEEEEEEEEECC-EE
Q ss_conf 20479875435751699999799------969999995158-950088999999998017-9871132899998298-33
Q 004565 383 TDNFNTPIGSGGFGTVYKGILQD------KSVVAVKKINSF-GIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQGR-QR 453 (745)
Q Consensus 383 t~~f~~~ig~G~fg~Vy~g~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~-~~ 453 (745)
...+.++||+|+||.||+|.... ++.||||+++.. .....+.+..|...+.++ +|+||+.+++++...+ ..
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEE
T ss_conf 97984498416783999999867775557839999998600171789999999999886149984997411540479757
Q ss_pred EEEEEECCCCCHHHHHCCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf 99995058999233300798---------------544888999999999999888650799960626789998345599
Q 004565 454 FLVYEYMNKGSLDRTLFGNG---------------SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK 518 (745)
Q Consensus 454 ~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~ 518 (745)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGG
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCC
T ss_conf 99998458992999998536666653222023321468999999999999999998873---797178677310657799
Q ss_pred CCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCC-CCCCCCCCCCCCCCC
Q ss_conf 97399047886347999763-1002345667558322367988876555414799999873998-997200024555688
Q 004565 519 LQVKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRK-NSSLKIQSRSTEKDS 596 (745)
Q Consensus 519 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~-p~~~~~~~~~~~~~~ 596 (745)
+.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|.. ||....
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~--------- 241 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--------- 241 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---------
T ss_pred CCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCC---------
T ss_conf 82898457520011356652224751667210203686468899663221367899999868899998999---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 99999999999996665432899999997503433012331238999999999999998702789999999889999850
Q 004565 597 SGDGNGPSSSSSPRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLE 676 (745)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 676 (745)
. ... .......+.. ...+......+.+++.+||+.||++||||.||++.|+
T Consensus 242 ----------------~---~~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 242 ----------------I---DEE-FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp ----------------C---SHH-HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----------------H---HHH-HHHHHHCCCC---------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf ----------------8---999-9999963898---------8888657899999999976779667919999999997
Q ss_pred CC
Q ss_conf 69
Q 004565 677 GG 678 (745)
Q Consensus 677 ~~ 678 (745)
..
T Consensus 293 ~i 294 (299)
T d1ywna1 293 NL 294 (299)
T ss_dssp HH
T ss_pred HH
T ss_conf 99
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.86 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=202.2
Q ss_pred CCCCCCCCCCEEEEEEEECC--C--CEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 79875435751699999799--9--69999995158---95008899999999801798711328999982983399995
Q 004565 386 FNTPIGSGGFGTVYKGILQD--K--SVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 458 (745)
+.+.||+|+||.||+|++.. + ..||||++... ..+..++|.+|++++++++||||++++|++.+. ..++|+|
T Consensus 12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e 90 (273)
T d1u46a_ 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTE 90 (273)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEE
T ss_pred EEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHHEEEE
T ss_conf 978980388839999999889990799999999835557989999999999999868999987898777401-0011465
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 05899923330079854488899999999999988865079996062678999834559997399047886347999763
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++|+|.+++......+++..++.++.|+|.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 91 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~ 167 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167 (273)
T ss_dssp CCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred EECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCCCCCC
T ss_conf 423861254442126899999999999999999987521---78752056688815655654332561155530358875
Q ss_pred --CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf --1002345667558322367988876555414799999873-9989972000245556889999999999999666543
Q 004565 539 --LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIIS-GRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 539 --~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
......|+..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---------------------------- 219 (273)
T d1u46a_ 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---------------------------- 219 (273)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------------------
T ss_pred CEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC----------------------------
T ss_conf 2654763257310799998379999421566148999999968999999969----------------------------
Q ss_pred CHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 28999999975034330123312389999999999999987027899999998899998506
Q 004565 616 YFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
...........+. +.+.+......+.+++..||+.||++||||.+|+++|..
T Consensus 220 -~~~~~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 220 -GSQILHKIDKEGE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -HHHHHHHHHTSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHHHHCCC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf -9999999984799---------999854453999999999768896679299999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=327.43 Aligned_cols=239 Identities=21% Similarity=0.256 Sum_probs=198.9
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 987543575169999979-9969999995158---950088999999998017987113289999829833999950589
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 462 (745)
.++||+|+||.||+|... ++..||||++... .....+.+.+|+++++.++||||+++++++.+....++|+||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCC
T ss_conf 88961176808999999899989999998267745889999999999999974877274034444322222322223346
Q ss_pred CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 99233300798544888999999999999888650799960626789998345599973990478863479997631002
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTT 542 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~ 542 (745)
|+|..++...+ .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 126 g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~----~~ 197 (350)
T d1rdqe_ 126 GEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WT 197 (350)
T ss_dssp CBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB----CC
T ss_pred CCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCCC----CC
T ss_conf 62266675158-98999999999999998999985---998617679999360778978861010333225666----43
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 34566755832236798887655541479999987399899720002455568899999999999996665432899999
Q 004565 543 MRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 543 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... .
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----------------------------~~~~-~ 247 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----------------------------PIQI-Y 247 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------------------------HHHH-H
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-----------------------------HHHH-H
T ss_conf 367635678899717998853311450078999975889989959-----------------------------9999-9
Q ss_pred HHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 99750343301233123899999999999999870278999999-----9889999
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 673 (745)
........ ..+......+.+++..||+.||.+|+ |++++++
T Consensus 248 ~~i~~~~~----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 248 EKIVSGKV----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHCCC----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHCCCC----------CCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 99861798----------89766899999999998340998606553454999971
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=328.13 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=192.2
Q ss_pred CCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC---CCHHHHHHH---HHHHHCCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 7987543575169999979-99699999951589---500889999---9999801798711328999982983399995
Q 004565 386 FNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCT---EITIIGNIHHVNLVRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 458 (745)
+.++||+|+||.||+|+.. ++..||||++.... ......+.. ++++++.++|||||++++++.+.+..++|||
T Consensus 8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE 87 (364)
T d1omwa3 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87 (364)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 10188428890999999999997999999845875426679999999999999850899858899999998998899999
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 05899923330079854488899999999999988865079996062678999834559997399047886347999763
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 88 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-- 161 (364)
T d1omwa3 88 LMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 161 (364)
T ss_dssp CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC--
T ss_pred ECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCCEEECCCEEEECCCCCEEEEEECEEEECCCCC--
T ss_conf 148983899987325-53278999999999999999997---796220444221678588967982201023337886--
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 1002345667558322367-988876555414799999873998997200024555688999999999999966654328
Q 004565 539 LFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... . ..
T Consensus 162 -~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------------------------~--~~ 214 (364)
T d1omwa3 162 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT------------------------K--DK 214 (364)
T ss_dssp -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS------------------------S--CH
T ss_pred -CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH------------------------H--HH
T ss_conf -43311345542168760389998441046778999999859998888998------------------------9--99
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 99999997503433012331238999999999999998702789999999-----889999
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPS-----MANVVS 673 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 673 (745)
. ........ ....+...+ ...+.+++..||+.||.+||| ++++++
T Consensus 215 ~-~~~~~~~~------~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 215 H-EIDRMTLT------MAVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp H-HHHHHSSS------CCCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred H-HHHHHCCC------CCCCCCCCC----CHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf 9-99986046------888788778----99999999998566988808874357999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.57 Aligned_cols=247 Identities=21% Similarity=0.317 Sum_probs=201.0
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCC
Q ss_conf 47987543575169999979-99699999951589500889999999980179871132899998298339999505899
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 463 (745)
.+.++||+|+||.||+|... ++..||||.++... .....+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCCC
T ss_conf 88789831778399999998999699999975786-65999999999998579979890989998899889999538998
Q ss_pred CHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 9233300798544888999999999999888650799960626789998345599--97399047886347999763100
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK--LQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~--~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
+|.+++...+..+++..+..|+.||+.||.|||+ .+|+||||||+|||++.+ ..+||+|||++........ ..
T Consensus 87 ~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~--~~ 161 (321)
T d1tkia_ 87 DIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FR 161 (321)
T ss_dssp BHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--EE
T ss_pred CHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCCC--CC
T ss_conf 0889987538999999999999999999999987---699751355444344378851899764411100346775--32
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 23456675583223679888765554147999998739989972000245556889999999999999666543289999
Q 004565 542 TMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLA 621 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (745)
...+++.|+|||.+.+..++.++||||+||++|||++|+.||.... .....
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----------------------------~~~~~ 212 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----------------------------NQQII 212 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----------------------------HHHHH
T ss_pred CCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCC-----------------------------HHHHH
T ss_conf 1223322234021048777840113027999999982899999989-----------------------------99999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9997503433012331238999999999999998702789999999889999
Q 004565 622 LELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 622 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
..... ... ..+......+ ...+.+++..|++.||.+|||+.|+++
T Consensus 213 ~~i~~-~~~--~~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 213 ENIMN-AEY--TFDEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHH-TCC--CCCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHH-CCC--CCCHHHCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 99983-899--9880223678----999999999986699668909999963
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.58 Aligned_cols=268 Identities=23% Similarity=0.272 Sum_probs=197.4
Q ss_pred CCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCC-----HHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf 87543575169999979-9969999995158950-----08899999999801798711328999982983399995058
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQ-----GKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMN 461 (745)
Q Consensus 388 ~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 461 (745)
++||+|+||.||+|... +++.||||++...... ..+.+.+|+++++.++|||||++++++.+.+..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHHC
T ss_conf 38512728299999999999699999984202124567999999999999986799998689854225874022045534
Q ss_pred CCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 99923330079854488899999999999988865079996062678999834559997399047886347999763100
Q 004565 462 KGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFT 541 (745)
Q Consensus 462 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~ 541 (745)
++++...... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 84 ~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~ 158 (299)
T d1ua2a_ 84 TDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YT 158 (299)
T ss_dssp EEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CC
T ss_pred CHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC-CC
T ss_conf 5077655412-6677899999999999999988631---63550357762588537784114657610005787554-33
Q ss_pred CCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 23456675583223679-88876555414799999873998997200024555688999999999999966654328999
Q 004565 542 TMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLL 620 (745)
Q Consensus 542 ~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (745)
...||+.|+|||++... .++.++|||||||++|||++|+.||......+....+....+..+... .+...
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~-~~~~~-------- 229 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ-WPDMC-------- 229 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT-SSSTT--------
T ss_pred CEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH-CCCHH--------
T ss_conf 020473336399972677888056436304289999859699999999999999998518997254-52100--------
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHCC
Q ss_conf 99997503433012331238999-----999999999998702789999999889999--8506
Q 004565 621 ALELHEQRRYLELADSRIEGQVS-----DEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEG 677 (745)
Q Consensus 621 ~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~--~L~~ 677 (745)
..............+ ......+.+++..|++.||++|||++|+++ .+..
T Consensus 230 --------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 230 --------SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp --------SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred --------CCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf --------02134430347898867856568999999999976389456908999967996578
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.59 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=192.5
Q ss_pred CCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHCCC-CCCCEEEEEEEEEE----CCEEEEEEEECC
Q ss_conf 8754357516999997-99969999995158950088999999998017-98711328999982----983399995058
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQGKKEFCTEITIIGNI-HHVNLVRLKGFCAQ----GRQRFLVYEYMN 461 (745)
Q Consensus 388 ~~ig~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e~~~ 461 (745)
+.||+|+||.||+|.. .++..||||+++. ...+.+|++++.++ +||||+++++++.+ ....++||||++
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEEECCC
T ss_conf 796545486999999889998999999897-----477999999999866999978298999503468978999997789
Q ss_pred CCCHHHHHCCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEECCCCCCCCCCCCCC
Q ss_conf 999233300798-54488899999999999988865079996062678999834559---99739904788634799976
Q 004565 462 KGSLDRTLFGNG-SVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD---KLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 462 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~---~~~~kl~Dfgl~~~~~~~~~ 537 (745)
+|+|.+++...+ ..+++..+..|+.||+.||.|||+ .+|+||||||+|||++. .+.+||+|||+++.......
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 9849999986278775799999999999999999997---6986444100220113555566311354551233368886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 31002345667558322367988876555414799999873998997200024555688999999999999966654328
Q 004565 538 SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~--------------------- 226 (335)
T d2ozaa1 170 --LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------------------- 226 (335)
T ss_dssp --CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------------------
T ss_pred --CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHH---------------------
T ss_conf --432267756379277748988888888764516778865889988988778899999---------------------
Q ss_pred HHHHHHHHHHCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9999999750343301233123--8999999999999998702789999999889999
Q 004565 618 PLLALELHEQRRYLELADSRIE--GQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
. .+...... ..........+.+++..|++.||++|||+.|+++
T Consensus 227 --------~-----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 --------T-----RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --------H-----HHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --------9-----98538888898543469999999999975699657909999970
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.64 Aligned_cols=244 Identities=21% Similarity=0.266 Sum_probs=197.5
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCHHHHHHHHHHHHC-CCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 47987543575169999979-9969999995158---9500889999999980-17987113289999829833999950
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF---GIQGKKEFCTEITIIG-NIHHVNLVRLKGFCAQGRQRFLVYEY 459 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~g~~~~~~~~~lv~e~ 459 (745)
.+.++||+|+||.||+|+.. +++.||||++... .....+.+..|..++. .++||||+++++++.+++..++||||
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy 84 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 84 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEEEEE
T ss_conf 88658940878289999999999899999980555338489999999999999847999687898897049831677750
Q ss_pred CCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 58999233300798544888999999999999888650799960626789998345599973990478863479997631
Q 004565 460 MNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 460 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~ 539 (745)
+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-~ 159 (320)
T d1xjda_ 85 LNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-K 159 (320)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-C
T ss_pred CCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCCC-C
T ss_conf 37980899864047-89999999999999999999986---8934034765404444899630155530232356653-3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 00234566755832236798887655541479999987399899720002455568899999999999996665432899
Q 004565 540 FTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPL 619 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (745)
.+...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-----------------------------~~~ 210 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----------------------------EEE 210 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------------------------HHH
T ss_pred CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----------------------------HHH
T ss_conf 454578777689999827998832320112278989873889999989-----------------------------999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 99999750343301233123899999999999999870278999999988-9999
Q 004565 620 LALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMA-NVVS 673 (745)
Q Consensus 620 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl~ 673 (745)
.......+. + .++......+.+++..|++.||.+||++. ++++
T Consensus 211 -~~~~i~~~~------~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 211 -LFHSIRMDN------P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -HHHHHHHCC------C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -HHHHHHCCC------C----CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf -999997189------9----8975679999999999654489878388999980
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=319.35 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=202.2
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC---CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC----EEEEE
Q ss_conf 47987543575169999979-99699999951589---500889999999980179871132899998298----33999
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG---IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR----QRFLV 456 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~lv 456 (745)
.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+++++.++||||+++++++.... ..++|
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lv 89 (277)
T d1o6ya_ 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 89 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEEEE
T ss_conf 98689960899299999999999899999985566469899999999999998569998873114354326887669999
Q ss_pred EEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCC
Q ss_conf 95058999233300798544888999999999999888650799960626789998345599973990478863479997
Q 004565 457 YEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 457 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~ 536 (745)
|||+++++|.+++...+ .+++..++.|+.|++.||.|||+ ++|+||||||+|||++.++..+++|||.+.......
T Consensus 90 mE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EECCCCCEEHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCC
T ss_conf 97788987101120358-99999999999999999999985---795276346755665754320100344432212354
Q ss_pred C--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 6--31002345667558322367988876555414799999873998997200024555688999999999999966654
Q 004565 537 S--SLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614 (745)
Q Consensus 537 ~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (745)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------------------------- 218 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------------------------- 218 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---------------------------
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC---------------------------
T ss_conf 43333464257624369999839999966320265289999976979989969---------------------------
Q ss_pred CCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHCC
Q ss_conf 3289999999750343301233123899999999999999870278999999-98899998506
Q 004565 615 VYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-SMANVVSMLEG 677 (745)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~ 677 (745)
............... .......++ ..+.+++.+|++.||.+|| |+++++..|..
T Consensus 219 --~~~~~~~~~~~~~~~---~~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 219 --PVSVAYQHVREDPIP---PSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp --HHHHHHHHHHCCCCC---GGGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --HHHHHHHHHHCCCCC---CCHHCCCCC----HHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf --999999998469999---710034789----9999999998667976777399999999999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.96 Aligned_cols=272 Identities=22% Similarity=0.264 Sum_probs=197.4
Q ss_pred CCCCCCCCEEEEEEEE-CCCCEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCCC
Q ss_conf 8754357516999997-999699999951589--5008899999999801798711328999982983399995058999
Q 004565 388 TPIGSGGFGTVYKGIL-QDKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 388 ~~ig~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 464 (745)
++||+|+||.||+|.. ..++.||||++.... ......+.+|++++++++||||+++++++.+....++|+||+.++.
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~ 87 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred CEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEECCCCH
T ss_conf 17723768099999999999799999980222575899999999999986799838874453322432037886237744
Q ss_pred HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 23330079854488899999999999988865079996062678999834559997399047886347999763100234
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
+..........+++..+..++.|++.||.|||+ .+|+||||||+|||++.+..+||+|||+++....... ......
T Consensus 88 ~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~ 163 (298)
T d1gz8a_ 88 KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEV 163 (298)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CTTCCB
T ss_pred HHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCC-CCEEEC
T ss_conf 555442025688889999999999999998652---8899213571140113467621035786134368864-100103
Q ss_pred CCCCCCCCCCCCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 566755832236798-8876555414799999873998997200024555688999999999999966654328999999
Q 004565 545 GTRGYLAPEWLTSSA-ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 545 gt~~y~aPE~~~~~~-~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
||+.|+|||.+.... ++.++||||+||++|+|++|+.||...........+....+.. .....+..
T Consensus 164 gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~------------ 230 (298)
T d1gz8a_ 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP-DEVVWPGV------------ 230 (298)
T ss_dssp CCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTG------------
T ss_pred CCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC-CHHHCCCC------------
T ss_conf 65215411221366577742210333313427966879989889999999999832898-33314442------------
Q ss_pred HHHHCCCCCCCCCCCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHCC
Q ss_conf 975034330123312389---99999999999998702789999999889999--8506
Q 004565 624 LHEQRRYLELADSRIEGQ---VSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEG 677 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~--~L~~ 677 (745)
................. ..+.....+.+++.+|++.||++|||+.|+++ .++.
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 231 -TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp -GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred -CCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf -2242124345432222044416678999999999976399557918999967870146
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=317.37 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=197.9
Q ss_pred CCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCC---------HHHHHHHHHHHHCCCC-CCCEEEEEEEEEECCEEE
Q ss_conf 798754357516999997-99969999995158950---------0889999999980179-871132899998298339
Q 004565 386 FNTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFGIQ---------GKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRF 454 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~ 454 (745)
+.+.||+|+||+||+|+. .++..||||++...... ..+.+.+|+.++++++ ||||+++++++.+.+..+
T Consensus 7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 86 (277)
T d1phka_ 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 86 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEE
T ss_conf 85288417684999999999998999999962446411478889999999999999998507997479976214676059
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCC
Q ss_conf 99950589992333007985448889999999999998886507999606267899983455999739904788634799
Q 004565 455 LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 455 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~ 534 (745)
+||||+++|+|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCHHEEECCC
T ss_conf 9997689866899998659-99999999999999999999987---5994323462548986899838712403167268
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 97631002345667558322367------988876555414799999873998997200024555688999999999999
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTS------SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSS 608 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (745)
... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 163 ~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------------------- 219 (277)
T d1phka_ 163 GEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------------------- 219 (277)
T ss_dssp TCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---------------------
T ss_pred CCC--EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCC---------------------
T ss_conf 872--134524678889888605344567889923318565602310322888988999---------------------
Q ss_pred CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 96665432899999997503433012331238999999999999998702789999999889999
Q 004565 609 PRESQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
..........+... . .. .........+.+++.+|++.||++|||+.||++
T Consensus 220 ---------~~~~~~~i~~~~~~-~-~~----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 220 ---------QMLMLRMIMSGNYQ-F-GS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---------HHHHHHHHHHTCCC-C-CT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---------HHHHHHHHHHCCCC-C-CC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ---------99999999818988-8-98----543468999999999976589668919999973
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=316.07 Aligned_cols=271 Identities=23% Similarity=0.257 Sum_probs=198.4
Q ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCCC
Q ss_conf 98754357516999997999699999951589--5008899999999801798711328999982983399995058999
Q 004565 387 NTPIGSGGFGTVYKGILQDKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKGS 464 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 464 (745)
.++||+|+||.||+|..++++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++++|++.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred CCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEEEHHHH
T ss_conf 31872277818999996899999999981232685899999999999986799868766012046773158997400456
Q ss_pred HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 23330079854488899999999999988865079996062678999834559997399047886347999763100234
Q 004565 465 LDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTMR 544 (745)
Q Consensus 465 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 544 (745)
+..+.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ......
T Consensus 87 ~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~ 161 (286)
T d1ob3a_ 87 KKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEI 161 (286)
T ss_dssp HHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------
T ss_pred HHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHCC---CCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC-CCCEEC
T ss_conf 78998604-775144568999999999998605---7488267877505686899787323664301146765-410102
Q ss_pred CCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 56675583223679-88876555414799999873998997200024555688999999999999966654328999999
Q 004565 545 GTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLALE 623 (745)
Q Consensus 545 gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (745)
+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+....+....+..+... .+.. . .
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~---~-------~ 230 (286)
T d1ob3a_ 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN-WPNV---T-------E 230 (286)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT-STTG---G-------G
T ss_pred CCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHH-CCCH---H-------H
T ss_conf 431101378871788888410021117589999779799898898999999998638997110-4212---3-------3
Q ss_pred HHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 97503433012331238999999999999998702789999999889999
Q 004565 624 LHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 624 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
............+.-...........+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 32214333335676466651258999999999986689668909999856
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.66 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=190.8
Q ss_pred CCCCCCCCCEEEEEEEEC-C-CCEEEEEEECCC--CCCHHHHHHHHHHHHCCC---CCCCEEEEEEEEEE-----CCEEE
Q ss_conf 987543575169999979-9-969999995158--950088999999998017---98711328999982-----98339
Q 004565 387 NTPIGSGGFGTVYKGILQ-D-KSVVAVKKINSF--GIQGKKEFCTEITIIGNI---HHVNLVRLKGFCAQ-----GRQRF 454 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~-----~~~~~ 454 (745)
.++||+|+||.||+|... . ++.||||++... .......+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCEEE
T ss_conf 88992155869999999888998999999802324516799999999999987425898802366322146666674699
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCC
Q ss_conf 99950589992333007985448889999999999998886507999606267899983455999739904788634799
Q 004565 455 LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 455 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~ 534 (745)
+++|++.++.+..........+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~ 168 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168 (305)
T ss_dssp EEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG
T ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEECCCCCEEECCHHHHHHHCC
T ss_conf 9997405871444443037899989999999999999999975---8898357986278985899754210001011002
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 97631002345667558322367988876555414799999873998997200024555688999999999999966654
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQR 614 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (745)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+....+..+ ....+.....
T Consensus 169 ~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~ 245 (305)
T d1blxa_ 169 Q--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG-EEDWPRDVAL 245 (305)
T ss_dssp G--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-GGGSCTTCSS
T ss_pred C--CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCC-HHCCCCCCCC
T ss_conf 3--457776548511483100179888111000328999999878799899898999999998407996-1105321111
Q ss_pred CCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32899999997503433012331238999999999999998702789999999889999
Q 004565 615 VYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
. ............ ..+.....+.+.+++.+|++.||++|||+.|+++
T Consensus 246 ~-----------~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 246 P-----------RQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp C-----------GGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-----------HHHHCCCCCCCH-HHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 0-----------333022345645-4404458999999999987489667918999966
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=307.21 Aligned_cols=264 Identities=23% Similarity=0.275 Sum_probs=188.0
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEEC------CEEEEEEEE
Q ss_conf 987543575169999979-9969999995158950088999999998017987113289999829------833999950
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG------RQRFLVYEY 459 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~lv~e~ 459 (745)
.++||+|+||+||+|+.. .++.||||++..... ...+|++++++++|+||+++++++... ...++||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEEEC
T ss_conf 1698217683999999999997999999881606----899999999866898987387899744765773189999841
Q ss_pred CCCCCHHHHHC--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEECCCCCCCCCCCCC
Q ss_conf 58999233300--7985448889999999999998886507999606267899983455999-73990478863479997
Q 004565 460 MNKGSLDRTLF--GNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLLTPEQ 536 (745)
Q Consensus 460 ~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~-~~kl~Dfgl~~~~~~~~ 536 (745)
++++.+..... .....+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||++..+....
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 6886078888631036899999999999999999999986---6876457886037873589711673366054404776
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 631002345667558322367-9888765554147999998739989972000245556889999999999999666543
Q 004565 537 SSLFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRV 615 (745)
Q Consensus 537 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (745)
.. ....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+....+..
T Consensus 178 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~------------- 242 (350)
T d1q5ka_ 178 PN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP------------- 242 (350)
T ss_dssp CC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC-------------
T ss_pred CC--CCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCC-------------
T ss_conf 53--200255555682776404688821000246527785502879989879999999999974898-------------
Q ss_pred CHHHHHHHHHH---HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 28999999975---03433012331238999999999999998702789999999889999
Q 004565 616 YFPLLALELHE---QRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 616 ~~~~~~~~~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
....+ ..... .......................+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 243 TREQI-REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CHHHH-HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHH-HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 17765-4306210110355445674444315689999999999976589557929999966
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=299.62 Aligned_cols=269 Identities=20% Similarity=0.210 Sum_probs=193.1
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEE--------CCEEEE
Q ss_conf 987543575169999979-9969999995158--95008899999999801798711328999982--------983399
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ--------GRQRFL 455 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--------~~~~~l 455 (745)
.++||+|+||+||+|... +++.||||++... .....+.+.+|+++++.++|+|++++++++.. ....++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCCCEEEE
T ss_conf 99972274829999999899979999998422246378999999999999835999660676540246544445763899
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCC
Q ss_conf 99505899923330079854488899999999999988865079996062678999834559997399047886347999
Q 004565 456 VYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPE 535 (745)
Q Consensus 456 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~ 535 (745)
|+|++..+.+...... ...++...+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 95 v~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~ 170 (318)
T d3blha1 95 VFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 170 (318)
T ss_dssp EEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-
T ss_pred EEECCCCCCCCHHHHC-CCCCCCHHHHHHHHHHHHHHHHHCC---CCEEECCCCCHHEEECCCCCEEEEECCEEEECCCC
T ss_conf 9853578741012220-3443308999999999999988522---99885676722203668996876313500223554
Q ss_pred CCC---CCCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 763---10023456675583223679-88876555414799999873998997200024555688999999999999966
Q 004565 536 QSS---LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 536 ~~~---~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........+....+..+... ....
T Consensus 171 ~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~ 249 (318)
T d3blha1 171 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV-WPNV 249 (318)
T ss_dssp ----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT-STTC
T ss_pred CCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH-CCCC
T ss_conf 443211356602497874289970799989178700678646617448799899899999999998418998255-3443
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCH-------HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 654328999999975034330123312389999-------999999999987027899999998899998
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSD-------EDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-------~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 674 (745)
... ................ .....+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 250 DNY--------------ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCC---------------------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHH--------------HHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 203--------------44433201334455503340444599899999999873896589099999749
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=302.24 Aligned_cols=273 Identities=22% Similarity=0.280 Sum_probs=194.7
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC------EEEEEE
Q ss_conf 987543575169999979-9969999995158--9500889999999980179871132899998298------339999
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR------QRFLVY 457 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~~lv~ 457 (745)
.++||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++|||+|++++++.... ..++||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEEEEEE
T ss_conf 88980177819999999999989999998522259699999999999998668987547999863576555541599998
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCC
Q ss_conf 50589992333007985448889999999999998886507999606267899983455999739904788634799976
Q 004565 458 EYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 458 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~ 537 (745)
||+ +.+|....... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||+++......
T Consensus 103 e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~- 175 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM- 175 (346)
T ss_dssp ECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-
T ss_pred ECC-CCCHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCHHHCCCCCCCCCCCCCCEECCCCCC-
T ss_conf 405-52189998740--22699999999999999999873---787645668511112100122113431022068763-
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 310023456675583223679-8887655541479999987399899720002455568899999999999996665432
Q 004565 538 SLFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVY 616 (745)
Q Consensus 538 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (745)
+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||................+..+... ....
T Consensus 176 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 246 (346)
T d1cm8a_ 176 ---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF------VQRL 246 (346)
T ss_dssp ---CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH------HHTC
T ss_pred ---CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHH------HHHH
T ss_conf ---1024553335889981787899650103003899999978699888976899999985037884888------8653
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHCCC
Q ss_conf 899999997503433012331238999999999999998702789999999889999--85069
Q 004565 617 FPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEGG 678 (745)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~--~L~~~ 678 (745)
........... ........+. .........+.+++..|++.||.+|||+.|+++ .++..
T Consensus 247 ~~~~~~~~~~~--~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 247 QSDEAKNYMKG--LPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCHHHHHHHHH--SCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCHHHHHHHCC--CCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 00034433115--7866655667-7556899999999999772995579299999639623758
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=300.59 Aligned_cols=274 Identities=22% Similarity=0.281 Sum_probs=193.1
Q ss_pred CCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC----EEEEEEEEC
Q ss_conf 98754357516999997-999699999951589-500889999999980179871132899998298----339999505
Q 004565 387 NTPIGSGGFGTVYKGIL-QDKSVVAVKKINSFG-IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGR----QRFLVYEYM 460 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e~~ 460 (745)
.++||+|+||+||+|.. .+++.||||++.... ....+.+.+|+++++.++|||++++++++.... ..+++++++
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEEE
T ss_conf 78994064809999999999949999998031095899999999999997689898858889950564554149999962
Q ss_pred CCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC--
Q ss_conf 899923330079854488899999999999988865079996062678999834559997399047886347999763--
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS-- 538 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~-- 538 (745)
.+|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 93 ~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (345)
T d1pmea_ 93 MGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167 (345)
T ss_dssp CCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred CCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCCCCE
T ss_conf 598656644058--99999999999999999999997---8986777876437887999778754570565047776410
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 1002345667558322367-988876555414799999873998997200024555688999999999999966654328
Q 004565 539 LFTTMRGTRGYLAPEWLTS-SAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
......|++.|+|||++.. ..++.++||||+|+++|||++|+.||......+........... +... ........
T Consensus 168 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~ 243 (345)
T d1pmea_ 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS-PSQE---DLNCIINL 243 (345)
T ss_dssp TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS-CCHH---HHHTCCCH
T ss_pred EECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCC-CCHH---HHHHHHHH
T ss_conf 1011026520003878604788874101004670133776697997888889999987652069-9756---64234332
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999999975034330123312389999999999999987027899999998899998
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSM 674 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 674 (745)
..+... ..........-..+.... ...+.+++..|++.||.+|||+.|+++.
T Consensus 244 ~~~~~~-~~~~~~~~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYL-LSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHH-HTSCCCCCCCHHHHCTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHCCC-CCCCCCCCCCHHHHCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 222024-467755778777837899----9999999999764895679089998619
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.17 Aligned_cols=236 Identities=24% Similarity=0.391 Sum_probs=189.9
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCC------CHHHHHHHHHHHHCCCC--CCCEEEEEEEEEECCEEEE
Q ss_conf 47987543575169999979-996999999515895------00889999999980179--8711328999982983399
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGI------QGKKEFCTEITIIGNIH--HVNLVRLKGFCAQGRQRFL 455 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~~l 455 (745)
.+.+.||+|+||.||+|... ++..||||++..... .....+..|+.++++++ ||||+++++++.+.+..++
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~l 86 (273)
T d1xwsa_ 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 86 (273)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEE
T ss_conf 99679840878399999999999799999985688443345567999999999999743589881279999830996899
Q ss_pred EEEECCC-CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEECCCCCCCCCC
Q ss_conf 9950589-99233300798544888999999999999888650799960626789998345599-973990478863479
Q 004565 456 VYEYMNK-GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDK-LQVKISDFGLSKLLT 533 (745)
Q Consensus 456 v~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~-~~~kl~Dfgl~~~~~ 533 (745)
|+||+.+ +++.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++...
T Consensus 87 v~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 87 ILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCEEEECCCCCCEECC
T ss_conf 9983368622899986158-99999999999999999999987---7975566761114774478848977546535324
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 997631002345667558322367988-8765554147999998739989972000245556889999999999999666
Q 004565 534 PEQSSLFTTMRGTRGYLAPEWLTSSAI-SDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612 (745)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (745)
... .+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....
T Consensus 163 ~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------------------ 215 (273)
T d1xwsa_ 163 DTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------------------ 215 (273)
T ss_dssp SSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------------------
T ss_pred CCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH------------------------
T ss_conf 445---56656587747999984899788653325540345367568899887367------------------------
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 5432899999997503433012331238999999999999998702789999999889999
Q 004565 613 QRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
... .. ......++ ..+.+++.+|++.||++|||++|+++
T Consensus 216 -----------i~~-~~------~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 -----------IIR-GQ------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----------HHH-CC------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------HHH-CC------CCCCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----------761-54------47787799----99999999976089758939999853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-45 Score=300.24 Aligned_cols=255 Identities=19% Similarity=0.201 Sum_probs=193.1
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEE-EEEEEEEECCEEEEEEEECCC
Q ss_conf 47987543575169999979-9969999995158950088999999998017987113-289999829833999950589
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNLV-RLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~ 462 (745)
.+.++||+|+||.||+|... +++.||||.+.... ...++..|+++++.++|+|++ .+.++..+....++|+||+ +
T Consensus 10 ~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEEC-C
T ss_conf 99689850788099999998899899999972100--58889999999997038996017999995198778999873-8
Q ss_pred CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEECCCCCCCCCCCCCCC-
Q ss_conf 992333007985448889999999999998886507999606267899983455---9997399047886347999763-
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLH---DKLQVKISDFGLSKLLTPEQSS- 538 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld---~~~~~kl~Dfgl~~~~~~~~~~- 538 (745)
++|...+......+++..++.++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+++.+......
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCCCC
T ss_conf 71333244306887689999999999999999997---994426678766064335777615650467513425544554
Q ss_pred -----CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf -----100234566755832236798887655541479999987399899720002455568899999999999996665
Q 004565 539 -----LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQ 613 (745)
Q Consensus 539 -----~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (745)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~-----------------------~ 220 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-----------------------T 220 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------------------------
T ss_pred CEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHH-----------------------H
T ss_conf 10001357767873532999991899898321886177899998498766553057-----------------------7
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 4328999999975034330123312389999999999999987027899999998899998506
Q 004565 614 RVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
......... .... ....+.+...++ ..+.+++..|++.+|++||++.++.+.|+.
T Consensus 221 ---~~~~~~~~~-~~~~-~~~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 221 ---KRQKYERIS-EKKM-STPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -------HHHHH-HHHH-HSCHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ---HHHHHHHHH-CCCC-CCCHHHHCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ---999999852-3567-898357534788----999999999843995579199999999999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=300.38 Aligned_cols=272 Identities=20% Similarity=0.265 Sum_probs=197.5
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECCCC
Q ss_conf 987543575169999979-9969999995158--9500889999999980179871132899998298339999505899
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSF--GIQGKKEFCTEITIIGNIHHVNLVRLKGFCAQGRQRFLVYEYMNKG 463 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 463 (745)
.++||+|+||+||+|+.. ++..||||+++.. .......+.+|+.+++.++|+||+++++++.+....++|+|++.++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEECCCC
T ss_conf 26971286819999999999969999998032178689999999999998567578882135444443115886302332
Q ss_pred CHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 92333007985448889999999999998886507999606267899983455999739904788634799976310023
Q 004565 464 SLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSSLFTTM 543 (745)
Q Consensus 464 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 543 (745)
+|..++...+ .+++..+..++.|++.||+|||+ ++|+||||||+|||++.+..+||+|||.++........ ....
T Consensus 87 ~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-~~~~ 161 (292)
T d1unla_ 87 LKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAE 161 (292)
T ss_dssp HHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-CCSC
T ss_pred CCCCCCCCCC-CCCHHHHHHHHHHHHHHHHHHHC---CCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCCC-CEEE
T ss_conf 2211212356-54036789999999999877433---99860014676121133782665204601104688751-0010
Q ss_pred CCCCCCCCCCCCCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 4566755832236798-887655541479999987399899720002455568899999999999996665432899999
Q 004565 544 RGTRGYLAPEWLTSSA-ISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFPLLAL 622 (745)
Q Consensus 544 ~gt~~y~aPE~~~~~~-~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (745)
.++..|.|||.+.... ++.++||||+||++|||++|+.||............+......+.....+....
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 232 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK--------- 232 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG---------
T ss_pred CCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHH---------
T ss_conf 34431014667506988880444026541889985189999889999999999986118997355134432---------
Q ss_pred HHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 997503433012331238999999999999998702789999999889999
Q 004565 623 ELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 623 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
..............-...........+.+++.+|++.||.+|||++|+++
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 -LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp -STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -22113344454431043306568999999999986499668909999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=302.21 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=199.2
Q ss_pred HCCCCCCCCCCCEEEEEEEEC----CCCEEEEEEECCCC----CCHHHHHHHHHHHHCCCCC-CCEEEEEEEEEECCEEE
Q ss_conf 047987543575169999979----99699999951589----5008899999999801798-71132899998298339
Q 004565 384 DNFNTPIGSGGFGTVYKGILQ----DKSVVAVKKINSFG----IQGKKEFCTEITIIGNIHH-VNLVRLKGFCAQGRQRF 454 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~ 454 (745)
+.+.++||+|+||.||+|... .++.||||.+.... ....+.+..|++++++++| +||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEE
T ss_conf 59998983287839999998765887948999998367721016899999999999986467983999620002487300
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCC
Q ss_conf 99950589992333007985448889999999999998886507999606267899983455999739904788634799
Q 004565 455 LVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 455 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~ 534 (745)
+|+||+.+|+|.+++...+ .++......++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 106 ~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCCCCEEECCCCCEEEEECCCHHHHCC
T ss_conf 1231234117999987304-54378888889999999988514---9989654773201246999888741320222034
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 976310023456675583223679--888765554147999998739989972000245556889999999999999666
Q 004565 535 EQSSLFTTMRGTRGYLAPEWLTSS--AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRES 612 (745)
Q Consensus 535 ~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (745)
..........|++.|+|||.+... .++.++|||||||+||||++|+.||.....
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~------------------------ 237 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE------------------------ 237 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS------------------------
T ss_pred CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH------------------------
T ss_conf 44432212223333310687605776887132517777999999768999888877------------------------
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 543289999999750343301233123899999999999999870278999999-----9889999
Q 004565 613 QRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRP-----SMANVVS 673 (745)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 673 (745)
............. .. ..++......+.+++..|++.||++|| |++|+++
T Consensus 238 -~~~~~~i~~~~~~-~~----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 238 -KNSQAEISRRILK-SE----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -CCCHHHHHHHHHH-CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -HHHHHHHHHHCCC-CC----------CCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf -7799999983356-89----------988654799999999997445898819997450999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.1e-44 Score=293.48 Aligned_cols=261 Identities=18% Similarity=0.259 Sum_probs=189.9
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCC-CCCEEEEEEEEEEC--CEEEEEEEEC
Q ss_conf 47987543575169999979-99699999951589500889999999980179-87113289999829--8339999505
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQG--RQRFLVYEYM 460 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~e~~ 460 (745)
.+.++||+|+||+||+|+.. +++.||||+++.. ..+.+.+|++++..++ ||||+++++++... ...++||||+
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEEEC
T ss_conf 8978983174819999998899979999998889---9999999999998515799876799999816877126888631
Q ss_pred CCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEECCCCCCCCCCCCCCCC
Q ss_conf 89992333007985448889999999999998886507999606267899983455999-73990478863479997631
Q 004565 461 NKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKL-QVKISDFGLSKLLTPEQSSL 539 (745)
Q Consensus 461 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~-~~kl~Dfgl~~~~~~~~~~~ 539 (745)
++++|.... +.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++........
T Consensus 115 ~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~-- 185 (328)
T d3bqca1 115 NNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 185 (328)
T ss_dssp CSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--
T ss_pred CCCCHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCCC--
T ss_conf 798589974----689999999999999999988764---33443456441237748998366415654266468874--
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 0023456675583223679-888765554147999998739989972000245556889999999999999666543289
Q 004565 540 FTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 540 ~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
.....+|..|+|||.+.+. .++.++||||+|++++||++|+.||............+.. ....+
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~---------------~~g~~ 250 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK---------------VLGTE 250 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH---------------HHCHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH---------------HHCCC
T ss_conf 443224864247610268888884523233545558760488999887601899999999---------------87884
Q ss_pred HHHHHHHHHCCC------CCCC--------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999999750343------3012--------331238999999999999998702789999999889999
Q 004565 619 LLALELHEQRRY------LELA--------DSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 619 ~~~~~~~~~~~~------~~~~--------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
........... .... ...............+.+++.+|++.||.+|||++|+++
T Consensus 251 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 251 -DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp -HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -15555542254447430000033343311211552112448999999999986699568908999964
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.1e-44 Score=293.82 Aligned_cols=255 Identities=16% Similarity=0.183 Sum_probs=199.1
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCC-CCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 47987543575169999979-996999999515895008899999999801798-7113289999829833999950589
Q 004565 385 NFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIHH-VNLVRLKGFCAQGRQRFLVYEYMNK 462 (745)
Q Consensus 385 ~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~ 462 (745)
.+.++||+|+||.||+|+.. +++.||||.+.... ....+..|++.+..++| +|++.++++.......++|+||+ +
T Consensus 8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEC-C
T ss_conf 99799841788299999998899799999975025--82999999999999648999877999960188117999964-8
Q ss_pred CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEECCCCCCCCCCCCCC
Q ss_conf 9923330079854488899999999999988865079996062678999834559-----99739904788634799976
Q 004565 463 GSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHD-----KLQVKISDFGLSKLLTPEQS 537 (745)
Q Consensus 463 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~-----~~~~kl~Dfgl~~~~~~~~~ 537 (745)
++|.+++......+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 85 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCCCCC
T ss_conf 88799997520311068999999999999999997---796626677131523475434479568723660577146766
Q ss_pred C------CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 3------1002345667558322367988876555414799999873998997200024555688999999999999966
Q 004565 538 S------LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRE 611 (745)
Q Consensus 538 ~------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (745)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~------------------------ 217 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK------------------------ 217 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC------------------------
T ss_pred CCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC------------------------
T ss_conf 54111024676277510267989648888869998983199999986987678853------------------------
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 654328999999975034330123312389999999999999987027899999998899998506
Q 004565 612 SQRVYFPLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVSMLEG 677 (745)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 677 (745)
.. ............ +. ....+.+...++ ..+.+++..|+..+|++||+++.+.+.|+.
T Consensus 218 -~~-~~~~~~~~i~~~-~~-~~~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 218 -AA-TNKQKYERIGEK-KQ-STPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp -SC-CHHHHHHHHHHH-HH-HSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred -CH-HHHHHHHHHHHC-CC-CCCHHHHCCCCC----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf -02-199999999705-67-999589657998----999999999843993008599999999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=298.97 Aligned_cols=270 Identities=22% Similarity=0.256 Sum_probs=195.4
Q ss_pred CCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEE------CCEEEEEEE
Q ss_conf 87543575169999979-99699999951589--5008899999999801798711328999982------983399995
Q 004565 388 TPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQ------GRQRFLVYE 458 (745)
Q Consensus 388 ~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~------~~~~~lv~e 458 (745)
++||+|+||+||+|... ++..||||++.... ......+.+|+.+++.++||||+++++++.. ....++|+|
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEEEEEEE
T ss_conf 89621758599999999999899999988233697999999999999986489876489989702564345762699984
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 05899923330079854488899999999999988865079996062678999834559997399047886347999763
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
|+.++.+ ..+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.+..+|++|||+++......
T Consensus 103 y~~~~l~-~~~~~---~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~-- 173 (355)
T d2b1pa1 103 LMDANLC-QVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 173 (355)
T ss_dssp CCSEEHH-HHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCHHHH-HHHHC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCEEEECHHHHHCCCCCC--
T ss_conf 1446778-76503---89999999999999999988652---211245677632113654431320102321146665--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 10023456675583223679888765554147999998739989972000245556889999999999999666543289
Q 004565 539 LFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYFP 618 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (745)
..+...+|..|+|||++.+..++.++||||+||+++||++|+.||...........+....+..++.. ......
T Consensus 174 ~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~------~~~~~~ 247 (355)
T d2b1pa1 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF------MKKLQP 247 (355)
T ss_dssp -------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH------HTTSCH
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH------HHHHHH
T ss_conf 53322146555581331477778774333566257898659899888977889999997205898799------987656
Q ss_pred HHHHHHHHHC-CCC-----CCCCCCCCC---CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9999997503-433-----012331238---999999999999998702789999999889999
Q 004565 619 LLALELHEQR-RYL-----ELADSRIEG---QVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS 673 (745)
Q Consensus 619 ~~~~~~~~~~-~~~-----~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 673 (745)
. ........ ... ......... .........+.+++.+|++.||++|||++|+++
T Consensus 248 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 248 T-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp H-HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-HHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 6-77776417543566642126433354321013337999999999987699457908999966
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=288.51 Aligned_cols=273 Identities=21% Similarity=0.238 Sum_probs=193.1
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCCEEEEEEEEEEC-----CEEEEEEE
Q ss_conf 987543575169999979-99699999951589--50088999999998017987113289999829-----83399995
Q 004565 387 NTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFG--IQGKKEFCTEITIIGNIHHVNLVRLKGFCAQG-----RQRFLVYE 458 (745)
Q Consensus 387 ~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e 458 (745)
.++||+|+||+||+|... +++.||||++.... ....+.+.+|+++++.++|+|++++++++... ...+++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEEEEEE
T ss_conf 88983178839999999999979999998820028689999999999998668987425999996346456686499999
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 05899923330079854488899999999999988865079996062678999834559997399047886347999763
Q 004565 459 YMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTPEQSS 538 (745)
Q Consensus 459 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~~~~~ 538 (745)
++.+|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++......
T Consensus 103 ~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~--- 174 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 174 (348)
T ss_dssp ECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTGG---
T ss_pred EECCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCC---
T ss_conf 62588623200224--53099999999999999999973---88765166776334554322001321000125754---
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 10023456675583223679-88876555414799999873998997200024555688999999999999966654328
Q 004565 539 LFTTMRGTRGYLAPEWLTSS-AISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGNGPSSSSSPRESQRVYF 617 (745)
Q Consensus 539 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (745)
.....|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||...........+....+..+... . ......
T Consensus 175 -~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~-~---~~~~~~ 249 (348)
T d2gfsa1 175 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL-L---KKISSE 249 (348)
T ss_dssp -GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH-H---TTCCCH
T ss_pred -CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH-H---HHCCCH
T ss_conf -44434543555835533775678551243205899999768899788988999999997307997577-3---200102
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHCC
Q ss_conf 99999997503433012331238999999999999998702789999999889999--8506
Q 004565 618 PLLALELHEQRRYLELADSRIEGQVSDEDVEKLVRIALCCVQEEPMLRPSMANVVS--MLEG 677 (745)
Q Consensus 618 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~--~L~~ 677 (745)
....... .........+.. ........+.+++.+|++.||.+|||+.|+++ .+..
T Consensus 250 --~~~~~~~--~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 250 --SARNYIQ--SLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp --HHHHHHT--TSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred --HHHHHHH--HCCCCCCCCHHH-HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf --4454443--035578755566-26789999999999977588345938999855995487
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-39 Score=264.86 Aligned_cols=269 Identities=19% Similarity=0.190 Sum_probs=189.4
Q ss_pred HCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHCCCC-----------CCCEEEEEEEEEE--
Q ss_conf 047987543575169999979-99699999951589500889999999980179-----------8711328999982--
Q 004565 384 DNFNTPIGSGGFGTVYKGILQ-DKSVVAVKKINSFGIQGKKEFCTEITIIGNIH-----------HVNLVRLKGFCAQ-- 449 (745)
Q Consensus 384 ~~f~~~ig~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~g~~~~-- 449 (745)
+.+.++||+|+||.||+|+.. +++.||||+++... ...+.+.+|+++++.++ |+|++++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 799899750778189999999999799999983431-3368999999999984014555554227676478998763125
Q ss_pred CCEEEEEEEECCCCCHHH--HHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCC------E
Q ss_conf 983399995058999233--30079854488899999999999988865079996062678999834559997------3
Q 004565 450 GRQRFLVYEYMNKGSLDR--TLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQ------V 521 (745)
Q Consensus 450 ~~~~~lv~e~~~~gsL~~--~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~------~ 521 (745)
....+++++++..+.... ........+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++. +
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred CCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHEEEECCCCCCCCCEE
T ss_conf 65202343200035420000012234678689999999999999888764--0586465677057056305765644305
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99047886347999763100234566755832236798887655541479999987399899720002455568899999
Q 004565 522 KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLLEIISGRKNSSLKIQSRSTEKDSSGDGN 601 (745)
Q Consensus 522 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~ 601 (745)
+++|||.+....... ....|+..|+|||.+....++.++||||+|++++||++|+.||.........
T Consensus 172 kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~--------- 238 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT--------- 238 (362)
T ss_dssp EECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred EEEECCCCCCCCCCC----CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC---------
T ss_conf 675314421234454----2236652105713214667776432012378999998788998987554321---------
Q ss_pred CCCCCCCCCCCCCCCHHHHHHH-------HHHH-CC---------CCCCC-C---------CCCCCCCCHHHHHHHHHHH
Q ss_conf 9999999966654328999999-------9750-34---------33012-3---------3123899999999999999
Q 004565 602 GPSSSSSPRESQRVYFPLLALE-------LHEQ-RR---------YLELA-D---------SRIEGQVSDEDVEKLVRIA 654 (745)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~---------~~~~~-d---------~~l~~~~~~~~~~~l~~l~ 654 (745)
.....+...... .... .. ..... . ..............+.+++
T Consensus 239 ----------~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 308 (362)
T d1q8ya_ 239 ----------KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308 (362)
T ss_dssp ----------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred ----------CHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHH
T ss_conf ----------0268999999983799878862453220001320122024323577644421000156743589999999
Q ss_pred HHCCCCCCCCCCCHHHHHH--HHCCC
Q ss_conf 8702789999999889999--85069
Q 004565 655 LCCVQEEPMLRPSMANVVS--MLEGG 678 (745)
Q Consensus 655 ~~cl~~~p~~RPt~~evl~--~L~~~ 678 (745)
..|++.||.+|||++|+++ .++..
T Consensus 309 ~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 309 SPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp GGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 99877994579089999669340789
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.2e-22 Score=158.56 Aligned_cols=169 Identities=15% Similarity=0.130 Sum_probs=119.5
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCC------------------CHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 7987543575169999979996999999515895------------------0088999999998017987113289999
Q 004565 386 FNTPIGSGGFGTVYKGILQDKSVVAVKKINSFGI------------------QGKKEFCTEITIIGNIHHVNLVRLKGFC 447 (745)
Q Consensus 386 f~~~ig~G~fg~Vy~g~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~g~~ 447 (745)
..++||+|+||.||+|...++..||||.++.... ........|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC
T ss_conf 27780248565999999799999999998604434666556563000888999999778999999981699914499862
Q ss_pred EECCEEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 82983399995058999233300798544888999999999999888650799960626789998345599973990478
Q 004565 448 AQGRQRFLVYEYMNKGSLDRTLFGNGSVLEWRERFEIALGTARGLAYLHTGCDHKIIHCDVKPENILLHDKLQVKISDFG 527 (745)
Q Consensus 448 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dik~~NIlld~~~~~kl~Dfg 527 (745)
. .+++||++++..+.. ++......++.|++.++.|||+ .+|+||||||+|||++++ .++|+|||
T Consensus 84 ~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 84 G----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp T----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred C----CEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHEEEECC-CEEEEECC
T ss_conf 8----889999504565420--------0157899999999999999826---888983689036114289-89998778
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHH
Q ss_conf 86347999763100234566755832236798887655541479999
Q 004565 528 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTSSAISDKTDVYSYGMVLL 574 (745)
Q Consensus 528 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvll~ 574 (745)
+|........... ...... .-.+++ ...++.++|+||..--++
T Consensus 148 ~a~~~~~~~~~~~--l~rd~~-~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 148 QSVEVGEEGWREI--LERDVR-NIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TCEETTSTTHHHH--HHHHHH-HHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCHHH--HHHHHH-HHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 8430899870999--987799-999997-578998446899999874
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.62 E-value=2.3e-07 Score=61.27 Aligned_cols=110 Identities=20% Similarity=0.228 Sum_probs=69.8
Q ss_pred CCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEEE-CCCCCEECCCCCEEECCCCCCCCCCCCCCEEEEEECCCCEEEEC
Q ss_conf 75202698138998365226668887410899997-38961001200000035531122389998026896244138980
Q 004565 35 TDAIVTGQTLRVGKSLAASVSENDLSVGEYSFVVT-DGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLA 113 (745)
Q Consensus 35 tDtllpg~kl~~~~~L~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 113 (745)
||||+|||.|..++.|++ |.|.|.++ |++.+++.++.++|.+.... ........+..+|...+.
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~~~~vW~s~~~~------~~~~~~l~l~~dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNNRAVWASGTNG------KASGCVLKMQNDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEETTEEEEECCCTT------SCSSEEEEECTTSCEEEE
T ss_pred CCEECCCCEECCCCEEEE---------CCEEEEECCCCCEEEECCCCEEEECCCCC------CCCCCEEEEECCCCEEEE
T ss_conf 989069999559999987---------87999981799889873983899846734------788857999615349999
Q ss_pred CCCCEEEEEECCCCCCEEEEEECCCCEEEEEEECCCCEEEEEECCCCCC
Q ss_conf 3896699998047550289976488419999970873069872145575
Q 004565 114 SDGSRFVLKVSLDAAGFRIAKLEPSGRLIVSKLVGDNLVQELAIPVENC 162 (745)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~~~~~~w~~~~~~p~~~C 162 (745)
+.+............+..+++|..||+|++|.- .....|+...+.|
T Consensus 66 ~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~---~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 66 SGSRAIWASNTNRQNGNYYLILQRDRNVVIYDN---SNNAIWATHTNVG 111 (112)
T ss_dssp ETTEEEEECCCCCSCCCCEEEECTTSCEEEECT---TSCEEEECCCCCC
T ss_pred ECCCEEEEEEECCCCCCEEEEECCCCCEEEECC---CCCEEECCCCCCC
T ss_conf 348749998303688725999967899999989---9967961888569
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.62 E-value=4.9e-08 Score=65.63 Aligned_cols=110 Identities=17% Similarity=0.211 Sum_probs=68.4
Q ss_pred CCEEEEECCCCCEE--ECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEEE-CCCCCEECCCCCEEECCCCCCC
Q ss_conf 45899917997201--10578975202698138998365226668887410899997-3896100120000003553112
Q 004565 15 GNLVLLDARNVSLW--QSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYSFVVT-DGDGVLQWNQMTYWKLSMYSYA 91 (745)
Q Consensus 15 GNlvl~~~~~~~~W--qSFd~PtDtllpg~kl~~~~~L~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~yw~~~~~~~~ 91 (745)
||+|+++..+.++| +++|.|+++|.++|.|.. |.|+|.++ |++.+++..+..+|.+...
T Consensus 1 g~~v~~~~~n~il~~~~~~~~~~~~l~~~q~l~~---------------g~y~L~~q~DGNLvL~~~~~~vW~s~t~--- 62 (120)
T d1dlpa2 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQL---------------SPYRLSMETDCNLVLFDRDDRVWSTNTA--- 62 (120)
T ss_dssp SCCCCSSCCCEECCCC--CCCCCCEECSSCCCBC---------------SSCEEEEETTTEEEEEBTTBCCSCCCCC---
T ss_pred CCEEEEECCCEEEECCCCCCCCCCEECCCCEEEC---------------CCEEEEECCCCCEEEECCCCEEEEECCC---
T ss_conf 9687872898699828988885628839972174---------------8879999689838996499689997522---
Q ss_pred CCCCCCCEEEEEECCCCEEEECCC-CCEEEEEECCCCCCEEEEEECCCCEEEEEE
Q ss_conf 238999802689624413898038-966999980475502899764884199999
Q 004565 92 FKDSDAPVSFLSVNRTGLYLLASD-GSRFVLKVSLDAAGFRIAKLEPSGRLIVSK 145 (745)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~ 145 (745)
.........+..+|...+.+. +.......+....+..+++|++||++++|.
T Consensus 63 ---~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 63 ---GKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG 114 (120)
T ss_dssp ---SSCSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC
T ss_pred ---CCCCCEEEEEECCEEEEEECCCCCEEEEECCCCCCCCEEEEECCCCCEEEEC
T ss_conf ---4777479999077649999299988998199999984899988898699968
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=7.7e-07 Score=57.98 Aligned_cols=132 Identities=14% Similarity=0.041 Sum_probs=87.9
Q ss_pred CCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHCCCC-CCCEEEEEEEEEECCEEEEEEEECCCCCHHHHHCC
Q ss_conf 57516999997999699999951589500889999999980179-87113289999829833999950589992333007
Q 004565 393 GGFGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIH-HVNLVRLKGFCAQGRQRFLVYEYMNKGSLDRTLFG 471 (745)
Q Consensus 393 G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 471 (745)
+....||+....+ ..+.+|+...........+..|...+..+. +-.+.+++.+..+.+..++||+++++.++......
T Consensus 25 ~s~~~v~rv~~~~-~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVGEN-ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEECSS-CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCCEEEEEECC-CEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCCCCC
T ss_conf 9877189999089-869999848876532556999999999876069987289997508964999986043343543344
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------------
Q ss_conf 985448889999999999998886507-----------------------------------------------------
Q 004565 472 NGSVLEWRERFEIALGTARGLAYLHTG----------------------------------------------------- 498 (745)
Q Consensus 472 ~~~~l~~~~~~~i~~~ia~~l~yLH~~----------------------------------------------------- 498 (745)
.. ....++.++++.++.||+.
T Consensus 104 ~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 104 EQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp CS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred CC------CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHC
T ss_conf 02------699999989999999855684214357644656555778998776555543033232005799999999844
Q ss_pred ---CCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf ---999606267899983455999739904788634
Q 004565 499 ---CDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 499 ---~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~ 531 (745)
....++|+|+.+.||+++++...-|+||+.+..
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.21 E-value=1.8e-05 Score=49.22 Aligned_cols=130 Identities=18% Similarity=0.099 Sum_probs=82.7
Q ss_pred CCCCC-CEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHCCCC--CCCEEEEEEEEEECCEEEEEEEECCCCCHH
Q ss_conf 54357-516999997999699999951589500889999999980179--871132899998298339999505899923
Q 004565 390 IGSGG-FGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIH--HVNLVRLKGFCAQGRQRFLVYEYMNKGSLD 466 (745)
Q Consensus 390 ig~G~-fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 466 (745)
+..|. ...||+....++..+.+|...... ...+..|.+.++.+. .-.+.+++++..+.+..++|++++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCCC
T ss_conf 678654775899993898789999589667---76899999999999865999886132224566159998744135543
Q ss_pred HHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q ss_conf 3300798544888999999999999888650-------------------------------------------------
Q 004565 467 RTLFGNGSVLEWRERFEIALGTARGLAYLHT------------------------------------------------- 497 (745)
Q Consensus 467 ~~l~~~~~~l~~~~~~~i~~~ia~~l~yLH~------------------------------------------------- 497 (745)
.... .. ..++.++++.|.-||+
T Consensus 95 ~~~~------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 95 SSHL------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp TSCC------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred CCCC------CH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHH
T ss_conf 2212------68---99999999999987368854488755412468899999987541101134011213799999999
Q ss_pred --C----CCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf --7----999606267899983455999739904788634
Q 004565 498 --G----CDHKIIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 498 --~----~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~ 531 (745)
. ....++|+|+.+.|||++++..+-|+||+.+..
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 8718765795678678887635773796589998533265
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.12 E-value=7.1e-06 Score=51.82 Aligned_cols=102 Identities=15% Similarity=0.183 Sum_probs=65.5
Q ss_pred EEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEEE-CCCCCEECCCCCEEECCCCCCCCCCCCCCEEEEEEC
Q ss_conf 0110578975202698138998365226668887410899997-389610012000000355311223899980268962
Q 004565 27 LWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYSFVVT-DGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVN 105 (745)
Q Consensus 27 ~WqSFd~PtDtllpg~kl~~~~~L~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~ 105 (745)
.||++|.|.+||-++|.|.. ..+.|.|+|.|+ |++.+++..+.++|.+.... .....+..+.
T Consensus 6 s~~~~~~~~~~l~~~q~l~~-----------~~~~~~y~l~mQ~DGNLVLy~~~~~vWssnt~~------~~~~~~l~l~ 68 (119)
T d1b2pa_ 6 SKQPDDNHPQILHATESLEI-----------LFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGG------LGNGCRAVLQ 68 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEE-----------EETTEEEEEEECTTSCEEEEETTEEEEECCCTT------SCSSCEEEEC
T ss_pred EEECCCCCCCEEECCCEEEE-----------ECCCCEEEEEECCCCCEEEEECCEEEEEECCCC------CCCCEEEEEE
T ss_conf 61017799888828975887-----------047853899988998299997996799946788------7741699998
Q ss_pred CCCEEEECC-CCCEEEEEECCCCCCEEEEEECCCCEEEEEE
Q ss_conf 441389803-8966999980475502899764884199999
Q 004565 106 RTGLYLLAS-DGSRFVLKVSLDAAGFRIAKLEPSGRLIVSK 145 (745)
Q Consensus 106 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~ 145 (745)
.+|...+.+ ++..+....+.......+++|+.||+|++|.
T Consensus 69 ~dGnLvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg 109 (119)
T d1b2pa_ 69 PDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp TTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE
T ss_pred ECCCEEEECCCCCEEEECCCCCCCCCEEEEECCCCCEEEEC
T ss_conf 37779998999857997887699886599996998899979
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.07 E-value=3.2e-06 Score=54.08 Aligned_cols=51 Identities=31% Similarity=0.535 Sum_probs=26.6
Q ss_pred CEEEEECCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEEECCCCCEECCCCCEE
Q ss_conf 25599416458999179972011057897520269813899836522666888741089999738961001200000
Q 004565 7 SSMQLQESGNLVLLDARNVSLWQSFDSPTDAIVTGQTLRVGKSLAASVSENDLSVGEYSFVVTDGDGVLQWNQMTYW 83 (745)
Q Consensus 7 ~~~~lld~GNlvl~~~~~~~~WqSFd~PtDtllpg~kl~~~~~L~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~yw 83 (745)
++|+|+++|||||++.++.++|||| ++.+.|.|.+.+ +++|.+...+..+|
T Consensus 68 ~~~~l~~~GnLvl~d~~~~~lW~S~-------------------------t~~~~~~~~l~L-q~DGnlvlY~~~~W 118 (120)
T d1dlpa2 68 CRAVLQPNGRMDVLTNQNIAVWTSG-------------------------NSRSAGRYVFVL-QPDRNLAIYGGALW 118 (120)
T ss_dssp CEEEEETTTEEEEEETTTEEEEECC-------------------------CCCSSSCCEEEE-CSSSCEEEECCCCC
T ss_pred EEEEEECCEEEEEECCCCCEEEEEC-------------------------CCCCCCCEEEEE-CCCCCEEEECCCCC
T ss_conf 7999907764999929998899819-------------------------999998489998-88986999689743
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.02 E-value=9.9e-07 Score=57.30 Aligned_cols=27 Identities=33% Similarity=0.513 Sum_probs=13.6
Q ss_pred CCCCEEEEECCCCEEEEECCCCCEEECC
Q ss_conf 7642559941645899917997201105
Q 004565 4 SRVSSMQLQESGNLVLLDARNVSLWQSF 31 (745)
Q Consensus 4 ~~~~~~~lld~GNlvl~~~~~~~~WqSF 31 (745)
.+..++.|.+.|||||.+ .+..+|+|.
T Consensus 25 ~g~~~l~~q~DGNLvL~~-~~~~vW~s~ 51 (115)
T d1dlpa1 25 LSSFRFTMQSDCNLVLFD-SDVRVWASN 51 (115)
T ss_dssp STTEEEEECTTSCEEEEE-SSSEEECCC
T ss_pred CCCEEEEECCCCEEEEEC-CCEEEEECC
T ss_conf 598899997998399981-990689711
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=6.9e-05 Score=45.56 Aligned_cols=142 Identities=15% Similarity=0.106 Sum_probs=78.6
Q ss_pred CCCCCCCCEEEEEEEECC-CCEEEEEEECCC----C---CCHHHHHHHHHHHHCCC-CC--CCEEEEEEEEEECCEEEEE
Q ss_conf 875435751699999799-969999995158----9---50088999999998017-98--7113289999829833999
Q 004565 388 TPIGSGGFGTVYKGILQD-KSVVAVKKINSF----G---IQGKKEFCTEITIIGNI-HH--VNLVRLKGFCAQGRQRFLV 456 (745)
Q Consensus 388 ~~ig~G~fg~Vy~g~~~~-~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l-~h--~niv~l~g~~~~~~~~~lv 456 (745)
+.||.|....||+....+ +..+++|.-... . .........|++.+..+ .+ ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf 9807985276899995799848999617713034677788877899999999998650579885528998--59887798
Q ss_pred EEECCCCCHH-HHHCCCCCCCCHHHHHHHHHHHH----------------------------------------------
Q ss_conf 9505899923-33007985448889999999999----------------------------------------------
Q 004565 457 YEYMNKGSLD-RTLFGNGSVLEWRERFEIALGTA---------------------------------------------- 489 (745)
Q Consensus 457 ~e~~~~gsL~-~~l~~~~~~l~~~~~~~i~~~ia---------------------------------------------- 489 (745)
||++++..+. ..+..... .......++..++
T Consensus 110 mE~L~~~~~~~~~l~~~~~--~~~~a~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~~~ 187 (392)
T d2pula1 110 MEDLSHLKIARKGLIEGEN--YPHLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDT 187 (392)
T ss_dssp ECCCTTSEEHHHHHHHTCC--CTTHHHHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTCTT
T ss_pred EECCCCCCCCHHHHCCCCH--HHHHHHHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHHHH
T ss_conf 7135776530222015421--28999999999999998735033442111012334465788877776401047889887
Q ss_pred ---------------------HHHHHHH---HCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCC
Q ss_conf ---------------------9988865---07999606267899983455999739904788634799
Q 004565 490 ---------------------RGLAYLH---TGCDHKIIHCDVKPENILLHDKLQVKISDFGLSKLLTP 534 (745)
Q Consensus 490 ---------------------~~l~yLH---~~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~~~~~ 534 (745)
..+..|. ......++|+|+.+.|||++++ .++|+||..+..-..
T Consensus 188 ~~~~~~~~~~~~~l~~d~~l~~~~~~l~~~~~~~~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G~~ 255 (392)
T d2pula1 188 NDFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIFASEH-ETKVIDPEFAFYGPI 255 (392)
T ss_dssp CCCCGGGHHHHHHHHTCHHHHHHHHHHHHHHHHBCCEEECSCCCGGGEEECSS-CEEECCCTTCEEECT
T ss_pred HHCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCEECCCCCCCCEEECCC-CEEEECHHHCCCCCH
T ss_conf 41065455778765520789999999874323688600335776784667599-308952265222878
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=97.90 E-value=5.7e-05 Score=46.06 Aligned_cols=95 Identities=18% Similarity=0.273 Sum_probs=59.9
Q ss_pred CCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEEE-CCCCCEECCCCCEEECCCCCCCCCCCCCCEEEEEECCCCEEEEC-
Q ss_conf 5202698138998365226668887410899997-38961001200000035531122389998026896244138980-
Q 004565 36 DAIVTGQTLRVGKSLAASVSENDLSVGEYSFVVT-DGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLA- 113 (745)
Q Consensus 36 Dtllpg~kl~~~~~L~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 113 (745)
|||+|||.|..+..|. .|.|+|.++ |++.+++....++|.+.... .....+..+..+|...+.
T Consensus 2 ~~L~~g~~L~~G~~l~---------ng~~~l~~q~DGNLvly~~~~~vW~s~~~~------~~~~~~l~l~~~Gnlvl~~ 66 (108)
T d1jpca_ 2 NILYSGETLSTGEFLN---------YGSFVFIMQEDCNLVLYDVDKPIWATNTGG------LSRSCFLSMQTDGNLVVYN 66 (108)
T ss_dssp CEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEETTEEEEECCCTT------SCSSCEEEECTTSCEEEEC
T ss_pred CCCCCCCEECCCCEEE---------CCCEEEEECCCCEEEEEECCCEEEEECCCC------CCCCCEEEEECCCEEEEEC
T ss_conf 9956997726999897---------288899987898099970990215707889------9875479981260399977
Q ss_pred CCCCEEEEEECCCCCCEEEEEECCCCEEEEEE
Q ss_conf 38966999980475502899764884199999
Q 004565 114 SDGSRFVLKVSLDAAGFRIAKLEPSGRLIVSK 145 (745)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~ 145 (745)
.++..+....+.......+++|..||+|++|.
T Consensus 67 ~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~ 98 (108)
T d1jpca_ 67 PSNKPIWASNTGGQNGNYVCILQKDRNVVIYG 98 (108)
T ss_dssp TTCCEEEECCCCCSCSCEEEEECTTSCEEEEE
T ss_pred CCCCCEEECCCCCCCCCEEEEECCCCCEEEEC
T ss_conf 98551277045588876799996888999969
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=97.78 E-value=0.0001 Score=44.47 Aligned_cols=96 Identities=18% Similarity=0.294 Sum_probs=59.7
Q ss_pred CCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEEE-CCCCCEECCCCCEEECCCCCCCCCCCCCCEEEEEECCCCEEEECC
Q ss_conf 5202698138998365226668887410899997-389610012000000355311223899980268962441389803
Q 004565 36 DAIVTGQTLRVGKSLAASVSENDLSVGEYSFVVT-DGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLAS 114 (745)
Q Consensus 36 Dtllpg~kl~~~~~L~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (745)
|||.|||.|..+..|++ |.|+|.++ |++.+++.+..++|.+..-. ............+|...+.+
T Consensus 2 ~~L~~g~~L~~g~~l~~---------g~~~l~~q~dgnLvl~~~~~~vW~ant~~-----~~~~~~~l~l~~dGnLvl~~ 67 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLYDHSTSVWASNTGI-----LGKKGCKAVLQSDGNFVVYD 67 (109)
T ss_dssp CEEETTCEEETTCEEEE---------TTEEEEECTTSCEEEEETTEEEEECCCCC-----TTCCCCEEEECTTSCEEEEC
T ss_pred CCCCCCCEEECCCEEEE---------CCEEEEECCCCEEEEEECCEEEEEECCCC-----CCCEEEEEEECCCCEEEEEE
T ss_conf 89259998828998983---------78899944898699986998999837899-----87510799993796099990
Q ss_pred -CCCEEEEEECCCCCCEEEEEECCCCEEEEEE
Q ss_conf -8966999980475502899764884199999
Q 004565 115 -DGSRFVLKVSLDAAGFRIAKLEPSGRLIVSK 145 (745)
Q Consensus 115 -~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~ 145 (745)
++..+....+....+..+++|..||+|++|.
T Consensus 68 ~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~ 99 (109)
T d1kj1a_ 68 AEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG 99 (109)
T ss_dssp SSSCEEEECCCCCCSSCCEEEECTTSCEEEEC
T ss_pred CCCCEEEEEEEECCCCCEEEEEECCCCEEEEC
T ss_conf 89867999730889997799994797599979
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.36 E-value=0.00092 Score=38.38 Aligned_cols=134 Identities=11% Similarity=0.044 Sum_probs=73.1
Q ss_pred CEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCE--EEEEE-----EEEECCEEEEEEEECCCCCHHH
Q ss_conf 5169999979996999999515895008899999999801798711--32899-----9982983399995058999233
Q 004565 395 FGTVYKGILQDKSVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNL--VRLKG-----FCAQGRQRFLVYEYMNKGSLDR 467 (745)
Q Consensus 395 fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lv~e~~~~gsL~~ 467 (745)
--.||++...+|..+++|..... ....+++..|...+..+....+ +..+. ........+.+++++++..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred CCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf 20269998389997999984787-78899999999999999855998787520689805665347999986527768899
Q ss_pred ----HHC--------------C----CCCCCCH-------------------H---HHHHHHHHHHHHHHHH-HHCCCCC
Q ss_conf ----300--------------7----9854488-------------------8---9999999999998886-5079996
Q 004565 468 ----TLF--------------G----NGSVLEW-------------------R---ERFEIALGTARGLAYL-HTGCDHK 502 (745)
Q Consensus 468 ----~l~--------------~----~~~~l~~-------------------~---~~~~i~~~ia~~l~yL-H~~~~~~ 502 (745)
.+. . .+..+++ . .....+..+...+.-. .+....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 99999999899999988630357865567789788766568999874769988989999999999999998454568712
Q ss_pred EEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 06267899983455999739904788634
Q 004565 503 IIHCDVKPENILLHDKLQVKISDFGLSKL 531 (745)
Q Consensus 503 i~H~dik~~NIlld~~~~~kl~Dfgl~~~ 531 (745)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 0247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.17 E-value=0.0011 Score=37.89 Aligned_cols=73 Identities=16% Similarity=0.191 Sum_probs=43.9
Q ss_pred CCCCCCCCEEEEEEEECCC--------CEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCE-EEEEEEEEECCEEEEEEE
Q ss_conf 8754357516999997999--------6999999515895008899999999801798711-328999982983399995
Q 004565 388 TPIGSGGFGTVYKGILQDK--------SVVAVKKINSFGIQGKKEFCTEITIIGNIHHVNL-VRLKGFCAQGRQRFLVYE 458 (745)
Q Consensus 388 ~~ig~G~fg~Vy~g~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 458 (745)
+.|+.|-.-.+|+....++ ..|.++.... . ........|.++++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-C-CHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf 9917853343489996887754457898179996599-6-1165899999999999757999808998189----56999
Q ss_pred ECCCCCHH
Q ss_conf 05899923
Q 004565 459 YMNKGSLD 466 (745)
Q Consensus 459 ~~~~gsL~ 466 (745)
|+++..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EECCCCCC
T ss_conf 73455488
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=96.76 E-value=0.0018 Score=36.52 Aligned_cols=29 Identities=38% Similarity=0.530 Sum_probs=21.7
Q ss_pred CCCCCEEEEECCCCEEEEECCCCCEEECCC
Q ss_conf 776425599416458999179972011057
Q 004565 3 DSRVSSMQLQESGNLVLLDARNVSLWQSFD 32 (745)
Q Consensus 3 ~~~~~~~~lld~GNlvl~~~~~~~~WqSFd 32 (745)
.++.-.+.|...|||||.. .+..+|+|.-
T Consensus 17 ~~g~~~l~~q~dgnLvl~~-~~~~vW~ant 45 (109)
T d1kj1a_ 17 DVEPYHFIMQEDCNLVLYD-HSTSVWASNT 45 (109)
T ss_dssp EETTEEEEECTTSCEEEEE-TTEEEEECCC
T ss_pred EECCEEEEECCCCEEEEEE-CCEEEEEECC
T ss_conf 8378899944898699986-9989998378
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=96.60 E-value=0.0039 Score=34.40 Aligned_cols=27 Identities=30% Similarity=0.459 Sum_probs=21.3
Q ss_pred CEEEEECCCCEEEEECCCCCEEECCCCC
Q ss_conf 2559941645899917997201105789
Q 004565 7 SSMQLQESGNLVLLDARNVSLWQSFDSP 34 (745)
Q Consensus 7 ~~~~lld~GNlvl~~~~~~~~WqSFd~P 34 (745)
=.+.|+..|||||.+. +..+|+|..+.
T Consensus 32 y~l~mQ~DGNLVLy~~-~~~vWssnt~~ 58 (119)
T d1b2pa_ 32 YRFIMQTDCNLVLYDN-NNPIWATNTGG 58 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTT
T ss_pred EEEEECCCCCEEEEEC-CEEEEEECCCC
T ss_conf 8999889982999979-96799946788
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=96.45 E-value=0.0046 Score=33.92 Aligned_cols=29 Identities=28% Similarity=0.396 Sum_probs=23.2
Q ss_pred CCCEEEEECCCCEEEEECCCCCEEECCCCC
Q ss_conf 642559941645899917997201105789
Q 004565 5 RVSSMQLQESGNLVLLDARNVSLWQSFDSP 34 (745)
Q Consensus 5 ~~~~~~lld~GNlvl~~~~~~~~WqSFd~P 34 (745)
+--++.|...|||||.+ .+..+|+|..++
T Consensus 19 g~~~l~~q~DGNLvly~-~~~~vW~s~~~~ 47 (108)
T d1jpca_ 19 GSFVFIMQEDCNLVLYD-VDKPIWATNTGG 47 (108)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTT
T ss_pred CCEEEEECCCCEEEEEE-CCCEEEEECCCC
T ss_conf 88899987898099970-990215707889
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.00 E-value=0.033 Score=28.47 Aligned_cols=33 Identities=18% Similarity=0.278 Sum_probs=28.7
Q ss_pred CCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 799960626789998345599973990478863
Q 004565 498 GCDHKIIHCDVKPENILLHDKLQVKISDFGLSK 530 (745)
Q Consensus 498 ~~~~~i~H~dik~~NIlld~~~~~kl~Dfgl~~ 530 (745)
....+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 180 ~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 180 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 454503337863656402045412674222123
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=95.36 E-value=0.0082 Score=32.32 Aligned_cols=78 Identities=14% Similarity=0.194 Sum_probs=42.4
Q ss_pred CCCEEEEEE-CCCCCEECCCCCEEECCCCCCCCCCCCCCEEEEEECCCCEEEECC-CCCEEEEEECCCCCCEEEEEECCC
Q ss_conf 410899997-389610012000000355311223899980268962441389803-896699998047550289976488
Q 004565 61 VGEYSFVVT-DGDGVLQWNQMTYWKLSMYSYAFKDSDAPVSFLSVNRTGLYLLAS-DGSRFVLKVSLDAAGFRIAKLEPS 138 (745)
Q Consensus 61 ~G~~~~~~~-~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~ 138 (745)
.|.|+|.++ |++.+++.++..+|.+.... ....+..+..+|..++.+ ++..+....+....+..+++|+.|
T Consensus 25 ~g~~~l~~q~DGNLvL~~~~~~vW~s~t~~-------~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l~Lq~D 97 (115)
T d1dlpa1 25 LSSFRFTMQSDCNLVLFDSDVRVWASNTAG-------ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPD 97 (115)
T ss_dssp STTEEEEECTTSCEEEEESSSEEECCCCCS-------CSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSS
T ss_pred CCCEEEEECCCCEEEEECCCEEEEECCCCC-------CCCEEEEEECCCCEEEECCCCCEEEECCCCCCCCCEEEEECCC
T ss_conf 598899997998399981990689711689-------9756899944678999905897899818889999789999899
Q ss_pred CEEEEEE
Q ss_conf 4199999
Q 004565 139 GRLIVSK 145 (745)
Q Consensus 139 G~l~~~~ 145 (745)
|++++|.
T Consensus 98 GNlvlY~ 104 (115)
T d1dlpa1 98 RTVTIYG 104 (115)
T ss_dssp SCEEEEC
T ss_pred CCEEEEC
T ss_conf 8699968
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=94.92 E-value=0.037 Score=28.20 Aligned_cols=30 Identities=30% Similarity=0.354 Sum_probs=23.2
Q ss_pred CCCCEEEEECCCCEEEEECCCCCEEECCCCC
Q ss_conf 7642559941645899917997201105789
Q 004565 4 SRVSSMQLQESGNLVLLDARNVSLWQSFDSP 34 (745)
Q Consensus 4 ~~~~~~~lld~GNlvl~~~~~~~~WqSFd~P 34 (745)
++.-.+.|.+.|||||.. .+..+|+|...+
T Consensus 18 ~g~~~l~~q~DGNLvly~-~~~~vW~s~~~~ 47 (112)
T d1xd5a_ 18 EGGYLFIIQNDCNLVLYD-NNRAVWASGTNG 47 (112)
T ss_dssp ETTEEEEECTTSCEEEEE-TTEEEEECCCTT
T ss_pred ECCEEEEECCCCCEEEEC-CCCEEEECCCCC
T ss_conf 787999981799889873-983899846734
|